Name,Term,ES,NES,NOM p-val,FDR q-val,FWER p-val,Tag %,Gene %,Lead_genes
prerank,collagen fibril organization (GO:0030199),0.7417138656882171,2.1762584329720265,0.0,0.0,0.0,32/88,8.31%,COL15A1;COL4A1;COL27A1;COL1A2;CYP1B1;COL24A1;COL18A1;COL4A2;COL7A1;COL1A1;COL3A1;LUM;TLL2;COL6A3;COL8A1;COL5A2;COL23A1;COL5A3;COL11A2;COL13A1;PLOD2;COL5A1;ADAMTS2;DPT;COL11A1;DDR2;BMP1;SERPINH1;LOXL1;PXDN;NF1;TGFBR1
prerank,extracellular structure organization (GO:0043062),0.6799406634329614,2.1253456468976317,0.0,0.0010300230994777645,0.002,67/204,8.45%,MMP3;MMP13;COL15A1;COL4A1;MMP27;COL27A1;COL1A2;COL24A1;IBSP;COL18A1;DCN;COL4A2;COL7A1;COL1A1;COL3A1;LAMA2;MMP2;LUM;POSTN;FBN2;SPP1;ITGB8;COL6A3;COL8A1;COL5A2;SPARC;COL23A1;MMP14;LAMB1;HSPG2;COL5A3;ADAM19;LAMA1;LAMC1;COL11A2;BGN;ADAM12;MMP11;NID1;ST7;COL13A1;COL5A1;ITGB5;ADAMTS2;VTN;VCAN;FBN1;COL11A1;ITGA8;ADAMTSL2;ADAMTS5;DDR2;ADAMTS7;LAMC3;ICAM1;MMP12;ADAMTS1;LOXL1;PXDN;NF1;LAMA4;ADAMTS6;ADAMTS12;MMP17;TGFBR1;ADAMTS15;MMP16
prerank,external encapsulating structure organization (GO:0045229),0.6783716176324238,2.1193083597650593,0.0,0.0006866820663185096,0.002,66/205,8.45%,MMP3;MMP13;COL15A1;COL4A1;MMP27;COL27A1;COL1A2;COL24A1;IBSP;COL18A1;DCN;COL4A2;COL7A1;COL1A1;COL3A1;LAMA2;MMP2;LUM;POSTN;FBN2;SPP1;ITGB8;COL6A3;COL8A1;COL5A2;SPARC;COL23A1;MMP14;LAMB1;HSPG2;COL5A3;ADAM19;LAMA1;LAMC1;COL11A2;BGN;ADAM12;MMP11;NID1;ST7;COL13A1;COL5A1;ITGB5;ADAMTS2;VTN;VCAN;FBN1;COL11A1;ITGA8;ADAMTSL2;ADAMTS5;DDR2;ADAMTS7;LAMC3;ICAM1;MMP12;ADAMTS1;LOXL1;PXDN;NF1;LAMA4;ADAMTS6;ADAMTS12;MMP17;ADAMTS15;MMP16
prerank,extracellular matrix organization (GO:0030198),0.6671992773098706,2.1014322164416073,0.0,0.0005150115497388822,0.002,83/276,8.45%,MMP3;MMP13;COL15A1;COL4A1;MMP27;SCUBE1;COL27A1;COL1A2;CYP1B1;COL24A1;IBSP;COL18A1;DCN;COL4A2;COL7A1;COL1A1;COL3A1;LAMA2;MMP2;CREB3L1;LUM;GPM6B;POSTN;FBN2;SPP1;TLL2;ITGB8;COL6A3;COL8A1;COL5A2;SPARC;COL23A1;MMP14;LAMB1;SH3PXD2B;HSPG2;COL5A3;ADAM19;LAMA1;LAMC1;COL11A2;FLRT2;BGN;ADAM12;MMP11;NID1;ST7;COL13A1;PLOD2;COL5A1;ITGB5;ADAMTS2;LCP1;TIMP1;VTN;DPT;VCAN;FBN1;COL11A1;ITGA8;ADAMTSL2;ADAMTS5;DDR2;ADAMTS7;BMP1;CAPN2;LAMC3;ICAM1;MMP12;ADAMTS1;SERPINH1;LOXL1;CTSS;PXDN;KLK2;NF1;LAMA4;ADAMTS6;ADAMTS12;MMP17;TGFBR1;ADAMTS15;MMP16
prerank,cellular potassium ion homeostasis (GO:0030007),-0.7629642379251708,-2.0843822689043163,0.0031545741324921135,0.11068938459038948,0.105,5/13,2.41%,ATP1B3;SLC12A2;ATP1B1;ATP1A2;KCNJ2
prerank,cellular component disassembly (GO:0022411),0.7364972261501768,2.0676109954892024,0.0,0.0010300230994777645,0.004,21/53,10.11%,MMP3;MMP13;SCUBE1;MMP2;TLL2;MMP14;SH3PXD2B;LAMC1;MMP11;LCP1;TIMP1;ADAMTS5;BMP1;CAPN2;MMP12;CTSS;KLK2;ADAMTS15;MMP16;ADAMTS4;CTSK
prerank,extracellular matrix disassembly (GO:0022617),0.736179397642616,2.065050139331701,0.0,0.0008583525828981369,0.004,21/53,10.11%,MMP3;MMP13;SCUBE1;MMP2;TLL2;MMP14;SH3PXD2B;LAMC1;MMP11;LCP1;TIMP1;ADAMTS5;BMP1;CAPN2;MMP12;CTSS;KLK2;ADAMTS15;MMP16;ADAMTS4;CTSK
prerank,regulation of humoral immune response (GO:0002920),0.7439963368220331,2.0403547138388336,0.0,0.0016186077277507728,0.01,10/44,8.73%,C6;CFH;C3;SERPING1;PROS1;VTN;GATA6;FCGR2B;C7;C1QB
prerank,potassium ion homeostasis (GO:0055075),-0.6194473398140609,-2.0236935388919663,0.0,0.13633692492230898,0.24,7/23,3.73%,ATP1B3;SLC12A7;SLC12A2;ATP1B1;ATP1A2;KCNJ2;SLC12A6
prerank,negative regulation of immune effector process (GO:0002698),-0.7188863037110543,-2.002633597436315,0.0,0.11608886676553043,0.292,9/13,19.68%,CD55;FER;CD47;GRN;RPS19;RC3H1;HAVCR2;ENPP3;APPL1
prerank,regulation of complement activation (GO:0030449),0.7424702864221426,1.9996212961839237,0.0,0.006823903034040189,0.041,6/40,3.33%,C6;CFH;C3;SERPING1;PROS1;VTN
prerank,regulation of immune effector process (GO:0002697),0.7385876798419211,1.994275503189863,0.0,0.006637926641078927,0.045,9/41,8.73%,C6;CFH;C3;SERPING1;PROS1;VTN;FCGR2B;C7;C1QB
prerank,positive regulation of sodium ion transmembrane transport (GO:1902307),-0.7505050119639936,-1.993241755846718,0.0,0.09989042024010758,0.322,6/12,14.11%,DMD;ATP1B3;ATP1B1;WNK4;WNK3;FXYD1
prerank,regulation of vascular endothelial growth factor production (GO:0010574),0.7876795368765444,1.9913531773990714,0.0,0.00638614321676214,0.048,8/26,9.14%,RORA;CYP1B1;C3;SULF1;CCBE1;ARNT;EIF2AK3;HPSE
prerank,chemokine-mediated signaling pathway (GO:0070098),0.7312436016269138,1.9850621998995623,0.0,0.006648330914811025,0.055,9/42,8.47%,CCL11;CCL7;CXCL5;CXCL1;CXCL12;XCL1;CCR1;CCL5;CXCL10
prerank,endoderm formation (GO:0001706),0.7602440090690618,1.9818959590469973,0.0,0.0064376443717360276,0.058,11/35,3.76%,COL4A2;COL7A1;MMP2;COL8A1;MMP14;LAMB1;ITGB5;DUSP2;VTN;DUSP5;COL11A1
prerank,positive regulation of vascular endothelial growth factor production (GO:0010575),0.7947841159873127,1.978047434926273,0.0,0.00641783623520761,0.061,8/24,9.14%,RORA;CYP1B1;C3;SULF1;CCBE1;ARNT;EIF2AK3;HPSE
prerank,establishment of endothelial barrier (GO:0061028),-0.585609800153597,-1.941900111652244,0.0,0.14830577707720477,0.504,15/29,17.06%,TJP1;PECAM1;RAPGEF3;TJP2;EZR;PPP1R16B;RAPGEF6;RDX;RAPGEF2;PDE2A;PDE4D;ROBO4;RAP1A;SOX18;F11R
prerank,potassium ion import across plasma membrane (GO:1990573),-0.5283303575247602,-1.9359943333827425,0.0,0.13063747151521576,0.519,9/41,3.89%,ATP1B3;SLC12A7;SLC12A2;ATP1B1;ATP1A2;KCNJ2;ABCC9;SLC12A6;KCNJ3
prerank,negative regulation of axon extension (GO:0030517),-0.5738908095385588,-1.9334348274518502,0.0,0.11634598496434664,0.536,22/30,26.92%,SEMA6A;MAP2;SEMA3C;SEMA7A;SEMA6D;SEMA3D;SEMA4D;SEMA5A;SEMA5B;SEMA4B;MAG;SEMA3G;RNF6;SEMA3B;CDKL3;TRIM46;SEMA6C;SEMA6B;SEMA4A;SEMA4G;SEMA3F;RTN4R
prerank,negative regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043124),0.7192130381507542,1.9220588891133272,0.0,0.022807654345579072,0.208,8/38,5.02%,RORA;NR1H4;ADIPOQ;TNIP1;TNFAIP3;STAT1;TREM2;TLE1
prerank,chondrocyte differentiation (GO:0002062),0.7339958475130713,1.9186040306378294,0.001288659793814433,0.023072517428301926,0.225,9/32,8.10%,RUNX1;RUNX2;SLC39A14;SULF1;RUNX3;SOX5;WNT2B;EIF2AK3;CREB3L2
prerank,ventricular cardiac muscle cell action potential (GO:0086005),-0.6485422697343022,-1.915070602181865,0.003676470588235294,0.1257629389959913,0.623,11/17,29.19%,ANK2;SNTA1;KCNQ1;NEDD4L;RYR2;KCNE4;SCN3B;KCNJ8;PKP2;KCNH2;SCN5A
prerank,positive regulation of potassium ion transmembrane transporter activity (GO:1901018),-0.6957665881192096,-1.9143619272753207,0.0,0.11298916403535691,0.63,4/14,2.04%,ATP1B3;ATP1B1;ACTN2;ANK2
prerank,response to peptide (GO:1901652),0.7458479418708459,1.9127528564432907,0.0,0.02529994238092259,0.255,11/33,9.88%,MMP3;MMP13;MMP2;CACNA1A;STAT1;IRS1;ANXA1;MMP12;STAT3;STAT5A;ERBIN
prerank,regulation of fat cell differentiation (GO:0045598),0.653816861726579,1.9083987245956386,0.0,0.025932346269204896,0.272,25/74,11.29%,RORA;ENPP1;ADIPOQ;ZFP36L1;YAP1;ASXL1;SFRP1;SFRP2;WNT5A;CMKLR1;LPL;ZFPM2;ZFP36L2;RUNX1T1;FRZB;E2F1;CARM1;TRIO;ASXL2;FTO;WDFY2;PPARG;SIRT2;XBP1;WWTR1
prerank,regulation of spindle organization (GO:0090224),0.8114691904904924,1.899495754906432,0.0,0.02987066988485517,0.327,11/18,13.17%,CLTC;PARP3;PSRC1;RAE1;FSD1;DYNC1H1;GPSM2;BORA;SENP6;TPX2;GNAI1
prerank,positive regulation of myeloid leukocyte differentiation (GO:0002763),0.7326103600966041,1.894207394326096,0.0,0.031225963436799595,0.356,7/33,5.52%,RUNX1;IL34;IL23R;ZFP36L1;TNFSF11;PRKCA;CCR1
prerank,acute inflammatory response (GO:0002526),0.7769078409544876,1.8916286808319673,0.0,0.031158198759202373,0.373,4/23,2.59%,HP;HPR;LBP;CRP
prerank,negative regulation of fat cell differentiation (GO:0045599),0.7213753345348988,1.8911484798640075,0.0,0.029968767322900672,0.374,16/34,15.60%,RORA;ENPP1;ADIPOQ;YAP1;ASXL1;WNT5A;ZFPM2;ZFP36L2;RUNX1T1;E2F1;TRIO;SIRT2;WWTR1;SMAD3;FLCN;TNF
prerank,endodermal cell differentiation (GO:0035987),0.7387562457733793,1.8884192491366838,0.0,0.029964308348444057,0.389,9/31,3.76%,COL4A2;COL7A1;MMP2;COL8A1;MMP14;LAMB1;ITGB5;VTN;COL11A1
prerank,cellular response to chemokine (GO:1990869),0.6907754715097358,1.8871485997997592,0.0,0.02946761736766822,0.398,9/46,8.47%,CCL11;CCL7;CXCL5;CXCL1;CXCL12;XCL1;CCR1;CCL5;CXCL10
prerank,response to UV-A (GO:0070141),0.8385816708295013,1.8869326452440687,0.0,0.02845438812307324,0.402,5/14,7.06%,MMP3;MMP2;TIMP1;PPID;EGFR
prerank,G protein-coupled glutamate receptor signaling pathway (GO:0007216),-0.6608700690392595,-1.8852490372641613,0.006622516556291391,0.14281630353247812,0.752,10/15,28.41%,GRM7;GRM1;GRM3;GRM8;HOMER2;GRM5;HOMER3;DAGLB;GRIK3;GRM4
prerank,cellular response to UV-A (GO:0071492),0.8719317284718591,1.8833922058778285,0.0,0.02925265602516851,0.423,4/11,6.04%,MMP3;MMP2;TIMP1;PPID
prerank,response to interferon-gamma (GO:0034341),0.6456773697982828,1.8774320232647315,0.0,0.03276265781800428,0.469,24/67,17.07%,CCL11;CCL7;IL23R;SYNCRIP;TLR2;WNT5A;STAT1;CD40;XCL1;CASP1;SHFL;GBP7;AIF1;CYP27B1;CCL5;TRIM21;LGALS9;GBP3;SIRPA;CCL2;GAPDH;CX3CL1;SP100;EPRS1
prerank,regulation of protein processing (GO:0070613),0.7806641129794055,1.8738382909764029,0.0,0.03425780530855676,0.494,5/21,3.61%,RUNX1;CCBE1;NKD2;SERPINE2;LRRK2
prerank,regulation of steroid metabolic process (GO:0019218),0.7571629203993826,1.8720175752770611,0.0013458950201884253,0.03421148151836861,0.508,6/23,4.50%,RORA;NR1H4;ABCA2;APOE;EPHX2;ABCG1
prerank,cartilage development (GO:0051216),0.6743502228918005,1.8709731322598089,0.0,0.03384869013111412,0.515,10/49,5.62%,RUNX1;RUNX2;SLC39A14;SULF1;RUNX3;ITGB8;COL11A2;SOX5;WNT2B;TRIP11
prerank,membrane repolarization (GO:0086009),-0.6545983578655068,-1.863434071201139,0.0,0.16427515466186404,0.829,6/15,9.98%,ATP1B3;ATP1B1;ATP1A2;KCNJ2;KCND3;KCNQ1
prerank,positive regulation of alpha-beta T cell differentiation (GO:0046638),0.8381817162611714,1.8564918079370505,0.0029850746268656717,0.044943341240546456,0.612,5/13,8.40%,RUNX1;RUNX3;GLI3;SHH;CBFB
prerank,regulation of defense response (GO:0031347),0.6367896989050574,1.8467209481068096,0.0,0.05126856911271582,0.678,26/76,9.90%,CASP4;ZBP1;IL1RL2;PTGES;SBNO2;BCL6;LACC1;BIRC3;WNT5A;JAK2;XCL1;APOE;IL1R1;CASP1;IRF1;TIRAP;ANXA1;TREM2;CELF1;CASP12;ADAMTS12;FCGR2B;AREL1;BRD4;NR1D2;PIK3AP1
prerank,regulation of acute inflammatory response (GO:0002673),0.7998710365443072,1.8445693967294585,0.0013908205841446453,0.05188741363619239,0.69,3/18,2.42%,OSMR;PTGES;CREB3L3
prerank,positive regulation of ion transmembrane transporter activity (GO:0032414),-0.5640835337584961,-1.8406368939044795,0.004098360655737705,0.19258153091336055,0.891,8/25,8.70%,DMD;ATP1B3;ATP1B1;ACTN2;SLC6A9;ANK2;WNK4;WNK3
prerank,lipid catabolic process (GO:0016042),0.7802808629441225,1.8393730199808866,0.002793296089385475,0.05505941659026596,0.715,4/18,3.05%,CEL;PLA1A;LIPC;LPL
prerank,negative regulation of B cell activation (GO:0050869),0.7476103186220759,1.8376815061287175,0.0014064697609001407,0.05559095257475582,0.731,7/21,8.05%,PARP3;TNFRSF21;TNFAIP3;SFRP1;BLK;ATM;FCGR2B
prerank,positive regulation of leukocyte migration (GO:0002687),0.7224664780416284,1.8372235146013138,0.0038071065989847717,0.05456179504090787,0.735,8/27,6.53%,EDN3;PTN;PLVAP;XCL1;MIA3;MDK;ICAM1;AIF1
prerank,response to amyloid-beta (GO:1904645),0.6776580905198242,1.8337866566906935,0.0,0.05656543521298723,0.758,13/44,8.05%,MMP3;MMP13;CASP4;MMP2;LRP1;CACNA1A;CACNB1;CACNA2D1;TREM2;ICAM1;MMP12;CD36;FCGR2B
prerank,positive regulation of lipid localization (GO:1905954),0.8671762005261082,1.831630749197769,0.0015360983102918587,0.05734723202497823,0.771,6/11,10.12%,C3;LRP1;LPL;IKBKE;VSTM2A;NFKB1
prerank,regulation of T cell proliferation (GO:0042129),0.6381319263913826,1.829953303485811,0.0,0.05751865834452148,0.78,11/61,8.44%,GLMN;IL23R;VSIG4;TNFRSF21;SPN;CD276;ANXA1;AIF1;CCL5;NCK2;NCK1
prerank,skeletal system development (GO:0001501),0.5918110450596179,1.8250080433431268,0.0,0.061061882204938245,0.81,37/148,10.21%,COL1A2;COL1A1;SULF1;TRPS1;ITGB8;PAX1;MMP14;SH3PXD2B;CDH11;GLI2;COL11A2;DEAF1;SOX5;COL13A1;CHD7;PAPSS2;WNT5A;CMKLR1;SUFU;VCAN;EXT1;FBN1;ANKRD11;BMP1;FGFR1;TRIP11;FRZB;EIF2AK3;PRELP;BMP5;CREB3L2;TGFBR1;MMP16;GNAS;ADAMTS4;AKAP13;SPEF2
prerank,maintenance of blood-brain barrier (GO:0035633),-0.5450309251729556,-1.8245149557879357,0.0,0.2121027357004086,0.935,14/30,6.02%,TJP1;DMD;JAM2;SLC12A2;OCLN;PECAM1;TJP2;CLDN5;ACTB;ESAM;CDH5;LSR;SLC1A1;GJA1
prerank,camera-type eye development (GO:0043010),0.7274922499434144,1.8239343137313908,0.0025906735751295338,0.06082286402416199,0.815,7/25,7.57%,CYP1B1;FBN2;LAMA1;TENM3;FBN1;CACNA1C;NF1
prerank,regulation of potassium ion transmembrane transporter activity (GO:1901016),-0.5642487239488008,-1.8211115592675984,0.004149377593360996,0.20363761346245868,0.94,7/26,7.06%,ATP1B3;ATP1B1;ACTN2;FHL1;ANK2;WWP2;CACNA1D
prerank,T cell differentiation in thymus (GO:0033077),0.8031105047938525,1.8209160889958234,0.0014184397163120568,0.062077733629501364,0.827,4/14,5.73%,ZFP36L1;GLI3;ZFP36L2;SHH
prerank,regulation of inflammatory response (GO:0050727),0.5808239307374911,1.819156574205104,0.0,0.06310117702276877,0.836,41/190,9.90%,RORA;MMP3;NR1H4;CASP4;ZBP1;ADIPOQ;IL1RL2;PTGES;SBNO2;TNIP1;BCL6;TNFAIP3;IL16;LACC1;TLR2;BIRC3;WNT5A;JAK2;LPL;XCL1;APOE;CCN4;SMPDL3B;IL1R1;CASP1;TSLP;ANXA1;CELF1;CASP12;MDK;CCL5;MVK;ADAMTS12;PLA2G7;IL33;PPARG;AREL1;BRD4;NR1D2;TLR7;PIK3AP1
prerank,skin development (GO:0043588),0.6418074179251099,1.8110602929831652,0.0,0.07047274322473449,0.864,12/65,4.59%,COL1A2;COL1A1;COL3A1;COL5A2;COL5A3;COL5A1;WNT5A;ERRFI1;GATA6;UGCG;JAG1;ANXA1
prerank,negative regulation of cell-cell adhesion mediated by cadherin (GO:2000048),-0.7298515833369441,-1.8088533517593979,0.008,0.21723916617983757,0.958,3/10,9.06%,BMP6;NEXMIF;NOTCH4
prerank,positive regulation of monocyte chemotaxis (GO:0090026),0.7792208323627086,1.807773808154074,0.0027816411682892906,0.0737871093080435,0.878,8/17,11.50%,CXCL12;CCR1;AIF1;CCL5;PLA2G7;CXCL10;MOSPD2;CREB3
prerank,triglyceride homeostasis (GO:0070328),0.7187692687622234,1.8075112886508045,0.0,0.07242206859439214,0.878,5/26,3.63%,RORA;NR1H4;LIPC;LPL;APOE
prerank,regulation of lipid storage (GO:0010883),0.739844028552159,1.8043836592896794,0.004103967168262654,0.07507972722932486,0.895,11/22,15.60%,C3;CRP;LPL;IKBKE;FTO;VSTM2A;NFKB1;MEST;FBXW7;PTPN2;TNF
prerank,high-density lipoprotein particle assembly (GO:0034380),0.8648278318625463,1.8037623832541545,0.0,0.07431507085806595,0.897,3/10,4.77%,ABCA1;APOE;BMP1
prerank,regulation of small molecule metabolic process (GO:0062012),0.7136012483814735,1.8022287800578594,0.0025974025974025974,0.07471959234128282,0.903,6/28,4.36%,RORA;NR1H4;ADIPOQ;NCOR2;APOE;EPHX2
prerank,negative regulation of lymphocyte proliferation (GO:0050672),0.6954643295515412,1.8019986698378103,0.0,0.07346797413622014,0.904,10/31,15.47%,GLMN;VSIG4;TNFRSF21;SPN;BLK;ATM;FCGR2B;GPNMB;DLG5;LST1
prerank,response to sterol (GO:0036314),0.8349430641552837,1.79875964473076,0.0,0.07599510427946946,0.911,4/11,8.31%,RORA;ABCA2;SMAD2;TGFBR1
prerank,negative regulation of T cell activation (GO:0050868),0.6774403121223074,1.7964795136320435,0.0024752475247524753,0.0776354665567162,0.918,4/35,1.57%,GLMN;VSIG4;TNFRSF21;SPN
prerank,eye morphogenesis (GO:0048592),0.7627446572931341,1.7952019758040132,0.0027397260273972603,0.07770731960098598,0.922,9/19,10.59%,FBN2;COL5A2;COL5A1;TENM3;FBN1;STAT3;NIPBL;NF1;AGTPBP1
prerank,response to fatty acid (GO:0070542),0.7791473918075651,1.7916733470736104,0.0028530670470756064,0.08092483370236625,0.933,6/17,8.36%,NR1H4;LPL;IRS1;PID1;CD36;GLDC
prerank,negative regulation of blood coagulation (GO:0030195),0.6735760128447552,1.7913259405696251,0.0,0.07990308821689547,0.933,8/38,7.25%,KNG1;PDGFRA;SERPING1;SERPINE2;VTN;APOE;PLAT;APOH
prerank,cellular response to fatty acid (GO:0071398),0.8381710073203551,1.787371252150872,0.0029895366218236174,0.08305731720334338,0.94,4/12,4.97%,NR1H4;LPL;IRS1;PID1
prerank,positive regulation of glial cell differentiation (GO:0045687),0.7836885552655434,1.782131486639103,0.0,0.08790143557864709,0.949,9/17,11.76%,IL34;SERPINE2;PTN;MDK;TENM4;BIN1;PTPRZ1;CXCR4;DICER1
prerank,negative regulation of axon extension involved in axon guidance (GO:0048843),-0.5896378436303715,-1.7816529293229657,0.0036231884057971015,0.2648558496118618,0.977,16/20,26.64%,SEMA6A;SEMA3C;SEMA7A;SEMA6D;SEMA3D;SEMA4D;SEMA5A;SEMA5B;SEMA4B;SEMA3G;SEMA3B;SEMA6C;SEMA6B;SEMA4A;SEMA4G;SEMA3F
prerank,negative regulation of T cell proliferation (GO:0042130),0.7006713369200236,1.778916140783026,0.0013020833333333333,0.09085887972235439,0.956,4/28,1.57%,GLMN;VSIG4;TNFRSF21;SPN
prerank,embryonic digestive tract development (GO:0048566),0.7662951190301656,1.7789159503979521,0.0027624309392265192,0.08929234731334827,0.956,9/18,15.60%,PDGFRA;GLI2;GLI3;RARB;NIPBL;SALL1;PCSK5;STRA6;TNF
prerank,intestinal lipid absorption (GO:0098856),0.843607491568247,1.7787857869003507,0.001524390243902439,0.08798841392149037,0.957,4/11,7.23%,CEL;UGCG;LIMA1;CD36
prerank,positive regulation of lipid transport (GO:0032370),0.837855106987608,1.7783459521294795,0.0,0.08719145537079276,0.958,4/12,3.63%,ADIPOQ;SPP1;LRP1;APOE
prerank,acylglycerol homeostasis (GO:0055090),0.7389068238610746,1.7780524150340613,0.001358695652173913,0.08613357099075536,0.958,5/20,7.49%,RORA;LIPC;LPL;APOE;ANGPTL4
prerank,"negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515)",0.8415381310024959,1.777635429143665,0.004524886877828055,0.08507658536170373,0.958,5/11,8.51%,RUNX1;RUNX3;XCL1;CBFB;LGALS9
prerank,negative regulation of macrophage derived foam cell differentiation (GO:0010745),0.823958233432126,1.7746440157548233,0.0030864197530864196,0.08758466260162513,0.964,5/12,8.94%,ABCA1;ADIPOQ;CRP;ABCG1;PPARG
prerank,cellular response to interferon-gamma (GO:0071346),0.6016020328574382,1.7732476102837933,0.0,0.08834057489114765,0.968,32/88,17.07%,CCL11;CCL7;MID1;JAK1;SYNCRIP;TLR2;IRF7;WNT5A;JAK2;STAT1;XCL1;CAMK2D;CASP1;IRF1;GBP7;ICAM1;AIF1;CCL5;TRIM21;LGALS9;TRIM8;GBP3;SIRPA;OASL;TRIM62;CCL2;IFNGR1;GAPDH;CX3CL1;SP100;IFNGR2;EPRS1
prerank,negative regulation of nervous system development (GO:0051961),0.7672698532226803,1.7729183232380739,0.00423728813559322,0.08742519138182811,0.969,4/17,2.88%,CCL11;ROBO2;SLIT1;TLR2
prerank,positive regulation of stem cell differentiation (GO:2000738),0.7687623748627157,1.7711913139940565,0.008264462809917356,0.08839470962790996,0.969,3/16,2.39%,LTBP3;SOX5;PTN
prerank,tight junction assembly (GO:0120192),-0.46668631874824656,-1.767969951441474,0.0,0.28183179510245504,0.989,14/49,17.65%,OCLN;PECAM1;CLDN5;ESAM;PARD3;RAMP2;CDH5;LSR;APC;CLDN14;CLDN1;F11R;ARL2;MPP7
prerank,regulation of AMPA receptor activity (GO:2000311),-0.5373442157559336,-1.7674003875759114,0.0038022813688212928,0.26712438205350086,0.989,13/25,21.95%,SHANK3;SHISA6;CACNG2;MEF2C;RELN;NLGN1;SHISA7;CACNG8;PRRT1;ADRB2;CACNG7;SHANK1;MINK1
prerank,positive regulation of G protein-coupled receptor signaling pathway (GO:0045745),0.7652082543919734,1.7632493613546252,0.00141643059490085,0.09832877230238479,0.978,3/16,2.11%,SLC39A14;C3;PRKCA
prerank,positive regulation of leukocyte chemotaxis (GO:0002690),0.6371925204041864,1.7589344858426181,0.0,0.10362335328716746,0.984,16/51,13.07%,IL34;EDN3;CXCL12;PTN;CMKLR1;XCL1;CCR1;MDK;AIF1;CCL5;PLA2G7;CXCL10;LGALS9;MOSPD2;CREB3;PTK2
prerank,positive regulation of vasoconstriction (GO:0045907),-0.6309909545366831,-1.7565041425768255,0.0030120481927710845,0.2790679734730743,0.992,3/13,6.34%,CAV1;ADRA1B;ADRA1A
prerank,lymphocyte chemotaxis (GO:0048247),0.6566022377213496,1.7558262349240874,0.0012330456226880395,0.10694326789360441,0.986,6/34,8.47%,CCL11;CYP7B1;CCL7;XCL1;CCL5;CXCL10
prerank,regulation of toll-like receptor 4 signaling pathway (GO:0034143),0.7122609049117946,1.755224285665853,0.0026560424966799467,0.10613652309333022,0.986,5/22,7.60%,LBP;TNFAIP3;TIRAP;TREM2;RAB7B
prerank,cholesterol homeostasis (GO:0042632),0.6065026905357616,1.753262819215663,0.0011198208286674132,0.10809439597477216,0.987,10/64,4.70%,RORA;CYP7B1;ABCA1;LIPC;ABCA2;LPL;APOE;EPHX2;ABCG1;LIMA1
prerank,cellular lipid catabolic process (GO:0044242),0.7001259796213104,1.7525130066377181,0.0013333333333333333,0.1076374138954264,0.988,5/27,10.71%,CEL;CYP1B1;SMPDL3B;ACOX1;SIRT2
prerank,sterol homeostasis (GO:0055092),0.6047858164512775,1.7513838590387916,0.0011198208286674132,0.10770090847005173,0.988,10/65,4.70%,RORA;CYP7B1;ABCA1;LIPC;ABCA2;LPL;APOE;EPHX2;ABCG1;LIMA1
prerank,bicellular tight junction assembly (GO:0070830),-0.470258623493909,-1.751337619358008,0.0,0.27717341832390213,0.994,13/46,17.65%,OCLN;PECAM1;CLDN5;ESAM;PARD3;RAMP2;CDH5;APC;CLDN14;CLDN1;F11R;ARL2;MPP7
prerank,positive regulation of smooth muscle cell migration (GO:0014911),0.7569603768203108,1.7485618941113767,0.004219409282700422,0.11037950241700908,0.988,10/17,7.35%,NRP1;PDGFRB;VTN;CCN4;IGFBP5;FGF9;MDK;AIF1;ADAMTS1;CCL5
prerank,regulation of mitotic spindle organization (GO:0060236),0.6578953761074235,1.7408293283821774,0.0037359900373599006,0.12118565106389058,0.996,13/35,13.17%,CLTC;PARP3;PSRC1;RAE1;FSD1;CHMP4B;DYNC1H1;GPSM2;PLK1;EML3;BORA;TPX2;GNAI1
prerank,pyroptosis (GO:0070269),0.7659372286072993,1.740357221211848,0.007363770250368188,0.12039072621922345,0.996,4/15,4.76%,CASP4;ZBP1;CASP1;TREM2
prerank,reverse cholesterol transport (GO:0043691),0.7936518647416801,1.7392351828175079,0.0045662100456621,0.12052607956226828,0.996,4/13,4.50%,ABCA1;LIPC;APOE;ABCG1
prerank,regulation of platelet-derived growth factor receptor signaling pathway (GO:0010640),0.7956080463350453,1.7391199542096287,0.010526315789473684,0.11912613308190914,0.996,7/12,17.61%,ADIPOQ;CBLB;APOD;CBL;IFT20;PTPRJ;HGS
prerank,establishment of endothelial intestinal barrier (GO:0090557),-0.6782086754093942,-1.738929413065611,0.005449591280653951,0.2971000787321604,0.997,4/11,7.06%,TJP1;TJP2;RAPGEF6;RAPGEF2
prerank,response to interleukin-1 (GO:0070555),0.5946494185400979,1.7381091310205934,0.0,0.11918279939653476,0.998,20/73,13.86%,CCL11;CCL7;PRKCA;SFRP1;CD40;XCL1;IL1R1;IRAK3;ANXA1;ADAMTS7;CCL5;ADAMTS12;LGALS9;NFKB1;MAPK11;GBP3;SIRPA;TANK;CCL2;IRAK2
prerank,dicarboxylic acid catabolic process (GO:0043649),-0.647006029613601,-1.7367574519510647,0.006134969325153374,0.28874958086606034,0.997,6/13,12.32%,DDO;MTHFS;GLUD1;ASPA;GAD1;GLUL
prerank,response to nitric oxide (GO:0071731),0.782033209243117,1.736211746237115,0.0073964497041420114,0.12107921534361121,0.998,1/13,0.03%,MMP3
prerank,phospholipid homeostasis (GO:0055091),0.8167729151786212,1.7361742137076857,0.00473186119873817,0.11964799188871958,0.998,5/11,11.07%,ABCA1;ABCG1;RCN3;TLCD2;TLCD1
prerank,regulation of chemotaxis (GO:0050920),0.6720200916300053,1.7359421052344957,0.005115089514066497,0.1184652176972536,0.998,9/30,10.70%,PDGFRA;MYCBP2;ZSWIM6;PDGFRB;TREM2;AIF1;USP14;ZSWIM8;CXCR4
prerank,regulation of interleukin-2 production (GO:0032663),0.6421425600386147,1.7338665640868667,0.0035714285714285713,0.12026450430167489,0.998,9/43,4.70%,RUNX1;GLMN;VSIG4;TNFAIP3;XCL1;STOML2;NAV3;ANXA1;PRKD2
prerank,regulation of T cell migration (GO:2000404),0.7399125302558758,1.7314811916601405,0.002886002886002886,0.12312454692685992,0.999,6/18,8.47%,APOD;CXCL12;SPN;AIF1;CCL5;CXCL10
prerank,muscle cell development (GO:0055001),-0.5248984384178645,-1.7306271753107416,0.00966183574879227,0.2919633042818969,0.998,8/30,6.74%,NEBL;DMD;SGCZ;ANK2;MYOF;RAMP2;DYSF;CXADR
prerank,neutrophil chemotaxis (GO:0030593),0.6151388809644119,1.7294213517028152,0.0034924330616996507,0.12499633260133107,0.999,9/53,8.47%,CCL11;CCL7;CXCL5;EDN3;CXCL1;JAML;XCL1;CCL5;CXCL10
prerank,postreplication repair (GO:0006301),-0.4735011386134286,-1.7279473975930635,0.013986013986013986,0.2860600660704883,0.998,28/45,29.95%,WDR33;UBE2N;MSH2;PCNA;ZBTB1;UBC;NSMCE1;PARP10;POLK;UBE2B;PRIMPOL;FAAP20;RFC3;UBA52;RFC2;POLD2;UBE2A;RPA2;UBB;SPRTN;BRCA1;PCLAF;RFC4;RPA3;POLD4;TRIM25;USP43;DTL
prerank,granulocyte chemotaxis (GO:0071621),0.6128826426829302,1.726274748711019,0.002331002331002331,0.12898045067762842,1.0,10/55,8.47%,CCL11;CCL7;CXCL5;EDN3;CXCL1;JAML;XCL1;ANXA1;CCL5;CXCL10
prerank,negative regulation of intracellular protein transport (GO:0090317),0.7188963990463308,1.7257476873000468,0.0038910505836575876,0.12835034967170628,1.0,9/22,16.24%,ADIPOQ;MDFIC;APOD;SUFU;LRRK2;LMAN1;ITGB1BP1;BAG4;SP100
prerank,positive regulation of interleukin-17 production (GO:0032740),0.7142371021472196,1.7204621716205357,0.003968253968253968,0.13581088662773297,1.0,3/22,0.97%,NR1H4;IL23R;RFTN1
prerank,interleukin-35-mediated signaling pathway (GO:0070757),0.8190667852345349,1.7204450197509524,0.003110419906687403,0.13430806819594893,1.0,5/11,8.73%,JAK1;JAK2;STAT1;STAT3;CANX
prerank,positive regulation of T cell migration (GO:2000406),0.7135192894174915,1.719384204458676,0.004160887656033287,0.13494447073269245,1.0,7/20,8.47%,CXCL12;SPN;WNT5A;XCL1;AIF1;CCL5;CXCL10
prerank,supramolecular fiber organization (GO:0097435),0.5399960252403441,1.7164297347614594,0.0,0.1387475071802026,1.0,74/333,12.01%,COL15A1;COL4A1;COL27A1;COL1A2;LTBP3;LTBP2;CYP1B1;COL24A1;COL18A1;COL4A2;COL7A1;COL1A1;COL3A1;LUM;TLL2;COL6A3;COL8A1;COL5A2;COL23A1;HSPG2;MYO1B;IAPP;COL5A3;MYO1A;COL11A2;PPP1R9B;COL13A1;PLOD2;RND3;COL5A1;ADAMTS2;DPT;USP9X;RHOD;FSD1;COL11A1;DDR2;DYNC1H1;BMP1;MYO5A;CARMIL1;MFAP4;FAT1;DBN1;RAC1;SERF1A;NCKAP5;SERPINH1;SIAH2;LOXL1;CDC42;CD36;PXDN;CAMSAP2;HOOK2;KIF2A;NF1;CGNL1;MYO19;DNAJB6;TGFBR1;MYO1H;ZBED3;MYO1D;COL4A5;MYO7A;EMILIN1;ADAMTS14;PCM1;WHAMM;TMOD1;LOXL3;CLIP3;FGF13
prerank,xenobiotic transport (GO:0042908),-0.6079618139199086,-1.7159508777679742,0.003861003861003861,0.3040988361039383,0.999,6/17,16.97%,ABCG2;SLC47A1;SLC7A5;GJA1;ABCA3;SLC22A2
prerank,epithelial cell morphogenesis (GO:0003382),0.7340227013777838,1.7156492178416698,0.0070028011204481795,0.13877322084811836,1.0,3/17,4.40%,COL15A1;COL18A1;SIPA1L3
prerank,regulation of B cell activation (GO:0050864),0.6821134142913313,1.71441084341935,0.01084010840108401,0.13947398808304826,1.0,6/25,10.26%,ZFP36L1;TNFAIP3;SH3KBP1;ZFP36L2;FCGR2B;AHR
prerank,bone morphogenesis (GO:0060349),0.7792161085159983,1.7139864433872203,0.009845288326300985,0.13906407612204583,1.0,2/14,2.24%,MMP13;SFRP4
prerank,regulation of chondrocyte differentiation (GO:0032330),0.6972250417151736,1.7131432260448909,0.009358288770053475,0.13902059138425152,1.0,8/24,8.31%,TRPS1;SOX5;SNAI2;ADAMTS7;WNT9A;MDK;ADAMTS12;TGFBR1
prerank,negative regulation of platelet-derived growth factor receptor signaling pathway (GO:0010642),0.8178392797764595,1.7124833762982978,0.0112,0.13894582435663594,1.0,3/10,1.00%,ADIPOQ;LRP1;APOD
prerank,regulation of extracellular matrix organization (GO:1903053),0.7618748384090586,1.7108313557439823,0.01466275659824047,0.14053974970709499,1.0,4/15,4.22%,RUNX1;FAP;LRP1;DDR2
prerank,positive regulation of interleukin-2 production (GO:0032743),0.6962707964041943,1.7104260139778678,0.009138381201044387,0.13968374481693357,1.0,5/25,4.70%,RUNX1;GLMN;STOML2;ANXA1;PRKD2
prerank,positive regulation of reproductive process (GO:2000243),0.6608906820996333,1.7102013584316056,0.004962779156327543,0.13866816030141058,1.0,7/31,10.71%,PDE3A;SYDE1;LHFPL2;SMURF2;ACVR1B;INHBB;SIRT2
prerank,negative regulation of peptidase activity (GO:0010466),0.6216010896308909,1.7093135420438166,0.006105006105006105,0.13885741404059743,1.0,10/47,7.24%,KNG1;SERPING1;LRP1;FETUB;SERPINE2;TIMP1;VTN;SERPINH1;SERPINA2;SERPINF1
prerank,transition metal ion homeostasis (GO:0055076),0.6677198008302141,1.7082970988380317,0.010512483574244415,0.13934886763627893,1.0,3/28,1.51%,SLC39A14;HEPH;CP
prerank,neutrophil migration (GO:1990266),0.5977702200548561,1.7075268243720445,0.004561003420752566,0.13953783518219362,1.0,8/58,3.54%,CCL11;CCL7;CXCL5;EDN3;CXCL1;JAML;PRTN3;XCL1
prerank,regulation of oligodendrocyte differentiation (GO:0048713),0.7370417914924372,1.706571500140633,0.008264462809917356,0.14012314242604307,1.0,9/18,12.37%,IL34;TNFRSF21;PTN;MDK;TENM4;NF1;PTPRZ1;CXCR4;DRD3
prerank,regulation of immune response (GO:0050776),0.5537754352697815,1.7024015414751459,0.002053388090349076,0.14600577435097314,1.0,18/135,6.24%,COL1A2;C3;COL1A1;COL3A1;SPN;ADCY7;BCL6;COLEC12;ULBP1;JAML;CD276;IRF7;BIRC3;CD40;IRF1;TIRAP;TREM2;ICAM1
prerank,cellular response to copper ion (GO:0071280),-0.5939387444889841,-1.7023521494624994,0.023411371237458192,0.329506860944499,0.999,10/16,25.45%,MT2A;HSF1;MT1B;MT1X;MT1G;MT1F;MT1E;MT1M;MT1H;MT1A
prerank,regulation of fibrinolysis (GO:0051917),0.7665779118589295,1.7013409781192719,0.004411764705882353,0.1464300457705199,1.0,3/13,7.25%,FAP;USF1;APOH
prerank,regulation of antigen receptor-mediated signaling pathway (GO:0050854),0.7724441579099681,1.7013092481652592,0.005988023952095809,0.14508749904058962,1.0,3/12,8.40%,RUNX1;BLK;CBFB
prerank,cytoplasmic translation (GO:0002181),-0.39657960165476214,-1.7011510814891344,0.0125,0.3206025866832148,0.999,44/91,22.20%,RPL34;RPL8;RPL18A;RPL36;RPL19;RPL38;RPL5;RPS23;RPLP0;RPS10;EIF4A2;RPL32;RPS4X;RPL10;RPL15;RPL29;RPS16;RPS27;RPS19;RPS12;RPS21;RPS13;RPL13;RPL27;RPL7A;RPL35;RPL28;RPL30;RPS8;RPS17;RPL37A;RPS6;RPL41;RPS18;GSPT2;RPS20;RPL7;RPL13A;RPS15A;RPS5;UBA52;RPS29;RPLP1;RPL21
prerank,positive regulation of epithelial to mesenchymal transition (GO:0010718),0.6398807268172646,1.6967209847347444,0.0036855036855036856,0.15238566041806553,1.0,16/40,13.89%,COL1A1;TCF7L2;SNAI1;SMAD2;JAG1;TGFB1I1;MDK;TGFBR1;OLFM1;TGFB3;GCNT2;WWTR1;PDPN;SMAD3;SDCBP;AXIN2
prerank,negative regulation of actin filament polymerization (GO:0030837),-0.5342349378777553,-1.6963483097203325,0.008849557522123894,0.32168700649396287,0.999,10/22,13.03%,KANK3;TMSB4X;TWF2;KANK4;HIP1R;GSN;SLIT2;TMSB10;PFN1;TWF1
prerank,regulation of epithelial to mesenchymal transition (GO:0010717),0.5860195717343808,1.6954088086481942,0.0011210762331838565,0.1533494575602127,1.0,25/74,15.98%,COL1A1;SNAI1;SFRP1;SFRP2;SMAD2;PTEN;SPRED1;SPRED2;TGFB1I1;MDK;BMP5;TGFBR1;OLFM1;TGFB3;SPRY2;GCNT2;WWTR1;PDPN;SMAD3;SDCBP;AXIN2;LDLRAD4;PHLDB1;PHLDB2;EZH2
prerank,positive regulation of receptor signaling pathway via STAT (GO:1904894),0.6942635592969331,1.6941566527087577,0.009776536312849162,0.15419162306585948,1.0,7/22,7.88%,CYP1B1;MGAT5;GHR;IL10RA;TSLP;CCL5;OCIAD2
prerank,cholesterol efflux (GO:0033344),0.7032498515888831,1.6913032251332811,0.011283497884344146,0.15831455038973238,1.0,5/20,9.71%,ABCA1;APOE;ABCG1;SOAT1;NPC2
prerank,positive regulation of transporter activity (GO:0032411),0.7924201071922801,1.6898133848343329,0.0075075075075075074,0.15968141888120152,1.0,4/13,7.68%,KMT2A;ADIPOQ;KCTD7;TRPC6
prerank,lipoprotein localization (GO:0044872),0.7896977271077695,1.6887869314777217,0.010819165378670788,0.16018698523842592,1.0,6/11,10.08%,LRP1;VMP1;MIA3;CD36;PPARG;ZDHHC3
prerank,regulation of phospholipase activity (GO:0010517),0.8209780611952335,1.687367706897902,0.010687022900763359,0.16160424363399367,1.0,3/10,5.13%,LRP1;PLA2G5;FGFR1
prerank,cotranslational protein targeting to membrane (GO:0006613),-0.388577765886464,-1.6865932398902699,0.0,0.33905024279074725,0.999,43/91,22.20%,ARL6IP1;RPL34;RPL8;RPL18A;RPL36;RPL19;RPL38;RPL5;RPS23;RPLP0;RPS10;RPL32;RPS4X;RPL10;RPL15;RPL29;RPS16;RPS27;RPS19;RPS12;RPS21;RPS13;RPL13;RPL27;RPL7A;RPL35;RPL28;RPL30;RPS8;RPS17;RPL37A;RPS6;RPL41;RPS18;RPS20;RPL7;RPL13A;RPS15A;RPS5;UBA52;RPS29;RPLP1;RPL21
prerank,phosphate ion homeostasis (GO:0055062),0.8073405375254628,1.6863291022379547,0.004893964110929853,0.16193047358632015,1.0,2/10,2.24%,ENPP1;SFRP4
prerank,growth hormone receptor signaling pathway (GO:0060396),0.7510089527386341,1.6817252723770801,0.008836524300441826,0.1695059752836234,1.0,8/14,13.50%,GHR;JAK2;STAT3;PIK3R1;STAT5A;PTPN1;PTK2;STAT6
prerank,osteoclast differentiation (GO:0030316),0.6888522004795764,1.6815953750002528,0.0027624309392265192,0.16829334314139716,1.0,6/22,7.28%,SBNO2;FARP2;TNFSF11;GAB2;TREM2;SNX10
prerank,positive regulation of synapse assembly (GO:0051965),-0.5121298424079304,-1.680866140055624,0.008064516129032258,0.34382702606369764,0.999,17/27,23.39%,NRXN1;GRID2;CUX2;EPHB1;SEMA4D;SYNDIG1;AGRN;LRRC4B;IL1RAPL1;CLSTN1;BDNF;NLGN1;CLSTN3;VSTM5;PTPRD;SEMA4A;SLITRK2
prerank,sodium ion transport (GO:0006814),-0.38598596848436306,-1.6791454740493008,0.0,0.3375547243684891,0.999,25/85,16.22%,ATP1B3;SLC6A6;SLC12A2;SLC24A2;ATP1B1;SLC6A9;ATP1A2;SCN2A;SCN8A;SLC9B2;SLC5A6;SLC8A3;SLC6A1;SLC4A8;SLC5A5;SCN3A;SLC6A17;SLC6A7;HCN1;SLC6A5;NEDD4L;SCN4B;SCN9A;SLC6A12;SLC8A2
prerank,toll-like receptor signaling pathway (GO:0002224),0.5757844465738697,1.677734692672435,0.0010683760683760685,0.17480460395923497,1.0,25/84,15.55%,NR1H4;RFTN1;LBP;TNIP1;COLEC12;TLR2;BIRC3;IRAK3;TIRAP;LY96;CTSS;CD36;LGALS9;CTSB;TLR7;PIK3AP1;CTSK;CD14;CTSL;IRAK2;PIK3C3;HSPD1;PIK3R4;CASP8;IRAK4
prerank,low-density lipoprotein particle remodeling (GO:0034374),0.7892720657477069,1.6763165289476143,0.01078582434514638,0.1759244537870751,1.0,4/11,8.20%,LIPC;PLA2G5;ABCG1;PLA2G7
prerank,inflammatory response (GO:0006954),0.5379831629980999,1.675819004740487,0.0,0.17552805406982844,1.0,46/195,15.90%,CCL11;SCUBE1;HP;HPR;CCL7;CXCL5;OLR1;CXCL1;HSPG2;CRP;ADM;TLR2;CMKLR1;CD40;XCL1;REL;ANXA1;CCR1;RAC1;AIF1;HRH4;STAT3;PTGDR;CCL5;FCGR2B;PXK;CXCL10;LGALS9;HRH1;NOD1;IL22;NFKB1;CD14;HDAC5;CXCR4;PTGER4;LOXL3;PJA2;LTB4R2;CCL2;PRDX5;RELB;TNFRSF4;TNF;TRAF3IP2;CX3CL1
prerank,response to cytokine (GO:0034097),0.5421776503679325,1.6748389425548824,0.0,0.1760996159073818,1.0,49/141,17.83%,COL3A1;IL23R;ADIPOQ;IL1RL2;OSMR;PTPN7;PRKCA;JAK2;STAT1;DPYSL3;TIMP1;CD40;ALDH1A2;REL;BCL2;IL1R1;IRAK3;CASP1;SHFL;ANXA1;PID1;PTPN13;KHSRP;CYP27B1;IKBKE;STAT3;TRIM21;DDOST;LGALS9;PTPN6;TRIM56;CDK9;PTPN18;CXCR4;EIF2AK2;PTPN5;SMAD3;IRAK2;RELB;CASP8;PTPN2;IFNAR2;SP100;TLE5;LIFR;TIMP2;PTPN23;RHOA;PTPN9
prerank,regulation of smooth muscle cell migration (GO:0014910),0.7065834817844838,1.6748123183355568,0.013717421124828532,0.17472086046926544,1.0,7/20,7.35%,LRP1;NRP1;PDGFRB;VTN;CCN4;IGFBP5;CCL5
prerank,regulation of response to external stimulus (GO:0032101),0.549322933536694,1.673986329005791,0.0,0.17502794160060275,1.0,31/121,10.70%,CASP4;ZBP1;IL1RL2;PDGFRA;PTGES;SBNO2;BCL6;LACC1;BIRC3;WNT5A;JAK2;XCL1;GATA6;IL1R1;CASP1;IRF1;TIRAP;ANXA1;TREM2;CELF1;CASP12;CD36;ADAMTS12;FCGR2B;AREL1;BRD4;NR1D2;GUCA1B;PIK3AP1;USP14;CXCR4
prerank,diacylglycerol metabolic process (GO:0046339),-0.5356434502690031,-1.6737091382151417,0.00851063829787234,0.34199532672858907,0.999,10/23,16.40%,PLCE1;DGKB;DGKI;DGKG;LIPE;DGAT1;DGKQ;DGKA;DGKZ;PNPLA2
prerank,actin filament bundle assembly (GO:0051017),0.6358603629949329,1.6731747962116554,0.00865265760197775,0.1755310096597839,1.0,12/33,6.53%,MYO1B;PDXP;LCP1;DPYSL3;RHOD;BAIAP2;CALD1;AIF1L;LIMA1;FSCN1;ADD2;AIF1
prerank,regulation of cell killing (GO:0031341),0.7238920405370717,1.6700202220000873,0.0058997050147492625,0.18082720042364075,1.0,5/16,6.24%,CFH;WNT5A;DVL2;RAC1;ICAM1
prerank,regulation of epidermal cell differentiation (GO:0045604),0.6946326156447157,1.6665329033785177,0.018641810918774968,0.1868626706148581,1.0,8/21,12.31%,RUNX1;ZFP36L1;SFRP4;ERRFI1;CBFB;CTSK;MAFG;CTSL
prerank,"regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043370)",0.7996410933984271,1.6653823993542571,0.015174506828528073,0.1878729434301427,1.0,4/10,12.06%,RUNX1;RUNX3;CBFB;SH3RF1
prerank,lipoprotein transport (GO:0042953),0.7923113514233455,1.6639123595780456,0.012718600953895072,0.1895404711401209,1.0,5/10,8.94%,LRP1;VMP1;MIA3;CD36;PPARG
prerank,establishment of protein localization to extracellular region (GO:0035592),0.6236487777921768,1.6636837066438963,0.008771929824561403,0.18855860364814825,1.0,11/39,9.79%,LTBP2;ABCA1;MIA3;ARFGAP3;STEAP3;RAB8B;RCN3;CANX;COPG1;RAB10;TVP23B
prerank,positive regulation of toll-like receptor 4 signaling pathway (GO:0034145),0.8063831650261644,1.6634669840876355,0.010852713178294573,0.18752808150647116,1.0,2/10,4.50%,LBP;TIRAP
prerank,regulation of fibroblast growth factor receptor signaling pathway (GO:0040036),0.6819392470025316,1.6632485537794874,0.009345794392523364,0.18653718331542313,1.0,6/20,12.01%,SULF1;CREB3L1;APLN;PRKD2;SPRY2;FGF2
prerank,positive regulation of lymphocyte chemotaxis (GO:0140131),0.7407413489381562,1.6604913766754508,0.017391304347826087,0.1914034527525742,1.0,4/14,7.35%,CCL7;WNT5A;XCL1;CCL5
prerank,regulation of axon guidance (GO:1902667),0.784888446116559,1.6592884376616215,0.012403100775193798,0.19258310678114565,1.0,4/10,10.48%,NRP1;MYCBP2;ZSWIM6;ZSWIM8
prerank,regulation of smoothened signaling pathway (GO:0008589),0.6010236974238264,1.658223636368333,0.0,0.19359013095974195,1.0,17/50,17.85%,RORA;STK36;GLI3;SFRP1;SUFU;KCTD21;SHH;RAB34;CREBBP;GAS1;ZIC1;DLG5;HERC4;TULP3;IFT81;PTCH1;SMO
prerank,positive regulation of cytokine production (GO:0001819),0.5263466534782095,1.6581360418739532,0.0,0.1923299102390533,1.0,58/292,13.50%,RORA;RUNX1;GLMN;NR1H4;CYP1B1;C3;ZBP1;SULF1;IL23R;ADIPOQ;CCBE1;RFTN1;LBP;IL16;LACC1;CD276;TLR2;IRF7;WNT5A;LPL;CD40;XCL1;STOML2;BATF;IL1R1;TSLP;IRF1;TIRAP;ANXA1;ARNT;PRKD2;TMEM106A;PLA2R1;POLR3D;MDK;NFKB2;AIF1;EIF2AK3;STAT3;CREBBP;PAEP;RAB7B;LGALS9;IL33;NOD1;HPSE;TLR7;NFKB1;CD14;MAPK11;XBP1;EIF2AK2;PTGER4;LAMTOR5;IL7;TRAF2;POLR2K;STAT6
prerank,eosinophil chemotaxis (GO:0048245),0.7305801968010817,1.6579539869526088,0.011267605633802818,0.18985749307138677,1.0,2/14,0.43%,CCL11;CCL7
prerank,eosinophil migration (GO:0072677),0.7305801968010817,1.6579539869526088,0.011267605633802818,0.18985749307138677,1.0,2/14,0.43%,CCL11;CCL7
prerank,sodium ion homeostasis (GO:0055078),-0.5259827068048197,-1.656916765683944,0.011194029850746268,0.3784000740517971,1.0,4/21,2.13%,ATP1B3;SLC12A2;ATP1B1;ATP1A2
prerank,negative regulation of epidermal growth factor receptor signaling pathway (GO:0042059),0.6088003483286196,1.6562960357839578,0.0059665871121718375,0.19219328826240945,1.0,22/43,20.05%,CBLB;SH3KBP1;ERRFI1;PTPN3;EGF;EGFR;CBL;CDC42;MVP;RAB7A;SPRY2;GRB2;SNX6;PTPN2;EPS15L1;SOCS5;ITGA1;PTPRJ;BTC;HGS;ZGPAT;EPS15
prerank,positive regulation of protein maturation (GO:1903319),0.7926080782290041,1.6560560725426048,0.01078582434514638,0.1913454505667534,1.0,2/11,1.22%,CCBE1;NKD2
prerank,regulation of cytokine-mediated signaling pathway (GO:0001959),0.5732280866325256,1.6531444120896504,0.0022197558268590455,0.1962601567602057,1.0,28/72,17.04%,RUNX1;ZBP1;JAK1;TNFAIP3;BIRC3;JAK2;STAT1;IRAK3;TSLP;CFLAR;ABCE1;CBFB;PTPN6;PTPN1;CLIP3;IL7;TRAF2;IRAK2;IFNGR1;CASP8;CDC37;PTPN2;IFNAR2;TNF;LIFR;IFNGR2;RBCK1;TNFRSF1A
prerank,branching involved in blood vessel morphogenesis (GO:0001569),0.7606499201584327,1.6531272532820998,0.01848998459167951,0.19488772772904644,1.0,5/13,8.86%,COL4A1;NRP1;SFRP2;SHH;SEMA3E
prerank,ATP transport (GO:0015867),-0.6717139152575133,-1.652566395400637,0.04336043360433604,0.379922387950849,1.0,6/10,22.07%,SLC25A4;SLC25A42;CD47;SLC25A17;SLC17A9;ABCC6
prerank,SRP-dependent cotranslational protein targeting to membrane (GO:0006614),-0.3858845922490754,-1.6515989086244867,0.0,0.37210145732685634,1.0,43/87,22.20%,RPL34;RPL8;RPL18A;RPL36;RPL19;RPL38;RPL5;RPS23;RPLP0;RPS10;RPL32;RPS4X;RPL10;RPL15;RPL29;RPS16;RPS27;RPS19;RPS12;RPS21;RPS13;RPL13;RPL27;RPL7A;RPL35;RPL28;RPL30;RPS8;RPS17;RPL37A;RPS6;RPL41;RPS18;RPS20;RPL7;RPL13A;RPS15A;RPS5;UBA52;ZFAND2B;RPS29;RPLP1;RPL21
prerank,negative regulation of tumor necrosis factor production (GO:0032720),0.6099775625173695,1.651430426248135,0.006082725060827251,0.19693895559447555,1.0,13/41,16.08%,NR1H4;ADIPOQ;LBP;TNFAIP3;IRAK3;LGALS9;ILRUN;PTPN6;DICER1;SIRPA;SELENOS;CX3CL1;MC1R
prerank,positive regulation of T-helper 1 type immune response (GO:0002827),0.7651937776897,1.6508559486596406,0.013761467889908258,0.19679969515444526,1.0,3/12,4.22%,IL23R;XCL1;IL1R1
prerank,regulation of toll-like receptor signaling pathway (GO:0034121),0.6638623799314107,1.65052745108696,0.009247027741083224,0.1961509723425069,1.0,10/26,9.15%,TLR2;IRF7;BIRC3;FLOT2;SMPDL3B;IRAK3;IRF1;TREM2;CD36;GPR108
prerank,cellular response to cytokine stimulus (GO:0071345),0.51973706982913,1.6499870963465162,0.0,0.19583314178820996,1.0,116/416,17.84%,RORA;MMP3;CCL11;COL1A2;IL34;CCL7;IL23R;MMP2;IL1RL2;CXCL1;ZEB1;OSMR;LBP;CXCL12;ZFP36L1;TNFRSF21;TEC;SBNO2;JAK1;BCL6;GHR;PTPN7;TNFSF11;IL16;SFRP1;GAB2;SYNCRIP;TLR2;WNT5A;NUMBL;JAK2;STAT1;DPYSL3;TIMP1;CD40;IL10RA;PRTN3;XCL1;ZFP36L2;BCL2;BATF;IL1R1;IRAK3;CASP1;IRF1;ANXA1;ADAMTS7;POU2F1;PID1;PTPN13;FSCN1;CCR1;KHSRP;GBP7;ICAM1;NPR2;AIF1;CEBPD;STAT3;CBL;CD36;CCL5;PIK3R1;ADAMTS12;CXCL10;LGALS9;PTPN6;GREM2;IL3RA;TCF7;STAT5A;IL22;CDK9;PTPRZ1;ERBIN;NFKB1;PTPN18;CXCR4;MAPK11;GBP3;XBP1;GRB2;SDC1;PTPN5;FGF2;SIRPA;IL7;TANK;STAT6;CCL2;SMAD3;IRAK2;JUNB;IFNGR1;GSK3B;BAG4;GAPDH;PTPN2;IRAK4;IFNAR2;TNF;CX3CL1;SOCS5;LIFR;IFNGR2;VAV1;TNFRSF1A;EPRS1;PTPRJ;TXLNA;PTPN23;SMPD4;RHOA;NFE2L2;PTPN9;PTGS2
prerank,regulation of macrophage derived foam cell differentiation (GO:0010743),0.664484997658875,1.6482328260086134,0.01227830832196453,0.19839665617458263,1.0,9/27,10.12%,ABCA1;ADIPOQ;CRP;LPL;PLA2G5;ABCG1;CD36;PPARG;NFKB1
prerank,basement membrane organization (GO:0071711),0.743746384626928,1.6477127077913556,0.013313609467455622,0.19825122683852506,1.0,6/14,7.26%,COL4A1;LAMB1;FLRT2;NID1;CTSS;PXDN
prerank,negative regulation of fibroblast growth factor receptor signaling pathway (GO:0040037),0.7441843382075422,1.647446669181934,0.013177159590043924,0.19751218454475664,1.0,5/14,12.01%,SULF1;CREB3L1;APLN;SPRY2;FGF2
prerank,apical junction assembly (GO:0043297),-0.43007768384736267,-1.6465741654144386,0.0,0.3760389368548394,1.0,14/53,17.65%,OCLN;PECAM1;CLDN5;ESAM;PARD3;RAMP2;CDH5;APC;CLDN14;CLDN1;VCL;F11R;ARL2;MPP7
prerank,regulation of chemokine production (GO:0032642),0.6242862626360811,1.6459905797006336,0.006211180124223602,0.19943474282861362,1.0,12/36,12.48%,TLR2;WNT5A;LPL;SNAI2;TSLP;TREM2;AIF1;LGALS9;IL33;TLR7;EIF2AK2;IL7
prerank,alcohol catabolic process (GO:0046164),0.8012142726867397,1.6437484341235906,0.015748031496062992,0.20300441838432234,1.0,2/10,3.63%,CEL;APOE
prerank,regulation of cellular response to growth factor stimulus (GO:0090287),0.7209928281888637,1.6436686267855636,0.009615384615384616,0.20186392703565229,1.0,4/17,2.54%,SULF1;FSTL1;SFRP4;CASK
prerank,regulation of macrophage differentiation (GO:0045649),0.7394958392939399,1.6434403532505737,0.02170767004341534,0.20101821667887576,1.0,3/15,2.11%,IL34;ADIPOQ;PRKCA
prerank,regulation of plasminogen activation (GO:0010755),0.7518542154633582,1.6432203864511623,0.011869436201780416,0.20017008115443213,1.0,4/12,10.64%,RUNX1;SERPINE2;ENO1;CLEC3B
prerank,cholesterol transport (GO:0030301),0.6019899535176321,1.6426798952307404,0.009685230024213076,0.20001971443518862,1.0,11/45,10.27%,CEL;ABCA1;LIPC;APOE;ABCG1;LIMA1;RELCH;CD36;SOAT1;NPC2;VPS4A
prerank,negative regulation of nucleocytoplasmic transport (GO:0046823),0.7625259785576153,1.6410958256843053,0.010071942446043165,0.20192465826775136,1.0,4/13,9.64%,MDFIC;APOD;SUFU;NUP153
prerank,negative regulation of tumor necrosis factor superfamily cytokine production (GO:1903556),0.5999333684418061,1.6369560487217951,0.008373205741626795,0.20998516077676052,1.0,13/43,16.08%,NR1H4;ADIPOQ;LBP;TNFAIP3;IRAK3;LGALS9;ILRUN;PTPN6;DICER1;SIRPA;SELENOS;CX3CL1;MC1R
prerank,protein autoprocessing (GO:0016540),0.7036424330842942,1.636715444519713,0.015193370165745856,0.20917392174009986,1.0,6/17,12.31%,CASP4;CASP1;FXN;OMA1;MYRF;CTSL
prerank,activin receptor signaling pathway (GO:0032924),0.7299221478893945,1.6363086261629105,0.015759312320916905,0.20879289898649586,1.0,8/15,17.47%,SMAD2;TGFBR1;ACVR1B;ACVR1;INHBB;ACVR2A;SMAD3;ACVR1C
prerank,negative regulation of cartilage development (GO:0061037),0.740435345759503,1.6361241149053833,0.01466275659824047,0.20781041988640947,1.0,5/13,8.31%,SNAI2;ADAMTS7;WNT9A;ADAMTS12;TGFBR1
prerank,negative regulation of protein polymerization (GO:0032272),-0.49201380642439263,-1.635901486120689,0.009216589861751152,0.3970565158070991,1.0,11/27,13.03%,MAP2;KANK3;CDH5;TWF2;EML2;KANK4;HIP1R;SLIT2;STMN2;PFN1;TWF1
prerank,lipid phosphorylation (GO:0046834),-0.659969101487291,-1.6347155735214773,0.024390243902439025,0.3904204523656741,1.0,6/10,14.70%,DGKB;DGKI;DGKG;DGKQ;DGKA;DGKZ
prerank,cellular response to organic substance (GO:0071310),0.5385594439638364,1.6338890228893332,0.0,0.21186085185736359,1.0,30/116,11.82%,NR1H4;CYP1B1;IBSP;IL1RL2;ROBO2;GHR;PTPN7;SLIT3;SFRP1;DPYSL3;LRRK2;CASP1;IGFBP5;PID1;PTPN13;KHSRP;STAT3;CCL5;TGFBR1;ACVR1B;PTPN6;ACVR1;CDK9;PTPN18;CLEC3B;CXCR4;ACVR2A;RPS6KB1;CYP1A1;PTPN5
prerank,toxin transport (GO:1901998),0.7933501238517962,1.633506158056088,0.012618296529968454,0.21143799174529812,1.0,2/10,0.68%,ANTXR2;ANTXR1
prerank,negative regulation of hemostasis (GO:1900047),0.7563443925536468,1.6323068188681988,0.01422475106685633,0.2127733431206925,1.0,5/12,7.25%,KNG1;SERPINE2;VTN;APOE;APOH
prerank,regulation of toll-like receptor 2 signaling pathway (GO:0034135),0.7506503607230662,1.6309920597902665,0.022156573116691284,0.21446098237891972,1.0,4/11,12.11%,TNFAIP3;TIRAP;TREM2;PJA2
prerank,positive regulation of osteoclast differentiation (GO:0045672),0.7203658797407073,1.6309573745745796,0.01867816091954023,0.2132400582323752,1.0,3/14,5.52%,IL23R;TNFSF11;CCR1
prerank,glutamine family amino acid catabolic process (GO:0009065),-0.5906404968435786,-1.630812799386269,0.020689655172413793,0.39217777371237433,1.0,6/13,12.32%,NOS3;PRODH;GLUD1;GAD1;GLS;GLUL
prerank,regulation of receptor signaling pathway via STAT (GO:1904892),0.7308547848082759,1.6297410834625694,0.01361573373676248,0.21479121938439064,1.0,4/13,4.44%,MGAT5;JAK2;EGF;TSLP
prerank,positive regulation of ERK1 and ERK2 cascade (GO:0070374),0.5273697232542112,1.6267884939270807,0.0020491803278688526,0.22043118585248084,1.0,34/151,15.90%,ROR2;CCL11;ROR1;CCL7;PDGFRA;FSHR;TNFSF11;PRKCA;NRP1;PDGFRB;PLA2G5;XCL1;APOE;TIRAP;PRKD2;TREM2;CCR1;ICAM1;EGFR;CD36;CCL5;LGALS9;MAP2K1;SPRY2;GCNT2;FGF2;GPNMB;CCL2;DDT;FBXW7;NTRK3;GAREM1;TNF;CX3CL1
prerank,regulation of interleukin-12 production (GO:0032655),0.5802968770543391,1.6264224544158379,0.012135922330097087,0.2200898755329898,1.0,12/47,13.99%,IL23R;IL16;TLR2;CMKLR1;CD40;IRAK3;TIRAP;MDK;LGALS9;MAPK11;MAST2;HSPD1
prerank,carnitine shuttle (GO:0006853),-0.6329099653832548,-1.6253426706333132,0.03757225433526012,0.3982793039438343,1.0,2/11,0.70%,PRKAG2;PRKAA2
prerank,negative regulation of chondrocyte differentiation (GO:0032331),0.7273441067874163,1.6225228398845721,0.023564064801178203,0.22783247468029424,1.0,5/14,8.31%,SNAI2;ADAMTS7;WNT9A;ADAMTS12;TGFBR1
prerank,blood vessel morphogenesis (GO:0048514),0.5751286798681968,1.6219440585896043,0.005820721769499418,0.2276841537036087,1.0,13/54,8.31%,GLMN;COL4A1;CYP1B1;CCBE1;ITGB8;LAMA1;NRP1;ADM;SHH;CCM2;TNNI3;NF1;TGFBR1
prerank,embryonic skeletal system development (GO:0048706),0.6226143250989047,1.6217476094077716,0.011138613861386138,0.22678792622229357,1.0,7/35,4.91%,COL1A1;SULF1;PDGFRA;DEAF1;WNT5A;HOXB3;WNT9A
prerank,regulation of intrinsic apoptotic signaling pathway in response to DNA damage (GO:1902229),0.7085995438440745,1.621708873570257,0.027220630372492838,0.2255265871103609,1.0,6/16,5.70%,CXCL12;SNAI1;SFRP2;SNAI2;CDKN2D;FBH1
prerank,negative regulation of endopeptidase activity (GO:0010951),0.587656671073031,1.6212335846866717,0.012121212121212121,0.22535218829042175,1.0,10/47,9.50%,KNG1;SERPING1;FETUB;SERPINE2;TIMP1;VTN;SERPINH1;SERPINA2;SERPINF1;BIN1
prerank,positive regulation of interleukin-12 production (GO:0032735),0.621849460559712,1.620534779470521,0.019762845849802372,0.22559302430480735,1.0,9/31,13.99%,IL23R;IL16;TLR2;CD40;TIRAP;MDK;LGALS9;MAPK11;HSPD1
prerank,cardiac muscle cell action potential (GO:0086001),-0.45931403568554213,-1.6204306904434536,0.01,0.4028320990258612,1.0,10/30,9.98%,DMD;ATP1B1;ANK2;ATP1A2;KCNJ2;FGF12;KCND3;CACNA1D;SLC4A3;KCNQ1
prerank,membrane assembly (GO:0071709),0.6115849405451184,1.6197949427595506,0.012690355329949238,0.2259918311380203,1.0,10/34,11.07%,CEL;RFTN1;UGCG;FLOT2;CHMP4B;PTEN;UBXN2A;TLCD2;VPS4A;TLCD1
prerank,"synaptic transmission, glutamatergic (GO:0035249)",-0.5589686397305028,-1.6179947468518723,0.02622950819672131,0.40140436138527996,1.0,4/18,2.40%,UNC13C;GRID2;GRIK4;UNC13B
prerank,actin filament depolymerization (GO:0030042),-0.6280841564832722,-1.617394919526247,0.011764705882352941,0.39403662943237905,1.0,10/11,34.51%,TWF2;GSN;MICAL3;MICAL1;TWF1;DSTN;MICAL2;CFL2;CFL1;WDR1
prerank,skeletal system morphogenesis (GO:0048705),0.6074854937778498,1.6171001571041441,0.01775147928994083,0.23124610550574365,1.0,9/42,10.21%,MMP13;PDGFRA;FBN2;SFRP4;ANKRD11;HOXB3;FGFR1;TGFBR1;SPEF2
prerank,lymphocyte migration (GO:0072676),0.6207385776396657,1.617064527700796,0.006321112515802781,0.23002475857537436,1.0,7/32,15.90%,CCL11;CCL7;XCL1;CCL5;MSN;CCL2;CX3CL1
prerank,regulation of execution phase of apoptosis (GO:1900117),0.7543828818112321,1.6165462731715556,0.03129890453834116,0.22988828051469357,1.0,2/11,0.29%,FAP;DLC1
prerank,regulation of extracellular matrix disassembly (GO:0010715),0.7110928500323668,1.6153277976376759,0.015337423312883436,0.2313362049352518,1.0,6/15,9.23%,FAP;LRP1;CARMIL2;DDR2;FSCN1;DDR1
prerank,regulation of Wnt signaling pathway (GO:0030111),0.5353345636367933,1.6148432179800898,0.004273504273504274,0.23117074607324278,1.0,27/108,12.51%,RUNX1;SULF1;LRP1;MDFIC;NKD2;KREMEN1;TNFAIP3;SFRP4;ATP6AP2;SFRP1;SFRP2;TLR2;GSKIP;LRRK2;TLE1;TAX1BP3;FRZB;CDK14;WLS;DISC1;CBFB;FAM53B;MDFI;SALL1;SFRP5;TERT;PTK7
prerank,regulation of tumor necrosis factor production (GO:0032680),0.5313266688940218,1.6140681006050457,0.002105263157894737,0.23158256781275213,1.0,33/112,18.81%,NR1H4;ADIPOQ;LBP;SPN;TNFAIP3;TLR2;WNT5A;JAK2;LPL;IRAK3;TIRAP;LY96;TMEM106A;ARFGEF2;STAT3;LGALS9;ILRUN;PTPN6;IL33;CD14;DICER1;SIRPA;EPHB2;SELENOS;DDT;IFNGR1;CX3CL1;MC1R;PSEN1;PTPRJ;SPHK2;TLR3;TRIM27
prerank,epithelial cell migration (GO:0010631),0.6046914395718552,1.61333962143106,0.013801756587202008,0.23203559255957704,1.0,6/37,3.24%,FAP;CYP1B1;ZEB2;FSTL1;NRP1;STAT1
prerank,positive regulation of receptor signaling pathway via JAK-STAT (GO:0046427),0.6495895495321321,1.6129961408010847,0.02032520325203252,0.23163000120465993,1.0,6/23,7.88%,CYP1B1;GHR;JAK2;IL10RA;CCL5;OCIAD2
prerank,muscle cell differentiation (GO:0042692),0.6188833087799835,1.6116648259295396,0.008771929824561403,0.23353792967005468,1.0,6/32,3.64%,RORA;GLMN;MRTFA;TBX18;FBXO40;GATA6
prerank,regulation of cellular carbohydrate metabolic process (GO:0010675),0.6950410787503567,1.6079719570821376,0.025423728813559324,0.2410591765269601,1.0,2/16,0.51%,RORA;ADIPOQ
prerank,regulation of interleukin-17 production (GO:0032660),0.6311566658079204,1.607226698773286,0.010256410256410256,0.24158520044055654,1.0,3/31,0.97%,NR1H4;IL23R;RFTN1
prerank,carbohydrate derivative transport (GO:1901264),0.6735109432114655,1.6070003273612399,0.026988636363636364,0.24073588527145717,1.0,7/18,9.71%,LBP;SLC15A3;SLC29A1;ABCG1;PLTP;SLC25A19;NPC2
prerank,response to copper ion (GO:0046688),-0.5233282060615573,-1.6068409137569926,0.03558718861209965,0.41594420074182387,1.0,11/20,25.45%,MT2A;ATP5F1D;HSF1;MT1B;MT1X;MT1G;MT1F;MT1E;MT1M;MT1H;MT1A
prerank,growth hormone receptor signaling pathway via JAK-STAT (GO:0060397),0.7665850114012748,1.606735683309133,0.012578616352201259,0.23998984441971977,1.0,6/10,13.50%,GHR;JAK2;STAT3;STAT5A;PTPN1;STAT6
prerank,cardiac muscle cell membrane repolarization (GO:0099622),-0.6326511963510055,-1.6058965167498858,0.033426183844011144,0.4092207546292935,1.0,5/11,9.98%,ATP1B1;KCNJ2;KCNJ3;KCND3;KCNQ1
prerank,Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation (GO:1904953),0.7810334433780781,1.6055994578039872,0.022364217252396165,0.2416037604940812,1.0,4/10,13.77%,WNT2;WNT5A;FZD1;LRP6
prerank,positive regulation of collagen biosynthetic process (GO:0032967),0.7089003296044604,1.6054554688101705,0.025787965616045846,0.2406418860386296,1.0,2/16,0.58%,RUNX1;CREB3L1
prerank,regulation of hemopoiesis (GO:1903706),0.7807354736631029,1.6047226189149555,0.023510971786833857,0.24127609873057984,1.0,5/10,8.40%,RUNX1;PTN;MAFB;CREBBP;CBFB
prerank,regulation of ERK1 and ERK2 cascade (GO:0070372),0.5143929210534189,1.6044721133784876,0.0,0.24056460547013575,1.0,51/214,15.90%,ROR2;CCL11;ROR1;EPHA7;CCL7;ADIPOQ;PDGFRA;FBLN1;FSHR;TNIP1;PRKCA;NRP1;PDGFRB;PLA2G5;XCL1;APOE;DUSP26;TIRAP;PRKD2;TREM2;PTEN;CCR1;CNKSR3;SPRED1;SPRED2;ICAM1;EGFR;CD36;CCL5;LGALS9;PTPN6;MAP2K1;PTPN1;SPRY2;EMILIN1;GCNT2;FGF2;GPNMB;SIRPA;EPHB2;RANBP9;CCL2;ITGB1BP1;DDT;FLCN;FBXW7;NTRK3;GAREM1;PTPN2;TNF;CX3CL1
prerank,negative regulation of coagulation (GO:0050819),0.7244486319020392,1.6038902814691192,0.01680672268907563,0.24074498014076628,1.0,5/14,7.25%,KNG1;SERPINE2;VTN;APOE;APOH
prerank,positive regulation of bone resorption (GO:0045780),0.7552597059831345,1.6032836711124572,0.0258751902587519,0.24094493472315015,1.0,3/11,2.11%,SPP1;TNFSF11;PRKCA
prerank,regulation of protein autophosphorylation (GO:0031952),0.607066498410859,1.6032314579447204,0.011180124223602485,0.2397605582592672,1.0,13/36,13.46%,EPHA7;ENPP1;ADIPOQ;ERRFI1;TNKS1BP1;RAP2A;RASSF2;MVP;PPP2R5A;CALM3;TOM1L1;GPNMB;CALM2
prerank,regulation of smooth muscle contraction (GO:0006940),-0.5175226174859969,-1.6030669777293514,0.022058823529411766,0.4087955780135699,1.0,10/20,22.37%,PLCE1;CAV1;KCNB2;CHRM2;CHRM3;MYOCD;ADRB2;SPHK1;ZDHHC21;SRF
prerank,cellular response to transforming growth factor beta stimulus (GO:0071560),0.5298669105940742,1.60098084611423,0.0,0.24391371747427062,1.0,26/112,13.71%,COL1A2;LTBP2;PDE3A;COL3A1;WNT2;ZFP36L1;SOX5;ZMIZ1;ITGB5;SFRP1;WNT5A;USP9X;XCL1;SMAD2;ZFP36L2;LIMS1;CBL;TGFBR1;ACVR1;TGFB3;CLEC3B;GCNT2;SMAD5;PTK2;SMURF1;SMAD3
prerank,negative regulation of B cell proliferation (GO:0030889),0.7554217501650795,1.600682616240954,0.028391167192429023,0.24341822817042985,1.0,4/11,8.05%,TNFRSF21;BLK;ATM;FCGR2B
prerank,negative regulation of cell junction assembly (GO:1901889),0.6340684335764594,1.6005731436926913,0.027450980392156862,0.24240752811025942,1.0,15/25,22.29%,DLC1;APOD;ROBO2;SLIT1;TLR2;PTEN;ARHGAP6;ITGB1BP1;PHLDB2;TNF;ROCK2;CORO1C;BCAS3;SRC;ACVRL1
prerank,retinal metabolic process (GO:0042574),0.7448075841626137,1.6001210331160964,0.020186335403726708,0.2424161978892745,1.0,2/12,3.48%,CYP1B1;RDH10
prerank,"positive regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043517)",0.714106346850512,1.5994493313130191,0.0286144578313253,0.24275251471732523,1.0,6/13,6.96%,EEF1E1;PLA2R1;SPRED1;SPRED2;ATM;ATR
prerank,negative regulation of lipid storage (GO:0010888),0.6674292527605884,1.5989983330011712,0.02653631284916201,0.2426558438523471,1.0,7/19,15.60%,ABCA1;CRP;ABCG1;TREM2;PPARG;PTPN2;TNF
prerank,glutamate receptor signaling pathway (GO:0007215),-0.4450291589636083,-1.5985966098213895,0.005376344086021506,0.41219876690224955,1.0,13/37,18.17%,GRM7;GRM1;GRID2;GRIK4;GRM3;GRM8;PLCB1;HOMER2;GRIN3A;GRIN2B;GRM5;GRIA2;HOMER3
prerank,toll-like receptor 4 signaling pathway (GO:0034142),0.6894977012143122,1.5985229862994899,0.02309782608695652,0.24252408888753704,1.0,7/19,10.63%,NR1H4;LBP;TIRAP;LY96;LGALS9;PIK3AP1;CD14
prerank,cellular response to tumor necrosis factor (GO:0071356),0.51404178073368,1.5984761632940718,0.0,0.2414251157343107,1.0,50/175,19.89%,PSMA7;CCL11;MAP3K14;CCL7;ZFP36L1;TNFRSF21;TNFSF11;SFRP1;BIRC3;JAK2;PLVAP;STAT1;CD40;XCL1;ZFP36L2;ADAMTS7;PID1;EDA2R;LIMS1;CCL5;ADAMTS12;TNFRSF12A;PSMD4;TNFRSF9;PSMD11;ERBIN;GBP3;PSMB8;PYDC1;EDA;TANK;TRAF2;CCL2;COMMD7;BAG4;TNFRSF4;TNF;PSMA6;CX3CL1;EDAR;TNFRSF1A;SMPD4;NFE2L2;PSMD14;FOXO3;PSMC6;PSMB10;PSMD12;PSMB1;TRAF5
prerank,bone development (GO:0060348),0.5950280778005517,1.5984465851455243,0.012033694344163659,0.24028093313659016,1.0,5/39,2.38%,MMP13;SULF1;SH3PXD2B;SFRP4;LRRC17
prerank,glycosaminoglycan catabolic process (GO:0006027),0.5629104065462858,1.596385942050652,0.009291521486643438,0.2441205485816463,1.0,19/55,16.63%,DCN;CEMIP;LUM;HSPG2;BGN;GPC6;SLC9A1;VCAN;PRELP;CEMIP2;HPSE;SDC2;SDC1;FGF2;HGSNAT;LYVE1;GALNS;GNS;IDS
prerank,steroid hormone mediated signaling pathway (GO:0043401),-0.596287914669855,-1.59593839036873,0.036414565826330535,0.4107168611486555,1.0,3/13,2.57%,NR3C2;BMP4;ESR1
prerank,embryonic eye morphogenesis (GO:0048048),0.7543569578584377,1.595468750474521,0.018518518518518517,0.2450192693546935,1.0,5/11,18.08%,FBN2;FBN1;TBX2;LRP6;MFAP5
prerank,neurotrophin signaling pathway (GO:0038179),-0.5052022202255709,-1.5922015202749886,0.011494252873563218,0.41243595648687187,1.0,9/21,13.56%,KIDINS220;SORT1;ZFYVE27;RAPGEF2;CASP3;DDIT4;NTRK2;BDNF;RAP1A
prerank,regulation of blood coagulation (GO:0030193),0.6307471138588197,1.5915745381578252,0.020075282308657464,0.25319977586333164,1.0,7/27,9.14%,FAP;KNG1;SERPINE2;VTN;APOE;APOH;HPSE
prerank,regulation of actomyosin structure organization (GO:0110020),0.7145588602917897,1.5909447209698793,0.03240058910162003,0.25369068931166666,1.0,7/13,11.72%,SLC9A1;ALMS1;ASAP3;RAC1;CDC42;AKAP13;PTGER4
prerank,regulation of homotypic cell-cell adhesion (GO:0034110),0.7505290031836986,1.5906468755617538,0.0336,0.2530921010083939,1.0,5/11,7.35%,JAK1;TNFSF11;PRKCA;BLK;CCL5
prerank,lipid homeostasis (GO:0055088),0.5609480810291818,1.589472321767736,0.011695906432748537,0.25490595695008617,1.0,16/57,11.07%,ABCA1;USF1;ABCA2;APOE;ABCG1;TREM2;RCN3;TLCD2;ZBTB20;PPARG;ACOX1;ADCK1;NR1D2;ACOX3;XBP1;TLCD1
prerank,negative regulation of cell differentiation (GO:0045596),0.5035344652036469,1.5885306980234881,0.0,0.2561061262557967,1.0,40/181,11.29%,RORA;ABCA1;ENPP1;ADIPOQ;COL5A2;YAP1;TNN;MEIS2;ASXL1;COL5A1;SFRP1;CRP;SFRP2;WNT5A;SUFU;ZFPM2;SNAI2;ZFP36L2;JAG1;ABCG1;ADAMTS7;WNT9A;RUNX1T1;PTEN;SHH;SPRED1;SPRED2;MEIS1;E2F1;EGFR;BMP5;TRIO;ADAMTS12;TGFBR1;PPARG;CDK6;SPRY2;SIRT2;ADGRV1;WWTR1
prerank,proteasomal ubiquitin-independent protein catabolic process (GO:0010499),0.6538339712734863,1.588264172607386,0.013280212483399735,0.2556124943151629,1.0,1/22,0.01%,PSMA7
prerank,regulation of monocyte chemotaxis (GO:0090025),0.6458293607070237,1.588239029274434,0.022546419098143235,0.25447428508377434,1.0,8/24,11.50%,CXCL12;CCR1;AIF1;CCL5;PLA2G7;CXCL10;MOSPD2;CREB3
prerank,interleukin-27-mediated signaling pathway (GO:0070106),0.7223765650799251,1.5874700794319994,0.021052631578947368,0.2551687884975128,1.0,6/13,12.75%,JAK1;JAK2;STAT1;STAT3;CANX;OASL
prerank,DNA dealkylation involved in DNA repair (GO:0006307),0.7633332255368463,1.5872806086115991,0.029411764705882353,0.2533182977827792,1.0,6/10,12.97%,MPG;ASCC3;MGMT;FTO;ALKBH1;ALKBH5
prerank,DNA dealkylation (GO:0035510),0.7633332255368463,1.5872806086115991,0.029411764705882353,0.2533182977827792,1.0,6/10,12.97%,MPG;ASCC3;MGMT;FTO;ALKBH1;ALKBH5
prerank,melanocyte differentiation (GO:0030318),0.7387630584485527,1.586699483150999,0.031007751937984496,0.2535294066249455,1.0,4/11,3.26%,ENPP1;LRMDA;SLC24A5;MITF
prerank,cellular response to sterol (GO:0036315),0.7263747932012987,1.5845465247975803,0.01908957415565345,0.2576249905059547,1.0,7/13,19.34%,RORA;INSIG2;GRAMD1A;LRP6;PTCH1;SMO;GRAMD1C
prerank,regulation of cytokine production (GO:0001817),0.5189941858640189,1.5836355081638547,0.0010416666666666667,0.2586876907762152,1.0,32/126,16.22%,GLMN;IGF2BP1;ZBP1;IGF2BP2;DTX4;BCL6;CRP;CD276;IRF7;SNAI2;CCN4;BATF;ANXA1;TREM2;PLA2R1;ATP2B1;TRIM21;FCGR2B;LGALS9;IL33;TRIM56;EIF2AK2;PTGER4;GPNMB;SIRPA;MAST2;PLD4;CASP8;GAPDH;TNF;LGR4;NPTN
prerank,regulation of adaptive immune response (GO:0002819),0.6541607385178103,1.5832040355274242,0.02676056338028169,0.2585688721051406,1.0,6/18,10.26%,ADCY7;IRF7;IRF1;FCGR2B;SASH3;AHR
prerank,negative regulation of protein metabolic process (GO:0051248),0.5731507335653647,1.5828989230701336,0.01179245283018868,0.25811720410657407,1.0,14/48,13.80%,IAPP;MAD2L1;APOE;FLOT2;IRAK3;TREM2;AZIN2;EGFR;INHBB;PFDN1;NFKB1;SIRT2;PFDN4;BANP
prerank,regulation of transmembrane transport (GO:0034762),-0.45824290542937235,-1.580772854804596,0.0,0.43753803892558835,1.0,11/31,17.02%,OCLN;SLC2A1;ACTB;KCNJ2;WWP2;KCNJ3;PRKCB;KCNJ13;KCNJ12;NEDD4L;ACE2
prerank,mesonephros development (GO:0001823),-0.620395325159464,-1.5806546593667177,0.04657534246575343,0.4294352865895598,1.0,3/11,4.53%,ZBTB16;BMP4;FGF1
prerank,regulation of cellular biosynthetic process (GO:0031326),0.6207011026176583,1.5795781277474297,0.020860495436766623,0.2649032134929632,1.0,8/28,7.35%,NR1H4;C3;ADIPOQ;NOS1AP;JAK2;MITF;RAC1;CCL5
prerank,cellular sodium ion homeostasis (GO:0006883),-0.5635633127837257,-1.5793397398929176,0.039473684210526314,0.4250534669988361,1.0,4/15,2.13%,ATP1B3;SLC12A2;ATP1B1;ATP1A2
prerank,"regulation of phagocytosis, engulfment (GO:0060099)",0.742401449268091,1.5793112658017538,0.024205748865355523,0.26429180940717695,1.0,2/10,4.76%,C3;TREM2
prerank,hematopoietic stem cell proliferation (GO:0071425),0.7473960004191588,1.5791883283858188,0.033182503770739065,0.26333329294576574,1.0,5/11,4.80%,RUNX1;ETV6;SFRP2;WNT5A;WNT2B
prerank,acute-phase response (GO:0006953),0.7185440841241495,1.5787146588310106,0.035036496350364967,0.26348729914667746,1.0,3/12,9.27%,LBP;CRP;IL22
prerank,regulation of calcium ion transmembrane transport via high voltage-gated calcium channel (GO:1902514),0.7513464618766506,1.5782838214290524,0.02416918429003021,0.26342380937402987,1.0,6/11,9.50%,NOS1AP;CACNB1;CAMK2D;CACNA2D1;SESTD1;BIN1
prerank,protein targeting to ER (GO:0045047),-0.3669084027614916,-1.5774542405979535,0.0136986301369863,0.4225009904529316,1.0,48/99,22.20%,RPL34;RPL8;RPL18A;RPL36;SRPRB;RPL19;RPL38;RPL5;RPS23;RPLP0;RPS10;SPCS2;SPCS3;RPL32;RPS4X;RPL10;RPL15;RPL29;RPS16;RPS27;RPS19;RPS12;RPS21;RPS13;RPL13;RPL27;RPL7A;RPL35;RPL28;RPL30;RPS8;SGTA;RPS17;RPL37A;RPS6;RPL41;RPS18;SPCS1;RPS20;RPL7;RPL13A;RPS15A;RPS5;UBA52;ZFAND2B;RPS29;RPLP1;RPL21
prerank,negative regulation of smooth muscle cell proliferation (GO:0048662),0.6105094887993437,1.577277883719477,0.01608910891089109,0.2646793135222485,1.0,9/33,9.37%,ADIPOQ;APOD;TNFAIP3;APLN;IGFBP5;PTEN;AIF1;PPARG;TGFB3
prerank,retinoid metabolic process (GO:0001523),0.5458707476230762,1.5772573665122895,0.008918617614269788,0.2635537423606225,1.0,14/71,14.40%,CYP1B1;LRP1;HSPG2;GPC6;LPL;ALDH1A2;RDH10;APOE;RDH12;SDC2;CYP1A1;SDC1;STRA6;OPN1MW
prerank,regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043122),0.5046013668799006,1.5765778802428876,0.0020222446916076846,0.26403984210841897,1.0,57/208,17.36%,RORA;NR1H4;ROR1;MAP3K14;ADIPOQ;TRIML2;NEK6;TNIP1;TNFAIP3;BIRC3;WNT5A;STAT1;CD40;ALPK1;REL;CASP1;CFLAR;TIRAP;LITAF;TREM2;TMEM106A;TLE1;EDA2R;UNC5CL;WLS;IKBKE;TRIM21;SLC20A1;LGALS9;TRIM8;SQSTM1;NOD1;TIFA;BRD4;AKAP13;TRIM13;LAMTOR5;TANK;TRAF2;TRIM62;SLC35B2;ATP2C1;CXXC5;CASP8;PELI2;GAPDH;IRAK4;TNF;TRAF3IP2;VAPA;CX3CL1;EDAR;CC2D1A;RBCK1;TNFRSF1A;LPAR1;RHOA
prerank,positive regulation of chemokine production (GO:0032722),0.5787997309563416,1.57631962086984,0.01444043321299639,0.2635232782400744,1.0,12/44,12.48%,ADIPOQ;TLR2;WNT5A;LPL;TSLP;TIRAP;AIF1;LGALS9;IL33;TLR7;EIF2AK2;IL7
prerank,regulation of collagen biosynthetic process (GO:0032965),0.6768288225713277,1.5762649432971991,0.026722925457102673,0.26251195700795094,1.0,5/19,12.70%,RUNX1;CREB3L1;TGFB3;EMILIN1;SUCO
prerank,protein secretion (GO:0009306),0.5573121114916664,1.5756850494090366,0.017543859649122806,0.26287980843193376,1.0,13/56,9.79%,LTBP2;ABCA1;ANXA1;MIA3;ARFGAP3;STEAP3;RAB8B;WLS;RCN3;CANX;COPG1;RAB10;TVP23B
prerank,monocyte chemotaxis (GO:0002548),0.603260999840019,1.575346651407638,0.01987577639751553,0.26252658010758817,1.0,6/32,7.35%,CCL11;CCL7;TNFSF11;XCL1;ANXA1;CCL5
prerank,negative regulation of protein autophosphorylation (GO:0031953),0.7436211589926677,1.575129104261882,0.027692307692307693,0.2619899271559607,1.0,4/10,7.41%,ENPP1;ADIPOQ;ERRFI1;MVP
prerank,"synaptic transmission, GABAergic (GO:0051932)",-0.645886976219001,-1.574344960571601,0.04395604395604396,0.4233593986953108,1.0,8/10,24.36%,GABRA2;GABRA5;GABRG3;GABRB2;GABRG1;GABRE;GABRA4;GABRG2
prerank,positive regulation of T cell mediated cytotoxicity (GO:0001916),0.7170030570719809,1.5739705145803886,0.029985007496251874,0.2638583207662203,1.0,2/13,3.54%,IL23R;XCL1
prerank,action potential (GO:0001508),-0.4258346272243685,-1.5738136321018452,0.005494505494505495,0.4173799721383954,1.0,21/44,27.14%,DMD;SCN2A;KCNJ2;AKAP6;SCN8A;KCND2;GNA11;SLC4A3;KCNQ1;SCN3A;GPER1;GNA14;SCN9A;CACNA1I;SRI;KCNE4;SCN3B;KCNMB2;CHRNA4;KCNB1;KCNH2
prerank,high-density lipoprotein particle remodeling (GO:0034375),0.7090978469761464,1.5731890959159278,0.020497803806734993,0.26471593656578546,1.0,4/15,5.72%,LIPC;APOE;ABCG1;PLTP
prerank,cellular defense response (GO:0006968),0.5813578884162367,1.5730947058142797,0.019464720194647202,0.26376919192966974,1.0,4/40,4.59%,IL1RL2;LBP;SPN;LY96
prerank,zymogen activation (GO:0031638),0.5908268387400656,1.5730808524440947,0.011292346298619825,0.26267334838546513,1.0,10/39,14.67%,HP;HPR;MMP14;PLAT;APOH;KLK2;OMA1;CTSL;GRIN2A;CASP8
prerank,inorganic anion transmembrane transport (GO:0098661),-0.3907710729150377,-1.5730488174185717,0.008130081300813009,0.41228903180183396,1.0,34/63,24.36%,SLC12A7;SLC12A2;GABRB1;SLC26A2;GLRA3;GABRA2;SLC12A6;ANO4;GABRA5;CLCN3;SLC5A6;SLC1A1;ANO3;SLC6A1;GABRG3;SLC4A8;SLC5A5;GABRB2;ANO1;GLRA2;SLC20A2;GABRG1;XPR1;SLC37A3;SLC25A14;GABRE;GABRA4;ANO2;CFTR;SLC37A2;ANO5;GLRA1;SLC25A30;GABRG2
prerank,sterol metabolic process (GO:0016125),0.5537334820868494,1.5726971893684143,0.011235955056179775,0.26257331467531064,1.0,7/60,4.75%,CYP7B1;CYP1B1;ABCA1;APOE;ABCG1;CLN6;INSIG2
prerank,vasoconstriction (GO:0042310),0.7481928625256217,1.57266784289923,0.02945736434108527,0.2615436385325199,1.0,3/11,4.75%,EDN3;CRP;EDNRA
prerank,actin filament bundle organization (GO:0061572),0.5960701808601065,1.572150983920099,0.02214022140221402,0.2616215575472707,1.0,11/33,6.53%,MYO1B;LCP1;DPYSL3;RHOD;BAIAP2;CALD1;AIF1L;LIMA1;FSCN1;ADD2;AIF1
prerank,neuromuscular synaptic transmission (GO:0007274),-0.5258139907137481,-1.5716411579321767,0.037037037037037035,0.40916076038290305,1.0,5/18,13.59%,FCHSD2;KIF1B;DTNA;ERC1;CHRNB1
prerank,regulation of amyloid-beta clearance (GO:1900221),0.6891234789518169,1.5707167448395238,0.026706231454005934,0.2643082190889089,1.0,6/16,15.60%,LRP1;APOE;TREM2;HDAC1;IFNGR1;TNF
prerank,regulation of monocyte differentiation (GO:0045655),0.7046953587637723,1.569498503198829,0.029585798816568046,0.26607505418252375,1.0,4/14,9.47%,IL34;ZFP36L1;IRF7;CDK6
prerank,"nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184)",-0.3562840243637762,-1.5682682553359586,0.0,0.4111364329795542,1.0,53/110,23.50%,RPL34;RPL8;RPL18A;RPL36;RPL19;RPL38;PYM1;RPL5;RPS23;PPP2R1A;RPLP0;RPS10;UPF1;RPL32;RPS4X;RPL10;RPL15;RPL29;RPS16;RPS27;RPS19;RPS12;RPS21;PNRC2;RPS13;RPL13;RPL27;RPL7A;RPL35;RPL28;RBM8A;RPL30;RPS8;RPS17;RPL37A;MAGOH;EIF4A3;RPS6;RPL41;RPS18;GSPT2;RPS20;RPL7;RPL13A;RPS15A;RPS5;UBA52;RPS29;RPLP1;RPL21;UPF2;SMG9;RPS26
prerank,regulation of receptor signaling pathway via JAK-STAT (GO:0046425),0.5907263517206844,1.5680007749450144,0.018703241895261846,0.26849552545973693,1.0,9/35,7.88%,CYP1B1;BCL3;GHR;JAK2;IL10RA;EGF;NF2;CCL5;OCIAD2
prerank,aorta development (GO:0035904),0.6952584729424409,1.5676190635045635,0.03571428571428571,0.26842910625773,1.0,7/14,10.48%,LRP1;ROBO2;PDGFRB;JAG1;PKD2;TBX2;ADAMTS9
prerank,positive regulation of collagen metabolic process (GO:0010714),0.6837032394736839,1.566399541533781,0.0392156862745098,0.270326185333023,1.0,2/17,0.58%,RUNX1;CREB3L1
prerank,endothelial cell migration (GO:0043542),0.5875201523190774,1.5659468042766693,0.018495684340320593,0.27035794064537383,1.0,7/37,4.52%,FAP;CYP1B1;FSTL1;NRP1;EGR3;STAT1;MYH9
prerank,negative regulation of complement activation (GO:0045916),0.759911460055259,1.5658233920080455,0.02157164869029276,0.2695143368584746,1.0,2/10,0.81%,VSIG4;SERPING1
prerank,response to tumor necrosis factor (GO:0034612),0.5245823038293873,1.5654994019681574,0.004310344827586207,0.26911542794209736,1.0,23/91,17.48%,CCL11;CCL7;ADIPOQ;ZFP36L1;TNFRSF21;SFRP1;JAK2;CD40;XCL1;ZFP36L2;ADAMTS7;PID1;CCL5;ADAMTS12;ERBIN;GBP3;TANK;CCL2;CASP8;BAG4;CX3CL1;SMPD4;NFE2L2
prerank,dopamine metabolic process (GO:0042417),-0.5364735250981232,-1.5647589583703292,0.03802281368821293,0.4140518167411757,1.0,5/18,6.00%,SNCAIP;MAOA;PRKN;MAOB;MOXD1
prerank,positive regulation of extracellular matrix organization (GO:1903055),0.6643943482428433,1.5644961834334825,0.03862660944206009,0.2705721162845905,1.0,7/18,13.71%,RUNX1;CARMIL2;DDR2;FSCN1;EMILIN1;PDPN;SMAD3
prerank,regulation of chromatin organization (GO:1902275),-0.560479425183536,-1.5623198791799742,0.029585798816568046,0.41402029434053,1.0,10/14,28.42%,MLLT3;HNRNPU;IGF2;METTL4;SSRP1;TLK1;PARG;HPF1;ALKBH4;MKI67
prerank,presynaptic endocytosis (GO:0140238),0.6295833667498785,1.5618217088976398,0.03866666666666667,0.27632748210889424,1.0,5/24,8.86%,CEL;STON2;OPHN1;CANX;SYT2
prerank,interleukin-6-mediated signaling pathway (GO:0070102),0.666503974777015,1.561786910735802,0.04628330995792426,0.27529633384362107,1.0,6/18,7.13%,YAP1;JAK1;JAK2;STAT1;STAT3;CBL
prerank,actin filament network formation (GO:0051639),0.7143057404008606,1.560809933054549,0.04285714285714286,0.27659608347012066,1.0,6/11,7.33%,CARMIL2;SPIRE2;LCP1;CARMIL1;FHOD3;SPIRE1
prerank,positive regulation of cell death (GO:0010942),0.5531950379705612,1.5604563768457143,0.018583042973286876,0.27643858041222286,1.0,9/59,8.05%,MMP3;HP;HPR;LRP1;WNT5A;LRRK2;CELF1;CD36;FCGR2B
prerank,androgen receptor signaling pathway (GO:0030521),0.7399198892092873,1.558954419508954,0.03143712574850299,0.27915254490866354,1.0,3/11,3.19%,PMEPA1;ZMIZ1;DDX17
prerank,cellular response to lipid (GO:0071396),0.4985611383309379,1.558742555512899,0.0010235414534288639,0.27865774529021287,1.0,38/191,13.55%,RORA;NR1H4;CXCL5;WNT2;SPP1;CXCL1;LBP;SBNO2;TNFAIP3;NRIP1;SFRP1;WNT5A;LPL;CASP1;IRS1;LY96;WNT9A;ADCY2;PID1;MGST1;ATM;NUGGC;EGFR;CD68;UBE2L3;CXCL10;NFKB1;AHR;CD14;XBP1;SETX;SIRPA;PTK7;MSN;SELENOS;GNAI1;LCOR;CCL2
prerank,copper ion transport (GO:0006825),0.7378342217074925,1.5586704214646994,0.02457757296466974,0.27780328888856176,1.0,4/11,5.97%,STEAP4;SLC11A2;STEAP2;STEAP3
prerank,negative regulation of NIK/NF-kappaB signaling (GO:1901223),-0.5034099844767266,-1.5584047670782382,0.02702702702702703,0.4171616324220236,1.0,7/23,8.88%,HDAC7;TMSB4X;CCN3;ADIPOR1;CYLD;C1QTNF3;NMI
prerank,"regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043516)",0.6196246025498676,1.558246289940726,0.022106631989596878,0.2777240017244246,1.0,9/27,6.96%,SNAI1;SNAI2;EEF1E1;PLA2R1;KMT5A;SPRED1;SPRED2;ATM;ATR
prerank,regulation of necroptotic process (GO:0060544),0.6481093065477949,1.5570235357291196,0.02880658436213992,0.2796853384200635,1.0,11/23,15.09%,ZBP1;BIRC3;FLOT2;CFLAR;OGT;MLKL;FZD9;SDCBP;CASP8;STUB1;CDC37
prerank,positive regulation of epithelial cell proliferation (GO:0050679),0.5115494804303827,1.5565008544927936,0.004223864836325237,0.27999860487896716,1.0,25/113,9.16%,CCL11;LAMB1;TCF7L2;YAP1;LAMC1;THBS4;PRKCA;NRP1;PTN;JAML;SFRP1;EGR3;WNT5A;FGF7;EGF;ARNT;PRKD2;FGF9;MDK;MMP12;AKT3;EGFR;BMP5;TGFBR1;STAT5A
prerank,positive regulation of cholesterol efflux (GO:0010875),0.6539199159010507,1.5564663445580706,0.029411764705882353,0.27900899841722593,1.0,6/21,8.94%,ADIPOQ;LRP1;APOE;TREM2;PLTP;PPARG
prerank,sulfate transport (GO:0008272),-0.5794064570779299,-1.5559630401734463,0.047619047619047616,0.4173277190850877,1.0,8/14,24.24%,SLC26A7;SLC26A2;SLC13A4;SLC26A6;SLC25A14;RACGAP1;SLC26A8;SLC25A30
prerank,intracellular lipid transport (GO:0032365),-0.5025081268493338,-1.555536785240977,0.03383458646616541,0.4120033449142604,1.0,4/21,6.01%,PRKAG2;PRKAA2;CERT1;ABCD3
prerank,regulation of establishment of planar polarity (GO:0090175),0.5208307993498851,1.5547083095097627,0.008629989212513484,0.2823768710945234,1.0,18/88,13.38%,PSMA7;ROR2;CLTC;PRICKLE2;WNT5A;SMURF2;DVL2;RAC1;CDC42;PSMD4;FZD1;PSMD11;FZD3;PRICKLE1;PSMB8;ARHGEF19;NPHP3;SMURF1
prerank,negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage (GO:1902230),0.6315757462100332,1.5543811281634252,0.028720626631853787,0.2820842571052553,1.0,6/24,5.59%,CXCL12;SNAI1;SFRP2;SNAI2;BCL2;CDKN2D
prerank,regulation of regulatory T cell differentiation (GO:0045589),0.6348835926444095,1.5543455107925084,0.034528552456839307,0.2811019528964088,1.0,5/22,8.40%,RUNX1;BCL6;IRF1;MDK;CBFB
prerank,dorsal/ventral pattern formation (GO:0009953),0.6479157478073896,1.5535841887279158,0.04594594594594595,0.2820226744995963,1.0,6/20,9.75%,GLI2;SFRP1;SHH;AIDA;ACVR1;MDFI
prerank,negative regulation of proteolysis (GO:0045861),0.5858277075155338,1.5529755197522732,0.02313624678663239,0.2824643270185292,1.0,10/34,10.90%,KNG1;SERPINE2;TIMP1;LRRK2;DNAJC1;PTPN3;PLAT;TRIM21;GAS1;BAG6
prerank,positive regulation of alpha-beta T cell activation (GO:0046635),0.6905491924979933,1.5517911282930767,0.037257824143070044,0.28457400454779264,1.0,4/15,9.94%,IL23R;GLI3;SHH;HSPH1
prerank,positive regulation of Wnt signaling pathway (GO:0030177),0.5060406318311514,1.5503968109341084,0.002061855670103093,0.2868072214624796,1.0,52/152,19.80%,PSMA7;COL1A1;ZEB2;SULF1;TNFAIP3;LYPD6;SFRP4;ATP6AP2;SFRP1;TMEM198;SFRP2;TLR2;GSKIP;LRRK2;EGF;UBR5;SMURF2;WLS;EGFR;DISC1;PSMD4;LRRK1;ZBED3;FAM53B;PSMD11;NFKB1;FZD9;SALL1;PSMB8;TERT;DKK2;PTK7;CCAR2;SCEL;CSNK1D;AXIN2;TBL1X;USP47;LGR4;PSMA6;RUVBL1;PSMD14;TRPM4;CDC73;TNKS2;CSNK2A1;PSMC6;PSMB10;SMARCA4;CSNK1G2;PSMD12;PSMB1
prerank,cellular response to fibroblast growth factor stimulus (GO:0044344),0.5260740522536127,1.5500335799571776,0.008658008658008658,0.28652773658244196,1.0,26/87,15.65%,ZFP36L1;FLRT2;FGF20;SFRP1;EGR3;FGF7;ZFP36L2;FGF9;FGFR1;GALNT3;SPRED1;SPRED2;FRS2;CBL;CCL5;GTF2F2;GRB2;SETX;RBFOX2;FGF2;POLR2K;CCL2;ITGB1BP1;FGFRL1;NCBP2;POLR2B
prerank,regulation of osteoclast differentiation (GO:0045670),0.5913345272133778,1.5500288948240664,0.0275,0.2854739767160817,1.0,6/33,5.52%,IL23R;TNFSF11;LRRC17;MAFB;FBN1;CCR1
prerank,connective tissue development (GO:0061448),0.591297876023207,1.5491449775213628,0.02334152334152334,0.28671401354162096,1.0,8/35,8.10%,SULF1;ITGB8;SH3PXD2B;COL11A2;SOX5;ARID5B;TRIP11;CREB3L2
prerank,negative regulation of bone remodeling (GO:0046851),0.7288195919952196,1.54904661550925,0.05680119581464873,0.2858810038098693,1.0,3/11,2.77%,TNFAIP3;SFRP1;TMEM119
prerank,cytokine-mediated signaling pathway (GO:0019221),0.4867302144511085,1.548966132066693,0.0,0.2850009302259804,1.0,124/532,17.20%,PSMA7;RORA;MMP3;CCL11;COL1A2;IL34;MAP3K14;CCL7;CXCL5;IL23R;MMP2;IL1RL2;CXCL1;ZEB1;OSMR;LBP;CXCL12;MID1;YAP1;TEC;JAK1;BCL6;GHR;TNFSF11;IL16;GAB2;IRF7;BIRC3;NUMBL;JAK2;LCP1;PLVAP;STAT1;TIMP1;CD40;IL10RA;PRTN3;XCL1;CAMK2D;UGCG;BCL2;BATF;IL1R1;IRAK3;CASP1;IRS1;TSLP;IRF1;ANXA1;POU2F1;EDA2R;FSCN1;CCR1;LIMS1;ICAM1;CEBPD;STAT3;CBL;CDC42;CD36;CCL5;PIK3R1;TNFRSF12A;TRIM21;CUL1;PSMD4;CXCL10;TRIM8;PTPN6;IL33;CANX;SQSTM1;RALA;GREM2;NOD1;IL3RA;STAT5A;IL22;PTPRZ1;TNFRSF9;PSMD11;NFKB1;GRB2;SDC1;PSMB8;FGF2;PYDC1;EDA;CAPZA1;IL7;TALDO1;OASL;TRAF2;MSN;TRIM62;FBXW11;STAT6;CCL2;LMNB1;SKP1;PELI3;COMMD7;IRAK2;JUNB;IFNGR1;PELI2;BAG4;TNFRSF4;IRAK4;IFNAR2;TNF;TRAF3IP2;PSMA6;CX3CL1;SOCS5;EDAR;SP100;LIFR;HNRNPDL;IFNGR2;VAV1;TNFRSF1A;PTPRJ;TXLNA
prerank,translesion synthesis (GO:0019985),-0.4260504865103754,-1.5488144300515354,0.019867549668874173,0.4247733255959192,1.0,26/42,29.95%,RCHY1;PCNA;ZBTB1;UBC;PARP10;REV3L;POLK;PRIMPOL;FAAP20;RFC3;UBA52;RFC2;POLD2;POLE2;RPA2;UBB;SPRTN;NPLOC4;PCLAF;UFD1;RFC4;RPA3;POLD4;TRIM25;USP43;DTL
prerank,Notch signaling involved in heart development (GO:0061314),0.7228129261385525,1.5485745984049064,0.045588235294117645,0.28485061605079753,1.0,6/11,12.71%,SNAI1;SNAI2;JAG1;HEYL;GALNT11;RBPJ
prerank,positive regulation of bone mineralization (GO:0030501),0.5963046509869359,1.5473996694403493,0.016049382716049384,0.28670862757990956,1.0,11/35,11.28%,GPM6B;FBN2;NELL1;PTN;TMEM119;ATP2B1;ACVR1;TGFB3;FZD9;ADGRV1;ACVR2A
prerank,"Wnt signaling pathway, planar cell polarity pathway (GO:0060071)",0.5240026254848958,1.5470184015469324,0.009944751381215469,0.286560696533177,1.0,16/85,12.14%,PSMA7;ROR2;CLTC;PRICKLE2;WNT5A;SMURF2;DVL2;RAC1;CDC42;PSMD4;FZD1;PSMD11;FZD3;PRICKLE1;PSMB8;ARHGEF19
prerank,fatty acid transmembrane transport (GO:1902001),-0.5199318734528585,-1.5466573472008116,0.03676470588235294,0.4240393334877359,1.0,4/19,6.01%,PRKAG2;PRKAA2;SLC2A1;ABCD3
prerank,artery morphogenesis (GO:0048844),0.6000828705895294,1.5459559383247568,0.030690537084398978,0.28832032046727224,1.0,10/30,10.85%,LRP1;NRP1;PDGFRB;JAG1;PKD2;TBX2;NF1;TGFBR1;ADAMTS9;HOXA1
prerank,cellular response to leucine starvation (GO:1990253),-0.6147713605021438,-1.5451772328972238,0.06166219839142091,0.4209687188770245,1.0,8/10,34.69%,RRAGB;SESN2;SESN3;RRAGD;LARS1;MTOR;EIF2AK4;IMPACT
prerank,defense response to tumor cell (GO:0002357),0.7383367857604104,1.5451418697883224,0.034108527131782945,0.2891118097588512,1.0,2/10,1.51%,RBMS3;DLEC1
prerank,positive regulation of lipid storage (GO:0010884),0.6393747823269793,1.5448623782748474,0.028037383177570093,0.28871882142906696,1.0,7/21,10.12%,C3;LPL;OSBPL11;PLIN2;IKBKE;VSTM2A;NFKB1
prerank,epidermis development (GO:0008544),0.5541248239160562,1.543992492184255,0.015783540022547914,0.28977365678797296,1.0,16/56,17.98%,COL7A1;EMP1;GATA6;FGF7;UGCG;FLOT2;ATP2A2;EDA2R;HDAC1;SVEP1;SCEL;ALDH3A2;ATP2C1;EDAR;FABP5;PLOD1
prerank,positive regulation of biomineral tissue development (GO:0070169),0.5803896428030901,1.5436210000926212,0.022004889975550123,0.2896026237112321,1.0,12/40,11.28%,GPM6B;FBN2;NELL1;PTN;TMEM119;ATP2B1;ACVR1;TGFB3;FBXO5;FZD9;ADGRV1;ACVR2A
prerank,positive regulation of osteoblast differentiation (GO:0045669),0.5725369668670419,1.541739170026784,0.02132701421800948,0.2935639406590163,1.0,12/43,12.70%,RUNX2;FBN2;YAP1;NELL1;TMEM119;CCN4;DDR2;ACVR1;FBXO5;ACVR2A;WWTR1;SUCO
prerank,negative regulation of cytoskeleton organization (GO:0051494),-0.44601891357549595,-1.5415139269146856,0.038834951456310676,0.4247324013490227,1.0,10/29,13.03%,TJP1;KANK3;SHANK3;PRKN;TWF2;KANK4;HIP1R;SLIT2;PFN1;TWF1
prerank,"wound healing, spreading of cells (GO:0044319)",0.610862559428252,1.5411807008807281,0.03443708609271523,0.2938791528627431,1.0,13/24,17.36%,MRTFA;CARMIL2;COL5A1;ARHGAP24;LCP1;MMP12;DDR1;CD151;PDPN;ITGA5;ARHGAP35;PDCD10;RHOA
prerank,digestive tract development (GO:0048565),0.5914536593446272,1.5409618964183673,0.034220532319391636,0.2934068282196785,1.0,16/32,20.07%,GLI2;CLMP;GLI3;RARB;GATA6;EPHB3;NIPBL;SALL1;CHD8;PCSK5;STRA6;TNF;BBS7;SMO;NPY;TGFB2
prerank,negative regulation of protein localization to nucleus (GO:1900181),0.679575649138096,1.5387827476349172,0.03314917127071823,0.2978586586288403,1.0,6/18,14.70%,MDFIC;APOD;SUFU;ILRUN;FLCN;GSK3B
prerank,regulation of keratinocyte differentiation (GO:0045616),0.6244749810093813,1.5379799890927688,0.03571428571428571,0.2988771604178314,1.0,7/24,12.31%,RUNX1;ZFP36L1;ERRFI1;CYP27B1;CBFB;CTSK;CTSL
prerank,regulation of B cell differentiation (GO:0045577),0.6644234355028343,1.5378553402316653,0.03038674033149171,0.2981826520084665,1.0,4/17,3.76%,MMP14;ZFP36L1;SFRP1;ZFP36L2
prerank,negative regulation of transforming growth factor beta receptor signaling pathway (GO:0030512),0.5331716252803586,1.5375220793541693,0.017877094972067038,0.2980404251653231,1.0,23/65,17.38%,FBN2;PMEPA1;SMAD2;FBN1;ADAMTSL2;HTRA3;SMURF2;SPRED1;SPRED2;TGFB1I1;LTBP1;TGFBR1;SPRY2;EMILIN1;WFIKKN1;HTRA4;SNX6;SMURF1;SMAD3;LDLRAD4;STUB1;SNX25;SKOR2
prerank,negative regulation of defense response (GO:0031348),0.5195134028765068,1.5368605127304233,0.013215859030837005,0.2987425881551537,1.0,19/77,17.44%,RORA;NR1H4;ADIPOQ;TNFAIP3;APOE;SMPDL3B;IRAK3;MVK;TRIM21;ILRUN;PPARG;SIRT2;PTGER4;SIRPA;SELENOS;DHX58;PTPN2;TNFRSF1A;ITCH
prerank,regulation of ion transmembrane transport (GO:0034765),-0.43826834324650876,-1.5365688014596957,0.010256410256410256,0.4320909142606667,1.0,10/33,14.50%,KCNJ2;AKAP6;WWP2;KCNJ3;CHRM3;WNK3;KCNQ1;KCNJ13;KCNJ12;NEDD4L
prerank,positive regulation of granulocyte chemotaxis (GO:0071624),0.6568671965314072,1.5364153962191736,0.03954802259887006,0.2988282987977956,1.0,6/19,10.90%,THBS4;XCL1;TIRAP;MDK;RAC1;MOSPD2
prerank,sterol biosynthetic process (GO:0016126),-0.42324541765132373,-1.5359663055127752,0.02127659574468085,0.42748508998694423,1.0,13/33,20.27%,PRKAG2;LBR;ACAT2;ACLY;SQLE;DHCR24;IDI1;FDFT1;HSD17B7;FDPS;NSDHL;EBP;HMGCS1
prerank,vesicle transport along actin filament (GO:0030050),0.6462847152055643,1.5356066718975583,0.046610169491525424,0.29997551623060736,1.0,7/19,10.27%,MYO1B;MYO1A;MYO5A;MYO19;MYO1H;MYO1D;MYO7A
prerank,response to organic cyclic compound (GO:0014070),0.5515900374518098,1.5343566736375875,0.023612750885478158,0.30203118719721095,1.0,15/52,13.55%,CYP1B1;SPP1;SFRP1;ABCA2;LRRK2;IGFBP5;ANXA1;CDKN2D;CYP27B1;STAT3;CCL5;GLDC;CYP1A1;DRD3;CCL2
prerank,negative regulation of phagocytosis (GO:0050765),0.6503650112316032,1.5343501806260182,0.04591104734576758,0.30102159612366663,1.0,5/17,12.21%,ADIPOQ;TLR2;PRTN3;FCGR2B;SIRPA
prerank,regulation of T cell mediated cytotoxicity (GO:0001914),0.6751527446488114,1.5342874310374757,0.039660056657223795,0.30017765649403877,1.0,2/16,3.54%,IL23R;XCL1
prerank,negative regulation of epithelial to mesenchymal transition (GO:0010719),0.594764220162263,1.5337378182962502,0.03439153439153439,0.30070698261511436,1.0,8/29,14.13%,SFRP1;SFRP2;PTEN;SPRED1;SPRED2;BMP5;SPRY2;LDLRAD4
prerank,negative regulation of cellular catabolic process (GO:0031330),0.5348986509722994,1.5322281576683638,0.016853932584269662,0.30342238283459616,1.0,14/63,10.71%,HP;DAP;NELL1;EIF4G2;EIF4G3;TIMP1;IL10RA;PTPN3;BCL2;KLHL22;TREM2;STAT3;FOXK2;SIRT2
prerank,regulation of T cell differentiation (GO:0045580),0.5909665260533314,1.5316926965788742,0.02389937106918239,0.30367525095213427,1.0,10/33,15.82%,RUNX1;ZMIZ1;MDK;CBFB;TCF7;XBP1;IL7;PRDM1;ABL1;CLPTM1
prerank,positive regulation of cell adhesion (GO:0045785),0.5252748152460085,1.5309482476643737,0.015855039637599093,0.30457365474625275,1.0,15/74,8.57%,IBSP;FBLN2;CXCL12;PRKCA;SFRP2;JAK2;RHOD;DUSP26;PRKD2;MDK;RAC1;LIMS1;ATM;CCL5;RSU1
prerank,non-canonical Wnt signaling pathway (GO:0035567),0.49613755419543104,1.530522692027446,0.005219206680584551,0.3046544753320681,1.0,25/124,12.38%,PSMA7;ROR2;CLTC;TCF7L2;PRICKLE2;SFRP4;SFRP1;SFRP2;WNT5A;SMURF2;FRZB;DVL2;RAC1;CDC42;PSMD4;FZD1;PSMD11;TNRC6B;FZD3;FZD9;PRICKLE1;SFRP5;PSMB8;ARHGEF19;PPP3CA
prerank,canonical Wnt signaling pathway (GO:0060070),0.5231747018201742,1.528553954188795,0.02244668911335578,0.3087546087484908,1.0,21/68,14.70%,WNT2;TCF7L2;SFRP4;SFRP1;SFRP2;WNT5A;LRRK2;WNT2B;WNT9A;PTEN;FRZB;DVL2;FZD1;TCF7;CSNK1A1;FZD3;FZD9;SFRP5;TCF7L1;LRP6;GSK3B
prerank,chloride transmembrane transport (GO:1902476),-0.408415531953182,-1.5285378674177656,0.031446540880503145,0.4413562441780094,1.0,16/48,8.94%,SLC12A7;SLC12A2;GABRB1;GLRA3;GABRA2;SLC12A6;ANO4;GABRA5;CLCN3;SLC1A1;ANO3;SLC6A1;GABRG3;SLC4A8;GABRB2;ANO1
prerank,regulation of stem cell differentiation (GO:2000736),0.5179743369723544,1.5282828834698239,0.011879049676025918,0.30838340415434784,1.0,28/89,21.00%,PSMA7;RUNX1;KMT2A;PDGFRA;YAP1;PTN;ZFP36L2;JAG1;PSMD4;CBFB;PSMD11;TCF12;EIF2AK2;PSMB8;TCF3;SP7;ABL1;PSMA6;GDNF;ITCH;PSMD14;PSMC6;PSMB10;PSMD12;PSMB1;YTHDF2;PSMA8;PSMF1
prerank,cellular response to mechanical stimulus (GO:0071260),0.5509053863771678,1.5270229405004057,0.0338389731621937,0.3106961677264729,1.0,12/46,11.92%,MAP3K14;SLC9A1;CD40;CASP8AP2;CASP1;IRF1;MAP2K4;PIEZO2;TLR7;NFKB1;PTGER4;TMEM150C
prerank,endocrine system development (GO:0035270),0.6353009429648914,1.526211831660778,0.030598052851182198,0.3116384506522941,1.0,8/21,14.16%,GLI2;MDK;NF1;TGFBR1;DKK3;FOXE1;SALL1;STRA6
prerank,negative regulation of ERK1 and ERK2 cascade (GO:0070373),0.5603735011453795,1.5254009931631445,0.020656136087484813,0.3127143308669464,1.0,17/46,15.51%,ADIPOQ;FBLN1;TNIP1;DUSP26;PTEN;CNKSR3;SPRED1;SPRED2;PTPN1;SPRY2;EMILIN1;SIRPA;EPHB2;RANBP9;ITGB1BP1;FLCN;PTPN2
prerank,regulation of platelet activation (GO:0010543),0.6244974856639015,1.5247517336964007,0.04065040650406504,0.3133887772863222,1.0,5/21,4.84%,PDGFRA;TEC;PRKCA;APOE;BLK
prerank,myeloid leukocyte differentiation (GO:0002573),0.5287175438914627,1.524250401966237,0.02164009111617312,0.3135878220489015,1.0,14/65,8.94%,RUNX1;SBNO2;FARP2;TNFSF11;GAB2;PRTN3;BATF;MYH9;TREM2;E2F1;CDC42;SNX10;LGALS9;PPARG
prerank,sequestering of extracellular ligand from receptor (GO:0035581),0.7162613286499822,1.5231069649032554,0.04093567251461988,0.31553491230657693,1.0,5/13,9.01%,FBN2;FSTL1;FBN1;LTBP1;GREM2
prerank,positive regulation of neutrophil chemotaxis (GO:0090023),0.6671331985539785,1.5230701037677339,0.04532163742690058,0.3146148333849305,1.0,6/17,10.90%,THBS4;XCL1;TIRAP;MDK;RAC1;MOSPD2
prerank,morphogenesis of a polarized epithelium (GO:0001738),-0.5784350861210542,-1.5230357044376273,0.05263157894736842,0.45066663901246856,1.0,9/12,23.12%,ACTB;LAMA3;LAMA5;TRAF3IP1;AHI1;CELSR1;VANGL2;ZDHHC7;ACTG1
prerank,positive regulation of interleukin-6 production (GO:0032755),0.5287371409477324,1.5217601652297212,0.016483516483516484,0.3170592276894096,1.0,15/68,10.96%,LBP;IL16;TLR2;WNT5A;LPL;TSLP;TIRAP;TMEM106A;AIF1;STAT3;RAB7B;LGALS9;IL33;TLR7;XBP1
prerank,negative regulation of inflammatory response (GO:0050728),0.48374876844588477,1.5203654851549568,0.0,0.3197452550784693,1.0,24/182,9.25%,RORA;MC5R;NR1H4;ADIPOQ;FSHR;GPR176;IAPP;ADCY7;GPR39;TNFAIP3;ADM;APOE;SMPDL3B;MYH9;TREM2;ADCY2;RXFP2;MDK;PTGDR;ADCYAP1R1;MVK;PPARG;GLP2R;PRKAR1B
prerank,negative regulation of signal transduction (GO:0009968),0.48015992842864014,1.5201470344648873,0.0,0.31926382653295093,1.0,71/249,17.61%,DCN;ENPP1;SULF1;ADIPOQ;CREB3L1;LRP1;MMP14;APOD;NKD2;TNFAIP3;GLI3;ASXL1;SFRP4;SFRP1;SFRP2;SUFU;KCTD21;SNAI2;LRRK2;BCL2;APLN;SMPDL3B;IRAK3;EGF;IRS1;IGFBP5;PIP4K2A;CSNK2A2;DLK1;BRAP;PID1;TLE1;TAX1BP3;RNF157;PTEN;FRZB;SIAH2;EGFR;BMP5;CCL5;ADAMTS12;NCK1;ACVR1;GPR108;DKK3;PIP4K2B;MDFI;PTPN1;SLC27A4;SPRY2;EMILIN1;PTPN18;RPS6KB1;SFRP5;FGF2;FBXW7;HERC4;TULP3;PTPN2;TNF;LGR4;UBASH3B;CTNNBIP1;CX3CL1;EZH2;SOCS5;PTPRJ;NLRP2B;PTCH1;TCIM;HGS
prerank,positive regulation of macrophage differentiation (GO:0045651),0.7232728721625783,1.5176641878502575,0.04360902255639098,0.32471976609310466,1.0,2/11,2.11%,IL34;PRKCA
prerank,regulation of cell size (GO:0008361),0.6096349438125924,1.5171251215988244,0.042440318302387266,0.32496069598540134,1.0,10/23,17.36%,PRR16;VAV2;VAV3;PTEN;RAC1;RPTOR;LAMTOR5;MSN;VAV1;RHOA
prerank,positive regulation of canonical Wnt signaling pathway (GO:0090263),0.5005911011262526,1.5165405757094372,0.006224066390041493,0.32542787502538834,1.0,46/129,21.00%,PSMA7;COL1A1;ZEB2;LYPD6;SFRP4;ATP6AP2;SFRP1;TMEM198;SFRP2;GSKIP;LRRK2;EGF;UBR5;SMURF2;WLS;EGFR;PSMD4;LRRK1;ZBED3;FAM53B;PSMD11;NFKB1;FZD9;PSMB8;DKK2;PTK7;CCAR2;SCEL;CSNK1D;AXIN2;TBL1X;USP47;LGR4;PSMA6;RUVBL1;PSMD14;TRPM4;TNKS2;PSMC6;PSMB10;CSNK1G2;PSMD12;PSMB1;DDX3X;PSMA8;PSMF1
prerank,response to cholesterol (GO:0070723),0.6570743563092275,1.5164352875944611,0.0339943342776204,0.3246613064702167,1.0,11/17,24.71%,ABCA2;SMAD2;TGFBR1;GRAMD1A;LRP6;PTCH1;SMO;GRAMD1C;GPLD1;TGFB1;MLC1
prerank,ceramide biosynthetic process (GO:0046513),-0.4063673555707025,-1.515948000875799,0.02,0.4638180186048738,1.0,11/40,6.92%,ST6GALNAC3;ST8SIA4;SGMS2;SGMS1;CERS4;B4GALT6;ST8SIA6;SPTLC2;DEGS2;SPTLC1;ST8SIA2
prerank,regulation of focal adhesion assembly (GO:0051893),0.5363563301837855,1.515284991012656,0.03286384976525822,0.32685847668204904,1.0,21/54,17.36%,DLC1;GPM6B;APOD;MAP4K4;NRP1;SLC9A1;SFRP1;PEAK1;PTEN;RAC1;LIMS1;EFNA5;ARHGAP6;PTK2;THY1;ITGB1BP1;PHLDB2;ABL1;PTPRJ;ROCK2;RHOA
prerank,negative regulation of cytokine production involved in inflammatory response (GO:1900016),0.6574208845576854,1.5148254821399902,0.05365126676602087,0.32703396904149096,1.0,6/16,18.04%,APOD;ADCY7;TREM2;SIRPA;CHID1;CUEDC2
prerank,positive regulation of inflammatory response (GO:0050729),0.5103302305601015,1.5142895940195118,0.012114537444933921,0.32752452866653564,1.0,21/86,15.90%,ZBP1;OSMR;LBP;TNIP1;IL16;CREB3L3;TLR2;WNT5A;LPL;CCN4;TSLP;MDK;PLA2G7;IL33;TLR7;PTGER4;DDT;SNX4;NFKBIZ;TNF;CX3CL1
prerank,regulation of cell differentiation (GO:0045595),0.4870007480832282,1.5123454904342915,0.00102880658436214,0.33179091083240847,1.0,25/148,9.56%,RUNX1;RUNX2;TRPS1;RUNX3;EDN3;ZFP36L1;ST7;BCL6;DDX17;SNAI2;MAFB;FLOT2;FGFR1;SHH;NREP;MDK;CEBPD;CREBBP;NF1;TGFBR1;CBFB;CDK6;BIN1;NR1D2;CDK9
prerank,positive regulation of T cell differentiation (GO:0045582),0.5697716397497583,1.5118993266150842,0.042131350681536554,0.33178728348681086,1.0,7/36,6.13%,IL23R;GLI2;BCL6;ZMIZ1;GLI3;SHH;MDK
prerank,synaptic vesicle recycling (GO:0036465),0.5860800774075052,1.5117841970796153,0.04974489795918367,0.3310410289995559,1.0,5/31,8.86%,CEL;STON2;OPHN1;CANX;SYT2
prerank,positive regulation of cell development (GO:0010720),0.5814682368654577,1.5114762681330969,0.03286978508217446,0.33075007370886783,1.0,5/31,7.24%,PDE3A;ADIPOQ;NKX6-1;NUMBL;SERPINF1
prerank,central nervous system myelination (GO:0022010),0.7127882409020304,1.5113394818058314,0.06451612903225806,0.3301657221111062,1.0,5/11,9.68%,B4GALT5;ABCA2;PTEN;TENM4;MYRF
prerank,regulation of B cell apoptotic process (GO:0002902),0.6911046903192095,1.5102469746591973,0.0392156862745098,0.33197772449348406,1.0,5/12,18.69%,BCL6;BLK;NOC2L;FNIP1;ORMDL3
prerank,organic anion transport (GO:0015711),-0.36271208352687384,-1.5097112980349678,0.010309278350515464,0.4750558107334056,1.0,18/76,9.69%,ABCC4;ABCG2;SLC4A10;SLC26A7;LRRC8D;SLCO1C1;SLCO3A1;SLC22A6;SLC39A8;SLC52A1;SLC25A4;SLCO2A1;SLC25A42;CA4;SLC4A8;SLC4A3;CYB5R4;SLC25A17
prerank,odontogenesis (GO:0042476),0.5831315849954698,1.5095665079131018,0.03785103785103785,0.3327771842814323,1.0,9/35,13.89%,COL1A2;LAMB1;GLI2;ANKRD11;HDAC1;TGFB3;EDA;LRP6;AXIN2
prerank,chloride transport (GO:0006821),-0.3706624073730831,-1.5093794594971197,0.0,0.4694509243400137,1.0,33/74,24.36%,SLC4A10;SLC12A7;SLC12A2;SLC26A7;GABRB1;GLRA3;GABRA2;SLC12A6;ANO4;GABRA5;CLCN3;SLC1A1;ANO3;SLC6A1;GABRG3;SLC4A8;GABRB2;ANO1;GLRA2;CLIC5;FXYD1;GABRG1;SLC26A6;ANO8;GABRE;GABRA4;ANO2;CFTR;SLC26A8;CLIC4;ANO5;GLRA1;GABRG2
prerank,regulation of muscle contraction (GO:0006937),-0.46370403091144796,-1.5086127941812915,0.05357142857142857,0.465591348537765,1.0,7/26,9.51%,PLCE1;CAV1;KCNB2;ATP1A2;CHRM2;MYL9;PPP1R12B
prerank,regulation of cholesterol efflux (GO:0010874),0.5897240020843031,1.5082493376510269,0.04258064516129032,0.33523119079268765,1.0,8/30,8.94%,ADIPOQ;LRP1;ABCA2;APOE;TREM2;PLTP;SHH;PPARG
prerank,muscle tissue morphogenesis (GO:0060415),-0.5251194456133932,-1.5079902217774823,0.0429042904290429,0.4612649739750344,1.0,7/16,19.70%,BMP4;TGFBR3;TBX1;PROX1;HEY2;ZFPM1;EFEMP2
prerank,synaptic vesicle endocytosis (GO:0048488),0.572281233530594,1.5072336623113585,0.04481434058898848,0.33702989675281364,1.0,8/33,8.86%,CEL;STON2;DNAJC6;OPHN1;ITSN1;DNM1;CANX;SYT2
prerank,positive regulation of actin filament polymerization (GO:0030838),0.5500957096164153,1.5060127778805903,0.02679658952496955,0.33922515353475674,1.0,12/44,11.52%,CCL11;CARMIL2;SPIRE2;BAIAP2;CARMIL1;CDC42EP4;SPIRE1;NCK2;NCK1;BIN1;WHAMM;CDC42EP5
prerank,response to hexose (GO:0009746),0.5940788643020957,1.5058676098361083,0.05215123859191656,0.3385689077901147,1.0,7/25,16.25%,ADIPOQ;TCF7L2;LPL;ZBED3;SELENOS;KHK;EIF2B3
prerank,regulation of keratinocyte proliferation (GO:0010837),0.6297564738704908,1.5053663852686283,0.0444743935309973,0.3388681787852015,1.0,5/22,6.13%,ZFP36L1;CASK;SNAI2;FGF7;MDK
prerank,positive regulation of T cell activation (GO:0050870),0.5327969199143129,1.5052149694718453,0.013651877133105802,0.3382483150990203,1.0,18/62,13.99%,IL23R;ZMIZ1;TNFSF11;CD276;FLOT2;ANXA1;MDK;AIF1;CCL5;NCK2;NCK1;LGALS9;XBP1;SIRPA;IL7;THY1;CCL2;HSPD1
prerank,positive regulation of response to external stimulus (GO:0032103),0.48846062926760025,1.5049782571563164,0.004123711340206186,0.33790375970686004,1.0,31/128,15.90%,ZBP1;TNIP1;PRKCA;IL16;USF1;PTN;TLR2;WNT5A;LPL;PDGFRB;CCN4;TSLP;LY96;TREM2;POLR3D;MDK;AIF1;APOH;CCL5;PLA2G7;IL33;PUM1;TLR7;SASH1;PTGER4;OASL;DDT;DHX58;NFKBIZ;TNF;CX3CL1
prerank,regulation of interleukin-4 production (GO:0032673),-0.47354275561339276,-1.5047393575917578,0.05058365758754864,0.4643788414438323,1.0,10/21,25.15%,LEF1;PRKCZ;SLC7A5;SYK;ZFPM1;HAVCR2;FCER1G;CD86;CEBPB;PRKCQ
prerank,regulation of mononuclear cell migration (GO:0071675),0.626599309678187,1.5044987621125918,0.03825136612021858,0.3380622944349423,1.0,9/23,15.60%,IL34;CMKLR1;MDK;AIF1;BMP5;CCL5;MSN;PTK2;TNF
prerank,negative regulation of cell population proliferation (GO:0008285),0.47535133405316143,1.5040452921271112,0.0,0.33824159148904914,1.0,67/351,13.89%,ROR2;GLMN;FAP;CYP1B1;COL18A1;DLC1;RUNX3;IGFBP7;FBLN1;CXCL1;APOD;TNN;TNFAIP3;NELL1;SFRP4;SFRP1;SFRP2;WNT5A;JAK2;ALDH1A2;GATA6;IGFBP5;IRF1;CDKN2B;PKD2;TREM2;WNT9A;EEF1E1;CELF1;PTEN;CDKN2D;NF2;FRZB;TGFB1I1;E2F1;AIF1;CYP27B1;ADAMTS1;CDK10;BMP5;PINX1;NF1;NCK2;STRN;PTPN6;PPARG;E2F3;TGFB3;CDK6;MAP2K1;FRK;SIRT2;MORC3;ABI1;TFDP1;EIF2AK2;SFRP5;MAGED1;GPNMB;PDPN;CTCF;RERG;BTG1;PDS5B;DLG5;ITGB1BP1;AXIN2
prerank,regulation of cellular component biogenesis (GO:0044087),-0.4093797513758475,-1.50394472928181,0.011976047904191617,0.4607327375685442,1.0,12/39,13.76%,TJP1;SNCAIP;EZR;TIE1;RDX;VPS11;RAPGEF2;ANKRA2;GFAP;PINK1;RAP1A;PARP10
prerank,regulation of autophagosome assembly (GO:2000785),0.5676868493214096,1.5038376053919973,0.03694267515923567,0.33770529115550557,1.0,18/33,20.59%,LRRK2;CHMP4B;CHMP4A;PIP4K2A;NPRL2;TMEM39A;IFT88;RAB3GAP2;PIP4K2B;PHF23;SCFD1;IFT20;SH3GLB1;SMCR8;FEZ2;RAB3GAP1;ADPRH;MTM1
prerank,hyaluronan catabolic process (GO:0030214),0.6363942442905143,1.5034519446523944,0.06134094151212553,0.3376964654554301,1.0,5/18,14.31%,CEMIP;SLC9A1;CEMIP2;FGF2;LYVE1
prerank,positive regulation of tumor necrosis factor production (GO:0032760),0.518024043145604,1.5030881629305481,0.03670745272525028,0.3376292732255338,1.0,21/69,18.60%,LBP;SPN;TLR2;WNT5A;JAK2;LPL;TIRAP;LY96;TMEM106A;ARFGEF2;STAT3;LGALS9;IL33;CD14;EPHB2;DDT;IFNGR1;PSEN1;PTPRJ;SPHK2;TLR3
prerank,negative regulation of blood vessel morphogenesis (GO:2000181),0.5236601543019902,1.5029926872432962,0.01560758082497213,0.3368727333381296,1.0,17/75,10.43%,DCN;COL4A2;SULF1;SPARC;HSPG2;THBS2;THBS4;STAT1;SPRED1;ADAMTS1;SERPINF1;APOH;CXCL10;SEMA3E;PPARG;SPRY2;EMILIN1
prerank,negative regulation of angiogenesis (GO:0016525),0.5133510623618848,1.5026115072991229,0.010917030567685589,0.336878682496557,1.0,19/84,10.48%,DCN;COL4A2;SULF1;CREB3L1;SPARC;HSPG2;THBS2;THBS4;STAT1;SPRED1;ADAMTS1;SERPINF1;APOH;CXCL10;SEMA3E;PPARG;SPRY2;EMILIN1;ADAMTS9
prerank,response to insulin (GO:0032868),0.5095956078763861,1.5025841678539245,0.013001083423618635,0.33592771108826,1.0,20/80,11.30%,SLC39A14;ENPP1;ADIPOQ;ZFP36L1;CPEB1;USF1;IRS1;INSIG2;MYO5A;OGT;DENND4C;RAB8B;PIK3R1;PPARG;INHBB;RAB10;ZBED3;HDAC5;XBP1;RPS6KB1
prerank,neurotransmitter secretion (GO:0007269),-0.40678307660426877,-1.50217618849779,0.03954802259887006,0.45993563777107804,1.0,15/44,15.58%,SYN3;NRXN1;SNAP25;LIN7A;PCLO;LIN7C;SNAPIN;RIMS2;NAAA;NRXN2;PTPRN2;PIP5K1C;GAD1;RIMS1;GAD2
prerank,regulation of oxidative stress-induced cell death (GO:1903201),0.7004494288867503,1.501455120500038,0.05572755417956656,0.33792353703427297,1.0,2/11,6.75%,MMP3;UBQLN1
prerank,plasma membrane invagination (GO:0099024),0.5845362819817657,1.5007455036332054,0.04568527918781726,0.3388260985732106,1.0,14/29,20.51%,SPIRE2;MYH9;AIF1;CDC42;CD36;SPIRE1;FCGR2B;SNX33;DOCK1;SNX18;SNX9;RHOA;MSR1;FCGR1A
prerank,negative regulation of ERBB signaling pathway (GO:1901185),0.5623791146998942,1.500373659887448,0.033169533169533166,0.3388836409193838,1.0,17/39,17.61%,SH3KBP1;ERRFI1;PTPN3;EGF;EGFR;CBL;CDC42;MVP;SPRY2;PTPN18;GRB2;PTPN2;EPS15L1;ITGA1;PTPRJ;BTC;HGS
prerank,positive regulation of chemotaxis (GO:0050921),0.5447846093716425,1.4984430035329808,0.04604486422668241,0.3429766097819542,1.0,11/43,12.01%,EDN3;NRP1;PTN;PDGFRB;XCL1;PRKD2;TREM2;MDK;AIF1;DSCAM;FGF2
prerank,regulation of amyloid precursor protein catabolic process (GO:1902991),0.6999596654447744,1.4974151941647211,0.047987616099071206,0.3446343177506302,1.0,6/12,20.29%,ABCA2;APOE;FLOT2;RANBP9;ROCK2;TMED10
prerank,cellular response to molecule of bacterial origin (GO:0071219),0.4993450515330855,1.4972121316777856,0.005411255411255411,0.3441774278853811,1.0,22/95,14.13%,CXCL5;CXCL1;LBP;SBNO2;TNFAIP3;TLR2;WNT5A;CASP1;TIRAP;LY96;NUGGC;FCGR2B;CD68;CXCL10;NFKB1;CD14;SIRT2;XBP1;SIRPA;SELENOS;CCL2;HMGB2
prerank,membrane lipid catabolic process (GO:0046466),0.7135972364775002,1.496963183340626,0.0696594427244582,0.3438903788123096,1.0,3/10,9.42%,CYP1B1;SMPDL3B;SGPL1
prerank,midbrain dopaminergic neuron differentiation (GO:1904948),0.7168880989892638,1.4968415741506491,0.04019292604501608,0.3432001244115421,1.0,4/11,13.77%,WNT2;WNT5A;FZD1;LRP6
prerank,regulation of endopeptidase activity (GO:0052548),0.5253382023752161,1.4959489567081365,0.02870264064293915,0.3446451354120038,1.0,11/59,7.24%,KNG1;SERPING1;FETUB;SERPINE2;BIRC3;TIMP1;VTN;SERPINH1;SERPINA2;HDAC1;SERPINF1
prerank,retinol metabolic process (GO:0042572),0.6777108124054182,1.4956081025657069,0.057863501483679525,0.34456048579426873,1.0,4/14,11.34%,CYP1B1;RDH10;RDH12;CYP1A1
prerank,negative regulation of interleukin-10 production (GO:0032693),0.6483751280314147,1.495257609210015,0.055632823365785816,0.3445146888972462,1.0,3/16,8.05%,IL23R;TNFRSF21;FCGR2B
prerank,regulation of calcium ion transmembrane transport (GO:1903169),0.6215225476075381,1.494918838826159,0.04015544041450777,0.3444250098496576,1.0,5/23,4.53%,NOS1AP;CBARP;CACNB1;CAMK2D;CACNA2D1
prerank,positive regulation of macrophage migration (GO:1905523),0.6374168305174144,1.493062272081741,0.049586776859504134,0.34823877832457784,1.0,7/19,15.90%,IL34;CMKLR1;TREM2;MDK;CCL5;PTK2;CX3CL1
prerank,negative regulation of cell development (GO:0010721),0.6101219610614337,1.492109080456278,0.0553306342780027,0.3497484401104569,1.0,6/25,15.60%,CCL11;FBN1;PCM1;FBXW7;GSK3B;TNF
prerank,positive regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043123),0.48252818429861577,1.4916224318929094,0.007142857142857143,0.3501465776607146,1.0,47/158,17.36%,ROR1;MAP3K14;ADIPOQ;TRIML2;NEK6;BIRC3;CD40;ALPK1;REL;CASP1;CFLAR;TIRAP;LITAF;TMEM106A;EDA2R;UNC5CL;WLS;IKBKE;TRIM21;SLC20A1;LGALS9;TRIM8;NOD1;TIFA;BRD4;AKAP13;TRIM13;LAMTOR5;TRAF2;TRIM62;SLC35B2;ATP2C1;CXXC5;CASP8;PELI2;GAPDH;IRAK4;TNF;TRAF3IP2;VAPA;CX3CL1;EDAR;CC2D1A;RBCK1;TNFRSF1A;LPAR1;RHOA
prerank,regulation of neuroinflammatory response (GO:0150077),0.6174782614607136,1.4903625490053716,0.06164383561643835,0.35272762784545614,1.0,3/19,8.61%,MMP3;TREM2;IL33
prerank,regulation of canonical Wnt signaling pathway (GO:0060828),0.47403325496928744,1.4894451901092047,0.0030211480362537764,0.35430473443219374,1.0,77/248,19.80%,PSMA7;RBMS3;COL1A1;ZEB2;BICC1;TCF7L2;NKD2;KREMEN1;GLI3;LYPD6;SFRP4;ATP6AP2;SFRP1;TMEM198;SFRP2;IGFBP4;WNT5A;GSKIP;SNAI2;LRRK2;APOE;EGF;UBR5;TLE1;SMURF2;FRZB;DVL2;CDK14;MDK;WLS;SIAH2;EGFR;HDAC1;PSMD4;LRRK1;ZBED3;FAM53B;DKK3;PSMD11;NFKB1;CSNK1A1;FZD9;CHD8;PRICKLE1;WWTR1;SFRP5;PSMB8;DKK2;PTK7;CCAR2;NPHP3;SCEL;CSNK1D;KLHL12;LRP6;AXIN2;TBL1X;DRAXIN;USP47;GSK3B;LGR4;PSMA6;PSEN1;TLE5;RUVBL1;CTNND2;PSMD14;TRPM4;TNKS2;DVL1;STK4;PSMC6;PSMB10;CSNK1G2;STK11;PSMD12;PSMB1
prerank,positive regulation of triglyceride metabolic process (GO:0090208),-0.5276824168021662,-1.4886090575400037,0.04878048780487805,0.4925677614272332,1.0,9/16,28.33%,SCARB1;LDLR;ABHD5;MFSD2A;PNPLA2;NR1H2;DAGLB;CTDNEP1;SLC27A1
prerank,regulation of sodium ion transmembrane transporter activity (GO:2000649),-0.41566544113377624,-1.4885424871051507,0.024096385542168676,0.48673109895663585,1.0,14/39,15.46%,DMD;FGF12;WNK4;FGF14;FXYD5;FXYD6;WNK3;HECW1;PRKCE;OSR1;FXYD1;NEDD4L;SCN4B;SLMAP
prerank,positive regulation of protein processing (GO:0010954),0.6342149789341907,1.4880885464869835,0.051771117166212535,0.3569869103451264,1.0,5/19,10.64%,CCBE1;NKD2;MYH9;ENO1;CLEC3B
prerank,regulation of cholesterol storage (GO:0010885),0.6650020592188397,1.4874933719134622,0.060240963855421686,0.35763152170747153,1.0,5/15,8.94%,ABCA1;LPL;ABCG1;TREM2;PPARG
prerank,proteolysis involved in cellular protein catabolic process (GO:0051603),0.512752118214456,1.48690429550943,0.02466367713004484,0.35826965472952566,1.0,31/71,22.49%,FAP;TNFAIP3;USP9X;CHMP4B;ADAMTS7;CAPN2;CTSS;ADAMTS12;ZYG11B;OMA1;CTSB;DDB1;CTSK;VPS4A;BAG6;CTSL;HM13;CASP8;STUB1;CHFR;MDM2;PSMA6;UBE2W;CTSW;CTSC;NGLY1;CTSH;PSMA8;NR1D1;RPS27A;CTSZ
prerank,chondroitin sulfate biosynthetic process (GO:0030206),0.6202037806391434,1.4868241517295997,0.04702627939142462,0.35748113671150994,1.0,5/21,3.46%,DCN;CHSY3;BGN;CHST13;VCAN
prerank,eye development (GO:0001654),0.5398046644634987,1.486766400137356,0.030197444831591175,0.3566655264211102,1.0,12/54,8.78%,FBN2;COL5A2;SH3PXD2B;LAMA1;MEIS2;COL5A1;FBN1;SIPA1L3;CACNA1C;MEIS1;NIPBL;PBX3
prerank,regulation of lipid catabolic process (GO:0050994),-0.4990004444063812,-1.4865464022632409,0.03436426116838488,0.48645822539694666,1.0,6/19,19.51%,ALK;PDE3B;BSCL2;ADRA2A;LONP2;TYSND1
prerank,chondroitin sulfate proteoglycan biosynthetic process (GO:0050650),0.5899107397276806,1.4849567946470443,0.052700922266139656,0.36063933429803746,1.0,5/27,3.46%,DCN;CHSY3;BGN;CHST13;VCAN
prerank,positive regulation of signal transduction by p53 class mediator (GO:1901798),0.6046834586209578,1.4828742127419086,0.06843575418994413,0.3655956022256879,1.0,7/22,6.96%,EEF1E1;PLA2R1;SPRED1;SPRED2;ATM;HEXIM1;ATR
prerank,defense response to protozoan (GO:0042832),0.6898434998481597,1.482073243523967,0.07076923076923076,0.36690955069165787,1.0,3/12,6.07%,CD40;BATF;GBP7
prerank,regulation of calcium-mediated signaling (GO:0050848),0.5904926737148353,1.4819049522321621,0.0520694259012016,0.36632035802141355,1.0,5/25,4.76%,CMKLR1;ITPR1;LRRK2;P2RX5;TREM2
prerank,positive regulation of neutrophil migration (GO:1902624),0.6462732409230222,1.4817569552626046,0.043859649122807015,0.36569206408773985,1.0,6/18,10.90%,THBS4;XCL1;TIRAP;MDK;RAC1;MOSPD2
prerank,regulation of peptidyl-tyrosine phosphorylation (GO:0050730),0.49625903437810287,1.4812753481285639,0.016357688113413305,0.36613381207365486,1.0,15/86,8.79%,EPHA7;IL23R;TEC;THBS4;GHR;NRP1;SFRP1;SFRP2;JAK2;VTN;FGF7;TREM2;EGFR;PTPN6;ACVR1
prerank,activation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0006919),0.5150732275412526,1.4808792611818953,0.019144144144144143,0.3662167142023341,1.0,22/73,17.05%,CASP4;DLC1;DAP;JAK2;CASP8AP2;CASP1;CFLAR;CASP12;BBC3;EIF2AK3;BAX;IFT57;PPARG;NOD1;HSPE1;TRAF2;SMAD3;HSPD1;CASP8;TNF;ROBO1;FAM162A
prerank,neuron migration (GO:0001764),0.538216444639518,1.4807047220405363,0.03800475059382423,0.36574216958902034,1.0,15/48,12.06%,LRP12;NRP1;DNAAF4;AUTS2;MDGA1;USP9X;ADGRL3;FGFR1;ASTN2;NAV1;MARK1;RAC1;DISC1;FGF13;SH3RF1
prerank,diol metabolic process (GO:0034311),-0.4935671844233448,-1.4802634550922256,0.04316546762589928,0.4985413451709961,1.0,11/19,27.90%,NOS3;DEGS2;CALM1;PTS;NAAA;ASAH2;SPHK1;GCH1;SGPP1;PRKG2;PLPP2
prerank,regulation of stem cell proliferation (GO:0072091),0.6424954658393196,1.4792626373819673,0.05379310344827586,0.36870919014585085,1.0,6/17,14.13%,FBLN1;ZFP36L1;YAP1;EIF2AK2;TERT;HMGB2
prerank,vasculogenesis (GO:0001570),0.5663414538412479,1.4790632718666783,0.04263565891472868,0.36831677344974495,1.0,8/32,7.16%,GLMN;ITGB8;ADM;PDGFRB;SHH;SPRED1;CCM2;TNNI3
prerank,regulation of steroid biosynthetic process (GO:0050810),0.6854918690938235,1.478413003322976,0.060842433697347896,0.36930076178769217,1.0,2/11,7.21%,NR1H4;BMP5
prerank,mammary gland epithelium development (GO:0061180),0.6690336135226254,1.478405679849139,0.07078313253012049,0.3683357065973886,1.0,2/14,3.03%,WNT2;JAK2
prerank,detection of visible light (GO:0009584),-0.5208909628863618,-1.4776408540751576,0.07868852459016394,0.5005448535455068,1.0,5/16,21.70%,ABCA4;GNA11;RP1;CACNA2D4;TULP1
prerank,regulation of DNA biosynthetic process (GO:2000278),0.5818698848815587,1.4776336561605952,0.05562913907284768,0.36950767002150187,1.0,8/27,13.14%,ADIPOQ;PDGFRB;PRKD2;ATM;PINX1;TOM1L1;FGF2;SMG6
prerank,membrane repolarization during action potential (GO:0086011),-0.5528807097334174,-1.4776206067739643,0.05128205128205128,0.4947407883222286,1.0,6/13,20.64%,ATP1B1;KCNJ2;KCND3;KCNQ1;ATP1A1;KCNE4
prerank,regulation of mitochondrial depolarization (GO:0051900),0.7141917112620352,1.4772636703495392,0.0765625,0.36963232687221714,1.0,4/10,10.47%,DCN;LRRK2;BCL2;FZD9
prerank,positive regulation of cholesterol transport (GO:0032376),0.5935442152088442,1.4772602803714858,0.04979811574697174,0.368652134123755,1.0,6/27,8.94%,ADIPOQ;LRP1;APOE;TREM2;PLTP;PPARG
prerank,embryonic cranial skeleton morphogenesis (GO:0048701),0.655460026363895,1.4771412683666312,0.0625,0.3679976676735266,1.0,5/15,10.85%,PDGFRA;MTHFD1L;NIPBL;TGFBR1;HOXA1
prerank,positive regulation of calcium ion import (GO:0090280),0.677158292337882,1.4760031759730667,0.07761194029850746,0.3702345628918617,1.0,4/12,17.95%,CXCL12;PDGFRB;CCL2;SPHK2
prerank,negative regulation of androgen receptor signaling pathway (GO:0060766),0.6771147918249005,1.475573503992404,0.0629800307219662,0.3705303730708663,1.0,5/12,12.34%,NCOR2;SFRP1;HDAC1;PIAS2;HEYL
prerank,endothelial cell differentiation (GO:0045446),0.6759150883286439,1.4739565606371403,0.06983655274888559,0.3739935059771349,1.0,3/12,3.90%,SCUBE1;FSTL1;JAG1
prerank,dermatan sulfate biosynthetic process (GO:0030208),0.6759599761920134,1.4738138800867737,0.06051873198847262,0.37341861119304015,1.0,3/12,3.46%,DCN;BGN;VCAN
prerank,neuron maturation (GO:0042551),0.6196270194355089,1.473597658406663,0.06747638326585695,0.37304408773658343,1.0,3/18,1.85%,C3;FARP2;B4GALT5
prerank,triglyceride catabolic process (GO:0019433),0.6242543801200986,1.4734818131450154,0.05804749340369393,0.37238570720779235,1.0,2/19,3.05%,LIPC;LPL
prerank,negative regulation of smoothened signaling pathway (GO:0045879),0.6062557821114867,1.4731689537712949,0.05387647831800263,0.3722659464123006,1.0,5/23,6.49%,ENPP1;GLI3;SUFU;KCTD21;GPR161
prerank,tumor necrosis factor-mediated signaling pathway (GO:0033209),0.4856599898589356,1.4720775176501493,0.010526315789473684,0.37443217312291827,1.0,34/114,21.00%,PSMA7;MAP3K14;TNFSF11;BIRC3;JAK2;PLVAP;STAT1;CD40;EDA2R;LIMS1;TNFRSF12A;PSMD4;TNFRSF9;PSMD11;PSMB8;PYDC1;EDA;TRAF2;COMMD7;BAG4;TNFRSF4;TNF;PSMA6;EDAR;TNFRSF1A;PSMD14;FOXO3;PSMC6;PSMB10;PSMD12;PSMB1;TRAF5;PSMA8;PSMF1
prerank,regulation of cholesterol metabolic process (GO:0090181),0.6136166857975496,1.4708636676313402,0.05211267605633803,0.37686271132918525,1.0,4/20,4.36%,NR1H4;ABCA2;APOE;EPHX2
prerank,steroid catabolic process (GO:0006706),0.6964881672193421,1.4704784988135307,0.07530120481927711,0.3770071335842409,1.0,3/10,11.94%,SPP1;CYP27B1;HSD11B1
prerank,positive regulation of DNA replication (GO:0045740),0.6312940457314647,1.4701310029166126,0.06125356125356125,0.3770549933687764,1.0,5/16,7.06%,GLI2;DNA2;EGF;BRPF3;EGFR
prerank,chondroitin sulfate catabolic process (GO:0030207),0.6659866743389762,1.4698563491025234,0.07407407407407407,0.3767866973069023,1.0,3/13,3.46%,DCN;BGN;VCAN
prerank,nerve growth factor signaling pathway (GO:0038180),-0.5900624921529241,-1.4694688058681464,0.06997084548104957,0.5129089501874202,1.0,4/10,13.56%,KIDINS220;RAPGEF2;BDNF;RAP1A
prerank,regulation of cardiac muscle cell proliferation (GO:0060043),0.6259001968406784,1.4692303005308531,0.07391910739191074,0.3776610144789578,1.0,6/19,12.71%,RUNX1;ZFPM2;TBX2;TGFBR1;FGF2;RBPJ
prerank,defense response to Gram-positive bacterium (GO:0050830),0.5422397527096104,1.4689494244475043,0.04305043050430504,0.3774480031763211,1.0,6/40,6.07%,LBP;CRP;TLR2;RNASE7;TIRAP;GBP7
prerank,angiogenesis involved in wound healing (GO:0060055),-0.5746375185476166,-1.4688202910352608,0.07836990595611286,0.5089063669248268,1.0,5/11,13.18%,ADIPOR2;CD34;KDR;GATA2;NDNF
prerank,regulation of cellular metabolic process (GO:0031323),0.5397532845297408,1.468790974173512,0.047225501770956316,0.37696474543726255,1.0,13/45,15.43%,CYP1B1;NCOR2;ABCA2;FASN;ABCG1;PID1;SSH1;FOXM1;TBC1D16;NPC2;PANK2;STUB1;MKLN1
prerank,ameboidal-type cell migration (GO:0001667),-0.38420647790422674,-1.4686954593999877,0.025477707006369428,0.5034914865398952,1.0,24/51,22.27%,SEMA6A;SEMA3C;SEMA7A;SEMA6D;GPC3;CCN3;SEMA3D;TBX1;CENPV;ITGA4;SEMA4D;SEMA5A;AMOTL2;SEMA5B;ERBB4;SEMA4B;SEMA3G;SEMA3B;FAT2;PKN3;SEMA6C;SEMA6B;SOX8;SEMA4A
prerank,negative regulation of canonical Wnt signaling pathway (GO:0090090),0.4760843504816964,1.4685791641774948,0.005186721991701245,0.37659956813661,1.0,38/161,14.70%,PSMA7;RBMS3;BICC1;TCF7L2;NKD2;KREMEN1;TNN;GLI3;SFRP4;TBX18;SFRP1;SFRP2;IGFBP4;WNT5A;SNAI2;APOE;TLE1;FRZB;DVL2;MDK;SIAH2;HDAC1;PSMD4;DKK3;PSMD11;CSNK1A1;CHD8;PRICKLE1;WWTR1;SFRP5;PSMB8;DKK2;NPHP3;KLHL12;LRP6;AXIN2;DRAXIN;GSK3B
prerank,positive regulation of phosphatidylinositol 3-kinase signaling (GO:0014068),0.5011289080708989,1.4683860658875072,0.0234375,0.37617596799451547,1.0,17/72,12.01%,ROR2;ROR1;DCN;PDGFRA;FSHR;JAK2;PDGFRB;EGF;TREM2;FGFR1;CBL;CCL5;PIK3R1;PTPN6;PIK3AP1;PIK3R5;FGF2
prerank,endoderm development (GO:0007492),0.6642477511525015,1.4681584411550221,0.057692307692307696,0.37581726063077536,1.0,3/13,3.66%,LAMC1;DUSP2;DUSP5
prerank,response to lipid (GO:0033993),0.4979197050393664,1.4680323382286458,0.008602150537634409,0.37521525008571016,1.0,20/105,9.88%,IL23R;SPP1;LBP;ASXL1;ABCA2;JAK2;GATA6;RXRG;IRAK3;ABCG1;TIRAP;LY96;ANXA1;CDKN2D;CYP27B1;STAT3;CD36;LGALS9;PPARG;ERBIN
prerank,mesoderm formation (GO:0001707),0.633833952225323,1.4677580844925786,0.06966618287373004,0.37510528086335193,1.0,3/17,3.80%,SNAI1;SMAD2;ITGA8
prerank,calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules (GO:0016338),-0.5330168924743588,-1.466813411228885,0.08361204013377926,0.5032438723909458,1.0,3/16,12.41%,CLDN5;CLDN14;CLDN1
prerank,regulation of T cell chemotaxis (GO:0010819),0.6794169459648884,1.4662159277213371,0.08456973293768547,0.3785451643828836,1.0,4/11,8.47%,WNT5A;XCL1;CCL5;CXCL10
prerank,positive regulation of natural killer cell mediated immunity (GO:0002717),-0.5169805652421862,-1.4660805014481888,0.04642857142857143,0.49959208777544895,1.0,14/16,46.88%,CADM1;LAMP1;AP1G1;PVR;NECTIN2;RAET1E;RASGRP1;SLAMF6;CD226;IL12A;CRTAM;KLRD1;CD160;KLRK1
prerank,iron ion transport (GO:0006826),0.5296224173700628,1.4651469069332779,0.045563549160671464,0.38055471529097323,1.0,6/47,5.97%,SLC39A14;HEPH;CLTC;CP;SLC11A2;STEAP3
prerank,regulation of leukocyte chemotaxis (GO:0002688),0.6345662669303977,1.4649466657602699,0.0599721059972106,0.3801224094032628,1.0,4/18,6.13%,EDN3;PTN;XCL1;MDK
prerank,glucose transmembrane transport (GO:1904659),-0.48724618216084686,-1.4644134541671319,0.07777777777777778,0.4993532095856085,1.0,7/18,26.88%,SLC2A1;SORT1;SLC2A8;SLC2A9;SLC45A1;RAB4B;SLC2A4
prerank,dermatan sulfate metabolic process (GO:0030205),0.6598060120308286,1.463680658273212,0.0707070707070707,0.382885336653372,1.0,3/13,3.46%,DCN;BGN;VCAN
prerank,pattern recognition receptor signaling pathway (GO:0002221),0.5194498806620018,1.462912769763064,0.036571428571428574,0.3841189883842989,1.0,18/56,18.60%,LBP;LACC1;TLR2;ALPK1;LY96;CTSS;CD36;NOD1;TIFA;CTSB;TLR7;CTSK;CD14;CTSL;IRAK2;IRAK4;RPS6KA3;TLR3
prerank,negative regulation of insulin receptor signaling pathway (GO:0046627),0.5733811295470419,1.4620699249668614,0.05221932114882506,0.38544899240506975,1.0,9/27,11.30%,ENPP1;IRS1;PIP4K2A;PID1;NCK1;PIP4K2B;PTPN1;SLC27A4;RPS6KB1
prerank,regulation of interleukin-8 production (GO:0032677),0.510686652297989,1.4616873861058417,0.032329988851727984,0.3854944516174523,1.0,15/69,12.66%,ADIPOQ;LBP;BCL3;CRP;TLR2;TIRAP;ANXA1;PRKD2;STAT3;LGALS9;NOD1;TLR7;CD14;LAMTOR5;SSC5D
prerank,regulation of bone mineralization (GO:0030500),0.5275983672450105,1.4614307724627005,0.03468208092485549,0.3852515852638307,1.0,15/55,11.28%,ENPP1;GPM6B;FBN2;NELL1;PTN;TMEM119;DDR2;CCR1;CYP27B1;ATP2B1;ACVR1;TGFB3;FZD9;ADGRV1;ACVR2A
prerank,cellular response to glucocorticoid stimulus (GO:0071385),0.611149124998567,1.4613456548370094,0.0677731673582296,0.38450635140159334,1.0,4/18,8.42%,ZFP36L1;ZFP36L2;ANXA1;UBE2L3
prerank,cholesterol metabolic process (GO:0008203),0.5119400935284544,1.460566627809502,0.03440621531631521,0.38582483484108115,1.0,8/68,7.67%,CEL;ABCA1;APOE;ABCG1;CLN6;INSIG2;MVK;SOAT1
prerank,mammary gland development (GO:0030879),0.6093279158762623,1.460490716010978,0.06891891891891892,0.385054016123937,1.0,5/21,9.37%,WNT2;GLI2;JAK2;APLN;TGFB3
prerank,protein processing (GO:0016485),0.485400445450887,1.4604134787315555,0.012698412698412698,0.38432231985980025,1.0,19/102,12.88%,CASP4;HP;HPR;MMP14;ADAM19;CPXM1;XPNPEP3;STOML2;CASP1;OGT;FXN;CTSS;KLK2;MMP16;OMA1;MYRF;CTSL;PCSK5;HM13
prerank,pinocytosis (GO:0006907),0.6844447786324436,1.4603288125822624,0.08742331288343558,0.38365464302577534,1.0,4/10,8.07%,CARMIL1;SNX5;RAB34;SNX33
prerank,sulfur compound transport (GO:0072348),-0.4594059315343628,-1.4600530551226965,0.0635593220338983,0.5063677423197854,1.0,8/27,10.76%,ABCG2;SLC6A6;SLC26A7;LRRC8D;SLC13A4;SLC5A6;SLC25A26;SLC35F3
prerank,lipoprotein catabolic process (GO:0042159),0.6880771272726072,1.4598421128883103,0.07561728395061729,0.3841634445847362,1.0,4/11,5.48%,APOE;ABHD17C;LYPLAL1;CTSD
prerank,regulation of cell adhesion (GO:0030155),0.47765206080167893,1.4592075677893375,0.01900739176346357,0.38493040867223177,1.0,36/129,17.28%,EPHA7;IBSP;KNG1;FBLN1;CXCL12;SPN;PRKCA;NUAK1;RHOD;DUSP26;MIA3;PRKD2;EPHB3;PLXNC1;MDK;ATM;CCL5;PLXND1;RSU1;ARHGDIG;DSCAM;EFNA5;CXCR4;PLXNA3;PPP3CA;EPHB2;PTK2;TPM1;ITGB1BP1;PPP1CB;FLCN;TNF;ABL1;ANGPT1;PTPRJ;ROCK2
prerank,positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557),0.5009080821531271,1.4585123213447666,0.03982300884955752,0.3859011542866244,1.0,21/73,18.60%,LBP;SPN;TLR2;WNT5A;JAK2;LPL;TIRAP;LY96;TMEM106A;ARFGEF2;STAT3;LGALS9;IL33;CD14;EPHB2;DDT;IFNGR1;PSEN1;PTPRJ;SPHK2;TLR3
prerank,oligosaccharide metabolic process (GO:0009311),-0.3851781351601081,-1.4584995172106165,0.011363636363636364,0.5054515258395833,1.0,10/46,6.92%,ST3GAL6;ST6GALNAC3;ST8SIA4;AMY1C;AMY1B;AMY1A;ST3GAL4;FUT9;ST8SIA6;ST8SIA2
prerank,regulation of epithelial cell proliferation (GO:0050678),0.4926410265019421,1.4584041299335684,0.022271714922048998,0.38522863920468386,1.0,15/85,7.21%,RUNX3;LAMB1;ZFP36L1;TCF7L2;YAP1;LAMC1;DEAF1;SFRP1;SFRP2;FGF7;CDKN2B;FGF9;LIMS1;EGFR;BMP5
prerank,Golgi localization (GO:0051645),0.6957568671507377,1.4583642181572638,0.06423357664233577,0.384390190449795,1.0,9/11,25.74%,ARCN1;CDC42;COPG1;PDCD10;RIPOR1;HOOK3;STK25;YWHAZ;ARHGAP21
prerank,"mitochondrial electron transport, cytochrome c to oxygen (GO:0006123)",-0.507081748996782,-1.4583629873210031,0.060810810810810814,0.5004764710458217,1.0,8/17,18.34%,COX5A;COX8A;COX4I1;COX6A1;COX6C;COX5B;COX6B1;COX10
prerank,positive regulation of ossification (GO:0045778),0.5538673113385727,1.458304023682635,0.032766990291262135,0.38367491761366446,1.0,12/39,11.28%,GPM6B;FBN2;NELL1;PTN;TMEM119;WNT5A;ATP2B1;ACVR1;TGFB3;FZD9;ADGRV1;ACVR2A
prerank,wound healing (GO:0042060),0.5085449546203337,1.4579202044690038,0.03669724770642202,0.38391635015967623,1.0,15/62,13.71%,COL3A1;PDGFRA;JAML;WNT5A;CFLAR;MYH9;MIA3;MMP12;NF1;TGFBR1;HPSE;FGF2;PPP3CA;TPM1;SMAD3
prerank,negative regulation of cellular protein metabolic process (GO:0032269),0.4878874956390552,1.4577973529376886,0.024918743228602384,0.38335137887949655,1.0,29/88,20.97%,IGF2BP1;KNG1;IGF2BP2;SERPINE2;NELL1;SYNCRIP;APOE;DNAJC1;IGFBP5;PLAT;ILF3;EIF2AK3;SAMD4A;PAIP2;NFKB1;BAG6;EIF2AK2;FMR1;GIGYF2;CAPRIN1;GAPDH;EPRS1;CLN3;CDK5;DAPK1;YBX1;DDX3X;CALR;CDK5RAP3
prerank,NLS-bearing protein import into nucleus (GO:0006607),0.6681257036255669,1.4576135108670305,0.07959479015918958,0.38295421020751175,1.0,4/13,14.67%,CBLB;KPNA3;KPNB1;NUP35
prerank,regulation of cellular senescence (GO:2000772),0.5750859094479229,1.456808131535913,0.050870147255689425,0.3842871145099345,1.0,14/28,23.06%,NEK6;NUAK1;EEF1E1;AKT3;CDK6;FBXO5;TERT;NEK4;YPEL3;RSL1D1;YBX1;MAP3K3;CGAS;TWIST1
prerank,regulation of calcium ion import (GO:0090279),0.6069455510636614,1.4561796040427297,0.08,0.38502263458478836,1.0,4/21,4.71%,CXCL12;PDGFRB;EGF;PKD2
prerank,regulation of endothelial cell proliferation (GO:0001936),0.4898664524706008,1.4555625110671737,0.020364415862808145,0.3858794376475843,1.0,19/88,9.16%,CCL11;SULF1;SPARC;THBS4;PRKCA;NRP1;NR2F2;EGR3;WNT5A;STAT1;APOE;EGF;ARNT;PRKD2;AKT3;APOH;NF1;TGFBR1;STAT5A
prerank,regulation of hematopoietic stem cell differentiation (GO:1902036),0.5083982570518539,1.455087464485674,0.03781979977753059,0.3862977153126727,1.0,22/70,21.00%,PSMA7;RUNX1;KMT2A;YAP1;PSMD4;CBFB;PSMD11;TCF12;EIF2AK2;PSMB8;TCF3;ABL1;PSMA6;ITCH;PSMD14;PSMC6;PSMB10;PSMD12;PSMB1;YTHDF2;PSMA8;PSMF1
prerank,inorganic cation import across plasma membrane (GO:0098659),-0.3458530563996347,-1.454978078820644,0.04081632653061224,0.5045295090003196,1.0,20/75,12.39%,ATP1B3;SLC12A7;SLC12A2;SLC24A2;SLC9A2;ATP1B1;ATP1A2;KCNJ2;SLC39A10;SLC39A8;ABCC9;SLC12A6;KCNJ3;SLC8A3;SLC6A1;TRPV2;KCNJ13;ATP2B4;KCNJ12;TRPV4
prerank,regulation of sensory perception of pain (GO:0051930),-0.580821280219147,-1.4542572538672223,0.08695652173913043,0.5014581588142187,1.0,7/11,30.63%,MGLL;CCN3;TMEM100;ZFHX2;ACP3;SPX;F2R
prerank,protein auto-ADP-ribosylation (GO:0070213),0.6664819907041513,1.454027473568247,0.08571428571428572,0.38822617687715943,1.0,3/12,6.47%,PARP8;PARP3;PARP11
prerank,negative regulation of cell-matrix adhesion (GO:0001953),0.5616182885960435,1.4536345579706405,0.06734434561626429,0.38840130469505646,1.0,12/32,15.32%,DLC1;APOD;MAP4K4;CASK;JAG1;PTEN;NF2;MMP12;SEMA3E;ARHGAP6;ITGB1BP1;PHLDB2
prerank,myelin assembly (GO:0032288),0.7143700144991545,1.4527402416440476,0.05409582689335394,0.3900467237264764,1.0,6/10,14.94%,ABCA2;TENM4;PMP22;DICER1;TPPP;EPB41L3
prerank,anion transport (GO:0006820),-0.41154314020363436,-1.452363098589702,0.024509803921568627,0.5014560327294562,1.0,6/33,3.44%,ABCG2;SLC26A7;LRRC8D;SLC13A3;SLC13A4;SLC22A6
prerank,hyaluronan metabolic process (GO:0030212),0.5865985609370735,1.4522799350819502,0.07076101468624833,0.3905286641672549,1.0,5/23,14.31%,CEMIP;SLC9A1;CEMIP2;FGF2;LYVE1
prerank,generation of neurons (GO:0048699),0.4672734962162359,1.4517264307491824,0.0,0.391059004149503,1.0,33/190,12.34%,RUNX1;RUNX2;WNT2;RUNX3;YAP1;LRP12;NRP1;DNAAF4;AUTS2;MDGA1;WNT5A;USP9X;ADGRL3;BHLHE22;WNT2B;WNT9A;FGFR1;ASTN2;NAV1;MARK1;SHH;OPHN1;RAC1;DISC1;FZD1;ACSL4;BHLHE40;CDK6;MAP2K1;FZD3;FGF13;SH3RF1;HEYL
prerank,negative regulation of cell migration (GO:0030336),0.47298311523121966,1.4515383585871442,0.010395010395010396,0.3906555132451567,1.0,22/137,6.34%,CYP1B1;DLC1;SULF1;COL3A1;ADIPOQ;LRP1;TNN;SFRP1;SFRP2;MITF;DPYSL3;TIMP1;JAG1;NAV3;RAP2A;IGFBP5;MIA3;PTEN;NF2;SHH;RAC1;SRGAP1
prerank,positive regulation of hormone secretion (GO:0046887),0.6228114353281522,1.4512370579531857,0.06555090655509066,0.390630858257889,1.0,2/17,0.80%,SPP1;EDN3
prerank,regulation of interleukin-6 production (GO:0032675),0.4843234254662816,1.450586189187875,0.023579849946409433,0.3916052008112183,1.0,24/96,15.90%,LBP;TNFAIP3;IL16;TLR2;WNT5A;LPL;IRAK3;TSLP;TIRAP;TREM2;TMEM106A;AIF1;STAT3;RAB7B;LGALS9;PTPN6;IL33;TLR7;XBP1;SIRPA;SELENOS;HSPD1;TNF;CX3CL1
prerank,sodium ion transmembrane transport (GO:0035725),-0.3419950187490151,-1.4501636418918797,0.01282051282051282,0.502647713100111,1.0,23/84,16.22%,ATP1B3;SLC6A6;SLC12A2;SLC24A2;SLC9A2;ATP1B1;SLC6A9;ATP1A2;SCN2A;SCN8A;SLC8A3;SLC6A1;SLC4A8;SCN3A;SLC6A17;SLC6A7;HCN1;SLC6A5;SCN4B;SLC9A5;SCN9A;SLC6A12;SLC8A2
prerank,peptidyl-lysine dimethylation (GO:0018027),0.6140451920144043,1.4494445533516158,0.07300275482093664,0.3938368600963751,1.0,7/18,17.58%,KMT2A;EHMT1;KMT2B;ASH1L;SETMAR;SETD7;KMT2D
prerank,cytoskeleton organization (GO:0007010),0.48183339875756004,1.4483206711370251,0.017894736842105262,0.3961893248257471,1.0,35/114,17.75%,CCL11;CCL7;KRT25;PALLD;TNFAIP3;RND3;FMNL2;SH3KBP1;MAST4;RHOD;APOE;SIPA1L3;FGD4;MARK1;MDK;RAC1;PDZD8;FMNL3;OBSL1;BIN1;LRCH3;MAST2;ANK1;ABI2;RANBP9;THY1;TPM1;CCL2;EPB41L3;FGD6;RHOBTB3;CFAP410;RHOA;WTIP;WDPCP
prerank,negative regulation of dephosphorylation (GO:0035305),-0.4930579662027804,-1.448094538767753,0.06920415224913495,0.5035426179998871,1.0,6/18,7.19%,PPP1R16B;INPP5K;URI1;PPP1R8;SH3RF2;YWHAB
prerank,cellular response to interleukin-7 (GO:0098761),0.61971644394989,1.4477991348310804,0.08298755186721991,0.3958326558140541,1.0,9/17,21.72%,JAK1;IRS1;TSLP;STAT3;STAT5A;IL7;SMARCA4;STAT5B;BRWD1
prerank,interleukin-7-mediated signaling pathway (GO:0038111),0.61971644394989,1.4477991348310804,0.08298755186721991,0.3958326558140541,1.0,9/17,21.72%,JAK1;IRS1;TSLP;STAT3;STAT5A;IL7;SMARCA4;STAT5B;BRWD1
prerank,positive regulation of macrophage chemotaxis (GO:0010759),0.6549700357575139,1.447719622285544,0.08127721335268505,0.3951594826051661,1.0,4/14,7.35%,IL34;CMKLR1;MDK;CCL5
prerank,regulation of tissue remodeling (GO:0034103),0.6130388188942527,1.4477023603894132,0.08134642356241234,0.39429331496774855,1.0,6/18,12.70%,RUNX1;THBS4;DDR2;MDK;GPNMB;SUCO
prerank,regulation of cardiac conduction (GO:1903779),-0.37582575926523193,-1.4476075309109628,0.022388059701492536,0.4999380545963006,1.0,22/54,22.05%,ATP1B3;ATP1B1;ANK2;ATP1A2;ITPR2;ABCC9;NPR1;ITPR3;SLC8A3;ATP2B2;FXYD6;TRPC1;ATP2B4;ATP2A3;FXYD1;SLC8A2;ACE2;ATP1A1;TMEM65;RYR2;CASQ2;STIM1
prerank,positive regulation of organelle assembly (GO:1902117),0.5259814184983215,1.4473837369814246,0.06372549019607843,0.3942867141962012,1.0,16/44,17.14%,LCP1;PIP4K2A;DYNC1H1;ASAP1;FSCN1;GPSM2;CCP110;ENTR1;RAB3GAP2;PIP4K2B;CEP120;SDC1;SDCBP;ARHGAP35;TNF;SH3GLB1
prerank,protein localization to condensed chromosome (GO:1903083),-0.5326981122665025,-1.4472486518545902,0.08143322475570032,0.4959504568196297,1.0,11/12,45.02%,BUB3;ZWILCH;IK;MTBP;KNL1;TTK;SPDL1;CDK1;MIS12;AURKB;CHAMP1
prerank,presynapse assembly (GO:0099054),0.6283606110938266,1.4470281550756856,0.08127721335268505,0.3943318798852283,1.0,4/16,8.58%,CEL;WNT5A;PTEN;FZD1
prerank,negative regulation of cellular response to insulin stimulus (GO:1900077),0.56456649726673,1.446097080265423,0.05613577023498695,0.3961529844237465,1.0,9/28,11.30%,ENPP1;IRS1;PIP4K2A;PID1;NCK1;PIP4K2B;PTPN1;SLC27A4;RPS6KB1
prerank,sodium-independent organic anion transport (GO:0043252),-0.568318035880649,-1.4457543728135231,0.09946236559139784,0.4949878234544246,1.0,3/10,4.50%,SLCO1C1;SLCO3A1;SLCO2A1
prerank,regulation of protein kinase A signaling (GO:0010738),0.6032449078290614,1.4455442212999956,0.07300275482093664,0.396881945998321,1.0,9/20,17.61%,ADIPOQ;FSHR;IAPP;LRRK2;PRKAR1B;ADGRV1;PJA2;MC1R;TCIM
prerank,positive regulation of MAPK cascade (GO:0043410),0.46256836569874166,1.4444828908845506,0.003036437246963563,0.39913278322099033,1.0,56/245,17.36%,ROR2;CCL11;ROR1;IL34;CCL7;PDGFRA;EDN3;FSHR;MID1;TAOK1;IAPP;TNFSF11;PRKCA;NRP1;PDGFRB;CD40;PLA2G5;XCL1;LRRK2;APOE;EGF;TIRAP;PRKD2;TREM2;TMEM106A;FGFR1;CCR1;ICAM1;EGFR;CD36;CCL5;LGALS9;MAP2K1;SPRY2;PIK3R5;GCNT2;TAOK3;EIF2AK2;FGF2;GPNMB;CCL2;DDT;FBXW7;PELI2;NTRK3;GAREM1;TNF;MST1R;CX3CL1;EZH2;ANGPT1;PDCD10;ROBO1;PTPRJ;ROCK2;LPAR1
prerank,negative regulation of cell-substrate junction organization (GO:0150118),0.6162740222989309,1.4443695507566752,0.08391608391608392,0.3975865912898404,1.0,11/16,24.16%,DLC1;APOD;PTEN;ARHGAP6;ITGB1BP1;PHLDB2;CORO1C;BCAS3;SRC;ACVRL1;CLASP2
prerank,negative regulation of focal adhesion assembly (GO:0051895),0.6162740222989309,1.4443695507566752,0.08391608391608392,0.3975865912898404,1.0,11/16,24.16%,DLC1;APOD;PTEN;ARHGAP6;ITGB1BP1;PHLDB2;CORO1C;BCAS3;SRC;ACVRL1;CLASP2
prerank,positive regulation of small molecule metabolic process (GO:0062013),0.6528151648295155,1.4442742176500305,0.07069219440353461,0.39696719074377734,1.0,4/15,8.94%,ADIPOQ;ADM;IRS1;PPARG
prerank,positive regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains (GO:0002824),0.6703944990184371,1.4442399914003035,0.07142857142857142,0.39619549189080894,1.0,1/12,0.46%,IL23R
prerank,regulation of cell-cell adhesion mediated by cadherin (GO:2000047),-0.47457125469346695,-1.4442395459198272,0.052083333333333336,0.4945681035696256,1.0,5/19,11.68%,TJP1;BMP6;NEXMIF;NOTCH4;PTPRU
prerank,positive regulation of phosphate metabolic process (GO:0045937),0.5768935095307672,1.4441144992906896,0.062095730918499355,0.3956697477982691,1.0,9/25,16.37%,GLMN;NRP1;EGF;EGFR;CCL5;DSCAM;SDCBP;PTH1R;PSEN1
prerank,glycogen metabolic process (GO:0005977),-0.44536448534287576,-1.4430602387191966,0.06147540983606557,0.49321327644368423,1.0,12/27,18.07%,PRKAG2;PYGB;PGM2L1;CALM1;PYGM;PPP1R3C;PER2;GBE1;UGP2;PHKG1;PGM2;AGL
prerank,regulation of B cell proliferation (GO:0030888),0.5253971578052593,1.4429748949648773,0.04801920768307323,0.39799216928971154,1.0,12/44,12.48%,TNFRSF21;VAV3;CD40;BCL2;TIRAP;BLK;ATM;FCGR2B;SASH3;AHR;EPHB2;IL7
prerank,negative regulation of lymphocyte migration (GO:2000402),0.6899464435710425,1.4429068636371867,0.10361067503924647,0.3973245131474351,1.0,3/10,5.99%,APOD;MIA3;PADI2
prerank,cell surface receptor signaling pathway involved in heart development (GO:0061311),0.6099040043625392,1.442393262472562,0.08344733242134063,0.3979009055777689,1.0,7/17,12.71%,SNAI1;SNAI2;JAG1;ACVR1;HEYL;GALNT11;RBPJ
prerank,regulation of sodium ion transport (GO:0002028),-0.4090321640496269,-1.4422259901327543,0.03954802259887006,0.4908300709335668,1.0,12/34,18.13%,NKAIN2;SNTA1;FGF12;WNK4;NKAIN3;WNK3;ATP2B4;NKAIN1;SCN4B;SLMAP;DRD2;ATP1A1
prerank,organophosphate catabolic process (GO:0046434),0.6785063375133157,1.4418732515764376,0.0732484076433121,0.3984335353399888,1.0,1/11,1.44%,PDXP
prerank,positive regulation of growth (GO:0045927),0.5009649176466467,1.4417172245923537,0.048,0.3979703218476694,1.0,24/64,20.26%,RFTN1;MMP14;EIF4G2;SFRP1;SFRP2;BCL2;KLHL22;INO80;FXN;EGFR;CDC42;PABIR1;CDKN2AIP;TGFBR1;RPTOR;EXOSC4;SDCBP;USP47;EXOSC2;TAF9B;RPS6KA3;CSNK2A1;TGFB2;DDX3X
prerank,regulation of hematopoietic progenitor cell differentiation (GO:1901532),0.5031018319592765,1.441520327080639,0.03867403314917127,0.3976869053215975,1.0,23/73,21.00%,PSMA7;RUNX1;KMT2A;YAP1;PSMD4;CBFB;PSMD11;TCF12;EIF2AK2;PSMB8;TCF3;ABL1;PSMA6;ITCH;PSMD14;SPI1;PSMC6;PSMB10;PSMD12;PSMB1;YTHDF2;PSMA8;PSMF1
prerank,interferon-gamma-mediated signaling pathway (GO:0060333),0.5345329423139235,1.4408072687504392,0.0485781990521327,0.3987530926168113,1.0,15/45,16.76%,MID1;JAK1;IRF7;JAK2;STAT1;CAMK2D;IRF1;ICAM1;TRIM21;TRIM8;OASL;TRIM62;IFNGR1;SP100;IFNGR2
prerank,regulation of intracellular estrogen receptor signaling pathway (GO:0033146),0.5717936989050149,1.4403142214529265,0.06597671410090557,0.3992292395282021,1.0,5/29,8.40%,RUNX1;YAP1;DNAAF4;CARM1;CBFB
prerank,protein N-linked glycosylation via asparagine (GO:0018279),0.5586806216379631,1.4397928383947471,0.05994897959183673,0.3998527034302364,1.0,14/30,19.11%,MGAT5;B4GALNT2;ALG5;ST6GAL1;UGGT2;DDOST;UBE2J1;LMAN1;DPM2;STT3A;OSTC;NUDT14;ALG8;TUSC3
prerank,regulation of osteoblast proliferation (GO:0033688),0.6313975220022705,1.4391583190424015,0.07965860597439545,0.4008009621165254,1.0,6/17,11.69%,TNN;NELL1;SFRP1;TMEM119;HPSE;EIF2AK2
prerank,regulation of MHC class II biosynthetic process (GO:0045346),0.6723031470606955,1.4390447190345028,0.08801213960546282,0.40022144808373444,1.0,4/11,10.96%,JAK2;TMEM106A;TAF7;XBP1
prerank,negative regulation of wound healing (GO:0061045),0.5669545650446757,1.4386214571479827,0.057692307692307696,0.4004945710807867,1.0,10/28,15.60%,KNG1;SERPINE2;CASK;VTN;APOE;PTEN;APOH;FGF2;PHLDB2;TNF
prerank,cellular response to oxidised low-density lipoprotein particle stimulus (GO:0140052),0.6933166583576644,1.4383522836433196,0.09062003179650238,0.40041194267105984,1.0,4/10,8.19%,MIA3;TREM2;CD36;CD68
prerank,positive regulation of natural killer cell mediated cytotoxicity (GO:0045954),-0.4982172126980619,-1.4377875245762328,0.06713780918727916,0.4986285952713104,1.0,6/17,21.62%,CADM1;LAMP1;AP1G1;PVR;NECTIN2;RAET1E
prerank,proteolysis (GO:0006508),0.4580190889380566,1.4367827966923992,0.004032258064516129,0.40386086140197625,1.0,68/252,19.60%,MMP3;FAP;CASP4;MMP2;OLR1;MMP14;ADAM19;CPXM1;ANPEP;SUFU;PRTN3;XPNPEP3;CAPN5;HTRA3;CASP1;ADAMTS7;PLAT;CPQ;BMP1;OGT;CAPN2;CTSD;MMP12;CTSS;CAPN15;XPNPEP1;ADAMTS12;MMP17;MMP16;CASP7;CTSB;CTSK;ADAMTS9;LAP3;CPA6;LACTB;ADGRV1;ATG4A;CNDP2;SENP6;HTRA4;PGPEP1L;CTSL;NLN;PCSK5;HM13;PAPPA2;TBL1X;ENPEP;CASP8;MDM2;NPEPPS;PSMA6;PSEN1;CTSW;HTRA1;LVRN;CUL7;PTCH1;DPP7;MMP15;FBXO2;CTSC;CTSA;SPPL3;CLN3;CTSH;SPG7
prerank,positive regulation of fibroblast proliferation (GO:0048146),0.5693368001921745,1.4367137974877775,0.06976744186046512,0.4031881309044719,1.0,7/27,12.19%,WNT2;PDGFRA;WNT5A;DDR2;E2F1;CDK6;S100A6
prerank,maintenance of gastrointestinal epithelium (GO:0030277),-0.5566898381348141,-1.4365367940463405,0.09269662921348315,0.4975513489083543,1.0,2/12,6.67%,RBP4;TLR4
prerank,mitotic nuclear membrane disassembly (GO:0007077),0.6672042900300036,1.4364510457453201,0.09146341463414634,0.4030333242099425,1.0,4/12,8.18%,NEK6;PRKCA;NEK9;PLK1
prerank,negative regulation of reproductive process (GO:2000242),0.6042204548355983,1.4359894647676312,0.08876560332871013,0.403493195677065,1.0,3/17,7.56%,SULF1;TIMP1;PAEP
prerank,peptidyl-asparagine modification (GO:0018196),0.5511516652765776,1.4346993927748928,0.07026348808030113,0.40620870022443467,1.0,14/31,19.11%,MGAT5;B4GALNT2;ALG5;ST6GAL1;UGGT2;DDOST;UBE2J1;LMAN1;DPM2;STT3A;OSTC;NUDT14;ALG8;TUSC3
prerank,regulation of nucleobase-containing compound metabolic process (GO:0019219),0.6701396180625444,1.433912051025093,0.10625909752547306,0.40761225946322766,1.0,2/11,1.13%,IGF2BP1;IGF2BP2
prerank,L-amino acid transport (GO:0015807),0.5633806356458089,1.4337922187269982,0.05867014341590613,0.4070359522936273,1.0,3/28,2.16%,SLC7A2;SLC1A3;SLC38A3
prerank,regulation of phosphatidylinositol 3-kinase signaling (GO:0014066),0.4775708182250277,1.4331509576922996,0.01847826086956522,0.4080655967464243,1.0,21/100,9.90%,ROR2;ROR1;DCN;PDGFRA;FSHR;JAK2;PDGFRB;EGF;PIP4K2A;TREM2;FGFR1;PTEN;PTPN13;PIP5K1B;EGFR;CBL;CCL5;PIK3R1;PTPN6;PIP4K2B;PIK3AP1
prerank,COPII-coated vesicle cargo loading (GO:0090110),0.6410577424525584,1.4326889720264566,0.06342182890855458,0.4085494186108087,1.0,6/14,11.65%,SEC31A;SEC24D;SEC23A;MIA3;SEC24A;TBC1D20
prerank,female gamete generation (GO:0007292),0.5641676559463579,1.4321265144948923,0.0708955223880597,0.4092727605118962,1.0,5/29,6.22%,FSHR;PTN;USP9X;MDK;DIAPH2
prerank,dendritic cell differentiation (GO:0097028),0.5872250118347508,1.4315570459512934,0.07797537619699042,0.4099163205145073,1.0,5/22,8.51%,PRTN3;BATF;TREM2;BLK;LGALS9
prerank,adherens junction organization (GO:0034332),-0.3850337848317361,-1.4314763825345829,0.0136986301369863,0.5070763700126582,1.0,18/48,17.56%,TJP1;CADM2;CADM1;ACTB;CDH1;RAMP2;CDH13;CDH5;CTNND1;CDH10;CDH12;PIP5K1C;CDH22;NECTIN1;VCL;CADM3;PVR;NECTIN2
prerank,negative regulation of ossification (GO:0030279),0.5820864927373622,1.431297132184529,0.08707482993197278,0.40978517717503593,1.0,6/23,12.71%,ENPP1;SFRP1;CCR1;MDK;CHSY1;RBPJ
prerank,cellular response to interleukin-6 (GO:0071354),0.5702823981196596,1.4307838636078847,0.077733860342556,0.41037691504871304,1.0,9/26,10.12%,YAP1;SBNO2;JAK1;JAK2;STAT1;PID1;STAT3;CBL;NFKB1
prerank,regulation of sequestering of triglyceride (GO:0010889),0.6406205694295691,1.4294723433148457,0.08575581395348837,0.41313943427023675,1.0,5/15,8.94%,LPL;OSBPL11;PLIN2;TREM2;PPARG
prerank,low-density lipoprotein receptor particle metabolic process (GO:0032799),0.6753939991573195,1.4293759932652315,0.10339506172839506,0.4116709585205405,1.0,2/10,2.18%,CLTC;MYLIP
prerank,low-density lipoprotein particle receptor catabolic process (GO:0032802),0.6753939991573195,1.4293759932652315,0.10339506172839506,0.4116709585205405,1.0,2/10,2.18%,CLTC;MYLIP
prerank,positive regulation of lipid biosynthetic process (GO:0046889),-0.42678948383460097,-1.4291588799375055,0.056910569105691054,0.5086246160271153,1.0,8/29,12.93%,SORBS1;SCARB1;CREBL2;ELOVL5;LDLR;LPGAT1;SLC45A3;MFSD2A
prerank,signal release from synapse (GO:0099643),-0.39316748036881477,-1.4284351800949455,0.05747126436781609,0.5058251263739239,1.0,14/43,15.58%,SYN3;NRXN1;SNAP25;LIN7A;PCLO;LIN7C;SNAPIN;NAAA;NRXN2;PTPRN2;PIP5K1C;GAD1;RIMS1;GAD2
prerank,negative regulation of heterotypic cell-cell adhesion (GO:0034115),0.6775293906737224,1.4273826251968733,0.07877813504823152,0.415479359541338,1.0,1/10,0.51%,ADIPOQ
prerank,regulation of cell-cell adhesion involved in gastrulation (GO:0070587),0.6775293906737224,1.4273826251968733,0.07877813504823152,0.415479359541338,1.0,1/10,0.51%,ADIPOQ
prerank,positive regulation of lymphocyte migration (GO:2000403),0.670276132110853,1.4272432322649993,0.09018987341772151,0.41499156608750165,1.0,5/12,8.47%,CXCL12;SPN;AIF1;CCL5;CXCL10
prerank,estrogen metabolic process (GO:0008210),0.6202052768659351,1.426764061488937,0.08345534407027819,0.4154390661870704,1.0,3/15,11.83%,CYP1B1;CYP1A1;HSD17B8
prerank,response to molecule of bacterial origin (GO:0002237),0.4989467582026314,1.4265400996820374,0.0430939226519337,0.4152066031624013,1.0,13/69,10.71%,IL23R;LBP;TNFAIP3;JAK2;IRAK3;TIRAP;LY96;CYP27B1;FCGR2B;LGALS9;ERBIN;CD14;SIRT2
prerank,negative regulation of cell motility (GO:2000146),0.4753755584820585,1.4262195729042946,0.023429179978700747,0.4152235114591226,1.0,20/108,8.72%,CYP1B1;DLC1;SULF1;ADIPOQ;FBLN1;SFRP1;SFRP2;MITF;DPYSL3;JAG1;NAV3;RAP2A;IGFBP5;MIA3;PTEN;NF2;SHH;SRGAP1;NF1;EPHA1
prerank,cobalamin metabolic process (GO:0009235),0.6112105652246269,1.42592156355664,0.08391608391608392,0.41523821261955157,1.0,2/17,0.90%,TCN1;MMAB
prerank,diterpenoid metabolic process (GO:0016101),0.5118552375953819,1.4253789585343812,0.06314580941446613,0.41592034199491984,1.0,12/55,14.40%,LRP1;HSPG2;GPC6;LPL;RDH10;APOE;RDH12;SDC2;SDC1;ALDH3A2;STRA6;OPN1MW
prerank,cellular protein catabolic process (GO:0044257),0.4930759868408603,1.4251305808029768,0.049943246311010214,0.41585905753274893,1.0,20/59,19.31%,FAP;CLTC;MYLIP;ADAMTS7;CAPN2;SIAH2;CTSS;RAB7A;ADAMTS12;CTSB;CTSK;CTSL;CASP8;MDM2;PSMA6;TCIRG1;CTSW;RAB12;CTSC;CTSH
prerank,negative regulation of epithelial cell proliferation (GO:0050680),0.4988552178656128,1.4248988917425862,0.042363433667781496,0.41571307543128977,1.0,13/66,7.57%,SULF1;RUNX3;SPARC;NR2F2;SFRP1;CASK;SFRP2;STAT1;SNAI2;APOE;CDKN2B;APOH;NF1
prerank,aorta morphogenesis (GO:0035909),0.6061817466521237,1.42340602284493,0.08286516853932584,0.41910283508730345,1.0,7/17,12.71%,LRP1;PDGFRB;JAG1;TBX2;ADAMTS9;MYLK;RBPJ
prerank,branching morphogenesis of an epithelial tube (GO:0048754),0.5357493336603799,1.4227475468408022,0.06740196078431372,0.42007387650221195,1.0,10/39,13.77%,COL4A1;GLI2;NRP1;SFRP2;PKD2;SHH;SEMA3E;SALL1;FGF2;LRP6
prerank,lipoprotein biosynthetic process (GO:0042158),0.6758701385880292,1.422613138424904,0.0887218045112782,0.4196056601497543,1.0,3/11,3.81%,WIPI1;APOE;UGCG
prerank,negative regulation of epidermal growth factor-activated receptor activity (GO:0007175),0.6509426591060865,1.4214639051386913,0.10136157337367625,0.4221578109430155,1.0,6/13,18.60%,CBLB;ERRFI1;CBL;SNX6;SOCS5;ZGPAT
prerank,nuclear membrane disassembly (GO:0051081),0.6406311201745396,1.4213045285973553,0.1,0.421750315389024,1.0,6/14,15.99%,NEK6;PRKCA;NEK9;PLK1;CCNB2;AKAP8L
prerank,positive regulation of cytokine-mediated signaling pathway (GO:0001961),0.5375827888505944,1.4210232853254723,0.07626076260762607,0.42161509676159187,1.0,5/36,4.44%,CASP4;ZBP1;WNT5A;CASP1;TSLP
prerank,secretory granule organization (GO:0033363),0.6846515342644605,1.4201805328772008,0.11930926216640503,0.4231133912537685,1.0,2/10,10.12%,ABCA1;DTNBP1
prerank,iron ion transmembrane transport (GO:0034755),0.67852288853932,1.4198749494075462,0.10550458715596331,0.42311176058344824,1.0,3/10,9.55%,SLC39A14;SLC11A2;SLC25A37
prerank,regulation of response to interferon-gamma (GO:0060330),0.629371146158282,1.4191546884390303,0.09037037037037036,0.4241985414905937,1.0,7/14,16.76%,JAK1;JAK2;STAT1;IFNGR1;CDC37;PTPN2;IFNGR2
prerank,secondary alcohol metabolic process (GO:1902652),0.5233581094558636,1.419095119631101,0.06385542168674699,0.4234976388460891,1.0,6/42,7.67%,ABCA1;APOE;ABCG1;CLN6;IDH3B;SOAT1
prerank,regulation of glucose metabolic process (GO:0010906),0.5461710159664837,1.4190569757353233,0.07653061224489796,0.4227642592108545,1.0,9/34,16.50%,RORA;ADIPOQ;IRS1;OGT;FOXK2;SDHAF3;SELENOS;KHK;ZNF692
prerank,cellular response to corticosteroid stimulus (GO:0071384),0.6207358022201471,1.4183980935893217,0.08100147275405008,0.4237850773187369,1.0,4/15,8.42%,ZFP36L1;ZFP36L2;ANXA1;UBE2L3
prerank,regulation of mRNA stability (GO:0043488),0.46442597315319245,1.4176069580297663,0.014477766287487074,0.425229937887214,1.0,48/145,21.00%,PSMA7;IGF2BP1;ZFP36L1;IGF2BP2;PRKCA;ZFP36L2;CELF1;TENT5A;KHSRP;ANP32A;E2F1;SAMD4A;FTO;PSMD4;XRN1;TNPO1;PSMD11;PUM1;CARHSP1;YTHDF3;METTL16;EXOSC4;PSMB8;RC3H2;DCP2;FMR1;GIGYF2;PAIP1;AXIN2;THRAP3;EXOSC2;PSMA6;NUP214;GDNF;EXOSC1;ZC3H14;ROCK2;PSMD14;EXOSC3;PSMC6;PSMB10;PSMD12;PSMB1;TBRG4;YBX1;YTHDF2;PSMA8;PSMF1
prerank,cellular response to organic cyclic compound (GO:0071407),0.4636507648357363,1.4174132381181477,0.015463917525773196,0.4249763843019661,1.0,19/141,8.68%,RORA;NR1H4;CYP1B1;PDE3A;SPP1;ZFP36L1;PDXP;NRIP1;SFRP1;LRRK2;IGFBP5;PKD2;ADCY2;SSH1;EGFR;CCL5;UBE2L3;CASP7;HRH1
prerank,regulation of megakaryocyte differentiation (GO:0045652),0.5092729618641098,1.4172505871152756,0.05328798185941043,0.4245920019743261,1.0,9/49,10.45%,RUNX1;KMT2A;CNOT4;KMT2B;RBBP5;HDAC1;RAB7B;CBFB;TNRC6B
prerank,negative regulation of hormone secretion (GO:0046888),-0.5822719933305387,-1.4171738701206875,0.08130081300813008,0.5318408869207902,1.0,3/10,15.78%,GJA1;RAB11FIP1;RAB11FIP3
prerank,monocarboxylic acid catabolic process (GO:0072329),0.5838311487840256,1.416959590292945,0.0885558583106267,0.42465940372541056,1.0,1/21,0.07%,CEL
prerank,cellular response to inorganic substance (GO:0071241),0.58565481437942,1.4166474075116615,0.08020698576972833,0.4247060185551863,1.0,4/21,12.19%,MMP3;DDX11;ATRX;FMR1
prerank,integrin-mediated signaling pathway (GO:0007229),0.4858115181878573,1.4162815493470493,0.052572706935123045,0.4248835046547573,1.0,19/73,13.91%,COL3A1;FBLN1;ITGB8;TEC;NRP1;PTN;ITGB5;MYH9;ITGBL1;CCM2;ADAMTS1;CDC42;DOCK1;ERBIN;PTK2;ITGA5;THY1;ITGB1BP1;ITGA11
prerank,positive regulation of interleukin-8 production (GO:0032757),0.5187995134815792,1.4162304100365952,0.06139315230224321,0.42424689518728204,1.0,11/49,12.43%,ADIPOQ;LBP;TLR2;TIRAP;PRKD2;STAT3;LGALS9;NOD1;TLR7;CD14;LAMTOR5
prerank,protein localization to cell-cell junction (GO:0150105),-0.5093324149373832,-1.4160614317255509,0.0946372239747634,0.5300089921411049,1.0,5/15,4.19%,TJP1;TJP2;ACTB;CDH5;LSR
prerank,digestive tract morphogenesis (GO:0048546),0.6393740745896833,1.4155466075908745,0.09077809798270893,0.425389341835807,1.0,5/14,17.78%,PDGFRA;EPHB3;NIPBL;STRA6;BBS7
prerank,negative regulation of smooth muscle cell migration (GO:0014912),0.6477689222797446,1.415501073322106,0.10189228529839883,0.42466875294456863,1.0,4/14,6.53%,ADIPOQ;LRP1;IGFBP5;AIF1
prerank,response to endoplasmic reticulum stress (GO:0034976),0.46361704283624205,1.4141579072264203,0.03691983122362869,0.42777042165648743,1.0,20/107,8.44%,CASP4;CREB3L1;THBS4;GORASP2;CREB3L3;ERN2;ITPR1;PDIA3;BCL2;ERLEC1;ATP2A2;BBC3;SEC16A;UBQLN1;EIF2AK3;RCN3;PIK3R1;CREB3L2;BAX;NCK1
prerank,actin cytoskeleton reorganization (GO:0031532),0.4958790031116102,1.4138584709600004,0.05034324942791762,0.4277637269622519,1.0,26/63,17.44%,ANTXR1;FARP2;S1PR2;NRP1;SYDE1;AUTS2;FGF7;RAP2A;MYH9;ANXA1;PARVA;RALA;PTPN1;RICTOR;DTNBP1;NRK;WHAMM;GRB2;PTK7;PDLIM4;ATP2C1;MKLN1;BRSK2;PIP5K1A;RHOA;MICALL2
prerank,macrophage activation (GO:0042116),0.5438237961593274,1.41364147551751,0.07061790668348046,0.4275830271655279,1.0,10/34,15.90%,LBP;SBNO2;JAK2;TREM2;TMEM106A;AIF1;CRTC3;IFNGR1;TNF;CX3CL1
prerank,plasma membrane bounded cell projection morphogenesis (GO:0120039),0.5087363429206305,1.4135757196457026,0.052948255114320095,0.42693245681471603,1.0,20/51,21.20%,GAS7;TAOK1;MAP4K4;LRRK2;DBN1;MAP1S;TRIO;DBNL;DTNBP1;NRK;TAOK3;ALS2;DICER1;DCLK1;EPB41L3;ANKRD27;NTF3;PAK1;SNX2;ATP7A
prerank,positive regulation of signal transduction (GO:0009967),0.4495143532642133,1.4124126109213915,0.004028197381671702,0.4293886119314136,1.0,59/238,13.85%,SLC39A14;C3;SULF1;ADIPOQ;MGAT5;CCBE1;YAP1;TNFAIP3;ZMIZ1;STK36;TNFSF11;PRKCA;NRP1;ASXL1;MYORG;ATP6AP2;SFRP1;TLR2;JAK2;VTN;LRRK2;JAG1;IRS1;TSLP;LY96;ARNT;PRKD2;PKD2;TREM2;PTEN;SHH;LIMS1;SNX5;CYP27B1;WLS;MAML3;STAT3;CD63;RAB34;PIK3R1;CREBBP;CDKN2AIP;DISC1;ASXL2;BAX;TGFBR1;DLG4;SALL1;XBP1;SASH1;MAML2;LOXL3;TERT;DRD3;IL7;RBPJ;ITGA5;DLG5;ITGB1BP1
prerank,NIK/NF-kappaB signaling (GO:0038061),0.4876606978400734,1.4118751287313855,0.04314159292035398,0.4300527499067622,1.0,24/72,21.00%,PSMA7;MAP3K14;BIRC3;REL;TIRAP;NFKB2;CUL1;PSMD4;PSMD11;DICER1;PSMB8;TRAF2;FBXW11;SKP1;RELB;PSMA6;PSMD14;TLR3;PSMC6;PSMB10;PSMD12;PSMB1;PSMA8;PSMF1
prerank,actin crosslink formation (GO:0051764),0.6583587070124415,1.4118144045853325,0.08295625942684766,0.4293730599943878,1.0,4/12,6.53%,LCP1;DPYSL3;BAIAP2;AIF1
prerank,positive regulation of sodium ion transmembrane transporter activity (GO:2000651),-0.5117348205092982,-1.4117269035278464,0.08490566037735849,0.5377263067075104,1.0,4/14,8.70%,DMD;ATP1B1;WNK4;WNK3
prerank,regulation of short-term neuronal synaptic plasticity (GO:0048172),-0.5419996310220805,-1.4113347774970448,0.09142857142857143,0.534185612268696,1.0,6/13,16.22%,SLC4A10;SHISA6;SYP;SHISA7;SYNGR1;SLC8A2
prerank,positive regulation of mononuclear cell migration (GO:0071677),0.5534796080573281,1.411317282958972,0.08115183246073299,0.42996851414425696,1.0,9/29,11.50%,CXCL12;CCR1;AIF1;CCL5;PLA2G7;CXCL10;LGALS9;MOSPD2;CREB3
prerank,chordate embryonic development (GO:0043009),0.5051159894357643,1.41098604950485,0.06473988439306358,0.43008164508602054,1.0,11/55,9.37%,COL1A1;SULF1;DEAF1;CHD7;WNT5A;ALDH1A2;PKD2;FGFR1;BMP5;TGFBR1;TGFB3
prerank,regulation of mast cell degranulation (GO:0043304),0.6245894142491245,1.4105483530212135,0.11416184971098266,0.43049575902417475,1.0,4/14,8.51%,UNC13D;GAB2;BLK;LGALS9
prerank,tetrapyrrole metabolic process (GO:0033013),0.5995590671219637,1.410542309570801,0.08839779005524862,0.4296730401778947,1.0,2/18,0.90%,TCN1;MMAB
prerank,hepatocyte growth factor receptor signaling pathway (GO:0048012),0.6666557640938738,1.4105072919099506,0.09291338582677165,0.42896684016243086,1.0,5/11,21.05%,NRP1;RAC1;SIRT2;MST1R;PAK1
prerank,neuron remodeling (GO:0016322),0.6777726807387676,1.409941057967344,0.1042296072507553,0.42978954219615645,1.0,2/10,1.74%,C3;FARP2
prerank,protein mono-ADP-ribosylation (GO:0140289),0.6573511751390008,1.4095509752626214,0.10889570552147239,0.4300643562367593,1.0,3/11,6.47%,PARP8;PARP3;PARP11
prerank,response to axon injury (GO:0048678),0.591238771636471,1.4093652755835837,0.10335570469798658,0.4297825750392922,1.0,4/18,5.93%,APOD;DPYSL3;TREM2;NREP
prerank,regulation of gene expression by genetic imprinting (GO:0006349),-0.5740795223571359,-1.4091050500180204,0.0955223880597015,0.5359181692239535,1.0,4/10,18.77%,PCGF5;IGF2;KDM1B;ZFP57
prerank,negative regulation of inflammatory response to antigenic stimulus (GO:0002862),0.4580209764231892,1.408992082211413,0.02931937172774869,0.42995176861016954,1.0,21/116,14.85%,MC5R;FSHR;GPR176;IAPP;ADCY7;GPR39;ADM;MYH9;TREM2;ADCY2;RXFP2;PTGDR;ADCYAP1R1;FCGR2B;GLP2R;PRKAR1B;PTGER4;GPR45;SELENOS;PTH1R;GNG2
prerank,negative regulation of receptor-mediated endocytosis (GO:0048261),0.5670880923255478,1.4081552699531998,0.08378378378378379,0.4315836175840494,1.0,9/25,19.98%,ADIPOQ;ABCA2;ATXN2;RAC1;DLG4;SDCBP;PSEN1;ANKRD13B;NEU3
prerank,negative regulation of immune response (GO:0050777),0.45190197761907586,1.4074340254086284,0.02158273381294964,0.43272371197106124,1.0,32/154,17.78%,MC5R;COL3A1;FSHR;GPR176;IAPP;ADCY7;GPR39;TNFAIP3;ADM;IRAK3;MYH9;TREM2;ADCY2;RXFP2;PTGDR;ADCYAP1R1;TRIM21;FCGR2B;ILRUN;GLP2R;PRKAR1B;SIRT2;PTGER4;GPR45;PTH1R;DHX58;GNG2;MC1R;YES1;ITCH;SPI1;CALCRL
prerank,positive regulation of phosphorylation (GO:0042327),0.4472856473278764,1.4072144369509645,0.00404040404040404,0.43246844146987556,1.0,63/240,16.69%,ROR2;GLMN;ROR1;EPHA7;IL34;C3;ADIPOQ;PDGFRA;FGF20;NRP1;TMEM119;PDGFRB;CD40;LRRK2;FGF7;RAP2A;DDR2;EGF;ARNT;TREM2;EPHB3;FGF9;FGFR1;FBH1;SLC4A4;DVL2;RAC1;EGFR;CCL5;PFKFB4;WDFY2;FAM20A;EPHA1;ZBTB20;DDR1;CCND3;MERTK;DSCAM;ERP29;EFNA5;ACVR2A;HDAC3;CLIP3;FGF2;FNIP1;GPNMB;FMR1;EPHB2;PTK2;CSNK1D;SDCBP;AXIN2;FLCN;PELI2;NTRK3;NIBAN1;TNF;MST1R;ABL1;ATG14;NPTN;PSEN1;ANGPT1
prerank,negative regulation of innate immune response (GO:0045824),0.5328306769283931,1.4069172962627245,0.08178438661710037,0.43250983262082576,1.0,8/34,15.51%,VSIG4;SERPING1;TNFAIP3;IRAK3;TRIM21;YTHDF3;DHX58;PTPN2
prerank,negative regulation of alcohol biosynthetic process (GO:1902931),0.6380797599890345,1.4068739521215232,0.09956709956709957,0.4318454910939517,1.0,5/13,10.12%,APOE;CYP27B1;BMP5;DKK3;NFKB1
prerank,Golgi organization (GO:0007030),0.470697718554984,1.4062773632570202,0.03232533889468196,0.4326701766217289,1.0,49/112,24.76%,SEC16B;VMP1;STX6;GORASP2;LRRK2;ATP8B1;LMAN2L;STX17;TRIP11;SEC16A;TJAP1;CDC42;UBXN2A;ATL2;RAB2A;SPTBN5;OBSL1;COG4;PI4K2B;CSNK1A1;LMAN1;TBC1D20;CSNK1D;DYNC2H1;VCPIP1;PRMT5;RAB30;PDCD10;CUL7;GOLGA5;GOLGA8B;TMED1;COG7;GBF1;TMED10;TRAPPC8;BCAS3;TMED7;VTI1B;SEC23IP;RAB1A;STK25;YWHAZ;HTT;TMED5;CLASP2;GAK;COG3;LYSMD3
prerank,negative regulation of tumor necrosis factor-mediated signaling pathway (GO:0010804),0.6221011785278345,1.4056426640602133,0.0943683409436834,0.4336786671523308,1.0,8/14,22.63%,ADIPOQ;PYDC1;PELI3;PTPN2;NLRP2B;TRAIP;CARD16;CCDC3
prerank,metanephric mesenchyme development (GO:0072075),0.6845188777449439,1.4051919662850394,0.10965630114566285,0.4341838880270328,1.0,3/10,5.73%,STAT1;PKD2;SHH
prerank,fibroblast growth factor receptor signaling pathway (GO:0008543),0.48572491198557854,1.405078406328098,0.04314159292035398,0.4336668817980159,1.0,19/72,15.65%,FLRT2;FGF20;FGF7;FGF9;FGFR1;GALNT3;SPRED1;SPRED2;FRS2;CBL;GTF2F2;GRB2;SETX;RBFOX2;FGF2;POLR2K;FGFRL1;NCBP2;POLR2B
prerank,response to glucocorticoid (GO:0051384),0.5570308265709195,1.404720051680336,0.08445040214477212,0.43392240039240154,1.0,5/26,8.42%,ZFP36L1;SLIT3;ZFP36L2;ANXA1;UBE2L3
prerank,cellular response to peptide hormone stimulus (GO:0071375),0.4661524160102337,1.4045563984036287,0.031982942430703626,0.4335798173452724,1.0,22/102,11.30%,SLC39A14;ENPP1;ADIPOQ;ZFP36L1;CPEB1;ADCY7;USF1;IRS1;INSIG2;MYO5A;ADCY2;DENND4C;RAB8B;PIK3R1;PPARG;INHBB;RAB10;PRKAR1B;NFKB1;HDAC5;XBP1;RPS6KB1
prerank,Wnt signaling pathway (GO:0016055),0.46702902893993203,1.4042698765028423,0.03791982665222102,0.4336127205292162,1.0,26/92,14.70%,WNT2;TCF7L2;SFRP4;SFRP1;SFRP2;WNT5A;LRRK2;WNT2B;WNT9A;PTEN;FRZB;DVL2;WLS;CUL1;STRN;FZD1;TCF7;CSNK1A1;FZD3;FZD9;SFRP5;KLHL12;TCF7L1;SKP1;LRP6;GSK3B
prerank,intracellular sterol transport (GO:0032366),0.6344460017070701,1.4030690335470717,0.10298507462686567,0.4360771253360993,1.0,5/13,10.27%,ABCA1;ABCG1;RELCH;NPC2;VPS4A
prerank,regulation of interferon-gamma-mediated signaling pathway (GO:0060334),0.5653782372467708,1.4029058134662762,0.08843537414965986,0.43568439759999766,1.0,9/23,16.76%,JAK1;JAK2;STAT1;PPARG;IFNGR1;CDC37;PTPN2;PARP14;IFNGR2
prerank,T cell activation involved in immune response (GO:0002286),0.6534535712428052,1.402101213352507,0.09347181008902077,0.4371306784016464,1.0,3/12,6.24%,LCP1;MDK;ICAM1
prerank,regulation of catabolic process (GO:0009894),0.5941988407303825,1.401718368162828,0.0907840440165062,0.43743625983602064,1.0,1/18,0.08%,FAP
prerank,negative regulation of endothelial cell apoptotic process (GO:2000352),-0.42080472796767837,-1.4015415566284477,0.07782101167315175,0.5534546808286358,1.0,10/24,13.18%,TEK;RAMP2;KDR;GAS6;CDH5;SCG2;KRIT1;GATA2;SEMA5A;NDNF
prerank,regulation of epidermal growth factor-activated receptor activity (GO:0007176),0.5553983359571016,1.4010209304677648,0.09114583333333333,0.4386082964175084,1.0,10/26,18.60%,CBLB;ERRFI1;EGF;CBL;NCK2;SNX6;FBXW7;SOCS5;BTC;ZGPAT
prerank,cellular response to interleukin-1 (GO:0071347),0.45913487590055513,1.4007897755243222,0.023638232271325797,0.43843886954363154,1.0,31/143,15.90%,PSMA7;CCL11;CCL7;SFRP1;CD40;XCL1;IL1R1;IRAK3;ADAMTS7;CCL5;ADAMTS12;CUL1;PSMD4;SQSTM1;NOD1;PSMD11;NFKB1;MAPK11;GBP3;PSMB8;SIRPA;TANK;FBXW11;CCL2;SKP1;PELI3;IRAK2;PELI2;IRAK4;PSMA6;CX3CL1
prerank,regulation of establishment of protein localization (GO:0070201),0.6378717980522829,1.400540790650846,0.09812409812409813,0.4383138592779538,1.0,5/13,12.29%,TREM2;CTSD;GAPVD1;CEP120;SCFD1
prerank,negative regulation of gene silencing by miRNA (GO:0060965),0.6430132985314971,1.3998776773681063,0.12347560975609756,0.43936756551081413,1.0,5/12,15.60%,POU5F1;NCOR2;PPARG;TERT;TNF
prerank,hexose metabolic process (GO:0019318),0.5179621718255366,1.399522577131238,0.08034610630407911,0.4396396568573915,1.0,11/39,17.76%,ADIPOQ;APOD;GALT;GALK1;AKR1A1;OMA1;GALK2;ADPGK;KHK;GAA;CHST1
prerank,respiratory tube development (GO:0030323),0.5398462613050583,1.3987244808217394,0.09176788124156546,0.4410960318024614,1.0,13/28,15.91%,GLI2;FGF7;FGF9;SHH;BAG6;LOXL3;FGF2;PCSK5;NPHP3;PDPN;STRA6;ITGA3;HECA
prerank,extracellular matrix assembly (GO:0085029),0.5779221531153921,1.398532203722886,0.07197943444730077,0.4408706760335368,1.0,6/23,10.43%,LTBP3;GPM6B;LAMB1;MFAP4;PXDN;EMILIN1
prerank,ERK1 and ERK2 cascade (GO:0070371),0.5804347310916963,1.3978890436386224,0.07927677329624479,0.441942163819336,1.0,10/21,23.28%,ZFP36L1;ZFP36L2;EGF;LGALS9;MAP2K1;PTGER4;CTSH;MAP2K2;IGF1;MAPK1
prerank,cellular response to oxygen-containing compound (GO:1901701),0.4415734188430477,1.3973745817033,0.0020060180541624875,0.4426331258364566,1.0,49/291,14.13%,RORA;MMP3;NR1H4;PDE3A;CXCL5;WNT2;PDGFRA;CXCL1;LBP;ZFP36L1;SBNO2;PDXP;CPEB1;TNFAIP3;NRIP1;SFRP1;TLR2;WNT5A;LPL;CASP1;IRS1;IGFBP5;TIRAP;LY96;PKD2;WNT9A;PID1;CAPN2;ATM;NUGGC;SSH1;EGFR;CD68;CXCL10;RPTOR;NFKB1;AHR;CD14;XBP1;SETX;SIRPA;LAMTOR5;PTK7;SELENOS;LCOR;TPM1;CCL2;PRDX5;HMGB2
prerank,dermatan sulfate proteoglycan biosynthetic process (GO:0050651),0.6098752961211698,1.3964237218238749,0.10140845070422536,0.4446391686358758,1.0,3/15,3.46%,DCN;BGN;VCAN
prerank,defense response to symbiont (GO:0140546),0.4680822318631563,1.3947560919441353,0.03965702036441586,0.448688568743365,1.0,20/92,15.56%,MAP3K14;ZBP1;TLR2;IRF7;STAT1;CD40;BCL2;SHFL;IRF1;RNASE1;ABCE1;MLKL;TRIM56;TLR7;EIF2AK2;EXOSC4;OASL;MOV10;RTP4;IFNAR2
prerank,cellular response to BMP stimulus (GO:0071773),0.4847697495600504,1.3936815387127772,0.05228031145717464,0.45088043879612477,1.0,17/66,16.73%,RUNX2;SFRP1;USP9X;SMAD2;ADAMTS7;BMP5;ADAMTS12;ACVR1;VSTM2A;TGFB3;ACVR2A;SMAD5;HIVEP1;SMURF1;SMAD3;ZFYVE16;RGMB
prerank,myeloid cell activation involved in immune response (GO:0002275),0.5735649069149658,1.3934561581984948,0.10955056179775281,0.4507519416725516,1.0,2/18,1.42%,LBP;SBNO2
prerank,regulation of angiogenesis (GO:0045765),0.45079154933183624,1.3933488087111212,0.013265306122448979,0.4502059297300729,1.0,38/192,11.02%,RUNX1;CYP1B1;DCN;COL4A2;SULF1;ITGB8;SPARC;HSPG2;THBS2;ADAM12;THBS4;TNFAIP3;PRKCA;SFRP1;SFRP2;WNT5A;RHOJ;STAT1;CD40;GATA6;PRKD2;SPRED1;ADAMTS1;SERPINF1;APOH;HK2;ANGPTL4;NF1;PLXND1;CXCL10;EPHA1;SEMA3E;CEMIP2;PPARG;SPRY2;EMILIN1;XBP1;SASH1
prerank,regulation of neuroblast proliferation (GO:1902692),0.6186183955686108,1.393314155821995,0.09078212290502793,0.4494942576518472,1.0,7/15,15.90%,PTN;LRRK2;NF1;DISC1;SMARCD3;FZD3;CX3CL1
prerank,positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress (GO:1990440),0.652605608073483,1.3926540148077335,0.09312977099236641,0.45062580978416206,1.0,2/11,2.42%,CREB3L1;CREB3L3
prerank,antimicrobial humoral immune response mediated by antimicrobial peptide (GO:0061844),0.5356677953333437,1.3922433210316147,0.08846153846153847,0.4509719514135133,1.0,4/32,8.47%,CXCL5;CXCL1;RNASE7;CXCL10
prerank,regulation of fatty acid oxidation (GO:0046320),-0.4806584697255218,-1.3918049673783504,0.0981012658227848,0.5775984529091305,1.0,8/16,30.79%,PRKAG2;PPARGC1A;LONP2;TYSND1;SIRT4;NR4A3;ACADL;FABP3
prerank,cell-matrix adhesion (GO:0007160),0.46693717662621953,1.3906751170535527,0.0397422126745435,0.4546755383595813,1.0,30/95,16.55%,DLC1;COL3A1;ITGB8;TNN;COL13A1;ITGB5;PEAK1;VTN;RHOD;ITGA8;TMEM8B;RAC1;ITGBL1;CD63;ADAMTS12;THBS3;HPSE;DDR1;EMILIN1;ADAMTS9;L1CAM;WHAMM;THY1;ITGB1BP1;ITGA11;LYVE1;ITGA3;MKLN1;ITGA1;PIP5K1A
prerank,cellular response to growth factor stimulus (GO:0071363),0.4496848992396338,1.3906019337480542,0.024640657084188913,0.4541162882203853,1.0,38/151,15.50%,RUNX2;IBSP;PDE3A;WNT2;ZFP36L1;SOX5;NRP1;SFRP1;EGR3;WNT5A;SNAI2;XCL1;ZFP36L2;ANXA1;ADAMTS7;PRKD2;LIMS1;EGFR;CCL5;ADAMTS12;TGFBR1;ACVR1B;ACVR1;GAS1;VSTM2A;SPRY2;CLEC3B;SIRT2;ACVR2A;RPS6KB1;SETX;CCL2;MTSS2;SMAD3;ITGB1BP1;ACAP2;NTRK3;GAREM1
prerank,phagosome-lysosome fusion (GO:0090385),0.6488268682223808,1.3904683147833585,0.11653543307086614,0.45366610589489564,1.0,4/10,7.60%,PLA2G5;RAB34;RAB7A;RAB7B
prerank,regulation of cell-cell adhesion (GO:0022407),0.5197610819508492,1.3902080986396055,0.07588739290085679,0.453573159388458,1.0,8/39,5.65%,EPHA7;B4GALNT2;TENM3;MDGA1;JAG1;FLOT2;EPHB3;NF2
prerank,regulation of B cell receptor signaling pathway (GO:0050855),0.5736061676426658,1.3899811167867901,0.09803921568627451,0.4533848998317349,1.0,4/21,8.40%,RUNX1;BLK;FCGR2B;CBFB
prerank,"regulation of synaptic transmission, glutamatergic (GO:0051966)",-0.35436368028456255,-1.3895326880909138,0.06535947712418301,0.5798342228474102,1.0,11/46,7.46%,GRM7;GRM1;NRXN1;SHANK3;ATP1A2;GRM3;GRM8;CACNG2;DGKI;MEF2C;RELN
prerank,regulation of programmed necrotic cell death (GO:0062098),0.5892416873982832,1.3893899972189638,0.10382513661202186,0.4542658915459734,1.0,9/20,15.09%,BIRC3;FLOT2;CFLAR;OGT;MLKL;SDCBP;CASP8;STUB1;CDC37
prerank,toll-like receptor 3 signaling pathway (GO:0034138),0.6622001132449756,1.3892579464143475,0.10698365527488855,0.45385347001206106,1.0,2/11,2.03%,RFTN1;COLEC12
prerank,embryonic digit morphogenesis (GO:0042733),0.5953171524643207,1.3888538097195937,0.10668563300142248,0.4542456754474889,1.0,10/18,23.06%,GLI3;TBX2;SHH;HDAC1;CREBBP;SALL1;TBX3;WDPCP;MAP3K20;TWIST1
prerank,neuron differentiation (GO:0030182),0.4479421148118256,1.3884330324706275,0.02053388090349076,0.454654752904413,1.0,23/165,10.96%,RUNX1;RUNX2;WNT2;RUNX3;GLI2;TENM3;WNT5A;UGCG;BHLHE22;WNT2B;WNT9A;SHH;OPHN1;TENM4;TGFBR1;FZD1;PBX3;TDP2;ACSL4;MAP2K1;MYO7A;FZD3;XBP1
prerank,regulation of smooth muscle cell proliferation (GO:0048660),0.5082302977268045,1.38836419673174,0.07582938388625593,0.4540615279958024,1.0,10/46,8.94%,APOD;TCF7L2;TNFAIP3;PDGFRB;STAT1;CCN4;IGFBP5;AIF1;CCL5;PPARG
prerank,negative regulation of interferon-gamma production (GO:0032689),0.5674035822689815,1.3881242138042433,0.08771929824561403,0.45394537460447254,1.0,3/23,8.51%,NR1H4;XCL1;LGALS9
prerank,negative regulation of translation (GO:0017148),0.4631491947574264,1.3875603137270882,0.05161290322580645,0.45466527576789134,1.0,28/87,20.49%,IGF2BP1;IGF2BP2;CPEB1;SYNCRIP;IGFBP5;CELF1;ILF3;EIF2AK3;SAMD4A;FTO;PAIP2;PUM1;YTHDF3;EIF2AK2;METTL16;FMR1;GIGYF2;CAPRIN1;GAPDH;EIF4EBP1;EPRS1;ROCK2;DAPK1;CPEB4;YBX1;DDX3X;YTHDF2;CALR
prerank,positive regulation of innate immune response (GO:0045089),0.5379346471357338,1.3875021084668187,0.09743589743589744,0.4540098824090715,1.0,6/30,7.35%,ZBP1;LBP;WNT5A;PLA2G5;POLR3D;CCL5
prerank,granulocyte differentiation (GO:0030851),-0.4663878965788932,-1.3874722131794517,0.07142857142857142,0.5813215606236135,1.0,6/18,13.62%,LEF1;LBR;CBFA2T3;EP300;CDK4;TAL1
prerank,cellular response to peptide (GO:1901653),0.49799914171366344,1.3870308069306585,0.06976744186046512,0.4545008605539205,1.0,19/56,16.37%,CASP4;LRP1;ZFP36L1;CACNA1A;CACNB1;CACNA2D1;TREM2;ICAM1;CD36;FCGR2B;NOD1;DDX11;XBP1;SNX6;GRIN2A;GSK3B;MDM2;TIMELESS;PSEN1
prerank,regulation of mitotic cell cycle (GO:0007346),0.44539746241969735,1.3860145760182203,0.019289340101522844,0.45671585642457924,1.0,56/171,21.00%,PSMA7;NEK6;PDXP;MEIS2;PRKCA;MAD2L1;PTPN3;ANAPC11;TMEM8B;CDK10;CKS1B;CUL1;PLK1;OBSL1;PSMD4;GAS1;CDK9;DDB1;PSMD11;ASNS;CDK13;FBXO5;FZR1;CDC27;RPS6KB1;BORA;CDC16;PSMB8;RCC1;ANAPC2;USP22;BTG1;TRIM35;SMAD3;SKP1;SDCBP;PRMT5;MDM2;PSMA6;HECA;EIF4EBP1;UBE2E1;RNF40;CUL7;PSMD14;MAEA;UBE2S;PSMC6;PSMB10;PSMD12;PSMB1;GBF1;CDK11B;PSMA8;CDK5RAP3;PSMF1
prerank,cellular response to amyloid-beta (GO:1904646),0.5289529990297845,1.3852284494295077,0.0779874213836478,0.4581095380927761,1.0,15/35,19.19%,CASP4;LRP1;CACNA1A;CACNB1;CACNA2D1;TREM2;ICAM1;CD36;FCGR2B;SNX6;GRIN2A;GSK3B;PSEN1;GRIN1;CDK5
prerank,endothelial cell proliferation (GO:0001935),-0.48221322793552457,-1.3850715373865798,0.10891089108910891,0.5839539972414938,1.0,6/17,15.93%,TEK;BMP4;CD34;ERN1;SEMA5A;PRKX
prerank,positive regulation of multicellular organismal process (GO:0051240),0.43631821494111206,1.3849536352382465,0.004012036108324975,0.45813698754673937,1.0,68/308,15.04%,GLMN;ABCA1;COL1A1;ADIPOQ;LRP1;LBP;PLAC8;SNAI1;SOX5;B4GALT5;GHR;NKX6-1;PTN;SYDE1;TMEM119;WNT5A;CMKLR1;JAK2;SMAD2;ALMS1;APOE;BATF;EGF;DYNC1H1;TREM2;BMP1;OGT;PLA2R1;SMURF2;EHMT1;SHH;TGFB1I1;MDK;CYP27B1;CD36;TGFBR1;ACVR1B;IL33;OMA1;ACVR1;OLFM1;INHBB;ZBED3;GNAS;TGFB3;ENO1;FBXO5;CXCR4;SHLD3;XBP1;GCNT2;WWTR1;ELOVL6;HDAC3;EIF2AK2;PTGER4;FGF2;TERT;PDPN;STAT6;SMAD3;SDCBP;AXIN2;RIF1;HCRT;SNX4;NR2C2;GAPDH
prerank,adenine nucleotide transport (GO:0051503),-0.48865922359199876,-1.3846508355367075,0.09090909090909091,0.5804815203440099,1.0,5/17,9.69%,ABCC4;LRRC8D;SLC25A4;SLC25A42;SLC25A17
prerank,regulation of trophoblast cell migration (GO:1901163),0.6198198230785806,1.3839660902955992,0.12071535022354694,0.4602477561514649,1.0,7/14,20.49%,SYDE1;TIMP1;SMURF2;ACVR1B;YTHDF3;ACVR1C;CALR
prerank,regulation of macrophage migration (GO:1905521),-0.5683135093139875,-1.3835791415258778,0.13392857142857142,0.5786518827777078,1.0,3/10,5.62%,MTUS1;CD81;CD200
prerank,positive regulation of acute inflammatory response (GO:0002675),0.6242159184582948,1.3833724258291686,0.12464183381088825,0.4610537717280862,1.0,2/14,2.42%,OSMR;CREB3L3
prerank,macrophage activation involved in immune response (GO:0002281),0.6174088343610169,1.3832003595575053,0.12406576980568013,0.460787551093331,1.0,3/13,4.76%,LBP;SBNO2;TREM2
prerank,androgen metabolic process (GO:0008209),0.5853209531776319,1.382739434030707,0.11001410437235543,0.4613359015549854,1.0,3/18,12.72%,SPP1;SHH;SRD5A3
prerank,negative regulation of receptor binding (GO:1900121),0.6635529529556868,1.3822494858585692,0.1104199066874028,0.4618823513217987,1.0,2/10,5.25%,ADIPOQ;ATP2A2
prerank,positive regulation of T-helper 17 type immune response (GO:2000318),0.6503199074071744,1.3816374432802125,0.1253968253968254,0.4628546015113472,1.0,1/11,0.46%,IL23R
prerank,actin filament polymerization (GO:0030041),0.5497558017062607,1.3814333600559727,0.09217171717171717,0.4626262471303818,1.0,9/29,11.68%,GAS7;SPIRE2;JAK2;TTC17;RAC1;AIF1;SPIRE1;PREX1;ARHGAP6
prerank,positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus (GO:1901522),0.5778824663393204,1.3813836341785466,0.10612244897959183,0.46196358421388173,1.0,12/20,27.97%,RUNX2;XBP1;CREB3;RBPJ;SMAD5;NFE2L2;CARF;CHD6;ATF4;SMAD1;HIF1A;RELA
prerank,positive regulation of leukocyte proliferation (GO:0070665),0.6434187951541209,1.3813732204829232,0.10365853658536585,0.4611932860024855,1.0,1/12,0.25%,IL34
prerank,poly(A)+ mRNA export from nucleus (GO:0016973),-0.47524358575797027,-1.3810584570729898,0.09615384615384616,0.5813076656659538,1.0,8/18,24.55%,NUP133;MCM3AP;NUP93;ZC3H11A;HHEX;PABPN1;DDX25;POLDIP3
prerank,response to growth factor (GO:0070848),0.5138142436283987,1.3807638999882246,0.08827085852478839,0.462128181636657,1.0,9/41,11.30%,IBSP;SFRP1;GATA6;TGFBR1;ACVR1B;ACVR1;TBC1D7;ACVR2A;RPS6KB1
prerank,"nucleotide-excision repair, DNA incision (GO:0033683)",-0.38335356666892845,-1.3806429932205968,0.05759162303664921,0.5778461958992913,1.0,21/39,27.83%,ERCC5;ERCC3;CHD1L;GTF2H2;RBX1;PCNA;UBC;POLK;ERCC1;OGG1;GTF2H4;RFC3;DDB2;UBA52;RFC2;POLD2;RPA2;UBB;RFC4;RPA3;POLD4
prerank,negative regulation of cellular response to growth factor stimulus (GO:0090288),0.46588490084893563,1.3805686133952046,0.04694323144104803,0.4619326749916944,1.0,16/79,13.38%,SULF1;CREB3L1;CASK;APLN;HTRA3;SMURF2;ADAMTS12;PPARG;PTPN1;SPRY2;EMILIN1;ACVR2A;LEMD2;FGF2;SMAD5;SMURF1
prerank,positive regulation of endocytosis (GO:0045807),0.4981875735687742,1.3803965706788677,0.0847457627118644,0.46154911790434455,1.0,12/45,12.85%,C3;LRP1;VTN;APOE;CALY;TREM2;RAB21;CBL;CDC42;ANKFY1;CLIP3;CD151
prerank,glycogen biosynthetic process (GO:0005978),-0.5290102936980231,-1.3802682266162654,0.13043478260869565,0.5697382177158317,1.0,6/12,18.02%,PGM2L1;PPP1R3C;PER2;GBE1;UGP2;PGM2
prerank,glucan biosynthetic process (GO:0009250),-0.5290102936980231,-1.3802682266162654,0.13043478260869565,0.5697382177158317,1.0,6/12,18.02%,PGM2L1;PPP1R3C;PER2;GBE1;UGP2;PGM2
prerank,purine ribonucleotide transport (GO:0015868),-0.4968148113147294,-1.3801887244347275,0.09868421052631579,0.5655071836633514,1.0,5/16,9.69%,ABCC4;LRRC8D;SLC25A4;SLC25A42;SLC25A17
prerank,negative regulation of microtubule polymerization (GO:0031115),-0.531856772204411,-1.3792982281237747,0.11455108359133127,0.5636271966363277,1.0,4/12,10.03%,MAP2;CDH5;EML2;STMN2
prerank,regulation of vascular associated smooth muscle cell proliferation (GO:1904705),0.5210486729300957,1.379103781212094,0.09482758620689655,0.46450872484602634,1.0,11/37,13.51%,MMP2;ADIPOQ;APLN;IGFBP5;FGF9;PTEN;ADAMTS1;PPARG;TGFB3;FGF2;TPM1
prerank,substrate adhesion-dependent cell spreading (GO:0034446),0.49917042790729693,1.3788252889283648,0.06107784431137724,0.4645245983970737,1.0,12/46,8.72%,ANTXR1;LAMB1;LAMC1;NRP1;PEAK1;ITGA8;EPHB3;LAMC3;RAC1;PIK3R1;PARVA;EPHA1
prerank,lung development (GO:0030324),0.5249809466991137,1.3784198654660635,0.10025706940874037,0.46487030601217505,1.0,13/33,15.28%,GLI2;ERRFI1;FGF7;FGF9;SHH;RCN3;BAG6;LOXL3;FGF2;NPHP3;PDPN;STRA6;ITGA3
prerank,positive regulation of T cell chemotaxis (GO:0010820),0.6534220949989805,1.3783910328601758,0.14674735249621784,0.46415853855208034,1.0,3/10,7.35%,WNT5A;XCL1;CCL5
prerank,positive regulation of nucleic acid-templated transcription (GO:1903508),0.43218485231434167,1.3782597395044498,0.0,0.4638024386658646,1.0,91/476,14.13%,RORA;RUNX1;NR1H4;RUNX2;COL1A1;KMT2A;RUNX3;CXXC1;SPP1;MDFIC;BCL3;GLI2;TCF4;SNAI1;YAP1;DEAF1;ZMIZ1;GLI3;PSRC1;NR2F2;SFRP1;ZBTB48;IRF7;WNT5A;STAT1;MITF;SMAD2;APOE;GATA6;FGF7;MAFB;EGF;IRF1;ZNF496;ILF3;SMARCC1;SHH;YAF2;TGFB1I1;E2F1;KMT2B;ARID1B;BRPF1;TEAD1;SNX5;RNF111;MYBL1;MED13;STAT3;EGFR;HDAC1;ELF4;CREBBP;CREB3L2;SMARCD3;MED12;TGFBR1;FZD1;FOXM1;ACVR1;FOXK2;PPARG;TRIM56;NSD3;TGFB3;BRD4;NR1D2;MAP2K1;FOXE1;MYRF;MED14;NFKB1;AHR;SALL1;CHD8;MMS19;CALCOCO1;ZIC1;FGF2;NEK4;USP22;SMAD5;CTCF;FBXW11;TCF3;SMAD3;CLOCK;LRP6;NSD1;TBL1X;HMGB2
prerank,regulation of cellular amide metabolic process (GO:0034248),0.5255160535697309,1.3781141733429518,0.09821428571428571,0.46345452910536133,1.0,12/32,23.41%,NR1H4;ATXN2;RBM4B;METAP1;PUM3;FOXO3;TMED10;SAMD8;NOLC1;RBM3;CYFIP1;PGAM1
prerank,regulation of mRNA 3'-end processing (GO:0031440),0.6472394757102586,1.377716412981198,0.1137370753323486,0.4638868499079503,1.0,4/11,17.88%,ZFP36L1;ZC3H3;NCBP2;CDC73
prerank,negative regulation of leukocyte apoptotic process (GO:2000107),0.6452954570277456,1.3772409577019806,0.12852664576802508,0.4644273241119953,1.0,4/11,13.14%,CXCL12;IRF7;MERTK;SELENOS
prerank,posttranslational protein targeting to endoplasmic reticulum membrane (GO:0006620),0.6405722308425541,1.376671945368901,0.10810810810810811,0.46529252579377,1.0,4/12,8.97%,CHMP4B;CHMP4A;SEC61A2;SEC63
prerank,regulation of keratinocyte migration (GO:0051547),0.6295135713595895,1.376002736977354,0.13582089552238805,0.4664357297293357,1.0,4/12,13.65%,MAP4K4;FGF7;PTEN;MAPRE2
prerank,error-prone translesion synthesis (GO:0042276),-0.4519154074089679,-1.3756735043623414,0.09387755102040816,0.5698406995818973,1.0,13/21,27.10%,PCNA;UBC;REV3L;POLK;PRIMPOL;RFC3;UBA52;RFC2;POLE2;RPA2;UBB;RFC4;RPA3
prerank,positive regulation of DNA-dependent DNA replication (GO:2000105),0.648660121638274,1.3755671466769046,0.12923076923076923,0.46693457239653524,1.0,5/10,13.72%,STOML2;INO80;E2F8;ATRX;DBF4
prerank,outflow tract septum morphogenesis (GO:0003148),0.5616543969989995,1.3755541089505685,0.09646739130434782,0.46619260256766093,1.0,7/24,8.79%,ROBO2;NRP1;ZFPM2;GATA6;TBX2;PARVA;ACVR1
prerank,regulation of signal transduction (GO:0009966),0.4410668432457134,1.375207320373128,0.01842374616171955,0.4663986002399116,1.0,49/190,17.16%,RORA;RUNX1;SULF1;ADIPOQ;IGFBP7;MDFIC;RGS16;IGFBP4;TIMP1;GSKIP;LRRK2;UGCG;IGFBP5;TREM2;BRAP;OGT;CD63;CD36;CREBBP;CDKN2AIP;NCK2;CBFB;NCK1;ACVR1;GAS1;LLGL1;PTPN1;ZDHHC3;DTNBP1;WWTR1;ZIC1;GALNT11;GNG7;TSPEAR;TCF7L1;ITGB1BP1;IRAK2;NUCKS1;TULP3;ITGA3;PTPN2;UBASH3B;CX3CL1;SOCS5;SP100;LIFR;GDNF;IFT81;PTCH1
prerank,negative regulation of interleukin-1 beta production (GO:0032691),0.571204136809274,1.3750678483132928,0.12916666666666668,0.466009664860884,1.0,7/19,22.73%,TNFAIP3;PYDC1;CX3CL1;NLRP2B;IGF1;CARD16;CPTP
prerank,positive regulation of cell-substrate junction organization (GO:0150117),0.556800058370505,1.3748844124792905,0.11716621253405994,0.46578366778253927,1.0,10/24,17.11%,MAP4K4;NRP1;SFRP1;RAC1;LIMS1;PIK3R1;THY1;MAPRE2;ABL1;PTPRJ
prerank,urogenital system development (GO:0001655),0.6265704042734281,1.3744744573766696,0.1482059282371295,0.46619188823396784,1.0,4/11,12.47%,ANXA1;EPHB3;SHH;EPHB2
prerank,regulation of myeloid cell differentiation (GO:0045637),0.4857569368632321,1.3743089451960244,0.06583427922814983,0.46589778607543075,1.0,13/62,10.45%,RUNX1;KMT2A;MEIS2;MAFB;CNOT4;MEIS1;KMT2B;RBBP5;HDAC1;CREBBP;CBFB;CDK6;TNRC6B
prerank,positive regulation of excitatory postsynaptic potential (GO:2000463),-0.46801111862549416,-1.374275061647899,0.08540925266903915,0.569354628129478,1.0,8/18,14.12%,NRXN1;SHANK3;PRKCZ;CUX2;RELN;RIMS2;NLGN1;RIMS1
prerank,cellular monovalent inorganic cation homeostasis (GO:0030004),-0.4457756352870083,-1.3740233993564344,0.0661764705882353,0.5657434536052582,1.0,5/20,2.41%,ATP1B3;SLC12A2;ATP1B1;ATP1A2;KCNJ2
prerank,negative regulation of oxidoreductase activity (GO:0051354),0.6639072309908259,1.3739414246323194,0.11856474258970359,0.46621206664884013,1.0,2/10,9.48%,HP;ETFBKMT
prerank,negative regulation of neurogenesis (GO:0050768),0.527390426599786,1.373449950575105,0.10552763819095477,0.4668720621941354,1.0,8/34,17.36%,CCL11;PTN;PTEN;NF1;PCM1;THY1;TNF;RHOA
prerank,chondroitin sulfate metabolic process (GO:0030204),0.5338956229764857,1.372412701065498,0.10472541507024266,0.46898964016006367,1.0,5/30,3.46%,DCN;CHSY3;BGN;CHST13;VCAN
prerank,membrane lipid biosynthetic process (GO:0046467),-0.3430880195517748,-1.3722575279058542,0.05511811023622047,0.5666456571578475,1.0,15/58,7.52%,CERT1;PPM1L;ST3GAL4;SGMS2;SGMS1;CERS4;ACER2;ST8SIA6;SPTLC2;ELOVL5;DEGS2;SPTLC1;GBGT1;ELOVL7;PRKD1
prerank,negative regulation of response to external stimulus (GO:0032102),0.4530356193076656,1.3711973956386088,0.040641711229946524,0.4718288953667268,1.0,20/105,13.14%,RORA;NR1H4;ADIPOQ;TNFAIP3;CASK;APOE;SMPDL3B;IRAK3;PTEN;MVK;TRIM21;ILRUN;PPARG;SIRT2;CERS2;PTGER4;FGF2;SIRPA;DRD3;SELENOS
prerank,regulation of granulocyte chemotaxis (GO:0071622),0.5895862079520324,1.370710077495142,0.12448700410396717,0.47252904586372174,1.0,4/19,7.35%,IL34;CMKLR1;MDK;CCL5
prerank,defense response to virus (GO:0051607),0.45766158352992514,1.3698354101791284,0.052294557097118465,0.47415509806486883,1.0,21/100,15.56%,MAP3K14;ZBP1;TLR2;IRF7;STAT1;CD40;BCL2;SHFL;IRF1;RNASE1;ABCE1;MLKL;CXCL10;TRIM56;TLR7;EIF2AK2;EXOSC4;OASL;MOV10;RTP4;IFNAR2
prerank,sensory perception of mechanical stimulus (GO:0050954),0.46100827462647,1.3689020001405932,0.05228758169934641,0.4760333071849605,1.0,17/85,14.08%,ROR1;COL1A1;CEMIP;MYO1A;COL11A2;SNAI2;COL11A1;CRYM;PIEZO2;NIPBL;MYO7A;ALDH7A1;HOXA1;ADGRV1;TPRN;TSPEAR;TBL1X
prerank,RNA destabilization (GO:0050779),0.5860874634703143,1.368771824395615,0.10614525139664804,0.47564910705555546,1.0,10/18,20.83%,CELF1;FTO;PUM1;YTHDF3;METTL16;GIGYF2;ROCK2;DXO;YTHDF2;LIN28B
prerank,development of primary male sexual characteristics (GO:0046546),0.5138116801200212,1.3687189297033464,0.09090909090909091,0.47504665347914493,1.0,6/34,4.94%,FSHR;LHFPL2;WNT5A;GATA6;WNT2B;FGF9
prerank,nucleotide-sugar metabolic process (GO:0009225),0.6260089514239622,1.3680398744963245,0.125,0.4762702062870025,1.0,4/12,7.54%,B4GALNT2;GALT;GFPT2;GMDS
prerank,protein localization to phagophore assembly site (GO:0034497),0.6380001241982615,1.367833799607701,0.12372634643377002,0.4761180794679155,1.0,8/11,26.30%,WIPI1;STX17;TRAPPC8;WDR45;PACS2;MFN2;WIPI2;ATG9A
prerank,regulation of inflammatory response to antigenic stimulus (GO:0002861),0.4452378491185443,1.3672062824618538,0.04716981132075472,0.4771308959792954,1.0,15/117,9.25%,MC5R;FSHR;GPR176;IAPP;ADCY7;GPR39;ADM;MYH9;TREM2;ADCY2;RXFP2;PTGDR;ADCYAP1R1;GLP2R;PRKAR1B
prerank,regulation of insulin-like growth factor receptor signaling pathway (GO:0043567),0.5972102782837586,1.3669534523818474,0.13428571428571429,0.4770751615115366,1.0,4/16,7.21%,MYORG;IGFBP4;IGFBP5;BMP5
prerank,epithelial tube morphogenesis (GO:0060562),0.5276266916056513,1.3667267416732805,0.10262828535669587,0.4769392162472911,1.0,7/32,8.79%,COL4A1;GLI2;PRKD2;PKD2;SHH;CCM2;ACVR1
prerank,regulation of cartilage development (GO:0061035),0.5804428427151715,1.3664685833970753,0.13342503438789546,0.47689233448109875,1.0,4/18,6.13%,TRPS1;SOX5;BMP1;MDK
prerank,B cell receptor signaling pathway (GO:0050853),0.5181020838360445,1.3662892590171272,0.10608020698576973,0.4766436066346724,1.0,9/32,13.05%,RFTN1;TEC;VAV3;BCL2;BLK;BAX;SH2B2;MS4A1;LAT2
prerank,positive regulation of lymphocyte proliferation (GO:0050671),0.47704332001002353,1.365203556408279,0.06734006734006734,0.4791240782535178,1.0,14/63,12.48%,IL23R;CD276;VAV3;CD40;BCL2;TIRAP;ANXA1;AIF1;CCL5;NCK2;NCK1;SASH3;EPHB2;IL7
prerank,regulation of mRNA catabolic process (GO:0061013),0.4504932395586873,1.365154632050576,0.03858185610010428,0.4784831699654802,1.0,36/121,21.00%,PSMA7;IGF2BP1;ZFP36L1;IGF2BP2;PRKCA;ZFP36L2;KHSRP;ANP32A;SAMD4A;PSMD4;XRN1;TNPO1;PSMD11;PUM1;CARHSP1;YTHDF3;EXOSC4;PSMB8;RC3H2;DCP2;FMR1;MOV10;EXOSC2;PSMA6;NUP214;EXOSC1;ZC3H14;PSMD14;EXOSC3;PSMC6;PSMB10;PSMD12;PSMB1;YTHDF2;PSMA8;PSMF1
prerank,positive regulation of receptor internalization (GO:0002092),0.5534836605245347,1.3647622221350921,0.11171662125340599,0.47890591744702693,1.0,9/22,19.65%,SFRP4;APLN;EGF;CD63;FMR1;ANGPT1;PICK1;ARRB1;NTF3
prerank,glycosphingolipid biosynthetic process (GO:0006688),-0.479352191771521,-1.3647084452653946,0.11458333333333333,0.5850183312592252,1.0,5/16,6.92%,ST6GALNAC3;ST8SIA4;B4GALT6;ST8SIA6;ST8SIA2
prerank,positive regulation of vasculogenesis (GO:2001214),-0.5523622561544788,-1.364572225470404,0.1277258566978193,0.5810487534741231,1.0,9/10,34.02%,CD34;KDR;RAPGEF2;RAP1A;TMEM100;CEACAM1;ASB4;HIF1AN;RRAS
prerank,placenta development (GO:0001890),0.6286782241573207,1.3639003909482466,0.12557427258805512,0.4806459320286088,1.0,5/12,17.15%,ADAM19;PPARG;E2F8;PTK2;CUL7
prerank,regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235),0.5509898458422361,1.3638683623115309,0.11668928086838534,0.47994605274299534,1.0,8/21,16.30%,CREB3L1;LRRK2;EIF2AK3;NCK1;XBP1;CREB3;SELENOS;SYVN1
prerank,"nucleotide-excision repair, DNA incision, 5'-to lesion (GO:0006296)",-0.3837566374179259,-1.363565222027767,0.07772020725388601,0.5794844258854048,1.0,20/37,27.83%,ERCC5;ERCC3;CHD1L;GTF2H2;RBX1;PCNA;UBC;POLK;ERCC1;GTF2H4;RFC3;DDB2;UBA52;RFC2;POLD2;RPA2;UBB;RFC4;RPA3;POLD4
prerank,camera-type eye morphogenesis (GO:0048593),0.6445452457428911,1.363559551749851,0.12962962962962962,0.4801064972891639,1.0,4/10,13.77%,TENM3;TBX2;NF1;LRP6
prerank,regulation of dendritic cell apoptotic process (GO:2000668),0.64827426440297,1.363531514356779,0.12400635930047695,0.47943118449971045,1.0,3/10,8.51%,CXCL12;BLK;LGALS9
prerank,negative regulation of vascular associated smooth muscle cell proliferation (GO:1904706),0.5908294621162326,1.363073957482212,0.12988826815642457,0.48001713294798487,1.0,6/17,13.51%,ADIPOQ;APLN;PTEN;PPARG;TGFB3;TPM1
prerank,regulation of nuclear division (GO:0051783),0.5565402883571167,1.362866147824849,0.13443072702331962,0.47982293311678725,1.0,8/20,17.15%,PDXP;OBSL1;CDK13;FBXO5;BORA;RCC1;PRMT5;CUL7
prerank,negative regulation of amyloid fibril formation (GO:1905907),0.6296535189056148,1.3622367191273625,0.13435114503816795,0.48093864845296785,1.0,5/12,12.79%,IAPP;APOE;TREM2;PFDN1;PFDN4
prerank,I-kappaB kinase/NF-kappaB signaling (GO:0007249),0.4878344953101583,1.361136786748671,0.07891770011273957,0.4832300885946455,1.0,18/59,18.60%,MAP3K14;BCL3;TLR2;BIRC3;REL;LY96;TIFA;TLR7;CD14;TANK;TRAF2;IRAK2;RELB;TNF;RBCK1;TNFRSF1A;ROCK2;TLR3
prerank,positive regulation of fatty acid biosynthetic process (GO:0045723),-0.554417296211415,-1.3609347187566156,0.13766233766233765,0.582852926366563,1.0,5/10,21.40%,ELOVL5;LPGAT1;SLC45A3;NR1H2;MLXIPL
prerank,positive regulation of cell differentiation (GO:0045597),0.43469915282116045,1.3607851925299579,0.013131313131313131,0.4834672970119503,1.0,61/237,17.39%,RUNX2;COL1A1;FBN2;EDN3;ZEB1;ZFP36L1;TCF4;SNAI1;YAP1;SOX5;NELL1;PTN;SFRP1;TMEM119;SFRP2;CMKLR1;LPL;PLA2G5;SMAD2;CCN4;DDR2;FGFR1;FRZB;TGFB1I1;MDK;CDC42;CD36;CARM1;ASXL2;WDFY2;TGFBR1;ACVR1;OLFM1;PPARG;LRRC8A;TGFB3;NFKB1;FBXO5;MAPK11;XBP1;GCNT2;ACVR2A;WWTR1;HEYL;SUCO;PDPN;BTG1;TCF3;SMAD3;SDCBP;AXIN2;AAMDC;MAPK9;SP7;ABL1;CTNNBIP1;EZH2;GDNF;RPS6KA3;RHOA;RIN2
prerank,positive regulation of myoblast differentiation (GO:0045663),-0.48258348262705836,-1.360429455518031,0.1027190332326284,0.579997661336278,1.0,4/16,5.71%,RANBP3L;PLCB1;AKIRIN1;MEF2C
prerank,glycosaminoglycan biosynthetic process (GO:0006024),0.4600306201896214,1.3599311902150535,0.05150214592274678,0.4851866586584483,1.0,16/95,7.06%,DCN;CEMIP;LUM;CHSY3;HSPG2;BGN;B4GALT5;GPC6;CHST13;ST3GAL3;VCAN;EXT1;HS2ST1;EXT2;SLC35D2;PRELP
prerank,fatty acid metabolic process (GO:0006631),0.4508272450803113,1.3598330454445304,0.04715969989281887,0.48470667043332805,1.0,20/115,11.83%,CEL;ADIPOQ;LIPC;LPL;SLC27A6;FASN;ACADSB;CD36;ALOX5AP;PPARG;ACOX1;THEM4;ACSL4;SLC27A2;SGPL1;SLC27A4;XBP1;CYP1A1;PON3;HSD17B8
prerank,positive regulation of immune effector process (GO:0002699),0.5313421514756609,1.3594816032417267,0.11651728553137004,0.4849029314797807,1.0,7/27,17.11%,IL23R;LBP;PLA2G5;LGALS9;XBP1;DHX58;PTPRJ
prerank,negative regulation of glucose transmembrane transport (GO:0010829),0.6376195525210238,1.3582701735475784,0.13875598086124402,0.4876842070333063,1.0,2/10,4.97%,ENPP1;PID1
prerank,negative regulation of reactive oxygen species metabolic process (GO:2000378),0.5644221067517831,1.3580816270392853,0.10298102981029811,0.48746899200158483,1.0,1/21,0.03%,MMP3
prerank,transcription initiation from RNA polymerase II promoter (GO:0006367),0.4397254592709612,1.3574628485828468,0.04479166666666667,0.4885521217094629,1.0,34/138,16.90%,RORA;NR1H4;NCOR2;YAP1;TEAD3;RARB;RXRG;TEAD1;MAML3;HDAC1;TAF4;CREBBP;TAF7;PPARG;E2F3;GTF2F2;NR1D2;CDK9;NRBF2;CDK7;HDAC5;MAML2;WWTR1;HDAC3;NR2F1;RBPJ;POLR2K;TBL1X;GTF2H1;NR2C2;POLR2B;TAF9B;CCNH;TAF2
prerank,positive regulation of endothelial cell proliferation (GO:0001938),0.4624679978198392,1.356821756638966,0.05856353591160221,0.48977274473532645,1.0,15/75,9.16%,CCL11;THBS4;PRKCA;NRP1;EGR3;WNT5A;APLN;EGF;ARNT;PRKD2;FGFR1;MDK;AKT3;TGFBR1;STAT5A
prerank,transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0007178),0.44677907021359553,1.3558980768960867,0.045881126173096975,0.4917592229406243,1.0,40/128,22.39%,RUNX2;COL1A2;LTBP2;COL3A1;ZMIZ1;ITGB5;USP9X;SMAD2;SMURF2;TGFB1I1;RNF111;CBL;BMP5;TGFBR1;ACVR1B;ACVR1;INHBB;TGFB3;GCNT2;ACVR2A;SMAD5;HIVEP1;PTK2;SMURF1;SMAD3;STUB1;ZFYVE16;RGMB;RHOA;ACVR1C;TGFBRAP1;TGFB2;CGN;RGMA;ITGB1;LRRC32;SRC;RPS27A;ACVRL1;BMP7
prerank,hemopoiesis (GO:0030097),0.45375796982212413,1.3554866016265152,0.08333333333333333,0.49214116223543075,1.0,13/87,6.08%,RUNX1;RUNX2;KMT2A;RUNX3;ETV6;SFRP1;SFRP2;WNT5A;ZFP36L2;JAG1;TIRAP;WNT2B;MEIS1
prerank,regulation of tumor necrosis factor-mediated signaling pathway (GO:0010803),0.487917695700506,1.355119022678153,0.0859106529209622,0.4923768324261017,1.0,16/54,17.13%,CASP4;ADIPOQ;TNFAIP3;BIRC3;CASP1;CFLAR;CLIP3;PYDC1;TRAF2;PELI3;CASP8;PTPN2;TNF;RBCK1;TNFRSF1A;NLRP2B
prerank,respiratory system development (GO:0060541),0.5142021920981367,1.3538304096549723,0.10588235294117647,0.49521579329579396,1.0,13/32,15.28%,GLI2;CHD7;FGF7;FGF9;SHH;SPEF2;BAG6;LOXL3;FGF2;NPHP3;PDPN;STRA6;ITGA3
prerank,MyD88-dependent toll-like receptor signaling pathway (GO:0002755),0.5344775787012545,1.3531743794024913,0.11764705882352941,0.4964293545401913,1.0,10/27,15.55%,TNIP1;TLR2;IRAK3;TIRAP;LY96;CD36;CD14;IRAK2;HSPD1;IRAK4
prerank,intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress (GO:0070059),0.5302298264538757,1.3531522629140462,0.11224489795918367,0.4957138583985107,1.0,9/28,15.46%,CASP4;ERN2;ITPR1;BCL2;BBC3;BAX;BAG6;TRAF2;BRSK2
prerank,regulation of oxidoreductase activity (GO:0051341),0.6120621403152637,1.3530191007071641,0.14285714285714285,0.4953385891095099,1.0,1/13,0.28%,HP
prerank,negative regulation of Wnt signaling pathway (GO:0030178),0.4338250079951667,1.3525425510833113,0.0196078431372549,0.49596571888704805,1.0,39/186,14.70%,PSMA7;RBMS3;BICC1;LRP1;TCF7L2;NKD2;KREMEN1;GLI3;SFRP4;SFRP1;SFRP2;IGFBP4;WNT5A;SNAI2;APOE;TLE1;TAX1BP3;FRZB;DVL2;MDK;SIAH2;HDAC1;PSMD4;DKK3;MDFI;PSMD11;CSNK1A1;CHD8;PRICKLE1;WWTR1;SFRP5;PSMB8;DKK2;NPHP3;KLHL12;LRP6;AXIN2;DRAXIN;GSK3B
prerank,regulation of Rho protein signal transduction (GO:0035023),0.46457936843063513,1.351600069591754,0.0728476821192053,0.49788442145686823,1.0,19/72,19.57%,ABCA1;DLC1;COL3A1;P2RY10;NRP1;APOE;OPHN1;RAC1;AKAP13;ARHGAP35;FLCN;ITGA3;ABL1;PDCD10;ROBO1;LPAR1;KCTD10;STARD13;ARRB1
prerank,gland development (GO:0048732),0.47978447297890625,1.3512268048281677,0.08323959505061868,0.4982521491218377,1.0,22/59,17.24%,GLI2;PRKCSH;ANXA1;ARID5B;PKD2;EPHB3;SHH;MDK;PHF2;NF1;TGFBR1;TGFB3;DKK3;FOXE1;SALL1;XBP1;MSN;ARHGAP35;STRA6;NKX2-8;GFER;TBX3
prerank,lipid droplet formation (GO:0140042),-0.5630314110696034,-1.3509764726986706,0.14105793450881612,0.6032943163659298,1.0,5/10,22.22%,BSCL2;CDS2;SQLE;PLA2G4C;FITM2
prerank,negative regulation of intrinsic apoptotic signaling pathway (GO:2001243),0.47520338490702524,1.3506521915291285,0.07845303867403315,0.4992252915403946,1.0,20/62,17.48%,CREB3L1;CXCL12;SNAI1;SFRP2;SNAI2;LRRK2;BCL2;CDKN2D;ENO1;XBP1;NOC2L;CREB3;BCL2L2;CCAR2;SELENOS;MDM2;SYVN1;TMEM161A;PPIF;NFE2L2
prerank,epithelial structure maintenance (GO:0010669),-0.5549242159078552,-1.3504656740467447,0.14697406340057637,0.6005726192982914,1.0,2/11,6.74%,RBP4;CXADR
prerank,positive regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030949),0.6369261729844229,1.348845703459509,0.14883720930232558,0.5036765270191663,1.0,4/10,13.47%,VTN;ARNT;PRKD2;ITGA5
prerank,regulation of translational initiation (GO:0006446),0.4753140072776076,1.3482050784534223,0.08381171067738231,0.5047986088372807,1.0,29/63,24.62%,EIF4G2;CTIF;EIF4G3;KHDRBS1;EIF2AK3;CCL5;NCK2;EIF3H;NCK1;PAIP2;ALKBH1;YTHDF3;RPS6KB1;EIF5B;EIF1;FMR1;PAIP1;EIF5;NCBP2;EIF4EBP1;MIF4GD;MTIF2;DDX3X;YTHDF2;KLHL25;DDX1;DNAJC3;CDC123;EIF4G1
prerank,lymphocyte proliferation (GO:0046651),0.5584239777108194,1.3476113461764359,0.12890094979647218,0.5057540190509605,1.0,8/22,15.25%,CD40;BCL2;ELF4;MS4A1;MSN;HSPD1;CTPS1;TNFRSF4
prerank,regulation of granulocyte macrophage colony-stimulating factor production (GO:0032645),0.6086815355949149,1.3465047625976831,0.12987012987012986,0.508125742474785,1.0,2/14,7.56%,IL23R;PAEP
prerank,embryonic limb morphogenesis (GO:0030326),0.5188226886293594,1.3463985808263124,0.11,0.5076355100894011,1.0,16/34,23.06%,GLI3;CACNA1C;TBX2;SHH;HDAC1;NIPBL;CREBBP;SALL1;LRP6;PTCH1;TBX3;WDPCP;TGFB2;MAP3K20;MEGF8;TWIST1
prerank,catecholamine metabolic process (GO:0006584),-0.5052019207540979,-1.346088451298543,0.13636363636363635,0.608868750706787,1.0,5/14,15.61%,SNCAIP;PRKN;DDC;RNF180;DRD2
prerank,positive regulation of ubiquitin protein ligase activity (GO:1904668),0.6232393180604805,1.3456953354214665,0.1435114503816794,0.5088629585570074,1.0,7/12,22.14%,PTEN;PLK1;FZR1;CDC14B;SKP1;UBE2S;RAB1A
prerank,response to glucose (GO:0009749),0.4852046680518595,1.3451116694660108,0.10328638497652583,0.5097590619150927,1.0,12/46,16.27%,SLC39A14;ADIPOQ;TCF7L2;NKX6-1;LPL;ZBTB20;ZBED3;XBP1;SELENOS;KHK;EIF2B3;GCK
prerank,regulation of fibroblast proliferation (GO:0048145),0.49686366542772337,1.3450042242089384,0.10093896713615023,0.5093094676645213,1.0,10/45,12.19%,WNT2;PDGFRA;SFRP1;WNT5A;DDR2;E2F1;NF1;CDK6;MORC3;S100A6
prerank,regulation of cell division (GO:0051302),0.46455151496390584,1.343865236238121,0.0706401766004415,0.5119026385544828,1.0,20/72,14.35%,POU5F1;PDXP;SFRP2;FSD1;SHH;KLHL13;CCP110;ENTR1;MYO19;PLK1;CSPP1;CALM3;SIRT2;CALM2;INSC;RAB11FIP4;PIK3C3;PIK3R4;ZFYVE26;FLCN
prerank,regulation of amyloid fibril formation (GO:1905906),0.5956035413592191,1.342956234872913,0.1471861471861472,0.5138435631192309,1.0,6/15,16.37%,IAPP;APOE;TREM2;PFDN1;PFDN4;PSEN1
prerank,actin polymerization or depolymerization (GO:0008154),0.48735521235939677,1.342756908713797,0.0996523754345307,0.5136903650945673,1.0,13/50,13.21%,GAS7;SVIL;SPIRE2;JAK2;TTC17;RAC1;AIF1;SPIRE1;VILL;PREX1;ABI1;ARHGAP6;ABI2
prerank,positive regulation of granulocyte macrophage colony-stimulating factor production (GO:0032725),0.6238850560568963,1.342589532189595,0.12648809523809523,0.5134125912703454,1.0,2/12,7.56%,IL23R;PAEP
prerank,inner ear morphogenesis (GO:0042472),0.5530757412962695,1.3420504046953974,0.13991769547325103,0.5142874122871282,1.0,6/22,15.58%,CHD7;TBX18;HOXA1;ZIC1;EPHB2;MYO3A
prerank,phasic smooth muscle contraction (GO:0014821),0.6349919241767019,1.341682468170825,0.16196136701337296,0.5146687281323994,1.0,2/10,4.18%,EDN3;HTR1D
prerank,positive regulation of cell killing (GO:0031343),0.6009080399403534,1.3413494094014082,0.14156626506024098,0.5148901875005751,1.0,3/13,6.18%,WNT5A;DVL2;RAC1
prerank,positive regulation of ubiquitin-protein transferase activity (GO:0051443),0.520913972025149,1.3409049616434323,0.11125158027812895,0.5153657658273905,1.0,13/31,18.59%,ARRDC4;PTEN;PLK1;UBE2L3;ARRDC3;FZR1;DCUN1D1;CDC14B;SKP1;FBXW7;DCUN1D5;UBE2S;TRIB3
prerank,negative regulation of autophagosome assembly (GO:1902902),0.6074906459048723,1.3403873407878986,0.14202049780380674,0.5161020711830583,1.0,9/13,20.59%,LRRK2;CHMP4B;CHMP4A;TMEM39A;PHF23;SCFD1;SMCR8;FEZ2;MTM1
prerank,negative regulation of toll-like receptor signaling pathway (GO:0034122),0.5144081641985285,1.3399404046094134,0.10349127182044887,0.516642548721965,1.0,15/34,24.81%,TNFAIP3;SMPDL3B;IRAK3;LY96;TREM2;RAB7B;GPR108;CD14;LGR4;NLRP2B;TLR3;NR1D1;PTPRS;CD300LF;TYRO3
prerank,lymphocyte differentiation (GO:0030098),-0.3225849219097635,-1.3395831781059446,0.02631578947368421,0.6242848102591453,1.0,18/68,16.36%,KIT;TOX;HDAC9;GPR89B;GPR89A;MSH2;TPD52;ITGA4;JAG2;VCAM1;DNAJB9;HDAC4;NHEJ1;PIK3CD;IKZF1;LFNG;RHOH;HHEX
prerank,regulation of transforming growth factor beta receptor signaling pathway (GO:0017015),0.4488284458918258,1.3393397141269108,0.07585470085470085,0.5176701228740207,1.0,27/95,15.28%,ZEB2;PMEPA1;SMAD2;ADAMTSL2;HTRA3;CDKN2B;SMURF2;NREP;SPRED1;SPRED2;TGFB1I1;RNF111;CREBBP;TGFBR1;DKK3;SPRY2;EMILIN1;WFIKKN1;HTRA4;SNX6;SMURF1;SMAD3;SDCBP;LDLRAD4;FLCN;STUB1;ITGA3
prerank,purine ribonucleoside bisphosphate metabolic process (GO:0034035),0.5988893137871331,1.3392223769661131,0.13432835820895522,0.5172399205522952,1.0,1/13,0.31%,ENPP1
prerank,positive regulation of actin filament depolymerization (GO:0030836),0.6451524695376464,1.3391544991553683,0.14691943127962084,0.516683024349412,1.0,3/10,5.42%,PDXP;CARMIL2;CARMIL1
prerank,regulation of heterotypic cell-cell adhesion (GO:0034114),0.5434902575033606,1.339020526324229,0.1376912378303199,0.5162540439709877,1.0,5/22,15.60%,ADIPOQ;FLOT2;GCNT2;THY1;TNF
prerank,tRNA aminoacylation for protein translation (GO:0006418),0.49403349511231537,1.3390052628500269,0.11913357400722022,0.515521949244892,1.0,23/42,26.15%,YARS1;PPA1;EEF1E1;TARS1;IARS2;EARS2;CARS2;FARSB;CARS1;AIMP1;GARS1;NARS1;PPA2;EPRS1;NARS2;FARS2;AIMP2;RARS1;TARS2;YARS2;TARS3;RARS2;WARS1
prerank,negative regulation of cell adhesion (GO:0007162),0.46113254796089653,1.3377845749664161,0.09161147902869757,0.518307316645855,1.0,19/72,13.85%,CYP1B1;KNG1;FBLN1;SPN;B4GALNT2;SNAI2;JAG1;MIA3;PLXNC1;NF2;MDK;PLXND1;ARHGDIG;DSCAM;GCNT2;PLXNA3;EPHB2;PTK2;ITGB1BP1
prerank,regulation of viral release from host cell (GO:1902186),0.5557606920954007,1.3375766369544102,0.14666666666666667,0.5181046845822544,1.0,9/21,16.59%,TRIM21;TRIM8;DDB1;VPS4A;TRIM13;TRIM11;TRIM62;TRIM35;CHMP3
prerank,negative regulation of cell adhesion mediated by integrin (GO:0033629),0.6477746977460863,1.3374924125123429,0.15325077399380804,0.5175904337249447,1.0,2/10,3.53%,CYP1B1;SNAI2
prerank,ncRNA catabolic process (GO:0034661),0.5181806357153699,1.3372880242718683,0.13093709884467267,0.5174185028274244,1.0,11/28,21.50%,ERN2;ZCCHC8;SND1;XRN1;MTREX;EXOSC4;POP1;EXOSC2;EXOSC3;LIN28B;DIS3L2
prerank,zinc ion transport (GO:0006829),0.5527811055407986,1.336403711108211,0.1106612685560054,0.5192903419921202,1.0,3/21,11.59%,SLC39A14;SLC30A9;SLC39A6
prerank,regulation of cysteine-type endopeptidase activity (GO:2000116),0.5659442328028101,1.3363038656057045,0.1448087431693989,0.518834520088867,1.0,2/21,2.93%,EPHA7;BIRC3
prerank,regulation of Golgi organization (GO:1903358),0.5664770432144638,1.3361690594850606,0.14866760168302945,0.5184576388383167,1.0,12/17,29.48%,MYO5A;CAMSAP2;MAP2K1;PDCD10;PDE4DIP;MAP2K2;MAPK1;AKAP9;RAB33B;STX5;ARMH3;RBSN
prerank,positive regulation of transcription by RNA polymerase II (GO:0045944),0.4173482864155984,1.3360291853654698,0.0,0.5180879461643136,1.0,205/834,17.90%,RORA;RUNX1;NR1H4;RUNX2;DCN;ZEB2;KMT2A;WNT2;POU5F1;GLI2;PLAC8;TCF7L2;TCF4;YAP1;SBNO2;MRTFA;TNIP1;ZMIZ1;NKX6-1;NRIP1;MEIS2;GLI3;TNFSF11;ASXL1;SLC9A1;USF1;CREB3L3;NR2F2;AUTS2;SATB2;SFRP2;TLR2;EAPP;IRF7;WNT5A;NFIX;DDX17;GLIS1;STAT1;MITF;CD40;ZFPM2;RARB;MLXIP;SMAD2;GATA6;NPAS4;REL;JAG1;APLN;RXRG;ACTR2;IRF1;GNL3;CDKN2B;ARNT;LAGE3;HOXB3;PRKD2;PKD2;LITAF;POU2F1;METTL23;OGT;PID1;MLIP;UBP1;INO80;SHH;DVL2;ZBTB38;MEIS1;E2F1;MMP12;ATM;NFKB2;TEAD1;RNF111;PPRC1;MYBL1;MED13;SUB1;PRDM2;MAML3;STAT3;EGFR;HDAC1;ELF4;BMP5;PIK3R1;CRTC3;CREBBP;HSF2;TAF7;MACC1;NCK2;ASXL2;SMARCD3;MED12;PLXND1;NCK1;CXCL10;IL33;FOXM1;ACVR1;SQSTM1;FOXK2;PPARG;E2F3;E2F8;ZBED3;TGFB3;BRD4;NR1D2;CDK9;MED14;SLC30A9;ETV5;TCF12;BCL11B;NFKB1;CDK13;FOXJ3;AHR;CDK7;HDAC5;SIRT2;SALL1;HOXA1;CHD8;XBP1;ATRX;CAMTA2;CRTC1;MAML2;ACVR2A;WWTR1;CALCOCO1;TFDP1;CREB3L4;CREB3;SETX;HDAC3;NR2F1;RRP1B;FGF2;TERT;GLIS3;HEYL;PPP3CA;RBPJ;HTATIP2;SMAD5;HIVEP1;CCNT1;TCF3;STAT6;SMAD3;CLOCK;LRP6;ITGB1BP1;JUNB;GLYR1;TBL1X;HMGB2;PTPRN;RTRAF;FLCN;ELK4;THRAP3;NR2C2;RSF1;YY1;SP7;MYSM1;TCEA1;GABPB1;TNF;NPAS2;ABL1;PELP1;CX3CL1;AKAP8L;ECD;MC1R;NKX2-8;TET2;MED21;KLF10;GDNF;ATF2;CCNC;MPND;TCERG1;TNFRSF1A;RPS6KA3;TBX3;HOXB2;NFE2L2;SPI1;KMT2D;EGR2;GABPA;CDC73;TFAP2C
prerank,positive regulation of cell projection organization (GO:0031346),0.4356573667437688,1.335959604500561,0.046462513199577615,0.5175448907935625,1.0,32/115,18.99%,ROR2;ROR1;ROBO2;CARMIL2;PTN;TENM3;AMIGO1;WNT5A;DPYSL3;APOE;PLXNC1;CARMIL1;DVL2;MDK;OBSL1;PLXND1;FZD1;DLG4;PLXNA3;SETX;PTK7;CAPRIN1;ARHGAP35;NTRK3;CX3CL1;NPTN;ROBO1;CUL7;RHOA;ARSB;DVL1;CAMK2B
prerank,regulation of cellular ketone metabolic process (GO:0010565),0.47171912019546397,1.335545873719468,0.10407239819004525,0.517983469328846,1.0,3/61,1.26%,PSMA7;NR1H4;NCOR2
prerank,regulation of actin filament-based process (GO:0032970),0.45478784803156386,1.3349889536081105,0.09550561797752809,0.5188094763215381,1.0,19/70,17.36%,DLC1;GPM6B;LRP1;TAOK1;RND3;PDGFRB;RHOD;BAIAP2;FSCN1;RAC1;CDK10;RICTOR;EFNA5;ARHGEF19;ARHGAP35;ABL1;RHOBTB3;ROCK2;RHOA
prerank,positive regulation of double-strand break repair (GO:2000781),0.4973967018566691,1.334895836753347,0.10794044665012408,0.5183266534094888,1.0,20/39,22.83%,PARP3;SPIRE2;ACTR2;MGMT;SPIRE1;KDM4D;FOXM1;SLF2;DDX11;SHLD3;MMS19;SETMAR;RIF1;TIMELESS;PARP1;FUS;PRKDC;WRAP53;DTX3L;KMT5B
prerank,"regulation of DNA-templated transcription, initiation (GO:2000142)",0.46452900705382816,1.3347539648759217,0.10376282782212087,0.5180609007010257,1.0,12/59,11.57%,RUNX2;TCF7L2;MITF;PTEN;MED13;BAX;MED12;CBFB;MED14;NFKB1;TNRC6B;SETX
prerank,negative regulation of cholesterol transport (GO:0032375),0.645951853142862,1.334191109098088,0.15512048192771086,0.5189434069212454,1.0,3/10,10.12%,ABCA2;SHH;NFKB1
prerank,response to lipopolysaccharide (GO:0032496),0.43772008362469167,1.3341131975590053,0.0498960498960499,0.5184429551593323,1.0,25/138,14.13%,CXCL5;IL23R;CXCL1;LBP;SBNO2;TNFAIP3;WNT5A;JAK2;IRAK3;CASP1;TIRAP;LY96;NUGGC;CYP27B1;CD68;CXCL10;LGALS9;ERBIN;NFKB1;CD14;XBP1;SIRPA;SELENOS;CCL2;HMGB2
prerank,adrenergic receptor signaling pathway (GO:0071875),-0.4441783531102987,-1.3338758261803623,0.128,0.6372719824948926,1.0,9/20,20.05%,ADRA1B;ADCY9;ADRA1A;RAPGEF2;PDE4D;ADRA2A;DRD2;ADRB2;ZDHHC21
prerank,positive regulation of protein serine/threonine kinase activity (GO:0071902),0.4452827898614149,1.3334162831697578,0.07348242811501597,0.5197127193080731,1.0,29/101,17.61%,IL34;CEMIP;ADIPOQ;EDN3;TNFSF11;PSRC1;WNT5A;PDGFRB;CD40;LRRK2;EGF;PKD2;FGFR1;EGFR;CCND3;RPTOR;INCENP;MAP2K1;CALM3;PIK3R5;FGF2;CALM2;TNF;MST1R;EZH2;PDCD10;ROBO1;RHOA;TCIM
prerank,positive regulation of interleukin-1 production (GO:0032732),0.4756040714846915,1.3330616167207803,0.11395348837209303,0.5200327249356086,1.0,12/51,15.60%,IL16;WNT5A;JAK2;LPL;CASP1;TMEM106A;STAT3;CD36;LGALS9;PYDC1;CASP8;TNF
prerank,regulation of RNA export from nucleus (GO:0046831),0.6329358977187403,1.3323221331249668,0.1523076923076923,0.521423742958451,1.0,7/11,27.51%,KHDRBS1;NUP153;NCBP2;AKAP8L;SETD2;IWS1;CPSF6
prerank,chromatin-mediated maintenance of transcription (GO:0048096),0.6370472653912529,1.3317421802827207,0.16717791411042945,0.5223562572682497,1.0,4/11,6.44%,ZMIZ1;SERTAD2;PADI2;ARID1B
prerank,positive regulation of leukocyte activation (GO:0002696),0.5659753229508947,1.33163749581432,0.13869625520110956,0.5219052405698799,1.0,5/18,13.99%,LBP;WNT5A;TSLP;IL33;HSPD1
prerank,muscle cell migration (GO:0014812),0.6393080604154651,1.3315733080349677,0.16211878009630817,0.5213124291042839,1.0,4/10,13.85%,THBS4;PLAT;DDR1;ITGB1BP1
prerank,negative regulation of cell communication (GO:0010648),0.5528017326389968,1.3311148687996877,0.13811420982735723,0.5218808511898793,1.0,6/21,16.05%,ADIPOQ;BRAP;ACVR1;PTPN1;UBASH3B;SOCS5
prerank,endomembrane system organization (GO:0010256),0.43182894230332264,1.331072735788557,0.038696537678207736,0.5212615456022357,1.0,64/178,21.08%,SEC16B;VMP1;SEC31A;GORASP2;LRRK2;ATP8B1;MIA3;LMAN2L;DNAJC13;STX17;TRIP11;ARFGEF2;SEC16A;EIF2AK3;TJAP1;CDC42;SNX10;HOOK2;WASHC4;UBXN2A;ATL2;RAB2A;REEP4;SPTBN5;SNX33;TLCD2;OBSL1;DNM1;SQSTM1;COG4;PI4K2B;VPS4A;CSNK1A1;ATL1;TLCD1;LMAN1;ALS2;TBC1D20;LEMD2;CSNK1D;DYNC2H1;A4GALT;TOR1AIP2;SUN1;SPTBN1;RAB30;VAPA;AP3D1;CUL7;GOLGA5;GOLGA8B;SMPD4;PLEKHF1;TMED1;TMCC1;COG7;GBF1;HOOK3;BNIP1;TMED10;SEC61A1;TRAPPC8;BCAS3;TMED7
prerank,positive regulation of cell migration (GO:0030335),0.4198955417197521,1.3310075507829051,0.021105527638190954,0.5207182339139428,1.0,52/253,13.07%,ROR2;CCL11;COL1A1;CEMIP;CCL7;MGAT5;PDGFRA;MMP14;LAMB1;CXCL12;SNAI1;MAP4K4;CARMIL2;PRKCA;NRP1;SYDE1;CCAR1;PDGFRB;VTN;SNAI2;RHOD;CCN4;DDR2;EGF;MIA3;SMURF2;CARMIL1;CCR1;MDK;ATM;AIF1;STAT3;EGFR;CCL5;NIPBL;DOCK1;TGFBR1;ACVR1B;EPHA1;ACVR1;SEMA3E;FBXO5;SPRY2;XBP1;GCNT2;GPNMB;MYLK;PPP3CA;EPHB2;CD151;PDPN;PTK2
prerank,negative regulation of establishment of protein localization (GO:1904950),-0.5425770735905471,-1.3309801549147944,0.16711590296495957,0.6414937237822469,1.0,3/10,14.94%,WWP2;NDFIP1;CORO2B
prerank,regulation of ossification (GO:0030278),0.5023665289353438,1.3308817070449137,0.11515151515151516,0.5203587775704157,1.0,12/36,13.77%,ENPP1;PTN;SFRP1;WNT5A;DDR2;MDK;CYP27B1;ACVR1;CHSY1;RBPJ;ANKH;LRP6
prerank,negative regulation of transport (GO:0051051),0.4727511498653749,1.3304866009466005,0.1212484993997599,0.5208246686106476,1.0,9/51,8.32%,ADIPOQ;TLR2;PRTN3;EGF;PTEN;RAB7A;FCGR2B;SNX33;PXK
prerank,positive regulation of Ras protein signal transduction (GO:0046579),0.4705290282985647,1.3304083649139702,0.09518348623853211,0.5203197892988881,1.0,14/62,17.36%,COL3A1;P2RY10;MAP4K4;AUTS2;JAK2;RAC1;AKAP13;ERBIN;ALS2;GRB2;MAPRE2;ROBO1;VAV1;LPAR1
prerank,negative regulation of protein catabolic process (GO:0042177),0.49351853853198885,1.3302645751618216,0.1039119804400978,0.5199757298343596,1.0,11/40,18.53%,NELL1;MAD2L1;TIMP1;PTPN3;IRAK3;AZIN2;EGFR;SIRT2;BANP;TIMP2;CTSA
prerank,regulation of epithelial cell differentiation (GO:0030856),-0.46109395526123714,-1.3300170641532292,0.11724137931034483,0.6397761437475458,1.0,9/17,27.86%,CAV1;KLF7;APOLD1;OSR1;PRKX;CEACAM1;CEBPB;DSPP;DLL1
prerank,neural crest cell migration (GO:0001755),-0.37693556525726335,-1.3299080326509038,0.08629441624365482,0.6356680032465075,1.0,18/36,22.27%,SEMA6A;SEMA3C;SEMA7A;SEMA6D;FN1;SEMA3D;TBX1;SEMA4D;SEMA5A;SEMA5B;ERBB4;SEMA4B;SEMA3G;SEMA3B;SEMA6C;SEMA6B;SOX8;SEMA4A
prerank,positive regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060213),-0.5043619431466673,-1.3292579498451516,0.15384615384615385,0.6335700608453916,1.0,10/13,31.54%,CPEB3;POLR2G;TOB1;ZFP36;TNRC6C;BTG2;PABPC1;EIF4ENIF1;CNOT1;TNRC6A
prerank,negative regulation of myeloid leukocyte differentiation (GO:0002762),0.5256897525243973,1.3288975688021545,0.1329987452948557,0.5231898447347357,1.0,4/26,3.72%,ADIPOQ;LRRC17;MAFB;FBN1
prerank,regulation of phosphate metabolic process (GO:0019220),0.5764850490732287,1.3288325667827146,0.1464088397790055,0.5226381350597298,1.0,7/16,23.99%,SMG7;SIRT2;MCM7;SMG6;PSEN1;PGAM1;CD24
prerank,regulation of lymphocyte activation (GO:0051249),0.6149593929603531,1.3286626239215404,0.16589861751152074,0.5224318302700701,1.0,2/12,7.35%,DCAF15;CCL5
prerank,heart trabecula morphogenesis (GO:0061384),-0.4491199261540598,-1.328456894577009,0.14084507042253522,0.6316475865633424,1.0,5/18,3.98%,TEK;RBP4;S1PR1;TGFBR3;ADGRG6
prerank,membrane raft organization (GO:0031579),0.5811791273164422,1.3283819225558535,0.14244604316546763,0.5225019598853694,1.0,2/15,3.93%,RFTN1;FLOT2
prerank,regulation of RNA polymerase II transcription preinitiation complex assembly (GO:0045898),-0.5242102422084681,-1.3278153455528565,0.17222222222222222,0.6293254568073346,1.0,5/10,21.37%,ESR1;PSMC3;TP53;PSMC4;PSMC2
prerank,regulation of receptor binding (GO:1900120),0.6362759566720311,1.3277194827746186,0.15987933634992457,0.5237660134933341,1.0,3/10,9.01%,ADIPOQ;ATP2A2;GREM2
prerank,negative regulation of cation channel activity (GO:2001258),0.53500190324456,1.3276737207319258,0.13743455497382198,0.5231654115760833,1.0,10/26,13.61%,CBARP;PKD2;UBQLN1;CALM3;FKBP1B;FMR1;DRD3;EPHB2;CALM2;KCNAB1
prerank,steroid metabolic process (GO:0008202),0.4593756783346916,1.3275516837200414,0.0929451287793953,0.5228031996530879,1.0,8/72,11.94%,CYP7B1;CYP1B1;DHRS4;SHH;CYP27B1;CYP2A6;CYP1A1;HSD11B1
prerank,regulation of lymphocyte differentiation (GO:0045619),0.5624418516575825,1.3274855614794123,0.15718157181571815,0.5222727749033309,1.0,6/18,21.94%,ZFP36L1;ZFP36L2;PRDM1;ABL1;PRKDC;PRELID1
prerank,receptor catabolic process (GO:0032801),0.5408781577198198,1.3273417591811474,0.15446071904127828,0.522006091323879,1.0,11/24,23.90%,CLTC;MYLIP;SMURF1;PIK3R4;MVB12A;SH3GLB1;SNX25;NEDD4;KIF16B;TGFB1;VLDLR
prerank,cellular response to lipopolysaccharide (GO:0071222),0.44040266229639563,1.3271266023276191,0.07127659574468086,0.5218856445764987,1.0,19/101,14.13%,CXCL5;CXCL1;LBP;SBNO2;TNFAIP3;WNT5A;CASP1;LY96;NUGGC;CCL5;CD68;CXCL10;NFKB1;CD14;XBP1;SIRPA;SELENOS;CCL2;HMGB2
prerank,striated muscle tissue development (GO:0014706),-0.3954336871199345,-1.3270919462835429,0.12,0.6272156872552712,1.0,8/29,5.71%,PGM5;CAV1;SGCD;SGCZ;RBP4;MYL6;NDUFV2;MEF2C
prerank,regulation of lipase activity (GO:0060191),0.601820649117826,1.3268840096294272,0.1664190193164933,0.5218178377798601,1.0,4/13,17.36%,LIPC;LPL;PCSK5;RHOA
prerank,chondroitin sulfate proteoglycan metabolic process (GO:0050654),-0.529310325544434,-1.3260830282695037,0.15885416666666666,0.6257039933046114,1.0,2/10,4.40%,CSGALNACT1;DSEL
prerank,regulation of fatty acid metabolic process (GO:0019217),-0.4549687196722393,-1.325605783523953,0.11458333333333333,0.6230382622004251,1.0,5/17,5.06%,PRKAG2;CAV1;PRKAA2;ADIPOR2;ADIPOR1
prerank,positive regulation of transforming growth factor beta receptor signaling pathway (GO:0030511),0.5421931373245055,1.3255328038610865,0.13430851063829788,0.5243686794147286,1.0,7/23,14.35%,ZEB2;CDKN2B;TGFB1I1;RNF111;CREBBP;SDCBP;FLCN
prerank,positive regulation of cellular response to transforming growth factor beta stimulus (GO:1903846),0.5421931373245055,1.3255328038610865,0.13430851063829788,0.5243686794147286,1.0,7/23,14.35%,ZEB2;CDKN2B;TGFB1I1;RNF111;CREBBP;SDCBP;FLCN
prerank,B cell proliferation (GO:0042100),0.5747222240784694,1.3249593386058014,0.17341040462427745,0.5252929741321245,1.0,5/17,14.56%,CD40;BCL2;MS4A1;HSPD1;CTPS1
prerank,regulation of innate immune response (GO:0045088),0.46984694236478197,1.3249447677455197,0.10183066361556065,0.5246125785174646,1.0,17/57,15.56%,TNFAIP3;BIRC3;IRAK3;IRF1;TIRAP;TREM2;POLR3D;ABCE1;CCL5;TRIM21;FCGR2B;PTPN6;PTPN1;DHX58;CASP8;CDC37;IFNAR2
prerank,glycine metabolic process (GO:0006544),0.6047830256451262,1.3247654875358421,0.1664145234493192,0.5244289037912504,1.0,4/12,13.57%,SDSL;AMT;GLDC;GCAT
prerank,calcium ion import across plasma membrane (GO:0098703),-0.48677474804434473,-1.3246516021073902,0.1757188498402556,0.6217515565644486,1.0,6/14,16.22%,SLC24A2;SLC8A3;TRPV2;ATP2B4;TRPV4;SLC8A2
prerank,negative regulation of protein processing (GO:0010955),0.6137093614067646,1.3240800869317046,0.14820359281437126,0.5257223493817035,1.0,3/12,8.88%,SERPINE2;LRRK2;GAS1
prerank,cellular response to UV (GO:0034644),0.45709469197097924,1.3239617779146386,0.08178844056706652,0.5253290436906344,1.0,16/76,16.85%,MMP3;MMP2;TIMP1;MFAP4;INO80;PPID;ATR;CREBBP;DDB1;NOC2L;FMR1;USP47;CDC25A;YY1;MC1R;TMEM161A
prerank,receptor signaling pathway via STAT (GO:0097696),0.5385835361631717,1.3235716475340389,0.13856209150326798,0.5257010921143551,1.0,9/25,15.56%,GHR;JAK2;STAT1;PKD2;STAT3;STAT5A;STAT6;CCL2;IFNAR2
prerank,artery development (GO:0060840),0.5406111210418288,1.3230930920528154,0.14905149051490515,0.52638771015512,1.0,8/23,16.91%,ROBO2;NRP1;PKD2;NF1;TGFBR1;HOXA1;STRA6;ROBO1
prerank,negative regulation of protein phosphorylation (GO:0001933),0.4262663896543655,1.3224986709606914,0.04643962848297214,0.5274119390978246,1.0,67/150,23.83%,ENPP1;ADIPOQ;FBLN1;PMEPA1;SFRP1;SFRP2;ERRFI1;GSKIP;LRRK2;PID1;PTEN;PTPN13;CNKSR3;SPRED1;SPRED2;RASSF2;MVP;NF1;TAF7;NCK2;NCK1;PTPN6;EPHA1;ZBED3;CALM3;DTNBP1;SPRY2;TARBP2;EMILIN1;SIRT2;IBTK;WWTR1;SIRPA;PYDC1;EPHB2;CALM2;THY1;LRP6;ITGB1BP1;LDLRAD4;RTRAF;NTRK3;NIBAN1;UBASH3B;ATG14;PRKRIP1;NLRP2B;SNX25;SMCR8;PLPP3;TRIB3;DVL1;TRIM27;NTF3;CORO1C;CDK5RAP3;TERF2IP;TRIB1;PRKDC;PARK7;YWHAG;TSC2;TWIST1;DNAJC3;XDH;TGFB1;FKBP8
prerank,regulation of mast cell activation (GO:0033003),0.638361742304097,1.3220476992493593,0.16510903426791276,0.5280542172360194,1.0,2/10,4.44%,MILR1;TSLP
prerank,regulation of protein import into nucleus (GO:0042306),0.5029975860946603,1.3218218194842573,0.13838748495788206,0.5279618401643551,1.0,9/36,13.71%,MDFIC;APOD;SUFU;UBR5;PIK3R1;BAG3;HDAC3;ZIC1;SMAD3
prerank,regulation of macrophage chemotaxis (GO:0010758),0.5530695185829573,1.3218097902357182,0.1472972972972973,0.5272648300732514,1.0,6/21,13.91%,IL34;CMKLR1;MDK;CCL5;PTK2;DDT
prerank,regulation of nervous system development (GO:0051960),0.5033723022575709,1.3213651040340069,0.12763320941759604,0.5277764279841393,1.0,10/37,15.90%,YAP1;PTN;TENM4;BHLHE40;PTPRZ1;SIRT2;HEYL;NPHP3;HMGB2;CX3CL1
prerank,regulation of response to cytokine stimulus (GO:0060759),0.5417036961575601,1.320766836754446,0.1615598885793872,0.5288571088605917,1.0,6/19,16.66%,RUNX1;WNT5A;CBFB;IRAK2;TLE5;LIFR
prerank,enzyme linked receptor protein signaling pathway (GO:0007167),0.42708212624190245,1.3207472291050872,0.05943691345151199,0.5281859003615819,1.0,28/138,13.07%,ROR2;ROR1;EPHA7;PDGFRA;PTN;JAK2;PDGFRB;DDR2;BLK;EPHB3;FGFR1;LCP2;NPR2;FRS2;EGFR;TRIO;ACVR1B;EPHA1;DDR1;GUCA1B;MERTK;STYK1;FRK;ACVR2A;ABI1;EPHB2;ANGPTL1;PTK2
prerank,heparan sulfate proteoglycan metabolic process (GO:0030201),0.5492122043083383,1.319682116803266,0.14150943396226415,0.5306080289848313,1.0,7/21,15.48%,SULF1;EXT1;HS2ST1;EXT2;HPSE;EXTL3;UGDH
prerank,regulation of ion transmembrane transporter activity (GO:0032412),-0.36374626678149075,-1.3192992351463728,0.06818181818181818,0.6341333025582476,1.0,12/39,15.22%,FHL1;ANK2;WWP2;FGF12;FXYD5;CHRM3;CACNA1D;FXYD6;WNK3;FXYD1;NEDD4L;SCN4B
prerank,positive regulation of erythrocyte differentiation (GO:0045648),0.5277360714842054,1.319243441168432,0.1591203104786546,0.5311844708950565,1.0,12/25,21.90%,STAT1;ARNT;BRD1;STAT3;ACVR1B;MAPK11;ACVR2A;HMGB2;FOXO3;STAT5B;ETS1;PRKDC
prerank,regulation of macromolecule metabolic process (GO:0060255),0.42545864470193884,1.3191185358773039,0.03987730061349693,0.5308156129547705,1.0,43/170,20.20%,IGF2BP1;TRIML2;POU5F1;EDN3;C1D;ZFP36L1;IGF2BP2;AFF2;AFF1;NELL1;APOE;FUBP1;TREM2;SHH;KHSRP;CGGBP1;AIF1;PRDM2;TRIM21;PRDM5;TBC1D16;CDK6;AHR;HMG20B;TRIM11;ZNF445;SIRPA;PRDM1;CTCF;NFKBIZ;MKLN1;HNRNPK;PSEN1;HNRNPDL;GDNF;ROCK2;TRIM44;TRIM17;TRIM27;TCF19;ARF1;YBX1;MTMR1
prerank,regulation of actin filament depolymerization (GO:0030834),0.609867599407322,1.3190195378172827,0.1568627450980392,0.530396901632179,1.0,3/12,9.40%,PDXP;LIMA1;PLEKHH2
prerank,epithelial cell differentiation (GO:0030855),0.43901424961026997,1.3188782664721521,0.09304812834224599,0.5300865727454855,1.0,14/88,14.63%,SCUBE1;FSTL1;GATA6;JAG1;ANXA1;HDAC1;PPARG;RAB10;E2F8;CTSB;DEUP1;ANXA7;GSTK1;CNN3
prerank,positive regulation of exosomal secretion (GO:1903543),0.5689153364343557,1.318319231470859,0.1539568345323741,0.5310734284132284,1.0,9/15,27.52%,RAB7A;VPS4A;SDC1;SDCBP;HGS;SMPD3;PDCD6IP;VPS4B;SNF8
prerank,regulation of mitotic sister chromatid separation (GO:0010965),0.5759869722400444,1.3182541095525493,0.17138599105812222,0.5305533600308657,1.0,4/15,11.72%,NEK6;PLK1;CDC27;CDC16
prerank,positive regulation of interleukin-4 production (GO:0032753),-0.44618193487745433,-1.318079796980206,0.12015503875968993,0.6337671421048828,1.0,8/17,25.15%,PRKCZ;SLC7A5;SYK;HAVCR2;FCER1G;CD86;CEBPB;PRKCQ
prerank,cellular response to nitrogen compound (GO:1901699),0.5537757517056635,1.3180426382262174,0.14925373134328357,0.5304000667407663,1.0,6/20,17.28%,NR1H4;DDX11;ATRX;FMR1;TIMELESS;ROCK2
prerank,negative regulation of histone modification (GO:0031057),0.5985683444751879,1.3180177579137142,0.13956834532374102,0.5297532291121981,1.0,8/14,26.14%,TAF7;NOC2L;SPHK2;AASS;JARID2;PRMT6;TWIST1;THAP7
prerank,defense response to Gram-negative bacterium (GO:0050829),0.4861487448612837,1.317968676577417,0.12545676004872108,0.5291614044809598,1.0,4/42,4.76%,IL23R;LBP;RNASE7;TREM2
prerank,cytoplasmic sequestering of protein (GO:0051220),0.6134485641508091,1.317651261231725,0.16500711237553342,0.5293716951515743,1.0,5/13,9.75%,SUFU;PKD2;NFKBIE;DBN1;MDFI
prerank,regulation of interleukin-10 production (GO:0032653),0.48327649346680834,1.3176361134368528,0.1111111111111111,0.5287009340799741,1.0,7/44,8.51%,IL23R;TNFRSF21;XCL1;TSLP;STAT3;FCGR2B;LGALS9
prerank,regulation of type I interferon-mediated signaling pathway (GO:0060338),0.5212375536609986,1.317299601528354,0.1375796178343949,0.5289964162114665,1.0,9/29,15.56%,ZBP1;WNT5A;ABCE1;PTPN6;PTPN1;YTHDF3;CDC37;PTPN2;IFNAR2
prerank,pancreas development (GO:0031016),0.589647328710317,1.3167954124607493,0.17138364779874213,0.5296980901978771,1.0,2/12,1.99%,TCF7L2;NKX6-1
prerank,cellular response to superoxide (GO:0071451),-0.5415579253935631,-1.3166903326051542,0.17045454545454544,0.634038548837035,1.0,4/10,20.56%,NOS3;PRDX2;ADPRS;SOD1
prerank,nitric oxide metabolic process (GO:0046209),0.5994632545951154,1.316357936116947,0.1695906432748538,0.5302016066099644,1.0,1/14,0.21%,CYP1B1
prerank,regulation of transcription initiation from RNA polymerase II promoter (GO:0060260),0.45657803245370876,1.3160029089349725,0.11778029445073612,0.5304340953376755,1.0,11/60,10.45%,RUNX2;TCF7L2;PTEN;MED13;SUB1;BAX;MED12;CBFB;MED14;NFKB1;TNRC6B
prerank,membrane repolarization during cardiac muscle cell action potential (GO:0086013),-0.46562566868018884,-1.3159862714518322,0.13355048859934854,0.632045154400981,1.0,8/15,23.28%,ATP1B1;KCNJ2;KCNJ3;KCND3;KCNQ1;ATP1A1;KCNJ8;KCNN2
prerank,regulation of fatty acid biosynthetic process (GO:0042304),-0.4154655650401053,-1.3159675346848108,0.09865470852017937,0.6280824403643788,1.0,8/26,11.66%,PRKAG2;PRKAA2;ADIPOR2;ERLIN1;ADIPOR1;ELOVL5;LPGAT1;SLC45A3
prerank,histone H3-K4 methylation (GO:0051568),0.5311353052683473,1.315644147658458,0.14923469387755103,0.5307575767164783,1.0,5/26,6.73%,KMT2A;CXXC1;OGT;KMT2B;RBBP5
prerank,positive regulation of macrophage activation (GO:0043032),0.5722007222628538,1.3154176150991919,0.15625,0.5306975677342939,1.0,5/17,13.99%,LBP;WNT5A;TREM2;IL33;HSPD1
prerank,regulation of pH (GO:0006885),0.612023816183076,1.3153439577490245,0.17099236641221374,0.5302071593354789,1.0,2/11,2.30%,LACC1;SLC9A1
prerank,regulation of striated muscle contraction (GO:0006942),-0.4016093720414111,-1.3152792871086456,0.0945945945945946,0.6262032365650808,1.0,5/27,7.13%,DMD;ANK2;ATP1A2;SLC8A3;CALM1
prerank,negative regulation of mitotic cell cycle phase transition (GO:1901991),0.44410812217449347,1.3148464653156613,0.08503767491926803,0.5309499474446268,1.0,29/87,21.00%,PSMA7;ZFP36L1;ZFP36L2;CDKN2B;PKD2;FBXL7;PTEN;CDKN2D;PINX1;CUL1;PSMD4;CDK6;PSMD11;FBXO5;PSMB8;GPNMB;CCL2;SKP1;USP47;PSMA6;WEE1;PSMD14;CDC73;PSMC6;PSMB10;PSMD12;PSMB1;PSMA8;PSMF1
prerank,regulation of cell-matrix adhesion (GO:0001952),0.4559822380523491,1.3147132686554697,0.11337868480725624,0.5306358679609874,1.0,20/64,17.36%,GPM6B;MAP4K4;SLC9A1;SFRP1;CASK;PEAK1;JAG1;NF2;CD36;NF1;EPHA1;SEMA3E;CDK6;EFNA5;PTK2;THY1;GSK3B;CX3CL1;ROCK2;RHOA
prerank,regulation of receptor internalization (GO:0002090),0.492170141345799,1.3141856189372587,0.12682926829268293,0.5314477951816868,1.0,14/35,19.76%,SFRP4;ATXN2;EGF;CD63;DLG4;FMR1;SDCBP;MKLN1;ANGPT1;PICK1;ARRB1;ANKRD13B;NTF3;ARF1
prerank,PERK-mediated unfolded protein response (GO:0036499),0.6321440789877272,1.3135459051261462,0.16535433070866143,0.5325178113213165,1.0,6/10,25.94%,EIF2AK3;CCL2;NFE2L2;HSPA5;DDIT3;ATF4
prerank,intracellular cholesterol transport (GO:0032367),0.575580402211696,1.313039235765391,0.14390602055800295,0.5332714251926416,1.0,6/15,13.77%,ABCA1;ABCG1;RELCH;NPC2;VPS4A;LRP6
prerank,nitric oxide biosynthetic process (GO:0006809),0.604068009229812,1.3126732182165974,0.18248175182481752,0.5336590879318276,1.0,1/13,0.21%,CYP1B1
prerank,cation transport (GO:0006812),-0.2714443759611194,-1.3125275137614174,0.0,0.6301150419712968,1.0,30/167,12.50%,TRPM3;SLC6A6;SLC47A1;SLC12A2;KCNB2;ATP1B1;SLC6A9;KCNK5;TRPM6;ATP1A2;SCN2A;KCNJ2;SCN8A;SLC9B2;ABCC9;KCNJ3;KCND3;SLC5A6;SLC1A1;SLC8A3;SLC8B1;SLC5A5;SLC38A5;ANO1;KCNJ13;SCN3A;SLC6A17;KCNJ12;TRPM7;NDFIP1
prerank,mitochondrion localization (GO:0051646),0.5510962487110386,1.3125079964610542,0.15841584158415842,0.5334408711605636,1.0,5/19,12.16%,LRRK2;TRAK1;MARK1;ZBED3;MSTO1
prerank,positive regulation of heart contraction (GO:0045823),0.5641336520650513,1.3121389122802085,0.16307277628032346,0.5338272775547414,1.0,4/19,5.25%,EDN3;ADM;APLN;ATP2A2
prerank,maintenance of protein localization in endoplasmic reticulum (GO:0035437),0.6045589714729916,1.312126017920599,0.17647058823529413,0.5331621161492015,1.0,7/12,27.31%,KDELR3;INSIG2;KDELR2;HSPA5;KDELR1;TAPT1;ANKRD13C
prerank,toll-like receptor 9 signaling pathway (GO:0034162),0.602081870402404,1.3120945008563252,0.16862170087976538,0.5325151120380979,1.0,6/13,15.55%,TLR7;PIK3AP1;IRAK2;PIK3C3;PIK3R4;IRAK4
prerank,establishment of spindle localization (GO:0051293),0.5824838817406057,1.3115096441389615,0.15151515151515152,0.5335628796815295,1.0,5/14,14.03%,DYNC1H1;ZBED3;LLGL1;KPNB1;MAP4
prerank,regulation of membrane protein ectodomain proteolysis (GO:0051043),0.5374848924670523,1.311441214844302,0.16353887399463807,0.5330424038374123,1.0,10/22,24.55%,TIMP1;APOE;PTPN3;SNX33;TNF;SNX9;TIMP2;NRDC;GPLD1;ADAM9
prerank,negative regulation of DNA metabolic process (GO:0051053),0.5248889570968956,1.3109330162656327,0.14133333333333334,0.5337846391754671,1.0,3/24,6.89%,KMT2A;ADIPOQ;SUB1
prerank,endoplasmic reticulum organization (GO:0007029),0.44444024212528377,1.310926245118813,0.1015625,0.5330994619778645,1.0,24/72,21.17%,SEC16B;SEC31A;LRRK2;TRAM2;MIA3;LMAN2L;SEC16A;EIF2AK3;ATL2;REEP4;RAB10;WDR83OS;ZBED3;ATL1;LMAN1;ALDH3A2;VCPIP1;TOR1AIP2;VAPA;SMPD4;TMCC1;BNIP1;SEC61A1;LPCAT3
prerank,adenylate cyclase-activating adrenergic receptor signaling pathway (GO:0071880),-0.4407184837554485,-1.3108821335266414,0.11805555555555555,0.6310588547589995,1.0,7/17,18.37%,ADRA1B;ADCY9;ADRA1A;RAPGEF2;ADRA2A;DRD2;ADRB2
prerank,negative regulation of bone mineralization (GO:0030502),0.5878459979299275,1.3103568264550594,0.16244411326378538,0.5340093012139667,1.0,2/13,5.52%,ENPP1;CCR1
prerank,regulation of actin cytoskeleton organization (GO:0032956),0.4376384233365373,1.3102653075901691,0.10509209100758396,0.5335709396392092,1.0,23/87,17.36%,DLC1;GPM6B;PDGFRA;LRP1;TAOK1;RND3;PDGFRB;RHOD;BAIAP2;FSCN1;MDK;RAC1;CDK10;SEMA3E;RICTOR;EFNA5;ARHGEF19;ARHGAP35;ABL1;NEB;RHOBTB3;ROCK2;RHOA
prerank,cell proliferation in forebrain (GO:0021846),0.6289672539496869,1.3099978124495397,0.191044776119403,0.5336507719503254,1.0,6/10,25.39%,NUMBL;CEP120;PCM1;HOOK3;NUMB;DOCK7
prerank,cellular biogenic amine metabolic process (GO:0006576),-0.5068488183817499,-1.3098592178948816,0.13846153846153847,0.6300346090428183,1.0,4/12,14.36%,MAOA;HNMT;DDC;OAZ2
prerank,eye photoreceptor cell differentiation (GO:0001754),0.5994294201953421,1.3098460621148766,0.16890881913303438,0.5333938123764126,1.0,5/12,10.59%,SDK2;STAT3;DSCAM;MYO7A;AGTPBP1
prerank,negative regulation of cytokine production (GO:0001818),0.4206982162099238,1.309419693326192,0.05344295991778006,0.5339151060455496,1.0,33/163,16.22%,NR1H4;IL23R;VSIG4;APOD;BCL3;TNFRSF21;ADCY7;TNFAIP3;CMKLR1;XCL1;NAV3;IRAK3;ANXA1;TREM2;RAC1;IKBKE;ATP2B1;FCGR2B;LGALS9;ILRUN;PTPN6;INHBB;PTGER4;GPNMB;SIRPA;SSC5D;SELENOS;CHID1;DHX58;TNF;LGR4;CX3CL1;NPTN
prerank,dopaminergic neuron differentiation (GO:0071542),0.5526700181632844,1.3093771753894454,0.16575342465753426,0.5333537804566767,1.0,2/19,5.73%,WNT2;SHH
prerank,regulation of interleukin-1 beta production (GO:0032651),0.4525472723135245,1.309092404207492,0.11136363636363636,0.5334913759353951,1.0,20/66,22.73%,TNFAIP3;WNT5A;JAK2;LPL;CASP1;TMEM106A;STAT3;CD36;LGALS9;SIRPA;PYDC1;CASP8;TNF;CX3CL1;NLRP2B;P2RX7;IGF1;GSDMD;CARD16;CPTP
prerank,negative regulation of cellular process (GO:0048523),0.4103801362881944,1.309083103045579,0.002,0.5328339076507338,1.0,92/521,13.89%,ROR2;GLMN;CYP1B1;COL18A1;DLC1;ENPP1;ADIPOQ;RUNX3;KNG1;IGFBP7;FBLN1;CXCL1;TNFRSF21;SPN;PPP1R9B;BCL6;SFRP4;SLIT3;PSRC1;SFRP1;CASK;SFRP2;TLR2;JAK2;ALDH1A2;PRTN3;CCN4;BCL2;CHMP4B;IRF1;CDKN2B;MYH9;MIA3;PKD2;TREM2;WNT9A;EEF1E1;PLXNC1;CELF1;PTEN;CDKN2D;NF2;FRZB;SHH;SERTAD2;TGFB1I1;MDK;CYP27B1;ADAMTS1;MYBL1;EIF2AK3;CDK10;BMP5;PINX1;CDKN2AIP;NCK2;FCGR2B;PLXND1;STRN;NCK1;ACVR1B;PTPN6;VPS13C;FOXM1;ARHGDIG;TGFB3;CDK6;MAP2K1;ENO1;DSCAM;FBXO5;FRK;EMILIN1;SIRT2;PLXNA3;ABI1;EIF2AK2;SFRP5;FGF2;GPNMB;SIRPA;EPHB2;CCAR2;PDPN;CTCF;RERG;BTG1;PDS5B;DLG5;SMAD3;ITGB1BP1;AXIN2
prerank,positive regulation of mitotic cell cycle phase transition (GO:1901992),0.4677026561494852,1.3090280902323548,0.1244343891402715,0.5323352759230585,1.0,14/56,11.72%,RAD51B;ANXA1;ANAPC11;AIF1;ADAMTS1;EGFR;CCND3;RPTOR;BRD4;FBXO5;CDC27;UBE2E2;TFDP1;CDC16
prerank,positive regulation of pri-miRNA transcription by RNA polymerase II (GO:1902895),0.49162337661660455,1.308818429362382,0.14646464646464646,0.5322295660814546,1.0,14/33,20.62%,APLN;GNL3;TEAD1;STAT3;PPARG;FGF2;TERT;SMAD3;TNF;SPI1;FOXO3;SMARCA4;TGFB2;ETS1
prerank,regulation of cholesterol esterification (GO:0010872),0.6359632304266397,1.3076604038675987,0.16051364365971107,0.5347869217033682,1.0,3/10,4.50%,ABCA2;APOE;ABCG1
prerank,defense response to bacterium (GO:0042742),0.4334276267415548,1.3074005526750916,0.08191489361702127,0.5348281240189648,1.0,10/105,6.07%,IL23R;LBP;SPN;COLEC12;CRP;TLR2;RNASE7;TIRAP;TREM2;GBP7
prerank,regulation of response to biotic stimulus (GO:0002831),0.5176542365777834,1.3068923671089794,0.15384615384615385,0.5355959802405079,1.0,10/28,15.90%,BIRC3;GATA6;IRF1;TIRAP;TREM2;CD36;FCGR2B;DHX58;CASP8;CX3CL1
prerank,renal filtration (GO:0097205),0.6248982578761304,1.3066296831129687,0.17011834319526628,0.535641364718319,1.0,4/10,15.28%,SULF1;XPNPEP3;TBC1D8B;ITGA3
prerank,regulation of myelination (GO:0031641),0.5299738655367269,1.3062765765063864,0.14416775884665792,0.5360623969905636,1.0,10/25,17.65%,TNFRSF21;PTN;TENM4;EIF2AK3;PTPRZ1;MYRF;SIRT2;DICER1;TPPP;EGR2
prerank,regulation of cell aging (GO:0090342),0.6117758976681154,1.30625144666014,0.1803030303030303,0.5354310257574699,1.0,4/11,12.90%,NEK6;NUAK1;FOXM1;NEK4
prerank,positive regulation of cell motility (GO:2000147),0.41401735894329733,1.3061826083380146,0.04843592330978809,0.5349408353861972,1.0,41/205,13.07%,ROR2;CCL11;COL1A1;CEMIP;CCL7;MGAT5;PDGFRA;MMP14;LAMB1;CXCL12;SNAI1;MAP4K4;CARMIL2;PRKCA;CCAR1;PDGFRB;SNAI2;RHOD;EGF;CARMIL1;CCR1;MDK;ATM;AIF1;STAT3;EGFR;CCL5;TGFBR1;EPHA1;ACVR1;SEMA3E;SPRY2;XBP1;GCNT2;GPNMB;MYLK;PPP3CA;EPHB2;CD151;PDPN;PTK2
prerank,odontogenesis of dentin-containing tooth (GO:0042475),0.5847237672706216,1.3060719821493627,0.17316017316017315,0.5345302220041148,1.0,5/15,13.77%,GLI2;ANKRD11;HDAC1;EDA;LRP6
prerank,response to peptide hormone (GO:0043434),0.4836305195554398,1.305895824455259,0.12930011862396204,0.5343778399065408,1.0,15/43,17.28%,ZFP36L1;STAT1;IRS1;IGFBP5;ANXA1;OGT;STAT3;STAT5A;ZBED3;XBP1;GNAI1;STAT6;KHK;EIF2B3;ROCK2
prerank,regulation of cell cycle process (GO:0010564),0.4327405826911161,1.305879588247922,0.08113804004214963,0.5337452603527773,1.0,32/104,19.00%,PDXP;SFRP1;FSD1;CDKN2B;DYNC1H1;CSNK2A2;KLHL13;NUGGC;CCP110;CDC42;SND1;ENTR1;MYO19;PLK1;OBSL1;CALM3;CDK13;FBXO5;BORA;RCC1;CALM2;RAB11FIP4;DBF4;PIK3C3;PIK3R4;ZFYVE26;FLCN;PRMT5;SH3GLB1;CUL7;CSNK2A1;MAD1L1
prerank,"positive regulation of DNA-templated transcription, initiation (GO:2000144)",0.5453580509840308,1.3057689868120388,0.15650969529085873,0.5333813968775787,1.0,9/21,23.06%,MITF;MED13;SUB1;MED12;MED14;SETX;MED24;BCLAF1;TWIST1
prerank,negative regulation of protein tyrosine kinase activity (GO:0061099),0.5361748792665473,1.30571927613044,0.1437908496732026,0.5328322699022827,1.0,10/23,18.60%,CBLB;ERRFI1;CBL;MVP;SH3BP5L;SH3BP5;SNX6;THY1;SOCS5;ZGPAT
prerank,retina homeostasis (GO:0001895),-0.40872556105779856,-1.305545509695785,0.10775862068965517,0.6389442790811597,1.0,9/23,23.12%,ACTB;POTEF;WHRN;HSPB1;BBS4;CCDC66;SOD1;TULP1;ACTG1
prerank,response to hydrogen peroxide (GO:0042542),0.47804561158251646,1.3053233105813946,0.11976047904191617,0.5332420354035188,1.0,11/45,17.48%,CYP1B1;HP;TNFAIP3;ANXA1;FXN;SETX;SIRPA;ABL1;PDCD10;PPIF;NFE2L2
prerank,neutral amino acid transport (GO:0015804),-0.38701431823398474,-1.3047140184243566,0.11790393013100436,0.6373983809838424,1.0,9/28,13.05%,SLC6A6;SLC6A9;SLC43A2;SLC1A1;SLC7A5;SLC38A5;SLC6A17;CTNS;SLC6A7
prerank,brain development (GO:0007420),0.4242247119418213,1.3046725023625574,0.06478578892371996,0.5343738765449221,1.0,22/136,10.91%,COL4A1;EPHA7;APOD;HSPG2;AFF2;ROBO2;ATXN1;AATK;MEIS2;MDGA1;AMIGO1;ADGRL3;PTEN;MEIS1;MAP1S;NIPBL;NF1;PBX3;SPEF2;CXCR4;BAG6;CHD8
prerank,epithelial to mesenchymal transition (GO:0001837),0.4802402689658835,1.3044829881313167,0.13452380952380952,0.5342070760065445,1.0,16/47,17.28%,SNAI1;WNT5A;DDX17;SNAI2;FGFR1;LIMS1;TGFBR1;OLFM1;LOXL3;HEYL;RBPJ;DLG5;GSK3B;CUL7;TBX3;ROCK2
prerank,positive regulation of T cell mediated immunity (GO:0002711),0.5351382197089147,1.3044026472341776,0.16116248348745046,0.5337700571551367,1.0,5/22,13.99%,IL23R;XCL1;FBXO38;TRAF2;HSPD1
prerank,negative regulation of lipid catabolic process (GO:0050995),-0.44993760321386206,-1.3039854109507583,0.13680781758957655,0.6354817385193835,1.0,5/17,12.93%,ALK;PDE3B;BSCL2;ADRA2A;MFSD2A
prerank,positive regulation of cell-matrix adhesion (GO:0001954),0.48153465483024277,1.3030409250493213,0.12280701754385964,0.5369018368326244,1.0,14/42,17.39%,MAP4K4;NRP1;SFRP1;RAC1;LIMS1;CD36;EPHA1;CDK6;THY1;GSK3B;ABL1;CX3CL1;PTPRJ;RIN2
prerank,secondary alcohol biosynthetic process (GO:1902653),-0.3721139219724791,-1.3029283944054288,0.1218274111675127,0.6348263911694001,1.0,13/30,23.17%,LBR;ACAT2;ACLY;SQLE;DHCR24;IDI1;FDFT1;HSD17B7;FDPS;NSDHL;EBP;HMGCS1;TM7SF2
prerank,cellular response to ATP (GO:0071318),0.5846354596054781,1.3027935732857687,0.1867816091954023,0.536946062002316,1.0,2/14,6.59%,PDXP;SSH1
prerank,neurotrophin TRK receptor signaling pathway (GO:0048011),-0.4686284693208854,-1.3022890569489614,0.13870967741935483,0.6329103865294735,1.0,6/15,12.34%,SORT1;ZFYVE27;CASP3;DDIT4;NTRK2;BDNF
prerank,negative regulation of cytokine production involved in immune response (GO:0002719),0.5696329355011289,1.302258724163141,0.1958762886597938,0.5377833056573239,1.0,7/15,23.69%,XCL1;IRAK3;TGFB3;TNF;CUEDC2;TGFB2;TGFB1
prerank,synaptic vesicle exocytosis (GO:0016079),-0.35784216272967867,-1.3017731646865647,0.0963855421686747,0.6305377333287602,1.0,12/40,20.03%,UNC13C;SNAP25;UNC13B;PCLO;SNAPIN;RIMS2;PIP5K1C;RIMS1;SYT7;STX3;BLOC1S6;SNPH
prerank,negative regulation of striated muscle cell differentiation (GO:0051154),0.5548195280993555,1.3012007833736496,0.13994565217391305,0.5401778374726962,1.0,6/18,11.57%,TMEM119;FRS2;HDAC1;HDAC5;XBP1;HDAC3
prerank,positive regulation of muscle hypertrophy (GO:0014742),0.5687720022971674,1.3008718128841354,0.16738197424892703,0.5404305355055888,1.0,8/15,24.17%,PRKCA;SLC9A1;CAMK2D;ROCK2;PDE9A;PARP1;IGF1;AGT
prerank,calcium ion homeostasis (GO:0055074),0.4360967018617966,1.30079340968305,0.0962566844919786,0.5399433240530769,1.0,14/95,8.36%,CCL11;CCL7;EDN3;CXCL12;SLC24A5;CD40;STOML2;ATP2A2;CCR1;CYP27B1;TNNI3;CCL5;ATP2B1;FAM20A
prerank,replicative senescence (GO:0090399),0.5783187278669515,1.3006320763630193,0.16666666666666666,0.5397854934399752,1.0,4/12,12.10%,PLA2R1;ATM;ATR;TERT
prerank,positive regulation of defense response (GO:0031349),0.4359192518779993,1.3005703648038425,0.10075839653304441,0.5392782176847858,1.0,21/89,17.04%,ZBP1;TNIP1;IL16;TLR2;WNT5A;LPL;CCN4;TSLP;POLR3D;MDK;CCL5;PLA2G7;IL33;TLR7;PTGER4;DDT;NFKBIZ;TNF;NPAS2;CX3CL1;TNFRSF1A
prerank,manganese ion transport (GO:0006828),0.5905881387788572,1.2999667090562443,0.1874125874125874,0.5404192191574,1.0,3/14,7.68%,SLC39A14;SLC11A2;TRPC6
prerank,regulation of erythrocyte differentiation (GO:0045646),0.5000293451244644,1.298623923360454,0.14232209737827714,0.5434941532302346,1.0,16/35,21.90%,ZFP36L1;STAT1;MAFB;ARNT;BRD1;STAT3;ACVR1B;CDK6;MAPK11;ACVR2A;HMGB2;SPI1;FOXO3;STAT5B;ETS1;PRKDC
prerank,transition metal ion transport (GO:0000041),0.49372904898628023,1.2983880778260937,0.14444444444444443,0.5434984904787786,1.0,7/35,14.10%,HEPH;CP;SLC11A2;TRPC6;SLC30A9;SLC31A1;ATP2C1
prerank,negative regulation of cilium assembly (GO:1902018),0.6017891820992075,1.2980708880102974,0.18740399385560677,0.543746088617027,1.0,5/12,14.03%,YAP1;CCP110;CDK10;TBC1D7;MAP4
prerank,positive regulation of amyloid-beta formation (GO:1902004),0.5438733943152834,1.2978283196096096,0.167574931880109,0.5437733616320788,1.0,7/18,17.28%,ABCA2;SLC2A13;ABCG1;GSAP;IFNGR1;TNF;ROCK2
prerank,negative regulation of cytokine-mediated signaling pathway (GO:0001960),0.4731778362840131,1.2976644084770514,0.14934289127837516,0.543606952929146,1.0,17/48,22.63%,ADIPOQ;SLIT3;IRAK3;TREM2;PADI2;PPARG;YTHDF3;PYDC1;PELI3;PTPN2;PARP14;ROBO1;NLRP2B;YTHDF2;TRAIP;CARD16;CCDC3
prerank,protein localization to cell periphery (GO:1990778),-0.29074862251459355,-1.297599208646417,0.02040816326530612,0.6393672543897061,1.0,33/133,8.95%,ATP1B3;KCNIP4;CAV1;KCNB2;BSG;CACNB2;TSPAN5;ATP1B1;ACTN2;EFR3B;EZR;CD81;ANK2;EHD4;LIN7A;RAPGEF6;CDH1;RAMP2;TTC7B;GAS6;C2CD5;RDX;ARL3;DPP6;ZFYVE27;INPP5K;PACSIN1;RAMP1;RAPGEF2;RAB3C;LIN7C;WNK3;DPP10
prerank,regulation of intracellular steroid hormone receptor signaling pathway (GO:0033143),0.49294490306765065,1.2974791991849388,0.1475609756097561,0.5434022865596566,1.0,14/33,24.26%,RUNX1;DNAAF4;KLK2;CARM1;CBFB;SAFB2;GPAM;UBA5;CALR;PKN1;DDRGK1;PARK7;RNF14;KDM1A
prerank,positive regulation of fat cell differentiation (GO:0045600),0.4770720536090458,1.2973907318382654,0.13064133016627077,0.5429715267742061,1.0,12/47,10.96%,ZFP36L1;SFRP1;SFRP2;CMKLR1;LPL;FRZB;CARM1;ASXL2;WDFY2;PPARG;VSTM2A;XBP1
prerank,negative regulation of viral release from host cell (GO:1902187),0.6013255409088017,1.2973372571483643,0.18287373004354138,0.542449256197755,1.0,6/13,16.59%,TRIM21;TRIM8;TRIM13;TRIM11;TRIM35;CHMP3
prerank,regulation of neurogenesis (GO:0050767),0.4662800280548626,1.2970084758298073,0.1118800461361015,0.5427643791112202,1.0,16/55,23.27%,CCL11;YAP1;NUMBL;SERPINF1;BHLHE40;PCM1;HEYL;HMGB2;TNF;CX3CL1;SPEN;HOOK3;YTHDF2;NAP1L1;NUMB;SOX11
prerank,positive regulation of focal adhesion assembly (GO:0051894),0.5550552775882724,1.2968034797740675,0.1774193548387097,0.5426413100910006,1.0,8/19,17.11%,MAP4K4;NRP1;SFRP1;RAC1;LIMS1;THY1;ABL1;PTPRJ
prerank,regulation of endothelial cell apoptotic process (GO:2000351),-0.35022157949452676,-1.2967737635286258,0.08333333333333333,0.6382038832889478,1.0,15/39,15.47%,TEK;RAMP2;KDR;GAS6;CDH5;SCG2;KRIT1;THBS1;ITGA4;GATA2;SEMA5A;ECSCR;NDNF;GPER1;PDCD4
prerank,ruffle organization (GO:0031529),0.5580843787123727,1.296699287000584,0.17721518987341772,0.5422700093005594,1.0,7/16,16.55%,AIF1L;LIMA1;CARMIL1;RAC1;AIF1;TPM1;PIP5K1A
prerank,DNA synthesis involved in DNA repair (GO:0000731),-0.34824668175076434,-1.2960386257037932,0.06857142857142857,0.6365989484491179,1.0,24/42,29.95%,PCNA;ZBTB1;UBC;PARP10;POLK;SIRT1;PRIMPOL;FAAP20;RFC3;UBA52;WRN;RFC2;POLD2;RPA2;UBB;SPRTN;PCLAF;POLE;RFC4;RPA3;POLD4;TRIM25;USP43;DTL
prerank,platelet-derived growth factor receptor signaling pathway (GO:0048008),0.5664817767025767,1.2960361145391914,0.18129496402877698,0.5434836913656886,1.0,7/16,17.11%,PDGFRA;NRP1;PDGFRB;PLAT;PTPN1;ABL1;PTPRJ
prerank,positive regulation of cell-substrate adhesion (GO:0010811),0.4440087729468757,1.2956642415274666,0.13088404133180254,0.5439109819616987,1.0,14/67,9.47%,FBLN2;NRP1;SFRP1;JAK2;CARMIL1;MDK;RAC1;LIMS1;CDC42;CD36;DOCK1;RSU1;EPHA1;CDK6
prerank,regulation of mitotic cell cycle phase transition (GO:1901990),0.418959554760876,1.2948295670043313,0.042726347914547304,0.5455433744756946,1.0,36/184,13.74%,PSMA7;ZFP36L1;NEK6;DYNLL1;PPP1R9B;MAD2L1;ALMS1;ZFP36L2;DYNC1H1;ANAPC11;INO80;HAUS3;E2F1;CCP110;TUBG1;CNTRL;CUL1;PLK1;PSMD4;PTPN6;DDB1;PSMD11;FBXO5;CEP41;PCM1;FZR1;SIRT2;DCTN3;CDC27;CDC16;CDC14B;PSMB8;ANAPC2;TPX2;CSNK1D;SKP1
prerank,endoplasmic reticulum to Golgi vesicle-mediated transport (GO:0006888),0.416311978539576,1.2947639481392044,0.06408952187182096,0.5450606889726568,1.0,63/173,22.73%,COL7A1;SEC16B;DYNLL1;SEC31A;SEC24D;KDELR3;COPZ2;SEC23A;COPA;PROS1;DYNC1H1;MIA3;LMAN2L;ARFGAP3;ARCN1;STX17;DCTN4;TRIP11;SEC16A;ERGIC2;ATL2;SEC24A;RAB2A;SPTBN5;GOSR1;COPB2;COG4;COPG1;ERGIC1;YIF1A;COPZ1;DCTN3;LMAN1;WHAMM;TBC1D20;ARFGAP1;SCFD1;CAPZA1;ANK1;KLHL12;TRAPPC4;SPTBN1;VAPA;KDELR2;USO1;PEF1;TMED1;CTSC;F8;SPTBN4;COG7;ACTR1A;BGLAP;GBF1;TMED10;TRAPPC8;TMED7;VTI1B;ARF4;CNIH4;RAB1A;CTSZ;TEX261
prerank,negative regulation of T cell differentiation (GO:0045581),0.6141991830284244,1.2946764304164606,0.1762917933130699,0.5446263053555112,1.0,3/10,6.13%,GLI3;IRF1;MDK
prerank,"G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger (GO:0007187)",0.4585847234936727,1.2945756497271304,0.16159250585480095,0.5442629341305947,1.0,13/53,20.22%,MC5R;HTR1D;ANXA1;CCR1;HRH4;HRH1;CCL2;LPAR3;MC1R;HRH3;CALCRL;NPY;MC2R
prerank,negative regulation of mitotic cell cycle (GO:0045930),0.4756352485354548,1.2944529878626627,0.13716295427901523,0.5439715826788231,1.0,14/45,17.29%,ZFP36L1;BCL6;MAD2L1;ZFP36L2;PTPN3;GAS1;FZD3;TOM1L1;BTG1;TRIM35;SMAD3;CHFR;HECA;WEE1
prerank,relaxation of cardiac muscle (GO:0055119),-0.49188742123541807,-1.2937137557006075,0.14878892733564014,0.6398860016329319,1.0,8/13,22.47%,ATP1B1;ATP1A2;KCNJ2;GSN;ATP1A1;CHGA;PIK3CA;PLN
prerank,negative regulation of potassium ion transmembrane transport (GO:1901380),-0.5009251115416419,-1.293634851543815,0.18571428571428572,0.6364639613947394,1.0,2/11,1.25%,CAV1;ACTN2
prerank,lamellipodium assembly (GO:0030032),-0.39167510253199445,-1.2933372962433933,0.13793103448275862,0.6337004980946012,1.0,11/26,17.42%,ABLIM1;KIT;ABLIM3;S1PR1;CDH13;PTPRO;PARVB;CCDC88A;VCL;SPATA13;ARHGEF6
prerank,regulation of neurotransmitter receptor activity (GO:0099601),-0.3290236953672011,-1.2933329807566263,0.06206896551724138,0.630079228880169,1.0,20/57,21.95%,ACTN2;LRRC7;DLGAP1;SHISA6;DLGAP2;CACNG2;DLG2;MEF2C;RELN;LYNX1;NLGN1;GRIN2B;SHISA7;CACNG8;PRRT1;GRIA2;CACNG7;OPRM1;SHANK1;MINK1
prerank,positive regulation of peptidyl-threonine phosphorylation (GO:0010800),0.5319706344412225,1.2930687752201868,0.15866666666666668,0.5471452260393389,1.0,7/23,9.97%,CEMIP;S1PR2;TNKS1BP1;EGF;PLK1;RPTOR;CALM3
prerank,positive regulation of biosynthetic process (GO:0009891),0.4758987695419957,1.292976531484734,0.1539408866995074,0.5467522246604277,1.0,7/40,9.37%,RUNX1;CREB3L1;APOE;CD36;CCL5;ZBTB20;TGFB3
prerank,negative regulation of protein-containing complex assembly (GO:0031333),0.4653841626357935,1.2926089923642732,0.11750599520383694,0.5471611773659479,1.0,20/49,22.73%,PMEPA1;IAPP;TREM2;AIDA;CDC42;PTGER4;PYDC1;LDLRAD4;GSK3B;ANKRD27;NLRP2B;LCMT1;PEX5;JAM3;DDX3X;SRC;DACT1;PARK7;HSPA5;CPTP
prerank,positive regulation of amyloid precursor protein catabolic process (GO:1902993),0.5251307983424495,1.2925445551774826,0.17989417989417988,0.5466579036173156,1.0,8/22,17.28%,ABCA2;SLC2A13;ABCG1;GSAP;RANBP9;IFNGR1;TNF;ROCK2
prerank,retinoic acid receptor signaling pathway (GO:0048384),0.6198905182768847,1.2922314507788837,0.19448698315467075,0.5468703156797147,1.0,3/10,8.94%,RARB;RXRG;PPARG
prerank,maturation of 5.8S rRNA (GO:0000460),0.5626384340288371,1.2920827390077083,0.17103448275862068,0.5466409493957956,1.0,6/17,12.49%,C1D;MAK16;PES1;MTREX;EXOSC4;MPHOSPH6
prerank,genitalia development (GO:0048806),0.5959488277046421,1.2920211811286306,0.19076005961251863,0.5461351205821486,1.0,5/12,17.24%,CHD7;WNT5A;SHH;STRA6;TBX3
prerank,serine family amino acid biosynthetic process (GO:0009070),-0.5038680706762468,-1.2917038634198539,0.1867816091954023,0.6310554800826399,1.0,7/12,33.34%,SEPHS1;CBS;SERINC3;SEPHS2;CTH;GGT1;PHGDH
prerank,positive regulation of tyrosine phosphorylation of STAT protein (GO:0042531),0.46307934851894716,1.2916988080726677,0.15625,0.5463511658754956,1.0,7/49,7.35%,IL23R;GHR;JAK2;CD40;TSLP;STAT3;CCL5
prerank,negative regulation of signaling receptor activity (GO:2000272),0.5157066061188199,1.2911447187364942,0.17523056653491437,0.5472349431180323,1.0,9/25,18.60%,CBLB;ERRFI1;CBL;PPARG;SNX6;EPHB2;TNF;SOCS5;ZGPAT
prerank,negative regulation of cellular component organization (GO:0051129),0.4390615544740816,1.2906681542900664,0.11648351648351649,0.5479371602415551,1.0,11/74,8.29%,FAP;NR1H4;IAPP;CARMIL2;DNAJB1;IRAK3;CARMIL1;AIDA;CDC42;SNX33;DNAJB6
prerank,regulation of cell migration (GO:0030334),0.4048276576913479,1.2903128041574659,0.01,0.5483294137194349,1.0,78/382,13.60%,ROR2;CCL11;CYP1B1;DLC1;COL1A1;CEMIP;SULF1;CCL7;ADIPOQ;MGAT5;PDGFRA;MMP14;LAMB1;CXCL12;SNAI1;MAP4K4;FGF20;CARMIL2;PRKCA;SERPINE2;SFRP1;CCAR1;SFRP2;PDGFRB;MITF;DPYSL3;SNAI2;RHOD;FGF7;JAG1;NAV3;RAP2A;EGF;IGFBP5;AMOTL1;ANXA1;MIA3;FGF9;PLXNC1;PTEN;CARMIL1;CCR1;NF2;SHH;MDK;RAC1;SRGAP1;ATM;AIF1;STAT3;EGFR;CCL5;KIF2A;NF1;TGFBR1;PLXND1;EPHA1;ACVR1;SEMA3E;SPRY2;YTHDF3;XBP1;GCNT2;SASH1;IGSF10;PLXNA3;MGAT3;FGF2;GPNMB;MYLK;PPP3CA;EPHB2;CD151;PDPN;PTK2;THY1;TPM1;DLG5
prerank,epiboly involved in wound healing (GO:0090505),0.5560684786900207,1.2899524153007422,0.1871345029239766,0.5487257201565396,1.0,9/16,17.36%,MRTFA;CARMIL2;LCP1;DDR1;CD151;PDPN;ARHGAP35;PDCD10;RHOA
prerank,negative regulation of response to DNA damage stimulus (GO:2001021),0.5084986131061466,1.28928806326347,0.1475826972010178,0.5499023322056581,1.0,9/30,16.85%,CXCL12;SNAI1;SFRP2;SNAI2;CDKN2D;FBXO5;CCAR2;MDM2;TMEM161A
prerank,nucleotide catabolic process (GO:0009166),-0.45274899388799794,-1.2891920276505227,0.1568627450980392,0.634807302091003,1.0,6/16,15.05%,NT5E;SAMHD1;ITPA;DERA;NT5C2;NT5C
prerank,protein localization to endoplasmic reticulum (GO:0070972),0.5679457485202268,1.289178560848778,0.1638418079096045,0.549536675520529,1.0,4/16,6.03%,SEC16B;LRRK2;MIA3;SEC16A
prerank,positive regulation of oxidoreductase activity (GO:0051353),0.5613176792014996,1.2891045232186846,0.18405797101449275,0.5490721440961893,1.0,10/18,24.17%,EDN3;POR;FXN;TNF;ABL1;GDNF;ATP7A;PARK7;SIRT3;AGT
prerank,intrinsic apoptotic signaling pathway by p53 class mediator (GO:0072332),-0.36789621159138997,-1.2890178215009527,0.1346153846153846,0.6316377293281175,1.0,12/32,18.01%,FHIT;HIPK1;PPP1R13B;MSH2;EP300;DDX5;DDIT4;MYBBP1A;DYRK2;TP53;SIRT1;TMEM109
prerank,positive regulation of apoptotic process (GO:0043065),0.41147995004938864,1.288998871141985,0.027190332326283987,0.5487494768472905,1.0,66/293,17.13%,FAP;CYP1B1;EPHA7;DLC1;ZBP1;ADIPOQ;KNG1;IAPP;BCL6;VAV2;SFRP4;SFRP1;CCAR1;SFRP2;VAV3;AIFM2;EEF1E1;FGD4;CTSD;FRZB;PPID;KALRN;E2F1;ATM;ITSN1;RASSF2;NF1;PHLDA1;TRIO;TNFRSF12A;CALHM2;BAX;TGFBR1;OMA1;SQSTM1;OLFM1;TGFB3;BIN1;AKAP13;PLEKHN1;PREX1;SLC27A4;FZD9;SIRT2;RRP1B;CLIP3;ARHGEF19;PAWR;CCAR2;BTG1;TRIM35;HSPD1;UBE2Z;FLCN;SAP18;CASP8;ARHGEF12;KCNMA1;TNF;ABL1;PSEN1;TLE5;VAV1;FAM162A;PLEKHG2;NLRP2B
prerank,limb morphogenesis (GO:0035108),0.5406021678461264,1.2885775890719868,0.17162162162162162,0.5492623057750191,1.0,10/20,22.93%,GLI3;SHH;NIPBL;PCSK5;LRP6;PTCH1;IQCE;TBX3;TGFB2;MEGF8
prerank,actin filament-based transport (GO:0099515),0.5315985939747078,1.2884959545806027,0.16920943134535368,0.5488606683143621,1.0,7/21,10.27%,MYO1B;MYO1A;MYO5A;MYO19;MYO1H;MYO1D;MYO7A
prerank,regulation of vasculogenesis (GO:2001212),-0.4720969920130682,-1.28833221677337,0.15358361774744028,0.6301064250321554,1.0,8/14,23.00%,CD34;KDR;RAPGEF2;HEY2;RAP1A;TMEM100;HEY1;CEACAM1
prerank,error-free translesion synthesis (GO:0070987),-0.4168068478178209,-1.2882753534807394,0.11693548387096774,0.6267672656356118,1.0,13/22,27.10%,RCHY1;PCNA;UBC;RFC3;UBA52;RFC2;RPA2;UBB;SPRTN;NPLOC4;UFD1;RFC4;RPA3
prerank,regulation of insulin secretion (GO:0050796),0.42227583937432317,1.2882023522026484,0.10184182015167931,0.5490531926807793,1.0,19/101,10.58%,NR1H4;CACNA1A;TCF7L2;PRKCA;SFRP1;ITPR1;RAPGEF4;IRS1;BLK;CACNA1C;CACNA2D2;KCNG2;CCL5;KCNA5;INHBB;ACSL4;LRRC8A;EIPR1;EFNA5
prerank,negative regulation of extracellular matrix organization (GO:1903054),0.6217485310279294,1.2880651309671054,0.18789808917197454,0.5488015132946745,1.0,1/10,0.08%,FAP
prerank,negative regulation of potassium ion transport (GO:0043267),-0.4746935716495275,-1.2876545876247025,0.1853035143769968,0.6250400569778903,1.0,2/13,1.25%,CAV1;ACTN2
prerank,cholesterol biosynthetic process (GO:0006695),-0.3615915280254183,-1.2872475497626323,0.13705583756345177,0.6227203899374344,1.0,13/31,23.17%,LBR;ACAT2;ACLY;SQLE;DHCR24;IDI1;FDFT1;HSD17B7;FDPS;NSDHL;EBP;HMGCS1;TM7SF2
prerank,positive regulation of type I interferon production (GO:0032481),0.4439632152554676,1.2863649268128554,0.13414634146341464,0.5529329891140066,1.0,28/73,23.63%,ZBP1;TLR2;IRF7;STAT1;IRF1;POLR3D;NFKB2;CREBBP;TRIM56;TLR7;NFKB1;CD14;POLR2K;STAT6;HSPD1;DHX58;GAPDH;CRCP;POLR3K;TLR3;POLR3A;POLR3E;DDX3X;CGAS;PRKDC;SETD2;POLR2L;IRF3
prerank,phosphatidylcholine catabolic process (GO:0034638),0.6071136620165924,1.2861717765551937,0.1870967741935484,0.5527749416453058,1.0,3/10,8.20%,LIPC;PLA2G5;PLA2G7
prerank,regulation of proteolysis (GO:0030162),0.4618497358429332,1.2860723303333803,0.1528436018957346,0.5523776754879227,1.0,18/48,19.56%,KNG1;SERPINE2;DNAJC1;PLAT;CLN6;OGT;SHH;GSAP;PLK1;BAG6;SPOP;FBXW11;CASP8;STUB1;ITCH;CLN3;CDK5;AURKAIP1
prerank,positive regulation of proteolysis (GO:0045862),0.4662942273388665,1.2857315095688213,0.13646788990825687,0.5526795561648139,1.0,18/55,19.56%,CCBE1;NKD2;TNIP1;APOE;CLN6;OGT;RCN3;SNX33;PLK1;TANK;FBXW11;CASP8;STUB1;TNF;SNX9;CTSC;CTSH;AURKAIP1
prerank,thymus development (GO:0048538),0.5823349541086263,1.2855126932517156,0.18513323983169705,0.5526381949960012,1.0,4/13,9.62%,EPHB3;SHH;TGFBR1;FOXE1
prerank,regulation of vascular endothelial growth factor signaling pathway (GO:1900746),0.5375553541577947,1.2851757255975034,0.181169757489301,0.5529144308188286,1.0,4/19,10.32%,DCN;CCBE1;CD63;SPRY2
prerank,innate immune response (GO:0045087),0.4137068133420972,1.2849539763829936,0.043522267206477734,0.5528556800608643,1.0,37/217,14.50%,C3;IL23R;TRIML2;LBP;COLEC12;MASP1;CRP;TLR2;IRF7;CD40;RNASE7;ALPK1;REL;SHFL;TREM2;BLK;MFAP4;CYP27B1;TRIM21;CXCL10;TRIM8;PPARG;TRIM56;TIFA;STYK1;FRK;TRIM13;TRIM11;PJA2;PYDC1;CAPZA1;TRIM62;PTK2;TRIM35;RELB;DHX58;ANKHD1
prerank,glucose metabolic process (GO:0006006),0.45608831545467976,1.2842389172140884,0.13937282229965156,0.5542960660203947,1.0,19/58,25.94%,SLC39A14;ADIPOQ;APOD;AKR1A1;OMA1;ENO1;ADPGK;G6PC3;GAPDH;GAA;ENO2;SLC25A10;PGAM1;SORD;LRP5;DCXR;PGM1;MDH2;ATF4
prerank,ERBB2 signaling pathway (GO:0038128),0.5005570114463859,1.284198477369564,0.1556420233463035,0.5537661688567331,1.0,10/31,17.19%,PRKCA;EGF;EGFR;PIK3R1;ERBIN;PTPN18;GRB2;STUB1;CDC37;BTC
prerank,negative regulation of interleukin-12 production (GO:0032695),0.5680371995839346,1.2837812148711538,0.18694362017804153,0.5542920501508334,1.0,2/14,4.25%,CMKLR1;IRAK3
prerank,regulation of hormone secretion (GO:0046883),0.5706690893560769,1.2836301148068594,0.19236209335219237,0.554026427068626,1.0,3/15,12.23%,EDN3;ANXA1;SNX6
prerank,regulation of nervous system process (GO:0031644),-0.4405401762638584,-1.2832779958813199,0.18085106382978725,0.6308098333111555,1.0,5/18,6.09%,NOS3;DLGAP1;DLGAP2;SLC8A3;HTR2C
prerank,positive regulation of pattern recognition receptor signaling pathway (GO:0062208),0.5704472239434554,1.2831604874530393,0.15142857142857144,0.5546875996632499,1.0,5/14,18.60%,TLR2;PUM1;OASL;DHX58;TLR3
prerank,renal system development (GO:0072001),0.4657511020705008,1.2830224759383884,0.14419695193434937,0.5544209169525504,1.0,13/52,14.16%,SULF1;GLI2;TBX18;STAT1;ITGA8;GREB1L;TGFBR1;IFT88;SALL1;BAG6;PCSK5;NPHP3;STRA6
prerank,positive regulation of neuron apoptotic process (GO:0043525),0.5233723725758281,1.2821823905613976,0.18181818181818182,0.5561405549453665,1.0,12/24,27.29%,EPHA7;NF1;BAX;FBXW7;TNF;FOXO3;CDK5;TGFB2;DDIT3;NUPR1;ATF4;PRNP
prerank,negative regulation of centrosome duplication (GO:0010826),-0.49257436121156073,-1.281572622301314,0.20527859237536658,0.6319164466939547,1.0,6/11,27.42%,TRIM37;KAT2B;KAT2A;CCNF;BRCA1;CDK5RAP2
prerank,COPII vesicle coating (GO:0048208),0.45695008773495976,1.2812541218729887,0.13942857142857143,0.5567882177618048,1.0,22/61,22.49%,COL7A1;SEC16B;SEC31A;SEC24D;SEC23A;SEC16A;TRAPPC10;SEC24A;LMAN1;TBC1D20;SCFD1;CSNK1D;KLHL12;TRAPPC4;USO1;PEF1;CTSC;F8;TMED10;SEC23IP;RAB1A;CTSZ
prerank,"vesicle targeting, rough ER to cis-Golgi (GO:0048207)",0.45695008773495976,1.2812541218729887,0.13942857142857143,0.5567882177618048,1.0,22/61,22.49%,COL7A1;SEC16B;SEC31A;SEC24D;SEC23A;SEC16A;TRAPPC10;SEC24A;LMAN1;TBC1D20;SCFD1;CSNK1D;KLHL12;TRAPPC4;USO1;PEF1;CTSC;F8;TMED10;SEC23IP;RAB1A;CTSZ
prerank,vesicle coating (GO:0006901),0.45695008773495976,1.2812541218729887,0.13942857142857143,0.5567882177618048,1.0,22/61,22.49%,COL7A1;SEC16B;SEC31A;SEC24D;SEC23A;SEC16A;TRAPPC10;SEC24A;LMAN1;TBC1D20;SCFD1;CSNK1D;KLHL12;TRAPPC4;USO1;PEF1;CTSC;F8;TMED10;SEC23IP;RAB1A;CTSZ
prerank,"retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum (GO:0006890)",0.43252022482201596,1.2804655563797729,0.1281767955801105,0.558438730947135,1.0,35/80,24.41%,KDELR3;COPZ2;COPA;ARFGAP3;ARCN1;ERGIC2;KIF2A;KIF1C;COPB2;COG4;COPG1;ERGIC1;COPZ1;ARFGAP1;SCFD1;KDELR2;RINT1;PICK1;KIF3C;KIF3A;KIFAP3;PLPP3;KIF5A;COG7;PITPNB;GBF1;BNIP1;TMED10;TMED7;ARF4;RAB1A;HTT;RAB6A;ERGIC3;COG3
prerank,heart development (GO:0007507),0.417695668153735,1.2803655959225997,0.07636738906088751,0.5580762096321067,1.0,34/150,14.92%,SCUBE1;DLC1;COL3A1;SH3PXD2B;GLI2;FLRT2;CHD7;DNAAF4;ZFPM2;FBN1;APLN;PKD2;CACNA1C;PTEN;TBX2;SHH;DVL2;PDLIM7;TNNI3;BMP5;NIPBL;NF1;TGFBR1;ACVR1;AKAP13;SALL1;PDLIM2;PCSK5;PDLIM4;PTK2;CACYBP;STRA6;CASP8;NTRK3
prerank,cellular glucan metabolic process (GO:0006073),-0.5082094524909078,-1.2798546837872018,0.1875,0.6334854426948655,1.0,5/11,16.01%,PRKAG2;PYGM;PPP1R3C;GBE1;UGP2
prerank,regulation of neutrophil chemotaxis (GO:0090022),0.5209347163784347,1.279833996197364,0.1810810810810811,0.558932170433065,1.0,6/23,10.90%,THBS4;XCL1;TIRAP;MDK;RAC1;MOSPD2
prerank,"negative regulation of transcription, DNA-templated (GO:0045892)",0.3983814816993877,1.279547928670404,0.003,0.5590788877659526,1.0,175/807,16.65%,RUNX1;NR1H4;RUNX2;ZEB2;TRPS1;ADIPOQ;CREB3L1;RUNX3;POU5F1;ZEB1;MDFIC;BCL3;GLI2;ETV6;TCF7L2;SNAI1;NCOR2;DAP;YAP1;SBNO2;ATXN1;CBX8;DEAF1;BCL6;NKX6-1;NRIP1;MEIS2;GLI3;BACH1;MIER2;NR2F2;RCOR1;SFRP1;ERN2;SFRP2;IRF7;WNT5A;NFIX;SUFU;GLIS1;STAT1;MITF;ZFPM2;PHC2;FHL2;RARB;USP9X;SNAI2;XCL1;SMAD2;GATA6;SFMBT1;CRYM;DUSP26;DNAJB1;ATP8B1;IRF1;ARID5B;POU2F1;KHDRBS1;TLE1;MLIP;RUNX1T1;KMT5A;SMURF2;EHMT1;ZHX2;ILF3;TBX2;SHH;YAF2;ZBTB5;SCMH1;ZBTB38;PPID;CGGBP1;LIMS1;E2F1;ARID5A;ZNF25;RNF2;HEXIM1;PRDM2;STAT3;HDAC1;MTA2;NIPBL;TSHZ3;CREBBP;TAF7;PLK1;PRDM5;CBFB;NONO;IL33;FOXM1;FOXK2;PPARG;E2F8;BHLHE40;NR1D2;DKK3;MXI1;ENO1;FOXE1;MDFI;MBD2;ETV5;NFKB1;AHR;FRK;MBD1;HDAC5;SIRT2;PHF21A;SALL1;CHD8;FOXP4;NOC2L;PRICKLE1;HDAC3;TSC22D4;NR2F1;LOXL3;DICER1;RBFOX2;FNIP1;GLIS3;SNX6;HEYL;GATAD2B;CCAR2;ZMYND15;RBPJ;PRDM1;HIVEP1;CTCF;FBXW11;BAHD1;LCOR;TCF3;SMAD3;CLOCK;TGIF2;COMMD7;SDCBP;NSD1;PHF12;TBL1X;PRDX5;HMGB2;RIF1;FLCN;SAP18;CXXC5;USP47;ELK4;NR2C2;RSF1;YY1;CIART;MDM2;TNFRSF4;TNF;TAF9B;EZH2;SP100;TIMELESS;KDM2A;PSEN1;TLE5;DNMT3B;ZNF692;KLF10;EID1
prerank,"positive regulation of transcription, DNA-templated (GO:0045893)",0.39878987315173453,1.2792123078517696,0.0,0.5593979378873039,1.0,246/1082,17.65%,RORA;RUNX1;NR1H4;RUNX2;DCN;COL1A1;ZEB2;KMT2A;WNT2;RUNX3;POU5F1;CXXC1;SPP1;MDFIC;BCL3;GLI2;PLAC8;TCF7L2;TCF4;SNAI1;YAP1;SBNO2;MRTFA;DEAF1;TNIP1;ZMIZ1;NKX6-1;NRIP1;MEIS2;GLI3;TNFSF11;ASXL1;SLC9A1;USF1;PSRC1;CREB3L3;NR2F2;SFRP1;AUTS2;SATB2;SFRP2;ZBTB48;TLR2;IRF7;WNT5A;NFIX;DDX17;GLIS1;STAT1;MITF;CD40;ZFPM2;RARB;MLXIP;SMAD2;APOE;GATA6;FGF7;MAFB;NPAS4;REL;JAG1;RXRG;EGF;ACTR2;IRF1;CDKN2B;ARNT;LAGE3;HOXB3;PRKD2;PKD2;LITAF;POU2F1;METTL23;OGT;PID1;MLIP;ZNF496;UBP1;INO80;ILF3;SMARCC1;SHH;DVL2;YAF2;SERTAD2;ZBTB38;PADI2;MEIS1;TGFB1I1;E2F1;KMT2B;MMP12;ATM;NFKB2;ARID1B;BRPF1;TEAD1;SNX5;RNF111;PPRC1;MYBL1;MED13;EIF2AK3;PRDM2;MAML3;STAT3;EGFR;HDAC1;ELF4;BMP5;PIK3R1;CRTC3;CREBBP;HSF2;TAF7;MACC1;NCK2;ASF1A;CREB3L2;ASXL2;SMARCD3;MED12;TGFBR1;NCK1;CXCL10;FZD1;IL33;FOXM1;ACVR1;SQSTM1;FOXK2;PPARG;E2F3;E2F8;TRIM56;ZBED3;NSD3;TGFB3;RPTOR;BRD4;NR1D2;MAP2K1;CDK9;FOXE1;MYRF;MED14;SLC30A9;ETV5;TCF12;BCL11B;NFKB1;FOXJ3;AHR;CDK7;HDAC5;SIRT2;SALL1;HOXA1;CHD8;XBP1;ATRX;CAMTA2;CRTC1;MAML2;ACVR2A;WWTR1;MMS19;CALCOCO1;TFDP1;CREB3L4;CREB3;SETX;HDAC3;NR2F1;RRP1B;ZIC1;FGF2;GLIS3;HEYL;PPP3CA;RBPJ;HTATIP2;NEK4;USP22;SMAD5;HIVEP1;CCNT1;CTCF;FBXW11;TCF3;STAT6;SMAD3;CLOCK;LRP6;ITGB1BP1;JUNB;GLYR1;NSD1;TBL1X;HMGB2;PTPRN;RTRAF;FLCN;GTF2H1;ELK4;THRAP3;NR2C2;RSF1;YY1;SP7;MYSM1;TCEA1;GABPB1;TNF;NPAS2;TADA3;ABL1;PELP1;CX3CL1;AKAP8L;ECD;MC1R;NKX2-8;HMGN1;SP100;TET2;MED21;PSEN1;KLF10;RGMB;GDNF;ATF2;CCNC;MPND;TCERG1;TNFRSF1A;RPS6KA3;TBX3;HOXB2;NIF3L1;NFE2L2;SPI1;KMT2D;EGR2
prerank,regulation of cell cycle phase transition (GO:1901987),0.4332636590210417,1.2789360112766794,0.11135135135135135,0.5595365295284854,1.0,28/91,21.00%,PSMA7;MAD2L1;ANAPC11;CUL1;PLK1;PSMD4;DDB1;PSMD11;FBXO5;FZR1;CDC27;CDC16;PSMB8;ANAPC2;DBF4;SKP1;FBXW7;PSMA6;UBE2E1;PSMD14;TCIM;UBE2S;PSMC6;PSMB10;PSMD12;PSMB1;PSMA8;PSMF1
prerank,T cell homeostasis (GO:0043029),-0.5101474604514176,-1.2785299894630986,0.18285714285714286,0.6338408345812757,1.0,7/10,34.29%,PPP2R3C;NCKAP1L;ZC3H8;FAS;JAK3;FADD;PMAIP1
prerank,chromatin organization involved in regulation of transcription (GO:0034401),0.5905585153153263,1.2784059572661588,0.21925925925925926,0.5603711166880481,1.0,4/13,6.44%,ZMIZ1;SERTAD2;PADI2;ARID1B
prerank,sensory perception of sound (GO:0007605),0.42958253071252,1.2781702919161193,0.1079607415485278,0.5604095771887619,1.0,16/88,14.08%,ROR1;COL1A1;CEMIP;MYO1A;COL11A2;SNAI2;COL11A1;CRYM;NIPBL;MYO7A;ALDH7A1;HOXA1;ADGRV1;TPRN;TSPEAR;TBL1X
prerank,muscle contraction (GO:0006936),-0.28514349863219135,-1.2779283047981387,0.06976744186046512,0.6321167976542699,1.0,21/126,11.30%,SORBS1;DMD;ACTN2;SORBS3;MYL6;SNTB1;SNTA1;MYOF;DYSF;TMOD3;ADRA1A;CALM1;MYL9;DTNA;MYOM1;ARHGEF11;CRYAB;LMOD1;KCNJ12;ACTA2;TPM2
prerank,negative regulation of cellular macromolecule biosynthetic process (GO:2000113),0.3993721484640677,1.2777664432358682,0.002,0.560901061945604,1.0,107/497,15.25%,RUNX2;ENPP1;IGF2BP1;ADIPOQ;CREB3L1;ZEB1;MDFIC;BCL3;IGF2BP2;TCF7L2;NCOR2;DAP;SBNO2;ATXN1;DEAF1;BCL6;GLI3;NR2F2;RCOR1;SFRP1;ERN2;SYNCRIP;SFRP2;WNT5A;ZFPM2;PHC2;XCL1;SMAD2;GATA6;SFMBT1;ATP8B1;IGFBP5;IRF1;ARID5B;POU2F1;KHDRBS1;TLE1;RUNX1T1;KMT5A;SMURF2;EHMT1;ZHX2;ILF3;TBX2;YAF2;SCMH1;ZBTB38;LIMS1;E2F1;ARID5A;EIF2AK3;HEXIM1;ATR;HDAC1;NIPBL;TSHZ3;TAF7;SAMD4A;PRDM5;NONO;FOXM1;FOXK2;PPARG;PAIP2;BHLHE40;NR1D2;DKK3;ENO1;FOXE1;MBD2;AHR;MBD1;HDAC5;SIRT2;SALL1;CHD8;PRICKLE1;HDAC3;TSC22D4;EIF2AK2;LOXL3;RBFOX2;FMR1;SNX6;HEYL;GIGYF2;CCAR2;ZMYND15;RBPJ;CTCF;SELENOS;FBXW11;BAHD1;CAPRIN1;CLOCK;COMMD7;PHF12;HMGB2;PDS5A;SAP18;USP47;GSK3B;RSF1;GAPDH;CIART;MDM2;TNFRSF4
prerank,negative regulation of interleukin-2 production (GO:0032703),0.5537319324728918,1.2777086461335294,0.1839080459770115,0.5604069966895259,1.0,4/18,4.00%,VSIG4;TNFAIP3;XCL1;NAV3
prerank,histone lysine methylation (GO:0034968),0.49168276257519716,1.2774818850652965,0.16990291262135923,0.5603901227035347,1.0,11/33,20.99%,KMT2A;CXXC1;KMT2B;RBBP5;PRDM5;SETDB1;SETMAR;EZH2;KMT2D;SETDB2;WDR5B
prerank,mitochondrial respiratory chain complex assembly (GO:0033108),-0.3020550885287984,-1.2774561265217352,0.043478260869565216,0.6301609562442129,1.0,40/87,27.26%,IMMP2L;NDUFAF5;NDUFS1;NDUFAF2;ECSIT;NDUFV2;COX16;NDUFA13;COX18;PET100;UQCC1;NDUFA8;NUBPL;NDUFA11;NDUFC2;NDUFB7;COX14;SAMM50;SDHAF2;NDUFA1;FOXRED1;TIMM21;TMEM126B;SDHAF4;NDUFAF6;SCO1;NDUFB11;UQCRFS1;LYRM7;COA3;CHCHD4;NDUFV1;UQCC3;NDUFA10;TIMMDC1;NDUFA3;NDUFAF8;NDUFC1;NDUFA12;NDUFS3
prerank,UDP-N-acetylglucosamine metabolic process (GO:0006047),0.5839768662433391,1.2774291546766943,0.20950965824665677,0.5599025913569358,1.0,7/13,27.91%,B4GALNT2;GFPT2;UAP1L1;AMDHD2;UAP1;GNPDA2;RENBP
prerank,heme catabolic process (GO:0042167),-0.4650272862648062,-1.2772587791714967,0.18012422360248448,0.6240544372157615,1.0,1/14,0.21%,ABCG2
prerank,porphyrin-containing compound catabolic process (GO:0006787),-0.4650272862648062,-1.2772587791714967,0.18012422360248448,0.6240544372157615,1.0,1/14,0.21%,ABCG2
prerank,gonad development (GO:0008406),0.47003192585676323,1.277208159903786,0.15066828675577157,0.5599054833673399,1.0,6/41,4.94%,FSHR;NR2F2;WNT5A;GATA6;WNT2B;FGF9
prerank,regulation of double-strand break repair (GO:2000779),0.47956739608895305,1.2771522726764206,0.15053763440860216,0.5594292047896797,1.0,19/39,24.26%,SPIRE2;ACTR2;UBR5;MGMT;SPIRE1;FOXM1;SLF2;DDX11;RNF169;PPP4C;TIMELESS;PPP4R2;SIRT7;TERF2IP;WRAP53;SETD2;TRIP12;TWIST1;KDM1A
prerank,negative regulation of ion transmembrane transporter activity (GO:0032413),-0.42292359752222375,-1.2770420559086393,0.12177121771217712,0.6213856706012647,1.0,10/20,22.47%,ACTN2;GOPC;HECW1;PRKCE;ADRA2A;OSR1;NEDD4L;TCAF2;CASQ2;PLN
prerank,cellular response to insulin stimulus (GO:0032869),0.41788813042217726,1.2769811440716243,0.07966457023060797,0.5592750916476104,1.0,40/124,19.66%,SLC39A14;ENPP1;ADIPOQ;ZFP36L1;CPEB1;USF1;BAIAP2;IRS1;INSIG2;MYO5A;DENND4C;AP3S1;RAB8B;PIK3R1;PPARG;INHBB;RAB10;SLC27A4;HDAC5;XBP1;SH2B2;RPS6KB1;GRB2;ATP6V1G1;SELENOS;ATP6V1D;GSK3B;PTPN2;ATP6V1F;TCIRG1;GCK;RAB8A;EPRS1;RAB12;ATP6V0A2;ATP6V1H;TRIB3;ATP6V1G2;RAB31;PARP1
prerank,ephrin receptor signaling pathway (GO:0048013),0.4359773623340527,1.276728095430715,0.11014176663031625,0.5593931469001765,1.0,24/82,17.36%,EPHA7;MMP2;VAV2;VAV3;EFNA4;ACTR2;EPHB3;KALRN;RAC1;ITSN1;ANKS1B;CDC42;NCK2;DNM1;EPHA1;SDC2;EFNA5;EPHB2;PTK2;SDCBP;PSEN1;YES1;ROCK2;RHOA
prerank,positive regulation of vascular endothelial cell proliferation (GO:1905564),0.5808227376718607,1.2764009129189435,0.2020497803806735,0.5596978813621216,1.0,5/13,12.01%,APLN;FGFR1;MDK;AKT3;FGF2
prerank,regulation of RIG-I signaling pathway (GO:0039535),0.5363077246666095,1.2744164197722831,0.1910569105691057,0.56479639601468,1.0,5/18,14.35%,BIRC3;SEC14L1;PUM1;OASL;DHX58
prerank,transforming growth factor beta receptor signaling pathway (GO:0007179),0.43081413541866054,1.2743803758268535,0.11739130434782609,0.5642423769813956,1.0,16/87,13.71%,COL1A2;LTBP2;COL3A1;ZMIZ1;ITGB5;USP9X;SMAD2;CBL;TGFBR1;ACVR1;TGFB3;GCNT2;SMAD5;PTK2;SMURF1;SMAD3
prerank,regulation of type I interferon production (GO:0032479),0.4366844490207193,1.2742053879452897,0.12238147739801543,0.5640847931211443,1.0,22/84,17.44%,ZBP1;DTX4;TNFAIP3;IRF7;IRF1;TIRAP;POLR3D;NFKB2;IKBKE;CREBBP;TRIM21;ILRUN;TRIM56;NFKB1;CD14;POLR2K;STAT6;DHX58;GAPDH;CRCP;POLR3K;ITCH
prerank,positive regulation of histone methylation (GO:0031062),0.5268792670924708,1.273522771743042,0.18396846254927726,0.5653665225065623,1.0,4/24,6.71%,KMT2A;AUTS2;OGT;PHF1
prerank,positive regulation of tissue remodeling (GO:0034105),-0.513401691710504,-1.2730606214469735,0.216,0.6295720830773858,1.0,2/10,6.08%,IL15;IL18
prerank,negative regulation of blood pressure (GO:0045776),0.578756020196161,1.273049930727661,0.1964549483013294,0.5660959597345908,1.0,2/13,4.04%,ADIPOQ;APLN
prerank,negative regulation of autophagy (GO:0010507),0.45044618639717626,1.2722807320815375,0.15227272727272728,0.5675498232641389,1.0,11/54,10.71%,DAP;EIF4G2;EIF4G3;IL10RA;LRRK2;BCL2;KLHL22;TREM2;STAT3;FOXK2;SIRT2
prerank,negative regulation of transcription by RNA polymerase II (GO:0000122),0.3976890833999542,1.2714562569765173,0.004,0.5692094280339949,1.0,141/572,19.05%,RUNX1;NR1H4;ZEB2;TRPS1;RUNX3;POU5F1;ZEB1;GLI2;ETV6;TCF7L2;SNAI1;NCOR2;YAP1;ATXN1;CBX8;DEAF1;BCL6;NKX6-1;NRIP1;MEIS2;GLI3;BACH1;MIER2;NR2F2;IRF7;NFIX;SUFU;GLIS1;STAT1;MITF;ZFPM2;FHL2;RARB;USP9X;SNAI2;SMAD2;GATA6;CRYM;DUSP26;DNAJB1;ARID5B;MLIP;KMT5A;SMURF2;ZHX2;TBX2;SHH;ZBTB5;PPID;CGGBP1;E2F1;ARID5A;ZNF25;RNF2;HEXIM1;PRDM2;STAT3;HDAC1;MTA2;NIPBL;CREBBP;TAF7;PLK1;PRDM5;CBFB;IL33;FOXM1;BAG3;PPARG;E2F8;BHLHE40;NR1D2;MXI1;ENO1;FOXE1;MDFI;MBD2;ETV5;NFKB1;FRK;HDAC5;SIRT2;PHF21A;SALL1;CHD8;FOXP4;NOC2L;ATRX;HDAC3;NR2F1;DICER1;FNIP1;GLIS3;GATAD2B;RBPJ;PRDM1;HIVEP1;CTCF;LCOR;TCF3;SMAD3;TGIF2;SDCBP;NSD1;PHF12;TBL1X;RIF1;FLCN;CXXC5;ELK4;NR2C2;YY1;MDM2;TNF;TAF9B;EZH2;SP100;PSEN1;TLE5;DNMT3B;ZNF692;KLF10;EID1;CC2D1A;TCERG1;HCFC2;PTCH1;TBX3;SKOR2;SPI1;CDC73;TFAP2C;KCNIP3;AASS;TRIB3;ZGPAT;MTA3;MOSPD1;TRIM27;CBX5;FOXO3
prerank,cellular divalent inorganic cation homeostasis (GO:0072503),0.4234908754600475,1.2712272054134344,0.10559662090813093,0.5692181376647779,1.0,13/107,7.70%,CCL11;SLC39A14;CCL7;EDN3;CXCL12;SLC24A5;CD40;STOML2;ATP2A2;CCR1;TNNI3;CCL5;ATP2B1
prerank,histone methylation (GO:0016571),0.5036882215947758,1.2710289271647546,0.17961783439490445,0.5691125113002395,1.0,11/26,22.30%,EHMT1;CREBBP;CARM1;NSD3;NSD1;PRMT5;EZH2;NTMT1;SIRT7;FBL;PRMT6
prerank,organelle organization (GO:0006996),0.40262749698703104,1.2707628403392977,0.01901901901901902,0.5692084223102608,1.0,141/388,24.76%,CCL11;CCL7;KRT25;SEC16B;PALLD;VMP1;IQCG;SEC31A;TNFAIP3;GORASP2;FMNL2;SH3KBP1;MAST4;PEX10;LRRK2;APOE;STOML2;CHMP4B;CHMP4A;ATP8B1;SIPA1L3;MIA3;PKD2;LMAN2L;TTC17;STX17;FGD4;TRIP11;MARK1;SEC16A;PPID;MDK;PDZD8;PPRC1;EIF2AK3;TJAP1;CDC42;RAB34;FMNL3;MTX2;RAB7A;UBXN2A;ATL2;RAB2A;SPTBN5;OBSL1;VPS13C;COG4;PI4K2B;ADCK1;BIN1;FAM161A;VPS4A;CSNK1A1;YTHDF3;AGTPBP1;ATL1;LMAN1;TBC1D20;TERT;MSTO1;MAST2;CSNK1D;ANK1;DYNC2H1;ABI2;RANBP9;RAB32;THY1;TPM1;TTC29;CCL2;CENPT;TOR1AIP2;FGD6;RAB30;GABPB1;VAPA;ZFYVE16;SLC25A36;CHMP3;CFAP410;CUL7;GOLGA5;GOLGA8B;SMPD4;PLEKHF1;WTIP;KIF5C;WDPCP;GABPA;KIF3A;PEX19;TMED1;CHMP7;KIFAP3;CAMSAP1;RAB31;TMCC1;PARP1;COG7;RAB3GAP1;PITPNB;EPS15;PEX11A;GBF1;BNIP1;TMED10;YTHDF2;DES;MTX1;CYCS;SEC61A1;CHCHD10;TRAPPC8;BCAS3;TMED7;ATP7A;BRWD1;SEC23IP;AUP1;RAB1A;BCS1L;PARK7;ZMYM4;SIRT3;POLRMT;HTT;STRIP1;ABCD2;CHMP2B;TMED5;CLASP2;PDCD6IP;KIF9;GAK;SPTSSB;COG3;PRKCI;PEX12;LYSMD3
prerank,cortical actin cytoskeleton organization (GO:0030866),0.5206050743433155,1.2701403027822344,0.18699186991869918,0.5703353132703073,1.0,7/20,17.28%,FMNL2;LCP1;FMNL3;FHOD3;LLGL1;TNF;ROCK2
prerank,regulation of ubiquitin protein ligase activity (GO:1904666),0.5273959742721935,1.270018046081519,0.19398907103825136,0.5700302864492995,1.0,7/21,13.74%,MAD2L1;PTEN;PLK1;FBXO5;FZR1;CDC14B;SKP1
prerank,COPII-coated vesicle budding (GO:0090114),0.4472122089121926,1.2691236306764817,0.14076576576576577,0.5718493505892219,1.0,24/68,22.49%,COL7A1;SEC16B;SEC31A;SEC24D;SEC23A;MIA3;SEC16A;TRAPPC10;SEC24A;LMAN1;TBC1D20;SCFD1;CSNK1D;KLHL12;TRAPPC4;VAPA;USO1;PEF1;CTSC;F8;TMED10;SEC23IP;RAB1A;CTSZ
prerank,"DNA-templated transcription, initiation (GO:0006352)",0.4093299556817032,1.2690981101173757,0.08119218910585817,0.5712843248050041,1.0,38/166,16.90%,RORA;NR1H4;NCOR2;YAP1;TEAD3;RARB;TAF1D;RXRG;TEAD1;MAML3;HDAC1;TAF4;CREBBP;POLR1E;TAF7;PPARG;E2F3;GTF2F2;NR1D2;CDK9;NRBF2;CDK7;HDAC5;MAML2;WWTR1;HDAC3;NR2F1;RBPJ;POLR2K;TBL1X;GTF2H1;NR2C2;RSF1;CRCP;POLR2B;TAF9B;CCNH;TAF2
prerank,positive regulation of Rho protein signal transduction (GO:0035025),0.4928481509922832,1.2689653009587152,0.16853932584269662,0.5709804299067552,1.0,4/30,9.65%,COL3A1;P2RY10;RAC1;AKAP13
prerank,positive regulation of glycogen biosynthetic process (GO:0045725),-0.4868019385649156,-1.2689367057565581,0.208,0.6379731916554994,1.0,4/12,12.01%,SORBS1;INSR;IGF2;DYRK2
prerank,negative regulation of platelet activation (GO:0010544),0.5593616017240459,1.268687895118428,0.19832402234636873,0.57114137832325,1.0,3/16,3.63%,PDGFRA;SERPINE2;APOE
prerank,actin filament organization (GO:0007015),0.41003429828729604,1.2684650953856862,0.0825593395252838,0.571129123434126,1.0,34/151,13.51%,SVIL;MYO1B;MYO1A;PPP1R9B;CARMIL2;RND3;SPIRE2;LCP1;DPYSL3;RHOD;BAIAP2;MYO5A;CARMIL1;FAT1;DBN1;RAC1;AIF1;CDC42;FHOD3;SPIRE1;CGNL1;MYO19;VILL;MYO1H;ZBED3;MYO1D;MYO7A;WHAMM;ABI1;TMOD1;SAMD14;ABI2;TPM4;TPM1
prerank,transmembrane receptor protein tyrosine kinase signaling pathway (GO:0007169),0.3972825593325895,1.2678686290129504,0.013013013013013013,0.5722157431423818,1.0,93/390,17.36%,ROR2;ROR1;SLC39A14;EPHA7;COL4A2;COL1A1;SULF1;MMP2;PDGFRA;FLRT2;FGF20;VAV2;GHR;NRP1;JAK2;VAV3;PDGFRB;EFNA4;FGF7;BAIAP2;DDR2;ACTR2;IRS1;PLAT;PRKD2;BLK;EPHB3;FGF9;FGFR1;GALNT3;SPRED1;SPRED2;AP3S1;KALRN;LCP2;RAC1;ITSN1;ANKS1B;FRS2;EIF2AK3;STAT3;EGFR;CBL;CDC42;MVP;PIK3R1;NCK2;DOCK1;NCK1;DNM1;EPHA1;DDR1;GTF2F2;SDC2;MERTK;STYK1;FRK;EFNA5;SIRT2;MAPK11;SH2B2;GRB2;ABI1;SETX;ATP6V1G1;RBFOX2;FGF2;SHB;EPHB2;ANGPTL1;GIGYF2;PTK2;POLR2K;ATP6V1D;SDCBP;GSK3B;NTRK3;COL4A6;FGFRL1;NCBP2;PTPN2;MST1R;POLR2B;UBASH3B;ATP6V1F;TCIRG1;PSEN1;ANGPT1;YES1;VAV1;PTPRJ;ROCK2;RHOA
prerank,amino acid import across plasma membrane (GO:0089718),0.5104396239990407,1.267816084911861,0.1952191235059761,0.5717140883282328,1.0,2/24,0.58%,SLC7A2;SLC1A3
prerank,positive regulation of kinase activity (GO:0033674),0.4193581448510704,1.2675444195017262,0.10531914893617021,0.5718304171890574,1.0,24/107,15.66%,ROR2;ROR1;EPHA7;PDGFRA;JTB;PDGFRB;DDR2;TREM2;EPHB3;FGFR1;LCP2;RASSF2;EGFR;CACUL1;EPHA1;DDR1;MERTK;ALS2;EPHB2;PTK2;NTRK3;TNF;MST1R;SNX9
prerank,negative regulation of viral process (GO:0048525),0.4563262836262881,1.2669704345661876,0.14549653579676675,0.5727963106413002,1.0,17/57,16.59%,TNIP1;STAT1;SHFL;UBP1;ILF3;HEXIM1;CCL5;TRIM21;TRIM8;TRIM13;TRIM11;EIF2AK2;OASL;TRIM62;TRIM35;TNF;CHMP3
prerank,secretion (GO:0046903),-0.4707755129506409,-1.2668644278181223,0.17933130699088146,0.6406033312574178,1.0,6/14,16.97%,SLC22A6;NPR1;TPD52;FBLN5;RIMS1;SLC22A2
prerank,amino acid transport (GO:0006865),0.45490345766589996,1.2665989288094721,0.14719626168224298,0.5732014680194131,1.0,10/49,13.63%,SLC7A2;SLC38A3;SLC25A47;SLC7A7;SLC38A4;SLC36A2;SLC7A11;PDPN;SLC7A8;SLC1A5
prerank,negative regulation of cell cycle G2/M phase transition (GO:1902750),0.4470771161802111,1.266512303846976,0.16103603603603603,0.5728007173504607,1.0,17/55,21.00%,PSMA7;FBXL7;PINX1;CUL1;PSMD4;PSMD11;PSMB8;SKP1;USP47;PSMA6;PSMD14;PSMC6;PSMB10;PSMD12;PSMB1;PSMA8;PSMF1
prerank,spindle assembly (GO:0051225),0.4389522304149852,1.2661551726358014,0.15454545454545454,0.5731586130351601,1.0,17/67,17.82%,NEK6;KIFC1;SMC1A;STAG1;INO80;HAUS3;STAG2;KIF2A;HDAC3;RCC1;TPX2;CSNK1D;KPNB1;MAPRE2;GOLGA8B;RHOA;TUBGCP4
prerank,phagolysosome assembly (GO:0001845),0.5621569990293555,1.2656308822469604,0.1985185185185185,0.5740272440216571,1.0,4/12,7.60%,PLA2G5;RAB34;RAB7A;RAB7B
prerank,regulation of peptidyl-threonine phosphorylation (GO:0010799),0.4763015889372774,1.2655633576793202,0.18372379778051787,0.573567958333548,1.0,11/37,10.71%,CEMIP;S1PR2;TNKS1BP1;EGF;SPRED1;SPRED2;PLK1;RPTOR;CALM3;SPRY2;SIRT2
prerank,negative regulation of cAMP-mediated signaling (GO:0043951),0.6004985599459527,1.2647855099019725,0.2082670906200318,0.5751281781939405,1.0,2/10,5.12%,PDE3A;RNF157
prerank,positive regulation of cell communication (GO:0010647),0.5031341943401679,1.2647308534487713,0.16666666666666666,0.5746352384938705,1.0,8/28,17.31%,ADIPOQ;EDN3;WLS;CDKN2AIP;DLG4;HCRT;TNF;PTPN23
prerank,embryonic organ morphogenesis (GO:0048562),0.472439528932195,1.2646111828414086,0.18396226415094338,0.5743300500482924,1.0,7/42,9.62%,PDGFRA;FBN2;FBN1;HOXB3;NIPBL;ACVR1;FOXE1
prerank,regulation of acrosome reaction (GO:0060046),-0.5158604448324035,-1.2642193189913193,0.1989100817438692,0.6449180475323635,1.0,2/10,23.69%,PLCB1;GLRA1
prerank,positive regulation of histone H3-K4 methylation (GO:0051571),0.5722727876287186,1.2642090721942545,0.1917024320457797,0.5748115835623059,1.0,2/14,2.71%,KMT2A;AUTS2
prerank,response to reactive oxygen species (GO:0000302),0.44327144295490084,1.2641356882309045,0.15995397008055237,0.5743930711713867,1.0,11/54,14.75%,HP;PDGFRA;APOD;APOE;PKD2;EGFR;COA8;TPM1;PRDX5;PTPRN;MAPK9
prerank,regulation of vasculature development (GO:1901342),0.5105319150867816,1.2636932949691475,0.18610747051114024,0.575031925866645,1.0,12/26,26.15%,SFRP1;NF1;PLXND1;FGF2;GPNMB;HTATIP2;RNH1;SP100;ETS1;EMP2;BMPER;WARS1
prerank,regulation of cellular localization (GO:0060341),0.45604313880980935,1.2633438334695912,0.1844888366627497,0.5754583062192593,1.0,7/46,4.84%,NR1H4;UNC13D;LRRK2;CAMK2D;TRIM67;DYNC1H1;BLK
prerank,small GTPase mediated signal transduction (GO:0007264),-0.2876002463472358,-1.2630394884748726,0.03076923076923077,0.6448735395089708,1.0,26/103,12.61%,PLCE1;RAPGEF5;ARHGAP18;RB1;ARHGAP31;RASGRP3;RAPGEF6;KSR2;RAB18;ARL3;RIT2;KRIT1;JUN;RGL2;USP8;RALBP1;RAPGEF2;PRKD1;CRKL;SHTN1;KRAS;MRAS;ADRA2A;CCDC88C;TP53;CCDC88A
prerank,cardiac muscle cell development (GO:0055013),0.5234689456146937,1.2630274190029644,0.20028011204481794,0.5756843786964406,1.0,4/20,8.19%,PDGFRA;PDGFRB;FHOD3;OBSL1
prerank,cell-cell junction organization (GO:0045216),-0.31130632044487894,-1.2629564932610506,0.07608695652173914,0.6418680349662879,1.0,13/79,4.71%,TJP1;PKP4;OCLN;CADM2;LIMS2;TJP2;CADM1;CLDN5;ARVCF;CDH1;CDH13;CDH5;CTNND1
prerank,inhibitory synapse assembly (GO:1904862),0.5797656861465101,1.2629339231433665,0.19165378670788252,0.575288501520321,1.0,3/11,3.70%,LGI2;WNT5A;NPAS4
prerank,negative regulation of G2/M transition of mitotic cell cycle (GO:0010972),0.4369621929476924,1.2628647626928122,0.15367727771679474,0.5748466318994441,1.0,21/65,21.00%,PSMA7;FBXL7;PABIR1;PINX1;CUL1;PSMD4;PSMD11;VPS4A;PSMB8;SKP1;USP47;CHFR;PSMA6;PSMD14;PSMC6;PSMB10;PSMD12;PSMB1;PSMA8;CDK5RAP3;PSMF1
prerank,heart morphogenesis (GO:0003007),0.45193266097135293,1.2623269722019965,0.1548311990686845,0.5757201063215168,1.0,10/50,13.07%,DLC1;FLRT2;CHD7;TBX2;NIPBL;TGFBR1;ACVR1;OLFM1;HEYL;PTK2
prerank,establishment of apical/basal cell polarity (GO:0035089),0.5621523172561076,1.2622938783644055,0.2116788321167883,0.5751589672753855,1.0,7/14,21.80%,RAP2A;FSCN1;OPHN1;CDC42;MSN;RHOA;MYO9A
prerank,intraciliary transport involved in cilium assembly (GO:0035735),0.46953277457781883,1.2621165796707448,0.16981132075471697,0.5750320439990484,1.0,17/37,19.68%,DYNLL1;TRIP11;IFT57;IFT88;WDR35;TNPO1;PCM1;DYNC2LI1;CLUAP1;DYNC2H1;IFT52;IFT20;IFT81;KIF3C;KIF3A;KIFAP3;IFT172
prerank,TRIF-dependent toll-like receptor signaling pathway (GO:0035666),0.4914248192114217,1.2609473880411581,0.1771356783919598,0.577820195865601,1.0,12/29,24.12%,IRF7;BIRC3;CD40;LY96;IKBKE;CD14;TANK;CASP8;TLR3;RPS27A;IRF3;CD300LF
prerank,respiratory chain complex IV assembly (GO:0008535),-0.40900214549664715,-1.260805801045893,0.15730337078651685,0.6451376219531564,1.0,10/21,26.82%,COX16;COX18;PET100;COX14;TIMM21;SCO1;COX10;COA3;COA6;COX15
prerank,negative regulation of signaling (GO:0023057),0.5099927858716045,1.2606133219440259,0.18523316062176165,0.578140824206654,1.0,6/25,16.05%,ADIPOQ;BRAP;ACVR1;PTPN1;UBASH3B;SOCS5
prerank,protein-containing complex assembly (GO:0065003),0.4035361024479246,1.2602298220872434,0.056451612903225805,0.5785697667272747,1.0,70/259,18.40%,COL7A1;KMT2A;SEC16B;CXCL12;SH3PXD2B;TCF7L2;YAP1;LAMC1;FARP2;SEC31A;SEC24D;SLC9A1;SEC23A;SKAP2;MITF;CD40;LRRK2;STOML2;KPNA3;WIPF1;TLE1;FBXL7;ADD2;SEC16A;PPID;TRAPPC10;TEAD1;RBBP5;HDAC1;CREBBP;SEC24A;DBNL;CUL1;TCF7;LLGL1;CSNK1A1;DLG4;TSPAN4;LMAN1;TBC1D20;TERT;SCFD1;CAPZA1;TRAF2;HGSNAT;CSNK1D;KLHL12;RANBP9;TCF7L1;SKP1;ITGB1BP1;AXIN2;TRAPPC4;CASP8;GSK3B;MDM2;TNF;SNX9;CX3CL1;PDE4DIP;RUVBL1;TNFRSF1A;EPRS1;USO1;KMT2D;PEF1;TUBGCP4;CDC73;CTSC;KIFAP3
prerank,histone H3 acetylation (GO:0043966),-0.34392970694669384,-1.2596675331883629,0.10555555555555556,0.6450199590333783,1.0,22/40,23.94%,LEF1;JADE1;PHF14;JADE2;LDB1;BRCA2;DR1;WDR5;JADE3;TAF6L;NAA60;TRIM16;KAT6A;SUPT7L;MAP3K7;KAT2B;KAT2A;TADA1;TAF10;TAF12;KAT14;TAF5L
prerank,positive regulation of keratinocyte migration (GO:0051549),0.6022234124406666,1.25962871390903,0.228125,0.5795808391907262,1.0,4/10,19.81%,MAP4K4;FGF7;MAPRE2;EPB41L4B
prerank,positive regulation of triglyceride biosynthetic process (GO:0010867),-0.4847188229766426,-1.2595794974233194,0.19613259668508287,0.642045461289771,1.0,6/11,28.33%,SCARB1;LDLR;MFSD2A;NR1H2;CTDNEP1;SLC27A1
prerank,import into cell (GO:0098657),0.46726198444810885,1.2594440302873877,0.16646415552855406,0.5794304861583662,1.0,7/41,4.76%,SLC39A14;SLC1A3;SLC11A2;IL10RA;SLC29A1;SLC12A4;TREM2
prerank,primary neural tube formation (GO:0014020),0.4859793684220989,1.2593086895600312,0.19600499375780275,0.5792034948131493,1.0,5/30,6.42%,DLC1;DEAF1;DVL2;MTHFD1L;MTHFR
prerank,regulation of lamellipodium organization (GO:1902743),0.5759842914864375,1.2592438466162992,0.18676470588235294,0.5787667007085334,1.0,5/14,13.03%,CARMIL2;CARMIL1;RAC1;CDC42;PDPN
prerank,mitotic metaphase plate congression (GO:0007080),0.45414292674794154,1.2589340962728313,0.16395348837209303,0.5790085112616981,1.0,12/51,19.00%,KIFC1;PSRC1;EML4;CHMP4B;CHMP4A;PINX1;EML3;VPS4A;KPNB1;CHMP3;CHMP7;MAD1L1
prerank,"phototransduction, visible light (GO:0007603)",-0.4623093857420201,-1.258717325730983,0.19584569732937684,0.6414809802491414,1.0,5/14,23.40%,ABCA4;GNA11;RP1;SAG;PDE6A
prerank,axon extension (GO:0048675),0.5107309508939244,1.2586996315124677,0.1865079365079365,0.5790850786674038,1.0,5/23,3.49%,NRP1;SLIT3;SLIT1;AUTS2;USP9X
prerank,3'-phosphoadenosine 5'-phosphosulfate metabolic process (GO:0050427),0.5193579202374249,1.2586540940611963,0.20445062586926285,0.578591246923058,1.0,2/19,2.35%,ENPP1;PAPSS2
prerank,acylglycerol metabolic process (GO:0006639),-0.34765999062970965,-1.2580652402294419,0.12643678160919541,0.6400356337871265,1.0,11/37,16.40%,DGKB;CAV1;MGLL;ABHD6;DGKI;DGKG;DGAT1;DGKQ;DGKA;DGKZ;PNPLA2
prerank,regulation of interferon-gamma production (GO:0032649),0.4351848340430313,1.2574709251159681,0.15358744394618834,0.5814001970522169,1.0,10/71,13.99%,NR1H4;IL23R;CD276;XCL1;IL1R1;LGALS9;TLR7;CD14;SIRPA;HSPD1
prerank,early endosome to late endosome transport (GO:0045022),0.5196475678205957,1.2573727955734586,0.2054421768707483,0.5810578453151121,1.0,10/20,21.77%,HOOK2;RAB7A;EEA1;PIK3C3;ANKRD27;PTPN23;HOOK3;WDR91;KIF16B;EMP2
prerank,positive regulation of stem cell proliferation (GO:2000648),0.5481678700267938,1.2565347801146738,0.2125,0.5828403118818094,1.0,1/17,0.18%,LTBP3
prerank,microglial cell activation (GO:0001774),0.5214109443062235,1.256089332885464,0.2054973821989529,0.5834620826438283,1.0,6/21,15.90%,JAK2;TREM2;AIF1;IFNGR1;TNF;CX3CL1
prerank,positive regulation of potassium ion transmembrane transport (GO:1901381),-0.3423923836042713,-1.2553845980038352,0.11464968152866242,0.6445074969287469,1.0,12/44,13.00%,ATP1B3;ATP1B1;ACTN2;ANK2;KCNJ2;AKAP6;KCNJ3;WNK4;WNK3;KCNQ1;KCNJ12;KCNN3
prerank,primary alcohol metabolic process (GO:0034308),0.5090634618025441,1.255365972739114,0.19295958279009126,0.5848334420186068,1.0,6/25,13.01%,CYP1B1;RDH10;RDH12;CYP1A1;GDPD3;ALDH3A2
prerank,acetylcholine receptor signaling pathway (GO:0095500),-0.43105961328887693,-1.2547034232993641,0.16104868913857678,0.6432033397007805,1.0,5/20,8.56%,PLCB1;GNA11;CHRM2;CHRM3;AGRN
prerank,bile acid and bile salt transport (GO:0015721),0.5107088544023136,1.254403487048348,0.1893644617380026,0.5869284342986151,1.0,3/24,4.35%,NR1H4;SLC10A6;ATP8B1
prerank,protein polymerization (GO:0051258),0.4500726140857589,1.2543208892507633,0.1765389082462253,0.5865237832349807,1.0,17/55,19.13%,GAS7;SPIRE2;JAK2;CHMP4B;CHMP4A;TTC17;RAC1;AIF1;SPIRE1;PREX1;ARHGAP6;FGF13;TPPP;CHMP3;MICALL2;UBE2S;TPPP3
prerank,Notch signaling pathway (GO:0007219),0.4489227533068414,1.2541430103994187,0.1677927927927928,0.5864048861762207,1.0,19/59,17.44%,DTX4;SNAI1;STAT1;SNAI2;JAG1;MDK;MAML3;CREBBP;GMDS;PLXND1;DTX2;MAML2;HEYL;GALNT11;RBPJ;MIB1;DTX3;PSEN1;ITCH
prerank,positive regulation of cellular process (GO:0048522),0.3932159188151253,1.253612426847516,0.008008008008008008,0.5873318931676537,1.0,127/565,17.24%,IBSP;IL34;HP;HPR;CXCL5;WNT2;PDGFRA;EDN3;LRP1;OSMR;MMP14;LBP;CXCL12;ZFP36L1;FGF20;S1PR2;MEIS2;COLEC12;PRKCA;EIF4G2;PTN;SFRP1;GAB2;CCAR1;SFRP2;TLR2;EAPP;WNT5A;PDGFRB;FASN;TIMP1;PLA2G5;PRTN3;RHOD;FGF7;BCL2;DUSP26;EGF;IRS1;TSLP;P2RX5;DYNC1H1;KLHL22;PRKD2;TREM2;FGF9;FGFR1;CELF1;PTEN;INO80;TBX2;SHH;DVL2;FXN;MEIS1;MDK;RAC1;TENM4;ATM;AIF1;EGFR;HDAC1;CDC42;BMP5;CD36;PABIR1;CACUL1;CCL5;CDKN2AIP;TRIM21;FCGR2B;TGFBR1;PTPN6;EPHA1;FOXM1;CSPP1;GLP2R;TGFB3;RPTOR;S1PR3;MYRF;MERTK;CDK13;FBXO5;SIRT2;XBP1;TRIM13;GCNT2;WWTR1;FKBP1B;DICER1;EXOSC4;FGF2;FMR1;SIRPA;PPP3CA;IL7;RAD23A;PDPN;PTK2;TPM1;LRP6;SDCBP;ITGB1BP1;AXIN2;TUB;FLCN;NOP2;USP47;TPPP;NTRK3;EXOSC2;MDM2;GAREM1;TNF;MST1R;CX3CL1;TAF9B;EZH2;TCIRG1;LIFR;PDCD10;GDNF;RPS6KA3;PTPRJ;BTC;TBX3
prerank,autophagy of peroxisome (GO:0030242),0.5828763257818476,1.2535091612278135,0.23007518796992482,0.586954873109116,1.0,7/12,20.89%,ATM;SQSTM1;PIK3C3;PIK3R4;PEX5;NBR1;TRAPPC8
prerank,regulation of axon extension involved in axon guidance (GO:0048841),-0.39963308595316616,-1.253181000663581,0.15416666666666667,0.6442985041586694,1.0,14/24,22.27%,SEMA6A;SEMA3C;SEMA7A;SEMA6D;SEMA3D;SEMA4D;SEMA5A;SEMA5B;SEMA4B;SEMA3G;SEMA3B;SEMA6C;SEMA6B;SEMA4A
prerank,synaptic vesicle cycle (GO:0099504),-0.37393768586647275,-1.2528382748224758,0.10784313725490197,0.6420467186762319,1.0,8/30,16.06%,SNAP25;PCLO;SYNDIG1;SNAPIN;PIP5K1C;NLGN1;RIMS1;SYT7
prerank,regulation of actin filament-based movement (GO:1903115),-0.5111546411888981,-1.252824014766868,0.2103825136612022,0.638991146215386,1.0,7/10,30.67%,PDE4B;ANK2;PDE4D;SRI;PLN;SCN5A;STC1
prerank,positive regulation of transferase activity (GO:0051347),0.40418141547355146,1.2527923199416784,0.08668730650154799,0.5883280371904666,1.0,20/142,10.07%,ROR2;ROR1;EPHA7;ADIPOQ;PDGFRA;ARRDC4;PDGFRB;DDR2;PARM1;TREM2;EPHB3;FGFR1;PKIB;EGFR;PLK1;UBE2L3;EPHA1;DDR1;ARRDC3;MERTK
prerank,positive regulation of interleukin-1 beta production (GO:0032731),0.4566909823533568,1.252767036761238,0.17520858164481526,0.5877594338954105,1.0,11/45,15.60%,WNT5A;JAK2;LPL;CASP1;TMEM106A;STAT3;CD36;LGALS9;PYDC1;CASP8;TNF
prerank,regulation of tube diameter (GO:0035296),-0.480179548103026,-1.2521054618524365,0.20376175548589343,0.6346641340030258,1.0,7/13,21.30%,NOS3;NPR1;ACE;GCLM;GCLC;ACE2;AGTR1
prerank,vascular process in circulatory system (GO:0003018),-0.480179548103026,-1.2521054618524365,0.20376175548589343,0.6346641340030258,1.0,7/13,21.30%,NOS3;NPR1;ACE;GCLM;GCLC;ACE2;AGTR1
prerank,positive regulation of glycogen metabolic process (GO:0070875),-0.4757095524111967,-1.2514986285686351,0.20977011494252873,0.6332679760323007,1.0,4/13,12.01%,SORBS1;INSR;IGF2;DYRK2
prerank,regulation of protein localization to cell periphery (GO:1904375),0.5221887755229883,1.2508450612434572,0.22038567493112948,0.592624401409348,1.0,8/18,21.26%,MMP14;ABCA2;PLK1;VPS4A;SPTBN1;CLN3;CDK5;VTI1B
prerank,intrinsic apoptotic signaling pathway in response to oxidative stress (GO:0008631),0.5824350528724112,1.2505302050880762,0.21515151515151515,0.5928437801318556,1.0,2/11,3.37%,CYP1B1;GSKIP
prerank,tube closure (GO:0060606),0.4828534898867207,1.2500254395210604,0.20802005012531327,0.5936148410353048,1.0,5/31,6.42%,DLC1;DEAF1;DVL2;MTHFD1L;MTHFR
prerank,positive regulation of mitotic cell cycle (GO:0045931),0.5027588229576261,1.249701044190665,0.2046936114732725,0.5940021383999082,1.0,7/26,16.03%,MEIS2;PRKCA;ASNS;RPS6KB1;USP22;MDM2;EIF4EBP1
prerank,cGMP-mediated signaling (GO:0019934),0.5626775917373731,1.2479050403716037,0.22801788375558868,0.5985872478673998,1.0,3/13,7.23%,PDE3A;APOE;CD36
prerank,vasodilation (GO:0042311),-0.4576048787306295,-1.2475253658187293,0.20945945945945946,0.6412227907244966,1.0,5/13,20.56%,NOS3;KLF2;GPER1;ADRB2;SOD1
prerank,MyD88-independent toll-like receptor signaling pathway (GO:0002756),0.48541740742991296,1.2472326302713854,0.18434343434343434,0.599930986345827,1.0,8/30,14.67%,IRF7;BIRC3;CD40;LY96;IKBKE;CD14;TANK;CASP8
prerank,dendritic cell chemotaxis (GO:0002407),0.5499337998742999,1.2467474866905497,0.2325925925925926,0.6006447777744576,1.0,4/14,17.88%,CCR1;CCL5;CXCR4;TRPM4
prerank,regulation of translation (GO:0006417),0.4022259780359556,1.2466816621602408,0.08444902162718847,0.6001671104159427,1.0,53/173,22.99%,PRR16;IGF2BP1;BCL3;IGF2BP2;EIF4G2;SYNCRIP;CTIF;EIF4G3;ATXN2;PLD1;IGFBP5;SHFL;ILF3;EIF2AK3;RBM4B;SAMD4A;EIF3H;PAIP2;ALKBH1;YTHDF3;RPS6KB1;EIF5B;GSPT1;EIF1;EIF2AK2;FMR1;METAP1;GIGYF2;PAIP1;CAPRIN1;EIF5;NEMF;GAPDH;NCBP2;NIBAN1;NAT10;RPS6KA3;EPRS1;PUM3;MIF4GD;MTIF2;FOXO3;DAPK1;TRAP1;YBX1;DDX3X;CALR;NOLC1;KLHL25;PRKDC;DDX1;RBM3;CYFIP1
prerank,positive regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090100),0.43000793187592984,1.2465385794224904,0.1404867256637168,0.5999218068923022,1.0,18/86,14.35%,ZEB2;SULF1;JAK2;SMAD2;CDKN2B;TGFB1I1;RNF111;BMP5;CREBBP;TGFBR1;ACVR1B;ACVR1;INHBB;TGFB3;ACVR2A;RBPJ;SDCBP;FLCN
prerank,regulation of osteoblast differentiation (GO:0045667),0.4281251245900311,1.246475913713414,0.15991237677984665,0.5994547362115599,1.0,18/82,13.07%,RUNX2;FBN2;YAP1;TNN;NELL1;TMEM119;SUFU;SNAI2;CCN4;DDR2;ACVR1;PPARG;CDK6;FBXO5;ACVR2A;WWTR1;SUCO;PTK2
prerank,organophosphate ester transport (GO:0015748),-0.3800869281476828,-1.2464168347924562,0.16153846153846155,0.641314325615655,1.0,11/24,21.57%,PITPNC1;PITPNA;SCARB1;LDLR;TNFAIP8L3;ABCA3;OSBPL2;PCTP;PRELID3A;SCP2;PITPNM1
prerank,heart contraction (GO:0060047),-0.338084773243562,-1.246220454612798,0.14465408805031446,0.6388198675324779,1.0,5/41,2.13%,DMD;SGCD;ATP1B1;SGCZ;ATP1A2
prerank,negative regulation of reactive oxygen species biosynthetic process (GO:1903427),0.5999003234018507,1.2460545502138258,0.23123123123123124,0.5999395375931544,1.0,7/11,28.81%,COA8;TRAP1;PARK7;ABCD2;ABCB7;SLC18A2;MPV17L
prerank,synapse assembly (GO:0007416),0.43103925652769165,1.2456300388886872,0.15179606025492468,0.60048809351644,1.0,17/67,12.78%,LGI2;SLITRK6;FARP1;PCDHB6;WNT5A;PCDHB16;SDK2;NPAS4;ADGRL3;PTEN;DBNL;OBSL1;PLXND1;FZD1;DSCAM;FGF13;SDK1
prerank,positive regulation of vascular permeability (GO:0043117),-0.4686582648911091,-1.2453741087528143,0.19382022471910113,0.6382289329742897,1.0,4/12,1.32%,TJP1;OCLN;BMP6;TJP2
prerank,negative regulation of nucleic acid-templated transcription (GO:1903507),0.39061255256951377,1.2446593728230044,0.027,0.6026896608584325,1.0,117/417,20.65%,RUNX2;ADIPOQ;CREB3L1;ZEB1;MDFIC;BCL3;TCF7L2;NCOR2;DAP;SBNO2;ATXN1;DEAF1;BCL6;GLI3;NR2F2;RCOR1;SFRP1;ERN2;SFRP2;WNT5A;ZFPM2;PHC2;XCL1;SMAD2;GATA6;SFMBT1;ATP8B1;IRF1;ARID5B;POU2F1;KHDRBS1;TLE1;RUNX1T1;KMT5A;SMURF2;EHMT1;ZHX2;ILF3;TBX2;YAF2;SCMH1;ZBTB38;LIMS1;E2F1;ARID5A;HEXIM1;HDAC1;NIPBL;TSHZ3;TAF7;PRDM5;NONO;FOXM1;FOXK2;PPARG;BHLHE40;NR1D2;DKK3;ENO1;FOXE1;MBD2;AHR;MBD1;HDAC5;SIRT2;SALL1;CHD8;PRICKLE1;HDAC3;TSC22D4;LOXL3;RBFOX2;SNX6;HEYL;CCAR2;ZMYND15;RBPJ;CTCF;FBXW11;BAHD1;CLOCK;COMMD7;PHF12;HMGB2;SAP18;USP47;RSF1;CIART;MDM2;TNFRSF4;TNF;EZH2;TIMELESS;TLE5;KLF10;EID1;TBX3;NIF3L1;SPI1;PHC3;SPINDOC;TRIB3;ZGPAT;MTA3;CBX5;CDK5;PATZ1;SMARCA4;MTERF3;RBM15;SPEN;SETDB2;JARID2;BCLAF1;CALR;MPHOSPH8;SFMBT2
prerank,positive regulation of B cell activation (GO:0050871),0.44784079219917355,1.2446176022399722,0.17981438515081208,0.6021745151090512,1.0,14/50,16.39%,MMP14;SH3KBP1;VAV3;CD40;BCL2;TIRAP;SASH3;SHLD3;XBP1;EPHB2;IL7;RIF1;TNFRSF4;HMCES
prerank,positive regulation of intracellular signal transduction (GO:1902533),0.39017763748361806,1.2444696288313783,0.018,0.6019373992594218,1.0,127/509,18.60%,ROR2;ROR1;DCN;MAP3K14;ADIPOQ;TRIML2;PDGFRA;FSHR;NEK6;TCF7L2;IAPP;NOS1AP;FGF20;TNFSF11;MYORG;GAB2;TLR2;BIRC3;WNT5A;JAK2;PDGFRB;CD40;ALPK1;FGF7;REL;BCL2;MIOS;CASP1;EGF;IRS1;CFLAR;TIRAP;P2RX5;PRKD2;LITAF;TREM2;TMEM106A;FGF9;FGFR1;EDA2R;BBC3;RAC1;LIMS1;UNC5CL;FRS2;WLS;IKBKE;HEXIM1;EGFR;CBL;CCL5;PIK3R1;TRIM21;SLC20A1;BAX;TGFBR1;STRN;LGALS9;TRIM8;PTPN6;NOD1;THEM4;HPSE;TIFA;RPTOR;BRD4;AKAP13;PUM1;TLR7;PIK3AP1;RICTOR;SPRY2;CD14;PIK3R5;TRIM13;GCNT2;SASH1;ADGRV1;GRB2;HDAC3;EIF2AK2;FGF2;FNIP1;LAMTOR5;OASL;TRAF2;TRIM62;PTK2;SLC35B2;DLG5;ITGB1BP1;ATP2C1;DHX58;FLCN;CXXC5;CASP8;PELI2;NTRK3;GAPDH;IRAK4;TNF;TRAF3IP2;MST1R;VAPA;RRAGC;CX3CL1;MC1R;EDAR;RASD2;ANGPT1;CC2D1A;VAV1;RBCK1;TNFRSF1A;PTPRJ;BTC;ROCK2;LPAR1;RHOA;TCIM;UNC5B;SPHK2;TRIM44;FIS1;SMCR8;TRIB3;TLR3
prerank,regulation of DNA methylation-dependent heterochromatin assembly (GO:0090308),0.571986308109253,1.2440551933157238,0.22442748091603054,0.6024902525281811,1.0,6/12,22.32%,APOBEC1;SETDB1;SETDB2;MPHOSPH8;RESF1;ATF7IP
prerank,cellular response to hydrogen peroxide (GO:0070301),0.48050723648132665,1.2438601252662282,0.19391634980988592,0.6024368083381407,1.0,9/33,17.48%,CYP1B1;TNFAIP3;ANXA1;FXN;SETX;SIRPA;ABL1;PPIF;NFE2L2
prerank,visual perception (GO:0007601),0.4213910666940763,1.2437021465372646,0.15969162995594713,0.6022394487235759,1.0,11/84,13.39%,COL18A1;COL1A1;RGS16;GPR179;RDH10;COL11A1;RDH12;MYO7A;ADGRV1;SFRP5;BEST1
prerank,T cell receptor signaling pathway (GO:0050852),0.4067605009343895,1.2434732457123214,0.11734164070612668,0.6023051899409724,1.0,34/138,21.05%,PSMA7;RFTN1;TNFRSF21;TEC;CD276;STOML2;PRKD2;KHDRBS1;LCP2;PIK3R1;CUL1;PSMD4;NCK1;PSMD11;NFKB1;PSMB8;RC3H2;FBXW11;THY1;SKP1;NFKBIZ;PSMA6;EIF2B3;RBCK1;PTPRJ;PSMD14;SPPL3;PSMC6;PSMB10;PSMD12;PSMB1;PSMA8;PSMF1;PAK1
prerank,positive regulation of smooth muscle cell proliferation (GO:0048661),0.45961293379969376,1.24315363033135,0.2,0.6025918224974377,1.0,9/43,7.35%,MMP2;PDGFRB;STAT1;CCN4;IGFBP5;FGF9;AIF1;ADAMTS1;CCL5
prerank,regulation of establishment of cell polarity (GO:2000114),-0.4286147080752023,-1.2430578377702768,0.18518518518518517,0.6416889275961511,1.0,4/16,9.11%,CDH5;KRIT1;GSN;SHTN1
prerank,regulation of viral transcription (GO:0046782),0.4661194489221816,1.242933123103842,0.18026796589524968,0.6025972309517085,1.0,16/39,19.27%,MDFIC;UBP1;HEXIM1;TRIM21;GTF2F2;CDK9;TARBP2;TRIM13;TRIM11;TRIM62;CCNT1;POLR2K;RSF1;POLR2B;TRIM27;GTF2F1
prerank,adenylate cyclase-activating G protein-coupled receptor signaling pathway (GO:0007189),0.4129708034541892,1.242368154629253,0.1365079365079365,0.6035913632494563,1.0,24/110,17.78%,MC5R;ABCA1;FSHR;IAPP;ADCY7;S1PR2;ADM;ADGRL3;ADCY2;RXFP2;GPR161;CXCL10;GNAS;S1PR3;PTGER4;DRD3;PTH1R;LPAR3;GNG2;LGR4;MC1R;LPAR2;LPAR1;CALCRL
prerank,regulation of histone H3-K4 methylation (GO:0051569),0.5519692282150339,1.2423473849549036,0.2148876404494382,0.6030020056414775,1.0,2/16,2.71%,KMT2A;AUTS2
prerank,DNA modification (GO:0006304),0.49940220225766596,1.2416694519449085,0.21161825726141079,0.6043709326753653,1.0,7/22,21.23%,PARP3;MPG;EXOSC4;NTHL1;EXOSC3;PARP1;TERF2IP
prerank,potassium ion transmembrane transport (GO:0071805),-0.2740659179020452,-1.2414093511528568,0.029411764705882353,0.6431871538318095,1.0,19/135,4.35%,ATP1B3;SLC12A7;SLC12A2;SLC24A2;KCNB2;SLC9A2;ATP1B1;KCNK5;ATP1A2;KCNH7;KCNJ2;KCNQ5;TMEM175;KCND2;ABCC9;SLC12A6;KCNJ3;KCND3;KCNC2
prerank,cellular response to reactive oxygen species (GO:0034614),0.4360962244902834,1.2411447539284806,0.1632183908045977,0.6051997657960999,1.0,15/59,17.48%,CYP1B1;PDGFRA;TNFAIP3;ANXA1;PKD2;FXN;EGFR;SETX;SIRPA;TPM1;PRDX5;MAPK9;ABL1;PPIF;NFE2L2
prerank,negative regulation of cellular protein localization (GO:1903828),0.4712192441035959,1.2403725821474414,0.20496894409937888,0.60676799824131,1.0,13/34,22.22%,ADIPOQ;GPM6B;TAX1BP3;SNX33;ILRUN;FLCN;GSK3B;ROCK2;SPI1;LEPROTL1;CTNNA1;LEPROT;LATS2
prerank,male gonad development (GO:0008584),0.46745471413797457,1.240091695575452,0.19047619047619047,0.6069051740450716,1.0,5/34,4.94%,FSHR;WNT5A;GATA6;WNT2B;FGF9
prerank,positive regulation of release of sequestered calcium ion into cytosol (GO:0051281),0.47288864670342384,1.24004219216118,0.20973782771535582,0.6064190818404409,1.0,8/32,15.90%,CEMIP;XCL1;PKD2;CXCL10;CALM3;CALM2;THY1;CX3CL1
prerank,positive regulation of protein kinase B signaling (GO:0051897),0.4038021976769647,1.2400046296712497,0.11295336787564766,0.6059016508833757,1.0,38/150,17.19%,PDGFRA;TCF7L2;IAPP;FGF20;MYORG;GAB2;PDGFRB;FGF7;EGF;IRS1;FGF9;FGFR1;RAC1;FRS2;EGFR;PIK3R1;TGFBR1;STRN;THEM4;HPSE;PIK3AP1;RICTOR;SPRY2;PIK3R5;GCNT2;GRB2;FGF2;PTK2;ITGB1BP1;TNF;MST1R;CX3CL1;MC1R;RASD2;ANGPT1;VAV1;PTPRJ;BTC
prerank,L-alpha-amino acid transmembrane transport (GO:1902475),0.4876837335290759,1.2397580268003252,0.2109479305740988,0.6060296055700362,1.0,2/27,0.58%,SLC7A2;SLC1A3
prerank,G1/S transition of mitotic cell cycle (GO:0000082),0.4226576622739909,1.2394848708656694,0.14855875831485588,0.6061788189323667,1.0,23/83,16.38%,BACH1;KHDRBS1;CDKN2D;CDK14;CCNE2;E2F1;CACUL1;CUL1;ACVR1B;ACVR1;E2F3;BRD4;CDK6;FBXO5;CDK7;RPS6KB1;TFDP1;GSPT1;RCC1;DBF4;CDC25A;EIF4EBP1;CCNH
prerank,positive regulation of cell cycle G2/M phase transition (GO:1902751),0.5093542039397226,1.2394317155111203,0.21796565389696168,0.6056729357453166,1.0,4/21,14.70%,RAD51B;BRD4;FBXO5;CDC25A
prerank,heart process (GO:0003015),-0.450740247461177,-1.2393886775966598,0.22712933753943218,0.6457797346537018,1.0,5/14,20.56%,SGCD;SGCZ;ACE;PPCS;SOD1
prerank,autophagosome assembly (GO:0000045),0.443519249873311,1.2390026326229056,0.18742857142857142,0.606216389692223,1.0,23/52,26.30%,VMP1;WIPI1;AMBRA1;ATP2A2;STX17;ATG3;UBQLN1;RAB7A;UBXN2A;SMURF1;PIK3C3;ATG16L2;ATG14;TRAPPC8;ATG16L1;WDR45;PACS2;RAB1A;ATG7;MFN2;WIPI2;ATG2A;ATG9A
prerank,regulation of cytoplasmic transport (GO:1903649),0.5867845288761216,1.238767539558944,0.2345679012345679,0.6062726692933409,1.0,7/11,23.28%,LRRK2;DNAJC13;MAP2K1;CHMP3;MAP2K2;SRC;MAPK1
prerank,regulation of MAP kinase activity (GO:0043405),0.4160916130684848,1.2385243990910346,0.15800865800865802,0.6063416936582374,1.0,35/92,24.28%,IL34;ADIPOQ;EDN3;TNFSF11;PDGFRB;CD40;LRRK2;APOE;IRAK3;EGF;FGFR1;EGFR;NF1;PTPN1;SPRY2;PIK3R5;FGF2;TNF;MST1R;EZH2;PDCD10;ROBO1;PTPRJ;HGS;TRIB3;UCHL1;FGF18;CDK5RAP3;TRIB1;BMP7;CDK12;TGFB1;CD24;AGT;KSR1
prerank,positive regulation of neuron projection development (GO:0010976),0.41580186035822575,1.2381411367278392,0.15641855447680691,0.6067510603276082,1.0,12/85,8.58%,ROR2;ROR1;PTN;TENM3;WNT5A;DPYSL3;APOE;DBN1;MDK;BMP5;DBNL;FZD1
prerank,positive regulation of G1/S transition of mitotic cell cycle (GO:1900087),0.4956087575288598,1.2376956976489455,0.21121251629726207,0.6073948884181071,1.0,9/26,11.49%,ANXA1;AIF1;ADAMTS1;EGFR;CDK10;CCND3;RPTOR;UBE2E2;TFDP1
prerank,positive regulation of transcription of Notch receptor target (GO:0007221),0.5403567394873342,1.2370447202222206,0.21468926553672316,0.6086987752662778,1.0,7/17,12.71%,STAT1;MAML3;CREBBP;PLXND1;MAML2;HEYL;RBPJ
prerank,IRE1-mediated unfolded protein response (GO:0036498),0.4416299025303613,1.2369748844262887,0.2,0.6082515889428,1.0,13/52,17.15%,CXXC1;WIPI1;SEC31A;KDELR3;ERN2;YIF1A;EDEM1;DDX11;XBP1;ARFGAP1;EXTL3;SYVN1;CUL7
prerank,cellular response to nerve growth factor stimulus (GO:1990090),-0.38993831376581733,-1.2366319530609908,0.18951612903225806,0.6506334550367616,1.0,7/22,13.56%,KIDINS220;SH3GL2;RAPGEF2;NTRK2;STMN2;BDNF;RAP1A
prerank,relaxation of muscle (GO:0090075),-0.45771727054948036,-1.236234066229711,0.19801980198019803,0.6487015492450493,1.0,7/13,22.47%,ATP1B1;ATP1A2;KCNJ2;GSN;ATP1A1;PIK3CA;PLN
prerank,negative regulation of actin filament bundle assembly (GO:0032232),-0.3705866992851027,-1.2361491781356022,0.14285714285714285,0.6459613382419955,1.0,7/27,4.95%,TJP1;TMEFF2;SHANK3;PRKN;RHPN2;ARHGAP28;INPP5K
prerank,amino sugar metabolic process (GO:0006040),0.5969984146076973,1.2351069947028492,0.23333333333333334,0.6128893348252817,1.0,3/10,5.87%,B4GALNT2;ST6GAL1;GFPT2
prerank,regulation of endothelial cell migration (GO:0010594),0.4163985489247173,1.2349596909055274,0.16198704103671707,0.6126230149023185,1.0,24/85,17.39%,DCN;SPARC;PRKCA;NRP1;PTN;NR2F2;WNT5A;RHOJ;APOE;EGF;PRKD2;RAC1;APOH;NF1;ADAMTS9;SASH1;FGF2;PTK2;ITGB1BP1;ABL1;SP100;ANGPT1;ROCK2;RIN2
prerank,positive regulation of stress-activated protein kinase signaling cascade (GO:0070304),0.5356682188480557,1.2345875630425922,0.2190082644628099,0.6130414444553988,1.0,7/17,22.48%,MID1;TAOK1;TAOK3;EIF2AK2;PDCD10;TGFB2;STK25
prerank,negative regulation of MAPK cascade (GO:0043409),0.42091397783247136,1.2345616952188867,0.15065502183406113,0.6124651284386979,1.0,21/87,15.51%,ADIPOQ;FBLN1;TNIP1;APOE;DUSP26;IRAK3;PTEN;CNKSR3;SPRED1;SPRED2;NF1;FOXM1;PTPN1;SPRY2;EMILIN1;SIRPA;EPHB2;RANBP9;ITGB1BP1;FLCN;PTPN2
prerank,neural tube closure (GO:0001843),0.4621052174493794,1.2344824131790262,0.20833333333333334,0.6120492826250437,1.0,5/34,6.42%,DLC1;DEAF1;DVL2;MTHFD1L;MTHFR
prerank,cellular response to steroid hormone stimulus (GO:0071383),-0.4255494947110797,-1.233944728994126,0.17105263157894737,0.6491404729559226,1.0,5/17,18.13%,BMP4;ATP1A2;URI1;GPER1;ATP1A1
prerank,negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902236),0.5490829195421596,1.2333392971551838,0.21357850070721357,0.6147625509329003,1.0,6/14,16.30%,CREB3L1;LRRK2;XBP1;CREB3;SELENOS;SYVN1
prerank,endothelial cell development (GO:0001885),0.500819450559656,1.2331987733748069,0.2238033635187581,0.6145603151586772,1.0,2/25,0.24%,COL15A1;COL18A1
prerank,glial cell development (GO:0021782),0.49979456699694796,1.232977108253797,0.21596858638743455,0.6145310477675612,1.0,9/25,18.15%,TLR2;MDK;NF1;CDK6;MYRF;TPPP;EIF2B3;PICK1;MXRA8
prerank,amyloid-beta metabolic process (GO:0050435),-0.4367447402647276,-1.2328989030310613,0.18092105263157895,0.6492612635108211,1.0,7/16,17.51%,BACE2;APH1A;APH1B;ACE;IDE;APEH;BACE1
prerank,regulation of kinase activity (GO:0043549),0.41334474260633264,1.2328508575968562,0.1627155172413793,0.6142490935325099,1.0,14/89,10.07%,ROR2;ROR1;EPHA7;PDGFRA;PDGFRB;DDR2;TREM2;EPHB3;FGFR1;NPRL2;EGFR;EPHA1;DDR1;MERTK
prerank,negative regulation of macromolecule metabolic process (GO:0010605),0.39791626916313927,1.2327987230391346,0.08841463414634146,0.6137648823470694,1.0,50/182,20.07%,RUNX1;RBMS3;CREB3L1;ITGB8;YAP1;APOBEC1;SFRP1;SFRP2;ATXN2;APOE;REL;FLOT2;APLN;CELF1;CCR1;SUB1;HDAC1;LGALS9;OLFM1;MAP2K1;NFKB1;EMILIN1;ERP29;TNRC6B;DLG4;DICER1;FGF2;TERT;SETDB1;SDCBP;FLCN;ANXA7;FBXW7;MOV10;YY1;TNF;PARP14;PSEN1;TLE5;PDCD10;ROBO1;ROCK2;SPI1;SMO;MSR1;SMCR8;MAP2K2;ANKRD13B;SETDB2;TGFB2
prerank,regulation of cytokinesis (GO:0032465),0.42158541722956416,1.2327355318961923,0.16883116883116883,0.6133164899983641,1.0,22/78,14.40%,SVIL;PDXP;FSD1;KLHL13;CCP110;CDC42;ENTR1;MYO19;PLK1;E2F8;CSPP1;CALM3;VPS4A;CDC14B;DRD3;CALM2;RAB11FIP4;PIK3C3;PIK3R4;ZFYVE26;FLCN;OPN1MW
prerank,phosphatidylserine acyl-chain remodeling (GO:0036150),0.5161463425859253,1.2327206093589933,0.2356948228882834,0.6127287974577109,1.0,7/21,21.63%,PLA1A;PLA2G5;PLA2G12A;OSBPL5;PLA2G4A;LPCAT3;PLA2G4E
prerank,lipid oxidation (GO:0034440),0.5735919971114654,1.2326451732832207,0.23660714285714285,0.6123171368389335,1.0,3/12,9.00%,ADIPOQ;PLA2G7;ACOX1
prerank,response to organonitrogen compound (GO:0010243),0.463188913603723,1.231892922589102,0.20245398773006135,0.6139000799941582,1.0,9/38,16.30%,NR1H4;ERLEC1;IRAK3;GLRB;RCN3;DRD3;BRSK2;RRAGC;SYVN1
prerank,regulation of lysosomal lumen pH (GO:0035751),0.5659572746641903,1.2316872199965503,0.2603719599427754,0.613883256848957,1.0,3/12,4.72%,ATP6AP2;LRRK2;CLN6
prerank,neurogenesis (GO:0022008),0.4511198649454244,1.2312864851142105,0.19785458879618595,0.6144744021246408,1.0,6/43,10.70%,WNT2;TRAK1;ANXA1;DCHS1;CDK6;CXCR4
prerank,regulation of lipoprotein lipase activity (GO:0051004),0.5362626666480204,1.231281625641274,0.22160664819944598,0.6138633490913088,1.0,5/17,12.50%,LIPC;LPL;APOH;ANGPTL4;PCSK5
prerank,positive regulation of toll-like receptor signaling pathway (GO:0034123),0.49282078216644487,1.231026403111967,0.22559366754617413,0.6140037901020184,1.0,3/26,4.50%,LBP;TLR2;TIRAP
prerank,negative regulation of developmental process (GO:0051093),-0.3043115809827954,-1.2310049850909788,0.12612612612612611,0.6514523888291116,1.0,20/69,11.70%,NFIB;RAPGEF3;BMP4;NOS3;PRKN;HUWE1;CST3;DCC;GAS6;KLF7;TBX1;ARHGEF15;TFRC;IL17D;PINK1;NOTCH4;GRIN3A;BNIP3;RC3H1;HEY2
prerank,vasculature development (GO:0001944),0.5303537099560723,1.2309652386168934,0.22807017543859648,0.6135483327127033,1.0,3/16,3.16%,PDGFRA;ERRFI1;PDGFRB
prerank,regulation of feeding behavior (GO:0060259),0.5800835178378021,1.23093812802469,0.25076923076923074,0.6130017777416872,1.0,2/11,6.99%,QRFP;STAT3
prerank,zinc ion transmembrane transport (GO:0071577),0.5086586084150844,1.23091512931249,0.2158176943699732,0.6124531974569223,1.0,1/22,0.16%,SLC39A14
prerank,cell cycle G1/S phase transition (GO:0044843),0.43640415712478126,1.2308768207475322,0.18663594470046083,0.6119422544255021,1.0,18/61,16.38%,KHDRBS1;CDKN2D;CCNE2;E2F1;CACUL1;CUL1;ACVR1B;ACVR1;E2F3;CDK6;CDK7;RPS6KB1;GSPT1;RCC1;DBF4;CDC25A;EIF4EBP1;CCNH
prerank,regulation of cell population proliferation (GO:0042127),0.3850127120056083,1.2305150014075577,0.008,0.6123758385105699,1.0,111/691,13.89%,ROR2;RUNX1;GLMN;CYP1B1;COL18A1;IL34;DLC1;CXCL5;WNT2;IGFBP7;PDGFRA;EDN3;CXCL1;OSMR;ZFP36L1;TCF7L2;YAP1;PPP1R9B;FGF20;S1PR2;BCL6;MEIS2;SFRP4;PTN;SFRP1;NUAK1;GAB2;CCAR1;SFRP2;EAPP;JAK2;PDGFRB;STAT1;TIMP1;ALDH1A2;PRTN3;FGF7;JAG1;BCL2;EGF;IRS1;TSLP;IRF1;GNL3;CDKN2B;PKD2;WNT9A;FGF9;EEF1E1;FGFR1;CELF1;PTEN;CDKN2D;TBX2;NF2;FRZB;SHH;FXN;MEIS1;TGFB1I1;LIMS1;AIF1;CYP27B1;ADAMTS1;STAT3;EGFR;HDAC1;CDK10;BMP5;CACUL1;PINX1;NCK2;TGFBR1;STRN;CXCL10;PTPN6;EPHA1;FOXM1;STAT5A;GLP2R;TGFB3;CDK6;MAP2K1;S1PR3;TNFRSF9;CDK13;FBXO5;FRK;SIRT2;XBP1;GCNT2;WWTR1;ABI1;EIF2AK2;SFRP5;RBFOX2;FGF2;GPNMB;IL7;PDPN;PTK2;CTCF;RERG;BTG1;PDS5B;STAT6;DLG5;SDCBP;ITGB1BP1;JUNB;AXIN2
prerank,positive regulation of mitochondrial translation (GO:0070131),0.5534685542855142,1.2302594904000057,0.2405446293494705,0.6125002678882407,1.0,2/14,3.62%,RPUSD3;TRUB2
prerank,negative regulation of protein depolymerization (GO:1901880),0.4933294980661671,1.230127104552957,0.22465753424657534,0.6122904687066312,1.0,7/24,12.61%,TAOK1;NAV3;LIMA1;CAMSAP2;PLEKHH2;FGF13;TPX2
prerank,negative regulation of organelle assembly (GO:1902116),0.4653805707619539,1.229999579739958,0.2105911330049261,0.612043675344176,1.0,14/35,20.59%,YAP1;LRRK2;CHMP4B;CHMP4A;CCP110;CDK10;TMEM39A;TBC1D7;PHF23;SCFD1;SMCR8;FEZ2;EVI5L;MTM1
prerank,protein ADP-ribosylation (GO:0006471),0.4772125703083501,1.2292147081753302,0.21524064171122995,0.6136289932057165,1.0,10/28,23.89%,PARP8;PARP3;PARP11;SIRT2;PARP14;TNKS2;PARP1;ARF4;SIRT3;PARP4
prerank,regulation of platelet aggregation (GO:0090330),0.5328952673562456,1.229192943303626,0.23098591549295774,0.6130712010068887,1.0,5/17,13.03%,PRKCA;SERPINE2;BLK;ADAMTS18;PDPN
prerank,negative regulation of cell morphogenesis involved in differentiation (GO:0010771),0.5763563889265217,1.2291702366746562,0.23916292974588937,0.6118927274382043,1.0,5/12,22.93%,FBLN1;EFNA5;ITGB1BP1;CORO1C;AP1AR
prerank,negative regulation of substrate adhesion-dependent cell spreading (GO:1900025),0.5763563889265217,1.2291702366746562,0.23916292974588937,0.6118927274382043,1.0,5/12,22.93%,FBLN1;EFNA5;ITGB1BP1;CORO1C;AP1AR
prerank,"negative regulation of translation, ncRNA-mediated (GO:0040033)",-0.4821782150484272,-1.2290494534101937,0.23353293413173654,0.6510031920434263,1.0,7/11,41.29%,NOTCH4;ZFP36;TNRC6C;RBM4;TNRC6A;TRIM71;AGO4
prerank,miRNA mediated inhibition of translation (GO:0035278),-0.4821782150484272,-1.2290494534101937,0.23353293413173654,0.6510031920434263,1.0,7/11,41.29%,NOTCH4;ZFP36;TNRC6C;RBM4;TNRC6A;TRIM71;AGO4
prerank,regulation of endothelial cell chemotaxis (GO:2001026),-0.4353827753761079,-1.2287708792874934,0.19614147909967847,0.6489137674248654,1.0,6/15,10.63%,TMSB4X;FGF1;HSPB1;THBS1;PRKD1;SEMA5A
prerank,positive regulation of G2/M transition of mitotic cell cycle (GO:0010971),0.5275227289831512,1.2278147886386894,0.2327469553450609,0.6151471688917266,1.0,4/18,14.70%,RAD51B;BRD4;FBXO5;CDC25A
prerank,mucosal immune response (GO:0002385),-0.43763504360706174,-1.2270228933614227,0.1830065359477124,0.6509760652201828,1.0,12/15,53.93%,DEFA6;IFNLR1;NOS2;OTUD7B;RAB17;IL4;CAMP;BPIFB1;DEFB1;FFAR2;LTF;PIGR
prerank,regulation of melanin biosynthetic process (GO:0048021),0.6028508613356935,1.2266156065700682,0.24574961360123648,0.6179725347879836,1.0,1/10,0.35%,ZEB2
prerank,carboxylic acid transport (GO:0046942),-0.3016885200961712,-1.226534120167605,0.125,0.6494998257577405,1.0,13/55,13.67%,SLC6A6;SLC6A9;SLC13A3;SLC16A11;SLC16A1;SLC1A1;SLC7A5;SLC16A9;SLC16A4;SLC38A5;SLC6A17;SLC6A7;SLC16A13
prerank,epidermal cell differentiation (GO:0009913),0.4532877465400004,1.2265162043996027,0.19184652278177458,0.6176196023479807,1.0,6/41,7.08%,WNT5A;GATA6;UGCG;JAG1;ANXA1;HDAC1
prerank,Fc-epsilon receptor signaling pathway (GO:0038095),0.4066317565728395,1.2264429448524483,0.15084388185654007,0.6172271653674378,1.0,30/109,21.05%,PSMA7;TEC;VAV2;GAB2;VAV3;MAP2K4;LCP2;RAC1;PIK3R1;CUL1;PSMD4;PSMD11;NFKB1;GRB2;PSMB8;PPP3CA;LAT2;FBXW11;SKP1;MAPK9;PSMA6;VAV1;PSMD14;PSMC6;PSMB10;PSMD12;PSMB1;PSMA8;PSMF1;PAK1
prerank,nucleoside triphosphate metabolic process (GO:0009141),0.5507401811255266,1.2261071289494652,0.23065693430656933,0.6175709497538833,1.0,1/14,0.31%,ENPP1
prerank,immune response-activating cell surface receptor signaling pathway (GO:0002429),0.5186978137161483,1.2255697823402205,0.23196605374823195,0.618567458515349,1.0,4/18,11.05%,CMKLR1;BLK;BAG6;SH2B2
prerank,polarized epithelial cell differentiation (GO:0030859),0.5521346480630455,1.2255226978148974,0.25588235294117645,0.6180960970598705,1.0,7/13,21.80%,RAP2A;OPHN1;CDC42;RAB10;MSN;RHOA;MYO9A
prerank,regulation of apoptotic signaling pathway (GO:2001233),-0.3418397027544576,-1.22535992274763,0.17010309278350516,0.6498560981054509,1.0,17/36,20.46%,RB1;TPD52L1;SGMS1;MADD;CRADD;CYLD;NR4A2;QARS1;TMBIM6;BDNF;BCL2L12;TRIM39;ASAH2;STYXL1;PPIA;FAS;TRAF1
prerank,regulation of transcription by RNA polymerase II (GO:0006357),0.38013232434272803,1.2251942416561081,0.0,0.6183589122902723,1.0,399/1668,19.66%,RORA;RUNX1;NR1H4;RUNX2;DCN;ZEB2;KMT2A;TRPS1;SOHLH2;CREB3L1;WNT2;RUNX3;POU5F1;ZEB1;PAX1;GLI2;PLAC8;ETV6;TCF7L2;TCF4;SNAI1;NCOR2;YAP1;SBNO2;MRTFA;ATXN1;CBX8;DEAF1;MED13L;TEAD3;PRRX1;SOX5;TNIP1;BCL6;ZMIZ1;NKX6-1;NRIP1;MEIS2;GLI3;TNFSF11;ASXL1;BRIP1;BACH1;PKNOX2;MIER2;SLC9A1;TBX18;USF1;CREB3L3;NR2F2;RCOR1;EGR3;AUTS2;SATB2;ABCA2;SFRP2;ZBTB48;TLR2;IRF7;WNT5A;NFIX;VGLL3;SUFU;DDX17;BAZ1A;GLIS1;STAT1;MITF;CD40;ZFPM2;FHL2;RARB;USP9X;SNAI2;MLXIP;SMAD2;ZIC4;APOE;GATA6;MAFB;NPAS4;CAMK2D;REL;JAG1;PRRX2;TRAK1;CRYM;DUSP26;BATF;RXRG;DNAJB1;ACTR2;IRF1;BAZ2B;CDKN2B;ARNT;LAGE3;ARID5B;HOXB3;PRKD2;PKD2;LITAF;BHLHE22;POU2F1;METTL23;OGT;PID1;MLIP;KMT5A;ZNF496;SMURF2;SOX21;ZNF292;PTEN;ZHX2;ZKSCAN1;ZBTB10;UBP1;INO80;SMARCC1;TBX2;SHH;ZNF260;DVL2;ZBTB5;ZBTB38;PPID;MEIS1;CGGBP1;E2F1;ARID5A;MMP12;ATM;NFKB2;ARID1B;ZNF25;TEAD1;RNF111;ZSCAN12;PPRC1;PHF2;MYBL1;MED13;RNF2;CEBPD;SUB1;HEXIM1;PRDM2;MAML3;STAT3;EGFR;HDAC1;SP110;ELF4;BMP5;MTA2;PIK3R1;NIPBL;TSHZ3;CRTC3;CREBBP;HSF2;CC2D1B;TAF7;MACC1;NCK2;CCNL1;CREB3L2;PLK1;ASXL2;SMARCD3;BAX;MED12;PRDM5;CBFB;NCK1;CXCL10;IL33;ZNF250;SP140;KDM7A;FOXM1;PBX3;ACVR1;SQSTM1;FOXK2;ZBTB20;PPARG;E2F3;E2F8;TCF7;STAT5A;ZBED3;PIAS2;TGFB3;BRD4;BHLHE40;NR1D2;CDK9;MXI1;ENO1;FOXE1;ZNF418;MED14;MDFI;ZBTB12;MBD2;SLC30A9;ETV5;TCF12;BCL11B;NFKB1;CHD2;CDK13;FOXJ3;AHR;CDK7;FRK;TNRC6B;HDAC5;SIRT2;PHF21A;SALL1;HOXA1;TADA2B;CHD8;FOXP4;NFE2L3;XBP1;NOC2L;ATRX;SAFB2;CAMTA2;CRTC1;MAML2;ACVR2A;WWTR1;AHRR;CALCOCO1;TFDP1;CREB3L4;CREB3;SETX;HDAC3;NR2F1;RRP1B;DICER1;ZNF367;MAFG;EPC2;ZIC1;BACH2;FGF2;ZNF445;FNIP1;GLIS3;HEYL;PPP3CA;GATAD2B;ZNF182;RBPJ;HTATIP2;PGBD1;HIVEP2;PRDM1;SMAD5;HIVEP1;CCNT1;CTCF;LCOR;TCF3;TCF7L1;NEUROD6;STAT6;SMAD3;CLOCK;LRP6;TGIF2;SDCBP;ITGB1BP1;JUNB;NUCKS1;GLYR1;HSPD1;NSD1;PHF12;TBL1X;RELB;HMGB2;RIF1;PTPRN;RTRAF;FLCN;GTF2H1;SAP18;CXXC5;NOP2;ZSCAN22;ELK4;THRAP3;MOV10;NR2C2;RSF1;YY1;SP7;MYSM1;MDM2;TCEA1;ZNF276;GABPB1;TNF;NPAS2;TADA3;ABL1;PELP1;CX3CL1;TAF9B;POU5F2;HMGB3;EZH2;AKAP8L;ECD;MAMLD1;ZNF35;MC1R;NKX2-8;HNRNPK;RBBP8;ZKSCAN8;SP100;TET2;MED21;KDM2A;PSEN1;CCNH;TLE5;DNMT3B;ZNF692;MED15;KLF10;EID1;CC2D1A;GDNF;ATF2;LIN9;ARID4B;CCNC;MPND;TCERG1;RUVBL1;TNFRSF1A;RPS6KA3;HCFC2;PTCH1;ZFP62;TBX3;HOXB2;SKOR2;NFE2L2;SPI1;KMT2D;EGR2;BBS7;GABPA;CDC73;TFAP2C;BBX;ZSCAN25;KCNIP3;SRCAP;RPAP2;AASS;SSBP2;TRIB3;ZGPAT;TLR3;MTA3;KDM3B;BRD3;MOSPD1;SAFB;DVL1;TRIM27;PHF20;CBX5;FOXO3;TFCP2;GRIN1;CARF;GTF2F1;TFCP2L1;ZNF23;ZNF32;ELK1;PATZ1;ARRB1;SMARCB1;SMARCA4;PARP1
prerank,protein homotrimerization (GO:0070207),0.5496409984852295,1.2251929504529375,0.23484848484848486,0.617131421986509,1.0,5/14,15.26%,STEAP4;MLKL;ALOX5AP;SLC1A5;ASIC1
prerank,protein trimerization (GO:0070206),0.5496409984852295,1.2251929504529375,0.23484848484848486,0.617131421986509,1.0,5/14,15.26%,STEAP4;MLKL;ALOX5AP;SLC1A5;ASIC1
prerank,positive regulation of vacuole organization (GO:0044090),0.5787907037442527,1.2247972808561503,0.24115755627009647,0.6176442390714386,1.0,6/10,21.68%,PIP4K2A;RAB3GAP2;PIP4K2B;SH3GLB1;RAB3GAP1;ANXA2
prerank,cellular response to decreased oxygen levels (GO:0036294),0.4260249214586171,1.2244293957272536,0.18857142857142858,0.618074208607085,1.0,15/65,17.84%,RORA;ZFP36L1;CPEB1;SFRP1;GATA6;UBQLN1;SIRT2;TBL2;TERT;STUB1;MDM2;NPEPPS;FAM162A;PICK1;PTGS2
prerank,mitochondrial cytochrome c oxidase assembly (GO:0033617),-0.41342508674143524,-1.2241700796622597,0.22033898305084745,0.6504293251355744,1.0,7/18,20.66%,COX16;COX18;PET100;COX14;TIMM21;SCO1;COA3
prerank,"protein localization to chromosome, centromeric region (GO:0071459)",-0.4041339303103919,-1.2236407908895723,0.16727272727272727,0.6489786307695136,1.0,8/17,30.92%,RB1;BUB3;ZWILCH;IK;MTBP;KNL1;TTK;SPDL1
prerank,clathrin-dependent endocytosis (GO:0072583),-0.3648113019525165,-1.223174116857,0.16379310344827586,0.6474236246192816,1.0,11/26,13.47%,FCHSD2;SGIP1;INPP5F;ITSN2;FNBP1L;CLTB;AP2M1;CLTA;PIP5K1C;LMBRD1;AP2B1
prerank,regulation of cation transmembrane transport (GO:1904062),-0.3709961917631599,-1.2227858476897295,0.1267605633802817,0.6456027401336992,1.0,8/29,10.58%,KCNIP4;SNTA1;FGF12;DPP6;CACNA1D;WNK3;DPP10;ATP2B4
prerank,myofibril assembly (GO:0030239),0.4437150259652619,1.2224620903705485,0.22506082725060828,0.6231690844256124,1.0,8/42,13.51%,PDGFRA;CSRP1;PDGFRB;CFLAR;FHOD3;OBSL1;TMOD1;TPM1
prerank,protein methylation (GO:0006479),0.45157316176435475,1.2223670439366177,0.20359281437125748,0.6228036202245671,1.0,15/40,23.49%,EHMT1;CARM1;NSD3;ETFBKMT;GSPT1;PCMT1;NSD1;PRMT5;VCPKMT;EZH2;LCMT1;FAM98A;NTMT1;PRMT6;RAB6A
prerank,miRNA metabolic process (GO:0010586),0.5073284359221001,1.222088214905794,0.22821576763485477,0.6229793868860223,1.0,10/20,24.61%,DDX17;KHSRP;SND1;TARBP2;DICER1;DGCR8;LIN28B;DIS3L2;TUT7;BCDIN3D
prerank,negative regulation of immune system process (GO:0002683),0.5344931769855077,1.2220718597904943,0.22416302765647744,0.6224059759891796,1.0,2/16,8.05%,COL3A1;FCGR2B
prerank,lamellipodium organization (GO:0097581),-0.3605095886449841,-1.2219684977285454,0.13875598086124402,0.6450063824969341,1.0,7/29,6.27%,ABLIM1;KIT;ABLIM3;S1PR1;CDH13;PTPRO;PARVB
prerank,actomyosin structure organization (GO:0031032),-0.3023876432464802,-1.2218147880688432,0.1326530612244898,0.642676827102674,1.0,10/75,6.61%,SORBS1;TJP1;PGM5;PHACTR1;FRMD5;ACTN2;EPB41;EPB41L5;TMOD3;KCTD13
prerank,peptide cross-linking (GO:0018149),0.49637383239162947,1.2216611792849479,0.22395833333333334,0.6228983269340833,1.0,2/25,4.59%,COL3A1;ANXA1
prerank,central nervous system neuron axonogenesis (GO:0021955),0.5602272798875063,1.22146721029901,0.2366412213740458,0.6228660514247711,1.0,5/12,13.99%,B4GALT5;MYCBP2;PTEN;EPHB2;ARHGAP35
prerank,regulation of cellular component movement (GO:0051270),0.43575973890400843,1.2212742297055195,0.1839348079161816,0.6227840652834512,1.0,18/49,21.05%,MYCBP2;ZSWIM6;EGF;EGFR;TGFBR1;CDK6;ZSWIM8;PDPN;MEMO1;ABL1;SP100;BTC;ROCK2;RHOA;FES;ZSWIM4;ETS1;PKN1
prerank,regulation of heart rate by cardiac conduction (GO:0086091),-0.3213331368287543,-1.220815633686691,0.14457831325301204,0.6428562207003098,1.0,7/38,3.94%,CAV1;CTNNA3;CACNB2;ANK2;KCNJ2;KCNJ3;KCND3
prerank,BMP signaling pathway (GO:0030509),0.43145948934014483,1.2200333286030194,0.19794050343249428,0.625630956617378,1.0,20/62,23.69%,RUNX2;USP9X;SMAD2;BMP5;ACVR1;TGFB3;ACVR2A;SMAD5;HIVEP1;SMURF1;SMAD3;ZFYVE16;RGMB;TGFB2;RGMA;ACVRL1;BMP7;MEGF8;CHRD;TGFB1
prerank,protein N-linked glycosylation (GO:0006487),0.4313628171144157,1.2200061825586148,0.18222722159730034,0.6250891856819888,1.0,22/66,19.51%,MGAT5;B4GALNT2;ALG5;ST6GAL1;GFPT2;UGGT2;DDOST;MAN1C1;UBE2J1;TMEM258;LMAN1;MGAT3;SRD5A3;DPM2;STT3A;ALG6;OSTC;NUDT14;ST3GAL1;ALG8;TUSC3;MGAT4A
prerank,regulation of vascular associated smooth muscle cell migration (GO:1904752),0.567684698322229,1.2196776155961284,0.2578241430700447,0.6253708781670977,1.0,4/12,6.78%,ADIPOQ;IGFBP5;FGF9;ADAMTS1
prerank,negative regulation of voltage-gated calcium channel activity (GO:1901386),0.589661199082582,1.2195609907503309,0.25076452599388377,0.625123852142484,1.0,4/10,12.37%,CBARP;CALM3;FMR1;DRD3
prerank,positive regulation of endoplasmic reticulum unfolded protein response (GO:1900103),0.5516877031221555,1.218896561856639,0.22288261515601784,0.6264946190631242,1.0,4/12,10.96%,PIK3R1;BAX;PTPN1;XBP1
prerank,"antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO:0002479)",0.42529039158386833,1.218765607551062,0.18089887640449437,0.6262520248293445,1.0,17/67,21.00%,PSMA7;ITGB5;PDIA3;CD36;PSMD4;PSMD11;PSMB8;PSMA6;PSMD14;PSMC6;PSMB10;PSMD12;PSMB1;CALR;FCGR1A;PSMA8;PSMF1
prerank,regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030947),0.48800885964811475,1.2184023685880485,0.2376502002670227,0.6266595971621969,1.0,8/24,20.05%,VTN;ARNT;PRKD2;PTPN1;EMILIN1;ITGA5;HGS;NEDD4
prerank,positive regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043280),0.4027010161421465,1.2181489633259117,0.15767195767195769,0.626750914725184,1.0,25/108,17.47%,CASP4;DLC1;DAP;JAK2;CASP8AP2;CASP1;CFLAR;CTSD;CASP12;BBC3;EIF2AK3;BAX;IFT57;LGALS9;PPARG;NOD1;HSPE1;TRAF2;SMAD3;HSPD1;CASP8;TNF;ROBO1;FAM162A;ACVR1C
prerank,regulation of protein exit from endoplasmic reticulum (GO:0070861),0.5543187359129609,1.21814537479423,0.27031019202363366,0.6261432893104939,1.0,3/13,7.07%,SEC16B;SEC16A;TM9SF4
prerank,regulation of leukocyte activation (GO:0002694),-0.44903098292108656,-1.2177239575820848,0.2079207920792079,0.6485899171270475,1.0,5/14,19.46%,CD200;MYO18A;SHPK;GPER1;MIF
prerank,mitochondrial ATP synthesis coupled electron transport (GO:0042775),-0.2968682449795246,-1.2176201703739997,0.1,0.6461456278336042,1.0,36/69,30.74%,COX5A;COX8A;NDUFS1;COX4I1;NDUFV2;NDUFA13;COX6A1;NDUFA8;NDUFA11;NDUFC2;NDUFB7;UQCRB;COX6C;COX5B;SDHAF2;NDUFA1;COX6B1;UQCRC2;NDUFB11;COX10;UQCRFS1;UQCR10;UQCR11;NDUFV1;UQCC3;NDUFA10;COA6;NDUFA3;NDUFC1;NDUFA12;COX15;NDUFS3;NDUFB10;UQCRH;NDUFA6;SDHD
prerank,negative regulation of interferon-beta production (GO:0032688),0.5772791632890694,1.217206740243773,0.2578616352201258,0.6281712554469384,1.0,4/10,15.00%,REL;SIRPA;RELB;YY1
prerank,positive regulation of receptor-mediated endocytosis (GO:0048260),0.44578744976819473,1.2170314213987838,0.2237163814180929,0.6280347283188463,1.0,13/40,19.65%,C3;SFRP4;VTN;EGF;RAB21;CD63;CBL;FMR1;HNRNPK;ANGPT1;PICK1;ARRB1;NTF3
prerank,positive regulation of cell growth (GO:0030307),0.40614498671410104,1.216939062515268,0.1819148936170213,0.6276675654611014,1.0,27/96,15.93%,MMP14;EIF4G2;SFRP1;SFRP2;BCL2;KLHL22;RNF157;INO80;FXN;DBN1;EGFR;CDC42;PABIR1;CDKN2AIP;DBNL;TGFBR1;SYT2;RPTOR;L1CAM;EXOSC4;SYT3;SMURF1;SDCBP;USP47;EXOSC2;UNC13A;TAF9B
prerank,apoptotic mitochondrial changes (GO:0008637),0.46167609780762386,1.216910849373954,0.2339622641509434,0.6271396437004348,1.0,13/32,20.27%,BCL2;AIFM2;BBC3;ATG3;HK2;BAX;THEM4;FZD9;CCAR2;HSPD1;FIS1;GGCT;TIMM50
prerank,fatty acid catabolic process (GO:0009062),0.4197016977725467,1.216873435929488,0.1875,0.6266388001927915,1.0,10/67,14.42%,CEL;ADIPOQ;EHHADH;ACOX1;SLC27A2;SLC27A4;MCEE;AIG1;ALDH3A2;PCCA
prerank,regulation of centrosome duplication (GO:0010824),0.4726586132644546,1.2160643169104501,0.2189873417721519,0.6284131891137476,1.0,11/29,24.18%,CEP295NL;ALMS1;CHMP4B;XRCC3;CEP120;FBXW5;CHMP3;NAT10;CENATAC;CHMP2B;PDCD6IP
prerank,B cell activation involved in immune response (GO:0002312),0.5537940794984322,1.2149917719604335,0.24850299401197604,0.6308151467705566,1.0,5/13,20.02%,BATF;FCGR2B;RNF8;EXOSC3;RNF168
prerank,T cell differentiation (GO:0030217),0.4476417873650344,1.2149685955417968,0.1941747572815534,0.6302682373182729,1.0,7/40,9.10%,ZFP36L1;GLI3;CHD7;ZFP36L2;ANXA1;SHH;TCF7
prerank,positive regulation of membrane protein ectodomain proteolysis (GO:0051044),0.5408670735524873,1.214589801758386,0.25702247191011235,0.6306905296347858,1.0,8/15,27.61%,APOE;SNX33;TNF;SNX9;NRDC;GPLD1;ADAM9;FURIN
prerank,response to exogenous dsRNA (GO:0043330),0.5131147001201922,1.214132466412464,0.23066485753052918,0.6313403444151392,1.0,3/18,4.25%,RFTN1;COLEC12;IRAK3
prerank,post-translational protein modification (GO:0043687),0.38175667988467926,1.214081275462598,0.06506506506506507,0.6308632484295636,1.0,56/332,14.60%,PSMA7;C3;ENAM;KNG1;IGFBP7;SPP1;LAMB1;CP;LAMC1;SPSB1;FSTL1;WSB2;IGFBP4;FBXO40;TIMP1;VCAN;APOE;FBN1;PRKCSH;IGFBP5;KLHL22;MIA3;FBXL7;CKAP4;DCAF10;KCTD7;CALU;COPS7A;FBXO7;LTBP1;KLHL13;RBBP5;RAB2A;CUL1;OBSL1;PSMD4;NEURL2;FN3KRP;DDB1;PSMD11;SDC2;FBXO31;TNC;DCUN1D1;UBE2F;PSMB8;CHML;FAM20C;FBXL18;FBXW10;FBXW11;STT3A;SKP1;FBXW5;FBXW7;FBXO30
prerank,negative regulation of response to biotic stimulus (GO:0002832),0.4744636315320655,1.2140690917091614,0.2282051282051282,0.6302935263769545,1.0,13/26,27.95%,TNFAIP3;IRAK3;TRIM21;ILRUN;SIRT2;DHX58;ITCH;TRIB1;TRAFD1;CARD16;TYRO3;LYAR;PPM1B
prerank,anaphase-promoting complex-dependent catabolic process (GO:0031145),0.41115696420687425,1.2140124049989236,0.19848975188781015,0.629830292637714,1.0,27/84,23.49%,PSMA7;MAD2L1;ANAPC11;PLK1;PSMD4;PSMD11;FBXO5;FBXO31;FZR1;CDC27;CDC16;PSMB8;ANAPC2;PSMA6;UBE2E1;PSMD14;UBE2S;PSMC6;PSMB10;PSMD12;PSMB1;PSMA8;PSMF1;RPS27A;PSME2;PSMA4;CDC23
prerank,carbohydrate derivative catabolic process (GO:1901136),-0.4149860348706038,-1.213709650038549,0.18345323741007194,0.6543506913873895,1.0,6/18,17.19%,OGA;SAMHD1;STT3B;DERA;FUCA1;FBXO44
prerank,tetrahydrobiopterin metabolic process (GO:0046146),-0.48465235203283313,-1.213079858379303,0.20771513353115728,0.6533524045091404,1.0,6/11,27.16%,NOS3;CALM1;PTS;DHFR;GCH1;PRKG2
prerank,regulation of mitotic metaphase/anaphase transition (GO:0030071),0.4826678685348475,1.2122716804073892,0.24473684210526317,0.6343174268562132,1.0,8/26,19.01%,NEK6;ANAPC11;PLK1;FBXO5;CDC27;CDC16;LCMT1;NSMCE2
prerank,kidney development (GO:0001822),0.4273638988842701,1.2117242541037423,0.2,0.6352851044327188,1.0,15/65,14.16%,SULF1;GLI2;ROBO2;ITGA8;GREB1L;SHH;NIPBL;NF1;TGFBR1;IFT88;SALL1;BAG6;PCSK5;NPHP3;STRA6
prerank,cellular response to hypoxia (GO:0071456),0.39806489021599367,1.2115670117500685,0.153125,0.6350959848330507,1.0,16/126,12.10%,PSMA7;RORA;ZFP36L1;CPEB1;BACH1;SFRP1;GATA6;ARNT;UBQLN1;CREBBP;PSMD4;PSMD11;SIRT2;TBL2;PSMB8;TERT
prerank,negative regulation of interleukin-17 production (GO:0032700),-0.4872056599398875,-1.2115503562801708,0.2647887323943662,0.6548072022286212,1.0,3/10,15.87%,TLR4;VSIR;NCKAP1L
prerank,monovalent inorganic cation homeostasis (GO:0055067),-0.3844769274963111,-1.2115082526895646,0.19921875,0.6522021823474887,1.0,4/23,4.08%,SLC12A7;SLC12A2;SLC12A6;CLCN3
prerank,positive chemotaxis (GO:0050918),0.5254046098485462,1.210947095120742,0.25034770514603616,0.6362541822088529,1.0,6/17,17.11%,NRP1;FGF7;GPNMB;CX3CL1;ANGPT1;PTPRJ
prerank,positive regulation of filopodium assembly (GO:0051491),0.4846520857277801,1.2108913400251862,0.22823218997361477,0.6358052577190407,1.0,8/24,12.19%,NRP1;DPYSL3;FSCN1;CDC42;PIK3R1;RALA;TGFB3;FMR1
prerank,positive regulation of transport (GO:0051050),0.4060416628285569,1.2106321088202323,0.18161683277962348,0.6359285512719135,1.0,19/85,15.60%,KMT2A;LRP1;PLA2G5;APOE;CALY;DYNC1H1;ANXA1;TREM2;KCTD7;FCGR2B;BAX;MERTK;CLIP3;FMR1;SIRPA;CD151;TUB;GSK3B;TNF
prerank,negative regulation of protein transport (GO:0051224),0.4850731086237614,1.210568821973452,0.24353741496598638,0.635495613192848,1.0,6/25,20.17%,ADIPOQ;APOE;ERP29;DRD3;DPH3;RHBDF1
prerank,regulation of cell communication (GO:0010646),0.4554684815196333,1.2104304564168658,0.22493887530562348,0.6352953583556744,1.0,5/35,4.59%,IGFBP7;TBX18;CAMK2D;UGCG;ANXA1
prerank,hexose transmembrane transport (GO:0008645),-0.37748239005949646,-1.2103870097061726,0.22310756972111553,0.6525118025289136,1.0,6/21,21.58%,SLC2A1;SLC2A12;SLC45A3;SLC2A8;SLC2A9;SLC45A1
prerank,cellular response to ketone (GO:1901655),0.4549027831281508,1.2097355103227847,0.2241169305724726,0.636671569973754,1.0,10/35,17.95%,SPP1;SFRP1;ADCY2;AHR;PTGER4;MSN;GNAI1;GNG2;ROCK2;SPHK2
prerank,calcium ion-regulated exocytosis of neurotransmitter (GO:0048791),-0.47063379091556834,-1.2082302206525437,0.22514619883040934,0.6558519168524943,1.0,5/12,16.06%,UNC13C;UNC13B;RIMS2;RIMS1;SYT7
prerank,metal ion homeostasis (GO:0055065),-0.32420905320811927,-1.2081521712746275,0.16483516483516483,0.6533520958755936,1.0,5/40,4.92%,SLC12A7;SLC12A2;CAV1;SLC12A6;LETM1
prerank,sulfur compound catabolic process (GO:0044273),0.4531914347742325,1.2081288547144073,0.23832923832923833,0.6405542313377542,1.0,14/38,22.11%,DCN;LUM;BGN;VCAN;PRELP;GALNS;GNS;IDS;ADO;ACAT1;ARSB;MLYCD;GLB1;GGT7
prerank,regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060211),-0.4345158819710563,-1.2074512000973114,0.20284697508896798,0.6524521219647019,1.0,10/15,31.54%,CPEB3;POLR2G;TOB1;ZFP36;TNRC6C;BTG2;PABPC1;EIF4ENIF1;CNOT1;TNRC6A
prerank,ear morphogenesis (GO:0042471),0.4975010736994196,1.2072391397092357,0.26021798365122617,0.6424264893079965,1.0,5/20,12.47%,CHD7;NIPBL;HOXA1;ZIC1;EPHB2
prerank,regulation of membrane depolarization (GO:0003254),0.5111548342568784,1.206779222185911,0.2369146005509642,0.6431619522881258,1.0,4/18,11.40%,LRRK2;CAMK2D;PTPN3;SCN2B
prerank,regulation of protein localization to cell surface (GO:2000008),0.4610198103675401,1.2067377444416396,0.23388116308470291,0.642663716587793,1.0,7/33,9.18%,GPM6B;ABCA2;EGF;TAX1BP3;TM9SF4;SNX33;KCNAB2
prerank,negative regulation of epithelial cell differentiation (GO:0030857),0.540083748382983,1.206673238966722,0.2526158445440957,0.6422439268838975,1.0,4/14,10.32%,ZEB1;SPRED1;SPRED2;SPRY2
prerank,peptidyl-threonine modification (GO:0018210),0.41872533986813737,1.2064798733697883,0.20317820658342792,0.6422120522168256,1.0,20/66,19.19%,PRKCA;LRRK2;CAMK2D;PRKD2;CSNK2A2;GALNT3;CDK10;TGFBR1;ACVR1B;ACVR1;MAP2K1;HIPK4;GALNTL6;GALNT11;HIPK3;GSK3B;ROCK2;GALNT16;CSNK2A1;CDK5
prerank,positive regulation of antigen receptor-mediated signaling pathway (GO:0050857),-0.39492078353711363,-1.2059719917365714,0.22900763358778625,0.6537580345539392,1.0,4/21,5.92%,PRKCH;CD81;SLC39A10;PRKCB
prerank,negative regulation of myotube differentiation (GO:0010832),0.5519947111780485,1.2057751309667242,0.2597968069666183,0.6436205080903108,1.0,5/12,11.57%,TMEM119;HDAC1;HDAC5;XBP1;HDAC3
prerank,regulation of substrate adhesion-dependent cell spreading (GO:1900024),0.43573617910297396,1.2054319599840646,0.2215568862275449,0.6440373492768833,1.0,13/47,15.79%,FBLN1;NRP1;CARMIL1;MDK;RAC1;LIMS1;CDC42;DOCK1;EFNA5;PDPN;PTK2;ITGB1BP1;ABL1
prerank,antigen receptor-mediated signaling pathway (GO:0050851),0.3885821529730175,1.2048053721330745,0.1408016443987667,0.6451922016407157,1.0,40/163,21.05%,PSMA7;RFTN1;TNFRSF21;TEC;CD276;VAV3;STOML2;BCL2;PRKD2;BLK;KHDRBS1;LCP2;PIK3R1;CUL1;PSMD4;NCK1;PSMD11;NFKB1;SH2B2;PSMB8;RC3H2;MS4A1;LAT2;FBXW11;THY1;SKP1;NFKBIZ;PSMA6;EIF2B3;RBCK1;PTPRJ;PSMD14;SPPL3;PSMC6;PSMB10;PSMD12;PSMB1;PSMA8;PSMF1;PAK1
prerank,cellular response to nutrient levels (GO:0031669),0.4181628455610333,1.204450057680101,0.2106430155210643,0.6455725914676623,1.0,27/62,26.78%,WIPI1;SFRP1;LPL;LRRK2;CDKN2B;CD68;INHBB;RPTOR;LAMP2;XBP1;FNIP1;FADS1;FLCN;RRAGC;ATG14;KLF10;VPS41;RIPOR1;WDR45;CLEC16A;STK24;ATG7;EIF4G1;SREBF1;WIPI2;FOXO1;PDK4
prerank,regulation of protein neddylation (GO:2000434),-0.4842109355763844,-1.204370418083686,0.2542372881355932,0.6557784046342576,1.0,4/10,11.88%,EPAS1;DCUN1D4;RPL5;DCUN1D3
prerank,nucleosome organization (GO:0034728),0.4304521460601689,1.2042146876034276,0.20809248554913296,0.645645985051342,1.0,21/55,22.37%,POLE3;INO80;SMARCC1;ASF1A;SMARCD3;RNF8;ATRX;GRWD1;CTCF;HMGB2;RSF1;ACTR6;NAP1L3;SRCAP;SPTY2D1;LIN54;SMARCB1;SMARCA4;NAP1L1;SMARCC2;SETD2
prerank,antigen processing and presentation of peptide antigen via MHC class II (GO:0002495),0.4050067066711938,1.204195716801856,0.20044052863436124,0.6444809749819351,1.0,17/78,12.38%,CLTC;DYNLL1;SEC31A;SEC24D;SEC23A;DYNC1H1;DCTN4;CTSD;CTSS;KIF2A;RAB7A;SEC24A;FCGR2B;CANX;DCTN3;CTSL;CAPZA1
prerank,antigen processing and presentation of exogenous peptide antigen via MHC class II (GO:0019886),0.4050067066711938,1.204195716801856,0.20044052863436124,0.6444809749819351,1.0,17/78,12.38%,CLTC;DYNLL1;SEC31A;SEC24D;SEC23A;DYNC1H1;DCTN4;CTSD;CTSS;KIF2A;RAB7A;SEC24A;FCGR2B;CANX;DCTN3;CTSL;CAPZA1
prerank,stress fiber assembly (GO:0043149),-0.42341944948368293,-1.2041462160961305,0.21987951807228914,0.6511508058989088,1.0,3/15,6.61%,SORBS1;PHACTR1;KCTD13
prerank,contractile actin filament bundle assembly (GO:0030038),-0.42341944948368293,-1.2041462160961305,0.21987951807228914,0.6511508058989088,1.0,3/15,6.61%,SORBS1;PHACTR1;KCTD13
prerank,protein transport (GO:0015031),0.3765590531951871,1.203995466926388,0.08308308308308308,0.6444092958279501,1.0,107/332,24.32%,LTBP2;ABCA1;CLTC;ARRDC4;LRP1;VMP1;SEC31A;STX6;COPZ2;AP4M1;COPA;AP3B1;IL10RA;APOE;ABCG1;MYH9;MIA3;RABGAP1L;LMAN2L;ARFGAP3;ARCN1;STX17;RAB21;STEAP3;RAB8B;WLS;RAB34;RCN3;CD36;RABGAP1;TBC1D2B;RAB7A;SNX33;STXBP1;COPB2;CANX;COPG1;PPARG;RAB3GAP2;RAB10;TBC1D16;ARRDC3;TVP23B;LAMP2;TBC1D8B;ERP29;SNX8;COPZ1;ATP6V1G1;ARL4C;SNX6;STX11;SCFD1;RAB32;ATP6V1D;SNX4;RUFY1;TBC1D13;SPTBN1;SNX9;ATP6V1F;TCIRG1;RAB8A;CHMP3;AP3D1;STXBP3;DNAJC27;USO1;PICK1;RAB12;ATP6V0A2;CALCRL;KIF3A;TMED1;TOM1;ATP6V1H;CTSA;ATP6V1G2;RAB31;SNX15;EVI5L;COG7;ARF1;SGSM3;ADPRH;RAB24;TMED10;RUNDC1;TMED7;EHD1;ARF4;SEC23IP;TBC1D1;RAB1A;TBC1D10B;NDC1;TMEM167A;SLC10A7;GGA2;RAB6A;CHMP2B;VLDLR;TMED5;REP15;ARL5B;SEC13;SCAMP1
prerank,positive regulation of cytoskeleton organization (GO:0051495),0.4133645764185067,1.2034967650558388,0.21420518602029312,0.6451763461958115,1.0,18/76,15.90%,CCL11;PDXP;NRP1;BAIAP2;SYNPO;DYNC1H1;CARMIL1;GPSM2;CDC42EP4;CDC42;NCK2;NCK1;BIN1;CDC42EP5;NTRK3;SNX9;ABL1;CX3CL1
prerank,vesicle cytoskeletal trafficking (GO:0099518),0.44538420381922467,1.2031903599408376,0.23638613861386137,0.6454584902448457,1.0,10/39,13.33%,MYO1B;MYO1A;TRAK1;MYO5A;MYO19;MYO1H;MYO1D;MYO7A;KIF5B;FBXW11
prerank,positive regulation of viral life cycle (GO:1903902),0.49613023115379035,1.2031441923018624,0.2613784135240572,0.6449894081478404,1.0,10/22,26.38%,LGALS9;DDB1;VPS4A;TRIM11;FMR1;CHMP3;CHMP2B;TMPRSS2;TYRO3;KPNA2
prerank,peptide biosynthetic process (GO:0043043),-0.2598011278520911,-1.2029359373740087,0.037037037037037035,0.651847086111716,1.0,58/153,22.20%,DMD;RPL34;RPL8;RPL18A;RPL36;RPL19;RPL38;RPL5;RPS23;RPLP0;MRPS15;RPS10;COPS5;RPL32;ABCF1;RPS4X;RPL10;RPL15;RPL29;RPS16;RPS27;RPS19;RPS12;DHPS;RPS21;RPS13;RPL13;RPL27;RPL7A;RPL35;RPL28;RPL30;RPS8;MRPS7;MRPS18C;RPS17;RPL37A;EIF4EBP2;RPS6;RPL41;RPS18;MRPL28;RPS6KB2;MRPL42;GSPT2;RPS20;MRPS16;RPL7;MRPS18B;RPL13A;MRPL23;RPS15A;RPS5;RPS29;RPLP1;MRPS12;MRPL18;RPL21
prerank,regulation of cardiac muscle hypertrophy (GO:0010611),0.48879494296137294,1.2028507050253185,0.2386058981233244,0.6452460037955233,1.0,4/22,5.07%,PRKCA;SLC9A1;CAMK2D;MLIP
prerank,positive regulation of carbohydrate metabolic process (GO:0045913),0.48738521471659946,1.2026873845315091,0.25603217158176944,0.6451381239951807,1.0,10/23,21.72%,EGF;ARNT;SLC4A4;PFKFB4;ZBTB20;NFKB1;PSEN1;P2RX7;PRXL2C;IGF1
prerank,protein kinase B signaling (GO:0043491),0.48805285134041826,1.202544107831489,0.25753424657534246,0.6449733844734593,1.0,13/23,24.81%,ZFP36L1;PTEN;CCL5;THEM4;SIRT2;SETX;CCL2;TNF;IGF1;TSC2;TGFB1;AKT1;TYRO3
prerank,mRNA destabilization (GO:0061157),0.4523000745730583,1.2022358706858753,0.21855921855921856,0.6452582605430143,1.0,12/38,14.86%,ZFP36L1;ZFP36L2;CELF1;KHSRP;FTO;PUM1;PLEKHN1;YTHDF3;METTL16;RC3H2;GIGYF2;MOV10
prerank,regulation of G2/M transition of mitotic cell cycle (GO:0010389),0.3927942129649133,1.2020547150719338,0.17930327868852458,0.6451979744769997,1.0,44/145,23.15%,PSMA7;RAD51B;DYNLL1;ALMS1;DYNC1H1;FBXL7;HAUS3;CCP110;TUBG1;PINX1;CNTRL;CUL1;PLK1;PSMD4;BRD4;PSMD11;FBXO5;CEP41;PCM1;DCTN3;PSMB8;TPX2;CSNK1D;SKP1;USP47;CDC25A;PSMA6;CEP72;PSMD14;TUBA1A;PCNT;PSMC6;PSMB10;ACTR1A;PSMD12;PSMB1;PSMA8;PSMF1;CKAP5;NINL;YWHAE;PSME2;YWHAG;PSMA4
prerank,positive regulation of cell cycle process (GO:0090068),0.40767842014381317,1.2017594747945912,0.18230852211434737,0.6454599246351027,1.0,20/91,14.40%,SVIL;EDN3;MAD2L1;PDGFRB;EGF;DYNC1H1;GPSM2;INO80;CDC42;XRCC3;E2F8;CSPP1;CEP120;DDX11;SIRT2;ATRX;CDC14B;DRD3;DBF4;OPN1MW
prerank,Fc receptor signaling pathway (GO:0038093),0.3974922607707422,1.2015743686644178,0.17684210526315788,0.6454014897891432,1.0,30/110,21.05%,PSMA7;TEC;VAV2;GAB2;VAV3;MAP2K4;LCP2;RAC1;PIK3R1;CUL1;PSMD4;PSMD11;NFKB1;GRB2;PSMB8;PPP3CA;LAT2;FBXW11;SKP1;MAPK9;PSMA6;VAV1;PSMD14;PSMC6;PSMB10;PSMD12;PSMB1;PSMA8;PSMF1;PAK1
prerank,cytoplasmic sequestering of transcription factor (GO:0042994),0.5487656648731658,1.2015148218185572,0.25072886297376096,0.6449831374015831,1.0,4/14,9.75%,SUFU;PKD2;NFKBIE;MDFI
prerank,sister chromatid segregation (GO:0000819),0.46297824916242714,1.2014554910078759,0.2268041237113402,0.6445511401571442,1.0,7/31,10.80%,KIFC1;SMC1A;KLHL22;INO80;TUBG1;PLK1;TOP2B
prerank,positive regulation of cellular response to insulin stimulus (GO:1900078),-0.45533277840849795,-1.2014064541448224,0.24915824915824916,0.6533050753702911,1.0,7/13,20.57%,SORBS1;PRKCZ;IGF2;GKAP1;SIRT1;SORL1;ECHDC3
prerank,negative regulation of viral transcription (GO:0032897),0.5458363114654996,1.2007427531402353,0.2698412698412698,0.6458734863371789,1.0,6/13,13.00%,UBP1;HEXIM1;TRIM21;TRIM13;TRIM11;TRIM62
prerank,cellular response to vascular endothelial growth factor stimulus (GO:0035924),-0.3416363861058857,-1.2001102012199707,0.1919191919191919,0.654137266477261,1.0,12/34,12.85%,FLT1;SEMA6A;GAB1;RAMP2;KDR;VEGFD;ERN1;HSPB1;PRKD1;NR4A1;FLT4;PGF
prerank,cellular iron ion homeostasis (GO:0006879),0.42307632000409146,1.1998287826991951,0.22632794457274827,0.6478998887230437,1.0,11/55,13.81%,SLC39A14;HEPH;CP;SLC11A2;FXN;CUL1;ATP6V1G1;NUBP1;ACO1;SKP1;SLC22A17
prerank,thyroid hormone generation (GO:0006590),0.5711195295036625,1.1993543648221514,0.2561349693251534,0.6486536902100437,1.0,3/10,10.11%,CPQ;FOXE1;CTSK
prerank,regulation of dendritic spine morphogenesis (GO:0061001),-0.35151193138275016,-1.1993206317410865,0.1935483870967742,0.6536930403050418,1.0,14/31,16.02%,EPHA4;SHANK3;ARHGAP44;CUX2;PDLIM5;RELN;NGEF;ZDHHC15;PPFIA2;SRCIN1;ABI3;NLGN1;TANC2;SIPA1L1
prerank,cilium movement (GO:0003341),0.43699742745676556,1.199111456427014,0.22102747909199522,0.6487123806951871,1.0,7/47,13.88%,TEKT4;CFAP251;DNAAF4;SPEF2;DNAH9;TTC29;DNAH11
prerank,positive regulation of supramolecular fiber organization (GO:1902905),0.40296721577796346,1.199088902325971,0.19099890230515917,0.6481879843322336,1.0,13/86,9.50%,CCL11;PDXP;PSRC1;APOE;BAIAP2;NAV3;SYNPO;CARMIL1;CDC42EP4;RAC1;NCK2;NCK1;BIN1
prerank,cell morphogenesis involved in differentiation (GO:0000904),0.41421426061912214,1.1990882650687638,0.20912124582869857,0.647586138478629,1.0,14/70,8.72%,ANTXR1;LAMB1;LAMC1;NRP1;PEAK1;ITGA8;SIPA1L3;EPHB3;LAMC3;OPHN1;RAC1;PIK3R1;PARVA;EPHA1
prerank,positive regulation of calcium ion transport (GO:0051928),0.45491855736055553,1.1988632668443815,0.23580246913580247,0.6475759048394811,1.0,15/36,21.25%,CXCL12;PDGFRB;P2RX5;CCR1;CCL5;TRPC6;ATP2B1;MYLK;CCL2;SPHK2;ORAI1;GRIN1;P2RX7;STIM2;CRACR2A
prerank,negative regulation of osteoclast differentiation (GO:0045671),0.5165379438364452,1.1984883183313464,0.2496570644718793,0.6480811790233141,1.0,3/18,3.72%,LRRC17;MAFB;FBN1
prerank,sensory perception of light stimulus (GO:0050953),0.40335445375458095,1.1980590008619902,0.18818380743982493,0.6487018719754514,1.0,11/87,13.39%,COL18A1;COL1A1;RGS16;GPR179;RDH10;COL11A1;RDH12;MYO7A;ADGRV1;SFRP5;BEST1
prerank,negative regulation of gene expression (GO:0010629),0.37953809363331614,1.198011831572999,0.08517034068136273,0.6482370814186986,1.0,85/302,20.65%,RUNX1;RBMS3;IGF2BP1;CREB3L1;ITGB8;IGF2BP2;NCOR2;YAP1;SFRP1;SYNCRIP;SFRP2;APOE;ZFP36L2;REL;FLOT2;APLN;IGFBP5;CELF1;CCR1;ILF3;PHF1;EIF2AK3;HDAC1;ATP2B1;SAMD4A;FCGR2B;LGALS9;PTBP3;OLFM1;PAIP2;MAP2K1;NFKB1;EMILIN1;ERP29;TNRC6B;EIF2AK2;PTGER4;DICER1;METTL16;FGF2;GPNMB;TERT;DCP2;FMR1;GIGYF2;SETDB1;CAPRIN1;FLCN;ANXA7;FBXW7;MOV10;YY1;GAPDH;RNH1;TNF;LGR4;PARP14;EZH2;NPTN;PSEN1;TLE5;DNMT3B;PDCD10;ROBO1;EPRS1;ROCK2;SPI1;SMO;MSR1;SMCR8;TRIM27;MAP2K2;RBBP4;DXO;DAPK1;SETDB2;LSM6;TGFB2;YBX1;JARID2;DDX3X;YTHDF2;CALR;MPHOSPH8;SFMBT2
prerank,nucleoside phosphate catabolic process (GO:1901292),0.5542304285802289,1.1978218101371072,0.2492753623188406,0.6481843976642453,1.0,2/13,6.61%,ENPP1;ENTPD7
prerank,mitotic sister chromatid segregation (GO:0000070),0.3980585160971151,1.19626608511965,0.18849840255591055,0.651966578641651,1.0,33/98,24.30%,KIFC1;PSRC1;EML4;SMC1A;CHMP4B;CHMP4A;KLHL22;CSNK2A2;NAA50;KMT5A;INO80;TUBG1;PINX1;NIPBL;PLK1;EML3;VPS4A;KPNB1;PDS5B;PDS5A;AKAP8L;CHMP3;CHMP7;CSNK2A1;TENT4A;TUBG2;DIS3L2;NCAPD2;CDC23;CHMP2B;NCAPG2;PDCD6IP;TEX14
prerank,negative regulation of chemotaxis (GO:0050922),-0.3517448900994869,-1.1961060948034574,0.15609756097560976,0.659820973362992,1.0,17/31,22.56%,SEMA6A;SEMA3C;SEMA7A;SEMA6D;SEMA3D;THBS1;SEMA4D;SLIT2;SEMA5A;SEMA5B;SEMA4B;SEMA3G;SEMA3B;SEMA6C;SEMA6B;SEMA4A;CORO1B
prerank,regulation of tyrosine phosphorylation of STAT protein (GO:0042509),0.4237681179854194,1.1959804774487295,0.2190366972477064,0.6521595055166711,1.0,8/57,7.35%,IL23R;GHR;JAK2;CD40;TSLP;NF2;STAT3;CCL5
prerank,negative regulation of gluconeogenesis (GO:0045721),0.571098799368344,1.1958511070644107,0.26371951219512196,0.651935320876096,1.0,1/11,0.51%,ADIPOQ
prerank,negative regulation of synaptic transmission (GO:0050805),0.4894336932250204,1.1957801634927636,0.2483221476510067,0.6515266001995015,1.0,5/23,12.37%,ADIPOQ;LRRK2;PTEN;STXBP1;DRD3
prerank,positive regulation of macromolecule biosynthetic process (GO:0010557),0.3864580043758872,1.1957342340318013,0.18867924528301888,0.6510428248710165,1.0,25/122,12.19%,PRR16;BCL3;GLI2;TLR2;JAK2;PDGFRB;DNA2;PLD1;EGF;IRS1;BRPF3;PRKD2;TMEM106A;EGFR;SAMD4A;IL33;SLC25A37;HSPH1;NFKB1;NMD3;YTHDF3;XBP1;RPS6KB1;FGF2;FMR1
prerank,positive regulation of MAP kinase activity (GO:0043406),0.4156298381004024,1.1955113960442347,0.19977678571428573,0.651117552443496,1.0,20/66,16.91%,IL34;EDN3;TNFSF11;PDGFRB;CD40;LRRK2;EGF;FGFR1;DVL2;EGFR;PIK3R5;SASH1;TAOK3;FGF2;TRAF2;TNF;MST1R;EZH2;PDCD10;ROBO1
prerank,positive regulation of myeloid cell differentiation (GO:0045639),0.45996126610037397,1.1954527787680753,0.2496894409937888,0.6506851708915815,1.0,14/33,21.90%,STAT1;ARNT;BRD1;STAT3;RAB7B;ACVR1B;MAPK11;ACVR2A;HMGB2;FOXO3;FES;STAT5B;ETS1;PRKDC
prerank,protein homotetramerization (GO:0051289),-0.31847734347163853,-1.1946779811728214,0.15894039735099338,0.6611401242961311,1.0,22/49,25.94%,KCNJ2;SAMHD1;UPB1;ALDH9A1;GBP5;KCNJ12;GLS;OSBPL2;HCN1;GOLGA2;CBR4;APIP;USP16;CRYZ;MCOLN1;CBY1;PKD2L1;CTH;ALDOA;TRPA1;HSD17B10;SSBP1
prerank,positive regulation of insulin receptor signaling pathway (GO:0046628),-0.462479267906212,-1.1942020377282798,0.2484076433121019,0.6597597741386582,1.0,4/12,10.39%,SORBS1;PRKCZ;IGF2;GKAP1
prerank,fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540),0.5463549139319539,1.193915067851386,0.26332288401253917,0.6544993568158664,1.0,3/14,10.76%,EHHADH;ACOX1;ACOX3
prerank,regulation of cytokine production involved in inflammatory response (GO:1900015),0.45463925761421603,1.193820956830656,0.24436090225563908,0.6541581349757574,1.0,9/37,18.04%,APOD;ADCY7;TREM2;STAT3;SIRPA;CHID1;PLD4;TNF;CUEDC2
prerank,Fc receptor mediated stimulatory signaling pathway (GO:0002431),0.4113389806219189,1.1936358669453397,0.22533632286995517,0.6540505194994316,1.0,27/73,23.28%,VAV2;MYO10;VAV3;BAIAP2;ACTR2;WIPF1;BLK;RAC1;CDC42;PIK3R1;FCGR2B;DOCK1;NCK1;GRB2;ABI1;PTK2;ABL1;YES1;VAV1;BRK1;ARPC2;FCGR1A;PAK1;SRC;FCGR3A;CYFIP1;MAPK1
prerank,regulation of ubiquitin-dependent protein catabolic process (GO:2000058),0.4485315487294968,1.1934921074413445,0.24167694204685575,0.6538695951751582,1.0,8/40,14.59%,GLMN;CSNK2A2;PTEN;ARAF;RAD23A;PTK2;SMURF1;FBXW7
prerank,exit from mitosis (GO:0010458),0.5391372993693004,1.1932814116077035,0.2773613193403298,0.6538368202798305,1.0,5/12,24.16%,CHMP4B;CHMP7;UBE2S;SIRT7;CLASP2
prerank,regulation of cellular amine metabolic process (GO:0033238),0.42948392919418055,1.192984169610982,0.23014959723820483,0.6540609055269212,1.0,13/50,21.00%,PSMA7;OAZ3;PSMD4;PSMD11;PSMB8;PSMA6;PSMD14;PSMC6;PSMB10;PSMD12;PSMB1;PSMA8;PSMF1
prerank,negative regulation of chemokine production (GO:0032682),0.5271123891988017,1.1925948144077603,0.27611940298507465,0.6545618234782561,1.0,3/14,12.21%,APOD;LGALS9;SIRPA
prerank,response to iron ion (GO:0010039),0.545771067244431,1.192567221501187,0.28041543026706234,0.654027110352538,1.0,4/12,13.29%,SLC11A2;BCL2;FXN;ACO1
prerank,regulation of bicellular tight junction assembly (GO:2000810),0.5062415879535629,1.1925370293816977,0.2669491525423729,0.6535280805427873,1.0,3/19,3.53%,RUNX1;SNAI1;SNAI2
prerank,negative regulation of DNA-binding transcription factor activity (GO:0043433),0.3898437767058687,1.1924254725436023,0.17805383022774326,0.6533036319929701,1.0,30/136,17.54%,CYP1B1;TCF7L2;DAP;TNFAIP3;SFRP4;CMKLR1;SUFU;XCL1;IRAK3;PKD2;NFKBIE;RNF2;TRIM21;BHLHE40;COMMD6;MDFI;ERBIN;SFRP5;PYDC1;HEYL;COMMD7;IRAK2;TNFRSF4;CTNNBIP1;SP100;RBCK1;NLRP2B;PTCH1;ITCH;SPI1
prerank,substantia nigra development (GO:0021762),0.4424047383210418,1.1924103903880736,0.25307125307125306,0.6527546660627719,1.0,11/37,14.03%,DYNLL1;GNB4;FGF9;PADI2;SEC16A;CDC42;MAPKAP1;CALM3;SIRT2;CALM2;NDRG2
prerank,antigen processing and presentation of peptide antigen via MHC class I (GO:0002474),0.47645001900696543,1.191803779064457,0.25263157894736843,0.6538663349285173,1.0,6/24,8.73%,SEC31A;SEC24D;SEC23A;PDIA3;SEC24A;CANX
prerank,plasma membrane organization (GO:0007009),0.4160917251873886,1.191759596917648,0.24646226415094338,0.6533898254480329,1.0,23/61,23.59%,PLSCR5;COL5A1;UGCG;CHMP4A;MYH9;SNX33;TLCD2;BIN1;CXCR4;TLCD1;WHAMM;A4GALT;EHD2;EPB41L3;SPTBN1;SNX9;CLN3;P2RX7;PLSCR4;BIN3;ANXA6;ARL8B;ABCD2
prerank,hematopoietic progenitor cell differentiation (GO:0002244),-0.3561224032212071,-1.1916954750869202,0.20657276995305165,0.6639052013013774,1.0,5/30,3.00%,FLT1;MLLT3;KIT;BMP4;KDR
prerank,establishment of epithelial cell apical/basal polarity (GO:0045198),0.5711513289019715,1.1914224573590095,0.28659476117103233,0.6537462294767015,1.0,6/10,21.80%,RAP2A;OPHN1;CDC42;MSN;RHOA;MYO9A
prerank,sodium ion export across plasma membrane (GO:0036376),-0.43954599947050244,-1.1912451226863219,0.24169184290030213,0.6625736667061204,1.0,3/13,2.13%,ATP1B3;ATP1B1;ATP1A2
prerank,integrated stress response signaling (GO:0140467),0.5259479557221768,1.1907894398707801,0.26323529411764707,0.6549911291627476,1.0,7/14,25.94%,EIF2AK3;OMA1;CCL2;NFE2L2;HSPA5;DDIT3;ATF4
prerank,cellular component assembly (GO:0022607),0.3796605032935337,1.1907571389666132,0.11871227364185111,0.6544766774081716,1.0,48/253,13.34%,KMT2A;GPM6B;MYO1B;VMP1;YAP1;LAMC1;FLNC;GORASP2;SKAP2;WNT5A;LCP1;RHOJ;MITF;DPYSL3;CD40;RHOD;BAIAP2;KPNA3;CALD1;AIF1L;LIMA1;WIPF1;FSCN1;ADD2;OPHN1;PPID;RAC1;LIMS1;AIF1;TEAD1;CDC42;CREBBP;TLCD2;PARVA;FZD1;LLGL1;YTHDF3;DLG4;TSPAN4;BAG6;NOC2L;TLCD1;CAPZA1;PAWR;TRAF2;NEFH;RANBP9;VCPIP1
prerank,positive regulation of protein polymerization (GO:0032273),0.4089234328205187,1.1903668632509536,0.23442808607021517,0.6548944607376704,1.0,11/65,11.52%,CCL11;PSRC1;BAIAP2;NAV3;CARMIL1;CDC42EP4;RAC1;NCK2;NCK1;BIN1;CDC42EP5
prerank,positive regulation of lymphocyte activation (GO:0051251),0.46991860141185277,1.1903079232167995,0.2599231754161332,0.6544638370118095,1.0,6/28,13.99%,TNFSF11;SH3KBP1;SIRPA;THY1;CCL2;HSPD1
prerank,coenzyme A biosynthetic process (GO:0015937),0.5725477603384734,1.189526376545778,0.28851963746223563,0.654917453058849,1.0,7/11,20.41%,DCAKD;SLC25A16;PANK2;COASY;ACAT1;PANK4;PANK1
prerank,purine nucleoside bisphosphate biosynthetic process (GO:0034033),0.5725477603384734,1.189526376545778,0.28851963746223563,0.654917453058849,1.0,7/11,20.41%,DCAKD;SLC25A16;PANK2;COASY;ACAT1;PANK4;PANK1
prerank,ribonucleoside bisphosphate biosynthetic process (GO:0034030),0.5725477603384734,1.189526376545778,0.28851963746223563,0.654917453058849,1.0,7/11,20.41%,DCAKD;SLC25A16;PANK2;COASY;ACAT1;PANK4;PANK1
prerank,"regulation of transcription, DNA-templated (GO:0006355)",0.3685488564819981,1.1884582402034676,0.001,0.6573828073880302,1.0,401/1646,20.66%,RORA;RUNX1;NR1H4;RUNX2;COL1A1;ZEB2;KMT2A;TRPS1;ADIPOQ;SOHLH2;CREB3L1;RUNX3;POU5F1;CXXC1;SPP1;ZEB1;MDFIC;PAX1;BCL3;GLI2;ETV6;TCF7L2;TCF4;SNAI1;NCOR2;DAP;YAP1;SBNO2;ATXN1;DEAF1;MED13L;TEAD3;PRRX1;SOX5;BCL6;ZMIZ1;NKX6-1;MEIS2;GLI3;BRIP1;BACH1;CHD7;PKNOX2;TBX18;USF1;PSRC1;CREB3L3;NR2F2;RCOR1;SFRP1;EGR3;ERN2;CCAR1;SATB2;ABCA2;SFRP2;ZBTB48;IRF7;WNT5A;NFIX;VGLL3;SUFU;DDX17;BAZ1A;GLIS1;STAT1;MITF;ZFPM2;PHC2;SNAI2;MLXIP;XCL1;SMAD2;ZIC4;APOE;GATA6;FGF7;MAFB;NPAS4;CAMK2D;REL;PRRX2;SFMBT1;TRAK1;BATF;RXRG;EGF;ATP8B1;IRF1;BAZ2B;ARNT;GON4L;ARID5B;HOXB3;LITAF;BHLHE22;POU2F1;OGT;KHDRBS1;TLE1;RUNX1T1;KMT5A;ZNF496;SMURF2;SOX21;EHMT1;ZNF292;ZHX2;ZKSCAN1;ZBTB10;UBP1;ILF3;SMARCC1;TBX2;SHH;ZNF260;DVL2;YAF2;ZBTB5;SCMH1;ZBTB38;CDK14;MEIS1;TGFB1I1;LIMS1;E2F1;ARID5A;KMT2B;NFKB2;ARID1B;BRPF1;ZNF25;TEAD1;SNX5;RNF111;ZSCAN12;PHF1;PHF2;MYBL1;MED13;CEBPD;SUB1;HEXIM1;PRDM2;STAT3;EGFR;HDAC1;SP110;ELF4;NIPBL;TSHZ3;CREBBP;HSF2;CC2D1B;CARM1;TAF7;CCNL1;CREB3L2;SMARCD3;MED12;TGFBR1;PRDM5;CBFB;UBE2L3;NONO;ACVR1B;FZD1;ZNF250;SP140;KDM7A;FOXM1;PBX3;ACVR1;FOXK2;ZBTB20;PPARG;E2F3;E2F8;TCF7;TRIM56;STAT5A;NSD3;PIAS2;TGFB3;BRD4;BHLHE40;NR1D2;MAP2K1;DKK3;MXI1;ENO1;FOXE1;ZNF418;MYRF;MED14;ZBTB12;MBD2;ETV5;TCF12;BCL11B;NFKB1;CHD2;FBXO5;FOXJ3;AHR;MBD1;HDAC5;SIRT2;SALL1;HOXA1;TADA2B;CHD8;FOXP4;NFE2L3;PRICKLE1;ATRX;SAFB2;CAMTA2;WWTR1;MMS19;AHRR;CALCOCO1;TFDP1;CREB3L4;CREB3;HDAC3;TSC22D4;NR2F1;LOXL3;ZNF367;MAFG;MAGED1;EPC2;ZIC1;RBFOX2;BACH2;FGF2;ZNF445;GLIS3;SNX6;FADS1;HEYL;ZNF182;CCAR2;ZMYND15;RBPJ;HTATIP2;PGBD1;HIVEP2;NEK4;USP22;PRDM1;SMAD5;HIVEP1;CCNT1;CTCF;POLR2K;BTG1;FBXW11;BAHD1;LCOR;TCF3;TCF7L1;NEUROD6;STAT6;SMAD3;CLOCK;LRP6;TGIF2;COMMD7;JUNB;NUCKS1;HSPD1;NSD1;PHF12;TBL1X;RELB;HMGB2;NFXL1;FOXN2;GTF2H1;SAP18;NOP2;ZSCAN22;USP47;NUP35;ELK4;THRAP3;NR2C2;RSF1;YY1;SP7;PRMT5;TULP3;CIART;MDM2;TNFRSF4;ZNF276;TNF;NPAS2;TADA3;ABL1;POU5F2;HMGB3;EZH2;MAMLD1;ZNF35;NKX2-8;HNRNPK;RBBP8;ZKSCAN8;SP100;TIMELESS;MED21;KDM2A;PSEN1;CCNH;TLE5;ZNF692;KLF10;EID1;CC2D1A;RGMB;ATF2;LIN9;ARID4B;CCNC;RUVBL1;RPS6KA3;HCFC2;ZFP62;TBX3;HOXB2;SKOR2;NIF3L1;NFE2L2;SPI1;KMT2D;TCIM;WTIP;EGR2;PHC3;NAB2;BBS7;GABPA;TFAP2C;TRIM44;BBX;SPINDOC;ZSCAN25;SRCAP;SSBP2;SPTY2D1;TRIB3;ZGPAT;MTA3;KDM3B;BRD3;SAFB;DVL1;PHF20;CBX5;FOXO3;TFCP2;CARF;BAZ2A;CDK5;LIN54;MAP2K2;TFCP2L1;ZNF23;ZNF32;ELK1;PATZ1;ARRB1;SMARCB1;SMARCA4;MTERF3;RBM15;SPEN;TGFBRAP1;MED24;SETDB2;YBX1;JARID2;SLTM;DRAP1;ATMIN;BCLAF1;STAT5B;HP1BP3;CALR;ZFHX4;MAFK;CDK11B;ZFHX3;MPHOSPH8;POU6F1;ETS1;SFMBT2;ATF1
prerank,positive regulation of sphingolipid biosynthetic process (GO:0090154),0.5747782505292731,1.1882248096854138,0.29513343799058084,0.656809545538597,1.0,7/10,25.07%,NSMAF;TNF;TNFRSF1A;SPHK2;SMPD3;SIRT3;SMPD2
prerank,positive regulation of ceramide biosynthetic process (GO:2000304),0.5747782505292731,1.1882248096854138,0.29513343799058084,0.656809545538597,1.0,7/10,25.07%,NSMAF;TNF;TNFRSF1A;SPHK2;SMPD3;SIRT3;SMPD2
prerank,tRNA aminoacylation (GO:0043039),0.4498697096550602,1.1881904474941847,0.2481012658227848,0.6563161100420145,1.0,15/37,21.40%,YARS1;PPA1;EEF1E1;TARS1;IARS2;FARSB;CARS1;AIMP1;GARS1;NARS1;PPA2;EPRS1;FARS2;AIMP2;RARS1
prerank,RNA transport (GO:0050658),0.4110405365685516,1.1880090999360764,0.225414364640884,0.6562512732593795,1.0,21/71,22.32%,RFTN1;ZFP36L1;RBFOX1;ATXN2;RAE1;SRSF2;NUP153;NUP188;SLBP;FMR1;RTRAF;NCBP2;NUP214;SRSF1;SIDT2;KIF5C;THOC3;HNRNPA2B1;YBX1;CKAP5;U2AF1
prerank,negative regulation of cellular senescence (GO:2000773),0.5450223570047277,1.1876942223926363,0.2867756315007429,0.6565751187334159,1.0,9/13,27.83%,AKT3;CDK6;FBXO5;TERT;YBX1;MAP3K3;TWIST1;TERF2;HMGA2
prerank,Fc-gamma receptor signaling pathway involved in phagocytosis (GO:0038096),0.411341941861366,1.1876350159255264,0.2249718785151856,0.6561450013039417,1.0,26/70,23.28%,VAV2;MYO10;VAV3;BAIAP2;ACTR2;WIPF1;RAC1;CDC42;PIK3R1;FCGR2B;DOCK1;NCK1;GRB2;ABI1;PTK2;ABL1;YES1;VAV1;BRK1;ARPC2;FCGR1A;PAK1;SRC;FCGR3A;CYFIP1;MAPK1
prerank,regulation of GTPase activity (GO:0043087),0.37981200261845843,1.1869722730294172,0.15714285714285714,0.6575398444932732,1.0,45/177,15.98%,CCL11;CCL7;RGS16;MAP4K4;VAV2;SFRP1;ARHGAP15;VAV3;CD40;PRTN3;XCL1;LRRK2;EPHB3;ASAP3;PLXNC1;FGD4;LIMS1;RGS10;RABGAP1;CCL5;NF1;PLXND1;RSU1;EPHA1;SNX18;RAB3GAP2;TBC1D7;ZC3H15;EFNA5;ALS2;PLXNA3;TBC1D20;RRP1B;PTK2;THY1;CCL2;MAPRE2;ITGB1BP1;FLCN;GSK3B;FGD6;RAP1GAP;SNX9;CX3CL1;EZH2
prerank,response to estradiol (GO:0032355),0.4645411289753827,1.1869411715223817,0.25065963060686014,0.6570286309747417,1.0,5/31,7.06%,NRIP1;SFRP1;ANXA1;STAT3;EGFR
prerank,chromatin disassembly (GO:0031498),0.5296859395347157,1.1868134156269743,0.2863372093023256,0.6562211928913726,1.0,6/14,21.97%,SMARCC1;SMARCD3;GRWD1;SMARCB1;SMARCA4;SMARCC2
prerank,nucleosome disassembly (GO:0006337),0.5296859395347157,1.1868134156269743,0.2863372093023256,0.6562211928913726,1.0,6/14,21.97%,SMARCC1;SMARCD3;GRWD1;SMARCB1;SMARCA4;SMARCC2
prerank,regulation of amyloid-beta formation (GO:1902003),0.4489487543076912,1.1865873738012036,0.2398989898989899,0.6562532377487326,1.0,10/34,17.28%,ABCA2;SLC2A13;APOE;ABCG1;RTN2;GSAP;BIN1;IFNGR1;TNF;ROCK2
prerank,response to retinoic acid (GO:0032526),0.4206319611563108,1.1861832348955905,0.20551090700344432,0.656800695689077,1.0,8/59,6.39%,WNT2;ASXL1;WNT5A;GATA6;RXRG;WNT9A;CDKN2D;ATM
prerank,negative regulation of MAP kinase activity (GO:0043407),0.43584113076854614,1.1859075645369939,0.23820754716981132,0.6570062821802343,1.0,8/44,10.32%,ADIPOQ;APOE;IRAK3;AIDA;NF1;MAPK8IP1;PTPN1;SPRY2
prerank,regulation of cellular amino acid metabolic process (GO:0006521),0.42330490697015316,1.1856058062969672,0.23603192702394526,0.6572554508365405,1.0,14/53,21.00%,PSMA7;OAZ3;PSMD4;PSMD11;PSMB8;PSMA6;PSMD14;PSMC6;PSMB10;PSMD12;PSMB1;PPM1K;PSMA8;PSMF1
prerank,positive regulation of ubiquitin-dependent protein catabolic process (GO:2000060),0.4059957905151945,1.1851065172958277,0.21986607142857142,0.6580274213361759,1.0,32/76,22.57%,NKD2;LRRK2;PTEN;PABIR1;ZYG11B;PLK1;RNF144A;RNF19B;CSNK1A1;SIRT2;PRICKLE1;ARIH1;RAD23A;PTK2;CSNK1D;SMURF1;FBXW7;GSK3B;STUB1;MDM2;ARIH2;SOCS5;BBS7;FBXO22;TRIB3;DVL1;RNF217;CDK5RAP3;TRIB1;PIAS1;DDRGK1;COP1
prerank,autophagosome maturation (GO:0097352),0.45780171367209743,1.1849238956117982,0.2598225602027883,0.6579754657217658,1.0,13/32,22.72%,VMP1;ATP2A2;STX17;UBQLN1;LIX1L;LAMP2;ATG14;CHMP3;CLN3;RUBCNL;VTI1B;SNX14;VPS16
prerank,fatty acid transport (GO:0015908),0.5072207342317768,1.1848404124996386,0.2803867403314917,0.657608568566495,1.0,5/17,10.23%,SLC27A6;APOE;CD36;PPARG;SLC27A4
prerank,chromosome organization (GO:0051276),0.39480472244913756,1.184516690570031,0.21244635193133046,0.6579493788482531,1.0,35/99,22.80%,TCF7L2;POLE3;RAE1;EHMT1;COPS7A;PADI2;PWWP3A;MTHFR;PHF1;HDAC1;DDB1;HDAC5;TOP2B;HDAC3;BAHD1;TCF7L1;SETD7;AXIN2;NUCKS1;HMGB2;CENPT;ABL1;EZH2;HMGN1;SAFB;SMARCA4;PARP1;LRWD1;COPS6;BRWD1;RPS27A;RAD23B;GATAD1;ZBTB7A;FAM50A
prerank,nuclear-transcribed mRNA catabolic process (GO:0000956),-0.24922325374989882,-1.1844935300557415,0.045454545454545456,0.6783195033202811,1.0,66/168,23.50%,RPL34;RPL8;RPL18A;RPL36;RPL19;RPL38;PYM1;RPL5;CNOT8;RPS23;PPP2R1A;RPLP0;DCPS;RPS10;DDX5;UPF1;NBAS;RPL32;RPS4X;RPL10;RPL15;RPL29;RPS16;CNOT11;TUT1;RPS27;RPS19;RPS12;RPS21;PNRC2;RPS13;RPL13;RC3H1;RPL27;RPL7A;RPL35;RPL28;RBM8A;POLR2G;RPL30;CNOT6L;RPS8;RPS17;RPL37A;MAGOH;EIF4A3;RPS6;RPL41;RPS18;TUT4;LSM1;ZFP36;GSPT2;PDE12;RPS20;RPL7;RPL13A;RPS15A;RPS5;UBA52;RPS29;RPLP1;RPL21;UPF2;SMG9;RPS26
prerank,negative regulation of protein dephosphorylation (GO:0035308),-0.37571225768904737,-1.1837932913590308,0.21348314606741572,0.6776903922845496,1.0,8/21,19.14%,PPP1R16B;PPP1R8;YWHAB;ARPP19;MASTL;STYXL1;CRY2;TIPRL
prerank,pyrimidine nucleobase metabolic process (GO:0006206),0.5700789619926396,1.1836994681430115,0.27675840978593275,0.6597006264197707,1.0,4/12,14.56%,DPYSL4;DPYSL3;DPYD;CTPS1
prerank,antigen processing and presentation of exogenous peptide antigen (GO:0002478),0.3976208371284081,1.183558869190577,0.22246696035242292,0.659501660125836,1.0,17/79,12.38%,CLTC;DYNLL1;SEC31A;SEC24D;SEC23A;DYNC1H1;DCTN4;CTSD;CTSS;KIF2A;RAB7A;SEC24A;FCGR2B;CANX;DCTN3;CTSL;CAPZA1
prerank,establishment or maintenance of apical/basal cell polarity (GO:0035088),-0.39389184220386275,-1.1830352028773115,0.22,0.6771350609269353,1.0,4/19,4.84%,LRRC7;PARD3;SYNJ2BP;DLG2
prerank,MAPK cascade (GO:0000165),0.37557969998004115,1.182730667848545,0.12424849699398798,0.6611629103936685,1.0,91/295,22.63%,PSMA7;PDGFRA;ZFP36L1;TAOK1;MAP4K4;RASA3;FGF20;JAK1;PTPN7;JAK2;PLVAP;PDGFRB;LRRK2;FGF7;DUSP5;ZFP36L2;PTPN3;EGF;IRS1;BRAP;ABHD17C;FGF9;FGFR1;SPRED1;CCM2;FRS2;EGFR;CCL5;PIK3R1;NF1;SPTBN5;CUL1;PSMD4;LGALS9;IL3RA;PDE6D;MAP2K1;PSMD11;RALGDS;NFKB1;NRK;DLG4;MAPK11;TAOK3;GRB2;SETX;PTGER4;PSMB8;FGF13;FGF2;ARAF;PTK2;RANBP9;FBXW11;CCL2;SKP1;PPP1CB;SPTBN1;TNF;PSMA6;ZDHHC9;ANGPT1;GDNF;BTC;PSMD14;FNTB;NEFL;CAMK2B;GRIN1;SPTBN4;CTSH;MAP2K2;PSMC6;PSMB10;RASAL1;PSMD12;PSMB1;FGF18;PSMA8;GFRA2;MAP3K3;PSMF1;PAK1;IGF1;PPP1CC;YWHAE;MAP3K20;MAP2K7;RPS27A;TNIP2;PSME2
prerank,"regulation of DNA-templated transcription, elongation (GO:0032784)",-0.3661318021703138,-1.1826937009709035,0.2170212765957447,0.6754951418637053,1.0,7/25,13.88%,WDR43;LDB1;EAF2;ERCC6;TSFM;CCNK;SUPT4H1
prerank,positive regulation of peptidyl-tyrosine phosphorylation (GO:0050731),0.3897693609755441,1.1825040467434027,0.19198312236286919,0.6612657387517551,1.0,18/121,10.74%,IL34;IL23R;TEC;THBS4;GHR;NRP1;JAK2;CD40;VTN;FGF7;TSLP;TREM2;STAT3;CCL5;ACVR1;PTPN1;EFNA5;DLG4
prerank,aerobic electron transport chain (GO:0019646),-0.2919946200969443,-1.1819695923715021,0.1391304347826087,0.6750139715694428,1.0,35/68,30.74%,COX5A;COX8A;NDUFS1;COX4I1;NDUFV2;NDUFA13;COX6A1;NDUFA8;NDUFA11;NDUFC2;NDUFB7;UQCRB;COX6C;COX5B;SDHAF2;NDUFA1;COX6B1;UQCRC2;NDUFB11;COX10;UQCRFS1;UQCR10;UQCR11;NDUFV1;UQCC3;NDUFA10;NDUFA3;NDUFC1;NDUFA12;COX15;NDUFS3;NDUFB10;UQCRH;NDUFA6;SDHD
prerank,positive regulation of peptidyl-lysine acetylation (GO:2000758),-0.38375799668762695,-1.181959179071599,0.22878228782287824,0.6724911881050076,1.0,3/20,4.12%,PRKAA2;RPS6KA5;PPARGC1A
prerank,negative regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902548),0.5417040241580704,1.1818654764187309,0.2755905511811024,0.6625019561499051,1.0,3/12,10.32%,DCN;ADAMTS12;SPRY2
prerank,regulation of natural killer cell mediated cytotoxicity (GO:0042269),-0.3693638659988252,-1.181607010662093,0.2033195020746888,0.6708601910057198,1.0,18/23,46.88%,CADM1;PIK3R6;LAMP1;AP1G1;PVR;NECTIN2;RAET1E;ARRB2;RASGRP1;LILRB1;SLAMF6;CD226;IL12A;CRTAM;NCR1;KLRD1;CD160;KLRK1
prerank,positive regulation of synaptic transmission (GO:0050806),-0.28651934533425233,-1.1815971047294165,0.17117117117117117,0.6683516927492451,1.0,23/72,18.82%,SLC24A2;NRXN1;SHANK3;PRKCZ;CACNG2;SLC8A3;ADRA1A;KCTD13;RELN;GRIN2D;LGI1;RIMS2;CLSTN1;NLGN1;GRIN2B;RIMS1;ADCY1;SHISA7;GPER1;SLC8A2;CACNG8;CLSTN3;CACNG7
prerank,apoptotic process (GO:0006915),0.3774900897891159,1.1815515949271322,0.1484848484848485,0.662773127782996,1.0,29/203,10.90%,FAP;CASP4;DLC1;TNFRSF21;IAPP;DAP;KREMEN1;TLR2;YARS1;JAK2;BCL2;AIFM2;CASP1;IRF1;CFLAR;OGT;CASP12;BBC3;HK2;PAEP;MCM2;BAX;IFT57;CASP7;AHR;EFNA5;CD14;CXCR4;BAG6
prerank,cellular response to epidermal growth factor stimulus (GO:0071364),0.4746818328906546,1.1811948381044173,0.2676962676962677,0.6631879889667477,1.0,4/26,7.06%,ZFP36L1;SNAI2;ZFP36L2;EGFR
prerank,sympathetic nervous system development (GO:0048485),0.5221738287372946,1.1810186616849632,0.26762589928057556,0.6630694435499186,1.0,6/15,23.27%,NRP1;NF1;FZD3;GDNF;SEMA3A;SOX11
prerank,dosage compensation by inactivation of X chromosome (GO:0009048),-0.4466730477233723,-1.1808441489608528,0.24610591900311526,0.6677696669585677,1.0,4/12,8.68%,PCGF5;SMCHD1;HNRNPU;YTHDC1
prerank,regulation of glucose transmembrane transport (GO:0010827),-0.39717953621782354,-1.180698390828633,0.23018867924528302,0.6656238514500405,1.0,6/18,5.92%,PRKAG2;OCLN;SLC2A1;C2CD5;INPP5K;PRKCB
prerank,midbody abscission (GO:0061952),0.518857085560481,1.1805540959212164,0.2699300699300699,0.6637467042800795,1.0,9/17,26.40%,CHMP4B;CHMP4A;VPS4A;CHMP3;CHMP7;KIF20A;CHMP2B;PDCD6IP;VPS4B
prerank,positive regulation of Notch signaling pathway (GO:0045747),0.4398635869143344,1.1804130839572766,0.24787363304981774,0.6635365399365368,1.0,14/39,17.72%,YAP1;ROBO2;ZMIZ1;JAG1;MAML3;STAT3;CREBBP;MAML2;RBPJ;ITGB1BP1;NEPRO;PDCD10;ROBO1;TSPAN14
prerank,regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090092),0.46562440930196314,1.1801056054351544,0.2547288776796974,0.6638589229037656,1.0,8/30,15.28%,FSTL1;SFRP4;SMAD2;SMURF2;NREP;DKK3;SMAD3;ITGA3
prerank,membrane depolarization during cardiac muscle cell action potential (GO:0086012),-0.39296346092693946,-1.1799660331393815,0.2490842490842491,0.6651566557848511,1.0,5/17,7.06%,CACNB2;ANK2;ATP1A2;KCNJ2;CACNA1D
prerank,negative regulation of cell aging (GO:0090344),0.5192722163914887,1.179630467459711,0.28796561604584525,0.6645959998760996,1.0,10/16,27.83%,AKT3;FOXM1;CDK6;FBXO5;TERT;YBX1;MAP3K3;TWIST1;TERF2;HMGA2
prerank,cellular response to estradiol stimulus (GO:0071392),0.4997856028264224,1.1793704745362221,0.28751753155680226,0.6647355992453694,1.0,4/18,13.39%,NRIP1;SFRP1;EGFR;LCOR
prerank,positive regulation of smoothened signaling pathway (GO:0045880),0.4860693766986731,1.1793335117050214,0.26819407008086255,0.6642594637277784,1.0,4/21,7.19%,STK36;SFRP1;SHH;RAB34
prerank,regulation of lipid metabolic process (GO:0019216),0.400422250580737,1.1780669598989781,0.23159018143009605,0.6672154700835661,1.0,16/88,12.40%,RORA;NCOR2;FASN;CHD9;CREBBP;MVK;CARM1;SMARCD3;PPARG;NR1D2;NPC2;LACTB;CERS2;ELOVL6;HDAC3;PANK2
prerank,glomerular visceral epithelial cell differentiation (GO:0072112),-0.45230181526056906,-1.177855967249763,0.27936507936507937,0.6682159162968878,1.0,3/12,3.81%,PODXL;PROM1;PTPRO
prerank,microtubule anchoring at centrosome (GO:0034454),0.5631078430936415,1.1776676038946636,0.28304821150855364,0.6677437347628424,1.0,7/10,24.45%,CEP19;NIN;PCM1;KIF3A;HOOK3;NINL;CCDC120
prerank,lysine catabolic process (GO:0006554),0.5494797017905284,1.1770630707270942,0.29347826086956524,0.6682146890737606,1.0,4/12,18.38%,CRYM;DLST;ALDH7A1;AASS
prerank,lysine metabolic process (GO:0006553),0.5494797017905284,1.1770630707270942,0.29347826086956524,0.6682146890737606,1.0,4/12,18.38%,CRYM;DLST;ALDH7A1;AASS
prerank,regulation of spindle assembly (GO:0090169),0.47134849454028777,1.1768999670504168,0.2609271523178808,0.6681045649110877,1.0,12/25,26.40%,CHMP4B;DYNC1H1;GPSM2;PLK1;EML3;SENP6;CHMP3;CHMP2B;PDCD6IP;NUMA1;DRG1;VPS4B
prerank,negative regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090101),0.3893846313167939,1.1768936365977711,0.2209178228388474,0.6675419242846108,1.0,23/104,14.74%,PMEPA1;SMAD2;ADAMTSL2;HTRA3;SMURF2;SPRED1;SPRED2;TGFB1I1;TGFBR1;ACVR1;PPARG;SPRY2;EMILIN1;WFIKKN1;ACVR2A;LEMD2;HTRA4;SNX6;SMAD5;SMURF1;SMAD3;LDLRAD4;STUB1
prerank,cellular metal ion homeostasis (GO:0006875),0.393597552078373,1.176550363396935,0.21716101694915255,0.6679162396757053,1.0,13/102,7.70%,CCL11;CCL7;EDN3;CXCL12;SLC9A1;SLC24A5;CD40;STOML2;ATP2A2;CCR1;TNNI3;CCL5;ATP2B1
prerank,dendritic cell migration (GO:0036336),0.5079634344747446,1.1764086184231888,0.28798842257597684,0.6677162775363503,1.0,4/16,17.88%,CCR1;CCL5;CXCR4;TRPM4
prerank,regulation of establishment or maintenance of cell polarity (GO:0032878),-0.39496173918873984,-1.1761855397608487,0.2290909090909091,0.6704091376953757,1.0,4/18,9.11%,TEK;CDH5;KRIT1;SHTN1
prerank,early endosome to Golgi transport (GO:0034498),0.5357028776785189,1.1758849152879218,0.2732919254658385,0.6686164268003254,1.0,8/11,29.48%,TRAPPC10;SNX8;LMAN1;SNX2;RAB6A;STX5;SNX1;RBSN
prerank,T cell activation (GO:0042110),0.40889763477487356,1.1754089929954301,0.23228803716608595,0.6693756533391952,1.0,16/69,15.51%,CHD7;JAML;CD276;LCP1;MDK;NCK2;DDOST;NCK1;PPP3CA;MSN;KIF13B;HSPD1;CTPS1;CASP8;TNFRSF4;PTPN2
prerank,regulation of pri-miRNA transcription by RNA polymerase II (GO:1902893),0.4268949422931034,1.175315263810513,0.2664233576642336,0.6690589125775026,1.0,15/43,20.62%,POU5F1;APLN;GNL3;TEAD1;STAT3;PPARG;FGF2;TERT;SMAD3;TNF;SPI1;FOXO3;SMARCA4;TGFB2;ETS1
prerank,positive regulation of protein modification process (GO:0031401),0.3767668741236945,1.1752682468991515,0.1606060606060606,0.6685893315633539,1.0,46/203,16.22%,IL34;DLC1;C3;ADIPOQ;TAOK1;NOS1AP;FGF20;TMEM119;CD40;LRRK2;FGF7;RAP2A;TREM2;FGF9;FBH1;DVL2;RAC1;EGFR;WDFY2;FAM20A;RAB3GAP2;CCND3;PPP2R5A;FAM161A;CALM3;ERP29;EFNA5;ACVR2A;HDAC3;CLIP3;FGF2;FNIP1;GPNMB;FMR1;PTK2;CSNK1D;CALM2;AXIN2;FLCN;PELI2;NTRK3;NIBAN1;TNF;ABL1;ATG14;NPTN
prerank,calcium ion import into cytosol (GO:1902656),-0.42056324008038126,-1.1750616692563285,0.2643312101910828,0.6709518303859584,1.0,6/15,16.22%,SLC24A2;SLC8A3;TRPV2;ATP2B4;TRPV4;SLC8A2
prerank,regulation of myotube differentiation (GO:0010830),0.47379455815096705,1.1749359771610148,0.2816711590296496,0.6689162469072172,1.0,6/24,11.57%,MMP14;TMEM119;HDAC1;HDAC5;XBP1;HDAC3
prerank,regulation of reactive oxygen species metabolic process (GO:2000377),0.41140704377528897,1.1743521376888462,0.2508710801393728,0.6699975319638459,1.0,8/55,11.35%,CYP1B1;PDGFRB;DHRS4;PID1;RAC1;FOXM1;SIRT2;GRB2
prerank,detection of mechanical stimulus (GO:0050982),0.501737323139711,1.174117007222684,0.2843273231622746,0.6700318051793696,1.0,7/19,23.14%,PKD2;PIEZO2;PKD2L2;PTK2;LHFPL5;PKD1L3;PIEZO1
prerank,mRNA stabilization (GO:0048255),0.43721228241092763,1.1737689314722288,0.2541766109785203,0.6704534999004507,1.0,9/40,16.77%,IGF2BP1;SYNCRIP;TIRAP;TENT5A;E2F1;PAIP1;AXIN2;THRAP3;GDNF
prerank,intra-Golgi vesicle-mediated transport (GO:0006891),0.45618569899907324,1.1736055385405118,0.27320261437908494,0.6703310415815986,1.0,7/29,10.73%,COPZ2;COPA;TRAPPC10;GOSR1;COPB2;COPG1;COPZ1
prerank,regulation of integrin-mediated signaling pathway (GO:2001044),0.5232552283449355,1.1735103114804366,0.2848575712143928,0.669989659241271,1.0,5/14,13.85%,TIMP1;LIMS1;CD63;LOXL3;ITGB1BP1
prerank,protein localization to kinetochore (GO:0034501),-0.41622515416054445,-1.1731610733069024,0.24125874125874125,0.67397272684064,1.0,8/14,30.92%,RCC2;BUB3;ZWILCH;IK;MTBP;KNL1;TTK;SPDL1
prerank,positive regulation of neuroblast proliferation (GO:0002052),0.5683265111415037,1.1728789843744285,0.29160063391442154,0.6711504644183236,1.0,4/10,15.90%,DISC1;SMARCD3;FZD3;CX3CL1
prerank,antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590),0.40566722064074073,1.1726974031996222,0.24195338512763595,0.6710666917631136,1.0,17/70,21.00%,PSMA7;ITGB5;PDIA3;CD36;PSMD4;PSMD11;PSMB8;PSMA6;PSMD14;PSMC6;PSMB10;PSMD12;PSMB1;CALR;FCGR1A;PSMA8;PSMF1
prerank,chromatin organization (GO:0006325),0.3846038093931694,1.1725860441443736,0.2008324661810614,0.6707839606439241,1.0,48/132,22.80%,SNAI1;SATB2;BAZ1A;BAZ2B;EHMT1;INO80;SMARCC1;PADI2;PWWP3A;PHF1;HDAC1;MTA2;KDM4D;SMARCD3;DDX11;HDAC5;TADA2B;ATRX;HDAC3;SETDB1;TCF7L1;SETD7;NUCKS1;HMGB2;RSF1;MYSM1;EZH2;HMGN1;MPND;RUVBL1;HCFC2;SPI1;SAFB;BAZ2A;RBBP4;SMARCB1;SMARCA4;LRWD1;SETDB2;JARID2;HP1BP3;PAK1;BRWD1;SMARCC2;SETD2;GATAD1;ZBTB7A;FAM50A
prerank,regulation of protein localization (GO:0032880),0.4123543033771709,1.1716485755674129,0.2491349480968858,0.6727668815788982,1.0,18/58,19.66%,TRIML2;STX6;TRIM67;RABGAP1L;CTSD;TRIM21;DNAJB6;VPS4A;BORA;FBXW7;RAB9A;WDPCP;TRIM17;DVL1;TRIM27;MMD;RSL1D1;PARP1
prerank,phospholipid metabolic process (GO:0006644),0.4071769684975677,1.171605680298778,0.24860022396416573,0.6722976671162544,1.0,17/71,22.55%,LGALS13;PDXP;ABCA2;LPL;PLA2G5;PIP4K2A;PIP4K2B;FADS1;PLPPR2;GPAM;PIP5K1A;SMPD3;PLPP3;AGPAT5;PLA2G4A;PLA2G4E;AGPAT1
prerank,visual system development (GO:0150063),0.45129294167941875,1.171515549800491,0.25307125307125306,0.6719731246280237,1.0,7/37,11.19%,C3;SH3PXD2B;MEIS2;SIPA1L3;MEIS1;PBX3;ADAMTS18
prerank,Fc-gamma receptor signaling pathway (GO:0038094),0.40407429567261777,1.17114639443261,0.24439461883408073,0.6724454656533249,1.0,26/71,23.28%,VAV2;MYO10;VAV3;BAIAP2;ACTR2;WIPF1;RAC1;CDC42;PIK3R1;FCGR2B;DOCK1;NCK1;GRB2;ABI1;PTK2;ABL1;YES1;VAV1;BRK1;ARPC2;FCGR1A;PAK1;SRC;FCGR3A;CYFIP1;MAPK1
prerank,potassium ion transport (GO:0006813),-0.25938475232964675,-1.1708216214373448,0.05,0.6776415816932977,1.0,25/120,13.73%,ATP1B3;SLC24A2;KCNB2;SLC9A2;KCNK5;ATP1A2;KCNH7;KCNJ2;KCNQ5;TMEM175;KCND2;ABCC9;KCNJ3;KCND3;KCNC2;KCNK10;KCNQ3;KCNQ1;KCNJ13;LRRC38;KCNJ12;CCDC51;KCNH5;KCNN3;HCN1
prerank,ion homeostasis (GO:0050801),-0.3518152128909849,-1.1704624253619513,0.23618090452261306,0.676083889009876,1.0,7/30,8.70%,SLC4A10;FHL1;KLHL3;WNK4;SLC4A8;SLC4A3;WNK3
prerank,regulation of mesenchymal cell proliferation (GO:0010464),0.5472409572098356,1.1703746450211736,0.2968036529680365,0.6740351331381524,1.0,2/11,3.24%,WNT5A;STAT1
prerank,apoptotic cell clearance (GO:0043277),0.4536996687316589,1.1697996073159915,0.27249022164276404,0.675041044571164,1.0,5/30,6.18%,LRP1;ANXA1;TREM2;TXNDC5;RAC1
prerank,regulation of gene expression (GO:0010468),0.36454065034106414,1.169341756470525,0.025,0.6757496890662672,1.0,219/903,20.74%,RORA;RUNX1;GLMN;RBMS3;IGF2BP1;CREB3L1;TRIML2;RUNX3;POU5F1;SEC16B;CXXC1;EDN3;ITGB8;C1D;ZFP36L1;IGF2BP2;AFF2;AFF1;YAP1;SBNO2;ADAM19;ATXN1;NOS1AP;FGF20;BCL6;NELL1;BACH1;SFRP4;CHD7;SFRP1;CRP;CD276;CCAR1;TMEM119;SFRP2;TLR2;WNT5A;SUFU;MITF;SNAI2;APOE;FGF7;MAFB;CCN4;REL;FLOT2;PRRX2;APLN;EGF;EPHX2;UBR5;FUBP1;GON4L;TREM2;FGF9;PID1;TLE1;CELF1;SOX21;CCR1;SHH;DVL2;YAF2;KHSRP;ZBTB38;CGGBP1;LIMS1;E2F1;ATM;NFKB2;AIF1;PHF1;MYBL1;EIF2AK3;PRDM2;STAT3;HDAC1;CD36;CREBBP;CARM1;TRIM21;TGFBR1;PRDM5;UBE2L3;NONO;ACVR1B;LGALS9;IL33;PTBP3;FOXK2;OLFM1;TCF7;NSD3;VSTM2A;BHLHE40;CDK6;NR1D2;MAP2K1;PUM1;NFKB1;DTNBP1;AHR;SPRY2;EMILIN1;ERP29;TNRC6B;HDAC5;MAPK11;GCNT2;ATRX;HMG20B;TRIM11;WWTR1;CALCOCO1;RRP1B;DICER1;METTL16;MAGED1;FGF2;TERT;SIRPA;FADS1;LAMTOR5;EPHB2;CCAR2;RBPJ;SETDB1;MSN;PRDM1;CTCF;BTG1;TCF3;TCF7L1;SMAD3;CLOCK;TGIF2;NSD1;PHF12;NFXL1;FOXN2;FLCN;ANXA7;IFNGR1;FBXW7;NUP35;CASP8;GSK3B;MAPK9;NFKBIZ;MOV10;NR2C2;NTRK3;YY1;PRMT5;TULP3;TNF;TADA3;PARP14;ABL1;ATG14;EZH2;ZNF35;HNRNPK;PSEN1;TLE5;DNMT3B;SON;HNRNPDL;ANGPT1;PDCD10;GDNF;ATF2;ROBO1;HCFC2;ROCK2;SKOR2;NFE2L2;SPI1;KMT2D;HGS;WTIP;NAB2;GABPA;SMO;TFAP2C;TRIM44;TRIM17;MSR1;SMCR8;SSBP2;SPTY2D1;TLR3;DVL1;TRIM27;HNRNPH2;BAZ2A;LIN54;CTSH;MAP2K2;PATZ1;TCF19;P2RX7;EPB41L4B;TGFBRAP1;SETDB2;TGFB2;YBX1;FGF18;DRAP1;DDX3X;YTHDF2;HP1BP3;CALR;FAM98A;CDK11B;ZFHX3;ETS1;SFMBT2;SAP30L
prerank,nervous system development (GO:0007399),0.3658838025429857,1.168992989962861,0.0920920920920921,0.6761170057213635,1.0,74/429,13.15%,ZEB2;IGF2BP1;PCDHA2;WNT2;GPM6B;DPYSL4;CXCL1;IGF2BP2;YAP1;ROBO2;ATXN1;SLITRK6;RBFOX1;FARP1;NELL1;PCDHB6;MYLIP;CHD7;PCDHA11;PTN;ATXN10;PCDHB16;NUMBL;ALDH1A2;SDK2;VCAN;HPCAL4;ZIC4;JAG1;NAV3;TRAK1;P2RX5;ADGRL3;PKD2;PTEN;NAV1;SHH;OPHN1;MDK;KALRN;SERF1A;GLRB;TEAD1;STAT3;MAP1S;PMP22;DCHS1;GDA;NF1;DBNL;OBSL1;TGFBR1;PLXND1;ACVR1B;PTPRZ1;MERTK;DSCAM;FZD9;EFNA5;CXCR4;DLG4;L1CAM;ADGRV1;SCD5;WWTR1;ZIC1;RBFOX2;FGF13;FGF2;EPHB2;DCLK1;SDK1;ALDH3A2;APLP1
prerank,SCF-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0031146),0.39624312559944347,1.1687136329505619,0.22340425531914893,0.6763045616385196,1.0,23/88,21.00%,PSMA7;FBXL7;CUL1;PSMD4;PSMD11;FBXO38;FBXO31;PSMB8;FBXL18;FBXW11;SKP1;FBXW5;FBXW7;PSMA6;PSMD14;FBXO2;PSMC6;PSMB10;PSMD12;PSMB1;PSMA8;FBXL12;PSMF1
prerank,positive regulation of cellular amide metabolic process (GO:0034250),0.397026454585574,1.1684132573181207,0.22601984564498345,0.6765365435064759,1.0,20/80,18.31%,PRR16;BCL3;ABCA2;SLC2A13;PLD1;ABCG1;GSAP;SAMD4A;YTHDF3;RPS6KB1;FMR1;NSMAF;IFNGR1;NIBAN1;TNF;NAT10;TNFRSF1A;ROCK2;SPHK2;SMPD3
prerank,secondary palate development (GO:0062009),0.5316881214837239,1.168023784630732,0.2967189728958631,0.6770381280560517,1.0,4/14,9.37%,CHD7;WNT5A;SMAD2;TGFB3
prerank,activation of adenylate cyclase activity (GO:0007190),0.4433186625182838,1.1674406968647324,0.26270136307311026,0.6780783954799297,1.0,5/35,5.06%,FSHR;ADCY7;EDNRA;ADCY2;RXFP2
prerank,Rho protein signal transduction (GO:0007266),0.42071763755035635,1.1669402950282572,0.2665094339622642,0.6789208670591765,1.0,12/53,13.03%,COL1A2;RHOJ;RHOD;TAX1BP3;CDC42EP4;CDC42;ARHGDIG;CTNNAL1;RTKN;CDC42EP5;ARHGAP6;PDPN
prerank,regulation of mitochondrial fission (GO:0090140),0.4795732477699638,1.1657956712711357,0.27956989247311825,0.6816400828442974,1.0,5/24,8.89%,DCN;LRRK2;SPIRE1;MYO19;RALA
prerank,modulation of excitatory postsynaptic potential (GO:0098815),-0.35227707418488635,-1.165560551640819,0.21610169491525424,0.687162360151543,1.0,10/26,16.22%,NRXN1;SHANK3;PRKCZ;CUX2;SLC8A3;RELN;RIMS2;NLGN1;RIMS1;SLC8A2
prerank,negative regulation of cellular amide metabolic process (GO:0034249),0.39120070243747024,1.1653141713385993,0.23420479302832245,0.6824221913116789,1.0,22/84,20.49%,IGF2BP1;IGF2BP2;SYNCRIP;APOE;IGFBP5;ILF3;RTN2;EIF2AK3;SAMD4A;PAIP2;BIN1;EIF2AK2;FMR1;GIGYF2;CAPRIN1;GAPDH;EPRS1;ORMDL3;DAPK1;YBX1;DDX3X;CALR
prerank,positive regulation of double-strand break repair via nonhomologous end joining (GO:2001034),0.5042230488095182,1.1652636184913767,0.30835734870317005,0.681978294164228,1.0,10/16,25.16%,PARP3;KDM4D;SHLD3;SETMAR;RIF1;PRKDC;WRAP53;DTX3L;KMT5B;PNKP
prerank,regulation of clathrin-dependent endocytosis (GO:2000369),-0.41250916013023503,-1.1651566698326994,0.25477707006369427,0.6857862168173906,1.0,9/15,34.76%,BMP2K;HIP1R;WASL;UBQLN2;PIK3CB;DGKD;DAB2;TNK2;UNC119
prerank,N-acetylneuraminate metabolic process (GO:0006054),0.5650312747463554,1.164116041115112,0.2809667673716012,0.6845781213083713,1.0,7/10,27.91%,ST6GAL1;ST3GAL1;AMDHD2;GNE;GNPDA2;NPL;RENBP
prerank,cellular response to estrogen stimulus (GO:0071391),0.5145724833624351,1.1638305956869064,0.28879310344827586,0.6848119905389163,1.0,6/14,26.04%,SFRP1;ARID5A;PELP1;BCAS3;WBP2;NCOA4
prerank,regulation of protein kinase B signaling (GO:0051896),0.37257129333353006,1.163461072632475,0.1871820956256358,0.6852927395850071,1.0,46/193,17.19%,PDGFRA;TCF7L2;IAPP;FGF20;MYORG;GAB2;PDGFRB;FGF7;EGF;IRS1;FGF9;FGFR1;PTEN;RAC1;FRS2;EGFR;RCN3;PIK3R1;TGFBR1;STRN;THEM4;HPSE;PIK3AP1;RICTOR;SPRY2;PIK3R5;GCNT2;GRB2;SFRP5;FGF2;DRD3;PTK2;ITGB1BP1;FLCN;OTUD3;PHLPP2;NTRK3;TNF;MST1R;CX3CL1;MC1R;RASD2;ANGPT1;VAV1;PTPRJ;BTC
prerank,neural tube development (GO:0021915),0.5220658782228434,1.1629957891020029,0.3166904422253923,0.6860354020415289,1.0,8/15,23.69%,ALDH1A2;PKD2;ARL13B;PTCH1;DVL1;DACT1;SOX11;TGFB1
prerank,positive regulation of hydrolase activity (GO:0051345),0.3785606856122984,1.1629578259119562,0.2159090909090909,0.6855712059631235,1.0,32/137,15.98%,CCL11;CCL7;RGS16;MAP4K4;SFRP1;CD40;PRTN3;XCL1;ASAP3;LIMS1;RGS10;RCN3;CCL5;NF1;RSU1;SNX18;TBC1D7;CALM3;ZC3H15;ALS2;TBC1D20;CALM2;THY1;CCL2;MAPRE2;HMGB2;FLCN;GSK3B;RAP1GAP;SNX9;CX3CL1;EZH2
prerank,regulation of gluconeogenesis (GO:0006111),0.4581841890656206,1.1628627505987763,0.27496757457846954,0.6852684623851903,1.0,8/27,16.50%,ADIPOQ;OGT;DDB1;SDHAF3;SELENOS;PTPN2;GCK;ZNF692
prerank,calcineurin-mediated signaling (GO:0097720),-0.4705016305345756,-1.1626144321285534,0.27055702917771884,0.6879146722945108,1.0,6/10,27.03%,NFATC1;NFATC2;PPP3CB;NFATC3;PPP3CC;ADGRB2
prerank,calcineurin-NFAT signaling cascade (GO:0033173),-0.4705016305345756,-1.1626144321285534,0.27055702917771884,0.6879146722945108,1.0,6/10,27.03%,NFATC1;NFATC2;PPP3CB;NFATC3;PPP3CC;ADGRB2
prerank,peptidyl-threonine phosphorylation (GO:0018107),0.4096602005488786,1.16216847915406,0.25951557093425603,0.6866618187428389,1.0,21/59,25.10%,PRKCA;LRRK2;CAMK2D;PRKD2;CSNK2A2;CDK10;TGFBR1;ACVR1B;ACVR1;MAP2K1;HIPK4;HIPK3;GSK3B;ROCK2;CSNK2A1;CDK5;CDC42BPA;PRKDC;MAPK1;AKT1;PDPK1
prerank,synaptic vesicle membrane organization (GO:0048499),-0.4104835469502087,-1.1620112804468397,0.27147766323024053,0.6869169799574554,1.0,6/17,17.78%,SNAP25;TOR1A;SYP;SYNGR1;SYNGR2;STX3
prerank,nuclear body organization (GO:0030575),0.5431295294560856,1.1617549854673945,0.31402439024390244,0.6872595035106411,1.0,2/12,4.86%,AFF2;USPL1
prerank,regulation of interferon-beta production (GO:0032648),0.42390851063073237,1.161639640352324,0.263905325443787,0.6870020174242628,1.0,15/46,20.26%,TLR2;IRF7;REL;IRF1;TIRAP;POLR3D;TRIM56;TLR7;SIRPA;RELB;DHX58;YY1;TLR3;POLR3A;DDX3X
prerank,neurotransmitter biosynthetic process (GO:0042136),-0.4255974373809557,-1.1612327425035858,0.29411764705882354,0.6867302261340447,1.0,5/14,28.55%,MOXD1;ALDH9A1;SLC22A2;DAGLB;CHAT
prerank,endodermal cell fate commitment (GO:0001711),0.5598373314240151,1.1609396311338012,0.30660377358490565,0.6884172368844086,1.0,1/10,0.63%,POU5F1
prerank,G2/M transition of mitotic cell cycle (GO:0000086),0.3812971917657784,1.1608286928047968,0.2299687825182102,0.6881514275662114,1.0,42/128,22.08%,DYNLL1;BACH1;ALMS1;CDKN2B;DYNC1H1;KHDRBS1;FBXL7;HAUS3;CDK14;CCP110;TUBG1;PHLDA1;CNTRL;CUL1;PLK1;FOXM1;CDK7;CEP41;PPP2R2A;PCM1;DCTN3;BORA;CSNK1D;FBXW11;SKP1;PPP1CB;CDC25A;CCNB2;BRSK2;CEP72;CCNH;TAF2;WEE1;TUBA1A;PCNT;LCMT1;BRSK1;ACTR1A;FBXL12;CKAP5;NINL;YWHAE
prerank,positive regulation of response to endoplasmic reticulum stress (GO:1905898),0.4884973817904571,1.1606478611202353,0.29232995658465993,0.6880882667580092,1.0,6/18,10.96%,PIK3R1;FCGR2B;BAX;NCK1;BAG6;XBP1
prerank,regulation of tau-protein kinase activity (GO:1902947),-0.47057216630506504,-1.160385495981404,0.27605633802816903,0.6866341499387575,1.0,3/10,20.22%,RB1;HSP90AB1;SORL1
prerank,peptidyl-tyrosine phosphorylation (GO:0018108),0.39953303991793754,1.1597657769888259,0.2562076749435666,0.6899894218533514,1.0,17/67,13.21%,PDGFRA;TEC;AATK;GHR;JAK2;PDGFRB;DDR2;BLK;FGFR1;EGFR;PTPN6;EPHA1;DDR1;ABI1;EPHB2;PTK2;ABI2
prerank,organic cation transport (GO:0015695),-0.38534420217163784,-1.1596299959395306,0.25650557620817843,0.6862048624866703,1.0,4/20,7.33%,SLC47A1;SLC25A42;RALBP1;SLC25A26
prerank,lytic vacuole organization (GO:0080171),0.44362731122053434,1.1591572689694825,0.26884422110552764,0.6911109931130814,1.0,10/32,20.17%,ABCA1;LRRK2;CLN6;HOOK2;MYO7A;GAA;ARSB;CLN3;TPCN2;HOOK3
prerank,negative regulation of protein localization to cell periphery (GO:1904376),0.48750630272753437,1.15908984954152,0.2887323943661972,0.6907196994055281,1.0,3/20,9.46%,CLTC;PID1;PPP2R5A
prerank,NAD biosynthesis via nicotinamide riboside salvage pathway (GO:0034356),-0.4271475232735415,-1.1590759667757435,0.2698412698412698,0.6852557610032021,1.0,7/13,35.55%,NAMPT;PARP10;NAXE;NAPRT;PARP9;NAXD;PARP16
prerank,cellular response to zinc ion (GO:0071294),-0.41489175308135395,-1.1587233602775007,0.2721311475409836,0.6838365235018131,1.0,12/15,25.45%,MT2A;GLRA2;ATP13A2;GLRA1;MT1B;MT1X;MT1G;MT1F;MT1E;MT1M;MT1H;MT1A
prerank,P-body assembly (GO:0033962),0.5296070684404534,1.1584565564257254,0.2919254658385093,0.6919447149973353,1.0,2/12,4.57%,ATXN2;DYNC1H1
prerank,DNA geometric change (GO:0032392),0.4634673012490524,1.1580392000910489,0.3075880758807588,0.6925472605090196,1.0,9/24,22.40%,DNA2;ANXA1;ASCC3;DDX11;MCM9;HMGB2;HMGB3;HNRNPA2B1;DDX1
prerank,negative regulation of vascular endothelial growth factor signaling pathway (GO:1900747),0.5494483739479871,1.1578720347028177,0.2988691437802908,0.6924454955145302,1.0,1/10,0.26%,DCN
prerank,regulation of cellular component organization (GO:0051128),-0.2526845236013609,-1.1577548240330517,0.1590909090909091,0.6840760036634721,1.0,32/135,14.02%,TJP1;PLCE1;SNCAIP;MLLT3;LTBP4;CDH13;CHPT1;LAMTOR1;RIT2;URI1;PACSIN1;HIP1R;HNRNPU;TFRC;RAPGEF2;TAOK2;SEMA4D;PAK5;HIP1;ANKRA2;GFAP;PINK1;FAM107A;METTL4;STK38L;SSRP1;ARHGEF11;NRG3;WFDC1;EBAG9;RAP1A;NET1
prerank,negative regulation of catalytic activity (GO:0043086),0.46111792300374677,1.1573763322104238,0.3047619047619048,0.6933069160283841,1.0,2/24,3.27%,HP;TIMP1
prerank,negative regulation of plasma membrane bounded cell projection assembly (GO:0120033),0.4695087350776425,1.1567332815946687,0.289544235924933,0.6945325590416961,1.0,5/25,9.43%,YAP1;ARHGAP24;CCP110;CDK10;TBC1D7
prerank,regulation of defense response to virus by host (GO:0050691),0.4537826792289199,1.1564486740306277,0.29277566539923955,0.6947295684695779,1.0,3/30,3.24%,IL23R;TNFAIP3;STAT1
prerank,ubiquitin-dependent protein catabolic process (GO:0006511),0.3668076701341576,1.1564155106659744,0.13941825476429287,0.6942509936867741,1.0,116/341,23.60%,PSMA7;SPSB1;TNFAIP3;RNF150;MYLIP;MAD2L1;KCTD21;USP9X;KLHL22;FBXL7;SMURF2;ANAPC11;CNOT4;TGFB1I1;FBXO7;UBR4;RNF111;NTAN1;UBQLN1;SIAH2;CBL;UBXN2A;PLK1;PSMD4;UBE2L3;APPBP2;RNF144A;SQSTM1;AREL1;RNF11;RNF19B;DDB1;PSMD11;RNF8;VPS4A;ZSWIM8;FZR1;SIRT2;BAG6;SPOP;XBP1;TRIM13;TOM1L1;CDC27;ARIH1;CDC16;PSMB8;RC3H2;ANAPC2;RAD23A;KCTD2;PCNP;RNF149;MIB1;FBXW11;SMURF1;CLOCK;TBL1X;FBXW5;KCTD5;MVB12A;FBXW7;STUB1;TRPC4AP;CHFR;MDM2;PSMA6;ARIH2;UBE2W;SYVN1;UBE2R2;UBE2E1;DCAF11;VPS37C;RBCK1;FBXO45;RNF40;PTPN23;RNF215;ITCH;NFE2L2;PSMD14;MAEA;SPSB3;FBXO22;KCTD10;UBE2S;RNF217;RNF213;PSMC6;PSMB10;ARRB1;UCHL1;PSMD12;PSMB1;RNF168;NEDD4;UBE3B;UBA1;WDR91;PSMA8;IFI27;PSMF1;PPP2R5C;KLHL25;DTX3L;TNFAIP1;RAD23B;COP1;PSME2;TRIP12;DDIT3;PSMA4;CDC23;COPS3;RNF14
prerank,phosphatidylserine metabolic process (GO:0006658),0.4440939433383037,1.1563911153471933,0.2862595419847328,0.6937526654502532,1.0,9/32,21.63%,PLA1A;PLA2G5;ABHD16A;PTDSS2;PLA2G12A;OSBPL5;PLA2G4A;LPCAT3;PLA2G4E
prerank,NADH dehydrogenase complex assembly (GO:0010257),-0.2875033350549394,-1.1562281791640736,0.16279069767441862,0.6834500802995973,1.0,28/56,30.33%,NDUFAF5;NDUFS1;NDUFAF2;ECSIT;NDUFV2;NDUFA13;NDUFA8;NUBPL;NDUFA11;NDUFC2;NDUFB7;NDUFA1;FOXRED1;TIMM21;TMEM126B;NDUFAF6;NDUFB11;NDUFV1;NDUFA10;TIMMDC1;NDUFA3;NDUFAF8;NDUFC1;NDUFA12;NDUFS3;NDUFB10;NDUFA6;DMAC2
prerank,mitochondrial respiratory chain complex I assembly (GO:0032981),-0.2875033350549394,-1.1562281791640736,0.16279069767441862,0.6834500802995973,1.0,28/56,30.33%,NDUFAF5;NDUFS1;NDUFAF2;ECSIT;NDUFV2;NDUFA13;NDUFA8;NUBPL;NDUFA11;NDUFC2;NDUFB7;NDUFA1;FOXRED1;TIMM21;TMEM126B;NDUFAF6;NDUFB11;NDUFV1;NDUFA10;TIMMDC1;NDUFA3;NDUFAF8;NDUFC1;NDUFA12;NDUFS3;NDUFB10;NDUFA6;DMAC2
prerank,negative regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903799),0.5380331362986047,1.1561940442563712,0.2938388625592417,0.6937128579900557,1.0,9/12,28.99%,NCOR2;STAT3;TERT;TNF;LIN28B;TGFB1;BCDIN3D;NCOR1;ZC3H12A
prerank,3'-UTR-mediated mRNA destabilization (GO:0061158),0.5026891684563571,1.1558348908587932,0.30758226037195996,0.6942244567656123,1.0,5/16,14.86%,ZFP36L1;ZFP36L2;KHSRP;PLEKHN1;MOV10
prerank,negative regulation of endothelial cell migration (GO:0010596),0.43192049631001006,1.1553931282129948,0.30354957160342716,0.6948744225126976,1.0,9/36,16.24%,DCN;NR2F2;APOE;APOH;PPARG;ADAMTS9;FGF2;TNF;SP100
prerank,second-messenger-mediated signaling (GO:0019932),0.3905951331419211,1.1552859676506124,0.2508108108108108,0.6945828924958073,1.0,15/82,13.08%,EDN3;PPP1R9B;TNFSF11;LRRK2;APOE;CCR1;EIF2AK3;RCAN3;CD36;RCAN2;HRH1;CXCR4;MCTP2;LAT2;SAMD14
prerank,protein polyubiquitination (GO:0000209),0.3676456191898603,1.1550637448461294,0.14415322580645162,0.6946917464968714,1.0,87/297,21.00%,PSMA7;TRIML2;SPSB1;TNFAIP3;DCAF15;MYLIP;FBXO40;BCL2;UBR5;FBXL7;SMURF2;ANAPC11;HECTD2;FBXO7;SIAH2;TRIM21;CUL1;PSMD4;CBFB;UBE2L3;RNF144A;UBE2J1;AREL1;TRIM56;RNF19B;PSMD11;FBXO38;RNF8;FBXO31;FZR1;SPOP;SASH1;CDC27;UBE2E2;ARIH1;CDC16;PSMB8;RC3H2;ANAPC2;TRAF2;TRIM62;FBXL18;FBXW10;FBXW11;TPP2;SMURF1;SKP1;PELI3;FBXW5;FBXW7;FBXO30;STUB1;PELI2;UBE2QL1;CHFR;MDM2;TRAF3IP2;NPEPPS;PSMA6;ARIH2;UBE2W;SYVN1;UBE2R2;UBE2E1;RBCK1;ITCH;PSMD14;FBXO2;FBXO22;UBE2S;TNKS2;TRIM27;RNF217;RNF213;PSMC6;PSMB10;ZNRF2;PSMD12;PSMB1;TRAF5;RNF168;NEDD4;UBE3B;PSMA8;IFI27;FBXL12;PSMF1
prerank,positive regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0045737),0.5059165713534239,1.1549828700456433,0.3149931224209078,0.69433439673994,1.0,4/17,9.37%,PSRC1;PKD2;EGFR;CCND3
prerank,negative regulation of cell activation (GO:0050866),0.5195822096550448,1.1548432357220528,0.3201754385964912,0.6941555507245828,1.0,4/14,10.43%,PDGFRA;APOE;TREM2;EMILIN1
prerank,phosphatidylinositol-mediated signaling (GO:0048015),0.39931915159748343,1.1546964766772772,0.26755852842809363,0.6939855056365793,1.0,20/69,18.65%,PDGFRA;ZFP36L1;GAB2;PDGFRB;IRS1;OGT;FGFR1;PTEN;PIK3R1;NF1;PLCL1;SIRT2;PIK3R5;RPS6KB1;PI4KA;PIK3C3;RHOA;PLCH1;PLCB3;EXOC1
prerank,protein import into mitochondrial matrix (GO:0030150),-0.3940028553423426,-1.1541491455959858,0.26229508196721313,0.6865780999507802,1.0,8/18,19.22%,GRPEL2;TOMM70;DNAJC19;DNAJC15;TIMM17B;TOMM40;TIMM21;ROMO1
prerank,mitotic cell cycle phase transition (GO:0044772),0.3666636488074595,1.1538564209527364,0.19878296146044624,0.6957202640602143,1.0,74/203,25.62%,DYNLL1;ALMS1;CHMP4B;CDKN2B;DYNC1H1;KHDRBS1;FBXL7;CDKN2D;HAUS3;CDK14;CCNE2;E2F1;CCP110;TUBG1;CACUL1;PHLDA1;CNTRL;CUL1;PLK1;ACVR1B;FOXM1;ACVR1;E2F3;CCND3;CDK6;CDK7;CEP41;PPP2R2A;PCM1;DCTN3;CDC27;RPS6KB1;BORA;GSPT1;CDC16;RCC1;CSNK1D;FBXW11;DBF4;SKP1;PPP1CB;CDC25A;CCNB2;BRSK2;EIF4EBP1;CEP72;CCNH;TAF2;WEE1;TUBA1A;CHMP7;UBE2S;PCNT;LCMT1;BRSK1;ACTR1A;FBXL12;CKAP5;NINL;YWHAE;LATS2;YWHAG;CDC23;AKAP9;CLASP2;USP37;PAFAH1B1;BCAT1;FBXL22;CDKN1B;MAX;INHBA;CUL5;CCNI
prerank,regulation of DNA replication (GO:0006275),0.40773139095666805,1.1538008554565418,0.25874125874125875,0.6953012565911662,1.0,10/49,14.27%,GLI2;DNA2;EGF;BRPF3;ZBTB38;ATR;EGFR;FBXO5;NUCKS1;PDS5A
prerank,positive regulation of programmed cell death (GO:0043068),0.36883806730298957,1.1537541767907122,0.158953722334004,0.6948294868154222,1.0,61/272,17.47%,CYP1B1;ZBP1;KNG1;IAPP;BCL6;VAV2;SFRP4;SFRP1;CCAR1;SFRP2;VAV3;LRRK2;AIFM2;EEF1E1;FGD4;CTSD;FRZB;PPID;KALRN;E2F1;ATM;ITSN1;RASSF2;NF1;PHLDA1;TRIO;TNFRSF12A;CALHM2;BAX;OMA1;SQSTM1;OLFM1;TGFB3;BIN1;AKAP13;PLEKHN1;PREX1;SLC27A4;FZD9;RRP1B;CLIP3;ARHGEF19;PAWR;CCAR2;HTATIP2;TRIM35;HSPD1;UBE2Z;FLCN;SAP18;CASP8;ARHGEF12;KCNMA1;TNF;ABL1;PSEN1;VAV1;FAM162A;PLEKHG2;NLRP2B;ACVR1C
prerank,negative regulation of amyloid precursor protein catabolic process (GO:1902992),0.4876290088181132,1.1533143842934315,0.2828282828282828,0.6954699012561117,1.0,4/19,9.50%,APOE;FLOT2;RTN2;BIN1
prerank,proteoglycan metabolic process (GO:0006029),0.45351955520317133,1.1532240361558894,0.291005291005291,0.6951427686693461,1.0,4/26,9.14%,SULF1;CHST13;ADAMTS12;HPSE
prerank,receptor signaling pathway via JAK-STAT (GO:0007259),0.4620392289850861,1.1526489109578475,0.2858974358974359,0.6961144936830507,1.0,9/29,15.56%,GHR;JAK2;STAT1;PKD2;STAT3;STAT5A;STAT6;CCL2;IFNAR2
prerank,negative regulation of protein localization to cell surface (GO:2000009),0.5401825420767769,1.15236631110116,0.32643312101910826,0.6963378986254366,1.0,3/11,8.07%,GPM6B;TAX1BP3;SNX33
prerank,regulation of carbohydrate biosynthetic process (GO:0043255),0.5494247227006883,1.1522068027971377,0.31384615384615383,0.696230552262014,1.0,5/10,21.10%,OGT;SDHAF3;SELENOS;ZNF692;SIRT7
prerank,positive regulation of stress-activated MAPK cascade (GO:0032874),0.38874958461536174,1.1519690386661847,0.24593716143011918,0.6962804181848452,1.0,22/93,20.07%,SH3RF3;MID1;TAOK1;TIRAP;EDA2R;UNC5CL;RASSF2;FCGR2B;MAPK8IP1;SASH1;TAOK3;EIF2AK2;SH3RF1;PJA2;TRAF2;SDCBP;EDAR;PDCD10;SPI1;SEMA3A;TRAF5;TGFB2
prerank,response to alcohol (GO:0097305),0.4529594427810847,1.1514646724904862,0.2887700534759358,0.697127394752362,1.0,6/27,13.46%,SLIT3;ABCA2;SMAD2;TGFBR1;DRD3;GRIN2A
prerank,positive regulation of exocytosis (GO:0045921),0.4282833871257635,1.1514263225704786,0.291358024691358,0.6966664909947349,1.0,10/35,18.31%,UNC13D;RAB2B;RAB7A;VPS4A;SDC1;RAB27B;SDCBP;RAB9A;HGS;SMPD3
prerank,positive regulation of protein phosphorylation (GO:0001934),0.364833994292158,1.1514121584489587,0.14,0.6961330686744429,1.0,77/348,17.28%,IL34;C3;CEMIP;ADIPOQ;TEC;FGF20;S1PR2;JTB;THBS4;GHR;NRP1;TMEM119;SFRP2;JAK2;CD40;VTN;LRRK2;FGF7;TNKS1BP1;RAP2A;DDR2;EGF;PRKD2;TREM2;FGF9;FBH1;DVL2;LCP2;RAC1;RASSF2;EGFR;BMP5;CACUL1;PLK1;WDFY2;TGFBR1;FAM20A;ACVR1;INHBB;TGFB3;CCND3;RPTOR;CDK9;CALM3;SPRY2;ERP29;EFNA5;TOM1L1;ACVR2A;ALS2;HDAC3;CLIP3;FGF2;FNIP1;GPNMB;FMR1;ARAF;PTK2;CSNK1D;CALM2;ITGA5;SDCBP;AXIN2;FLCN;PELI2;NTRK3;NIBAN1;TNF;SNX9;ABL1;ATG14;CX3CL1;NPTN;ANGPT1;PDCD10;PTPRJ;ROCK2
prerank,keratinocyte differentiation (GO:0030216),0.44724279763035146,1.1512993301560779,0.2962962962962963,0.6958765372212008,1.0,4/29,4.59%,WNT5A;UGCG;JAG1;ANXA1
prerank,positive regulation of DNA-binding transcription factor activity (GO:0051091),0.36764053982403944,1.151158276481067,0.17953861584754263,0.6957204839816277,1.0,48/234,13.86%,ROR1;WNT2;TRIML2;STK36;NKX6-1;TNFSF11;TLR2;WNT5A;CD40;FLOT2;DDR2;IRAK3;CFLAR;TIRAP;ARID5B;PRKD2;PTEN;EDA2R;SHH;DVL2;NFKB2;PPRC1;IKBKE;STAT3;CD36;CRTC3;RAB7B;TRIM21;LGALS9;TRIM8;FZD1;PPARG;NOD1;NFKB1;HDAC5;TRIM13;CRTC1;TFDP1;EIF2AK2;EDA;LAMTOR5;TRAF2;TRIM62;TCF3;SMAD3;CLOCK;LRP6;IRAK2
prerank,regulation of androgen receptor signaling pathway (GO:0060765),0.4456722226337395,1.151157309050017,0.2935897435897436,0.6951555325830281,1.0,13/30,24.26%,NCOR2;SFRP1;HDAC1;KLK2;PIAS2;SAFB2;HEYL;SMARCA4;PKN1;PARK7;ZBTB7A;RNF14;KDM1A
prerank,isotype switching (GO:0045190),0.5543687686641058,1.1507537664289733,0.34177215189873417,0.6957617157430831,1.0,5/10,20.02%,BATF;RNF8;HSPD1;EXOSC3;RNF168
prerank,peptidyl-lysine trimethylation (GO:0018023),0.4574886225289449,1.1504098791941808,0.277992277992278,0.696146312224406,1.0,7/26,17.58%,KMT2A;OGT;ANTKMT;ETFBKMT;VCPKMT;TET2;KMT2D
prerank,regulation of mitochondrion organization (GO:0010821),0.4161516571706839,1.1503532250677737,0.2769409038238702,0.6957282225387943,1.0,12/47,15.22%,IAPP;LRRK2;CSNK2A2;TREM2;PID1;MYO19;OMA1;SQSTM1;FLCN;FBXW7;GSK3B;INF2
prerank,establishment of epithelial cell polarity (GO:0090162),0.4890861095225164,1.1501277967820447,0.27823691460055094,0.6957705546913814,1.0,5/19,7.15%,CYTH3;RAP2A;SIPA1L3;OPHN1;CDC42
prerank,positive regulation of vascular associated smooth muscle cell proliferation (GO:1904707),0.4740333025318769,1.149911078853139,0.29403606102635227,0.6958119813302359,1.0,4/21,6.78%,MMP2;IGFBP5;FGF9;ADAMTS1
prerank,epithelium development (GO:0060429),0.3822316062632572,1.1498188669179024,0.2417815482502651,0.6955113931144119,1.0,22/107,18.76%,WNT2;ERRFI1;JAK2;STAT1;ALDH1A2;SNAI2;GATA6;PKD2;TBX2;SHH;RCN3;PPARG;CTSB;SALL1;LOXL3;ANXA7;GSTK1;CNN3;TIMELESS;PTCH1;SMO;DVL1
prerank,negative regulation of transcription regulatory region DNA binding (GO:2000678),-0.4268746245764957,-1.1490707354957628,0.26517571884984026,0.6980506412734376,1.0,5/13,22.12%,TMSB4X;SIN3A;HEY2;PER2;HEY1
prerank,response to laminar fluid shear stress (GO:0034616),0.5438741076484672,1.1487511888239357,0.3359375,0.6979713868102716,1.0,1/10,0.26%,ABCA1
prerank,mitotic nuclear division (GO:0140014),0.39124039443290404,1.1486383649574883,0.2665903890160183,0.6977388161699809,1.0,21/71,24.16%,KIFC1;SMC1A;CHMP4B;KLHL22;STAG1;INO80;STAG2;TUBG1;KIF2A;PLK1;TPX2;KPNB1;RHOA;CHMP7;UBE2S;NDEL1;TUBG2;BCCIP;CCDC61;NCAPG2;CLASP2
prerank,regulation of integrin activation (GO:0033623),0.4885530205001051,1.148604220504321,0.3048048048048048,0.697255580095146,1.0,7/15,23.14%,FARP2;PTGER4;FBLIM1;JAM3;RAP1B;SRC;PIEZO1
prerank,negative regulation of macroautophagy (GO:0016242),0.4573240905061039,1.148420918360601,0.2846054333764554,0.6971914686708673,1.0,13/26,24.65%,LRRK2;CHMP4B;CHMP4A;TMEM39A;PHF23;SCFD1;SMCR8;FEZ2;MTM1;CLEC16A;TSC2;NUPR1;AKT1
prerank,preassembly of GPI anchor in ER membrane (GO:0016254),0.4999681690405127,1.1484124887217697,0.2984218077474892,0.6966520015740315,1.0,9/16,24.01%,PIGW;PIGN;PIGL;DPM2;PIGG;PIGC;PIGX;PIGH;PIGP
prerank,regulation of insulin receptor signaling pathway (GO:0046626),0.42064058864576515,1.1483959429374242,0.2889963724304716,0.6961350381401842,1.0,11/43,11.30%,ENPP1;IRS1;PIP4K2A;OGT;PID1;SNX5;NCK1;PIP4K2B;PTPN1;SLC27A4;RPS6KB1
prerank,positive regulation of cellular catabolic process (GO:0031331),0.3731748744724392,1.1480338398616459,0.23164426059979318,0.6965624735318214,1.0,43/132,23.59%,DCN;TRIML2;LRRK2;APOE;IRS1;ARNT;SLC4A4;KHSRP;NPRL2;TRIM21;SNX33;PFKFB4;TRIM8;ZBTB20;PTPN1;ZSWIM8;MSN;FLCN;GSK3B;MOV10;TNF;SNX9;PSEN1;TPCN1;SH3GLB1;ITCH;PLEKHF1;ORMDL3;TRIM27;FOXO3;DXO;DAPK1;STK11;P2RX7;LIN28B;PRXL2C;IGF1;NRDC;DTX3L;DACT1;TWIST1;GPLD1;ABCD2
prerank,positive regulation of mesenchymal cell proliferation (GO:0002053),0.5440210551087702,1.147939878487676,0.3333333333333333,0.6962441140919948,1.0,2/10,5.73%,STAT1;SHH
prerank,interleukin-12-mediated signaling pathway (GO:0035722),0.41246087163835626,1.147705448077339,0.2703349282296651,0.6963155351135178,1.0,16/46,22.63%,JAK1;JAK2;LCP1;CDC42;RALA;CAPZA1;TALDO1;MSN;LMNB1;HNRNPDL;AIP;HNRNPA2B1;ARF1;RAP1B;ANXA2;PSME2
prerank,negative regulation of transcription from RNA polymerase II promoter in response to stress (GO:0097201),0.5546642893145863,1.1472729025684936,0.31703470031545744,0.696975662703951,1.0,4/10,10.71%,DNAJB1;NCK1;BAG3;SIRT2
prerank,embryonic organ development (GO:0048568),0.40078856074813046,1.147244219472091,0.2654462242562929,0.6964804061972371,1.0,16/61,16.77%,KMT2A;GLI2;TEAD3;COL13A1;GLI3;RARB;TBX2;TEAD1;PBX3;FOXE1;SALL1;PCSK5;RBPJ;STRA6;TNF;GDNF
prerank,release of cytochrome c from mitochondria (GO:0001836),0.49078454374379615,1.1464211167770597,0.29839883551673946,0.6981528031988408,1.0,7/17,20.27%,BCL2;BBC3;BAX;FZD9;FIS1;GGCT;TIMM50
prerank,regulation of cytoskeleton organization (GO:0051493),0.3776450546802924,1.1464178931704376,0.25026511134676566,0.6975986565173925,1.0,26/108,17.36%,DLC1;GPM6B;LRP1;TAOK1;RND3;SYDE1;PDGFRB;RHOD;BAIAP2;CAPN2;FSCN1;RAC1;CDK10;RICTOR;EFNA5;ARHGEF19;PTK2;ARHGAP35;GSK3B;TPPP;PHLDB1;PHLDB2;ABL1;RHOBTB3;ROCK2;RHOA
prerank,beta-catenin-TCF complex assembly (GO:1904837),0.4516072836783035,1.1464089415993253,0.29961089494163423,0.697065239248264,1.0,13/29,19.61%,TCF7L2;TLE1;RBBP5;HDAC1;CREBBP;TCF7;TERT;TCF7L1;AXIN2;RUVBL1;KMT2D;CDC73;SMARCA4
prerank,positive regulation of GTPase activity (GO:0043547),0.3657709532191996,1.1460163860174102,0.20408163265306123,0.6975874806259448,1.0,57/188,20.99%,CCL11;CCL7;RGS16;MAP4K4;ARHGAP24;SFRP1;SYDE1;ARHGAP42;CD40;PRTN3;XCL1;SIPA1L3;RABGAP1L;ASAP3;TAX1BP3;LIMS1;RGS10;RABGAP1;TBC1D2B;CCL5;NF1;RSU1;EPHA1;SNX18;TBC1D16;TBC1D7;ZC3H15;SLC27A4;TBC1D8B;ALS2;TBC1D20;ARHGEF19;THY1;CCL2;MAPRE2;MTSS2;FLCN;GSK3B;TBC1D13;NTRK3;RAP1GAP;SNX9;CX3CL1;EZH2;PIP5K1A;RAP1GDS1;EVI5L;NTF3;RAB3GAP1;NDEL1;SGSM3;ADPRH;CORO1C;SIPA1L2;ARHGEF26;RUNDC1;BCAS3
prerank,regulation of cell morphogenesis (GO:0022604),0.44088537016340973,1.1460103586919559,0.3107769423558897,0.6970417217228725,1.0,11/30,23.42%,SPARC;FMNL2;PDZD8;EFNA5;PDPN;MOV10;WTIP;CAMSAP1;MYO9A;ZMYM4;STRIP1
prerank,regulation of NLRP3 inflammasome complex assembly (GO:1900225),0.5081536989934117,1.1456319620408337,0.3179190751445087,0.6975722171348724,1.0,7/15,22.73%,TREM2;CD36;EIF2AK2;PYDC1;NLRP2B;DDX3X;CPTP
prerank,positive regulation of JNK cascade (GO:0046330),0.39504836744092636,1.1456185632258549,0.2768361581920904,0.6970512401927456,1.0,13/70,13.84%,SH3RF3;TAOK1;TIRAP;EDA2R;UNC5CL;RASSF2;FCGR2B;MAPK8IP1;TAOK3;SH3RF1;PJA2;TRAF2;SDCBP
prerank,regulation of myoblast fusion (GO:1901739),0.534578649866451,1.1456090316350012,0.31587057010785824,0.6965203924701162,1.0,4/11,21.48%,CFLAR;CD53;EHD2;EHD1
prerank,regulation of proteasomal protein catabolic process (GO:0061136),0.414468867443222,1.1452644124604243,0.30369515011547343,0.6969142872683803,1.0,17/53,22.63%,GLMN;DNAAF4;APOE;TREM2;OPHN1;USP14;FMR1;ARAF;RAD23A;FBXW7;PSMD14;PSMC6;RHBDF1;PSMF1;DDRGK1;RAD23B;PSME2
prerank,cortical cytoskeleton organization (GO:0030865),0.4164604246052621,1.1449702012448262,0.2844932844932845,0.6971151946804719,1.0,13/41,17.36%,RND3;FMNL2;LCP1;RHOD;RAC1;FMNL3;FHOD3;LLGL1;EPB41L3;TNF;RHOBTB3;ROCK2;RHOA
prerank,regulation of stress-activated MAPK cascade (GO:0032872),0.42504389523651254,1.1449650789970076,0.2768166089965398,0.6965732450776095,1.0,11/47,11.69%,MID1;TAOK1;MAP4K4;RAP2A;EGFR;LGALS9;FOXM1;MAPK8IP1;MAP2K1;TAOK3;EIF2AK2
prerank,regulation of glucose import (GO:0046324),0.44645795534359684,1.1447467822069055,0.31066666666666665,0.6966042118090435,1.0,6/30,7.45%,ENPP1;ADIPOQ;IRS1;PID1;RTN2;PIK3R1
prerank,positive regulation of lamellipodium organization (GO:1902745),0.43945126147661917,1.1446803922886701,0.31474597273853777,0.6962209877771818,1.0,8/32,7.45%,CARMIL2;AUTS2;ACTR2;FSCN1;CARMIL1;RAC1;CDC42;PIK3R1
prerank,negative regulation of intracellular steroid hormone receptor signaling pathway (GO:0033144),0.4509586959567861,1.1435211832682501,0.29658792650918636,0.6988809158665809,1.0,9/26,22.56%,NCOR2;SFRP1;HDAC1;PIAS2;HEYL;CLOCK;SMARCA4;CALR;ZBTB7A
prerank,protein ubiquitination (GO:0016567),0.361147940902259,1.143016638253989,0.105,0.6996853574026428,1.0,126/471,20.39%,PSMA7;TRIML2;SH3RF3;ARRDC4;DTX4;PDZRN3;SPSB1;DCAF15;MYLIP;MYCBP2;PEX10;FBXO40;USP9X;BCL2;UBR5;KLHL22;BRAP;FBXL7;RNF157;SMURF2;ANAPC11;FBH1;ATG3;HECTD2;CNOT4;FBXO7;KLHL13;RNF111;SIAH2;CBL;TRIM21;CUL1;PLK1;PSMD4;CBFB;UBE2L3;RNF144A;DTX2;UBE2J1;AREL1;RNF11;RNF19B;DDB1;EIPR1;PSMD11;RNF8;FBXO31;ZSWIM8;SPOP;TRIM13;SASH1;RNF138;TRIM11;CDC27;UBE2E2;ARIH1;CDC16;PSMB8;SH3RF1;PJA2;RC3H2;PCNP;TRAF2;USP22;TRIM62;SELENOS;FBXL18;FBXW10;KLHL12;MIB1;FBXW11;VCPIP1;TPP2;SMURF1;TRIM35;SKP1;PELI3;UBE2Z;FBXW5;FBXW7;FBXO30;STUB1;PELI2;UBE2QL1;TRPC4AP;CHFR;MDM2;NPEPPS;PSMA6;ARIH2;UBE2W;DTX3;SYVN1;UBE2R2;RNF103-CHMP3;UBE2E1;RBCK1;FBXO45;RNF40;CUL7;ITCH;NFE2L2;PSMD14;CDC73;FBXO2;TRIM44;FBXO22;KCTD10;TRIM17;UBE2S;TNKS2;PEX5;TRIM27;RNF217;RNF213;PSMC6;PSMB10;ARRB1;ZNRF2;PSMD12;PSMB1;RNF181;RNF168;NEDD4;UBE3B;UBA1
prerank,negative regulation of endothelial cell proliferation (GO:0001937),0.43367842559906034,1.1429909272927186,0.30759951749095293,0.6991975151149971,1.0,8/35,8.94%,SULF1;SPARC;NR2F2;STAT1;APOE;APOH;NF1;PPARG
prerank,mitotic cytokinetic process (GO:1902410),0.48498031285883797,1.1429100070097966,0.3018867924528302,0.6988821176967686,1.0,10/20,26.40%,CHMP4B;CHMP4A;VPS4A;CHMP3;RHOA;CHMP7;KIF20A;CHMP2B;PDCD6IP;VPS4B
prerank,RNA catabolic process (GO:0006401),0.41312666207228643,1.142159302083162,0.27197149643705465,0.7004181581359967,1.0,15/46,21.50%,ZFP36L2;DNA2;PABPC4;SND1;METTL16;MTREX;DCP2;RNASEH2A;RNASEH1;RNH1;SIDT2;DXO;LSM6;YTHDF2;DIS3L2
prerank,cellular response to interleukin-12 (GO:0071349),0.4072828543248699,1.1421310672503588,0.2840095465393795,0.6999390567018569,1.0,17/48,22.63%,JAK1;JAK2;LCP1;CDC42;RALA;SIRPA;CAPZA1;TALDO1;MSN;LMNB1;HNRNPDL;AIP;HNRNPA2B1;ARF1;RAP1B;ANXA2;PSME2
prerank,"nucleotide-excision repair, preincision complex stabilization (GO:0006293)",-0.3738938315662506,-1.1420069556064958,0.26501766784452296,0.7127717117694483,1.0,9/21,23.18%,ERCC5;ERCC3;CHD1L;GTF2H2;RBX1;ERCC1;GTF2H4;DDB2;RPA2
prerank,"nucleotide-excision repair, DNA incision, 3'-to lesion (GO:0006295)",-0.3738938315662506,-1.1420069556064958,0.26501766784452296,0.7127717117694483,1.0,9/21,23.18%,ERCC5;ERCC3;CHD1L;GTF2H2;RBX1;ERCC1;GTF2H4;DDB2;RPA2
prerank,positive regulation of nuclear division (GO:0051785),0.4502219315881399,1.1418060781624382,0.3104359313077939,0.7002721731512076,1.0,5/25,12.37%,EDN3;PDGFRB;EGF;SIRT2;DRD3
prerank,fat cell differentiation (GO:0045444),0.40255656270359025,1.141784109914509,0.2847222222222222,0.6997776474495546,1.0,11/57,11.97%,ADIPOQ;STEAP4;TCF7L2;OSBPL11;MAFB;PID1;TMEM120B;PPARG;INHBB;CLIP3;PSMB8
prerank,blood circulation (GO:0008015),0.4167554986155235,1.1416803181936575,0.30012004801920766,0.6995086359193318,1.0,7/49,8.47%,OLR1;EDN3;SERPING1;CXCL12;STAT1;TNNI3;CXCL10
prerank,"positive regulation of synaptic transmission, glutamatergic (GO:0051968)",-0.3866672625700516,-1.1415358461560758,0.22419928825622776,0.7116013800876316,1.0,7/18,18.82%,NRXN1;SHANK3;CACNG2;RELN;NLGN1;CACNG8;CACNG7
prerank,positive regulation of production of molecular mediator of immune response (GO:0002702),0.43923721519977416,1.1410762021529621,0.28865979381443296,0.7005881917658034,1.0,8/34,17.95%,LACC1;WNT5A;XCL1;SASH3;XBP1;EPHB2;TNFRSF4;SPHK2
prerank,cellular response to increased oxygen levels (GO:0036295),-0.4497087813060764,-1.1410354837379164,0.3003003003003003,0.7105675689452354,1.0,6/11,20.08%,CAV1;ATP6V1A;ATP6V0D1;TMEM199;ATP6AP1;FAS
prerank,liver development (GO:0001889),0.43525208799070664,1.1409539222598044,0.30456852791878175,0.7003612391778987,1.0,11/32,17.18%,PRKCSH;ANXA1;ARID5B;PKD2;PHF2;NF1;E2F8;XBP1;NPHP3;NKX2-8;GFER
prerank,negative regulation of fatty acid biosynthetic process (GO:0045717),-0.4303471617460851,-1.1406615956090516,0.29829545454545453,0.7092509639763254,1.0,5/12,27.14%,ERLIN1;SIRT1;CEACAM1;BRCA1;ACADL
prerank,cellular response to pH (GO:0071467),0.5002453281724621,1.1405757389786941,0.3173734610123119,0.7008608595837709,1.0,2/17,2.48%,SLC9A1;HVCN1
prerank,negative regulation of macrophage activation (GO:0043031),-0.39936365244725863,-1.1404707907777998,0.27177700348432055,0.7073777686780518,1.0,4/16,8.79%,LRFN5;LDLR;CD200;GRN
prerank,vascular endothelial growth factor receptor signaling pathway (GO:0048010),0.39624196701884573,1.1404263789683673,0.27986348122866894,0.7007363216120144,1.0,16/67,13.07%,SULF1;VAV2;NRP1;VAV3;BAIAP2;PRKD2;RAC1;CDC42;PIK3R1;NCK2;DOCK1;NCK1;MAPK11;ABI1;SHB;PTK2
prerank,adenylate cyclase-modulating G protein-coupled receptor signaling pathway (GO:0007188),0.3673657312567253,1.1404042969040067,0.23541453428863868,0.7002470109482725,1.0,17/152,9.57%,MC5R;ABCA1;FSHR;IAPP;ADCY7;S1PR2;ADM;HTR1D;ADGRL3;ADCY2;RXFP2;GPR161;ADCYAP1R1;CXCL10;GLP2R;GNAS;S1PR3
prerank,RNA metabolic process (GO:0016070),0.3740063235842121,1.1395348684549786,0.25467775467775466,0.7021345738872027,1.0,37/127,20.26%,RBMS1;ATXN1;APOBEC1;SYNCRIP;ATXN2;DDX17;LAGE3;SNRNP40;PABPC4;RNASE1;SND1;FTO;DHX8;GTF2F2;ALKBH1;RBM39;WDR74;SETX;DICER1;MTREX;RBFOX2;POLR2K;RNASEH2A;PAPOLG;RBMS2;NCBP2;RNASEH1;POLR2B;HNRNPK;HNRNPUL1;SIDT2;HNRNPH2;RBM6;GTF2F1;HNRNPA2B1;TBRG4;DDX3X
prerank,phosphatidylinositol 3-kinase signaling (GO:0014065),0.43711321974268946,1.13948082018638,0.31683168316831684,0.701732388116382,1.0,7/33,10.93%,ZFP36L1;IRS1;PTEN;PIK3R1;NF1;SIRT2;PIK3R5
prerank,negative regulation of cell-cell adhesion (GO:0022408),0.41956132749000713,1.1394002420864675,0.29679802955665024,0.7014182203080793,1.0,5/39,5.65%,ADIPOQ;B4GALNT2;JAG1;MIA3;NF2
prerank,cellular protein modification process (GO:0006464),0.3544914864161697,1.1390435147478633,0.057,0.701779639331551,1.0,275/983,23.38%,PSMA7;CCL11;CEL;C3;COL3A1;ENAM;RUNX3;KNG1;IGFBP7;SPP1;PARP8;LAMB1;NEK6;PARP3;TAOK1;TEC;PDXP;CP;LAMC1;MAP4K4;WIPI1;AATK;JAK1;SPSB1;B4GALT5;ALG5;STK36;PLOD2;PTPN7;PRKCA;FSTL1;NUAK1;ERN2;DUSP2;PEAK1;WSB2;IGFBP4;FBXO40;JAK2;TIMP1;ST3GAL3;VCAN;LRRK2;APOE;DUSP5;CAMK2D;FBN1;UGCG;PTPN3;PRKCSH;DUSP26;IRAK3;IGFBP5;KLHL22;ANXA1;MIA3;PLAT;PRKD2;COQ8B;FBXL7;FGFR1;MAP4K5;CKAP4;PTEN;PTPN13;DCAF10;ILF3;KCTD7;MARK1;CALU;ATG3;COPS7A;CDK14;FBXO7;LTBP1;KLHL13;ATM;SSH1;RBBP5;EIF2AK3;AKT3;IKBKE;LOXL1;CDK10;PPP4R1;RAB2A;DDOST;CUL1;PLK1;OBSL1;TGFBR1;PSMD4;PXK;FAM20A;UBE2L3;ACVR1B;PTPN6;MAN2A1;ACVR1;NEURL2;B3GALNT1;PRKAR1B;PPP2R5A;CDK6;MAP2K1;CDK9;PTPRZ1;FN3KRP;DDB1;PSMD11;PTPN1;SDC2;MERTK;CDK13;FBXO31;CDK7;CSNK1A1;FRK;NRK;PPP2R2A;PTPN18;SIRT2;PHKA2;DAPP1;TNC;MORC3;GCNT2;TAOK3;DCUN1D1;ACVR2A;UBE2F;UBE2E2;EIF2AK2;CDC14B;PTPN5;PSMB8;CHML;PPP3CA;MAST2;FAM20C;METAP1;DCLK1;ARAF;NEK4;CCNT1;CSNK1D;FBXL18;FBXW10;FBXW11;CCL2;STT3A;SKP1;PIK3C3;PIK3R4;HIPK3;PPP1CB;FBXW5;FBXW7;FBXO30;GSK3B;MAPK9;PTAR1;PPM1H;BRSK2;PPP2R5E;PARP14;ABL1;PSMA6;SOCS5;PIGK;ASB3;RAB8A;ST3GAL2;UBE2E1;DCAF11;YES1;ST3GAL1;PPP4R2;PTPRJ;CUL7;ROCK2;PICK1;ACVR1C;PSMD14;FNTB;MMP15;PTPN9;SPSB3;FBXO2;SSH2;FBXO22;MAP3K6;MXRA8;METAP1D;ILKAP;HUNK;UBE2S;TNKS2;LCMT1;NGLY1;CSNK2A1;STK4;CAMK2B;CDK5;PSMC6;MGAT4A;DAPK1;PSMB10;CSNK1G2;STK11;BRSK1;PARP1;COG7;PSMD12;PSMB1;ZDHHC6;TGFB2;ADPRH;TIMM50;COPS6;CDK11B;MTM1;CDC42BPA;PSMA8;CTDSP2;FBXL12;PSMF1;PKN1;PAK1;SIRT7;PPP2R5D;DCAF5;CDK16;WDR45;PDIA6;ARF4;PPP2R5C;TRIB1;KLHL25;RABGGTB;PRKDC;SIK3;PPP1CC;GMFB;MAP3K20;RAB1A;LATS2;B4GALT7;B3GNT9;ACVRL1;PARK7;FUT4;PRKAB1;PTPRM;ST8SIA3;STK25;COP1;PSME2;PPM1D;STK24;SIRT3;YWHAZ;DAPK2;PIGH;FCGR3A;ASB5;CDK12;DNAJC3;PSMA4;CUL9;MAPK1;ATG4B;ATG7;DUSP6;MACROD1
prerank,circulatory system development (GO:0072359),0.3787580613142336,1.1388322421241936,0.2547568710359408,0.7017874560550078,1.0,27/118,14.92%,COL3A1;SH3PXD2B;HSPG2;GLI2;DNAAF4;ZFPM2;FBN1;PKD2;CACNA1C;PTEN;SHH;DVL2;PDLIM7;TNNI3;NF1;TGFBR1;ACVR1;AKAP13;SALL1;PDLIM2;PCSK5;PDLIM4;CACYBP;STRA6;FBXW7;CASP8;NTRK3
prerank,neuron projection regeneration (GO:0031102),0.5559199536739288,1.1387365037231965,0.32223903177004537,0.7015119234513773,1.0,4/10,20.78%,PTN;NREP;MAPK8IP3;RTN4RL1
prerank,linoleic acid metabolic process (GO:0043651),-0.39350028768935774,-1.1379855514586479,0.27147766323024053,0.7119014237089597,1.0,3/17,6.90%,ACSL1;ELOVL5;PNPLA8
prerank,positive regulation of catalytic activity (GO:0043085),-0.31836306649693696,-1.1379650206846288,0.23039215686274508,0.7095879888723404,1.0,17/37,28.06%,XRCC4;CAV1;APH1A;MSH2;YWHAB;IGF2;NHEJ1;FGFR4;CIB1;SOD1;WRN;NOD2;CHTOP;MAPK8;SSBP1;MAPK14;MAPK3
prerank,negative regulation of cell death (GO:0060548),-0.25347702839227837,-1.137915182295737,0.1111111111111111,0.7073261454538601,1.0,26/88,20.22%,MECOM;BMP4;PRKN;CD34;PPARGC1A;CCN3;CCN2;CD200;DCPS;BTBD10;CCN1;PRKD1;PINK1;BNIP3L;BNIP3;IKBKG;WFS1;ATG5;HTRA2;WNT11;TMEM109;CHGA;PDE12;KANK2;ATP13A2;SORL1
prerank,negative regulation of cell-substrate adhesion (GO:0010812),0.4270561636917172,1.1377458977436075,0.2882991556091677,0.7036735489125311,1.0,11/39,17.36%,FBLN1;MAP4K4;CASK;JAG1;NF2;SEMA3E;EFNA5;GCNT2;ITGB1BP1;CX3CL1;RHOA
prerank,regulation of intracellular protein transport (GO:0033157),0.435295889452057,1.1376816288305058,0.29020556227327693,0.7032938081834049,1.0,13/32,24.78%,ADIPOQ;LCP1;PTPN1;PCM1;PDCD10;RIPOR1;PCNT;NDEL1;IFI27;BCAS3;SIRT7;TGFB1;RUFY3
prerank,cell chemotaxis (GO:0060326),0.39681127977587943,1.13742805741686,0.2834285714285714,0.7034397394967478,1.0,12/60,17.36%,PDGFRA;CXCL12;NRP1;EGR3;PDGFRB;CCR1;PARVA;CXCR4;HMGB2;CX3CL1;PIP5K1A;LPAR1
prerank,protein localization to synapse (GO:0035418),-0.45027241014854946,-1.137292068040589,0.32326283987915405,0.7066842270824475,1.0,6/12,13.84%,NRXN1;PCLO;ZDHHC15;NRXN2;BSN;NLGN1
prerank,histone acetylation (GO:0016573),-0.2740773243537283,-1.137279076270656,0.14953271028037382,0.7043782954035755,1.0,30/69,23.94%,LEF1;JADE1;EPC1;ACTL6A;JADE2;PHF20L1;BRCA2;DR1;EP300;WDR5;JADE3;TAF6L;NAA60;TRIM16;KAT6A;SUPT7L;APBB1;KAT5;MAP3K7;KAT2B;KAT2A;TADA1;DMAP1;BEND3;TAF10;NAA40;TAF12;YEATS4;KAT14;TAF5L
prerank,negative regulation of developmental growth (GO:0048640),-0.32955164792211067,-1.1371090888357065,0.24034334763948498,0.7024779947098526,1.0,10/30,18.84%,MAP2;DCC;ULK2;DUSP10;WWC2;MAG;SEMA3G;RNF6;CDKL3;TRIM46
prerank,histone H4-K16 acetylation (GO:0043984),0.4783513492935194,1.1370324367855935,0.3398328690807799,0.7039024967777214,1.0,3/19,8.91%,KMT2A;OGT;KANSL1
prerank,regulation of multicellular organism growth (GO:0040014),0.4920196018682502,1.1367154717697434,0.3357348703170029,0.7042382914192102,1.0,5/15,21.72%,GHR;STAT5A;PTCH1;STAT5B;IGF1
prerank,regulation of vacuole organization (GO:0044088),0.46878784234021087,1.136476791569602,0.31197771587743733,0.704361451359026,1.0,14/20,31.53%,NPRL2;IFT88;ENO1;IFT20;ENO2;ADPRH;MTM1;ANXA2;SCARB2;TBC1D12;RAB5A;PIKFYVE;ENO3;MTMR3
prerank,sphingolipid biosynthetic process (GO:0030148),-0.2742601489082229,-1.1363441799096363,0.1926605504587156,0.7022653241344488,1.0,20/71,15.99%,CERT1;PPM1L;SGMS2;SGMS1;CERS4;ACER2;B4GALT6;SPTLC2;ELOVL5;DEGS2;SPTLC1;ELOVL7;PRKD1;ASAH1;SPNS2;HACD3;ST6GALNAC5;HACD4;ASAH2;HACD1
prerank,ERBB signaling pathway (GO:0038127),0.3991180091813289,1.1362747210399442,0.28914285714285715,0.7043784465529253,1.0,24/64,25.45%,FAM83A;PRKCA;EGF;EGFR;CBL;MVP;PIK3R1;NCK2;ERBIN;PTPN18;GRB2;PTK2;STUB1;CDC37;GAREM1;BTC;KIF16B;SRC;MAPK1;PTPN12;TGFB1;AKT1;PDPK1;CUL5
prerank,female gonad development (GO:0008585),0.4822222923403405,1.1361823409903824,0.31676136363636365,0.7040600962281567,1.0,3/19,8.99%,FSHR;NR2F2;INHBB
prerank,cellular response to low-density lipoprotein particle stimulus (GO:0071404),0.5218950764067438,1.1360934279710064,0.3447251114413076,0.7037566697294115,1.0,4/13,8.94%,ABCA1;LPL;CD36;PPARG
prerank,positive regulation of lymphocyte differentiation (GO:0045621),0.48470729017768693,1.1357762400625595,0.31408450704225355,0.7040303999061108,1.0,5/19,12.48%,MMP14;ZMIZ1;MDK;XBP1;IL7
prerank,polyol metabolic process (GO:0019751),-0.306741810587356,-1.135709342924736,0.21839080459770116,0.7016218573141624,1.0,16/46,20.79%,PLCE1;INPP4B;INPP5D;PLCB4;PLCB1;PPIP5K1;ITPK1;CALM1;OCRL;SYNJ1;INPPL1;ITPKB;IMPA2;IPPK;NUDT11;PLCD4
prerank,protein targeting to lysosome (GO:0006622),0.4712008164313503,1.1352869969236834,0.31543624161073824,0.7047951065573448,1.0,11/20,26.04%,AP4M1;RAB7A;LAMP2;VPS4A;ZFYVE16;HGS;NEDD4;GNPTAB;SCARB2;GGA3;NCOA4
prerank,T cell migration (GO:0072678),-0.42747512050996833,-1.1352569500122676,0.292817679558011,0.7005931391030152,1.0,3/13,10.23%,SLC12A2;S1PR1;PIK3CD
prerank,intrinsic apoptotic signaling pathway (GO:0097193),0.37731373490891545,1.13487894740344,0.2619047619047619,0.7053523012730447,1.0,12/94,8.27%,CYP1B1;CASP4;ERN2;ITPR1;GSKIP;BCL2;BBC3;E2F1;ATM;IKBKE;CUL1;BAX
prerank,B cell differentiation (GO:0030183),-0.2983594209068722,-1.1344636339741005,0.23529411764705882,0.7003298953034806,1.0,9/46,8.90%,KIT;HDAC9;MSH2;TPD52;ITGA4;VCAM1;DNAJB9;HDAC4;NHEJ1
prerank,peptidyl-lysine monomethylation (GO:0018026),0.5533222142589336,1.1342173451485171,0.3390625,0.7066102298071387,1.0,3/10,13.72%,KMT5A;EHMT1;SETD7
prerank,mesenchymal cell differentiation (GO:0048762),0.41359975013457795,1.1340712107523703,0.3060747663551402,0.706451323620812,1.0,15/51,17.28%,SNAI1;WNT5A;DDX17;SNAI2;FGFR1;LIMS1;TGFBR1;LOXL3;HEYL;RBPJ;DLG5;LRP6;GSK3B;CUL7;ROCK2
prerank,positive regulation of protein dephosphorylation (GO:0035307),0.4321969851690389,1.133940442489014,0.2906530089628681,0.7062320270834491,1.0,7/32,16.16%,DLC1;PDGFRB;DUSP26;PPP2R5A;CALM3;CALM2;ITGA1
prerank,interleukin-2-mediated signaling pathway (GO:0038110),0.525784867475706,1.1339116087097614,0.33579881656804733,0.7052065498105868,1.0,2/11,9.16%,JAK1;STAT5A
prerank,cellular response to interleukin-2 (GO:0071352),0.525784867475706,1.1339116087097614,0.33579881656804733,0.7052065498105868,1.0,2/11,9.16%,JAK1;STAT5A
prerank,atrial cardiac muscle cell action potential (GO:0086014),-0.40677721718728016,-1.1336710702058135,0.3021148036253776,0.7002735584951802,1.0,5/13,9.98%,CACNB2;ANK2;KCNJ3;GJA1;KCNQ1
prerank,negative regulation of mitotic metaphase/anaphase transition (GO:0045841),0.4729713076586338,1.1332994956374502,0.3288409703504043,0.7063769464331248,1.0,5/21,10.17%,MAD2L1;KLHL22;ATM;PLK1;FBXO5
prerank,negative regulation of protein localization to plasma membrane (GO:1903077),0.4736763459222123,1.133075676224287,0.3328690807799443,0.7064407462383501,1.0,3/20,9.46%,CLTC;PID1;PPP2R5A
prerank,interleukin-1-mediated signaling pathway (GO:0070498),0.38445682852885776,1.1328557202126484,0.25344644750795337,0.7064702724379521,1.0,29/94,23.15%,PSMA7;IL1R1;IRAK3;CUL1;PSMD4;SQSTM1;NOD1;PSMD11;NFKB1;PSMB8;FBXW11;SKP1;PELI3;IRAK2;PELI2;IRAK4;PSMA6;PSMD14;PSMC6;PSMB10;PSMD12;PSMB1;PSMA8;MAP3K3;PSMF1;RPS27A;TNIP2;PSME2;PSMA4
prerank,sulfur compound biosynthetic process (GO:0044272),0.3793933374631939,1.1325527690390054,0.2630457933972311,0.7067403830220894,1.0,25/104,16.94%,DCN;LUM;CHSY3;BGN;B4GALT5;PAPSS2;CHST13;ST3GAL3;VCAN;MGST1;AKR1A1;SLC35D2;PRELP;CNDP2;METTL16;GSTT1;CHSY1;SLC35B2;CHST11;GSTK1;UGDH;CHPF2;ST3GAL2;ANGPT1;ST3GAL1
prerank,peptidyl-amino acid modification (GO:0018193),0.5507077617186795,1.131726254537786,0.346031746031746,0.7084456026707777,1.0,5/10,25.39%,TTLL4;METAP1;METAP1D;ATP7A;FKBP10
prerank,positive regulation of neuron differentiation (GO:0045666),0.42663057386012637,1.1317114949660172,0.2855421686746988,0.7079557304723887,1.0,4/40,5.13%,ZEB1;TCF4;FGF20;FGFR1
prerank,positive regulation of epithelial cell differentiation (GO:0030858),0.48385914942235153,1.1315546962922076,0.3409090909090909,0.7078461358194202,1.0,4/17,13.32%,NKX6-1;SFRP4;FGF2;BTG1
prerank,cellular response to organonitrogen compound (GO:0071417),0.37904919222202826,1.1314706414339875,0.26959247648902823,0.7075229462029213,1.0,14/99,10.96%,NR1H4;PDE3A;ZFP36L1;PDXP;CPEB1;SFRP1;IGFBP5;PKD2;CAPN2;SSH1;HRH1;RPTOR;AHR;XBP1
prerank,cellular calcium ion homeostasis (GO:0006874),0.3711334080369718,1.1312291016788634,0.2578616352201258,0.7076575136760775,1.0,17/133,8.27%,CCL11;CCL7;EDN3;CXCL12;SLC24A5;CD40;CAMK2D;STOML2;BCL2;ATP2A2;CCR1;PDZD8;TNNI3;CCL5;TRPC6;ATP2B1;BAX
prerank,positive regulation of B cell proliferation (GO:0030890),0.44145536052034445,1.1311834078679004,0.3230769230769231,0.7072321997299118,1.0,8/29,15.25%,VAV3;CD40;BCL2;TIRAP;SASH3;EPHB2;IL7;TNFRSF4
prerank,negative regulation of small molecule metabolic process (GO:0062014),0.4767218570509761,1.1311377237004867,0.3237704918032787,0.7068320248512125,1.0,1/20,0.51%,ADIPOQ
prerank,positive regulation of cell population proliferation (GO:0008284),0.3567868365057486,1.1305733411426246,0.15115115115115116,0.7077939880540125,1.0,69/423,12.71%,IL34;CXCL5;WNT2;PDGFRA;EDN3;OSMR;LAMB1;TCF7L2;YAP1;LAMC1;FGF20;S1PR2;MEIS2;PTN;SFRP1;GAB2;CCAR1;TMEM119;SFRP2;EAPP;WNT5A;PDGFRB;STAT1;TIMP1;ZFPM2;PRTN3;FGF7;CCN4;BCL2;DDR2;EGF;IRS1;TSLP;FGF9;PID1;FGFR1;PTEN;TBX2;SHH;FXN;MEIS1;MDK;E2F1;AIF1;EGFR;HDAC1;BMP5;CACUL1;CCL5;TGFBR1;PTPN6;EPHA1;FOXM1;HPSE;GLP2R;TGFB3;CDK6;S1PR3;CDK13;FBXO5;FZD9;XBP1;GCNT2;WWTR1;FGF2;TERT;S100A6;IL7;RBPJ
prerank,glycine transport (GO:0015816),-0.45737751590521003,-1.1304642227519395,0.3471502590673575,0.7069552530383816,1.0,4/10,14.03%,SLC6A9;SLC38A5;SLC6A17;SLC6A5
prerank,organic cyclic compound biosynthetic process (GO:1901362),-0.3250958360200053,-1.1300968071568505,0.22340425531914893,0.7057595002322583,1.0,11/31,27.02%,GPHN;DHRS11;FDFT1;NOXRED1;NFS1;SCP2;GCH1;PYCR2;STAR;MOCS3;PYCR3
prerank,regulation of cation channel activity (GO:2001257),-0.26458121048866157,-1.130020283142585,0.2112676056338028,0.7036918688963534,1.0,25/89,19.63%,DMD;CACNB2;ACTN2;ANK2;LRRC7;FGF12;SHISA6;CACNG2;DLG2;FGF14;MEF2C;CALM1;RELN;PDE4D;NLGN1;GRIN2B;SHISA7;SLMAP;JPH4;CACNB4;CACNG8;PRRT1;GRIA2;CACNG7;OPRM1
prerank,multivesicular body assembly (GO:0036258),0.44126535268470746,1.1299585477664054,0.32697201017811706,0.7089090604460101,1.0,14/30,27.52%,CHMP4B;CHMP4A;VPS4A;MVB12A;CHMP3;VPS37C;HGS;CHMP7;CHMP2B;VPS37A;PDCD6IP;VTA1;VPS4B;SNF8
prerank,regulation of cell-substrate adhesion (GO:0010810),0.42009646504977194,1.129760550486094,0.29304029304029305,0.7088938931874826,1.0,12/42,17.36%,FBLN2;JAK2;RAC1;LIMS1;NF1;RSU1;GCNT2;PDPN;PTK2;THY1;CX3CL1;RHOA
prerank,regulation of cAMP-dependent protein kinase activity (GO:2000479),0.5111352310943628,1.1296931051704653,0.31492537313432833,0.7085417079227935,1.0,3/14,9.25%,ADIPOQ;PKIB;PRKAR1B
prerank,regulation of membrane repolarization (GO:0060306),-0.4236895921327585,-1.1294064466832066,0.30944625407166126,0.7031393194601958,1.0,5/13,14.50%,CAV1;KCNJ2;AKAP6;KCNQ1;NEDD4L
prerank,negative regulation of TOR signaling (GO:0032007),-0.3187586733628639,-1.1291474934207877,0.25405405405405407,0.701598099471146,1.0,13/36,16.87%,PRKAA2;RNF152;SESN2;DDIT4;NPRL3;DEPDC5;SESN3;SPAAR;MINAR1;AKT1S1;ITFG2;SIRT1;TNFAIP8L1
prerank,autophagosome organization (GO:1905037),0.40691526491643765,1.1289753498631527,0.30243337195828507,0.7099117494817764,1.0,8/50,7.61%,VMP1;WIPI1;AMBRA1;ATP2A2;ATG3;UBQLN1;RAB7A;UBXN2A
prerank,intracellular steroid hormone receptor signaling pathway (GO:0030518),0.43031080505260194,1.1286015886531036,0.31203007518796994,0.7103809845630334,1.0,8/35,11.98%,PMEPA1;YAP1;ZMIZ1;DDX17;UBR5;PADI2;CALCOCO1;RBFOX2
prerank,glycerolipid catabolic process (GO:0046503),-0.3712655104330351,-1.128034861694623,0.26717557251908397,0.702398452796211,1.0,3/19,2.06%,GPCPD1;MGLL;ABHD6
prerank,positive regulation of transmembrane transport (GO:0034764),0.5182559675920066,1.1279918180223827,0.34057971014492755,0.711562898899945,1.0,3/13,11.82%,C3;AZIN2;CLIP3
prerank,regulation of telomere maintenance via telomere lengthening (GO:1904356),0.49325204128412387,1.127683599968238,0.33432835820895523,0.7118378159332197,1.0,6/16,19.73%,ATM;PINX1;SMG6;TNKS2;PARP1;HNRNPA2B1
prerank,calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0016339),0.41675412981259496,1.1276200014011655,0.31875,0.7114706090293739,1.0,8/35,15.37%,CDH11;PCDHB6;PCDHB16;DCHS1;CDH6;ATP2C1;CDH18;CDH24
prerank,modification-dependent protein catabolic process (GO:0019941),0.36448626479019625,1.1272646570235143,0.24491869918699186,0.7118901963284077,1.0,69/193,23.60%,SPSB1;RNF150;MYLIP;MAD2L1;KCTD21;FBXL7;SMURF2;ANAPC11;CNOT4;FBXO7;UBR4;RNF111;NTAN1;UBQLN1;SIAH2;CBL;PLK1;UBE2L3;RNF144A;SQSTM1;AREL1;RNF11;RNF19B;DDB1;PSMD11;RNF8;FZR1;BAG6;XBP1;CDC27;ARIH1;CDC16;RC3H2;ANAPC2;RNF149;MIB1;SMURF1;STUB1;TRPC4AP;CHFR;MDM2;ARIH2;SYVN1;UBE2R2;UBE2E1;FBXO45;RNF40;RNF215;ITCH;PSMD14;FBXO22;KCTD10;UBE2S;RNF217;RNF213;ARRB1;RNF168;NEDD4;UBE3B;UBA1;WDR91;PSMF1;KLHL25;DTX3L;RPS27A;TRIP12;CDC23;COPS3;RNF14
prerank,receptor-mediated endocytosis (GO:0006898),0.36693700241704924,1.127247178013077,0.27801268498942916,0.7113989653641781,1.0,17/132,8.73%,HP;HPR;CLTC;LRP1;SPARC;HSPG2;COLEC12;MASP1;ADM;APOE;DNAJC6;DNAJC13;PDLIM7;CD36;FCGR2B;DNM1;CANX
prerank,myelin maintenance (GO:0043217),0.5472480818922603,1.127084252974552,0.32532051282051283,0.7112935655753828,1.0,4/10,14.94%,PTEN;MYRF;CXCR4;EPB41L3
prerank,positive regulation of protein exit from endoplasmic reticulum (GO:0070863),0.5160524839028365,1.1269991938516386,0.3502906976744186,0.710974030988046,1.0,4/13,10.49%,SEC16B;SEC16A;TM9SF4;EDEM1
prerank,cardiac muscle cell action potential involved in contraction (GO:0086002),-0.3203692504031343,-1.1269299957292738,0.2617801047120419,0.7030475440029996,1.0,13/30,21.30%,ANK2;KCNJ2;SNTA1;FGF12;GJA1;CACNA1D;KCNQ1;NEDD4L;SCN4B;ATP1A1;RYR2;KCNE4;SCN3B
prerank,neural crest cell development (GO:0014032),-0.29999145329673155,-1.1267003519163503,0.2751677852348993,0.7013927345508093,1.0,18/44,22.54%,SEMA6A;SEMA3C;SEMA7A;SEMA6D;SEMA3D;TBX1;SEMA4D;SEMA5A;SEMA5B;ERBB4;SEMA4B;SEMA3G;SEMA3B;SEMA6C;SEMA6B;SOX8;SEMA4A;KBTBD8
prerank,regulation of cellular component size (GO:0032535),0.4368464469896638,1.126584914350196,0.32041343669250644,0.7115763752348965,1.0,11/30,20.47%,VAV2;VAV3;PTEN;RAC1;RPTOR;LAMTOR5;MSN;NEB;VAV1;PEX11A;HP1BP3
prerank,aminoglycan catabolic process (GO:0006026),0.44321932541741427,1.1264411617003196,0.32100396301188905,0.7114289114143528,1.0,10/28,21.43%,HSPG2;GPC6;HPSE;SDC2;SDC1;HGSNAT;GNS;IDS;GLB1;GPC4
prerank,negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway (GO:1902176),-0.3722985005055198,-1.125919126892453,0.28214285714285714,0.7012577474964309,1.0,8/18,19.45%,PRKN;HSPB1;PINK1;NME5;SIRT1;HTRA2;MAPK7;PPIA
prerank,stem cell development (GO:0048864),0.4952575785482452,1.1258144660326035,0.3381294964028777,0.7126238223352811,1.0,8/16,26.92%,SNAI2;SHH;KLHL12;PEF1;NOLC1;SOX11;TAPT1;PTPRC
prerank,regulation of cell-substrate junction assembly (GO:0090109),0.47114327335832434,1.1257926830670686,0.33755274261603374,0.7121334874624058,1.0,7/21,17.36%,GPM6B;SLC9A1;PEAK1;EFNA5;PTK2;ROCK2;RHOA
prerank,cell-cell junction assembly (GO:0007043),-0.2826584703222547,-1.1253775371140433,0.20930232558139536,0.7005444878242415,1.0,14/63,12.39%,TJP1;PKP4;CLDN5;ACTB;ARVCF;RAMP2;CDH5;CTNND1;GJA1;CDH10;CDH12;PIP5K1C;CDH22;TRPV4
prerank,positive regulation of vasculature development (GO:1904018),0.3781351092356187,1.1252474186408947,0.2886266094420601,0.7130806285843738,1.0,16/94,12.01%,RUNX1;CYP1B1;ITGB8;ADAM12;PRKCA;SFRP2;WNT5A;CD40;GATA6;PRKD2;HK2;ANGPTL4;EPHA1;XBP1;SASH1;FGF2
prerank,positive regulation of cardiac muscle hypertrophy (GO:0010613),0.484774173443395,1.1251287406285415,0.3328631875881523,0.7128585112547465,1.0,3/16,3.71%,PRKCA;SLC9A1;CAMK2D
prerank,positive regulation of peptidase activity (GO:0010952),-0.37891889565335146,-1.124897036117852,0.268,0.6997960952199843,1.0,7/20,9.52%,APH1A;NDUFA13;VSIR;APH1B;GRN;PINK1;MAPK12
prerank,cellular response to DNA damage stimulus (GO:0006974),0.3553634860797958,1.124861754764663,0.1748743718592965,0.7130117076476324,1.0,75/336,17.21%,RAD51B;BCL3;PARP3;TAOK1;YAP1;BCL6;SUSD6;BACH1;POLE3;IRF7;LIG1;VAV3;BCL2;BATF;SMC1A;UBR5;BLK;RAD52;INO80;FBH1;ZBTB38;BABAM2;PWWP3A;E2F1;ATM;PHF1;RBBP5;MGMT;IKBKE;ATR;NIPBL;CDKN2AIP;XRCC3;ASF1A;USP3;GNL1;BAX;DDB1;SLF2;ALKBH1;RNF8;FBXO31;PAXX;DDX11;TAOK3;RNF169;MMS19;GRB2;UBE2E2;SETX;BCL2L2;MTREX;FMR1;MCM7;NEK4;MCM9;TANK;WDHD1;VCPIP1;PDS5B;SETD7;RIF1;PDS5A;GTF2H1;USP47;YY1;ABL1;ENDOV;RBBP8;TIMELESS;PSEN1;HMCES;ATF2;FBXO45;DCUN1D5
prerank,negative regulation of BMP signaling pathway (GO:0030514),0.4046730873271644,1.1243954106387766,0.30011723329425555,0.713737598856767,1.0,10/51,13.38%,FSTL1;FBN1;HTRA3;SMURF2;PPARG;GREM2;ACVR2A;LEMD2;SMAD5;SMURF1
prerank,positive regulation of cell cycle (GO:0045787),0.40167635690091963,1.1242191736837615,0.3089064261555806,0.7136731769049002,1.0,15/62,17.24%,MEIS2;PRKCA;PSRC1;PKD2;EGFR;TRIM21;CCND3;ASNS;RPS6KB1;RAD23A;USP22;LRP6;MDM2;EIF4EBP1;TBX3
prerank,C4-dicarboxylate transport (GO:0015740),-0.40535420180995896,-1.123726572168351,0.29874213836477986,0.7008945378151092,1.0,11/14,35.92%,LRRC8D;SLC1A1;SLC1A2;SLC25A12;SLC25A14;SLC1A6;SLC25A30;SLC25A13;SLC25A18;SLC25A11;LRRC8E
prerank,cellular modified amino acid catabolic process (GO:0042219),-0.403673096706286,-1.1231624820968003,0.3111111111111111,0.7004000172550674,1.0,8/15,30.23%,GGACT;PRODH;CHAC2;HOGA1;ALDH4A1;GGT5;GGT1;GOT2
prerank,regulation of ubiquitin-protein transferase activity (GO:0051438),0.44205411653440796,1.1230121012406968,0.3266078184110971,0.7163884396275878,1.0,12/29,22.31%,ARRDC4;PLK1;UBE2L3;ARRDC3;FBXO5;DCUN1D1;FBXW7;ABL1;DCUN1D5;TRIB3;DTX3L;PARK7
prerank,positive regulation of NF-kappaB transcription factor activity (GO:0051092),0.3638095330201302,1.1229333869014384,0.2792607802874743,0.7160607347078061,1.0,32/149,15.90%,ROR1;TRIML2;TNFSF11;TLR2;WNT5A;CD40;FLOT2;IRAK3;CFLAR;TIRAP;PRKD2;EDA2R;NFKB2;STAT3;CD36;RAB7B;TRIM21;LGALS9;TRIM8;NOD1;NFKB1;TRIM13;EIF2AK2;EDA;LAMTOR5;TRAF2;TRIM62;CLOCK;IRAK2;TNF;PSMA6;CX3CL1
prerank,regulation of G1/S transition of mitotic cell cycle (GO:2000045),0.39275151652129286,1.1227831342201726,0.31158605174353204,0.7159373574667318,1.0,18/66,13.55%,CDKN2B;ANXA1;PKD2;PTEN;INO80;CDKN2D;E2F1;AIF1;ADAMTS1;EGFR;PTPN6;CCND3;RPTOR;CDK6;UBE2E2;TFDP1;GPNMB;CCL2
prerank,semaphorin-plexin signaling pathway involved in neuron projection guidance (GO:1902285),0.5043461387220101,1.122511663627755,0.33692307692307694,0.716106134709105,1.0,4/13,11.38%,NRP1;PLXNC1;PLXND1;PLXNA3
prerank,neuron projection morphogenesis (GO:0048812),0.3664244604862248,1.1223942375555225,0.27615062761506276,0.7158606370358469,1.0,29/137,12.98%,GAS7;TAOK1;SLITRK6;MAP4K4;TNN;FARP1;LRRK2;BAIAP2;EPHB3;PTEN;DBN1;MAP1S;CDC42;TRIO;DBNL;RAB10;LLGL1;SDC2;DTNBP1;NRK;DLG4;ATL1;TAOK3;ALS2;DICER1;S100A6;EPHB2;DCLK1;NEFH
prerank,regulation of endocytosis (GO:0030100),0.3916853008652113,1.1222483087652784,0.317016317016317,0.7157052096890798,1.0,13/61,15.85%,STON2;LRP1;APOE;CALY;OPHN1;SNX33;PTPN1;CLIP3;ARFGAP1;CD151;RUFY1;ABL1;ZFYVE16
prerank,smooth muscle cell differentiation (GO:0051145),0.5173126114339685,1.1220855317447493,0.35365853658536583,0.7156342409863761,1.0,3/12,3.64%,MRTFA;TBX18;GATA6
prerank,cellular response to ionizing radiation (GO:0071479),0.40931761542942796,1.122064642854254,0.3348729792147806,0.715147199934937,1.0,12/47,15.24%,YAP1;TNKS1BP1;INO80;ATM;ATR;NIPBL;KDM4D;GRB2;TANK;CLOCK;NUCKS1;MDM2
prerank,UDP-N-acetylglucosamine biosynthetic process (GO:0006048),0.5303012372920924,1.1220423405762472,0.3472222222222222,0.7146902075425863,1.0,6/11,27.91%,GFPT2;UAP1L1;AMDHD2;UAP1;GNPDA2;RENBP
prerank,atrioventricular valve morphogenesis (GO:0003181),0.4761416976020767,1.121936049856518,0.3384401114206128,0.7144567111536292,1.0,4/19,12.34%,SLIT3;ACVR1;OLFM1;HEYL
prerank,icosanoid biosynthetic process (GO:0046456),0.5359844090425401,1.1218313554871093,0.3120243531202435,0.7142304976372773,1.0,4/10,20.46%,PLA2G5;ALOX5AP;FADS1;PLA2G4A
prerank,regulation of receptor-mediated endocytosis (GO:0048259),0.42319972706963477,1.1212890117712153,0.3333333333333333,0.7150954613697987,1.0,5/35,7.13%,C3;VTN;RAB21;RAC1;CBL
prerank,lipopolysaccharide-mediated signaling pathway (GO:0031663),0.4656790658044296,1.1212297138252338,0.34441489361702127,0.7147260285706339,1.0,5/20,15.60%,LBP;CCL5;CD14;CCL2;TNF
prerank,positive regulation of transforming growth factor beta production (GO:0071636),0.5358428487169437,1.1211208936139017,0.3742690058479532,0.7144993518453512,1.0,4/11,8.51%,ATP6AP2;XCL1;GATA6;LGALS9
prerank,regulation of exit from mitosis (GO:0007096),0.4221101137713299,1.1207826586422496,0.31470230862697446,0.7148314224330966,1.0,10/38,18.37%,PPP1R9B;MAD2L1;ANAPC11;SIRT2;CDC27;CDC16;CDC14B;ANAPC2;UBE2E1;UBE2S
prerank,positive regulation of protein kinase activity (GO:0045860),0.3639178073199251,1.1206126842016646,0.2647362978283351,0.7147416250455895,1.0,41/148,21.94%,IL34;IL23R;TAOK1;MAP4K4;JTB;DDR2;LCP2;RASSF2;CACUL1;CCL5;RPTOR;INCENP;MAP2K1;PTPN1;CALM3;NRK;DLG4;TOM1L1;TAOK3;ALS2;BORA;TPX2;PTK2;CALM2;TNF;SNX9;EZH2;PDCD10;RHOA;NAB2;MMD;STK4;TELO2;MAP2K2;STK11;TGFB2;DDX3X;FCGR1A;PAK1;EMP2;SRC
prerank,neuron projection development (GO:0031175),0.3605468093881096,1.1205682298244442,0.24922440537745605,0.7143244707938219,1.0,53/168,21.48%,GAS7;GPM6B;LAMB1;TAOK1;PPP1R9B;MAP4K4;LRP12;ATXN10;LRRK2;APOE;BLK;EPHB3;PTEN;DBN1;OPHN1;MAP1S;CDC42;CAMSAP2;TRIO;DBNL;IFT88;DTNBP1;NRK;DLG4;L1CAM;ADGRV1;TAOK3;ALS2;DICER1;EPHB2;DCLK1;NEFH;SAMD14;MAP4;STMN4;GSK3B;EPB41L3;VAPA;MAPK8IP3;ANKRD27;GDNF;CTNND2;MICALL2;CAMSAP1;NPY;GPRIN1;CDK5;NTF3;NEDD4;PAK1;ATP7A;CDK16;EHD1
prerank,polyamine metabolic process (GO:0006595),-0.4163601854673792,-1.1205283361688088,0.2934131736526946,0.7052660079532885,1.0,6/13,21.66%,DHPS;OAZ2;SAT1;PAOX;SAT2;HDAC10
prerank,positive regulation of viral process (GO:0048524),0.4004280734701471,1.120425123519571,0.3181818181818182,0.714189201055456,1.0,19/60,20.26%,MDFIC;PPID;CCL5;RAB7A;TMEM39A;GTF2F2;CDK9;DDB1;VPS4A;TARBP2;TBC1D20;RAD23A;CCNT1;POLR2K;RSF1;POLR2B;STAU1;GTF2F1;DDX3X
prerank,innate immune response in mucosa (GO:0002227),-0.4514513216835354,-1.1202944508930635,0.3125,0.703777226368527,1.0,1/10,4.65%,DEFA6
prerank,positive regulation of calcium-mediated signaling (GO:0050850),0.5344837507551126,1.119627630104629,0.3673469387755102,0.7158407821948286,1.0,2/11,4.76%,P2RX5;TREM2
prerank,phospholipid translocation (GO:0045332),0.44004927333343236,1.1190527766480332,0.32329842931937175,0.7168333269436882,1.0,3/28,4.35%,ABCA1;PLSCR5;ATP8B1
prerank,neurotransmitter uptake (GO:0001504),0.5260796809856061,1.1190438318566165,0.34384384384384387,0.7163248617537403,1.0,2/12,3.99%,SLC1A3;SLC29A1
prerank,regulation of DNA binding (GO:0051101),0.41141891424394383,1.1185793810024487,0.319047619047619,0.7170106940502641,1.0,12/44,17.85%,BCL3;JAK2;EGF;E2F1;ILRUN;PPARG;MDFI;SIRT2;HMGB2;RSF1;SP100;SMO
prerank,hepaticobiliary system development (GO:0061008),0.4705946060469632,1.1178136165702508,0.33793103448275863,0.7185323555924772,1.0,9/20,17.18%,PRKCSH;ARID5B;PKD2;PHF2;NIPBL;NF1;XBP1;NKX2-8;GFER
prerank,actin nucleation (GO:0045010),0.4642940928473433,1.1175535649174755,0.3473541383989145,0.7186982361705733,1.0,7/21,20.67%,SPIRE2;ACTR2;SPIRE1;WHAMM;TRIM27;ARPC2;WASHC1
prerank,glycosaminoglycan metabolic process (GO:0030203),0.3997511760212993,1.1174008913270843,0.3189755529685681,0.7185657667908218,1.0,15/54,16.63%,HSPG2;GPC6;EXT1;HS2ST1;CLN6;EXT2;SLC35D2;HPSE;SDC2;GCNT2;SDC1;HGSNAT;UGDH;GNS;IDS
prerank,cardiac myofibril assembly (GO:0055003),0.48977349728013014,1.1173178760540885,0.34522111269614836,0.7182658860626047,1.0,4/15,8.19%,PDGFRA;PDGFRB;FHOD3;OBSL1
prerank,regulation of actin filament bundle assembly (GO:0032231),0.44524646514593974,1.1170604815239837,0.3337696335078534,0.7184064732670961,1.0,9/26,17.28%,SLC9A1;ALMS1;SYNPO;ASAP3;RAC1;CDC42;PTGER4;CX3CL1;ROCK2
prerank,regulation of primary metabolic process (GO:0080090),0.372309672441339,1.1165906192966457,0.29590766002098634,0.7191120722799352,1.0,32/126,21.00%,PSMA7;NCOR2;FASN;APOE;CHD9;CREBBP;MVK;CARM1;OAZ3;SMARCD3;PSMD4;PPARG;NR1D2;PSMD11;LACTB;CERS2;ELOVL6;HDAC3;PSMB8;TBL1X;PSMA6;GPAM;TGS1;ROCK2;PSMD14;PSMC6;PSMB10;PSMD12;PSMB1;PSMA8;RUBCNL;PSMF1
prerank,regulation of stress fiber assembly (GO:0051492),0.3815499555319132,1.1165670285557205,0.302247191011236,0.7186550982344514,1.0,24/74,17.36%,DLC1;NRP1;SLC9A1;SFRP1;ALMS1;ASAP3;CARMIL1;NF2;RAC1;CDC42;PIK3R1;CGNL1;TGFBR1;EPHA1;TGFB3;ARHGAP6;PTGER4;TPM1;ITGB1BP1;PHLDB2;ABL1;ROCK2;LPAR1;RHOA
prerank,positive regulation of cellular metabolic process (GO:0031325),0.37431153261896344,1.1163785848889818,0.3082706766917293,0.718636330128046,1.0,34/98,26.40%,ADIPOQ;SFRP4;PDGFRB;FASN;APOE;DHRS4;EGF;PID1;CD63;CCL5;PPARG;GRB2;FMR1;ANGPT1;PICK1;ARRB1;NTF3;IL10RB;ANXA2;PRELID1;RAB1A;AGPAT1;XDH;TGFB1;AGT;IFNAR1;EIF4G1;AKT1;GADD45A;DCXR;PAX8;INHBA;VAMP3;CSF1
prerank,response to prostaglandin E (GO:0034695),0.5265692233817572,1.116357957842537,0.35064935064935066,0.7181568497997021,1.0,3/10,14.85%,SFRP1;PTGER4;GNG2
prerank,response to acidic pH (GO:0010447),0.5082406807809783,1.116088952073542,0.3541666666666667,0.7183493351589094,1.0,2/13,7.16%,SLC9A1;CTSS
prerank,positive regulation of mitotic nuclear division (GO:0045840),0.4189512718669406,1.1159846024427156,0.34474017743979724,0.71809208639839,1.0,7/34,12.37%,EDN3;PDGFRB;EGF;ANAPC11;CDC27;CDC16;DRD3
prerank,pre-replicative complex assembly (GO:0036388),0.3883882138754947,1.1157131784343892,0.32408435072142067,0.7182919100103016,1.0,18/64,23.15%,PSMA7;MCM2;PSMD4;PSMD11;PSMB8;MCM7;PSMA6;PSMD14;PSMC6;PSMB10;PSMD12;PSMB1;PSMA8;PSMF1;ORC6;RPS27A;PSME2;PSMA4
prerank,positive regulation of endopeptidase activity (GO:0010950),-0.3429503342828625,-1.1149512849514274,0.30833333333333335,0.7160192575245219,1.0,8/26,16.97%,EPHA4;APH1A;VSIR;APH1B;TTBK1;AIM2;GRIN2B;PSME1
prerank,negative regulation of response to stimulus (GO:0048585),0.39402640134520317,1.1149497831751434,0.3395784543325527,0.7198287293382701,1.0,15/60,16.40%,COL3A1;CASK;BRAP;AKT3;FCGR2B;VPS13C;ACVR1;CDK6;PTPN1;FBXO5;TERT;THY1;UBASH3B;SOCS5;TLE5
prerank,gene expression (GO:0010467),-0.20433929122172298,-1.1148433009814347,0.0,0.7141231803334952,1.0,120/348,22.20%,BICD1;TSPAN5;WDR33;TASP1;EPC1;RPL34;ADAR;RNGTT;RBM5;CDC40;RPL8;RPL18A;RPL36;RPL19;ADARB2;RPL38;CREBL2;RPL5;NUP133;RPS23;PRPF4;RPLP0;MRPS15;DROSHA;PTMA;HNRNPU;RPS10;PWP1;UPF1;COPS5;RPL32;ABCF1;RPS4X;DTX1;YTHDC1;RPL10;RPL15;RPL29;RPS16;SRSF7;CPSF2;NR4A2;RPS27;DKC1;RPS19;RPS12;DHPS;POLR2H;NUP50;RPS21;RPS13;RPL13;RPL27;RPL7A;RPL35;RPL28;MCM3AP;ELAVL4;RBM8A;POLR2G;RPL30;NUP93;POLR2F;MEF2A;RPS8;ZC3H11A;NUP160;NUP43;MRPS7;MRPS18C;RPS17;RPL37A;U2AF2;MAGOH;EIF4EBP2;EIF4A3;DEDD2;RPS6;RPL41;NUP85;NUP205;RPS18;TSPAN15;POLR2E;HHEX;SEH1L;MRPL28;FASTKD2;POM121;RPS6KB2;TSPAN17;HOXD3;MRPL42;GSPT2;CLP1;CPSF4;PABPN1;RPS20;NFKBIB;CELF2;MRPS16;RPL7;MRPS18B;NOVA1;POLR2A;RPL13A;SORL1;LMF1;NOL9;MRPL23;RPS15A;RPS5;THAP1;DDX39A;RPS29;DDX25;RPLP1;MRPS12;MRPL18;RPL21
prerank,positive regulation of lamellipodium assembly (GO:0010592),0.45471217186709345,1.1145056044548023,0.3256756756756757,0.7204383886887662,1.0,7/24,7.45%,CARMIL2;AUTS2;ACTR2;FSCN1;RAC1;CDC42;PIK3R1
prerank,"protein localization to chromosome, telomeric region (GO:0070198)",0.4939503992961085,1.1142187303015694,0.34887218045112783,0.7206851717492031,1.0,6/14,21.23%,ATR;PINX1;ATRX;TERT;TNKS2;TERF2IP
prerank,regulation of protein phosphorylation (GO:0001932),0.353856516961023,1.1132927543675086,0.23943661971830985,0.722653332449441,1.0,57/256,16.22%,EPHA7;IL34;C3;ADIPOQ;FBLN1;FGF20;TMEM119;CD40;LRRK2;FGF7;RAP2A;TREM2;FGF9;PID1;PTEN;PTPN13;FBH1;DVL2;RAC1;EIF2AK3;EGFR;KDM4D;WDFY2;FAM20A;ZBED3;CCND3;BRD4;PPP2R5A;ERP29;EFNA5;IBTK;ACVR2A;WWTR1;HDAC3;CLIP3;FGF2;FNIP1;GPNMB;FMR1;SIRPA;EPHB2;PTK2;CSNK1D;SMG8;LRP6;AXIN2;NSD1;FLCN;PELI2;NTRK3;PPP2R5E;NIBAN1;TNF;ABL1;ATG14;AKAP8L;NPTN
prerank,"negative regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043518)",0.5185806067360005,1.1132720087792871,0.3746312684365782,0.7221774923817584,1.0,2/13,3.53%,SNAI1;SNAI2
prerank,regulation of mitotic nuclear division (GO:0007088),0.39315331639927353,1.1130721574386184,0.313588850174216,0.7221668396562528,1.0,20/55,24.09%,EDN3;PDXP;PDGFRB;EGF;OBSL1;CDK13;FBXO5;TOM1L1;BORA;RCC1;DRD3;PRMT5;CUL7;BTC;LCMT1;AURKAIP1;IGF1;BMP7;CUL9;LRP5
prerank,regulation of cell adhesion mediated by integrin (GO:0033628),0.43060394556840265,1.11299114427258,0.33251231527093594,0.7218510383939241,1.0,3/33,3.53%,CYP1B1;SFRP2;SNAI2
prerank,neuron development (GO:0048666),0.3629248139335705,1.1124811663450427,0.2773722627737226,0.7227004983431571,1.0,15/141,6.30%,RUNX1;RUNX3;GPM6B;LAMB1;GLI2;PPP1R9B;LRP12;B4GALT5;ATXN10;TENM3;APOE;UGCG;BLK;OPHN1;TENM4
prerank,response to interferon-beta (GO:0035456),0.45951628582740334,1.1119626123079691,0.3418230563002681,0.7235050786286443,1.0,4/22,6.86%,STAT1;SHFL;IRF1;IKBKE
prerank,negative regulation of NF-kappaB transcription factor activity (GO:0032088),0.3834622042502884,1.1118443992549305,0.3148984198645598,0.7232829722949646,1.0,15/76,17.54%,CYP1B1;DAP;TNFAIP3;CMKLR1;IRAK3;TRIM21;COMMD6;ERBIN;PYDC1;COMMD7;IRAK2;RBCK1;NLRP2B;ITCH;SPI1
prerank,positive regulation of angiogenesis (GO:0045766),0.3685050918891454,1.1118140237919456,0.29157894736842105,0.7228440662070313,1.0,14/108,7.49%,RUNX1;CYP1B1;ITGB8;ADAM12;JAK1;PRKCA;SFRP2;WNT5A;CD40;GATA6;PRKD2;MDK;HK2;ANGPTL4
prerank,positive regulation of voltage-gated potassium channel activity (GO:1903818),0.5257180312809975,1.111281409106555,0.3612403100775194,0.7237533884541844,1.0,2/11,4.76%,NOS1AP;TREM2
prerank,regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032434),0.3719894553624655,1.1109487172809402,0.3158458244111349,0.7240822325678405,1.0,37/100,22.57%,GLMN;NKD2;LRRK2;OGT;PABIR1;ZYG11B;PLK1;EIF3H;RNF144A;RNF19B;CSNK1A1;SIRT2;BAG6;PRICKLE1;ARIH1;CCAR2;ARAF;RAD23A;CSNK1D;SDCBP;GSK3B;STUB1;MDM2;ARIH2;SOCS5;BBS7;FBXO22;TRIB3;DVL1;RNF217;GIPC1;TRIB1;PIAS1;DDRGK1;PARK7;RAD23B;COP1
prerank,negative regulation of calcium ion transmembrane transporter activity (GO:1901020),0.45077766462914565,1.110882745657668,0.3486238532110092,0.7237471551885818,1.0,8/26,13.46%,CBARP;PKD2;UBQLN1;CALM3;FKBP1B;FMR1;DRD3;CALM2
prerank,regulation of RNA metabolic process (GO:0051252),0.3912798437600307,1.1107582988375164,0.3265073947667804,0.7235548956592571,1.0,9/59,12.75%,IGF2BP1;IGF2BP2;AFF2;MITF;CELF1;PTBP3;RRP1B;RC3H2;OASL
prerank,negative regulation of epithelial cell migration (GO:0010633),0.42727289702829385,1.1107152594923522,0.32540675844806005,0.7231420894037061,1.0,6/33,10.48%,DCN;NR2F2;APOE;PTEN;APOH;ADAMTS9
prerank,central nervous system development (GO:0007417),0.3528860150914407,1.1102346816303896,0.25757575757575757,0.7239177379734868,1.0,34/250,11.96%,COL4A1;EPHA7;C3;APOD;HSPG2;AFF2;ROBO2;ATXN1;AATK;MEIS2;CHD7;ATP6AP2;MDGA1;AMIGO1;VCAN;HPCAL4;ZIC4;ADGRL3;PKD2;PTEN;SHH;MEIS1;STAT3;MAP1S;NIPBL;NF1;PBX3;PTPRZ1;MYRF;CXCR4;BAG6;CHD8;LOXL3;ZIC1
prerank,regulation of nitric-oxide synthase biosynthetic process (GO:0051769),0.49782107596989106,1.1099854041301191,0.3557833089311859,0.7240217740488039,1.0,5/13,13.55%,TLR2;JAK2;IL33;SELENOS;CCL2
prerank,positive regulation of cellular component biogenesis (GO:0044089),0.3747487628390906,1.1098933201231025,0.3120260021668472,0.7237193267026077,1.0,21/88,19.30%,MMP3;PRKCA;SYNPO;TIRAP;RAB7A;BAX;SLF2;VPS4A;EMILIN1;SDC1;FNIP1;SMAD3;SDCBP;GSK3B;TPPP;TNF;CX3CL1;SH3GLB1;HGS;SMPD3;BRK1
prerank,positive regulation of neuron death (GO:1901216),0.4018870319156445,1.1096898465385088,0.3415492957746479,0.7237352813383463,1.0,13/46,24.29%,EPHA7;WNT5A;NF1;FCGR2B;BAX;GSK3B;TNF;FOXO3;CDK5;TGFB2;EFNB2;DDIT3;NUPR1
prerank,negative regulation of intracellular signal transduction (GO:1902532),0.353170491382288,1.109029353642043,0.26693629929221435,0.725010212862316,1.0,31/190,15.24%,RORA;NR1H4;PDE3A;ADIPOQ;TNIP1;TNFAIP3;ITPR1;STAT1;BCL2;TREM2;TLE1;RNF157;PTEN;SPRED1;NPRL2;NF1;CGNL1;THEM4;TBC1D7;NOC2L;BCL2L2;SFRP5;FNIP1;DRD3;TANK;DLG5;FLCN;OTUD3;CASP8;PHLPP2;MDM2
prerank,cell cycle G2/M phase transition (GO:0044839),0.3639641135735914,1.1087150339907266,0.31321540062434966,0.7253434591536593,1.0,42/129,22.08%,DYNLL1;ALMS1;CDKN2B;DYNC1H1;KHDRBS1;FBXL7;HAUS3;CDK14;CCP110;TUBG1;PHLDA1;CNTRL;CUL1;PLK1;FOXM1;CDK7;CEP41;PPP2R2A;PCM1;DCTN3;BORA;CSNK1D;FBXW11;SKP1;PPP1CB;CDC25A;CCNB2;BRSK2;AKAP8L;CEP72;CCNH;TAF2;WEE1;TUBA1A;PCNT;LCMT1;BRSK1;ACTR1A;FBXL12;CKAP5;NINL;YWHAE
prerank,positive regulation of natural killer cell activation (GO:0032816),0.5073730453747625,1.1079561258998738,0.3674074074074074,0.7268038120827661,1.0,1/13,0.46%,IL23R
prerank,positive regulation of signaling (GO:0023056),0.4165054758433597,1.107788082512327,0.32335329341317365,0.7267348816982987,1.0,8/37,17.31%,ADIPOQ;EDN3;WLS;CDKN2AIP;DLG4;HCRT;TNF;PTPN23
prerank,mitotic spindle assembly (GO:0090307),0.4044688900460448,1.1073794755094397,0.33906633906633904,0.7273301740492844,1.0,7/42,13.34%,KIFC1;SMC1A;STAG1;STAG2;KIF2A;TPX2;KPNB1
prerank,neuron cell-cell adhesion (GO:0007158),0.4956597013178473,1.1072214391057689,0.3537313432835821,0.7272483295999621,1.0,2/14,5.51%,CEL;ASTN2
prerank,fatty acid elongation (GO:0030497),-0.4008860339874537,-1.1072114691395845,0.338368580060423,0.7330946173319318,1.0,6/13,15.99%,TECR;ELOVL5;ELOVL7;HACD3;HACD4;HACD1
prerank,"positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:1900153)",0.4882436307090434,1.1066235272776204,0.3557142857142857,0.7277461980848413,1.0,3/15,10.45%,ZFP36L1;ZFP36L2;TNRC6B
prerank,"regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:1900151)",0.4882436307090434,1.1066235272776204,0.3557142857142857,0.7277461980848413,1.0,3/15,10.45%,ZFP36L1;ZFP36L2;TNRC6B
prerank,positive regulation of non-canonical Wnt signaling pathway (GO:2000052),-0.4348182241398272,-1.1063354996334993,0.29464285714285715,0.7332557524213524,1.0,3/11,2.44%,MLLT3;RSPO3;CSNK1E
prerank,regulation of T cell activation (GO:0050863),0.4036766294644941,1.1062664542241447,0.3405275779376499,0.7281870287935064,1.0,8/42,15.79%,TNFSF11;CCL5;GPNMB;SIRPA;THY1;CCL2;HSPD1;ABL1
prerank,positive regulation of ERAD pathway (GO:1904294),-0.42093974210702145,-1.1058904798741518,0.31962025316455694,0.732240785314107,1.0,7/13,17.58%,CAV1;RNF185;ATXN3;BCAP31;SGTA;USP13;UBQLN2
prerank,positive regulation of behavior (GO:0048520),-0.4398829404721891,-1.1058877641242388,0.32857142857142857,0.7300165748134163,1.0,3/10,13.84%,SGIP1;MEF2C;NLGN1
prerank,spinal cord development (GO:0021510),0.5149500099269991,1.1058750101268149,0.3456614509246088,0.7287168890947034,1.0,4/12,11.74%,GLI2;PKD2;NF1;LOXL3
prerank,nuclear membrane organization (GO:0071763),0.46145408144572014,1.1058729093263657,0.35302197802197804,0.7282011546338836,1.0,7/19,18.34%,CHMP4B;UBXN2A;PLK1;VPS4A;AKAP8L;TMEM43;CHMP7
prerank,regulation of nucleic acid-templated transcription (GO:1903506),0.3493793864348211,1.105615291615862,0.23423423423423423,0.7283846825831417,1.0,86/327,21.77%,RORA;RUNX3;POU5F1;CXXC1;SBNO2;ATXN1;ZMIZ1;BACH1;CHD7;CCAR1;SUFU;MITF;SNAI2;MAFB;PRRX2;GON4L;SOX21;DVL2;YAF2;ZBTB38;E2F1;NFKB2;PHF1;MYBL1;PRDM2;STAT3;CREBBP;CARM1;TGFBR1;UBE2L3;NONO;ACVR1B;FOXK2;TCF7;NSD3;BHLHE40;NR1D2;AHR;ATRX;WWTR1;MAGED1;FADS1;CCAR2;BTG1;TCF3;TCF7L1;CLOCK;TGIF2;NSD1;PHF12;NFXL1;FOXN2;NUP35;NR2C2;PRMT5;TULP3;ABL1;EZH2;ZNF35;ATF2;HCFC2;SKOR2;NIF3L1;SPI1;KMT2D;WTIP;NAB2;SSBP2;SPTY2D1;DVL1;BAZ2A;LIN54;PATZ1;TGFBRAP1;YBX1;DRAP1;HP1BP3;CALR;CDK11B;ZFHX3;SAP30L;HINT1;TERF2IP;SP3;FUS;ZSCAN21
prerank,postsynaptic membrane organization (GO:0001941),0.4763334716894525,1.105527733987137,0.3380084151472651,0.7281205931375094,1.0,2/17,3.63%,CEL;APOE
prerank,regulation of cell junction assembly (GO:1901888),0.4430743226615524,1.1053858082889172,0.3381578947368421,0.727971411697121,1.0,3/27,3.53%,RUNX1;SNAI1;SNAI2
prerank,regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880),-0.34694337181969803,-1.1053664014033417,0.2874015748031496,0.7292118295427311,1.0,6/21,9.57%,DMD;ANK2;ATP1A2;AKAP6;CALM1;PDE4D
prerank,aminoglycan biosynthetic process (GO:0006023),0.4013445553271231,1.1050885086925664,0.3518957345971564,0.7282322382732854,1.0,10/49,11.41%,HSPG2;GPC6;EXT1;HS2ST1;EXT2;SLC35D2;B3GALNT1;SDC2;GCNT2;SDC1
prerank,regulation of BMP signaling pathway (GO:0030510),0.3802154522878968,1.1041356714677864,0.34509371554575524,0.7302354666458782,1.0,12/73,13.38%,SULF1;FSTL1;SFRP4;SMAD2;HTRA3;SMURF2;PPARG;ACVR2A;LEMD2;RBPJ;SMAD5;SMURF1
prerank,purinergic nucleotide receptor signaling pathway (GO:0035590),0.4661597406752933,1.1039229098947672,0.35771276595744683,0.7302797417331027,1.0,2/20,4.26%,C3;CASP1
prerank,regulation of mRNA polyadenylation (GO:1900363),0.478159538098305,1.103908010334449,0.35833333333333334,0.7297897855633202,1.0,7/17,17.02%,CPEB1;ZC3H3;CDK9;CCNT1;NCBP2;ZC3H14;RNF40
prerank,amyloid precursor protein metabolic process (GO:0042982),0.47503545088460536,1.1037636618483655,0.355021216407355,0.7296509880123302,1.0,3/18,4.50%,ADAM19;APOE;ABCG1
prerank,endochondral bone morphogenesis (GO:0060350),0.5307583949123753,1.1037498011652715,0.38402457757296465,0.7291562950434508,1.0,2/11,2.77%,COL13A1;TMEM119
prerank,cell-cell junction maintenance (GO:0045217),-0.44762634509168014,-1.1037130061418765,0.3485714285714286,0.7317470962131801,1.0,1/11,0.04%,TJP1
prerank,metanephros development (GO:0001656),0.4429679927864777,1.1033216520581528,0.348,0.7298084938647382,1.0,5/26,7.57%,ROBO2;PKD2;SHH;NIPBL;NF1
prerank,protein-DNA complex disassembly (GO:0032986),0.48098226583528325,1.102302219483287,0.3746397694524496,0.7320385922888324,1.0,6/16,21.97%,SMARCC1;SMARCD3;GRWD1;SMARCB1;SMARCA4;SMARCC2
prerank,inositol phosphate metabolic process (GO:0043647),-0.292030577351004,-1.1021908191759349,0.25842696629213485,0.7335955072455095,1.0,16/46,20.79%,PLCE1;INPP4B;INPP5D;PLCB4;PLCB1;PPIP5K1;ITPK1;CALM1;OCRL;SYNJ1;INPPL1;ITPKB;IMPA2;IPPK;NUDT11;PLCD4
prerank,rRNA catabolic process (GO:0016075),0.4728992672769524,1.1021221044050582,0.3627311522048364,0.7319720033575332,1.0,5/16,19.03%,ERN2;XRN1;EXOSC4;EXOSC2;EXOSC3
prerank,regulation of triglyceride biosynthetic process (GO:0010866),0.4857540776030128,1.1017572403125773,0.3476968796433878,0.7324322589869804,1.0,1/15,0.33%,C3
prerank,regulation of ATP biosynthetic process (GO:2001169),0.4782559346239538,1.101627295625678,0.352112676056338,0.7322628489006902,1.0,7/16,19.66%,TREM2;PID1;ANTKMT;ENO1;FLCN;SPHK2;PARP1
prerank,cellular response to drug (GO:0035690),-0.34286286498346885,-1.1015070236206173,0.28820960698689957,0.7332426318672458,1.0,9/25,12.58%,PDE4B;PPM1E;GAS6;ACER2;MEF2C;TFRC;KCNQ1;AIM2;TP53
prerank,regulation of cell-cell adhesion mediated by integrin (GO:0033632),-0.45344591678752355,-1.1014653357709445,0.35405405405405405,0.7311623120007181,1.0,2/10,2.77%,PODXL;DPP4
prerank,regulation of microtubule-based movement (GO:0060632),-0.4249667688773895,-1.1010596169438889,0.34011627906976744,0.7300832764638687,1.0,7/11,33.02%,MAP2;LAMP1;TTC21B;CFAP298;HDAC6;DRC1;CCDC65
prerank,regulation of cholesterol transport (GO:0032374),0.45579482765771917,1.100922470154179,0.35825105782792666,0.7335984219342435,1.0,3/20,10.12%,LRP1;ABCA2;NFKB1
prerank,transcription preinitiation complex assembly (GO:0070897),0.5188264133545046,1.100670651881785,0.3803863298662704,0.7337263764952262,1.0,3/12,10.56%,POLR1E;TAF7;BDP1
prerank,mesenchyme development (GO:0060485),0.49351117481021534,1.1006174851628923,0.36428571428571427,0.7333530372122711,1.0,3/15,8.31%,SFRP2;PKD2;TGFBR1
prerank,positive regulation of heart rate (GO:0010460),0.4770771580651828,1.099856499370456,0.3695054945054945,0.734847281800595,1.0,3/17,5.25%,EDN3;ADM;ATP2A2
prerank,regulation of potassium ion transport (GO:0043266),-0.32063324860558295,-1.0989063027710941,0.27884615384615385,0.734060944865182,1.0,7/31,8.95%,KCNIP4;ACTN2;FHL1;ANK2;DPP6;CACNA1D;DPP10
prerank,limb development (GO:0060173),0.43780950215024234,1.098595994809828,0.3629441624365482,0.7377047353844846,1.0,10/28,23.56%,KREMEN1;GLI3;CHD7;SALL1;PCSK5;PTCH1;IQCE;MAP3K20;MEGF8;LRP4
prerank,positive regulation of cytosolic calcium ion concentration (GO:0007204),0.35987166199966697,1.0985332730648547,0.3124346917450366,0.7373585701503875,1.0,27/140,19.11%,P2RY10;KNG1;PDGFRA;CACNA1A;IAPP;CMKLR1;CACNA2D1;P2RX5;EDNRA;CACNA1C;CCR1;CD36;PTGDR;S1PR3;CXCR4;DLG4;PTGER4;DRD3;LPAR3;ABL1;NPTN;LPAR2;LPAR1;TRPM4;FIS1;SPPL3;GRIN1
prerank,cytoskeleton-dependent cytokinesis (GO:0061640),0.38949179962996705,1.098285004187974,0.3559127439724455,0.7374841380981112,1.0,17/56,17.36%,JTB;SPIRE2;CHMP4B;SPIRE1;SNX33;PLK1;SNX18;INCENP;VPS4A;RTKN;DCTN3;SPTBN1;SNX9;SON;CUL7;ROCK2;RHOA
prerank,mitochondrion distribution (GO:0048311),0.5093445480556605,1.0980630820053547,0.34668721109399075,0.7375563140980943,1.0,3/12,12.16%,LRRK2;TRAK1;MSTO1
prerank,cellular response to interleukin-15 (GO:0071350),0.5016539367173627,1.0977056384508612,0.37181409295352325,0.7374164667589821,1.0,4/13,11.35%,JAK1;STAT3;STAT5A;GRB2
prerank,interleukin-15-mediated signaling pathway (GO:0035723),0.5016539367173627,1.0977056384508612,0.37181409295352325,0.7374164667589821,1.0,4/13,11.35%,JAK1;STAT3;STAT5A;GRB2
prerank,cochlea morphogenesis (GO:0090103),0.5237588869865457,1.0970033432971686,0.3873581847649919,0.7387607907422462,1.0,3/10,15.58%,TBX18;HOXA1;MYO3A
prerank,histone H3-K4 trimethylation (GO:0080182),0.513356008444039,1.096912164510601,0.375186846038864,0.7385033013945879,1.0,2/11,4.96%,KMT2A;OGT
prerank,synaptic vesicle localization (GO:0097479),-0.413462857119588,-1.0968421599925182,0.32326283987915405,0.7377176437514873,1.0,7/13,18.98%,RAB27A;SYNDIG1;SNAPIN;TOR1A;SYNJ1;NLGN1;DNM2
prerank,cardiac epithelial to mesenchymal transition (GO:0060317),0.4585149953754537,1.0963000530791154,0.35978835978835977,0.7395006532821153,1.0,9/20,22.29%,SNAI1;SNAI2;TGFBR1;OLFM1;HEYL;RBPJ;TBX3;TGFB2;ACVRL1
prerank,acidic amino acid transport (GO:0015800),-0.38036048408094636,-1.096123596687265,0.32525951557093424,0.7374512349006428,1.0,7/17,9.91%,SLC6A6;LRRC8D;SLC1A1;GJA1;SLC6A1;ARL6IP5;SLC1A2
prerank,detection of light stimulus involved in sensory perception (GO:0050962),-0.44978583816273543,-1.0960082352629616,0.3629032258064516,0.7334163890599517,1.0,3/10,30.57%,CACNA2D4;TULP1;CNGB1
prerank,detection of light stimulus involved in visual perception (GO:0050908),-0.44978583816273543,-1.0960082352629616,0.3629032258064516,0.7334163890599517,1.0,3/10,30.57%,CACNA2D4;TULP1;CNGB1
prerank,cellular response to alcohol (GO:0097306),0.40996094198550054,1.0957972301119856,0.33569739952718675,0.7403231142432508,1.0,14/42,19.34%,ADCY7;SFRP1;ADCY2;GRAMD1A;AHR;PTGER4;GNAI1;LRP6;GNG2;PTCH1;SMO;SPHK2;CTNNA1;GRAMD1C
prerank,adipose tissue development (GO:0060612),0.5098740947001548,1.0957911043794393,0.37574850299401197,0.739817718041804,1.0,3/11,10.96%,SH3PXD2B;ARID5B;XBP1
prerank,catecholamine biosynthetic process (GO:0042423),-0.4230372491129598,-1.0957521078532027,0.32919254658385094,0.7319580385500877,1.0,3/11,21.01%,MOXD1;DDC;GCH1
prerank,positive regulation of pseudopodium assembly (GO:0031274),0.5116593729895675,1.095747780240685,0.3659305993690852,0.738898152937394,1.0,5/10,24.18%,CDC42EP4;CDC42;CDC42EP5;WASHC1;CDC42EP1
prerank,regulation of pseudopodium assembly (GO:0031272),0.5116593729895675,1.095747780240685,0.3659305993690852,0.738898152937394,1.0,5/10,24.18%,CDC42EP4;CDC42;CDC42EP5;WASHC1;CDC42EP1
prerank,negative regulation of phosphoprotein phosphatase activity (GO:0032515),0.44264604295419596,1.0951219526437062,0.358695652173913,0.7400712350552027,1.0,5/22,17.28%,MGAT5;FKBP1B;GSK3B;TNF;ROCK2
prerank,positive regulation of myelination (GO:0031643),0.5200931490886037,1.0950052198124909,0.3726346433770015,0.7398372377864094,1.0,6/11,22.97%,TENM4;MYRF;DICER1;TPPP;EGR2;NCMAP
prerank,regulation of intracellular signal transduction (GO:1902531),0.34288389067920033,1.0949558315778987,0.23523523523523523,0.7394532217034733,1.0,93/420,17.12%,DLC1;FSHR;BCL3;TAOK1;MAP4K4;VAV2;TNFSF11;BRIP1;ATP6AP2;ARHGAP24;SYDE1;NUAK1;ARHGAP15;BIRC3;WNT5A;CMKLR1;VAV3;RHOJ;RHOD;LRRK2;DNA2;ARHGAP32;PIP4K2A;PRKD2;CSNK2A2;TREM2;KMT5A;EHMT1;PTEN;PTPN13;FGD4;NF2;PIP5K1B;SPRED1;OPHN1;KALRN;RAC1;SRGAP1;ATM;ITSN1;BRPF1;ATR;RASSF2;EGFR;HDAC1;CDC42;RCN3;TAF4;MTA2;TRIO;TAF7;MAPKAP1;SQSTM1;PRKAR1B;ARHGDIG;PIP4K2B;AKAP13;PREX1;RICTOR;RMI1;NRK;MAPK11;NOC2L;TAOK3;ARHGAP6;PJA2;ARHGEF19;FAM13B;ARAF;TPX2;PTPMT1;TRAF2;PRDM1;ARHGAP20;GNAI1;BANP;ARHGAP35;FLCN;NOP2;NTRK3;PRMT5;ARHGEF12;MDM2;TNF;RRAGC;TAF9B;RBBP8;RASD2;PIP5K1A;TTI1;TAF2;VAV1;PLEKHG2
prerank,negative regulation of Ras protein signal transduction (GO:0046580),0.4185315211396711,1.0947968596042803,0.3674775928297055,0.7393832295036642,1.0,8/35,15.28%,DLC1;ARHGAP24;MAPKAP1;SPRY2;EPHB2;ARHGAP35;FLCN;ITGA3
prerank,ovarian follicle development (GO:0001541),-0.41948816709282644,-1.094735930082809,0.3090909090909091,0.7326880910132368,1.0,8/13,29.72%,KIT;EIF2B2;SOD1;CEBPB;EIF2B4;FOXL2;ANG;LHCGR
prerank,regulation of peptide hormone secretion (GO:0090276),0.3777451731363351,1.0939931294767766,0.333710407239819,0.7409843259231197,1.0,11/67,9.69%,CACNA1A;PRKCA;CHD7;ITPR1;RAPGEF4;CACNA1C;CACNA2D2;KCNG2;CCL5;KCNA5;EIPR1
prerank,negative regulation of cellular biosynthetic process (GO:0031327),0.40344114654986096,1.0938001799881822,0.3595238095238095,0.7409530313078003,1.0,11/47,18.59%,ADIPOQ;SNAI1;ABCA2;SNAI2;KHSRP;NFKB1;SIRPA;FBXW7;GCK;ROCK2;TRIB3
prerank,regulation of Rac protein signal transduction (GO:0035020),0.47690614437268963,1.0933321993400509,0.39363241678726485,0.7416368140220208,1.0,4/16,11.31%,ARHGAP24;AUTS2;OGT;ALS2
prerank,positive regulation of T cell proliferation (GO:0042102),0.38823139460459943,1.093150061704407,0.33064516129032256,0.7415892603807875,1.0,7/55,8.44%,IL23R;CD276;ANXA1;AIF1;CCL5;NCK2;NCK1
prerank,axonogenesis (GO:0007409),0.34576676926174044,1.092666914459961,0.2937625754527163,0.7423400231089485,1.0,45/237,13.32%,EPHA7;LAMA2;CXCL12;PALLD;GLI2;ROBO2;LAMA1;SLITRK6;B4GALT5;PRKCA;NRP1;SLIT3;SLIT1;SH3KBP1;GAB2;AUTS2;WNT5A;EFNA4;USP9X;BAIAP2;EPHB3;PTEN;SHH;OPHN1;FRS2;PDLIM7;MAP1S;PIK3R1;SPTBN5;EPHA1;SEMA3E;RAB10;LLGL1;DSCAM;EFNA5;CXCR4;ATL1;L1CAM;KIF5B;GRB2;S100A6;EPHB2;NEFH;PTK2;RANBP9
prerank,glucose import (GO:0046323),-0.4109822478671842,-1.0922513647939853,0.34935897435897434,0.7371793025227158,1.0,2/13,2.46%,SLC2A1;SORT1
prerank,regulation of filopodium assembly (GO:0051489),0.4068790723091993,1.0916811843429655,0.3493827160493827,0.7444081956247398,1.0,9/38,12.19%,NRP1;MYO10;DPYSL3;FSCN1;CDC42;PIK3R1;RALA;TGFB3;FMR1
prerank,negative regulation of transmembrane transport (GO:0034763),-0.4474327435281527,-1.0916584382103922,0.36243386243386244,0.7366200267127058,1.0,3/10,7.36%,INPP5K;PRKCB;THBS1
prerank,cellular nitrogen compound biosynthetic process (GO:0044271),0.4372683321149319,1.0915684249811715,0.3645699614890886,0.7441985178579918,1.0,2/26,2.79%,CYP1B1;ABCA2
prerank,regulation of viral life cycle (GO:1903900),0.46247237400216645,1.0905570631127612,0.3544973544973545,0.7463192545195838,1.0,4/21,13.00%,TRIML2;TRIM21;VPS4A;TRIM62
prerank,positive regulation of rRNA processing (GO:2000234),-0.4309359765426384,-1.0904540839452659,0.34626865671641793,0.7378376696160994,1.0,3/10,14.38%,WDR43;RIOK1;UTP15
prerank,peptidyl-tyrosine autophosphorylation (GO:0038083),0.47776568852762025,1.090425283293215,0.38264580369843526,0.7461688312733896,1.0,4/15,9.23%,TEC;AATK;EGFR;DDR1
prerank,homologous chromosome segregation (GO:0045143),-0.3585556063666264,-1.0899602328877662,0.3168724279835391,0.7370501844707016,1.0,14/20,48.68%,PTTG1;CENPC;PRDM9;MEI4;SGO1;ZCWPW1;MEIOB;FANCD2;FMN2;IHO1;RNF212B;MEIKIN;ANKRD31;TERB2
prerank,fructose 6-phosphate metabolic process (GO:0006002),0.5168412062741449,1.0895808976665666,0.3767885532591415,0.7479237298925894,1.0,2/10,7.38%,GFPT2;HK2
prerank,regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0000079),0.37645386261219527,1.0895798795270901,0.3440265486725664,0.7474039708760318,1.0,18/78,16.38%,PSRC1;NR2F2;CDKN2B;PKD2;PTEN;CDKN2D;CCNE2;HEXIM1;EGFR;PLK1;CCND3;CDK7;CCNT1;GTF2H1;CDC25A;CDC37;CCNB2;CCNH
prerank,negative regulation of interleukin-6 production (GO:0032715),0.42147933648208974,1.0894280038548387,0.36688741721854307,0.7473075450630383,1.0,7/27,15.90%,TNFAIP3;IRAK3;PTPN6;SIRPA;SELENOS;TNF;CX3CL1
prerank,regulation of autophagy (GO:0010506),0.3477269926381381,1.0891594736527892,0.3125,0.7475254854712378,1.0,61/216,20.09%,DCN;TRIML2;DAP;EIF4G2;EIF4G3;ITPR1;IL10RA;LRRK2;BCL2;PIP4K2A;KLHL22;CSNK2A2;TREM2;DRAM1;RMC1;NPRL2;ATM;SNX5;UBQLN1;STAT3;TRIM21;TRIM8;EXOC4;FOXK2;RPTOR;PIP4K2B;SIRT2;ATP6V1G1;SNX6;LAMTOR5;ATP6V1D;FLCN;FBXW7;GSK3B;GAPDH;RRAGC;DCAF12;ABL1;RAB8A;WDR6;TPCN1;SH3GLB1;PLEKHF1;ATP6V0A2;ATP6V1H;SMCR8;CTSA;TRIB3;EXOC7;EXOC1;ORMDL3;TRIM27;ATP6V1G2;FOXO3;CDK5;DAPK1;UCHL1;STK11;CAPNS1;NEDD4;TPCN2
prerank,protein modification by small protein conjugation (GO:0032446),0.3457593871829511,1.0889928481387907,0.25725725725725723,0.7474312550793061,1.0,114/361,23.60%,TRIML2;ARRDC4;DTX4;PDZRN3;SPSB1;DCAF15;MYLIP;MYCBP2;PEX10;USP9X;RAE1;BRAP;FBXL7;RNF157;SMURF2;ANAPC11;FBH1;ATG3;CNOT4;FBXO7;KLHL13;RNF111;NUP37;CBL;TRIM21;CUL1;PLK1;UBE2L3;RNF144A;DTX2;AREL1;PIAS2;NUP153;DDB1;EIPR1;RNF8;ZSWIM8;NUP188;TRIM13;RNF138;SAE1;DCUN1D1;TRIM11;CDC27;UBE2F;ARIH1;CDC16;PJA2;PCNP;TRIM62;SELENOS;MIB1;FBXW11;VCPIP1;SMURF1;TRIM35;SKP1;UBE2Z;FBXW5;FBXW7;NUP35;STUB1;TRPC4AP;CHFR;MDM2;ARIH2;NUP214;UBE2W;DTX3;SYVN1;UBE2R2;RNF103-CHMP3;UBE2E1;FBXO45;RNF40;CUL7;DCUN1D5;ITCH;NFE2L2;EGR2;TRPM4;CDC73;FBXO2;TRIM44;KCTD10;TRIM17;UBE2S;PEX5;TRIM27;NSMCE2;RNF213;ARRB1;UBA5;RNF181;RNF168;NEDD4;UBA1;CDK5RAP3;PIAS1;KLHL25;TRAIP;PRKDC;DDRGK1;URM1;DTX3L;RPS27A;TNFAIP1;NDC1;ASB5;CUL9;ATG7;SDE2;CDC23;RNF14
prerank,glutamate metabolic process (GO:0006536),-0.3520436926914032,-1.088866218382983,0.3188405797101449,0.7379578405755862,1.0,8/19,16.54%,MTHFS;PRODH;GLUD1;GCLM;GAD1;GLS;GLUL;GCLC
prerank,phosphate-containing compound metabolic process (GO:0006796),0.34814393355162093,1.088841614533156,0.30505050505050507,0.7473564550027596,1.0,44/198,19.37%,EPHA7;ENPP1;LGALS13;TAOK1;PDXP;LPL;INPP1;PLA2G5;LRRK2;DUSP5;DUSP28;PPA1;EPHX2;PIP4K2A;XYLB;PTEN;GFPT2;STAT3;HKDC1;DUSP18;HK2;SLC20A1;PFKFB4;ITPKC;PIP4K2B;PPP3CA;PANK2;EPHB2;PLD4;PI4KA;G6PC3;PPA2;PLPPR2;GCK;GK;THNSL2;NUDT14;PLCH1;SPHK2;PLCB3;PLPP3;CDK5;NUDT4;IP6K2
prerank,arachidonic acid metabolic process (GO:0019369),0.41667514801074945,1.0884091496006802,0.35723431498079383,0.7479624882229922,1.0,5/35,11.34%,CYP1B1;PTGES;EPHX2;CYP2A6;CYP1A1
prerank,potassium ion export across plasma membrane (GO:0097623),0.4954728418384007,1.088385937380771,0.37280701754385964,0.7475055370783851,1.0,2/13,7.35%,KCNT2;KCNA5
prerank,regulation of cilium assembly (GO:1902017),0.38136302450735704,1.0882373476930822,0.3652073732718894,0.7473645029090263,1.0,17/62,15.84%,YAP1;ATG3;CCP110;CDK10;RABGAP1;TBC1D2B;ENTR1;IFT88;TBC1D16;TBC1D7;CEP120;DYNC2LI1;TBC1D20;ARHGAP35;TBC1D19;TBC1D13;IFT20
prerank,cranial nerve development (GO:0021545),0.5164239613631592,1.0878959937176782,0.37732919254658387,0.7477732472019761,1.0,2/11,10.82%,CHD7;SALL1
prerank,mRNA cleavage involved in mRNA processing (GO:0098787),-0.41086071202086166,-1.087819821458194,0.3685897435897436,0.7387409683167268,1.0,4/14,9.32%,CSTF2;ERN1;CPSF2;TUT1
prerank,positive regulation of actin cytoskeleton reorganization (GO:2000251),0.467790802353909,1.0870325417890239,0.3539325842696629,0.7494921056128052,1.0,9/17,20.99%,NRP1;BAIAP2;CDC42;NTRK3;ABL1;CDK5;NTF3;FES;BCAS3
prerank,regulation of cell death (GO:0010941),0.3656666993977868,1.086833537478033,0.33828207847295866,0.7494838156567674,1.0,10/94,8.44%,HP;HPR;LRP1;LRRK2;CCN4;CHMP4B;CELF1;CD36;CCL5;NCK1
prerank,negative regulation of multicellular organismal process (GO:0051241),0.34489401626303684,1.0867207927488642,0.3119918699186992,0.7492535984720522,1.0,42/199,17.54%,NR1H4;ADIPOQ;PARP3;TBX18;SFRP1;ADM;SFRP2;TIMP1;SFMBT1;ADAMTS5;PTEN;SHH;SPRED1;SPRED2;MDK;EGFR;BMP5;PAEP;LAMA4;ATP2B1;FCGR2B;PLCL1;ARRDC3;SPRY2;ACOT13;PTGER4;GPNMB;CHSY1;RBPJ;LDLRAD4;FLCN;IFNGR1;GSK3B;TNF;LGR4;NPTN;ROBO1;PTCH1;ROCK2;PTPN23;ACVR1C;SPI1
prerank,C21-steroid hormone biosynthetic process (GO:0006700),-0.41040512862997447,-1.0863209938902003,0.36507936507936506,0.7408617079908195,1.0,7/12,37.10%,STARD3NL;STAR;TSPOAP1;TSPO;FDX1;FDX2;AKR1B1
prerank,mitotic spindle assembly checkpoint signaling (GO:0007094),0.45705523074992166,1.0860308528659572,0.3780487804878049,0.7495345348986803,1.0,4/20,8.18%,MAD2L1;KLHL22;ATM;PLK1
prerank,spindle assembly checkpoint signaling (GO:0071173),0.45705523074992166,1.0860308528659572,0.3780487804878049,0.7495345348986803,1.0,4/20,8.18%,MAD2L1;KLHL22;ATM;PLK1
prerank,mitotic spindle checkpoint signaling (GO:0071174),0.45705523074992166,1.0860308528659572,0.3780487804878049,0.7495345348986803,1.0,4/20,8.18%,MAD2L1;KLHL22;ATM;PLK1
prerank,regulation of transforming growth factor beta production (GO:0071634),0.4611192302469586,1.0858064998806132,0.384297520661157,0.7496106607617418,1.0,8/18,21.74%,ITGB8;XCL1;LTBP1;LGALS9;SMAD3;PTGS2;TGFB2;LRRC32
prerank,DNA catabolic process (GO:0006308),0.5096300867454621,1.0857480759228617,0.40161290322580645,0.7492478764043609,1.0,4/11,16.53%,FBH1;SETMAR;DFFB;DNASE1L2
prerank,positive regulation of actin filament bundle assembly (GO:0032233),0.38650747819349746,1.0856319259593938,0.36717827626918537,0.7490768608266042,1.0,17/51,17.36%,NRP1;SFRP1;SYNPO;CARMIL1;NF2;RAC1;CDC42;TGFBR1;EPHA1;TGFB3;TPM1;ITGB1BP1;ABL1;CX3CL1;ROCK2;LPAR1;RHOA
prerank,regulation of microtubule depolymerization (GO:0031114),0.4253796397935451,1.0850592507393022,0.3853459972862958,0.7501045882994121,1.0,6/25,12.61%,TAOK1;NAV3;MAP1S;CAMSAP2;FGF13;TPX2
prerank,cellular polysaccharide catabolic process (GO:0044247),-0.38244897155177343,-1.0849187119974317,0.34935897435897434,0.742702125304691,1.0,7/16,18.07%,PYGB;PGM2L1;CALM1;PYGM;PHKG1;PGM2;AGL
prerank,regulation of pathway-restricted SMAD protein phosphorylation (GO:0060393),0.3817360717787502,1.0849076230261785,0.36177474402730375,0.7499777875393254,1.0,18/56,25.37%,PMEPA1;BMP5;TGFBR1;ACVR1;INHBB;TGFB3;EMILIN1;ACVR2A;SDCBP;LDLRAD4;SNX25;TGFB2;ACVRL1;BMP7;TGFB1;BMPER;GDF9;INHBA
prerank,positive regulation of phagocytosis (GO:0050766),0.38407218337340276,1.0844183618598482,0.33811230585424135,0.7507539333129061,1.0,14/47,21.63%,C3;PLA2G5;TREM2;FCGR2B;MERTK;SIRPA;CCL2;TUB;TNF;PTPRJ;RAB31;CAMK1D;CALR;C4B
prerank,regulation of protein-containing complex assembly (GO:0043254),0.35584569905771873,1.0843731443098723,0.35490605427974947,0.7503654698022706,1.0,24/110,19.30%,MMP3;ABCA1;IAPP;FARP2;APOE;TIRAP;AIDA;CDC42;CD36;BAX;STXBP1;SLF2;EIF2AK2;FNIP1;TRAF2;GSK3B;TPPP;BBS10;TNF;SH3GLB1;FBLIM1;LCMT1;PEX5;BRK1
prerank,positive regulation of cell cycle G1/S phase transition (GO:1902808),0.42194323023336816,1.0836807811931979,0.3844221105527638,0.7516570624127312,1.0,17/33,26.97%,ANXA1;AIF1;ADAMTS1;EGFR;CCND3;RPTOR;UBE2E2;TFDP1;EZH2;CDC73;DDX3X;KMT2E;DDRGK1;EIF4G1;AKT1;GLI1;ANKRD17
prerank,regulation of calcium ion-dependent exocytosis (GO:0017158),0.41615972593251943,1.0835071950861053,0.37055837563451777,0.7515965677645469,1.0,8/31,19.92%,CBARP;SYT10;STXBP1;SYT2;SYT3;STXBP3;DOC2B;RAB3GAP1
prerank,monocarboxylic acid biosynthetic process (GO:0072330),0.3829006060524869,1.0831820389153801,0.36199095022624433,0.7519817237585025,1.0,8/59,13.22%,CYP7B1;LIPC;LPL;ALDH1A2;SLC27A2;XBP1;HSD17B8;NDUFAB1
prerank,stabilization of membrane potential (GO:0030322),-0.3824698571657128,-1.0827983510943555,0.3114754098360656,0.7461955806945385,1.0,7/16,31.97%,KCNK5;KCNK10;KCNK6;KCNK13;KCNK12;KCNN4;KCNK4
prerank,negative regulation of protein exit from endoplasmic reticulum (GO:0070862),0.5209181573406116,1.0823591040966611,0.3796875,0.7535999851800897,1.0,2/10,8.90%,ERLEC1;UBE2J1
prerank,membrane depolarization during action potential (GO:0086010),-0.3257779129377844,-1.0816763163323566,0.3319672131147541,0.7472334665064838,1.0,10/26,21.30%,ATP1A2;SCN2A;KCNJ2;SCN8A;CACNA1D;SCN3A;SCN4B;SCN9A;CACNA1I;SCN3B
prerank,natural killer cell mediated immunity (GO:0002228),0.4726137694790602,1.0816514198623026,0.38269794721407624,0.7548886517526681,1.0,2/15,11.23%,ULBP1;KIF5B
prerank,"retrograde transport, endosome to Golgi (GO:0042147)",0.3695560194937886,1.0816146206092443,0.3487858719646799,0.7544708133367355,1.0,23/80,22.29%,CLTC;HEATR5A;STX6;TMEM87B;TRAPPC10;SNX5;RAB7A;RAB7B;DENND5A;GOSR1;SNX8;LMAN1;ANKFY1;SNX6;RAB9A;RHOBTB3;TRIM27;GBF1;WASHC1;SNX2;VTI1B;VPS54;TBC1D10B
prerank,negative regulation of microtubule depolymerization (GO:0007026),0.44016031700935176,1.0813071210636145,0.3854748603351955,0.7547601482257906,1.0,5/21,12.61%,TAOK1;NAV3;CAMSAP2;FGF13;TPX2
prerank,regulation of trans-synaptic signaling (GO:0099177),0.41679142933277324,1.081181196575345,0.383248730964467,0.7545678020146274,1.0,2/33,1.12%,CEL;CACNA1A
prerank,mitochondrial fission (GO:0000266),-0.3874458072932317,-1.0810648942314462,0.3508771929824561,0.7468082086301839,1.0,2/16,2.11%,DNM3;PRKN
prerank,striated muscle cell development (GO:0055002),-0.3898355258405224,-1.0810170197180293,0.3575949367088608,0.7448124231771389,1.0,4/14,17.14%,PGM5;TMOD3;LMOD1;FLII
prerank,regulation of cardiac muscle cell action potential (GO:0098901),0.43078958005061047,1.0803374307332592,0.39040207522697795,0.7562602320075681,1.0,7/25,12.01%,NOS1AP;TBX18;CAMK2D;CACNA1C;ATP2A2;CALM3;FGF13
prerank,coenzyme A metabolic process (GO:0015936),0.49698078526391753,1.0802224108758047,0.3866279069767442,0.7560453748240318,1.0,8/14,21.60%,DCAKD;SLC25A16;PANK2;COASY;ACAT1;PANK4;PANK1;CROT
prerank,transcription by RNA polymerase II (GO:0006366),0.33941897693994066,1.0801998738998622,0.2901606425702811,0.755595216042771,1.0,60/305,16.90%,RORA;NR1H4;PAX1;NCOR2;YAP1;DEAF1;TEAD3;PRRX1;SOX5;NFIX;RARB;RXRG;POU2F1;TRIP11;TEAD1;CEBPD;MAML3;HDAC1;TAF4;CREBBP;TAF7;CSTF1;CBFB;SNAPC3;PPARG;E2F3;GTF2F2;NR1D2;CDK9;TTF2;NFKB1;CDK13;NRBF2;CDK7;MBD1;HDAC5;NFE2L3;XBP1;MAML2;WWTR1;TFDP1;SETX;HDAC3;SLBP;NR2F1;GLIS3;RBPJ;CCNT1;POLR2K;TBL1X;GTF2H1;NR2C2;TCEA1;NCBP2;POLR2B;TAF9B;NKX2-8;CCNH;INTS1;TAF2
prerank,engulfment of apoptotic cell (GO:0043652),-0.3865909349255026,-1.0801882346561418,0.343042071197411,0.744963301778969,1.0,5/15,15.61%,XKR4;RHOBTB1;THBS1;RHOG;RHOH
prerank,regulation of interleukin-13 production (GO:0032656),0.48329066094070616,1.0800779644965268,0.4172661870503597,0.755412634893118,1.0,3/13,8.51%,TNFRSF21;TSLP;LGALS9
prerank,signal transduction in response to DNA damage (GO:0042770),0.3867038735250232,1.0797158680807888,0.3731513083048919,0.7558191867067283,1.0,10/49,15.79%,BCL3;BRIP1;BATF;E2F1;ATM;ATR;ATRX;GRB2;CLOCK;ABL1
prerank,oogenesis (GO:0048477),0.48471274775240936,1.0795853724496158,0.39215686274509803,0.7556590932818164,1.0,2/15,6.13%,PTN;MDK
prerank,regulation of anatomical structure morphogenesis (GO:0022603),0.35982014347780583,1.0795133049822907,0.33226495726495725,0.7553181065806553,1.0,37/118,21.05%,SPARC;BCL6;TNFAIP3;FMNL2;SFRP1;LRRK2;RAP2A;EPHB3;PID1;PDZD8;NF1;MYO19;PLXND1;SDC2;EFNA5;FGF2;GPNMB;HTATIP2;ABI2;KIF13B;ARHGAP35;GSK3B;PHLDB1;INF2;PHLDB2;RNH1;BRSK2;SP100;GDNF;WTIP;CAMSAP1;CDK5;KNDC1;BRSK1;NEDD4;ETS1;PAK1
prerank,regulation of mitochondrial translation (GO:0070129),0.44642265240910084,1.0793654141988596,0.39591836734693875,0.7552046907619451,1.0,3/21,9.74%,RPUSD3;TRUB2;ALKBH1
prerank,telomere maintenance (GO:0000723),0.3805603060492974,1.079336746344368,0.36395759717314485,0.7547708995052532,1.0,15/50,21.90%,PARP3;ZBTB48;DNA2;ATM;ATR;XRCC3;TERT;RIF1;SP100;LTO1;NSMCE2;PARP1;CTC1;TERF2IP;PRKDC
prerank,pore complex assembly (GO:0046931),-0.35357551772667406,-1.0793183805248296,0.313953488372093,0.7452704983862624,1.0,11/19,30.40%,PLEKHA7;ADAM10;TMEM170A;NUP93;NUP205;AFDN;AHCTF1;TSPAN33;BAD;NUP98;RTN4
prerank,heterocycle biosynthetic process (GO:0018130),-0.3960891156692492,-1.0793067308248492,0.3509933774834437,0.743194736862343,1.0,10/14,35.55%,GPHN;NOXRED1;NFS1;GCH1;PYCR2;MOCS3;PYCR3;LIAS;PYCR1;ALOX5
prerank,positive regulation of monooxygenase activity (GO:0032770),0.4395537442704101,1.0793060420802933,0.37926509186351703,0.7543376960415922,1.0,12/26,27.44%,NOS1AP;POR;APOE;CYP27B1;TERT;TNF;GDNF;ATP7A;PARK7;AKT1;TERF2;HIF1A
prerank,regulation of dendritic spine development (GO:0060998),-0.3680521063786006,-1.0790529302483924,0.35125448028673834,0.7418439812179064,1.0,9/19,15.68%,CPEB3;SHANK3;MEF2C;GRIN3A;LLPH;PPFIA2;NLGN1;CAMK1;TANC2
prerank,anterograde axonal transport (GO:0008089),0.4008239613467595,1.078659582392884,0.3610421836228288,0.7555578582872673,1.0,14/37,18.67%,AP3B1;TRAK1;RAB21;AP3S1;KIF1C;DTNBP1;KIF5B;RAB27B;MAPK8IP3;AP3D1;KIF5C;KIF3A;NEFL;KIF5A
prerank,insulin receptor signaling pathway (GO:0008286),-0.26225308263728603,-1.0786368021975052,0.33636363636363636,0.7408853716817239,1.0,13/69,8.27%,SORBS1;IGF1R;PIK3R3;GRB14;NAMPT;GAB1;C2CD5;CAV2;INSR;APC;FER;ATP6V1A;IGF2
prerank,positive regulation of gene expression (GO:0010628),0.3393716551241565,1.078613312337001,0.26753507014028055,0.7551700072928967,1.0,90/442,17.95%,GLMN;RBMS3;PRR16;SEC16B;ITGB8;BCL3;YAP1;ADAM19;NOS1AP;FGF20;SFRP4;CRP;TMEM119;TLR2;WNT5A;MITF;FGF7;TAF1D;PLD1;BATF;EGF;EPHX2;UBR5;FUBP1;TREM2;FGF9;PID1;TLE1;PLA2R1;CELF1;LIMS1;E2F1;ATM;PHF2;EIF2AK3;STAT3;EGFR;CD36;PIK3R1;POLR1E;SAMD4A;TGFBR1;LGALS9;IL33;OLFM1;VSTM2A;MAP2K1;DTNBP1;SPRY2;EMILIN1;ERP29;TNRC6B;YTHDF3;MAPK11;RPS6KB1;CALCOCO1;SETX;EIF2AK2;PTGER4;FGF2;FMR1;LAMTOR5;EPHB2;RBPJ;MSN;CTCF;POLR2K;SMAD3;IFNGR1;GSK3B;MAPK9;MOV10;NTRK3;GAPDH;NIBAN1;TNF;TADA3;PSEN1;DNMT3B;ANGPT1;PDCD10;ATF2;ROBO1;NAT10;ROCK2;NFE2L2;HGS;GABPA;SMO;SPHK2
prerank,mitochondrial fusion (GO:0008053),0.45695817972294794,1.0782738034459796,0.36063218390804597,0.7555543275603316,1.0,8/18,26.41%,STOML2;BAX;MIGA2;FIS1;SPG7;AFG3L2;MFN2;MIEF2
prerank,peptidyl-tyrosine modification (GO:0018212),0.38072540830177776,1.0779587611835821,0.369284876905041,0.7558761878977741,1.0,14/56,13.21%,PDGFRA;TEC;JAK2;PDGFRB;DDR2;BLK;FGFR1;EGFR;PTPN6;EPHA1;ABI1;EPHB2;PTK2;ABI2
prerank,positive regulation of calcium ion transport into cytosol (GO:0010524),0.41877460385059084,1.077922218236689,0.3844221105527638,0.755462478932838,1.0,8/32,19.78%,CEMIP;XCL1;P2RX5;CXCL10;THY1;CX3CL1;GRIN1;P2RX7
prerank,DNA recombination (GO:0006310),0.4013862486281695,1.0774050361833074,0.35990338164251207,0.7562968933697187,1.0,4/37,7.89%,RAD51B;RAD52;FBH1;XRCC3
prerank,cardiac atrium morphogenesis (GO:0003209),-0.38297764574979143,-1.0772742265682704,0.3333333333333333,0.7425390949108993,1.0,11/16,43.04%,PROX1;HEY2;ZFPM1;ENG;NOTCH2;NOTCH1;TBX20;NOG;MYH6;GATA4;ISL1
prerank,regulation of dopamine secretion (GO:0014059),0.43479480929004355,1.0764944553710027,0.38633377135348224,0.7581185323795483,1.0,7/25,16.77%,FGF20;SYT10;SYT2;DTNBP1;DRD3;SYT3;GDNF
prerank,endosome organization (GO:0007032),0.40032697592172534,1.0763616693613962,0.38031591737545567,0.757959572257618,1.0,11/41,11.49%,DNAJC13;ARFGEF2;SNX10;HOOK2;WASHC4;SNX33;DNM1;SQSTM1;PI4K2B;ALS2;EEA1
prerank,positive regulation of macromolecule metabolic process (GO:0010604),0.33991084503961044,1.0763604383864864,0.2972972972972973,0.7574540170989911,1.0,101/348,23.28%,RBMS3;SEC16B;ITGB8;YAP1;ADAM19;NOS1AP;FGF20;SFRP4;CRP;TMEM119;TLR2;WNT5A;MITF;FGF7;EGF;EPHX2;UBR5;FUBP1;TREM2;FGF9;PID1;TLE1;CELF1;LIMS1;E2F1;ATM;EIF2AK3;STAT3;CD63;CD36;TGFBR1;LGALS9;IL33;OLFM1;VSTM2A;MAP2K1;PTPN1;DTNBP1;SPRY2;EMILIN1;ERP29;TNRC6B;MAPK11;CALCOCO1;FGF2;FMR1;LAMTOR5;EPHB2;RBPJ;SETDB1;MSN;CTCF;SMAD3;IFNGR1;GSK3B;MAPK9;MOV10;NTRK3;TNF;TADA3;PSEN1;DNMT3B;ANGPT1;PDCD10;ATF2;ROBO1;ROCK2;PICK1;ITCH;NFE2L2;HGS;GABPA;SMO;TLR3;CTSH;ARRB1;NTF3;P2RX7;EPB41L4B;SETDB2;FGF18;DDX3X;FAM98A;MPHOSPH8;RESF1;ETS1;MED26;POU3F3;ANXA2;IGF1;DDRGK1;DTX3L;PARK7;ATF7IP;PRKAB1;BMP7;ZBTB7B;TWIST1;C1QTNF1;SOX11;MAPK1
prerank,positive regulation of lipid metabolic process (GO:0045834),0.4389051660697064,1.0761329840501748,0.3909348441926346,0.757541786880048,1.0,4/22,8.94%,ADIPOQ;APOE;ZBTB20;PPARG
prerank,regulation of transcription from RNA polymerase II promoter in response to stress (GO:0043618),0.3645217805168993,1.0759365141376749,0.3743257820927724,0.7575878774912794,1.0,9/86,9.76%,PSMA7;BACH1;DNAJB1;ARNT;INO80;CREBBP;PSMD4;BAG3;PSMD11
prerank,aortic valve morphogenesis (GO:0003180),0.4211789583552772,1.0755292238732532,0.38125802310654683,0.7581399188447795,1.0,5/30,3.90%,SNAI1;ROBO2;SLIT3;SNAI2;JAG1
prerank,arachidonate transport (GO:1903963),0.5194560976733451,1.0752180464723575,0.39622641509433965,0.7578951443397638,1.0,3/10,12.37%,PLA2G5;ANXA1;DRD3
prerank,arachidonic acid secretion (GO:0050482),0.5194560976733451,1.0752180464723575,0.39622641509433965,0.7578951443397638,1.0,3/10,12.37%,PLA2G5;ANXA1;DRD3
prerank,platelet aggregation (GO:0070527),0.40665078862913207,1.0750708621566523,0.3727735368956743,0.7577757666473869,1.0,8/33,17.01%,PDGFRA;CSRP1;MYH9;STXBP1;GNAS;METAP1;UBASH3B;STXBP3
prerank,ceramide catabolic process (GO:0046514),-0.38462649683249805,-1.0750631041248515,0.3434343434343434,0.7464984087953664,1.0,12/14,43.24%,ACER2;ASAH1;ASAH2;GM2A;ACER3;NEU2;HEXA;HEXB;NEU4;GLA;ACER1;NAGA
prerank,aromatic amino acid family metabolic process (GO:0009072),0.5267034146048349,1.075037107942783,0.4059097978227061,0.7573638346394648,1.0,5/10,21.20%,PCBD1;KYAT1;QDPR;ASRGL1;ATP7A
prerank,heterotypic cell-cell adhesion (GO:0034113),-0.3269297647961467,-1.0748705940278134,0.33079847908745247,0.7449415774902565,1.0,10/25,24.85%,CTNNA3;CD200;CXADR;ITGA4;VCAM1;DSG2;ITGA7;PKP2;DSP;ITGB2
prerank,serine family amino acid catabolic process (GO:0009071),0.5098954816170258,1.0743850656161684,0.39781591263650545,0.7585406079490332,1.0,3/10,16.52%,AMT;GLDC;THNSL2
prerank,regulation of chemokine (C-X-C motif) ligand 2 production (GO:2000341),0.4834822721988954,1.0741156557794893,0.4027355623100304,0.758765757846487,1.0,2/12,4.50%,LPL;TIRAP
prerank,phosphorylation (GO:0016310),0.3381104189178352,1.0735541985011117,0.3059177532597793,0.7597512389827558,1.0,116/385,24.65%,CCL11;EPHA7;RUNX3;NEK6;TAOK1;TEC;MAP4K4;AATK;JAK1;STK36;PRKCA;NUAK1;ERN2;PEAK1;JAK2;LRRK2;CAMK2D;IRAK3;PRKD2;COQ8B;XYLB;FGFR1;MAP4K5;ILF3;MARK1;CDK14;ATM;EIF2AK3;AKT3;IKBKE;STAT3;CDK10;PPP4R1;PLK1;TGFBR1;PXK;FAM20A;ACVR1B;ACVR1;PRKAR1B;CDK6;MAP2K1;CDK9;MERTK;CDK13;CDK7;CSNK1A1;FRK;NRK;GNPTG;MORC3;TAOK3;ACVR2A;EIF2AK2;PANK2;MAST2;FAM20C;EPHB2;DCLK1;NEK4;CCNT1;CSNK1D;CCL2;PI4KA;PIK3R4;HIPK3;GSK3B;MAPK9;DGKH;BRSK2;ABL1;GK;ROCK2;PICK1;ACVR1C;SPHK2;MAP3K6;HUNK;CSNK2A1;STK4;CAMK2B;CDK5;DAPK1;CSNK1G2;STK11;BRSK1;TGFB2;CDK11B;CDC42BPA;PKN1;PAK1;CDK16;TRIB1;PRKDC;SIK3;GMFB;MAP3K20;LATS2;ACVRL1;PRKAB1;STK25;STK24;YWHAZ;DAPK2;CDK12;GNPTAB;MAPK1;NRBP1;TGFB1;CDKL1;MAML1;MKNK1;GRK4;POMK;PRKCI;AKT1
prerank,very long-chain fatty acid biosynthetic process (GO:0042761),-0.3945859964064604,-1.0734680660441633,0.36716417910447763,0.746724519707407,1.0,7/13,20.18%,TECR;ELOVL5;ELOVL7;HACD3;HACD4;HACD1;TECRL
prerank,chemical synaptic transmission (GO:0007268),-0.22961666743911424,-1.0734118654161198,0.25,0.7448285689374989,1.0,69/284,15.82%,UNC13C;FCHSD2;SLC12A7;GRM7;SYN3;CACNB2;GRM1;GABRB1;KIF1B;NRXN1;GRID2;GRIK4;SNAP25;LIN7A;GLRA3;GABRA2;UNC13B;GRM3;SYNJ2BP;DLGAP1;KCND2;SLC12A6;SHISA6;GABRA5;CHRM2;DLGAP2;HTR1F;RIT2;DLG2;SLC1A1;PTCHD1;HTR2C;SLC6A1;CHRM3;HTR7;ATXN3;CALM1;GABRG3;GRIN2D;CACNA1B;GABRB2;LIN7C;SNAPIN;DTNA;ERC1;KCNQ3;NAAA;SLC1A2;CAMKK2;NRXN2;PTPRN2;CAMK4;GLRA2;GAD1;PRKAR2A;PCDHB14;BSN;CHRNB1;PRKAR1A;NLGN1;GRIN2B;SLC6A5;RIMS1;GABRG1;CAMK1;GAD2;DRD2;APBA2;CACNB4
prerank,DNA double-strand break processing (GO:0000729),0.4593653736497439,1.0733974211241315,0.40446304044630405,0.7596599373358316,1.0,6/18,16.18%,DNA2;RAD52;ATM;RNF138;SETMAR;RBBP8
prerank,myeloid cell differentiation (GO:0030099),0.38834997914790426,1.0733545554688082,0.3825265643447462,0.7592460583807167,1.0,4/47,4.51%,RUNX1;JAK2;TIRAP;CDKN2B
prerank,positive regulation of cellular component organization (GO:0051130),0.3577796448241123,1.0733099309536134,0.36363636363636365,0.758867799543081,1.0,17/107,12.85%,MMP3;RUNX1;LRP1;APOE;CALY;TIRAP;ASAP1;TREM2;BAX;TGFBR1;TGFB3;SLF2;LMAN1;CLIP3;FNIP1;ANAPC2;CD151
prerank,regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis (GO:1903587),-0.3798724220706799,-1.0731736450074607,0.36824324324324326,0.74343007668304,1.0,6/16,21.49%,PPP1R16B;THBS1;GATA2;JCAD;AGTR1;APLNR
prerank,positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770),0.5121277418895092,1.0727988867135965,0.38845553822152884,0.7597420147580961,1.0,4/10,13.55%,TLR2;JAK2;IL33;CCL2
prerank,positive regulation of nitric oxide metabolic process (GO:1904407),0.4268704686625756,1.0723160012799187,0.3905635648754915,0.7605134354070093,1.0,7/26,17.84%,NOS1AP;PKD2;TMEM106A;CD36;SMAD3;TNF;PTGS2
prerank,purine ribonucleotide biosynthetic process (GO:0009152),0.38672872114853407,1.0718434214548003,0.3730994152046784,0.7612351062348963,1.0,15/48,20.73%,ADCY7;DCAKD;PAPSS2;ADCY2;NPR2;ADSL;SLC25A16;GMPS;PANK2;SLC35B2;COASY;ACAT1;PANK4;PANK1;AMPD3
prerank,regulation of G protein-coupled receptor signaling pathway (GO:0008277),0.36304738621866683,1.0718335072364824,0.3741648106904232,0.7607550368571632,1.0,15/75,17.73%,SLC39A14;C3;RGS16;PPP1R9B;RNF157;CCL5;GUCA1B;ZDHHC3;METAP1;GNG7;TULP3;PDE6H;ROCK2;FNTB;RIC8B
prerank,regulation of metal ion transport (GO:0010959),0.4648242340411056,1.0712779874077711,0.3802612481857765,0.7617072218996326,1.0,3/16,4.53%,IL16;BCL2;CACNA2D1
prerank,nitrogen compound transport (GO:0071705),0.34942467316753456,1.07099451952165,0.35051546391752575,0.7619321936073071,1.0,24/141,14.75%,SLC7A2;TCN1;ARRDC4;SLC15A3;SLC38A3;SLC6A2;SLC25A47;MYH9;MIA3;LMAN2L;SLC7A7;SEC14L1;SLC38A4;RCN3;RAB7A;ARRDC3;SLC36A2;SLC7A11;PDPN;SLC7A8;TCN2;SLC1A5;SNX4;RUFY1
prerank,somite development (GO:0061053),0.5194478749715301,1.0708986237285023,0.39356814701378257,0.7616593070181474,1.0,5/11,17.85%,SFRP2;SHH;LOXL3;PTCH1;SMO
prerank,triglyceride metabolic process (GO:0006641),0.39137749966380364,1.0708111759638397,0.3780630105017503,0.7614059333240498,1.0,9/48,18.90%,LIPC;LPL;APOE;APOH;MOGAT3;GK;GPAM;FABP5;GPAT3
prerank,regulation of phosphorylation (GO:0042325),0.3526374950403892,1.0707831961220837,0.3608786610878661,0.7609772383365367,1.0,27/120,16.37%,GLMN;DYNLL1;NRP1;RAE1;EGF;CDKN2B;OGT;CDKN2D;NUP37;EGFR;CCL5;KDM4D;NUP153;DSCAM;SIRT2;NUP188;FNIP1;MCM7;PTK2;SDCBP;FLCN;NUP35;ATG14;NUP214;GCK;PRKRIP1;PSEN1
prerank,L-glutamate transmembrane transport (GO:0015813),0.513921972462737,1.0701490505756823,0.42289348171701113,0.7621385441066227,1.0,1/10,0.58%,SLC1A3
prerank,smoothened signaling pathway (GO:0007224),0.410046803931802,1.069911857509771,0.3915737298636927,0.7622389363830508,1.0,8/32,17.85%,GLI2;STK36;GLI3;SHH;ARL13B;CC2D2A;PTCH1;SMO
prerank,regulation of epidermal growth factor receptor signaling pathway (GO:0042058),0.3707408042116018,1.0697124548633554,0.3784090909090909,0.7622880356018541,1.0,21/65,20.17%,SH3KBP1;ERRFI1;PTPN3;EGF;EGFR;CBL;CDC42;MVP;SPRY2;GRB2;MVB12A;PDE6H;PTPN2;EPS15L1;ITGA1;PTPRJ;BTC;HGS;NEU3;EPS15;RHBDF1
prerank,"nucleotide-excision repair, preincision complex assembly (GO:0006294)",-0.3178261280568022,-1.0691859167888353,0.33766233766233766,0.7523253842193308,1.0,13/29,23.32%,ERCC5;ERCC3;CHD1L;GTF2H2;RBX1;UBC;XPC;GTF2H4;DDB2;UBA52;CETN2;RPA2;UBB
prerank,negative regulation of myeloid cell differentiation (GO:0045638),0.4474157643855156,1.0690348201496593,0.3870094722598105,0.763527970132603,1.0,5/20,9.47%,ZFP36L1;MEIS2;MAFB;MEIS1;CDK6
prerank,glucan catabolic process (GO:0009251),-0.38273959203428753,-1.0690186889015583,0.3644859813084112,0.7507025957664659,1.0,7/15,18.07%,PYGB;PGM2L1;CALM1;PYGM;PHKG1;PGM2;AGL
prerank,response to interferon-alpha (GO:0035455),-0.36370270581118036,-1.0685704498500097,0.36462093862815886,0.749848795931098,1.0,5/16,19.45%,ADAR;GAS6;BST2;PDE12;RO60
prerank,positive regulation of leukocyte cell-cell adhesion (GO:1903039),0.4284217936461445,1.0681596260202575,0.4007989347536618,0.765371198739592,1.0,9/27,20.62%,TNFSF11;MDK;SIRPA;THY1;CCL2;HSPD1;TNF;RHOA;ETS1
prerank,aortic valve development (GO:0003176),0.40467421268840853,1.0678199578938548,0.3951219512195122,0.7657020164464781,1.0,5/34,3.90%,SNAI1;ROBO2;SLIT3;SNAI2;JAG1
prerank,atrioventricular valve development (GO:0003171),0.47500961579821144,1.067226950686303,0.4005805515239477,0.7667140901046607,1.0,3/14,12.34%,SLIT3;ACVR1;HEYL
prerank,insulin-like growth factor receptor signaling pathway (GO:0048009),0.5046786176698096,1.0670086637615404,0.4208860759493671,0.7667532745506517,1.0,5/11,12.56%,GHR;IRS1;EIF2AK3;PIK3R1;GIGYF2
prerank,bicarbonate transport (GO:0015701),-0.3329397817913805,-1.0669788942837513,0.3,0.7521957971831092,1.0,12/25,21.03%,SLC4A10;SLC26A7;SLC39A8;CA4;SLC4A8;SLC4A3;CYB5R4;CA2;CYB5R1;SLC26A6;CYB5RL;CFTR
prerank,positive regulation of macrophage derived foam cell differentiation (GO:0010744),0.47212198331464617,1.066842690920115,0.38929088277858176,0.7666626352625451,1.0,6/15,18.42%,LPL;PLA2G5;CD36;NFKB1;MAPK9;MSR1
prerank,positive regulation of substrate adhesion-dependent cell spreading (GO:1900026),0.40609908053774746,1.0667918807544083,0.38642297650130547,0.7662916938903855,1.0,7/34,8.21%,NRP1;CARMIL1;MDK;RAC1;LIMS1;CDC42;DOCK1
prerank,calcium-mediated signaling (GO:0019722),0.3597829195160943,1.0667269966544604,0.3605514316012725,0.7659660248550573,1.0,19/93,13.08%,PPP1R9B;TNFSF11;SLC9A1;LRRK2;CACNA1C;ATP2A2;CCR1;STIMATE;EIF2AK3;EGFR;TNNI3;RCAN3;RCAN2;CXCR4;MCTP2;FKBP1B;PPP3CA;LAT2;SAMD14
prerank,regulation of MAPK cascade (GO:0043408),0.35009416950121036,1.0666685214454448,0.37104994903160043,0.7656055237834538,1.0,18/157,12.01%,ROR2;ROR1;EPHA7;TAOK1;IAPP;MAP4K4;ATP6AP2;EGF;TMEM106A;FGFR1;SPRED1;EGFR;NF1;PTPN6;MAP2K1;NRK;TAOK3;FGF2
prerank,platelet degranulation (GO:0002576),0.3511551773332227,1.0663424103604233,0.38010471204188484,0.765938729707185,1.0,17/118,10.64%,KNG1;SERPING1;SPARC;MAGED2;LHFPL2;PROS1;TIMP1;EGF;BRPF3;BLK;CD63;CD36;APOH;STXBP1;TGFB3;LAMP2;CLEC3B
prerank,membrane fusion (GO:0061025),-0.30458129248994537,-1.065971678879256,0.32105263157894737,0.7528326793705669,1.0,6/33,7.00%,DNM3;HUWE1;MYOF;HACE1;DYSF;GCA
prerank,establishment of spindle orientation (GO:0051294),0.4267787493840642,1.065851821027403,0.3979591836734694,0.7666764638371231,1.0,12/28,25.12%,MAD2L1;GPSM2;PLK1;LLGL1;FBXW11;INSC;MAP4;NDEL1;ITGB1;HTT;PAFAH1B1;NUMA1
prerank,peptidyl-tyrosine dephosphorylation (GO:0035335),0.40668404995105456,1.065713085469421,0.3790123456790123,0.7665300615589936,1.0,12/34,17.83%,DUSP2;DUSP5;PTPN13;DUSP18;PTPN6;PTPRZ1;PTPN1;PTPN18;PTPN2;UBASH3B;PTPRJ;PTPN9
prerank,monoacylglycerol metabolic process (GO:0046462),-0.3963995376704421,-1.065570556198259,0.38080495356037153,0.751941130067005,1.0,3/13,9.28%,MGLL;ABHD6;DGAT1
prerank,regulation of small GTPase mediated signal transduction (GO:0051056),0.3455416793324487,1.0654398964357754,0.37125129265770423,0.7667287706303654,1.0,29/140,14.35%,DLC1;VAV2;ARHGAP24;SYDE1;ARHGAP15;VAV3;RHOJ;RHOD;ARHGAP32;FGD4;OPHN1;KALRN;RAC1;SRGAP1;ITSN1;CDC42;TRIO;CGNL1;FOXM1;SQSTM1;ARHGDIG;AKAP13;PREX1;ARHGAP6;ARHGEF19;FAM13B;ARHGAP20;ARHGAP35;FLCN
prerank,negative regulation of lymphocyte activation (GO:0051250),0.4436534656134619,1.065196953742666,0.4096209912536443,0.7668549010338976,1.0,4/21,15.47%,TNFAIP3;FCGR2B;GPNMB;LST1
prerank,positive regulation of leukocyte mediated cytotoxicity (GO:0001912),0.42416233365349243,1.06516899349817,0.38939197930142305,0.7664128336095823,1.0,2/29,3.54%,IL23R;XCL1
prerank,regulation of exocytosis (GO:0017157),0.39210553660069103,1.0650808968234649,0.3902147971360382,0.7661097169521357,1.0,13/46,17.38%,UNC13D;RAB2B;ANXA1;RAB21;RAB8B;RALA;RAB10;RAB27B;RAB9A;RAB8A;CHMP3;CPLANE2;RAB12
prerank,C21-steroid hormone metabolic process (GO:0008207),-0.34765085853785554,-1.0649093161021905,0.32926829268292684,0.751685054239265,1.0,16/20,55.09%,STARD3NL;STAR;HSD17B10;TSPOAP1;TSPO;FDX1;FDX2;AKR1B1;CYP46A1;HSD3B2;AKR1C1;DHRS9;STARD3;AKR1D1;CYP11B1;CYP11A1
prerank,regulation of histone H3-K9 acetylation (GO:2000615),0.5222049332165178,1.0641060278755061,0.42362204724409447,0.7680977362993656,1.0,4/10,19.58%,KMT2A;HDAC5;SPHK2;SMARCB1
prerank,positive regulation of insulin secretion involved in cellular response to glucose stimulus (GO:0035774),-0.40547310973101625,-1.063983270057153,0.38392857142857145,0.7522818864023775,1.0,7/12,33.80%,ANO1;PLA2G6;PPP3CB;CFTR;BAIAP3;ADCY8;C2CD2L
prerank,peroxisome organization (GO:0007031),0.4249967218319458,1.0637637854037705,0.39176626826029215,0.7684491378247185,1.0,2/25,2.66%,SEC16B;PEX10
prerank,mitochondrion disassembly (GO:0061726),0.40678440690352563,1.063237862774349,0.39776951672862454,0.7692750085993066,1.0,7/34,10.11%,WIPI1;AMBRA1;ATG3;FBXO7;SQSTM1;FUNDC2;CTSK
prerank,regulation of sodium ion transmembrane transport (GO:1902305),-0.3211677997604112,-1.06200532764761,0.33783783783783783,0.7556331627747074,1.0,9/27,15.46%,SNTA1;FGF12;FXYD5;FXYD6;ATP2B4;FXYD1;NEDD4L;SCN4B;SLMAP
prerank,neuron fate commitment (GO:0048663),0.47955602082619525,1.0618071421262072,0.42232277526395173,0.7725126120843389,1.0,2/14,8.31%,SHH;TGFBR1
prerank,positive regulation of defense response to virus by host (GO:0002230),0.4339597669724393,1.0618007392602022,0.3880794701986755,0.7720275422331307,1.0,2/24,3.24%,IL23R;STAT1
prerank,proteasomal protein catabolic process (GO:0010498),0.3399961726484254,1.0617619780358911,0.3662258392675483,0.7716116841938347,1.0,62/201,23.15%,PSMA7;SPSB1;ERLEC1;KLHL22;SMURF2;SIAH2;RCN3;UBXN2A;PSMD4;APPBP2;AREL1;DDB1;PSMD11;ZSWIM8;SIRT2;BAG6;SPOP;TRIM13;PSMB8;RAD23A;KCTD2;PCNP;FBXW11;SMURF1;CLOCK;TBL1X;FBXW5;KCTD5;FBXW7;STUB1;MDM2;BRSK2;PSMA6;UBE2W;SYVN1;DCAF11;RBCK1;FBXO45;ITCH;NFE2L2;PSMD14;MAEA;SPSB3;KCTD10;PSMC6;PSMB10;ARRB1;UCHL1;PSMD12;PSMB1;NEDD4;PSMA8;IFI27;PSMF1;PPP2R5C;NR1D1;TNFAIP1;RAD23B;COP1;PSME2;DDIT3;PSMA4
prerank,regulation of vesicle-mediated transport (GO:0060627),0.354455589226501,1.0614500396784667,0.3890675241157556,0.771930755680832,1.0,23/91,17.38%,STON2;NRP1;LRRK2;PLD1;DNAJC13;RAB21;OPHN1;RAB8B;GAS1;RALA;RAB10;MAP2K1;PTPN1;ARFGAP1;SCFD1;RUFY1;ABL1;ZFYVE16;RINT1;RAB8A;CHMP3;CPLANE2;RAB12
prerank,regulation of cell cycle G1/S phase transition (GO:1902806),0.4080301694907236,1.0613691861721979,0.40224159402241594,0.7716330088182242,1.0,14/33,26.37%,PTEN;INO80;E2F1;PTPN6;FBXW7;EZH2;TCIM;CDC73;DDRGK1;PSME2;CDKN1B;MN1;GLI1;APPL2
prerank,regulation of cellular macromolecule biosynthetic process (GO:2000112),0.33417194960592456,1.0612398895239823,0.3336673346693387,0.7714664997394098,1.0,93/366,21.77%,RORA;RUNX3;POU5F1;CXXC1;SBNO2;ATXN1;BACH1;CHD7;CCAR1;ATXN2;SUFU;MITF;SNAI2;MAFB;PRRX2;GON4L;SOX21;DVL2;YAF2;ZBTB38;E2F1;NFKB2;PHF1;MYBL1;PRDM2;STAT3;CREBBP;CARM1;RBM4B;TGFBR1;UBE2L3;NONO;ACVR1B;FOXK2;TCF7;NSD3;BHLHE40;NR1D2;FBXO5;AHR;ATRX;TOM1L1;WWTR1;MAGED1;FADS1;METAP1;CCAR2;BTG1;TCF3;TCF7L1;CLOCK;TGIF2;NUCKS1;NSD1;PHF12;NFXL1;FOXN2;NUP35;NR2C2;PRMT5;TULP3;ABL1;EZH2;ZNF35;ATF2;HCFC2;PUM3;SKOR2;SPI1;KMT2D;WTIP;NAB2;SSBP2;SPTY2D1;DVL1;FOXO3;BAZ2A;LIN54;PATZ1;TGFBRAP1;YBX1;DRAP1;HP1BP3;CALR;CDK11B;ZFHX3;SAP30L;HINT1;TERF2IP;NOLC1;SP3;FUS;ZSCAN21
prerank,mRNA modification (GO:0016556),0.4399006798889827,1.061167985489966,0.3962516733601071,0.771154019295017,1.0,5/22,13.96%,TRUB2;TRMT61B;ZC3H13;METTL16;PUS3
prerank,vesicle transport along microtubule (GO:0047496),0.4233129597925809,1.0608289025603201,0.4149933065595716,0.7715181284851474,1.0,14/23,24.78%,TRAK1;DYNC1H1;KIF1C;KIF5B;FBXW11;KIF3A;KIFAP3;KIF5A;CLN3;NDEL1;RAB1A;HTT;PAFAH1B1;FYCO1
prerank,regulation of viral entry into host cell (GO:0046596),0.4171778389701424,1.0606990613499367,0.4128787878787879,0.7713573766185342,1.0,5/30,13.00%,TRIML2;TRIM21;LGALS9;TRIM11;TRIM62
prerank,amino acid import (GO:0043090),-0.3492588053842621,-1.0602857087151223,0.33840304182509506,0.7585358105259062,1.0,5/21,6.18%,SLC6A6;SLC47A1;SLC1A1;SLC7A5;SLC6A1
prerank,negative regulation of protein localization to membrane (GO:1905476),0.4310392894533273,1.0593621837450637,0.412483039348711,0.7743036349738245,1.0,4/24,13.85%,CLTC;PID1;PPP2R5A;ITGB1BP1
prerank,peptidyl-lysine methylation (GO:0018022),0.42524591994422417,1.0590682354194179,0.41534391534391535,0.7745037977287447,1.0,6/26,15.59%,KMT5A;EHMT1;ANTKMT;ETFBKMT;SETD7;VCPKMT
prerank,ceramide metabolic process (GO:0006672),-0.2736930864240373,-1.05869629598705,0.3225806451612903,0.7608494324936059,1.0,9/49,5.71%,ST6GALNAC3;SGMS2;SGMS1;CERS4;ACER2;SPTLC2;DEGS2;SPTLC1;PPP2R1A
prerank,regulation of protein kinase C signaling (GO:0090036),0.46545280177221204,1.0581050718281788,0.41142020497803805,0.7764937083972873,1.0,5/14,17.95%,WNT5A;CD40;ADGRV1;MC1R;SPHK2
prerank,negative regulation of kinase activity (GO:0033673),0.3737941457146044,1.0576035723936428,0.3925759280089989,0.777223234294329,1.0,31/62,26.92%,GSKIP;SPRED1;NPRL2;NF1;TAF7;EPHA1;PPP2R5A;DTNBP1;TARBP2;WWTR1;PYDC1;THY1;LRP6;ITGB1BP1;RTRAF;UBASH3B;PRKRIP1;SMCR8;TRIB3;DVL1;TRIM27;TRIB1;PARK7;YWHAG;TSC2;AKT1;PDPK1;CDKN1B;GNAQ;WARS1;PTPRC
prerank,"regulation of gene expression, epigenetic (GO:0040029)",0.36599451941102756,1.0574350674404822,0.3984375,0.7771213876783806,1.0,28/73,24.76%,GLMN;TAF1D;CGGBP1;PHF1;PHF2;POLR1E;HDAC5;CTCF;POLR2K;EZH2;DNMT3B;SPI1;TFAP2C;SPHK2;TRIM27;RBBP4;JARID2;POLR1B;MPHOSPH8;SF3B1;WBP2;PPM1D;TBP;POLR2L;AEBP2;TAF1A;DNMT3A;CREBZF
prerank,ncRNA transcription (GO:0098781),0.4875210448543091,1.0573614196013885,0.4255952380952381,0.7767975242237698,1.0,5/13,21.10%,USPL1;SNAPC3;GTF3A;RPAP2;SIRT7
prerank,positive regulation of glucose transmembrane transport (GO:0010828),0.4285504617685496,1.0572189163862786,0.3943089430894309,0.7766507506385902,1.0,4/26,7.45%,C3;ADIPOQ;IRS1;PIK3R1
prerank,pseudouridine synthesis (GO:0001522),0.48123289902380717,1.057171403866465,0.3924963924963925,0.7762743105449049,1.0,4/13,13.96%,TRUB2;NHP2;PUS7L;PUS3
prerank,"nucleotide-excision repair, DNA duplex unwinding (GO:0000717)",-0.34580886275911926,-1.0571276431044452,0.33955223880597013,0.7632273363611249,1.0,11/22,23.32%,ERCC3;CHD1L;GTF2H2;RBX1;UBC;XPC;GTF2H4;DDB2;UBA52;CETN2;UBB
prerank,endoplasmic reticulum tubular network organization (GO:0071786),-0.3726057261839392,-1.0571003160084704,0.3894080996884735,0.7612816329542339,1.0,5/15,8.14%,ARL6IP1;REEP1;RAB18;ZFYVE27;TMEM170A
prerank,regulation of histone deacetylation (GO:0031063),0.481536119815272,1.0567682937330019,0.4222873900293255,0.776807866853336,1.0,6/13,22.88%,CAMK2D;NIPBL;AKAP8L;SPHK2;PRMT6;ZBTB7B
prerank,regulation of phagocytosis (GO:0050764),0.3706422206763091,1.0567592478180723,0.4057623049219688,0.7763273454530324,1.0,10/53,15.60%,ADIPOQ;TLR2;PLA2G5;PRTN3;TREM2;FCGR2B;MERTK;SIRPA;TUB;TNF
prerank,cell junction assembly (GO:0034329),0.3483916044668924,1.0567316998502936,0.40216216216216216,0.7759026361638051,1.0,29/100,17.36%,CDH11;VMP1;SLITRK6;FARP1;FLNC;PCDHB6;PCDHB16;SDK2;ADGRL3;PTEN;FSCN1;OPHN1;LIMS1;CDC42;DCHS1;DBNL;OBSL1;PLXND1;DSCAM;CDH6;CAPZA1;SDK1;FLCN;GJC1;CDH18;CDH24;CTNND2;FBLIM1;RHOA
prerank,regulation of cellular response to stress (GO:0080135),0.3479985519648914,1.0565274832907463,0.37735849056603776,0.7758938067815146,1.0,29/115,19.24%,NEK6;NUAK1;RAE1;CAMK2D;AIFM2;DNAJB1;DNAJC7;ATM;NUP37;ATR;CREBBP;DNAJB6;BAG3;RPTOR;NUP153;HSPH1;NUP188;CCAR2;NEK4;NUP35;GSK3B;BAG4;NPAS2;ABL1;NUP214;ROCK2;CAMK2B;CLN3;RSL1D1
prerank,regulation of phospholipase C activity (GO:1900274),-0.36620900173250676,-1.056503019418307,0.3662420382165605,0.7609270250522709,1.0,4/15,2.57%,FLT1;BICD1;KIT;ESR1
prerank,positive regulation of transcription from RNA polymerase II promoter in response to stress (GO:0036003),0.43164898132386875,1.0561253788391074,0.40324763193504737,0.7764561170022644,1.0,2/24,2.42%,CREB3L1;CREB3L3
prerank,glycogen catabolic process (GO:0005980),-0.3767633211739529,-1.0555713092457266,0.38390092879256965,0.7615288143047626,1.0,7/15,18.07%,PYGB;PGM2L1;CALM1;PYGM;PHKG1;PGM2;AGL
prerank,regulation of histone acetylation (GO:0035065),0.40934583298804256,1.0552174739738442,0.43012048192771085,0.7782435097257809,1.0,14/33,26.14%,KMT2A;TAF7;HDAC5;TADA2B;NOC2L;GLYR1;FLCN;SPI1;ARRB1;PARK7;IWS1;TADA2A;PAXIP1;THAP7
prerank,chromatin remodeling (GO:0006338),0.35471189280176824,1.0549934814475,0.40084835630965004,0.7783293609384738,1.0,33/100,22.56%,POLE3;SATB2;BAZ1A;BAZ2B;INO80;SMARCC1;ARID1B;HDAC1;MTA2;KDM4D;SMARCD3;MBD2;HDAC5;TADA2B;CHD8;ATRX;GATAD2B;BAHD1;RSF1;MYSM1;MPND;RUVBL1;HCFC2;SRCAP;BAZ2A;RBBP4;SMARCB1;SMARCA4;JARID2;PAK1;SMARCC2;GATAD1;ZBTB7A
prerank,mitotic spindle organization (GO:0007052),0.34150581495160215,1.0549454019259135,0.38485158648925283,0.7779471503682475,1.0,25/153,14.03%,NEK6;TAOK1;DYNLL1;KIFC1;MAD2L1;EML4;SMC1A;CENPQ;DYNC1H1;NEK9;STAG1;GPSM2;CENPN;STAG2;NUP37;TUBG1;KIF2A;PLK1;INCENP;B9D2;RCC1;TPX2;KPNB1;SPC25;MAP4
prerank,keratan sulfate biosynthetic process (GO:0018146),0.41886439829845334,1.0548904177135046,0.4005167958656331,0.7776025254666454,1.0,5/26,7.06%,LUM;B4GALT5;ST3GAL3;SLC35D2;PRELP
prerank,vascular endothelial growth factor signaling pathway (GO:0038084),-0.39228863176914636,-1.054663736152131,0.3630573248407643,0.762106122499971,1.0,6/14,12.85%,GAB1;KDR;VEGFD;PIK3CD;FLT4;PGF
prerank,organic acid transport (GO:0015849),0.357955987798953,1.0542366714128566,0.3926645091693635,0.7788000683339938,1.0,18/94,15.47%,NR1H4;SLC7A2;SLC38A3;SLC25A47;SLC10A6;ATP8B1;SLC7A7;SLC38A4;SLC13A5;SLC27A4;SLC36A2;SLC7A11;SFXN5;PDPN;SLC7A8;SLC1A5;SLC10A1;SLCO1B1
prerank,negative regulation of Rho protein signal transduction (GO:0035024),0.4530644212670091,1.0541443097411833,0.4341736694677871,0.7785367081549824,1.0,5/18,18.29%,DLC1;ARHGAP35;FLCN;ITGA3;KCTD10
prerank,nucleic acid metabolic process (GO:0090304),0.3647213498902442,1.0541235729411322,0.42524916943521596,0.778091217260247,1.0,21/69,23.08%,ENPP1;ATXN2;DNA2;GTF2F2;WDR74;MMS19;RBFOX2;POLR2K;SETMAR;NCBP2;POLR2B;HNRNPK;DNASE1L2;HNRNPH2;POLG;GTF2F1;DXO;HNRNPA2B1;RBMX;DDX1;POLR2L
prerank,negative regulation of telomere maintenance (GO:0032205),0.4640273989871506,1.0538823115918,0.40956651718983555,0.7781642825501043,1.0,6/15,21.23%,ATM;PINX1;SMG6;TNKS2;PARP1;TERF2IP
prerank,transcription-coupled nucleotide-excision repair (GO:0006283),-0.2565881362319265,-1.0537476182098053,0.3,0.7626638663585352,1.0,33/72,27.83%,ERCC5;AQR;ERCC3;ERCC6;EP300;COPS5;POLR2H;GTF2H2;RBX1;PCNA;POLR2G;POLR2F;UBC;PRPF19;UVSSA;POLK;ERCC1;ISY1;COPS4;POLR2E;GTF2H4;RFC3;POLR2A;UBA52;RFC2;POLD2;RPA2;UBB;POLR2J;PPIE;RFC4;RPA3;POLD4
prerank,positive regulation of interferon-gamma production (GO:0032729),0.3850883576321148,1.0535860209164736,0.4002361275088548,0.7784128863103983,1.0,6/48,10.63%,IL23R;CD276;IL1R1;LGALS9;TLR7;CD14
prerank,regulation of cytosolic calcium ion concentration (GO:0051480),0.3415071959809227,1.0534402141554848,0.39604989604989604,0.7783015542624055,1.0,30/142,19.14%,KNG1;PDGFRA;CACNA1A;IAPP;WNT5A;CMKLR1;EDNRA;CACNA1C;CCR1;CD36;PTGDR;TRPC6;ATP2B1;S1PR3;FZD9;CXCR4;DLG4;FKBP1B;PTGER4;DRD3;SMAD3;LPAR3;ABL1;NPTN;LPAR2;LPAR1;TRPM4;FIS1;SPPL3;CLN3
prerank,long-term synaptic potentiation (GO:0060291),-0.3419732793949737,-1.053350368929509,0.35507246376811596,0.7617863667228637,1.0,6/21,16.22%,SLC24A2;PRKCZ;SLC8A3;GRIN2D;GRIN2B;SLC8A2
prerank,regulation of endocytic recycling (GO:2001135),-0.41749446406860535,-1.053113668364299,0.40625,0.7604364715754752,1.0,2/11,1.25%,INPP5F;ACTN2
prerank,positive regulation of developmental growth (GO:0048639),-0.2730330123073799,-1.053036337707468,0.3402777777777778,0.7586389632335516,1.0,15/49,14.50%,ITSN2;SEMA7A;PLCB1;ZFYVE27;TWF2;INSR;SEMA4D;AGRN;SHTN1;RIMS2;BDNF;LIMK1;NTN1;RIMS1;NEDD4L
prerank,positive regulation of blood coagulation (GO:0030194),0.4495305395995853,1.052822579148656,0.3904494382022472,0.7793971139789069,1.0,3/17,9.14%,USF1;APOH;HPSE
prerank,negative regulation of phosphorylation (GO:0042326),0.3555731061047177,1.0526649688221617,0.40286975717439294,0.7792958387485847,1.0,33/85,25.37%,FBLN1;DYNLL1;LRRK2;CDKN2B;PID1;PTEN;PTPN13;CDKN2D;NPRL2;ZBED3;IBTK;WWTR1;SIRPA;EPHB2;LRP6;NTRK3;NIBAN1;ATG14;PRKRIP1;PLPP3;CORO1C;CDK5RAP3;TERF2IP;PRKDC;PARK7;BMP7;XDH;TGFB1;FKBP8;NUPR1;ANKLE2;CDKN1B;INHBA
prerank,regulation of cell cycle (GO:0051726),0.33493337727474104,1.0524807351747285,0.3667334669338677,0.7792895289126264,1.0,68/271,21.22%,FAP;RUNX3;NEK6;TCF7L2;PPP1R9B;EIF4G2;SFRP1;BIRC3;RASSF1;GATA6;IRF1;CDKN2B;PKD2;CSNK2A2;CDKN2D;NF2;TMEM8B;ATM;STAT3;CDK10;PES1;SND1;TRIM21;CKS1B;PLK1;TGFBR1;FOXM1;CDK6;BIN1;MAP2K1;CDK9;PUM1;FBXO5;CDK7;FZD9;SIRT2;WHAMM;CDC14B;RAD23A;SETMAR;SMAD3;LRP6;SDCBP;JUNB;CDC25A;CCNB2;MDM2;ABL1;SON;WDR6;LIN9;RNF40;NLRP2B;TBX3;MAEA;CSNK2A1;CDK5;LIN54;RBBP4;STK11;TBRG4;TGFB2;GBF1;CALR;CDK11B;FBXL12;CDK5RAP3;HBP1
prerank,regulation of cellular protein metabolic process (GO:0032268),0.3814077853061577,1.0524696118990973,0.40581395348837207,0.7788198812860224,1.0,19/47,26.40%,ATXN2;APOE;SSH1;RBM4B;NFKB1;METAP1;PUM3;FOXO3;WDR91;NOLC1;RBM3;CYFIP1;TGFB1;AGT;EIF4G1;AKT1;INHBA;GEMIN5;CSF1
prerank,regulation of isotype switching (GO:0045191),0.4694457289787658,1.0522694509793276,0.4088235294117647,0.778788231524301,1.0,4/14,16.39%,PARP3;SHLD3;RIF1;HMCES
prerank,regulation of protein localization to plasma membrane (GO:1903076),0.35938768841996305,1.052080759606982,0.371523915461624,0.7787914602078863,1.0,17/78,15.60%,CLTC;LRP1;MMP14;NKD2;TREM2;PID1;EGFR;PIK3R1;SQSTM1;PPP2R5A;VPS4A;KIF5B;CLIP3;EPHB2;SPTBN1;ITGA3;TNF
prerank,positive regulation of cellular biosynthetic process (GO:0031328),0.33545340593419865,1.0519754223465263,0.3987667009249743,0.7785673965127814,1.0,30/166,15.60%,PRR16;ZEB2;BCL3;GLI2;NOS1AP;PDGFRB;DNA2;PLD1;EGF;IRS1;ARNT;BRPF3;PRKD2;PKD2;EGFR;CD36;CCL5;SAMD4A;SLC25A37;DDB1;NMD3;YTHDF3;RPS6KB1;FGF2;FMR1;SMAD3;PTH1R;PTPN2;NIBAN1;TNF
prerank,ribosomal subunit export from nucleus (GO:0000054),0.479673611629857,1.0517400540765816,0.40902255639097745,0.7786515093384191,1.0,3/13,12.76%,ABCE1;NMD3;NOP9
prerank,positive regulation of embryonic development (GO:0040019),0.4453539247580143,1.0516192448025208,0.41954022988505746,0.7784796494032623,1.0,4/19,14.87%,B4GALT5;TENM4;ZBED3;NR2C2
prerank,histone H4 deacetylation (GO:0070933),0.504083721792577,1.0516115587041264,0.4330708661417323,0.7780011649673507,1.0,4/10,11.57%,RCOR1;HDAC1;SIRT2;HDAC3
prerank,regulation of transcription from RNA polymerase II promoter in response to hypoxia (GO:0061418),0.3623451109619445,1.0515798492658062,0.42024202420242024,0.7775855362332983,1.0,21/74,23.15%,PSMA7;BACH1;ARNT;CREBBP;PSMD4;PSMD11;SIRT2;PSMB8;RBPJ;PSMA6;NFE2L2;PSMD14;PSMC6;PSMB10;PSMD12;PSMB1;PSMA8;PSMF1;RPS27A;PSME2;PSMA4
prerank,transcription elongation from RNA polymerase II promoter (GO:0006368),-0.25541328527057683,-1.051103249308605,0.3181818181818182,0.7619908191354541,1.0,19/62,19.58%,MLLT3;ELOC;NELFB;CTR9;ERCC3;EAF2;LEO1;SSRP1;POLR2H;GTF2H2;POLR2G;POLR2F;CCNK;ELOB;SUPT4H1;POLR2E;GTF2H4;NELFE;POLR2A
prerank,regulation of macrophage cytokine production (GO:0010935),0.4797619052867895,1.0509552327630194,0.411144578313253,0.7786791284011306,1.0,7/13,24.98%,WNT5A;IRAK3;TGFB3;CUEDC2;TGFB2;TGFB1;GPRC5B
prerank,phosphatidylinositol dephosphorylation (GO:0046856),-0.33361500754786216,-1.050050123555564,0.38114754098360654,0.7628283971097232,1.0,8/23,18.45%,INPP5F;MTMR10;INPP5K;MTMR11;OCRL;SYNJ1;MTMR7;MTMR12
prerank,organic hydroxy compound transport (GO:0015850),0.3967284145927346,1.049921176972319,0.4050314465408805,0.78084650758809,1.0,7/36,15.47%,NR1H4;SLC10A6;ATP8B1;NPC2;STRA6;SLC10A1;SLCO1B1
prerank,presynapse organization (GO:0099172),0.5003758596917113,1.0497003598827082,0.41148325358851673,0.7808954998003296,1.0,2/10,8.58%,WNT5A;FZD1
prerank,regulation of synapse assembly (GO:0051963),0.38103248320938926,1.0495591837784382,0.4085005903187721,0.7807640450837107,1.0,6/46,4.89%,ROBO2;GPC6;SLIT1;MDGA1;TLR2;EPHB3
prerank,phospholipase C-activating G protein-coupled receptor signaling pathway (GO:0007200),-0.25601018254292796,-1.0491502138915763,0.358974358974359,0.7634128331682165,1.0,35/76,33.11%,PLCE1;GRM1;ADRA1B;ACTN2;ESR1;GNA11;CHRM2;HTR2C;ADRA1A;ANO1;ADRA2A;GNA14;LPAR4;PTGER3;DRD2;GRM5;P2RY6;OPRM1;GPR4;AGTR1;CCKBR;CALCA;P2RY1;CX3CR1;NMBR;GPR35;LHCGR;NMUR2;TGM2;F2R;GRPR;CHRM1;F2RL2;GPR20;OPRL1
prerank,positive regulation of cell-cell adhesion (GO:0022409),0.387730824794819,1.0487072710968524,0.4022140221402214,0.7824432986367087,1.0,11/41,18.52%,ADAM19;JAK1;TNFSF11;MDK;CCL5;GCNT2;THY1;TNF;CX3CL1;PTPN23;PLPP3
prerank,RNA polyadenylation (GO:0043631),-0.3170324961013945,-1.0486451264646592,0.3657587548638132,0.7609082607849765,1.0,9/26,26.68%,WDR33;LEO1;CPSF2;TUT1;CLP1;PAPOLB;SCAF8;TENT2;PABPC1
prerank,mRNA polyadenylation (GO:0006378),-0.3170324961013945,-1.0486451264646592,0.3657587548638132,0.7609082607849765,1.0,9/26,26.68%,WDR33;LEO1;CPSF2;TUT1;CLP1;PAPOLB;SCAF8;TENT2;PABPC1
prerank,regulation of protein polymerization (GO:0032271),-0.300088947066769,-1.0485809640243888,0.35353535353535354,0.7591579639407575,1.0,5/35,4.54%,FCHSD2;ARHGAP18;MAP2;ESAM;ARHGAP28
prerank,regulation of axonogenesis (GO:0050770),0.36441141063724736,1.0485528851070554,0.4023529411764706,0.782336486512914,1.0,14/51,17.36%,ROBO2;AMIGO1;EPHB3;PLXNC1;PTEN;PLXND1;PLXNA3;THY1;KIF13B;ARHGAP35;GSK3B;BRSK2;ROBO1;RHOA
prerank,positive regulation of developmental process (GO:0051094),0.33935317133802134,1.0483693170214448,0.38699690402476783,0.7823296155914422,1.0,41/164,18.99%,DCN;EDN3;SOX5;B4GALT5;PTN;SYDE1;TMEM119;WNT5A;APOE;BMP1;FGFR1;SMURF2;SHH;DVL2;MDK;BMP5;SPIRE1;ACVR1B;ACVR1;RALA;ZBED3;FBXO5;SHLD3;DLG4;XBP1;FMR1;ANAPC2;DLG5;RIF1;NR2C2;PHLDB1;PHLDB2;TNF;PSEN1;HMCES;GDNF;RPS6KA3;TRPM4;FIS1;DVL1;CAMK2B
prerank,regulation of wound healing (GO:0061041),0.3897379422485842,1.0483039594406347,0.40047675804529204,0.7819896256433941,1.0,9/42,13.07%,TNFAIP3;CASK;VTN;ANXA1;TNFRSF12A;FGF2;MYLK;EPHB2;PTK2
prerank,positive regulation of protein targeting to membrane (GO:0090314),0.4292417954446176,1.047894362050831,0.41310160427807485,0.7825478341842624,1.0,1/24,0.38%,CEMIP
prerank,positive regulation of cartilage development (GO:0061036),0.4522424019749245,1.0476974859713215,0.42411347517730497,0.7825499579457778,1.0,3/17,6.13%,SOX5;BMP1;MDK
prerank,regulation of synapse maturation (GO:0090128),-0.41786589413752234,-1.0469849535615425,0.40336134453781514,0.761649206432521,1.0,3/10,7.46%,NRXN1;ARHGEF15;RELN
prerank,positive regulation of glycoprotein biosynthetic process (GO:0010560),0.4758293407223574,1.0468970440876366,0.43894899536321486,0.784096137656464,1.0,3/13,8.61%,ABCA2;SOAT1;IL33
prerank,positive regulation of calcineurin-NFAT signaling cascade (GO:0070886),0.47763968343220226,1.0466757181581934,0.4122137404580153,0.7836578205038105,1.0,6/12,21.72%,SLC9A1;STIMATE;TNF;CHERP;SPPL3;IGF1
prerank,positive regulation of calcineurin-mediated signaling (GO:0106058),0.47763968343220226,1.0466757181581934,0.4122137404580153,0.7836578205038105,1.0,6/12,21.72%,SLC9A1;STIMATE;TNF;CHERP;SPPL3;IGF1
prerank,cellular response to heat (GO:0034605),-0.29973170678615163,-1.0465159152485968,0.39893617021276595,0.7609872233607239,1.0,10/35,19.03%,FGF1;ATXN3;THBS1;ANO1;HSP90AB1;TRPV4;HSF1;HTRA2;HIKESHI;IER5
prerank,Ras protein signal transduction (GO:0007265),0.3435259332047929,1.0463795279220687,0.40332640332640335,0.7838949883408272,1.0,30/137,13.34%,COL1A2;FARP2;RASSF1;RHOD;PLD1;RAP2A;BRAP;TAX1BP3;GPSM2;CDC42EP4;RAC1;AIF1;RAB42;NF1;DBNL;RALA;ARHGDIG;RALGDS;CTNNAL1;RTKN;MAPK11;GRB2;CDC42EP5;ARHGAP6;FGF2;SETDB1;PDPN;RERG;ABI2;KPNB1
prerank,lysosome organization (GO:0007040),0.3957990989609546,1.0459278065151096,0.4111111111111111,0.7845848857227468,1.0,10/36,20.17%,ABCA1;LRRK2;CLN6;HOOK2;MYO7A;GAA;ARSB;CLN3;TPCN2;HOOK3
prerank,positive regulation of response to wounding (GO:1903036),0.4272882646811468,1.0457918716886017,0.4102902374670185,0.7844268045387461,1.0,6/24,13.07%,PTN;VTN;ANXA1;MDK;MYLK;PTK2
prerank,positive regulation of protein localization to nucleus (GO:1900182),0.3666741235580684,1.0455629102848254,0.4126984126984127,0.7845133016246453,1.0,15/66,13.71%,YAP1;CCT8;UBR5;EIF2AK3;PINX1;PIK3R1;PLK1;BAG3;NMD3;WWTR1;HDAC3;ZIC1;TERT;LAMTOR5;SMAD3
prerank,post-Golgi vesicle-mediated transport (GO:0006892),0.3528595644821262,1.0455591869356071,0.4197002141327623,0.7840289664182102,1.0,19/88,12.29%,CLTC;MYO1B;AP4M1;STEAP2;DNAJC6;TXNDC5;MYO5A;ARFGEF2;CLINT1;RABIF;EXOC4;VPS13C;RAB10;LLGL1;PUM1;ACBD3;DTNBP1;CCDC93;SCFD1
prerank,axon guidance (GO:0007411),0.3330452931992246,1.0455288631987465,0.3894523326572008,0.7836099806651756,1.0,34/201,11.38%,EPHA7;LAMA2;CXCL12;PALLD;GLI2;ROBO2;LAMA1;PRKCA;NRP1;SLIT3;SLIT1;SH3KBP1;GAB2;WNT5A;EFNA4;EPHB3;PLXNC1;SHH;OPHN1;RAC1;FRS2;PDLIM7;PIK3R1;SPTBN5;PLXND1;EPHA1;SEMA3E;DSCAM;EFNA5;CXCR4;L1CAM;KIF5B;GRB2;PLXNA3
prerank,positive regulation of cysteine-type endopeptidase activity (GO:2001056),-0.2677192601461812,-1.0452669832548425,0.35294117647058826,0.7625200020524856,1.0,17/57,17.12%,CYFIP2;MAP3K5;TNFSF10;NDUFA13;GRAMD4;ARL6IP5;PERP;BCAP31;TTBK1;AIM2;MALT1;GRIN2B;GPER1;SOX7;SYK;SIRT1;HTRA2
prerank,protein modification by small protein removal (GO:0070646),0.3344074878307539,1.0446179311226593,0.39354187689202824,0.7853913193529266,1.0,67/252,22.69%,PSMA7;TNIP1;TNFAIP3;OTULINL;ASXL1;BIRC3;USP9X;SMAD2;USPL1;USP24;OGT;USP42;SMURF2;PTEN;USP38;INO80;COPS7A;BABAM2;CCP110;SIAH2;USP40;USP3;ASXL2;TGFBR1;PSMD4;IL33;FOXK2;PSMD11;USP14;TADA2B;SENP6;PSMB8;RAD23A;TRAF2;USP22;VCPIP1;SMAD3;OTUD3;USP47;CDC25A;YY1;MYSM1;MDM2;TADA3;PSMA6;TAF9B;RUVBL1;RHOA;PSMD14;HGS;USP12;PSMC6;PSMB10;UCHL1;PSMD12;PSMB1;SENP5;COPS6;PSMA8;PSMF1;NFRKB;JOSD2;RPS27A;RAD23B;TNIP2;PSME2;USP34
prerank,negative regulation of interleukin-1 production (GO:0032692),0.42414282061158165,1.044487018163738,0.4201101928374656,0.7852164166822363,1.0,8/23,25.91%,TNFAIP3;PYDC1;CX3CL1;NLRP2B;IGF1;CARD16;CPTP;NLRP12
prerank,regulation of cellular response to heat (GO:1900034),0.35811767441682146,1.0444125523426424,0.4043956043956044,0.7849176654357877,1.0,19/77,15.96%,RAE1;CAMK2D;DNAJB1;DNAJC7;ATM;NUP37;ATR;CREBBP;DNAJB6;BAG3;RPTOR;NUP153;HSPH1;NUP188;CCAR2;NUP35;GSK3B;BAG4;NUP214
prerank,positive regulation of myeloid leukocyte cytokine production involved in immune response (GO:0061081),-0.3781540111260132,-1.0443041306861593,0.39263803680981596,0.7631816311645078,1.0,5/14,16.81%,KIT;SEMA7A;MAVS;CAMK4;SIRT1
prerank,long-chain fatty acid metabolic process (GO:0001676),0.3605581778666684,1.044162002612576,0.40249433106575966,0.7850571293391442,1.0,10/64,12.26%,CYP1B1;EPHX2;ACOX1;ACSL4;SLC27A2;SLC27A4;CYP1A1;ELOVL6;AIG1;FADS1
prerank,ethanol metabolic process (GO:0006067),-0.3939822805304872,-1.0437823541724243,0.3905325443786982,0.7626096484942851,1.0,5/12,18.08%,ALDH1A1;ACSS1;ACSS2;ALDH2;SULT1A1
prerank,purine nucleoside monophosphate biosynthetic process (GO:0009127),0.4903412289209286,1.0436662637931005,0.4323922734026746,0.7857940383943237,1.0,4/12,14.95%,ADSL;GMPS;GART;PPAT
prerank,regulation of cellular respiration (GO:0043457),-0.3605344645967013,-1.0434496053082205,0.38848920863309355,0.7616974057161483,1.0,4/17,12.26%,PRDM16;CBFA2T3;IDE;NOP53
prerank,regulation of urine volume (GO:0035809),-0.41445121528897105,-1.0428337165563704,0.4186666666666667,0.7614425927364072,1.0,3/10,4.95%,NPR3;NPR1;INPP5K
prerank,positive regulation of mRNA catabolic process (GO:0061014),0.386312576297224,1.0427071016102674,0.40968122786304606,0.787621965163533,1.0,11/44,14.86%,ZFP36L1;ZFP36L2;CELF1;KHSRP;FTO;PUM1;TNRC6B;YTHDF3;METTL16;GIGYF2;MOV10
prerank,cellular response to hormone stimulus (GO:0032870),0.3619059227030618,1.042686674524284,0.40586245772266066,0.78717871723706,1.0,12/69,12.31%,ZFP36L1;ROBO2;GHR;SLIT3;SFRP1;ARID5A;STAT3;CTSS;UBE2L3;CTSB;XBP1;CTSL
prerank,ganglioside biosynthetic process (GO:0001574),-0.36952114054223784,-1.0421634831659496,0.3853820598006645,0.7613563808608189,1.0,5/15,6.92%,ST6GALNAC3;ST8SIA4;B4GALT6;ST8SIA6;ST8SIA2
prerank,positive regulation of plasma membrane bounded cell projection assembly (GO:0120034),0.3531305678768746,1.0420599966445825,0.40963855421686746,0.7882742946122794,1.0,19/80,13.99%,CARMIL2;NRP1;AUTS2;DPYSL3;ACTR2;FSCN1;CDC42EP4;RAC1;CCP110;CDC42;PIK3R1;ENTR1;RALA;TGFB3;CEP120;CDC42EP5;FMR1;ABI2;ARHGAP35
prerank,embryo development ending in birth or egg hatching (GO:0009792),0.46213143345145125,1.0416446868380158,0.4506849315068493,0.7888032773399412,1.0,5/15,12.95%,FGFR1;CELF1;RICTOR;SCEL;USP22
prerank,positive regulation of stress fiber assembly (GO:0051496),0.3780362081277443,1.0414874862693908,0.41997593261131166,0.7886933838151748,1.0,15/44,17.36%,NRP1;SFRP1;CARMIL1;NF2;RAC1;CDC42;TGFBR1;EPHA1;TGFB3;TPM1;ITGB1BP1;ABL1;ROCK2;LPAR1;RHOA
prerank,carbohydrate derivative biosynthetic process (GO:1901137),0.4237966575727118,1.0412792208361124,0.4360385144429161,0.7887385810232576,1.0,7/26,18.08%,TNIP1;B4GALT5;TKT;ALG6;GK;ST3GAL2;ALG8
prerank,amino sugar biosynthetic process (GO:0046349),0.4888714646648866,1.0412193921866364,0.4338461538461538,0.7883879051036454,1.0,6/12,27.91%,GFPT2;UAP1L1;AMDHD2;UAP1;GNPDA2;RENBP
prerank,regulation of calcium ion transport (GO:0051924),0.3731486286609949,1.0411194596654154,0.41122565864833904,0.7881346324507793,1.0,11/54,12.36%,IL16;BCL2;EGF;CACNA2D1;PKD2;CCR1;CCL5;TRPC6;ATP2B1;EFHB;MYLK
prerank,positive regulation of proteasomal protein catabolic process (GO:1901800),0.3512358071829403,1.0410365056615052,0.4170305676855895,0.7878483039375596,1.0,32/85,22.57%,NKD2;LRRK2;TREM2;PABIR1;ZYG11B;PLK1;RNF144A;RNF19B;CSNK1A1;SIRT2;BAG6;PRICKLE1;ARIH1;FMR1;RAD23A;CSNK1D;FBXW7;GSK3B;STUB1;MDM2;ARIH2;SOCS5;BBS7;FBXO22;TRIB3;DVL1;RNF217;PSMC6;TRIB1;PIAS1;DDRGK1;COP1
prerank,purine ribonucleoside triphosphate metabolic process (GO:0009205),0.470248946456839,1.0405210848170063,0.41654357459379615,0.7886680354993876,1.0,2/13,6.61%,LRRK2;ENTPD7
prerank,pyrimidine-containing compound catabolic process (GO:0072529),0.46395144166980484,1.0390751452548153,0.43802816901408453,0.7918313794039447,1.0,4/16,11.13%,DPYSL4;DPYSL3;NT5M;DPYD
prerank,sensory organ development (GO:0007423),0.3814519254851731,1.0388387381390263,0.41637426900584795,0.7919314664609179,1.0,9/51,11.19%,SH3PXD2B;MEIS2;CHD7;MAFB;SIPA1L3;MEIS1;PBX3;MYO7A;ADAMTS18
prerank,cellular response to gamma radiation (GO:0071480),0.45054868856750263,1.038607342115243,0.42165242165242167,0.7919859774991361,1.0,3/17,6.96%,YAP1;ATM;ATR
prerank,regulation of autophagosome maturation (GO:1901096),0.47888172604413287,1.0384410837295046,0.4336810730253353,0.7919015916214145,1.0,8/13,29.26%,TMEM39A;PHF23;SMCR8;CLN3;CLEC16A;FYCO1;IRGM;UVRAG
prerank,regulation of double-strand break repair via nonhomologous end joining (GO:2001032),0.40822217732408417,1.0384107196986132,0.4418604651162791,0.791479084422856,1.0,11/28,22.83%,PARP3;ACTR2;KDM4D;SHLD3;SETMAR;RIF1;SIRT7;PRKDC;WRAP53;DTX3L;KMT5B
prerank,negative regulation of peptidyl-tyrosine phosphorylation (GO:0050732),0.40007489825400955,1.0378924856577498,0.42802056555269924,0.7923037360837752,1.0,10/30,15.73%,SFRP1;SFRP2;NF2;MVP;PTPN6;SH3BP5L;SH3BP5;THY1;PTPN2;PARP14
prerank,regulation of nitric oxide biosynthetic process (GO:0045428),0.383283537146594,1.037834071979852,0.42472460220318237,0.7919606868729849,1.0,11/38,17.84%,NOS1AP;JAK2;PKD2;KHSRP;RAC1;CD36;SIRPA;SMAD3;TNF;ROCK2;PTGS2
prerank,negative regulation of anoikis (GO:2000811),0.47618943634605393,1.0376361932767308,0.4315937940761636,0.7919677855909028,1.0,5/14,13.47%,SNAI2;BCL2;TLE1;PTK2;ITGA5
prerank,sensory perception of taste (GO:0050909),0.49320084504535616,1.0369205720463575,0.44086021505376344,0.7932612882680845,1.0,3/10,21.28%,CD36;ASIC1;PKD1L3
prerank,RNA 3'-end processing (GO:0031123),-0.25854893396433043,-1.0367338490066178,0.3684210526315789,0.774187407481279,1.0,22/69,25.32%,WDR33;CSTF2;CDC40;RPRD1A;SRSF7;CPSF2;TUT1;RBM8A;ZC3H11A;SUPV3L1;U2AF2;MAGOH;EIF4A3;TUT4;CLP1;CPSF4;PABPN1;DDX39A;POLDIP3;DDX39B;TENT2;CHTOP
prerank,regulation of NMDA receptor activity (GO:2000310),-0.2995561999679815,-1.036680254622957,0.3875598086124402,0.7723621783903183,1.0,8/32,13.88%,ACTN2;SLC6A9;LRRC7;DLG2;MEF2C;RELN;NLGN1;GRIN2B
prerank,recombinational repair (GO:0000725),0.3558139943970183,1.0365665024494113,0.4214046822742475,0.7936857015617614,1.0,22/77,19.66%,RAD51B;RAD52;INO80;FBH1;HELQ;KDM4D;XRCC3;RMI1;MMS22L;RNF138;MCM9;NUCKS1;ZFYVE26;AP5Z1;YY1;LIG3;SEM1;RBBP8;PSMD14;XRCC2;NSMCE2;PARP1
prerank,protein-DNA complex assembly (GO:0065004),0.3396622492596172,1.0364346371159436,0.42691903259726605,0.7935152723208683,1.0,33/116,23.15%,PSMA7;TCF4;ASF1A;MCM2;PSMD4;DDB1;PSMD11;CDK7;ATRX;PSMB8;MCM7;GRWD1;HMGB2;GTF2H1;RSF1;PSMA6;CCNH;PSMD14;NAP1L3;SPTY2D1;PSMC6;PSMB10;PARP1;PSMD12;PSMB1;PSMA8;NAP1L1;PSMF1;ORC6;RPS27A;RAD23B;PSME2;PSMA4
prerank,regulation of exosomal secretion (GO:1903541),0.43431988736841,1.0360202206569835,0.4149377593360996,0.7940682343651965,1.0,10/19,27.52%,RAB7A;VPS4A;SDC1;SDCBP;CHMP3;HGS;SMPD3;PDCD6IP;VPS4B;SNF8
prerank,morphogenesis of an epithelium (GO:0002009),-0.3185666047859559,-1.0358218407575914,0.3907563025210084,0.7727004595392689,1.0,10/25,23.12%,ACTB;LAMA3;LAMA5;LIN7C;TRAF3IP1;VCL;PRKX;AHI1;SOX8;ACTG1
prerank,prostanoid metabolic process (GO:0006692),0.4820827358613866,1.035444788205383,0.4431137724550898,0.7950149631776455,1.0,2/13,9.00%,PTGES;ACOX1
prerank,mitotic G2 DNA damage checkpoint signaling (GO:0007095),0.40256766100448516,1.0351770240926865,0.42327365728900257,0.7951975431154045,1.0,7/32,11.78%,TAOK1;BABAM2;ATM;PLK1;FZR1;TAOK3;CDC14B
prerank,regulation of insulin secretion involved in cellular response to glucose stimulus (GO:0061178),0.41099218559621115,1.034936576355045,0.4073587385019711,0.795308730241925,1.0,1/26,0.10%,NR1H4
prerank,regulation of viral genome replication (GO:0045069),0.3716217028716494,1.0347279894073431,0.4212328767123288,0.7953283355555125,1.0,11/56,12.75%,TNIP1;SHFL;ILF3;PPID;CCL5;TMEM39A;DDB1;TARBP2;EIF2AK2;RAD23A;OASL
prerank,negative regulation of interleukin-8 production (GO:0032717),0.44962000128812873,1.0345662946251553,0.4414668547249647,0.7952400276605117,1.0,3/17,12.66%,BCL3;ANXA1;SSC5D
prerank,regulation of leukocyte cell-cell adhesion (GO:1903037),0.48167985756623233,1.0345472377191922,0.44036697247706424,0.794789671382499,1.0,5/12,24.65%,MIA3;MDK;ASS1;FUT4;AKT1
prerank,lipid transport (GO:0006869),0.3462347192551324,1.0340965506353614,0.4360086767895879,0.7954294753632911,1.0,11/97,7.23%,NR1H4;ABCA1;LBP;ABCA2;APOE;SLC10A6;UGCG;ATP8B1;ABCG1;PLTP;CD36
prerank,negative regulation of cardiac muscle hypertrophy (GO:0010614),-0.39559818853118256,-1.0339845171912152,0.39457831325301207,0.7759114089050908,1.0,3/11,10.58%,GLRX3;LMNA;ATP2B4
prerank,positive regulation of activated T cell proliferation (GO:0042104),0.4364115510565873,1.0336697668798556,0.4346590909090909,0.796038085791355,1.0,1/18,0.46%,IL23R
prerank,ventricular septum morphogenesis (GO:0060412),0.4092072449981951,1.0328416662494542,0.4467805519053876,0.7976462163646669,1.0,6/27,12.34%,ROBO2;SLIT3;ZFPM2;TGFBR1;ACVR1;HEYL
prerank,sphingoid metabolic process (GO:0046519),-0.3826676355399551,-1.0327757285421177,0.40114613180515757,0.777284265281953,1.0,7/12,33.05%,DEGS2;NAAA;ASAH2;SPHK1;SGPP1;PLPP2;SPTLC3
prerank,vascular transport (GO:0010232),0.35053094760978426,1.032602212484483,0.42702702702702705,0.7977579520841009,1.0,10/81,5.71%,SLC7A2;SLC1A3;LRP1;SLC38A3;ABCA2;SLC2A13;SLC28A2;SLC16A12;SLC29A1;SLC4A4
prerank,cilium-dependent cell motility (GO:0060285),0.421402562836042,1.031986902771941,0.4266666666666667,0.7988262264641065,1.0,1/22,0.50%,TEKT4
prerank,protein phosphorylation (GO:0006468),0.3234299875397862,1.0315506198928612,0.418,0.799426204145171,1.0,87/479,14.75%,CCL11;RUNX3;PDGFRA;NEK6;TAOK1;TEC;MAP4K4;AATK;JAK1;STK36;PRKCA;MAST4;NUAK1;ERN2;PEAK1;TLR2;JAK2;PDGFRB;SMAD2;LRRK2;CAMK2D;DDR2;IRAK3;PRKD2;CSNK2A2;COQ8B;BLK;EPHB3;FGFR1;MAP4K5;ILF3;MARK1;CDK14;ATM;EIF2AK3;AKT3;IKBKE;ATR;EGFR;CDK10;PPP4R1;PLK1;TGFBR1;PXK;FAM20A;ACVR1B;PTPN6;EPHA1;ACVR1;DDR1;PRKAR1B;CDK6;INCENP;MAP2K1;CDK9;TLR7;RICTOR;MERTK;CDK13;CDK7;CSNK1A1;HIPK4;FRK;NRK;MORC3;TAOK3;ACVR2A;RPS6KB1;ABI1;EIF2AK2;MAST2;FAM20C;EPHB2;DCLK1;HTATIP2;NEK4;CCNT1;PTK2;CSNK1D;ABI2;CCL2;CAMK1G;PIK3R4;HIPK3;GTF2H1;GSK3B;MAPK9
prerank,establishment or maintenance of epithelial cell apical/basal polarity (GO:0045197),-0.307026901367499,-1.031416213354343,0.3869565217391304,0.779069097059972,1.0,7/31,8.43%,EZR;LRRC7;LIN7A;PARD3;SYNJ2BP;DLG2;LIN7C
prerank,cellular response to interferon-beta (GO:0035458),0.4636888356441823,1.0313505355640833,0.44138929088277856,0.7994381245375313,1.0,2/14,4.45%,STAT1;IRF1
prerank,chromatin assembly (GO:0031497),0.3877172208401645,1.0312982936528154,0.4392059553349876,0.7990972221643322,1.0,14/38,20.85%,POLE3;ASF1A;NOC2L;ATRX;GRWD1;CTCF;BAHD1;HMGB2;RSF1;NAP1L3;SPTY2D1;LIN54;RBBP4;NAP1L1
prerank,negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315),0.49041226434826873,1.0312903306363457,0.4396946564885496,0.7981386764310122,1.0,4/11,13.46%,PKD2;CALM3;FKBP1B;CALM2
prerank,negative regulation of release of sequestered calcium ion into cytosol (GO:0051280),0.49041226434826873,1.0312903306363457,0.4396946564885496,0.7981386764310122,1.0,4/11,13.46%,PKD2;CALM3;FKBP1B;CALM2
prerank,negative regulation of T-helper cell differentiation (GO:0045623),0.4843780706880756,1.0304177495397409,0.44805194805194803,0.7998214415223698,1.0,3/11,16.05%,ANXA1;RC3H2;SOCS5
prerank,monosaccharide transmembrane transport (GO:0015749),-0.35542157829088916,-1.0300177198327514,0.3851851851851852,0.7809095531185435,1.0,4/16,17.45%,SLC2A12;SLC45A3;SLC2A8;SLC2A9
prerank,regulation of mitotic cell cycle spindle assembly checkpoint (GO:0090266),0.46419499858743957,1.0297994389824143,0.4515669515669516,0.8008505150256205,1.0,2/13,7.89%,MAD2L1;XRCC3
prerank,regulation of macrophage activation (GO:0043030),0.40388199125822283,1.0295917855057395,0.4339152119700748,0.8008583755836914,1.0,6/30,13.99%,LBP;WNT5A;FCGR2B;IL33;PJA2;HSPD1
prerank,"positive regulation of DNA-templated transcription, elongation (GO:0032786)",0.41828577086161206,1.0292904563588836,0.4388586956521739,0.8011290773715946,1.0,7/22,17.88%,EAPP;BRD4;CDK13;CCNT1;HMGN1;TCERG1;CDC73
prerank,cellular zinc ion homeostasis (GO:0006882),0.40746838341387615,1.028955461611357,0.45057766367137353,0.8015245096007548,1.0,1/26,0.16%,SLC39A14
prerank,positive regulation of neurogenesis (GO:0050769),0.3583085311979725,1.0288489430060526,0.43121387283236995,0.8012882564156263,1.0,17/68,17.36%,ROBO2;AMIGO1;NUMBL;PLXNC1;SERPINF1;DISC1;OBSL1;SMARCD3;PLXND1;FZD3;PLXNA3;CAPRIN1;CX3CL1;NPTN;ROBO1;CUL7;RHOA
prerank,cellular response to retinoic acid (GO:0071300),0.3785306126529012,1.0283677791122239,0.46256038647342995,0.8019756086453071,1.0,6/42,12.51%,WNT2;WNT5A;WNT9A;ATM;SETX;PTK7
prerank,negative regulation of pri-miRNA transcription by RNA polymerase II (GO:1902894),0.46502150209364057,1.0283194271661436,0.4471299093655589,0.8016082632430866,1.0,2/13,8.94%,POU5F1;PPARG
prerank,positive regulation of positive chemotaxis (GO:0050927),0.4489280839222419,1.0280261722141582,0.42565597667638483,0.8018218892839098,1.0,2/15,2.21%,CXCL12;IL16
prerank,regulation of ceramide biosynthetic process (GO:2000303),0.46193791078843294,1.0279855502021837,0.45319465081723626,0.80143440863101,1.0,9/15,25.07%,NSMAF;TNF;TNFRSF1A;SPHK2;SMPD3;ORMDL3;SAMD8;SIRT3;SMPD2
prerank,positive regulation of interferon-alpha production (GO:0032727),0.4377284087108666,1.0276863504145102,0.4562146892655367,0.8017123744783843,1.0,8/19,23.63%,IRF7;STAT1;TLR7;HSPD1;TLR3;DDX3X;SETD2;IRF3
prerank,cellular biogenic amine catabolic process (GO:0042402),0.4994460004305983,1.0275797305883672,0.46015037593984964,0.8014987704200571,1.0,4/10,17.85%,ALDH7A1;COMT;DMGDH;SMOX
prerank,receptor clustering (GO:0043113),-0.32090918552103864,-1.0272788319400308,0.3738738738738739,0.7867262749727639,1.0,9/27,14.94%,NRXN1;LRRC7;SYNJ2BP;DLG2;ITGA4;AGRN;NRXN2;NLGN1;DNAJA3
prerank,negative regulation of response to endoplasmic reticulum stress (GO:1903573),0.41069231825474567,1.0267867850685657,0.4501940491591203,0.8029445947108684,1.0,6/24,16.30%,CREB3L1;LRRK2;XBP1;CREB3;SELENOS;SYVN1
prerank,intracellular protein transport (GO:0006886),0.32160496402821226,1.0267713483129537,0.4318637274549098,0.8025029970722464,1.0,85/304,22.29%,LTBP2;CLTC;SEC31A;STX6;COPZ2;AP4M1;COPA;AP3B1;TRAK1;RABGAP1L;ARFGAP3;ARCN1;STX17;RAB21;SEC16A;RTN2;MMP12;WLS;STAT3;RABGAP1;TBC1D2B;RAB7A;STXBP1;COPB2;BAG3;E2F3;RAB3GAP2;XPO7;TNPO1;FAM53B;TBC1D16;NUP153;LAMP2;TBC1D8B;ERP29;SNX8;COPZ1;NUP188;PRICKLE1;LMAN1;ARL4C;CLIP3;SNX6;STX11;SCFD1;KPNB1;SMURF1;RAB32;KIF13B;NXT2;TBC1D13;CDC37;SNX9;NXT1;NUP214;CACNG3;AP3D1;STXBP3;DNAJC27;USO1;PICK1;EGR2;HEATR3;TMED1;CTSA;RAB31;SNX15;EVI5L;COG7;ARF1;SGSM3;ADPRH;RAB24;TMED10;CALR;RUNDC1;GIPC1;TMED7;EHD1;ARF4;SEC23IP;TBC1D1;RAB1A;BCS1L;TBC1D10B
prerank,DNA strand elongation (GO:0022616),-0.34434222838842016,-1.0267298831819516,0.3902439024390244,0.7862526060889624,1.0,10/18,27.29%,GINS3;DCLRE1B;MCMDC2;RFC3;GINS4;MRE11;POLD2;GINS1;RFC4;MCM3
prerank,dendritic spine morphogenesis (GO:0060997),0.4551136986531382,1.0267270613219348,0.4489795918367347,0.8021425129418779,1.0,6/15,17.11%,EPHB3;PTEN;CDC42;DLG4;EPHB2;CTNND2
prerank,regulation of apoptotic process (GO:0042981),0.3218130858489005,1.0265968060512292,0.408,0.8019684941763003,1.0,137/676,17.61%,NR1H4;CYP1B1;ZBP1;KNG1;BCL3;IAPP;MAP4K4;BCL6;VAV2;FSTL1;SFRP4;SFRP1;EGR3;MAD2L1;CCAR1;SFRP2;BIRC3;WNT5A;JAK2;VAV3;STAT1;FHL2;GATA6;BCL2;AIFM2;CASP1;TSLP;CFLAR;ANXA1;TXNDC5;EEF1E1;USP42;RNF157;FGD4;CTSD;NF2;FRZB;SHH;FXN;STEAP3;ANP32A;PPID;BABAM2;KALRN;E2F1;ATM;NUGGC;ITSN1;MGMT;SIAH2;RASSF2;EGFR;HDAC1;CBL;PIK3R1;ANGPTL4;CREBBP;NF1;PHLDA1;TRIO;TNFRSF12A;CALHM2;PLK1;BAX;IFT57;CXCL10;PTPN6;OMA1;SQSTM1;BAG3;OLFM1;GAS1;AREL1;TGFB3;CTSB;BIN1;AKAP13;PLEKHN1;ASNS;PREX1;NFKB1;SLC27A4;SPRY2;FZD9;RTKN;XBP1;RPS6KB1;SETX;HDAC3;BCL2L2;RRP1B;CLIP3;MAGED1;SH3RF1;ARHGEF19;PAWR;IL7;CCAR2;ARAF;HTATIP2;TRAF2;PDPN;PTK2;TRIM35;HSPD1;HIPK3;PRDX5;UBE2Z;FLCN;SAP18;USP47;CASP8;GSK3B;BAG4;ARHGEF12;KCNMA1;GLS2;TNF;ABL1;CX3CL1;TAF9B;HNRNPK;PSEN1;SON;ANGPT1;PDCD10;GDNF;VAV1;FAM162A;PPIF;RPS6KA3;PLEKHG2;NLRP2B;TBX3;ITCH;ACVR1C;TCIM
prerank,myoblast fusion (GO:0007520),0.47549616827791924,1.0265048932819296,0.44169096209912534,0.8017004805891056,1.0,4/12,10.75%,ADAM12;ADAMTS5;ADAMTS15;PTGFRN
prerank,keratan sulfate catabolic process (GO:0042340),0.4851903681446398,1.0264932727837446,0.4402332361516035,0.8012494822778962,1.0,4/11,16.19%,LUM;PRELP;GALNS;GNS
prerank,protein deubiquitination (GO:0016579),0.32910776227655947,1.0262029950250293,0.4409687184661958,0.8014601636431348,1.0,53/242,19.80%,PSMA7;TNIP1;TNFAIP3;OTULINL;ASXL1;BIRC3;USP9X;SMAD2;USP24;OGT;USP42;SMURF2;PTEN;USP38;INO80;BABAM2;CCP110;SIAH2;USP40;USP3;ASXL2;TGFBR1;PSMD4;IL33;FOXK2;PSMD11;USP14;TADA2B;PSMB8;RAD23A;TRAF2;USP22;VCPIP1;SMAD3;OTUD3;USP47;CDC25A;YY1;MYSM1;MDM2;TADA3;PSMA6;TAF9B;RUVBL1;RHOA;PSMD14;HGS;USP12;PSMC6;PSMB10;UCHL1;PSMD12;PSMB1
prerank,ventricular septum development (GO:0003281),0.3859194980435745,1.0260667631076001,0.43842364532019706,0.8012900919995998,1.0,9/37,16.91%,ROBO2;SLIT3;ZFPM2;TGFBR1;ACVR1;SALL1;HEYL;STRA6;ROBO1
prerank,positive regulation of heterotypic cell-cell adhesion (GO:0034116),0.4645118624421651,1.0258144765200155,0.43797856049004597,0.8014108728821937,1.0,4/12,22.39%,GCNT2;THY1;TNF;BMP7
prerank,"DNA damage response, signal transduction by p53 class mediator (GO:0030330)",0.35866140140987285,1.0255735334407978,0.4448123620309051,0.8014798823402572,1.0,12/72,11.49%,BCL3;TNKS1BP1;BATF;CNOT4;E2F1;ATM;CARM1;BAX;FOXM1;E2F8;ATRX;TFDP1
prerank,positive regulation of dephosphorylation (GO:0035306),0.40951264377966334,1.0253443871530616,0.42800528401585203,0.801538862595842,1.0,10/27,25.78%,DLC1;PPP2R5A;CALM3;CALM2;SPPL3;SRC;TGFB1;MTMR9;ANKLE2;PTPA
prerank,cardiac right ventricle morphogenesis (GO:0003215),0.4833272156940619,1.025086328775692,0.4527736131934033,0.8017300967474928,1.0,2/11,3.90%,ZFPM2;JAG1
prerank,purine ribonucleotide metabolic process (GO:0009150),0.3538772960767654,1.0250732754834506,0.43209876543209874,0.801283467010375,1.0,16/68,21.84%,ENPP1;LRRK2;ENTPD7;ACOT9;THEM4;ACOT13;ACSF2;TPST1;SULT4A1;ACAT1;PDE9A;MLYCD;AMPD3;HINT1;CROT;ACOT11
prerank,activation of protein kinase activity (GO:0032147),0.33718584140719343,1.0248840060576807,0.4432661717921527,0.8012679994964572,1.0,30/106,22.31%,TAOK1;MAP4K4;ADCY7;GHR;WNT5A;JAK2;TIRAP;ADCY2;MAPKAP1;PRKAR1B;RICTOR;NRK;TOM1L1;TAOK3;BORA;TPX2;TRAF2;ITGB1BP1;NTRK3;ABL1;ANGPT1;TLR3;STK4;STK11;NTF3;TGFB2;PAK1;IGF1;EMP2;PARK7
prerank,hippo signaling (GO:0035329),0.40316777478129806,1.0239030184684719,0.4463350785340314,0.8032127571194912,1.0,6/26,7.50%,YAP1;TEAD3;AMOTL1;DVL2;TEAD1;DCHS1
prerank,synaptic membrane adhesion (GO:0099560),-0.37472766100907756,-1.0236297431004966,0.416403785488959,0.7928658737955032,1.0,3/14,2.23%,LRRC4C;LRFN5;NTNG1
prerank,cellular response to virus (GO:0098586),0.3996829862014738,1.023593705757106,0.44485294117647056,0.8034508642979946,1.0,10/30,20.26%,CCL5;BAX;CXCL10;LGALS9;MAPK11;RRP1B;FMR1;ARF1;GBF1;DDX3X
prerank,global genome nucleotide-excision repair (GO:0070911),-0.31796665302131155,-1.0229412206940092,0.40784313725490196,0.7928525696636676,1.0,13/26,23.32%,ERCC3;CHD1L;GTF2H2;RBX1;UBC;USP45;ERCC1;XPC;GTF2H4;DDB2;UBA52;CETN2;UBB
prerank,positive regulation of mRNA metabolic process (GO:1903313),-0.37958956808778405,-1.0227319122234442,0.40131578947368424,0.7914587311259045,1.0,4/13,10.75%,PRR5L;CNOT8;UPF1;RC3H1
prerank,negative regulation of fatty acid metabolic process (GO:0045922),-0.35379705483560653,-1.021997195899094,0.4243421052631579,0.7915167921412825,1.0,5/16,27.14%,ERLIN1;SIRT4;CEACAM1;BRCA1;ACADL
prerank,negative regulation of calcium ion transmembrane transport (GO:1903170),0.5010336104376885,1.0219225001638335,0.478806907378336,0.8071194114847062,1.0,4/10,11.63%,CBARP;SESTD1;BIN1;FKBP1B
prerank,negative regulation of biomineral tissue development (GO:0070168),0.41424011418918405,1.0218305580648726,0.44565217391304346,0.8068423491950066,1.0,2/21,5.52%,ENPP1;CCR1
prerank,regulation of fibroblast migration (GO:0010762),0.43117604898149514,1.0217547886321559,0.4579310344827586,0.8065396371481907,1.0,10/20,26.37%,DDR2;RAC1;FGF2;PTK2;ITGB1BP1;CLN3;CORO1C;ITGB1;TGFB1;APPL2
prerank,establishment of vesicle localization (GO:0051650),-0.3452737843480831,-1.0215640329060378,0.4375,0.7907358167944281,1.0,7/18,18.98%,RAB27A;SNAPIN;IKBKG;TOR1A;SYNJ1;TESK1;DNM2
prerank,regulation of rRNA processing (GO:2000232),-0.3479483868240709,-1.020475000601957,0.43205574912891986,0.7917606297700126,1.0,6/16,24.68%,WDR43;RIOK1;UTP15;KAT2B;NUDT16;TRMT112
prerank,positive regulation of purine nucleotide metabolic process (GO:1900544),0.42603670927873016,1.0202346063892502,0.4435146443514644,0.8091804623591408,1.0,8/20,21.72%,ARNT;SLC4A4;PFKFB4;ZBTB20;PSEN1;P2RX7;PRXL2C;IGF1
prerank,positive regulation of glycolytic process (GO:0045821),0.42603670927873016,1.0202346063892502,0.4435146443514644,0.8091804623591408,1.0,8/20,21.72%,ARNT;SLC4A4;PFKFB4;ZBTB20;PSEN1;P2RX7;PRXL2C;IGF1
prerank,regulation of leukocyte migration (GO:0002685),0.43985329463008105,1.0191697355637719,0.4339622641509434,0.8113290643117268,1.0,3/16,6.18%,ANXA1;MIA3;RAC1
prerank,regulation of cytokine production involved in immune response (GO:0002718),0.4243584570493148,1.0188825837113173,0.4386206896551724,0.811583527256641,1.0,5/22,17.95%,LACC1;WNT5A;TNF;TRPM4;SPHK2
prerank,positive regulation of cardiac muscle cell proliferation (GO:0060045),0.4729773611484284,1.0187222043173167,0.44642857142857145,0.8115064744349025,1.0,4/13,12.71%,ZFPM2;TBX2;FGF2;RBPJ
prerank,negative regulation of epithelial cell apoptotic process (GO:1904036),0.39191798484923124,1.0187215261679956,0.4592220828105395,0.8110239152733602,1.0,5/33,6.24%,TCF7L2;YAP1;TNFAIP3;MDK;ICAM1
prerank,male meiosis I (GO:0007141),0.45277546497338805,1.0186935420414445,0.46131386861313867,0.8106109300983395,1.0,4/16,21.77%,MYBL1;FOXJ3;SYCP3;ZSCAN21
prerank,negative regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032435),-0.29863771882625145,-1.018533932066826,0.41836734693877553,0.7950715765849257,1.0,11/30,16.00%,FHIT;UCHL5;CAMLG;MAP1A;SVIP;HSP90AB1;NOP53;WAC;SGTA;TRIM39;HFE
prerank,negative regulation of stress fiber assembly (GO:0051497),-0.3177123237505752,-1.0184229485302427,0.4482758620689655,0.7934961907383342,1.0,5/24,4.95%,TJP1;TMEFF2;RHPN2;ARHGAP28;INPP5K
prerank,organic substance transport (GO:0071702),0.3334678149524137,1.0178504885628794,0.452431289640592,0.8121692120552846,1.0,26/121,18.18%,ABCA1;TCN1;ARRDC4;SLC6A2;ABCA2;ABCG1;MYH9;MIA3;LMAN2L;PLTP;RCN3;RAB7A;ARRDC3;ABCA9;TCN2;SLC50A1;SNX4;RUFY1;SLCO1B1;CHMP3;PICK1;CALCRL;ABCG4;KIF3A;PEX19;TOM1
prerank,regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882),0.4345002342511674,1.0175730276907629,0.4657718120805369,0.8123596518110618,1.0,8/20,13.46%,SLC9A1;CAMK2D;CACNA1C;ATP2A2;TNNI3;CALM3;FKBP1B;CALM2
prerank,protein localization to chromosome (GO:0034502),0.3862632885924503,1.0172441663327545,0.46017699115044247,0.8126986794537419,1.0,12/34,18.48%,PARP3;ATR;PINX1;PLK1;SLF2;ATRX;LEMD2;MCM9;CTCF;IFFO1;CHMP7;TNKS2
prerank,fatty acid beta-oxidation (GO:0006635),0.3660786601092215,1.0168107747773871,0.45368171021377673,0.8132646942632009,1.0,6/51,10.76%,ADIPOQ;EHHADH;ETFA;ACOX1;SLC27A2;ACOX3
prerank,negative regulation of TORC1 signaling (GO:1904262),-0.386908793675898,-1.016758486489124,0.43154761904761907,0.7961834996307899,1.0,6/13,16.38%,RNF152;SESN2;DEPDC5;SESN3;SPAAR;ITFG2
prerank,dephosphorylation (GO:0016311),0.3310224298394829,1.016288790634036,0.4614594039054471,0.8140665032668637,1.0,53/147,25.88%,PDXP;PTPN7;DUSP2;DUSP5;PTPN3;DUSP26;DUSP28;EPHX2;PTEN;PTPN13;SSH1;PPP4R1;DUSP18;PTPN6;PPP2R5A;PTPRZ1;PTPN1;PPP2R2A;PTPN18;DAPP1;CDC14B;PTPN5;PPP3CA;FBXW11;PPP1CB;PPM1H;PPP2R5E;PLPPR2;THNSL2;PPP4R2;PTPRJ;PTPN9;SSH2;ILKAP;PLPP3;STK11;TIMM50;MTM1;CTDSP2;PPP2R5D;PPP2R5C;PPP1CC;PTPRM;PPM1D;DUSP6;PTPN12;PTPRS;PPP2CB;PXYLP1;PNKP;PPM1M;PTPRA;MTMR2
prerank,membrane lipid metabolic process (GO:0006643),0.4094074463520798,1.0162018258384695,0.44906166219839144,0.8137882263188645,1.0,2/22,4.08%,CYP1B1;SMPDL3B
prerank,positive regulation of ATP metabolic process (GO:1903580),0.38696667513772526,1.016051030176063,0.4533001245330012,0.8136808266642247,1.0,7/32,9.59%,ARNT;TREM2;PID1;SLC4A4;PFKFB4;ZBTB20;ENO1
prerank,DNA replication-independent nucleosome organization (GO:0034724),0.48704554117414145,1.0159385872408628,0.46801872074882994,0.8134717787743446,1.0,4/11,19.40%,UBN1;ASF1A;ATRX;RBBP4
prerank,protein localization to mitochondrion (GO:0070585),0.4850285385368016,1.0159331984846496,0.4687022900763359,0.8130056270141486,1.0,3/11,8.89%,LRRK2;HK2;RALA
prerank,leukocyte cell-cell adhesion (GO:0007159),0.4197350528130561,1.0158633366741487,0.4649006622516556,0.8127016978471646,1.0,4/24,7.35%,OLR1;TNIP1;ICAM1;CCL5
prerank,T cell mediated immunity (GO:0002456),-0.3865084373961739,-1.015629539410258,0.44554455445544555,0.7973904345880716,1.0,3/13,3.58%,CADM1;CD46;CD55
prerank,positive regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032436),0.3483113477238074,1.0148401413030588,0.4576837416481069,0.8147066545919832,1.0,26/78,18.87%,NKD2;LRRK2;UBQLN1;PABIR1;ZYG11B;PLK1;RNF144A;RNF19B;CSNK1A1;FZR1;SIRT2;PRICKLE1;ARIH1;RAD23A;CSNK1D;GSK3B;STUB1;MDM2;ARIH2;SOCS5;NFE2L2;BBS7;FBXO22;TRIB3;DVL1;RNF217
prerank,positive regulation of protein-containing complex disassembly (GO:0043243),-0.3830057427250329,-1.0147687395257556,0.46176470588235297,0.7978165494486475,1.0,3/12,10.27%,IGF1R;INSR;BNIP3
prerank,transport across blood-brain barrier (GO:0150104),0.3418787784754534,1.0145632943527554,0.4624463519313305,0.8148626507365567,1.0,11/83,7.23%,SLC7A2;SLC1A3;LRP1;SLC38A3;ABCA2;SLC2A13;SLC28A2;SLC16A12;SLC29A1;SLC4A4;CD36
prerank,positive regulation of mitochondrial fission (GO:0090141),0.4335707754873798,1.014118242705272,0.4605809128630705,0.8154261919345799,1.0,3/18,8.89%,DCN;SPIRE1;RALA
prerank,negative regulation of protein serine/threonine kinase activity (GO:0071901),0.351283285835668,1.014046814405325,0.4609375,0.8151129951687551,1.0,12/75,10.32%,ADIPOQ;NR2F2;APOE;IRAK3;PTEN;PKIB;HEXIM1;NF1;PLK1;PRKAR1B;PTPN1;SPRY2
prerank,oxoacid metabolic process (GO:0043436),0.39652311580716687,1.0132111429014392,0.4658792650918635,0.8166654456835686,1.0,2/27,4.27%,ENPP1;PPA1
prerank,keratan sulfate metabolic process (GO:0042339),0.3932403936302846,1.0131214176757715,0.465,0.8164080245486294,1.0,10/31,17.76%,LUM;B4GALT5;ST3GAL3;SLC35D2;PRELP;GALNS;GNS;ST3GAL2;ST3GAL1;CHST1
prerank,negative regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0045736),0.4250088258391564,1.013044662052734,0.4590846047156727,0.8161033405602329,1.0,4/20,8.18%,NR2F2;PTEN;HEXIM1;PLK1
prerank,sphingolipid metabolic process (GO:0006665),-0.22529544508711294,-1.0128945784947836,0.3333333333333333,0.80101983875485,1.0,18/108,7.52%,ST6GALNAC3;CERT1;PPM1L;SGMS2;SGMS1;TECR;ESYT2;CERS4;ACER2;SPTLC2;ELOVL5;DEGS2;SPTLC1;PPP2R1A;ESYT1;SERINC1;ELOVL7;PRKD1
prerank,positive regulation of leukocyte apoptotic process (GO:2000108),0.47215472129252845,1.0127426508414,0.4574961360123648,0.8163481596372839,1.0,3/11,8.51%,ANXA1;BLK;LGALS9
prerank,protein insertion into ER membrane by stop-transfer membrane-anchor sequence (GO:0045050),0.48688613941937736,1.0127260191891196,0.5038759689922481,0.8159056010121677,1.0,4/10,16.42%,EMC1;EMC7;EMC8;MMGT1
prerank,erythrocyte differentiation (GO:0030218),-0.26975003312121454,-1.0126834732248184,0.38636363636363635,0.7996568821834044,1.0,13/44,22.36%,KIT;TGFBR3;FLVCR1;CASP3;RPS19;ABCB10;IKZF1;TAL1;ZFPM1;NCKAP1L;HSPA9;UFL1;HIPK2
prerank,negative regulation of stress-activated MAPK cascade (GO:0032873),-0.29060727698728195,-1.0125490151597063,0.4263157894736842,0.7981315330494174,1.0,8/36,10.86%,MECOM;EZR;PRKN;SH3RF2;DUSP10;CYLD;PINK1;QARS1
prerank,plasma membrane bounded cell projection organization (GO:0120036),0.3325613855677944,1.0125337337681628,0.469601677148847,0.8158945680795338,1.0,32/124,19.19%,GPM6B;LAMB1;PPP1R9B;LRP12;IQCG;ATXN10;APOE;LIMA1;PKD2;BLK;TTC17;CARMIL1;OPHN1;RAC1;FAM161A;DTNBP1;L1CAM;SAMD14;TPM1;TTC29;MAP4;STMN4;GSK3B;VAPA;GDNF;MICALL2;WDPCP;KIFAP3;CAMSAP1;NPY;GPRIN1;CDK5
prerank,positive regulation of viral genome replication (GO:0045070),0.39904450325418356,1.0125230896418955,0.4544303797468354,0.8154424573670677,1.0,7/29,12.68%,PPID;CCL5;TMEM39A;DDB1;TARBP2;TOP2B;RAD23A
prerank,positive regulation of translation (GO:0045727),0.34014732464796477,1.0124180782537169,0.4665948275862069,0.8151951825358587,1.0,11/94,12.19%,PRR16;BCL3;RPUSD3;TRUB2;PLD1;KHDRBS1;CCL5;SAMD4A;YTHDF3;RPS6KB1;FMR1
prerank,cellular response to interleukin-4 (GO:0071353),0.4851366056091231,1.0115038646515215,0.46564885496183206,0.8169079779379701,1.0,4/10,13.50%,XCL1;TCF7;XBP1;STAT6
prerank,negative regulation of voltage-gated potassium channel activity (GO:1903817),-0.4084482930860637,-1.0114558031868695,0.45576407506702415,0.7990615195104819,1.0,1/10,0.66%,CAV1
prerank,regulation of calcineurin-NFAT signaling cascade (GO:0070884),0.4018537741245102,1.0112561266471942,0.4497991967871486,0.8170190596403005,1.0,9/26,21.72%,SLC9A1;FHL2;STIMATE;EFHB;GSK3B;TNF;CHERP;SPPL3;IGF1
prerank,cellular component maintenance (GO:0043954),-0.3900039849251196,-1.0111578363097333,0.42485549132947975,0.7980170850370649,1.0,4/12,13.42%,IGF1R;INSR;CLDN1;SUPV3L1
prerank,regulation of neuron projection development (GO:0010975),0.3256140514644854,1.0109815621382519,0.4659206510681587,0.8172004186061163,1.0,43/163,21.05%,ROR2;ROR1;MYLIP;PTN;TENM3;WNT5A;DPYSL3;LRRK2;APOE;EPHB3;PTEN;MARK1;DBN1;MDK;FBXO7;CAMSAP2;DISC1;DENND5A;FZD1;SETX;PTK7;ABI2;KIF13B;ARHGAP35;GSK3B;NTRK3;BRSK2;CX3CL1;NPTN;PSEN1;LPAR1;PTPN9;ARSB;CAMK2B;CDK5;KNDC1;BRSK1;SEMA3A;CAMK1D;NDEL1;FES;RTN4RL1;PAK1
prerank,positive regulation of response to biotic stimulus (GO:0002833),0.37888956195280127,1.0108130012720684,0.4489051094890511,0.817131034192653,1.0,8/38,14.35%,PRKCA;LY96;POLR3D;CCL5;PUM1;SASH1;OASL;DHX58
prerank,RNA interference (GO:0016246),0.4390834454574577,1.0105123712083626,0.4693295292439372,0.817376982787168,1.0,4/17,12.10%,CELF1;TARBP2;DICER1;TERT
prerank,negative regulation of sodium ion transmembrane transporter activity (GO:2000650),-0.41954932493912284,-1.0103806582607773,0.42894736842105263,0.7982255706629656,1.0,5/10,14.50%,ATP1A2;HECW1;PRKCE;OSR1;NEDD4L
prerank,ureteric bud morphogenesis (GO:0060675),0.43641054014777636,1.0102860528097954,0.4595744680851064,0.8174505675831887,1.0,5/16,16.77%,PKD2;SHH;SALL1;FGF2;GDNF
prerank,cellular response to cadmium ion (GO:0071276),-0.3277034976697031,-1.010266809602939,0.3855421686746988,0.7966734792241398,1.0,13/24,28.06%,JUN;MT2A;HSF1;MAPK8;MT1B;MT1X;MT1G;MT1F;MT1E;MT1M;MT1H;MT1A;MAPK3
prerank,nucleobase-containing compound catabolic process (GO:0034655),0.37757598042731827,1.0100536934668347,0.46964064436183395,0.817528910177683,1.0,9/37,16.96%,PABPC4;ENTPD7;SND1;MTREX;RNASEH2A;RNASEH1;DFFB;DNASE1L2;SIDT2
prerank,regulation of peptidase activity (GO:0052547),-0.3394067724599491,-1.0095745801580784,0.42748091603053434,0.7966454305470577,1.0,6/19,13.49%,CAV1;CST3;NDUFA13;PINK1;MAPK12;PSMA3
prerank,negative regulation of leukocyte mediated cytotoxicity (GO:0001911),0.4858713877094001,1.0093480078216344,0.4651898734177215,0.8186843881610616,1.0,2/10,8.51%,FCGR2B;LGALS9
prerank,water-soluble vitamin metabolic process (GO:0006767),0.3505914291864636,1.0093253927982317,0.4647577092511013,0.8182538582309946,1.0,6/68,6.81%,ENPP1;TCN1;MMAB;MTHFD1L;MTHFR;SLC25A19
prerank,regulation of systemic arterial blood pressure (GO:0003073),0.4376266232899442,1.0092491838126028,0.463519313304721,0.8179658849254797,1.0,2/16,7.37%,ADM;KLK2
prerank,cellular transition metal ion homeostasis (GO:0046916),0.33886577287629505,1.0092413368620132,0.48390557939914164,0.8175097001841041,1.0,14/91,13.81%,SLC39A14;HEPH;CP;SLC11A2;FXN;CUL1;SLC30A9;SLC39A6;ATP6V1G1;NUBP1;SLC31A1;ACO1;SKP1;SLC22A17
prerank,nucleotide-excision repair (GO:0006289),-0.22981108367519798,-1.0091122650045732,0.3709677419354839,0.7959683951698122,1.0,45/101,26.23%,ERCC5;AQR;BRCA2;ERCC3;ERCC6;EP300;CHD1L;ATXN3;COPS5;HUS1;POLR2H;GTF2H2;RBX1;PCNA;POLR2G;POLR2F;TP53;UBC;USP45;PRPF19;UVSSA;POLK;ERCC1;ISY1;COPS4;POLR2E;SIRT1;OGG1;XPC;GTF2H4;RFC3;POLR2A;DDB2;UBA52;RFC2;POLD2;CETN2;RPA2;UBB;LIG4;POLB;POLR2J;POLE;PPIE;RFC4
prerank,regulation of cardiac muscle cell contraction (GO:0086004),-0.30551601491374797,-1.0085983467595507,0.4155844155844156,0.7955951956085995,1.0,4/27,2.04%,CAV1;CTNNA3;PDE4B;ANK2
prerank,negative regulation of macromolecule biosynthetic process (GO:0010558),0.46056128890127723,1.0083294956695261,0.4878048780487805,0.8192934146487338,1.0,3/12,13.14%,CLTC;TAF7;SELENOS
prerank,regulation of plasma membrane bounded cell projection organization (GO:0120035),0.4021578046911484,1.008243387410461,0.45263157894736844,0.8190077520965272,1.0,11/27,19.92%,TREM2;PTEN;MARK1;FBXO7;FCGR2B;DISC1;GSK3B;BRSK2;PSEN1;BRSK1;NDEL1
prerank,positive regulation of epithelial cell apoptotic process (GO:1904037),0.42038410919199765,1.0079509087109615,0.4486486486486487,0.8192247713750987,1.0,3/20,5.03%,SFRP4;CD40;PLA2R1
prerank,regulation of release of sequestered calcium ion into cytosol (GO:0051279),0.3684951904560145,1.0079220213668088,0.4632438739789965,0.818811107095677,1.0,11/48,16.68%,CEMIP;XCL1;CAMK2D;CXCL10;CALM3;FKBP1B;CALM2;THY1;UBASH3B;CX3CL1;SELENON
prerank,bile acid biosynthetic process (GO:0006699),0.4088330618545521,1.0078935345220505,0.46122448979591835,0.8184021431029539,1.0,1/24,0.14%,CYP7B1
prerank,macroautophagy (GO:0016236),0.33086074929017845,1.0078202973770045,0.49417989417989416,0.8180953952597324,1.0,47/118,25.70%,DYNLL1;WIPI1;CHMP4B;CHMP4A;PIP4K2A;CSNK2A2;AMBRA1;STX17;ATG3;UBQLN1;VPS39;ILRUN;SQSTM1;LIX1L;PIP4K2B;LAMP2;VPS4A;TOMM7;PIK3C3;PIK3R4;MVB12A;ATG14;TCIRG1;CHMP3;VPS37C;VPS41;HGS;CSNK2A1;CLN3;MTERF3;NBR1;RUBCNL;ATG16L1;VTI1B;SNX14;SRC;PRKAB1;VPS16;ARL8B;ATG4B;ATG7;CHMP2B;VPS37A;TOMM22;VTA1;MFN2;WIPI2
prerank,positive regulation of response to stimulus (GO:0048584),0.37538345913602866,1.0077159604311308,0.4628501827040195,0.8178636102436266,1.0,11/40,21.65%,ADIPOQ;WNT5A;EEF1E1;CDKN2AIP;FCGR2B;FMR1;SELENON;YPEL3;TGFB2;BCLAF1;CGAS
prerank,regulation of intracellular transport (GO:0032386),0.37844270948323055,1.007398530862063,0.47072879330943845,0.8181546236183428,1.0,10/38,15.98%,LCP1;LRRK2;DYNC1H1;ANTKMT;GAS1;PTPN1;SCFD1;NEFH;NUP214;RINT1
prerank,response to ketone (GO:1901654),0.4092573720644689,1.007177040896037,0.4648648648648649,0.8182205432556297,1.0,4/24,9.37%,YAP1;SLIT3;CATSPER3;TGFB3
prerank,establishment of mitotic spindle localization (GO:0040001),0.40115576377607903,1.0069100281455827,0.4711168164313222,0.8183704695370285,1.0,12/28,25.12%,MAD2L1;GPSM2;PLK1;FBXW11;KPNB1;INSC;NDEL1;ITGB1;HTT;CLASP2;PAFAH1B1;NUMA1
prerank,carbohydrate biosynthetic process (GO:0016051),-0.3338724321789014,-1.0067004519153018,0.45018450184501846,0.7987709481658397,1.0,7/21,15.14%,ST3GAL6;ST3GAL4;FUT9;ST8SIA6;B3GALT2;FUT8;ST6GALNAC5
prerank,response to ATP (GO:0033198),0.42953450605920707,1.0064763051900527,0.46143250688705234,0.8189121820838099,1.0,2/18,6.59%,PDXP;SSH1
prerank,negative regulation of programmed necrotic cell death (GO:0062099),0.4800212958953598,1.0058645242104798,0.46226415094339623,0.8198923882145889,1.0,7/11,27.42%,BIRC3;FZD9;CASP8;NUPR1;ARHGEF2;YBX3;RIPK1
prerank,positive regulation of cytoplasmic transport (GO:1903651),-0.39620781095095203,-1.005613112518804,0.45535714285714285,0.7998307359422551,1.0,4/11,5.83%,EZR;PRKN;RDX;VPS11
prerank,"regulation of mRNA splicing, via spliceosome (GO:0048024)",-0.23002045742806781,-1.005590545577761,0.4523809523809524,0.7980480590128183,1.0,28/84,20.37%,MBNL1;NOVA2;QKI;WTAP;CWC22;NCL;RBM5;HNRNPU;DDX5;RBFOX3;KHDRBS2;DAZAP1;LARP7;YTHDC1;SRSF7;SRRM4;RBM8A;U2AF2;MAGOH;SRSF10;HNRNPA1;CIRBP;FXR1;CELF2;NOVA1;KHDRBS3;ZC3H10;CELF6
prerank,inositol lipid-mediated signaling (GO:0048017),0.36208637005740857,1.005574077119109,0.4817001180637544,0.8201471995162466,1.0,15/50,18.65%,PDGFRA;GAB2;PDGFRB;IRS1;OGT;FGFR1;PIK3R1;PLCL1;RPS6KB1;PI4KA;PIK3C3;RHOA;PLCH1;PLCB3;EXOC1
prerank,regulation of protein transport (GO:0051223),0.3982935478878922,1.0048762090694616,0.4885204081632653,0.8213544407804209,1.0,9/27,20.17%,LCP1;DNAJC1;LLGL1;GAPVD1;PTPN1;SCFD1;TNF;NDEL1;RHBDF1
prerank,"phagocytosis, engulfment (GO:0006911)",0.37952164480816103,1.0046960150205975,0.460880195599022,0.8213470068806008,1.0,7/36,8.21%,MYH9;RAC1;AIF1;CDC42;CD36;FCGR2B;DOCK1
prerank,positive regulation of viral transcription (GO:0050434),0.40316845264767576,1.0045389802230473,0.47513089005235604,0.8212527987323064,1.0,7/25,15.65%,MDFIC;GTF2F2;CDK9;CCNT1;POLR2K;RSF1;POLR2B
prerank,regulation of protein tyrosine kinase activity (GO:0061097),0.3738705182142349,1.0043176577497257,0.4746987951807229,0.8213124258644198,1.0,8/38,13.51%,IL34;MVP;NCK2;SH3BP5L;PTPN1;SH3BP5;DLG4;THY1
prerank,glycerophospholipid metabolic process (GO:0006650),0.3447343102360069,1.0042065562074414,0.48552338530066813,0.8210993833577486,1.0,26/75,24.38%,PLA1A;PDXP;PDGFRB;CPNE7;PIGW;PIGN;PLA2G7;PIGL;GDPD3;DPM2;CRLS1;PRDX6;PIGG;DGKH;PIGC;PIP5K1A;SMPD4;PLCB3;CLN3;PLA2G4A;PIGX;PLA2G4E;PIGH;GPLD1;PIGP;PAFAH1B1
prerank,positive regulation of phosphatidylinositol 3-kinase activity (GO:0043552),0.39319373161634097,1.003845763893689,0.44329896907216493,0.8214977908022251,1.0,8/27,15.88%,PDGFRA;PDGFRB;IRS1;AMBRA1;FGF2;PTK2;PIK3R4;ATG14
prerank,regulation of G0 to G1 transition (GO:0070316),0.3717840079868979,1.0036679254141438,0.46833930704898447,0.8214389434722151,1.0,11/38,19.40%,CDKN2B;EHMT1;YAF2;E2F1;RNF2;TFDP1;EZH2;RBBP8;PHC3;CBX5;RBBP4
prerank,peptidyl-lysine acetylation (GO:0018394),-0.3996147531303902,-1.00339057197633,0.44385026737967914,0.8021272405074937,1.0,6/10,17.77%,EP300;KAT5;SIRT1;ESCO1;KAT2B;KAT2A
prerank,regulation of protein serine/threonine kinase activity (GO:0071900),0.33313257152280923,1.0031971566292968,0.4830148619957537,0.8220813677740396,1.0,40/104,26.09%,CDKN2B;CDKN2D;CCNE2;CCND3;RPTOR;INCENP;MAP2K1;CALM3;CDK7;CCNT1;CALM2;THY1;LRP6;GTF2H1;CDC25A;CDC37;CCNB2;ABL1;EZH2;CCNH;PDCD10;RHOA;HGS;TRIB3;TELO2;MAP2K2;DDX3X;CDK5RAP3;TRIB1;BCCIP;SRC;CDK12;HTT;LRP5;KSR1;AKT1;GADD45A;CDKN1B;CCNI;SERTAD1
prerank,G protein-coupled acetylcholine receptor signaling pathway (GO:0007213),-0.3453800971332419,-1.0031445903421126,0.447098976109215,0.8010021655722568,1.0,5/18,8.56%,PLCB1;GNA11;CHRM2;CHRM3;AGRN
prerank,inorganic anion transport (GO:0015698),-0.2579236137126512,-1.0020128344362758,0.4423076923076923,0.8022564715854682,1.0,19/53,24.24%,SLC4A10;SLC26A7;SLC13A4;ANO4;SLC5A5;ANO1;CLIC5;FXYD1;XPR1;SLC26A6;ANO8;SLC25A14;ENPP3;RACGAP1;SLC26A8;CLIC4;ANO5;GLRA1;SLC25A30
prerank,endocytic recycling (GO:0032456),0.35764298715239057,1.0019780625136108,0.4668218859138533,0.824488461170161,1.0,17/50,21.48%,STX6;VPS39;RAB7A;ENTR1;EIPR1;CCDC93;ARL4C;RAB11FIP4;SNX4;EHD2;ACAP2;ANKRD27;PTPN23;MICALL2;EPS15;WASHC1;EHD1
prerank,multivesicular body organization (GO:0036257),0.3890462805488632,1.0018830293689498,0.48860759493670886,0.8242533343861433,1.0,14/31,27.52%,CHMP4B;CHMP4A;VPS4A;MVB12A;CHMP3;VPS37C;HGS;CHMP7;CHMP2B;VPS37A;PDCD6IP;VTA1;VPS4B;SNF8
prerank,sodium ion import across plasma membrane (GO:0098719),-0.33938002810268997,-1.0018695350188391,0.46075085324232085,0.800786650682858,1.0,3/17,6.18%,SLC12A2;SLC9A2;SLC6A1
prerank,microtubule nucleation (GO:0007020),0.4262179330869925,1.0015727976941227,0.4793388429752066,0.824511151128347,1.0,10/19,24.16%,TUBG1;TPX2;CSNK1D;RANBP9;TPPP;TUBGCP4;NDEL1;TUBG2;AKAP9;CLASP2
prerank,positive regulation of intracellular transport (GO:0032388),0.37632036220838067,1.0013350025105228,0.482311320754717,0.8246138686570542,1.0,16/38,25.12%,DYNC1H1;EIPR1;PCM1;TBC1D20;EHD2;PDCD10;RIPOR1;PCNT;STK11;NEDD4;BCAS3;EHD1;PLA2G4E;MLC1;RUFY3;NUMA1
prerank,neutrophil degranulation (GO:0043312),0.3132498385240068,1.0011787273548571,0.509,0.8245254580228557,1.0,108/425,23.52%,HP;C3;OLR1;TCN1;CXCL1;PLAC8;UNC13D;DYNLL1;ATP6AP2;HVCN1;ANPEP;TLR2;CCT8;PRTN3;PLD1;ACTR2;DYNC1H1;TXNDC5;MGST1;DNAJC13;CKAP4;CTSD;PADI2;RAC1;UBR4;CD53;CD63;PYGL;CTSS;CD36;MVP;RAB7A;DBNL;DDOST;CD68;PTPN6;RAB10;HPSE;KCNAB2;CTSB;SLC27A2;NPC2;PSMD11;KCMF1;NFKB1;CDK13;LAMP2;FRK;CD14;PDAP1;MOSPD2;FGL2;GGH;SIRPA;HGSNAT;KPNB1;ATP6V1D;SDCBP;PRDX6;GALNS;VAPA;GNS;TCIRG1;PSEN1;TIMP2;STXBP3;PTPRJ;GAA;RHOA;RAB37;PSMD14;FABP5;DPP7;TSPAN14;SLC2A3;ARSB;TOM1;CTSC;CTSA;ORMDL3;RAB31;CTSH;CYB5R3;PSMD12;PSMB1;SLCO4C1;RAB24;PTGES2;DDX3X;AMPD3;VAT1;GLB1;CRACR2A;PLEKHO2;RHOF;RAP1B;ANXA2;NEU1;GSDMD;CTSZ;FCGR3B;CYFIP1;DNAJC3;MAPK1;ATG7;PGAM1;RAB6A;SRP14
prerank,negative regulation of T cell mediated immunity (GO:0002710),0.4692247912751813,1.0007869844575754,0.4692913385826772,0.8250021159601193,1.0,2/11,10.26%,XCL1;AHR
prerank,regulation of actin filament polymerization (GO:0030833),0.3451559546474772,1.000671314290239,0.4845814977973568,0.824801249589143,1.0,10/69,9.50%,CCL11;BAIAP2;CARMIL1;CDC42EP4;DBN1;SSH1;NCK2;DBNL;NCK1;BIN1
prerank,protein-containing complex subunit organization (GO:0043933),0.3343505508809601,1.0005858656351516,0.4820295983086681,0.8245269569600392,1.0,21/109,15.66%,KMT2A;YAP1;LAMC1;SKAP2;MITF;CD40;KPNA3;WIPF1;ADD2;PPID;TEAD1;CREBBP;LLGL1;DLG4;TSPAN4;CAPZA1;TRAF2;RANBP9;NUP35;MDM2;SNX9
prerank,neutrophil mediated immunity (GO:0002446),0.31312794360181007,1.0003873453873389,0.509,0.8245290385825291,1.0,110/432,23.52%,HP;C3;OLR1;TCN1;CXCL1;PLAC8;UNC13D;DYNLL1;ATP6AP2;HVCN1;ANPEP;TLR2;CCT8;PRTN3;PLD1;ACTR2;DYNC1H1;TXNDC5;MGST1;DNAJC13;CKAP4;CTSD;PADI2;RAC1;UBR4;CD53;CD63;PYGL;CTSS;CD36;MVP;RAB7A;DBNL;DDOST;CD68;PTPN6;RAB10;HPSE;KCNAB2;CTSB;SLC27A2;NPC2;PSMD11;KCMF1;NFKB1;CDK13;LAMP2;FRK;CD14;PDAP1;MOSPD2;FGL2;GGH;SIRPA;HGSNAT;KPNB1;ATP6V1D;SDCBP;PRDX6;GALNS;IRAK4;VAPA;GNS;TCIRG1;PSEN1;TIMP2;STXBP3;PTPRJ;GAA;RHOA;RAB37;PSMD14;FABP5;DPP7;TSPAN14;SLC2A3;ARSB;TOM1;CTSC;CTSA;ORMDL3;RAB31;CTSH;CYB5R3;PSMD12;PSMB1;SLCO4C1;RAB24;PTGES2;DDX3X;AMPD3;VAT1;GLB1;CRACR2A;PLEKHO2;RHOF;RAP1B;KMT2E;ANXA2;NEU1;GSDMD;CTSZ;FCGR3B;CYFIP1;DNAJC3;MAPK1;ATG7;PGAM1;RAB6A;SRP14
prerank,protein autophosphorylation (GO:0046777),0.32067349083141156,1.0003786836034234,0.5025641025641026,0.8240754393849478,1.0,21/157,9.23%,PDGFRA;NEK6;TAOK1;TEC;AATK;PEAK1;JAK2;PDGFRB;LRRK2;CAMK2D;DDR2;PRKD2;EPHB3;FGFR1;ATM;EIF2AK3;ATR;EGFR;ACVR1B;EPHA1;DDR1
prerank,DNA alkylation (GO:0006305),0.4207873377023411,1.0001590881833597,0.45557122708039494,0.8236261462727443,1.0,10/19,26.21%,EHMT1;ATRX;DNMT3B;BAZ2A;KMT2E;GATAD2A;ATF7IP;PPM1D;DNMT3A;MTRR
prerank,DNA methylation or demethylation (GO:0044728),0.4207873377023411,1.0001590881833597,0.45557122708039494,0.8236261462727443,1.0,10/19,26.21%,EHMT1;ATRX;DNMT3B;BAZ2A;KMT2E;GATAD2A;ATF7IP;PPM1D;DNMT3A;MTRR
prerank,cytosolic transport (GO:0016482),0.3336756801745929,0.9999879350517695,0.48128342245989303,0.8235629949568531,1.0,33/108,22.29%,CLTC;HEATR5A;STX6;AP4M1;TMEM87B;SNX5;HOOK2;RAB7A;DENND5A;GOSR1;VPS13C;MYO1D;EEA1;ANKFY1;SNX6;PIK3C3;RAB9A;ANKRD27;RHOBTB3;PTPN23;TRIM27;CLN3;EPS15;GBF1;HOOK3;WDR91;WASHC1;SNX2;VTI1B;KIF16B;VPS54;EMP2;TBC1D10B
prerank,Golgi to plasma membrane transport (GO:0006893),-0.26640370475863223,-0.9998742746452205,0.45517241379310347,0.8044464752731879,1.0,9/47,7.27%,EXOC6B;KIF13A;EXOC6;STXBP6;PREPL;GOPC;ARL3;VAMP4;EXOC2
prerank,regulation of dephosphorylation (GO:0035303),0.43589793056896997,0.9996254040034818,0.4681753889674682,0.8239948008902694,1.0,8/15,25.88%,SMG7;PPP1R16A;SMG6;MTMR1;CDK5RAP3;SRC;MTMR9;MTMR2
prerank,negative regulation of cyclin-dependent protein kinase activity (GO:1904030),0.4125519423301621,0.9993931224148337,0.47619047619047616,0.8240664013921242,1.0,4/22,8.18%,NR2F2;PTEN;HEXIM1;PLK1
prerank,positive regulation of TOR signaling (GO:0032008),0.3717166090958274,0.9989393191747277,0.47451456310679613,0.8247055558403018,1.0,16/40,24.25%,MIOS;KLHL22;TREM2;RPTOR;RICTOR;HDAC3;FNIP1;LAMTOR5;FLCN;RRAGC;SMCR8;TELO2;SIK3;CLEC16A;GPR137;SEC13
prerank,cell junction organization (GO:0034330),0.34317915575493,0.9987973330615648,0.4882154882154882,0.8245479693682886,1.0,22/71,18.76%,VMP1;FLNC;SDK2;PPFIA4;PPFIBP2;OPHN1;LIMS1;RAB8B;CDC42;PPFIBP1;SEMA3E;TGFB3;L1CAM;CAPZA1;SDK1;SMAD3;PSEN1;CTNND2;FBLIM1;RHOA;ELFN1;DVL1
prerank,positive regulation of fatty acid metabolic process (GO:0045923),0.4401009977874253,0.9987068542060042,0.47674418604651164,0.824294294253918,1.0,2/15,8.94%,ADIPOQ;PPARG
prerank,central nervous system projection neuron axonogenesis (GO:0021952),0.45298682455616757,0.9986474370369358,0.47941176470588237,0.8239612232838452,1.0,2/12,2.31%,GLI2;MYCBP2
prerank,positive regulation of cyclin-dependent protein kinase activity (GO:1904031),0.4214215373206771,0.9983992740209529,0.49132176234979974,0.8240692138242248,1.0,4/20,9.37%,PSRC1;PKD2;EGFR;CCND3
prerank,cardiolipin metabolic process (GO:0032048),0.44413369341330683,0.9979072018271682,0.47540983606557374,0.8248268148251332,1.0,7/13,23.71%,PLA2G5;PTPMT1;CRLS1;PGS1;HADHB;PLA2G4A;LCLAT1
prerank,positive regulation of interferon-beta production (GO:0032728),0.38492404566545296,0.9977367822799806,0.4657534246575342,0.8247650695519131,1.0,10/33,20.26%,TLR2;IRF7;IRF1;POLR3D;TRIM56;TLR7;DHX58;TLR3;POLR3A;DDX3X
prerank,protein import into nucleus (GO:0006606),0.34872362194789674,0.9975165642988687,0.4762979683972912,0.8247558088678297,1.0,15/66,15.96%,CBLB;KPNA3;MMP12;STAT3;E2F3;TNPO1;FAM53B;NUP153;NUP188;PRICKLE1;KPNB1;NXT2;NUP35;NXT1;NUP214
prerank,lung epithelium development (GO:0060428),0.47712491869620455,0.9971848175291615,0.47049924357034795,0.8250773433284747,1.0,3/10,14.16%,ERRFI1;RCN3;STRA6
prerank,mesenchyme morphogenesis (GO:0072132),0.42743895005068844,0.9971391950727884,0.49173553719008267,0.8247243777657485,1.0,4/17,12.34%,SMAD2;TBX2;ACVR1;HEYL
prerank,positive regulation of phospholipase activity (GO:0010518),0.4065742640038778,0.996951089641922,0.47761194029850745,0.8247245627685545,1.0,5/22,7.35%,PDGFRA;PDGFRB;PLA2G5;FGFR1;CCL5
prerank,semaphorin-plexin signaling pathway (GO:0071526),-0.2809879707712815,-0.9969339641408868,0.4577114427860697,0.8106410216483828,1.0,13/35,17.20%,SEMA6A;PLXNA4;SEMA3C;SEMA7A;SEMA6D;SEMA3D;SEMA4D;NRP2;SEMA5A;SEMA5B;SEMA4B;SEMA3G;SEMA3B
prerank,neutrophil activation involved in immune response (GO:0002283),0.3117718760439378,0.996807729676458,0.518,0.8245819662635573,1.0,108/428,23.52%,HP;C3;OLR1;TCN1;CXCL1;PLAC8;UNC13D;DYNLL1;ATP6AP2;HVCN1;ANPEP;TLR2;CCT8;PRTN3;PLD1;ACTR2;DYNC1H1;TXNDC5;MGST1;DNAJC13;CKAP4;CTSD;PADI2;RAC1;UBR4;CD53;CD63;PYGL;CTSS;CD36;MVP;RAB7A;DBNL;DDOST;CD68;PTPN6;RAB10;HPSE;KCNAB2;CTSB;SLC27A2;NPC2;PSMD11;KCMF1;NFKB1;CDK13;LAMP2;FRK;CD14;PDAP1;MOSPD2;FGL2;GGH;SIRPA;HGSNAT;KPNB1;ATP6V1D;SDCBP;PRDX6;GALNS;VAPA;GNS;TCIRG1;PSEN1;TIMP2;STXBP3;PTPRJ;GAA;RHOA;RAB37;PSMD14;FABP5;DPP7;TSPAN14;SLC2A3;ARSB;TOM1;CTSC;CTSA;ORMDL3;RAB31;CTSH;CYB5R3;PSMD12;PSMB1;SLCO4C1;RAB24;PTGES2;DDX3X;AMPD3;VAT1;GLB1;CRACR2A;PLEKHO2;RHOF;RAP1B;ANXA2;NEU1;GSDMD;CTSZ;FCGR3B;CYFIP1;DNAJC3;MAPK1;ATG7;PGAM1;RAB6A;SRP14
prerank,regulation of receptor recycling (GO:0001919),-0.3438071653365884,-0.9963823639615601,0.44966442953020136,0.8103291365720093,1.0,2/16,3.78%,INPP5F;LAMTOR1
prerank,membrane protein ectodomain proteolysis (GO:0006509),0.4136186788149707,0.9962251982340921,0.5086551264980027,0.8254924579058657,1.0,8/21,22.17%,ADAM19;PRTN3;MYH9;HM13;PSEN1;SPPL3;PSENEN;RBMX
prerank,lipid droplet organization (GO:0034389),-0.32507556799766224,-0.9960350736788661,0.4631578947368421,0.809413946780089,1.0,7/22,22.22%,RAB18;BSCL2;CDS2;SQLE;PLA2G4C;PPIA;FITM2
prerank,regulation of supramolecular fiber organization (GO:1902903),0.40884311414692875,0.9954098081037444,0.4784876140808344,0.8269700386518831,1.0,8/22,22.31%,APOE;MAP1S;CAMSAP2;AKAP13;ABL1;GBA2;CAMSAP1;PARK7
prerank,negative regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902042),0.39014358398508375,0.9952384267061527,0.4714104193138501,0.8268997287078579,1.0,10/30,22.31%,TNFAIP3;CFLAR;ICAM1;BMP5;TRAF2;CASP8;GSK3B;FAIM2;DDX3X;PARK7
prerank,regulation of lipid kinase activity (GO:0043550),-0.38818817740699896,-0.9950825174991321,0.4750733137829912,0.8100900374599158,1.0,2/11,1.49%,RB1;PIK3R3
prerank,epidermal growth factor receptor signaling pathway (GO:0007173),0.36333444729659065,0.9950813554422436,0.4743130227001195,0.8268019455334469,1.0,11/45,17.19%,FAM83A;EGF;EGFR;CBL;PIK3R1;NCK2;ERBIN;GRB2;PTK2;GAREM1;BTC
prerank,positive regulation of potassium ion transport (GO:0043268),-0.2817874818321916,-0.994898273949852,0.4161849710982659,0.8087530506527162,1.0,10/38,13.00%,ACTN2;FHL1;ANK2;KCNJ2;AKAP6;KCNJ3;KCNQ1;KCNJ12;ADRA2A;KCNN3
prerank,purine ribonucleoside monophosphate biosynthetic process (GO:0009168),0.44184836044207293,0.9948205299951044,0.4887640449438202,0.8269567991748628,1.0,7/16,25.32%,ADSL;GMPS;GART;PPAT;AMPD3;AMPD2;IMPDH2
prerank,regulation of nitric-oxide synthase activity (GO:0050999),-0.2856434442900271,-0.9947702019033653,0.4467005076142132,0.80724294522194,1.0,14/36,21.01%,CAV1;NOS3;NPR3;SCARB1;CALM1;NOSIP;NOSTRIN;ATP2B4;WASL;DHFR;DNM2;PIK3CB;ZDHHC21;GCH1
prerank,negative regulation of purine nucleotide metabolic process (GO:1900543),-0.3958411538953043,-0.9945536933279433,0.46111111111111114,0.8041458532234129,1.0,2/10,8.84%,CBFA2T3;HDAC4
prerank,negative regulation of glycolytic process (GO:0045820),-0.3958411538953043,-0.9945536933279433,0.46111111111111114,0.8041458532234129,1.0,2/10,8.84%,CBFA2T3;HDAC4
prerank,regulation of interferon-alpha production (GO:0032647),0.40603390547179197,0.9944699253723865,0.4838274932614555,0.8273539040134937,1.0,9/23,24.06%,IRF7;STAT1;TLR7;HSPD1;TLR3;DDX3X;SETD2;IRF3;PTPRS
prerank,retrograde axonal transport (GO:0008090),0.4273547581022832,0.9941332095173726,0.48179271708683474,0.8276598453350243,1.0,8/16,24.43%,DYNC1H1;KIF1C;KIF5B;FBXW11;NEFL;KIF5A;PAFAH1B1;TMEM108
prerank,regulation of embryonic development (GO:0045995),0.37647310407671347,0.994030993023451,0.4844961240310077,0.8274273237751454,1.0,10/34,17.75%,B4GALT5;EHMT1;NIPBL;ZBED3;BAG6;NPHP3;NR2C2;PHLDB1;PHLDB2;WDPCP
prerank,regulation of heart contraction (GO:0008016),-0.23532810511263763,-0.9937191032307301,0.5294117647058824,0.804656314441904,1.0,29/90,22.47%,ATP1B3;ATP1B1;ANK2;ATP1A2;ITPR2;ABCC9;NPR1;ITPR3;SLC8A3;ATP2B2;CALM1;FXYD6;TRPC1;PDE4D;KCNQ1;ATP2B4;KCNJ12;ATP2A3;FXYD1;SLC8A2;ACE2;ATP1A1;TMEM65;CELF2;RYR2;SRI;CASQ2;STIM1;PLN
prerank,dendrite self-avoidance (GO:0070593),0.4360494257863655,0.9936187730777921,0.4892703862660944,0.8279339703428824,1.0,2/16,1.86%,PALLD;TNN
prerank,regulation of potassium ion transmembrane transport (GO:1901379),-0.26116986051752383,-0.9936105901959119,0.460431654676259,0.803142707396526,1.0,14/54,14.50%,KCNIP4;CAV1;FHL1;KCNJ2;AKAP6;WWP2;KCNJ3;DPP6;CACNA1D;DPP10;KCNQ1;KCNJ12;KCNN3;NEDD4L
prerank,cellular respiration (GO:0045333),-0.26237826690053523,-0.993561070283549,0.4723926380368098,0.8014587084246501,1.0,20/41,26.82%,ME3;NDUFS1;PPARGC1A;UQCRB;ATP5F1D;ETFRF1;ETFB;UQCRC2;SDHAF4;SLC25A14;COX10;UQCRFS1;LYRM7;UQCR10;MTLN;NR4A3;MTFR2;ETFDH;SLC25A13;COX15
prerank,regulation of protein targeting to membrane (GO:0090313),0.39697136087775403,0.9935581491012603,0.48046875,0.8276203470854904,1.0,1/28,0.38%,CEMIP
prerank,regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902041),0.3732930404996873,0.9935284661806235,0.48698884758364314,0.8272200763250894,1.0,11/38,20.26%,TNFAIP3;SFRP1;CFLAR;ICAM1;BMP5;TRAF2;CASP8;GSK3B;SP100;FAIM2;DDX3X
prerank,regulation of developmental growth (GO:0048638),0.39072164637779555,0.9931496809518204,0.49029754204398446,0.827642526861394,1.0,10/29,22.22%,GHR;APOE;NIPBL;OLFM1;STAT5A;GSK3B;ABL1;STAT5B;IGF1;LATS2
prerank,neuron projection extension (GO:1990138),0.3842656372050007,0.9928637690248102,0.4767879548306148,0.8278131173428018,1.0,4/32,3.49%,TNN;NRP1;AUTS2;USP9X
prerank,regulation of JNK cascade (GO:0046328),0.33253022165527774,0.9926906355814338,0.5053995680345572,0.8277410192048855,1.0,19/101,13.84%,SH3RF3;TAOK1;MAP4K4;RAP2A;TIRAP;EDA2R;UNC5CL;AIDA;RASSF2;EGFR;FCGR2B;MAPK8IP1;TAOK3;HDAC3;SH3RF1;PJA2;SIRPA;TRAF2;SDCBP
prerank,anterior/posterior axis specification (GO:0009948),0.43533212982859815,0.9923188067189513,0.48563218390804597,0.8281863445446912,1.0,4/15,23.03%,SHH;WLS;TBX3;DDIT3
prerank,positive regulation of peptide hormone secretion (GO:0090277),0.3569603912263091,0.9921752439430107,0.4938118811881188,0.828048903490965,1.0,5/39,9.15%,TCF7L2;TNFSF11;BLK;ACSL4;LRRC8A
prerank,regulation of gene silencing by miRNA (GO:0060964),0.34914807727802954,0.9920325757045546,0.5067567567567568,0.8279197648132279,1.0,14/62,17.64%,POU5F1;RAE1;NUP37;STAT3;PPARG;NUP153;PUM1;NUP188;FMR1;POLR2K;NUP35;POLR2B;NUP214;WTIP
prerank,regulation of protein localization to nucleus (GO:1900180),0.3681313032271018,0.9918695154600045,0.4743276283618582,0.8278500957196252,1.0,18/43,24.65%,YAP1;SHH;EIF2AK3;PLK1;ILRUN;WWTR1;LAMTOR5;FLCN;GSK3B;ORMDL3;CTNNA1;CDK5RAP3;BYSL;DTX3L;LATS2;PARK7;TGFB1;AKT1
prerank,substrate-dependent cell migration (GO:0006929),0.44333596045416207,0.9917759566160177,0.4876632801161103,0.8275950778503193,1.0,5/14,13.91%,NRP1;OPHN1;SDCBP;ITGB1BP1;ITGA11
prerank,positive regulation of binding (GO:0051099),0.3409393016036623,0.991668423921989,0.5070729053318824,0.8273775284040843,1.0,21/84,18.94%,LRP1;TCF7L2;VTN;LRRK2;APOE;EGF;ADD2;KDM4D;TRIM21;PPARG;NMD3;DDX11;SIRT2;TERT;HMGB2;GSK3B;PSEN1;DPH3;TRIB3;STK4;SPPL3
prerank,negative regulation of extrinsic apoptotic signaling pathway (GO:2001237),0.338881084243157,0.9916022092204893,0.4989010989010989,0.8270632603790895,1.0,25/74,23.13%,TCF7L2;TNFAIP3;SNAI2;BCL2;CFLAR;ICAM1;SIAH2;BMP5;TGFBR1;ACVR1;SH3RF1;TERT;TRAF2;PELI3;CASP8;GSK3B;TNF;GDNF;UNC5B;FAIM2;DDX3X;IGF1;SRC;PARK7;HTT
prerank,positive regulation of type 2 immune response (GO:0002830),-0.35349771284956744,-0.9915119421830471,0.4463276836158192,0.8051857269523246,1.0,6/14,23.20%,CD81;PRKCZ;IL18;RSAD2;CD86;NOD2
prerank,regulation of mRNA metabolic process (GO:1903311),0.46148430178497946,0.9914441081439772,0.500780031201248,0.8269576722576227,1.0,5/11,24.31%,SAFB2;SAFB;SLTM;CDK11B;IWS1
prerank,inner dynein arm assembly (GO:0036159),0.4803514418397439,0.9912516233318096,0.5232919254658385,0.8269357184281423,1.0,1/10,2.33%,DNAAF4
prerank,rRNA pseudouridine synthesis (GO:0031118),0.46846786707211424,0.9911407992301091,0.4937888198757764,0.826735259698842,1.0,2/10,8.17%,RPUSD3;NHP2
prerank,fatty acid biosynthetic process (GO:0006633),0.34553096070121625,0.9908156762067764,0.5050847457627119,0.8270309205930576,1.0,12/63,15.07%,LIPC;LPL;EPHX2;HACD2;XBP1;SCD5;CYP1A1;ELOVL6;HSD17B8;FADS1;NDUFAB1;ELOVL1
prerank,mRNA 3'-end processing (GO:0031124),-0.23450343094285403,-0.9906504320286031,0.47,0.805723397111187,1.0,24/78,25.32%,WDR33;CSTF2;CDC40;LEO1;RPRD1A;SRSF7;CPSF2;TUT1;RBM8A;ZC3H11A;U2AF2;MAGOH;EIF4A3;LSM11;CLP1;CPSF4;PABPN1;PAPOLB;SCAF8;DDX39A;POLDIP3;DDX39B;TENT2;CHTOP
prerank,DNA replication (GO:0006260),0.3293695673798606,0.9904888499135819,0.5042553191489362,0.827342460815546,1.0,30/105,25.34%,RBMS1;BRIP1;POLE3;BAZ1A;DNA2;ATM;ATR;MCM2;NT5M;RMI1;MCM7;GRWD1;MCM9;WDHD1;DBF4;RNASEH2A;RBBP8;TIMELESS;POLA2;POLG;NAP1L1;HELB;ORC6;REV1;RAD9A;RFC1;ATRIP;KIN;PNKP;ING5
prerank,rRNA methylation (GO:0031167),0.4067833416581813,0.9903473195814263,0.4930167597765363,0.8272075005379542,1.0,13/22,30.77%,METTL15;METTL16;MTERF4;NOP2;MRM1;MRM2;FBL;BUD23;METTL5;DIMT1;NSUN4;FTSJ3;FDXACB1
prerank,mitotic G2/M transition checkpoint (GO:0044818),0.3633200560357466,0.9903354494151122,0.4909963985594238,0.8267690634458367,1.0,10/43,15.98%,TAOK1;BABAM2;ATM;PABIR1;PLK1;FZR1;TAOK3;CDC14B;CHFR;RINT1
prerank,mRNA methylation (GO:0080009),0.4363459843167928,0.9903313974793886,0.48405797101449277,0.8263114659097246,1.0,3/15,11.76%,TRMT61B;ZC3H13;METTL16
prerank,chemical homeostasis (GO:0048878),0.3491971917159974,0.9902289259295326,0.5028968713789108,0.8260663942696198,1.0,12/61,11.07%,USF1;TREM2;SLC4A4;SLC4A5;TLCD2;ZBTB20;PPARG;ACOX1;ADCK1;NR1D2;ACOX3;TLCD1
prerank,muscle organ development (GO:0007517),0.35036015641169677,0.9896665381199253,0.5011848341232228,0.8269157082330969,1.0,7/54,10.14%,LAMA2;COL6A3;FHL3;EGR3;CXCL10;TCF12;CHD2
prerank,NAD biosynthetic process (GO:0009435),-0.33485496431042533,-0.9895999837942104,0.46774193548387094,0.8065286517336558,1.0,12/20,36.74%,NAMPT;NMNAT3;PARP10;NAXE;NAPRT;NMNAT1;PARP9;KYNU;NAXD;HAAO;PARP16;QPRT
prerank,regulation of neuron death (GO:1901214),-0.22882864967148553,-0.989470638456345,0.4268292682926829,0.8051174655624435,1.0,23/82,20.22%,GRID2;RILPL1;PRKN;CD34;MAP3K5;DCC;PPARGC1A;CD200;MEF2C;BTBD10;EPHB1;DDIT4;EGLN3;DHCR24;TRIM2;IKBKG;GRIN2B;AKT1S1;HTRA2;CHGA;SARM1;ATP13A2;SORL1
prerank,protein deacylation (GO:0035601),0.39994475026160115,0.9893655684296131,0.4894459102902375,0.8271633680371997,1.0,10/23,22.74%,ABHD17C;LYPLAL1;HDAC1;HDAC5;SIRT2;HDAC3;ABHD10;SIRT7;SIRT3;LYPLA2
prerank,cellular glucose homeostasis (GO:0001678),0.36717677477718225,0.9893322543950606,0.5089179548156956,0.8267740508976118,1.0,8/41,10.96%,SLC39A14;HKDC1;HK2;PIK3R1;FOXK2;ZBTB20;LRRC8A;XBP1
prerank,negative regulation of sequestering of calcium ion (GO:0051283),0.3957369694138057,0.9890910266690769,0.4928104575163399,0.8269171847681509,1.0,5/24,12.01%,ITPR1;XCL1;PKD2;IBTK;FGF2
prerank,microtubule polymerization (GO:0046785),0.39174236279784147,0.9887699636889979,0.4868766404199475,0.8271943841389348,1.0,13/28,24.16%,TUBG1;FGF13;TPX2;CSNK1D;RANBP9;TPPP;TUBGCP4;TPPP3;NDEL1;TUBG2;CKAP5;AKAP9;CLASP2
prerank,cellular response to lectin (GO:1990858),0.3314365419519378,0.9885864182777382,0.5079030558482613,0.8266907853218624,1.0,22/104,23.15%,PSMA7;CREBBP;CUL1;PSMD4;PSMD11;NFKB1;PSMB8;FBXW11;SKP1;RELB;PSMA6;PSMD14;PSMC6;PSMB10;PSMD12;PSMB1;PSMA8;PSMF1;PAK1;SRC;PSME2;PSMA4
prerank,stimulatory C-type lectin receptor signaling pathway (GO:0002223),0.3314365419519378,0.9885864182777382,0.5079030558482613,0.8266907853218624,1.0,22/104,23.15%,PSMA7;CREBBP;CUL1;PSMD4;PSMD11;NFKB1;PSMB8;FBXW11;SKP1;RELB;PSMA6;PSMD14;PSMC6;PSMB10;PSMD12;PSMB1;PSMA8;PSMF1;PAK1;SRC;PSME2;PSMA4
prerank,lymphocyte mediated immunity (GO:0002449),-0.3778460554457277,-0.9885091969064513,0.4570552147239264,0.8058010400976389,1.0,3/12,5.55%,CD46;CD55;MSH2
prerank,mitochondrial translational elongation (GO:0070125),-0.2267846103267787,-0.9881686347628388,0.4470588235294118,0.804955915146105,1.0,39/88,27.33%,MRPS9;MRPS15;PTCD3;MRPL39;MRPS28;MRPS35;ERAL1;TSFM;MRPS31;MRPL4;MRPS7;MRPS18C;MRPS25;MRPL28;MRPL30;MRPL42;MRPL22;MRPL40;MRPL46;MRPS24;MRPS16;MRPS22;MRPS18B;MRPL20;MRPL58;MRPL23;MRPS10;MRPS12;MRPL18;MRPS34;MRPL43;MRPL44;MRPS21;MRPL35;MRPL2;MRPL13;MRPL54;MRPL16;MRPL34
prerank,protein palmitoylation (GO:0018345),-0.29369209225397536,-0.9877228913024343,0.45867768595041325,0.8043801265054693,1.0,14/30,29.61%,ZDHHC13;ZDHHC5;SELENOK;ZDHHC15;GLUL;GOLGA7;ZDHHC21;ZDHHC20;ZDHHC7;ZDHHC14;ZDHHC17;ZDHHC23;ZDHHC16;ZDHHC12
prerank,cellular response to dsRNA (GO:0071359),-0.3553593754463581,-0.9867173774495159,0.4716312056737589,0.8052961765247488,1.0,5/15,11.17%,CAV1;MAVS;IFIH1;RIOK3;IFIT1
prerank,innate immune response activating cell surface receptor signaling pathway (GO:0002220),0.3304423343963247,0.9864287562189915,0.5120925341745531,0.8312591221407962,1.0,22/105,23.15%,PSMA7;CREBBP;CUL1;PSMD4;PSMD11;NFKB1;PSMB8;FBXW11;SKP1;RELB;PSMA6;PSMD14;PSMC6;PSMB10;PSMD12;PSMB1;PSMA8;PSMF1;PAK1;SRC;PSME2;PSMA4
prerank,aspartate family amino acid catabolic process (GO:0009068),0.4205309833938886,0.9858166991941332,0.4879432624113475,0.8322293501045553,1.0,4/19,10.34%,SDSL;CRYM;DLST;ALDH7A1
prerank,histone ubiquitination (GO:0016574),-0.32472989786535966,-0.9857521682147727,0.4774436090225564,0.8060740111243863,1.0,8/21,22.59%,HUWE1;UBE2N;CTR9;LEO1;WAC;UBE2B;PHC1;UBE2A
prerank,cellular protein localization (GO:0034613),0.31007650181413726,0.9856075928216288,0.5311244979919679,0.8322517707488124,1.0,82/285,22.29%,CLTC;SH3PXD2B;WIPI1;SEC31A;STX6;COPZ2;AP4M1;COPA;AP3B1;WNT5A;LRRK2;FGF7;RAP2A;RABGAP1L;ARFGAP3;ARCN1;STX17;ARMCX3;RAB21;ITSN1;WLS;CD63;EGFR;TM9SF4;RABGAP1;TBC1D2B;NIPBL;STXBP1;COPB2;RAB3GAP2;TBC1D16;MYO7A;TBC1D8B;ERP29;SNX8;COPZ1;ARL4C;SNX6;STX11;SCFD1;SMURF1;RAB32;AXIN2;TBC1D13;EPB41L3;RTP4;RRAGC;SNX9;PIGK;AP3D1;ANGPT1;STXBP3;DNAJC27;USO1;TM9SF2;CPLANE2;PICK1;HGS;TMED1;CTSA;RAB31;SNX15;EVI5L;COG7;ARF1;SGSM3;ADPRH;RAB24;JAM3;TMED10;RUNDC1;TRAPPC8;TMED7;WDR45;EHD1;ARF4;PACS2;EMP2;SEC23IP;TBC1D1;RAB1A;TBC1D10B
prerank,skeletal muscle tissue development (GO:0007519),0.37870750086129823,0.9853985828072773,0.4849673202614379,0.8322345501248686,1.0,3/32,4.49%,SVIL;MYORG;CFLAR
prerank,positive regulation of protein modification by small protein conjugation or removal (GO:1903322),0.3376905688032055,0.9851871872653485,0.4961915125136017,0.8322454663104638,1.0,19/76,17.21%,TNIP1;MYCBP2;BIRC3;LRRK2;GNL3;UBQLN1;UBE2L3;TBC1D7;PHF23;PRICKLE1;SAE1;DCUN1D1;HDAC3;TANK;FBXW7;STUB1;RASD2;ANGPT1;DCUN1D5
prerank,bile acid metabolic process (GO:0008206),0.39065197449083044,0.9851805496051671,0.5019973368841545,0.8317969892137355,1.0,1/27,0.14%,CYP7B1
prerank,regulation of lamellipodium assembly (GO:0010591),0.38169685179308366,0.9850724666096081,0.4811083123425693,0.8315834461191663,1.0,7/34,7.45%,CARMIL2;AUTS2;ACTR2;FSCN1;RAC1;CDC42;PIK3R1
prerank,histone H4-K5 acetylation (GO:0043981),-0.3488458644951671,-0.9848860959623881,0.44936708860759494,0.8049158195090395,1.0,4/15,8.50%,JADE1;JADE2;WDR5;JADE3
prerank,histone H4-K8 acetylation (GO:0043982),-0.3488458644951671,-0.9848860959623881,0.44936708860759494,0.8049158195090395,1.0,4/15,8.50%,JADE1;JADE2;WDR5;JADE3
prerank,autophagy of mitochondrion (GO:0000422),0.37110990554308726,0.9847865880737289,0.4896969696969697,0.8317585474893551,1.0,7/38,10.11%,WIPI1;AMBRA1;ATG3;FBXO7;SQSTM1;FUNDC2;CTSK
prerank,regulation of protein kinase activity (GO:0045859),0.3268563208215257,0.9847668301177872,0.5219206680584552,0.8313454421191859,1.0,30/106,18.89%,JTB;GSKIP;DDR2;SPRED1;LCP2;RASSF2;CACUL1;NF1;TAF7;EPHA1;DTNBP1;TARBP2;WWTR1;ALS2;PYDC1;PTK2;THY1;SMG8;LRP6;ITGB1BP1;RTRAF;TNF;SNX9;UBASH3B;PRKRIP1;SMCR8;TRIB3;DVL1;TRIM27;MMD
prerank,establishment of mitotic spindle orientation (GO:0000132),0.4082664555115473,0.9845630465327532,0.5053050397877984,0.8313459494648853,1.0,10/23,25.12%,MAD2L1;GPSM2;PLK1;FBXW11;INSC;NDEL1;ITGB1;HTT;PAFAH1B1;NUMA1
prerank,regulation of ERAD pathway (GO:1904292),-0.38280327712599055,-0.9842571762760333,0.45179063360881544,0.8048149729428048,1.0,6/11,27.09%,RNF185;ATXN3;AQP11;USP13;HERPUD1;UBXN1
prerank,smooth muscle tissue development (GO:0048745),0.47071199364450994,0.9841685440953265,0.4894578313253012,0.8318228633775884,1.0,6/10,17.85%,SHH;NF1;MYLK;STRA6;PTCH1;SMO
prerank,positive regulation of cytokine production involved in immune response (GO:0002720),0.3932831031445816,0.9839943532666998,0.5032594524119948,0.8317316492294662,1.0,3/25,3.54%,LACC1;WNT5A;XCL1
prerank,negative regulation of cellular metabolic process (GO:0031324),0.36893449524121263,0.9838434038243186,0.49440993788819876,0.8316291106034222,1.0,7/37,13.84%,ABCA2;ATXN2;APOE;NFKB1;SIRT2;DLG4;SDCBP
prerank,histone mRNA catabolic process (GO:0071044),0.4365547733136572,0.9837124261388253,0.5007112375533428,0.8314844341547013,1.0,5/15,12.16%,ATM;XRN1;ERI1;EXOSC4;DCP2
prerank,"negative regulation of gene expression, epigenetic (GO:0045814)",0.40645237113174826,0.9835916721028484,0.4993197278911565,0.8312936953690493,1.0,12/24,24.76%,PHF1;EZH2;DNMT3B;SPI1;TRIM27;RBBP4;JARID2;MPHOSPH8;PPM1D;AEBP2;DNMT3A;CREBZF
prerank,regulation of coagulation (GO:0050818),-0.3855524836976496,-0.9832471599436933,0.49122807017543857,0.8056966445688581,1.0,1/11,0.66%,CAV1
prerank,double-strand break repair (GO:0006302),0.3169131947058302,0.9832429327843596,0.5183673469387755,0.8316392817168861,1.0,35/158,16.35%,RAD51B;PARP3;BRIP1;TNKS1BP1;DNA2;RAD52;INO80;FBH1;BABAM2;ATM;HELQ;KDM4D;XRCC3;TDP2;DCLRE1C;MDC1;RNF8;PAXX;RMI1;MMS22L;RNF138;SETX;MCM9;SETMAR;NUCKS1;HMGB2;RIF1;ZFYVE26;AP5Z1;YY1;LIG3;IFFO1;SEM1;RBBP8;KDM2A
prerank,positive regulation of BMP signaling pathway (GO:0030513),0.39649469202754184,0.9829230844703104,0.5077519379844961,0.8318984128014593,1.0,4/25,12.71%,SULF1;SMAD2;ACVR2A;RBPJ
prerank,double-strand break repair via homologous recombination (GO:0000724),0.3288522549747967,0.9821689334071299,0.5227765726681128,0.8331286009227807,1.0,25/95,19.66%,RAD51B;RAD52;INO80;FBH1;HELQ;NIPBL;KDM4D;XRCC3;MCM2;RMI1;MMS22L;RNF138;MCM7;MCM9;NUCKS1;ZFYVE26;AP5Z1;YY1;LIG3;SEM1;RBBP8;PSMD14;XRCC2;NSMCE2;PARP1
prerank,negative regulation of cellular carbohydrate metabolic process (GO:0010677),0.40397372456559405,0.982005385284862,0.4959016393442623,0.8330666261127816,1.0,1/23,0.51%,ADIPOQ
prerank,primary miRNA processing (GO:0031053),0.472317967585523,0.9819559376852737,0.517774343122102,0.8327065252505691,1.0,4/10,19.73%,SMAD2;DGCR8;SMAD3;HNRNPA2B1
prerank,synapse organization (GO:0050808),0.3213022476637797,0.9819537139360309,0.5305907172995781,0.8322507017477783,1.0,20/125,8.86%,PDZRN3;SLITRK6;GPC6;FARP1;PCDHB6;PCDHB16;CACNB1;SDK2;LRRK2;PPFIA4;ADGRL3;PTEN;PPFIBP2;CDC42;DBNL;OBSL1;PLXND1;PPFIBP1;C1QB;SEMA3E
prerank,regulation of Notch signaling pathway (GO:0008593),0.33754652575210053,0.9816898971165533,0.5126234906695939,0.8323979335057223,1.0,27/76,22.56%,MMP14;YAP1;ZMIZ1;JAG1;EGF;DLK1;MAML3;STAT3;EGFR;CREBBP;LLGL1;MAML2;GALNT11;RBPJ;TSPEAR;ITGB1BP1;FBXW7;NEPRO;PDCD10;TCIM;TSPAN14;ARRB1;TGFB2;YTHDF2;EGFL7;SRC;ZBTB7A
prerank,protein insertion into ER membrane (GO:0045048),0.3633046087712092,0.9816880300927749,0.49135802469135803,0.8319427830524354,1.0,9/37,16.42%,EMC1;TRAM2;EMC7;WDR83OS;BAG6;ALDH3A2;EMC8;VAPA;MMGT1
prerank,negative regulation of supramolecular fiber organization (GO:1902904),0.3379798377281386,0.9816722651807962,0.5132450331125827,0.8315176609905923,1.0,15/72,12.79%,TAOK1;IAPP;APOE;NAV3;LIMA1;TREM2;SSH1;CAMSAP2;PLEKHH2;PFDN1;EMILIN1;CLIP3;FGF13;TPX2;PFDN4
prerank,regulation of catecholamine secretion (GO:0050433),0.38872840898172084,0.9812233564522794,0.5219638242894057,0.8320554972873379,1.0,6/29,12.78%,FGF20;SYT10;SYT2;DTNBP1;DRD3;SYT3
prerank,regulation of centriole replication (GO:0046599),0.41602593972143703,0.981056925084944,0.48,0.8319801724497057,1.0,2/17,3.61%,CEP295NL;ALMS1
prerank,regulation of cellular protein localization (GO:1903827),0.35715005863328525,0.981035539089803,0.49821215733015495,0.8315716043909303,1.0,16/45,22.37%,GPC6;ABCA2;LCP1;TRIM67;EGF;SHH;KCNAB2;PTPN1;VCPIP1;CEP72;DVL1;PARP1;NDEL1;GBF1;GPC4;SETD2
prerank,regulation of peptidyl-lysine acetylation (GO:2000756),-0.38967680406260674,-0.9808555706566514,0.486646884272997,0.8103537382598288,1.0,5/10,28.84%,PRKAA2;MYOCD;SIRT1;KLF15;DIP2A
prerank,diol biosynthetic process (GO:0034312),-0.34108415258215297,-0.9807134594431617,0.47318611987381703,0.8089737159467221,1.0,8/15,21.01%,ACER2;SPTLC2;SPTLC1;ASAH1;DHFR;ASAH2;SPHK1;GCH1
prerank,microtubule cytoskeleton organization involved in mitosis (GO:1902850),0.32246427773036607,0.9804548056293962,0.5311203319502075,0.8324518645303559,1.0,22/125,15.74%,NEK6;TAOK1;DYNLL1;MAD2L1;EML4;CENPQ;DYNC1H1;NEK9;GPSM2;CENPN;NUP37;TUBG1;KIF2A;PLK1;INCENP;B9D2;RCC1;KPNB1;SPC25;MAP4;CENPT;CENPL
prerank,natural killer cell activation (GO:0030101),0.40212973232051413,0.980201853331758,0.5026455026455027,0.8325593473169137,1.0,4/23,14.67%,ULBP1;ELF4;BAG6;CASP8
prerank,amino acid transmembrane transport (GO:0003333),-0.2620815249847129,-0.979611486191012,0.47619047619047616,0.810252748146511,1.0,15/45,23.74%,SLC6A6;SLC47A1;LRRC8D;SLC38A11;SLC7A5;SLC38A5;SLC22A2;SLC25A12;SLC7A1;SLC38A9;SLC1A6;SLC38A2;SLC38A1;SFXN2;SLC7A10
prerank,regulation of muscle cell differentiation (GO:0051147),-0.2919964969038195,-0.9794804795407448,0.4716981132075472,0.8088497998189682,1.0,9/31,15.46%,HDAC9;CTNNA2;MEF2C;IGF2;MAPK12;MEF2A;BOC;MYOCD;CAMK1
prerank,protein quality control for misfolded or incompletely synthesized proteins (GO:0006515),0.3887109656879949,0.9793530770092463,0.49265687583444595,0.8340108355406618,1.0,11/25,26.65%,UGGT2;ZYG11B;OMA1;BAG6;POMT2;STUB1;UBE2W;NGLY1;AUP1;UGGT1;VCP
prerank,positive regulation of protein autophosphorylation (GO:0031954),0.40774742166659866,0.9792512176042278,0.5041322314049587,0.8337909722179488,1.0,7/22,13.46%,TNKS1BP1;RAP2A;RASSF2;CALM3;TOM1L1;GPNMB;CALM2
prerank,skeletal muscle contraction (GO:0003009),0.4178357350699017,0.9792295552350793,0.5092198581560283,0.8333825315140171,1.0,3/19,7.17%,CCDC78;TNNI3;TNNC1
prerank,positive regulation of intracellular protein transport (GO:0090316),0.32040791686471976,0.9788764765342431,0.5400410677618069,0.833681938205562,1.0,33/144,18.44%,CEMIP;SEC16B;TCF7L2;BCL2;UBR5;CSNK2A2;BBC3;SEC16A;E2F1;TM9SF4;PIK3R1;UBE2L3;BAG3;PCM1;SAE1;TFDP1;HDAC3;ZIC1;TOMM7;SMAD3;ITGB1BP1;FBXW7;CASP8;GSK3B;NPEPPS;ARIH2;PSEN1;PDCD10;SH3GLB1;MICALL2;RIPOR1;PCNT;FIS1
prerank,regulation of lipopolysaccharide-mediated signaling pathway (GO:0031664),0.41787604685783997,0.9786298022715517,0.4931506849315068,0.8337901460917309,1.0,7/17,22.58%,PRKCA;LY96;CD36;SASH1;CX3CL1;TRIB1;CARD16
prerank,endothelial tube morphogenesis (GO:0061154),0.46141152837263744,0.9786261898287294,0.4919093851132686,0.8333406119296494,1.0,6/10,22.29%,PRKD2;CCM2;RBPJ;RHOA;STARD13;ACVRL1
prerank,response to cadmium ion (GO:0046686),-0.3126502739989575,-0.9781952812600322,0.43775100401606426,0.8105280746298591,1.0,13/26,28.06%,JUN;MT2A;HSF1;MAPK8;MT1B;MT1X;MT1G;MT1F;MT1E;MT1M;MT1H;MT1A;MAPK3
prerank,positive regulation of immune system process (GO:0002684),0.424194641338545,0.9778040663537246,0.5007429420505201,0.8347135715680266,1.0,3/16,8.51%,ANXA1;MIA3;LGALS9
prerank,organelle assembly (GO:0070925),0.3065465915136964,0.9775811473306679,0.5763052208835341,0.8347652230536101,1.0,87/384,19.09%,TEKT4;SH3PXD2B;NEK6;VMP1;DYNLL1;WIPI1;FARP2;STK36;GORASP2;ATXN2;CEP19;CHMP4B;CHMP4A;ACTR2;SYNPO;DYNC1H1;ASAP1;AMBRA1;ATP2A2;INO80;HAUS3;ATG3;RAB8B;UBQLN1;SNX10;RAB7A;UBXN2A;DBNL;DISC1;PARVA;EXOC4;IFT88;WDR35;PDE6D;FAM161A;CPLANE1;VPS4A;B9D2;TMEM138;CEP41;YTHDF3;PCM1;TMOD1;HDAC3;CDC14B;RCC1;GALNT11;NPHP3;CLUAP1;CSNK1D;DYNC2H1;RAB32;MAPRE2;ATP6V1D;PIK3C3;IFT52;MVB12A;DHX29;ATG16L2;EHD2;CENPT;EXOC5;ARL13B;CC2D2A;IFT20;ATG14;IQCB1;RAB8A;CHMP3;VPS37C;IFT81;CFAP410;GOLGA8B;PTPN23;CPLANE2;HGS;WDPCP;BBS7;TUBGCP4;KIF3A;CHMP7;PCNT;CEP126;EXOC7;EXOC1;PRRC2C;KIF27
prerank,regulation of axon extension (GO:0030516),-0.27110955615678634,-0.977194856581281,0.5077720207253886,0.8114865539399065,1.0,15/37,19.99%,MAP2;SEMA7A;ZFYVE27;TWF2;SIN3A;SHTN1;LIMK1;NTN1;MAG;SEMA3G;RNF6;CDKL3;TRIM46;DNM2;MACF1
prerank,negative regulation of apoptotic process (GO:0043066),0.3080184331767787,0.9771387993745969,0.5751503006012024,0.8353064734289501,1.0,91/444,17.90%,NR1H4;BCL3;YAP1;MAP4K4;FGF20;PRKCA;FSTL1;SFRP1;EGR3;MAD2L1;BIRC3;WNT5A;FHL2;SNAI2;APOE;GATA6;BCL2;TSLP;CFLAR;ANXA1;CSNK2A2;TREM2;TXNDC5;TLE1;RNF157;CDKN2D;SHH;FXN;MDK;BABAM2;NUGGC;MGMT;SIAH2;EGFR;HDAC1;CBL;APOH;PIK3R1;ANGPTL4;PLK1;DNAJB6;SQSTM1;BAG3;AREL1;TGFB3;PTPRZ1;ASNS;MERTK;NFKB1;SPRY2;FZD3;FZD9;XBP1;RPS6KB1;SETX;HDAC3;BCL2L2;SH3RF1;FNIP1;SNX6;LAMTOR5;IL7;ARAF;HTATIP2;PDPN;PTK2;ITGA5;CCL2;HSPD1;HIPK3;PRDX5;UBE2Z;USP47;GSK3B;BAG4;TNF;CX3CL1;TAF9B;HNRNPK;PSEN1;SON;ANGPT1;PDCD10;GDNF;PPIF;RPS6KA3;TBX3;ITCH;TCIM;UNC5B;MAEA
prerank,heterochromatin organization (GO:0070828),0.4371598399155699,0.977119365910464,0.4934687953555878,0.834886940925471,1.0,7/14,20.47%,SNAI1;POLE3;SETDB1;BAHD1;SETD7;SETDB2;HP1BP3
prerank,regulation of signal transduction by p53 class mediator (GO:1901796),0.313778620024127,0.9770282534523368,0.5375128468653648,0.8346378488815815,1.0,35/148,19.64%,BRIP1;NUAK1;DNA2;PIP4K2A;CSNK2A2;KMT5A;EHMT1;ATM;BRPF1;HEXIM1;ATR;HDAC1;TAF4;MTA2;TAF7;MAPKAP1;PIP4K2B;RICTOR;RMI1;MAPK11;NOC2L;TPX2;PRDM1;BANP;NOP2;PRMT5;MDM2;TAF9B;RBBP8;TAF2;CSNK2A1;PHF20;CDK5;RBBP4;STK11
prerank,protein K11-linked ubiquitination (GO:0070979),0.38466973649746317,0.9768653472060909,0.5221354166666666,0.8345639809600435,1.0,9/27,18.37%,ANAPC11;UBE2L3;FZR1;CDC27;UBE2E2;CDC16;ANAPC2;UBE2W;UBE2S
prerank,regulation of protein acetylation (GO:1901983),0.4542712410653806,0.9765979362415125,0.5044510385756676,0.8347257721075688,1.0,6/12,22.31%,TAOK1;FAM161A;GSK3B;DDX3X;TERF2IP;PARK7
prerank,neuromuscular process (GO:0050905),0.42568566475127884,0.9759974200137304,0.5,0.835635319481559,1.0,6/16,19.70%,MYCBP2;AGTPBP1;HOXA1;STRA6;CLN3;UBA5
prerank,plasma membrane bounded cell projection assembly (GO:0120031),0.3072063200458752,0.9757463739646605,0.5714285714285714,0.8357272699736578,1.0,77/259,22.14%,TEKT4;DYNLL1;PPP1R9B;MAP4K4;S1PR2;STK36;NRP1;EMP1;CEP19;RHOD;RAP2A;ACTR2;AIF1L;ASAP1;FSCN1;FGD4;CARMIL1;OPHN1;RAC1;RAB8B;AIF1;PMP22;SNX10;DISC1;PARVA;EXOC4;IFT88;WDR35;PDE6D;FAM161A;CPLANE1;B9D2;TMEM138;CEP41;PCM1;WHAMM;CDC14B;MYLK;GALNT11;NPHP3;CLUAP1;DYNC2H1;ATP6V1D;SDCBP;IFT52;EHD2;EXOC5;FGD6;ARL13B;CC2D2A;IFT20;IQCB1;RAB8A;PIP5K1A;IFT81;CFAP410;PTPN23;CPLANE2;WDPCP;BBS7;KIF3A;PCNT;CEP126;EXOC7;EXOC1;KIF27;IFT172;P2RX7;GBF1;CEP162;RAP1B;EHD1;ITGB1;ARF4;EMP2;WDR90;RAB1A
prerank,positive regulation of cation channel activity (GO:2001259),-0.265662843609094,-0.9747669457023046,0.5277777777777778,0.8161061015388181,1.0,7/40,7.46%,ACTN2;ANK2;SHANK3;AKAP6;TMSB4X;CALM1;RELN
prerank,heterochromatin assembly (GO:0031507),0.4054044125627348,0.9747570861741018,0.5125698324022346,0.8375743694200253,1.0,5/20,13.36%,POLE3;HDAC1;MBD2;SIRT2;BAHD1
prerank,ceramide transport (GO:0035627),0.4485761208646911,0.9743780939326536,0.5007518796992482,0.8380000894325301,1.0,2/12,5.72%,ABCA2;PLTP
prerank,regulation of transport (GO:0051049),-0.27015575411624154,-0.9742780142022408,0.5125,0.815671774883561,1.0,7/36,9.01%,ICA1;EPB41;ACTB;PRKN;REEP5;PINK1;ARL6IP5
prerank,modified amino acid transport (GO:0072337),0.43472652246309,0.9740919295073298,0.4838235294117647,0.8381988193676186,1.0,3/15,13.03%,SLC16A12;MGST1;PDPN
prerank,natural killer cell mediated cytotoxicity (GO:0042267),0.4197280364082664,0.9740863525883944,0.5036390101892285,0.8377528681143122,1.0,2/16,11.23%,ULBP1;KIF5B
prerank,proteasome-mediated ubiquitin-dependent protein catabolic process (GO:0043161),0.3076269162874848,0.9740462395800114,0.5754527162977867,0.8373790945984936,1.0,86/314,22.63%,PSMA7;SPSB1;MAD2L1;KLHL22;FBXL7;SMURF2;ANAPC11;UBQLN1;SIAH2;UBXN2A;CUL1;PLK1;PSMD4;APPBP2;UBE2J1;AREL1;DDB1;PSMD11;FBXO38;FBXO5;FBXO31;ZSWIM8;EDEM1;FZR1;SIRT2;BAG6;SPOP;TRIM13;CDC27;CDC16;PSMB8;ANAPC2;RAD23A;KCTD2;PCNP;SELENOS;FBXL18;FBXW11;SMURF1;SKP1;CLOCK;TBL1X;FBXW5;KCTD5;FBXW7;STUB1;NEMF;MDM2;DCAF12;PSMA6;UBE2W;SYVN1;RNF103-CHMP3;UBE2E1;DCAF11;RBCK1;FBXO45;ITCH;NFE2L2;PSMD14;MAEA;RNF121;SPSB3;FBXO2;KCTD10;UBE2S;PSMC6;PSMB10;ARRB1;UCHL1;PSMD12;PSMB1;NEDD4;PSMA8;IFI27;FBXL12;PSMF1;PPP2R5C;AUP1;RHBDD2;RPS27A;TNFAIP1;RAD23B;HSPA5;COP1;PSME2
prerank,regulation of systemic arterial blood pressure by hormone (GO:0001990),0.43617099075904947,0.9740049785484894,0.5043988269794721,0.8370247603937694,1.0,1/14,0.80%,EDN3
prerank,translation (GO:0006412),-0.19786413939624767,-0.9736090346425054,0.7333333333333333,0.8157727246904761,1.0,74/208,22.20%,WARS2;RPL34;RPL8;RPL18A;RPL36;RPL19;RPL38;RPL5;RPS23;RPLP0;MRPS15;RPS10;COPS5;RPL32;ABCF1;RPS4X;DARS2;PTCD3;RPL10;RPL15;RPL29;RPS16;MRPS28;RPS27;RPS19;RPS12;DHPS;IARS1;RPS21;RPS13;RPL13;QARS1;TSFM;RPL27;RPL7A;RPL35;RPL28;RPL30;RPS8;EEF1D;EEF2;MRPS7;MRPS18C;QRSL1;RPS17;RPL37A;EIF4EBP2;APEH;RPS6;RPL41;RPS18;MRPL28;FASTKD2;RPS6KB2;MRPL42;GSPT2;RPS20;MRPS24;MRPS16;RPL7;MRPS18B;RPL13A;VARS1;GATC;MRPL23;RPS15A;EEF1G;RPS5;UBA52;RPS29;RPLP1;MRPS12;MRPL18;RPL21
prerank,regulation of calcium ion transmembrane transporter activity (GO:1901019),-0.2915320144352938,-0.9734870531860029,0.46601941747572817,0.8143280739608586,1.0,8/27,15.82%,DMD;CACNB2;ANK2;CALM1;PDE4D;ADRA2A;JPH4;CACNB4
prerank,negative regulation of viral life cycle (GO:1903901),-0.3480558032600888,-0.9731286361763041,0.48172757475083056,0.8135124278306223,1.0,4/15,19.45%,LY6E;GSN;BST2;PPIA
prerank,positive regulation of protein ubiquitination (GO:0031398),0.33045283965322947,0.9729363960696691,0.5255157437567861,0.8389809498425775,1.0,19/80,18.59%,ARRDC4;MYCBP2;BIRC3;LRRK2;UBQLN1;PLK1;UBE2L3;TBC1D7;ARRDC3;PHF23;PRICKLE1;DCUN1D1;HDAC3;FBXW7;STUB1;ANGPT1;DCUN1D5;PEF1;TRIB3
prerank,ATP-dependent chromatin remodeling (GO:0043044),0.36408057551025197,0.9726683156313901,0.5146341463414634,0.8391288401653213,1.0,15/42,19.61%,INO80;SMARCC1;ARID1B;HDAC1;MTA2;MBD2;RNF8;CHD8;GATAD2B;ACTR6;SRCAP;SPTY2D1;RBBP4;SMARCB1;SMARCA4
prerank,positive regulation of cardiocyte differentiation (GO:1905209),-0.37802839390113485,-0.9724562983576142,0.5102639296187683,0.8135448602163288,1.0,3/11,15.39%,MEF2C;GPER1;MYOCD
prerank,endoplasmic reticulum calcium ion homeostasis (GO:0032469),0.410486276576921,0.9720134290495822,0.5059760956175299,0.840143398988686,1.0,8/20,21.69%,CAMK2D;BCL2;ATP2A2;BAX;PSEN1;FIS1;RAP1GDS1;PACS2
prerank,snRNA 3'-end processing (GO:0034472),0.4065983178926999,0.9720104634596627,0.5061224489795918,0.8396939341595677,1.0,10/19,28.85%,EXOSC4;USB1;EXOSC2;INTS1;EXOSC3;TOE1;INTS8;INTS6;INTS14;EXOSC5
prerank,positive regulation of protein tyrosine kinase activity (GO:0061098),-0.26465591126432975,-0.971802749362487,0.5083798882681564,0.8136190119181823,1.0,11/41,12.34%,TGFA;EPHA4;NEDD9;DOCK3;GAS6;RELN;ACE;NTRK2;SRCIN1;ADRA2A;BDNF
prerank,regulation of phosphoprotein phosphatase activity (GO:0043666),0.36586795399750616,0.9714681421724575,0.5331632653061225,0.8404742849373371,1.0,8/35,16.16%,NUAK1;PDGFRB;PPP1R2;CALM3;FKBP1B;CALM2;GSK3B;ITGA1
prerank,transferrin transport (GO:0033572),0.36954275834447053,0.9707535551134322,0.5062972292191436,0.8416114526735086,1.0,9/33,18.85%,CLTC;STEAP3;ATP6V1G1;ATP6V1D;ATP6V1F;TCIRG1;ATP6V0A2;ATP6V1H;ATP6V1G2
prerank,nuclear membrane reassembly (GO:0031468),0.3521748148484807,0.9705679088692755,0.5260047281323877,0.8415740438331916,1.0,17/54,18.34%,CHMP4B;CHMP4A;NUP37;UBXN2A;CC2D1B;REEP4;VPS4A;PPP2R2A;SIRT2;NUP188;LEMD2;RCC1;KPNB1;NUP35;CCNB2;CHMP3;CHMP7
prerank,regulation of aerobic respiration (GO:1903715),-0.34945107165875866,-0.9701520633052971,0.4894366197183099,0.8162539975278567,1.0,4/15,12.26%,CBFA2T3;PINK1;IDE;NOP53
prerank,regulation of dendrite morphogenesis (GO:0048814),-0.2795803659141145,-0.9700386867203626,0.5051020408163265,0.8148254349972003,1.0,14/32,22.73%,ADGRB3;CUX2;RAPGEF2;SEMA4D;CUX1;IL1RAPL1;HECW1;LZTS1;NEDD4L;CDKL3;SARM1;TNIK;PTPRD;NSMF
prerank,regulation of astrocyte differentiation (GO:0048710),0.45619914363529257,0.9699632136645294,0.5120845921450151,0.8424786338325924,1.0,2/12,9.50%,SERPINE2;BIN1
prerank,regulation of lymphocyte migration (GO:2000401),0.4632008132962026,0.9699016331030648,0.4968152866242038,0.8421689461193583,1.0,3/10,12.95%,SPN;MIA3;MSN
prerank,glucose homeostasis (GO:0042593),0.3297336974368066,0.9696178397969627,0.5249457700650759,0.8423456527527573,1.0,12/83,9.15%,ADIPOQ;TCF7L2;USF1;IRS1;STAT3;HKDC1;PYGL;HK2;PIK3R1;FOXK2;PPARG;LRRC8A
prerank,regulated exocytosis (GO:0045055),0.3134789798771978,0.969077895503384,0.5557830092118731,0.8431114685428716,1.0,22/173,10.64%,KNG1;SERPING1;SPARC;MAGED2;LHFPL2;PROS1;TIMP1;STEAP2;EGF;MYH9;BRPF3;BLK;SYT10;CD63;CD36;APOH;STXBP1;SYT2;RAB10;TGFB3;LAMP2;CLEC3B
prerank,filopodium assembly (GO:0046847),0.4207589456958824,0.9683708839219245,0.5176803394625177,0.8442741174239934,1.0,3/16,5.41%,PPP1R9B;S1PR2;FGD4
prerank,V(D)J recombination (GO:0033151),0.4540475834098296,0.9682087011621892,0.5162287480680062,0.8441620182108545,1.0,4/11,15.17%,LIG1;TCF3;HMGB2;LIG3
prerank,attachment of mitotic spindle microtubules to kinetochore (GO:0051315),-0.371788377480878,-0.9677739115852408,0.4815950920245399,0.8191124113038317,1.0,10/12,45.71%,SEH1L;CENPC;CENPE;NDC80;NUF2;MIS12;KIF2C;RMDN1;CHAMP1;CDT1
prerank,ribosomal small subunit biogenesis (GO:0042274),-0.2649832167630244,-0.9674454043514067,0.4539877300613497,0.8182894483699371,1.0,19/39,25.95%,RIOK1;RPS16;RPS27;RPS19;ERAL1;LTV1;RIOK3;RRP7A;EMG1;MRPS7;RPS17;RPS6;NOB1;METTL17;RPS5;TSR3;PWP2;SURF6;WDR3
prerank,mitotic sister chromatid cohesion (GO:0007064),0.42745216968101263,0.96735228278728,0.5364511691884457,0.845628964222711,1.0,5/16,14.27%,SMC1A;NAA50;NIPBL;PDS5B;PDS5A
prerank,negative regulation of Notch signaling pathway (GO:0045746),0.3807294008346108,0.9673218901057975,0.4986979166666667,0.8452413975795914,1.0,10/28,22.56%,MMP14;EGF;DLK1;EGFR;FBXW7;TCIM;ARRB1;YTHDF2;EGFL7;ZBTB7A
prerank,regulation of multicellular organismal development (GO:2000026),0.38895922318648546,0.9669180711595926,0.5195822454308094,0.8456434149778207,1.0,6/25,15.21%,PTN;EHMT1;NIPBL;HPSE;BAG6;MYSM1
prerank,regulation of cellular response to transforming growth factor beta stimulus (GO:1903844),0.39863032595543557,0.9662355951883114,0.5067385444743935,0.8467111586591283,1.0,9/23,23.69%,SMAD2;SMURF2;NREP;DKK3;SMAD3;ITGA3;LATS2;SOX11;TGFB1
prerank,sterol transport (GO:0015918),-0.31901150968054653,-0.9661165990260775,0.4778481012658228,0.8199701074317866,1.0,3/19,5.53%,CAV1;OSBP;LDLR
prerank,positive regulation of epithelial cell migration (GO:0010634),0.323559063763673,0.965861916397888,0.540453074433657,0.8471125066425155,1.0,31/92,24.65%,SPARC;MAP4K4;PRKCA;NRP1;WNT5A;FGF7;EGF;PRKD2;RAC1;DOCK1;SASH1;FGF2;MAPRE2;ITGB1BP1;ABL1;ANGPT1;ROCK2;RIN2;CTSH;EPB41L4B;TGFB2;CALR;ETS1;BCAS3;SRC;INSL3;GPLD1;CLASP2;AGT;ADAM9;AKT1
prerank,positive regulation of nervous system development (GO:0051962),-0.2650433098639529,-0.9648473582306252,0.47368421052631576,0.82145211823664,1.0,15/42,20.74%,NRXN1;GRID2;CUX2;EPHB1;SYNDIG1;LRRC4B;IL1RAPL1;CLSTN1;BDNF;NLGN1;TRIM32;GPER1;CLSTN3;OPRM1;PTPRD
prerank,GTP metabolic process (GO:0046039),0.4293740988619443,0.9642348551091507,0.5334302325581395,0.8502040049621573,1.0,2/15,6.61%,LRRK2;ENTPD7
prerank,"DNA catabolic process, endonucleolytic (GO:0000737)",0.38793692746541575,0.9641273664926425,0.5113788487282463,0.8499811532235105,1.0,7/23,16.53%,FBH1;DICER1;KPNB1;SETMAR;HMGB2;DFFB;DNASE1L2
prerank,kinetochore organization (GO:0051383),-0.36590611485617275,-0.9637022415438088,0.49846153846153846,0.8226636043483153,1.0,10/13,40.26%,POGZ;CENPC;CENPE;CENPH;NDC80;CENPF;DLGAP5;NUF2;CENPW;MIS12
prerank,non-motile cilium assembly (GO:1905515),0.3745446051737507,0.9632442851034052,0.5126262626262627,0.8515197089034642,1.0,7/30,15.35%,DISC1;IFT57;IFT88;PCM1;CSNK1D;BBS10;ARL13B
prerank,regulation of regulated secretory pathway (GO:1903305),0.37028968472976004,0.963039701564341,0.542997542997543,0.8515198750658513,1.0,7/34,14.70%,UNC13D;LRRK2;SYT10;SYT2;DTNBP1;SYT3;GSK3B
prerank,negative regulation of programmed cell death (GO:0043069),0.3049165628190978,0.9628821556537205,0.614070351758794,0.8514194161415878,1.0,69/355,17.61%,NR1H4;BCL3;MAP4K4;FSTL1;SFRP1;EGR3;MAD2L1;BIRC3;WNT5A;FHL2;GATA6;BCL2;AIFM2;TSLP;CFLAR;ANXA1;TREM2;TXNDC5;RNF157;SHH;FXN;BABAM2;NUGGC;MGMT;SIAH2;EGFR;HDAC1;CBL;PIK3R1;ANGPTL4;RAB7A;PLK1;SQSTM1;BAG3;AREL1;ASNS;NFKB1;SPRY2;XBP1;RPS6KB1;SETX;HDAC3;BCL2L2;SH3RF1;IL7;ARAF;HTATIP2;PDPN;PTK2;HSPD1;HIPK3;PRDX5;UBE2Z;USP47;GSK3B;BAG4;CX3CL1;TAF9B;HNRNPK;PSEN1;SON;ANGPT1;PDCD10;GDNF;PPIF;RPS6KA3;TBX3;ITCH;TCIM
prerank,purine ribonucleoside monophosphate metabolic process (GO:0009167),0.4062448898128116,0.9627130230882124,0.5080862533692723,0.8513212753558687,1.0,12/20,30.77%,ADSL;GMPS;GART;PPAT;AMPD3;AMPD2;IMPDH2;AK3;AK4;HPRT1;GMPR2;IMPDH1
prerank,positive regulation of translational initiation (GO:0045948),0.41486526944254465,0.9626905786222951,0.5248618784530387,0.8509238979812244,1.0,6/18,20.30%,KHDRBS1;CCL5;YTHDF3;RPS6KB1;DDX3X;YTHDF2
prerank,zinc ion homeostasis (GO:0055069),0.37716549982784586,0.9625820012316361,0.5191815856777494,0.8506875771321412,1.0,1/28,0.16%,SLC39A14
prerank,focal adhesion assembly (GO:0048041),0.3983469715636378,0.9625519047925244,0.5116918844566712,0.8502948267605334,1.0,3/21,3.60%,DLC1;PEAK1;RHOD
prerank,amyloid precursor protein catabolic process (GO:0042987),0.428757837212396,0.9625368958594862,0.521044992743106,0.8498710668514915,1.0,5/14,21.04%,ADAM19;ABCG1;PSEN1;CLN3;PSENEN
prerank,positive regulation of actin nucleation (GO:0051127),-0.3806707946076062,-0.962273784465062,0.5013404825737265,0.8247737086364471,1.0,4/11,14.33%,FCHSD2;GSN;NCKAP1;WASF2
prerank,regulation of inclusion body assembly (GO:0090083),-0.3743060556969836,-0.9622673423179675,0.48502994011976047,0.8230756291493817,1.0,2/11,1.34%,SNCAIP;SACS
prerank,muscle filament sliding (GO:0030049),-0.2628900280699937,-0.9616741185758214,0.5294117647058824,0.8212158712889821,1.0,3/38,1.97%,DMD;ACTN2;MYL6
prerank,actin-myosin filament sliding (GO:0033275),-0.2628900280699937,-0.9616741185758214,0.5294117647058824,0.8212158712889821,1.0,3/38,1.97%,DMD;ACTN2;MYL6
prerank,positive regulation of calcium ion transmembrane transport (GO:1904427),0.38736176903426667,0.9615491002138474,0.5345501955671447,0.8516119662423252,1.0,5/25,15.90%,CEMIP;XCL1;CXCL10;THY1;CX3CL1
prerank,glycolytic process through glucose-6-phosphate (GO:0061620),0.3822360407591783,0.9615005192653537,0.5092592592592593,0.8512738822604782,1.0,7/25,19.16%,HK2;FOXK2;ENO1;ADPGK;GAPDH;GCK;ENO2
prerank,regulation of neuron apoptotic process (GO:0043523),0.32429945728660364,0.9613497417380501,0.5673603504928806,0.8511723327936714,1.0,23/96,20.07%,EPHA7;FGF20;APOE;BCL2;TREM2;MDK;NF1;BAX;TGFB3;PTPRZ1;FZD9;SNX6;CCL2;TNF;GDNF;UNC5B;FOXO3;CLN3;CDK5;NTF3;FAIM2;CPEB4;TGFB2
prerank,apical protein localization (GO:0045176),-0.3898429778661606,-0.9612434237315491,0.5,0.8206396489665426,1.0,3/10,3.67%,ACTB;MAL;GOPC
prerank,sphingosine metabolic process (GO:0006670),-0.32051175484416794,-0.9611738042062208,0.4966442953020134,0.8191418124679966,1.0,8/17,22.14%,ACER2;SPTLC2;SPTLC1;NAAA;ASAH1;ASAH2;SPHK1;SGPP1
prerank,positive regulation of nucleocytoplasmic transport (GO:0046824),0.34952843673823847,0.9611675403785557,0.513953488372093,0.8511138094490294,1.0,11/46,16.37%,TCF7L2;UBR5;KHDRBS1;PIK3R1;BAG3;HDAC3;ZIC1;SMAD3;GSK3B;NCBP2;PSEN1
prerank,protein deacetylation (GO:0006476),0.35622023357361776,0.9610628294405835,0.5309090909090909,0.8509013675666596,1.0,14/41,22.68%,MIER2;RCOR1;HDAC1;MTA2;PRDM5;HDAC5;SIRT2;HDAC3;TBL1X;MTA3;BAZ2A;SIRT7;RCOR2;SIRT3
prerank,protein heterotetramerization (GO:0051290),0.447312336350035,0.960562339986204,0.5296671490593343,0.8515482378445076,1.0,4/13,19.11%,PKD2;FARSB;HSD17B8;GRIN1
prerank,regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO:0010881),-0.3279806245712434,-0.9601972602983004,0.5309090909090909,0.8199414886098194,1.0,4/16,7.13%,DMD;ANK2;ATP1A2;CALM1
prerank,RNA biosynthetic process (GO:0032774),0.3725980248458848,0.9601672628129252,0.528809218950064,0.8519549034226608,1.0,11/31,22.81%,SMN1;TAF4;TAF7;TTF2;SETX;TERT;RSF1;PRMT5;POLA2;HELB;TBP
prerank,regulation of protein localization to centrosome (GO:1904779),-0.38987143556859305,-0.9598635951037068,0.4702702702702703,0.8190671459796549,1.0,6/10,31.70%,BICD1;APC;UBXN2B;MARK4;NUP62;NSFL1C
prerank,cilium organization (GO:0044782),0.3040279791535232,0.9598489804422178,0.5860323886639676,0.8521876347627588,1.0,52/209,19.09%,TEKT4;DYNLL1;IQCG;STK36;CEP19;ACTR2;ASAP1;PKD2;TTC17;RAB8B;CCP110;SNX10;DISC1;PARVA;EXOC4;IFT88;WDR35;PDE6D;FAM161A;CPLANE1;B9D2;TMEM138;CEP41;PCM1;CDC14B;GALNT11;NPHP3;CLUAP1;DYNC2H1;TTC29;ATP6V1D;IFT52;EHD2;EXOC5;ARL13B;CC2D2A;IFT20;IQCB1;RAB8A;IFT81;CFAP410;PTPN23;CPLANE2;WDPCP;BBS7;KIF3A;KIFAP3;PCNT;CEP126;EXOC7;EXOC1;KIF27
prerank,organophosphate biosynthetic process (GO:0090407),-0.26070950338599175,-0.9596597587608181,0.49760765550239233,0.8179552982188215,1.0,4/37,4.13%,TPK1;GPHN;MBOAT1;PPIP5K1
prerank,glycolipid metabolic process (GO:0006664),-0.248023608636704,-0.9596179476993865,0.5316455696202531,0.8163906855299338,1.0,11/47,13.35%,ST3GAL6;ST6GALNAC3;ST3GAL4;ESYT2;ST8SIA6;ESYT1;GBGT1;ASAH1;ESYT3;SUMF1;FUCA1
prerank,lipid translocation (GO:0034204),0.395343235352253,0.9593944926697903,0.5377229080932785,0.8527191924888639,1.0,2/21,4.35%,ABCA1;ATP8B1
prerank,regulation of plasma membrane bounded cell projection assembly (GO:0120032),0.3325014792712877,0.9593384946870155,0.54627539503386,0.8524049947774038,1.0,17/67,15.84%,MYO10;PLD1;ATP8B1;FSCN1;ATG3;RAC1;CDC42;RABGAP1;TBC1D2B;IFT88;TBC1D16;DYNC2LI1;TBC1D20;FMR1;TBC1D19;TBC1D13;IFT20
prerank,receptor metabolic process (GO:0043112),0.33860090298521045,0.9587890776721509,0.5508083140877598,0.8531633641644011,1.0,20/53,24.40%,CLTC;LRP1;ADM;ARFGEF2;CD36;DNM1;GRB2;SMURF1;PIK3R4;MVB12A;SH3GLB1;SNX25;CALCRL;RAB31;NEDD4;KIF16B;ITGB1;TGFB1;REP15;GRK4
prerank,response to chemokine (GO:1990868),0.4466358850913246,0.9585921356541999,0.5350223546944859,0.8531292334888881,1.0,1/13,1.03%,CXCL12
prerank,regulation of lipid biosynthetic process (GO:0046890),0.36270870704756364,0.9581195877768194,0.5278481012658228,0.8537166575604556,1.0,3/32,3.63%,C3;ADIPOQ;APOE
prerank,regulation of cell growth (GO:0001558),0.3051909274052348,0.957986224722844,0.6004036326942482,0.853529571796314,1.0,50/204,20.57%,ENPP1;MMP14;PPP1R9B;BCL6;EIF4G2;SLIT3;PSRC1;SFRP1;SFRP2;CAMK2D;BCL2;KLHL22;INO80;CDKN2D;FRZB;FXN;SERTAD2;CYP27B1;EGFR;CDC42;PABIR1;CDKN2AIP;TGFBR1;ACVR1B;RPTOR;ENO1;EXOSC4;CCAR2;NUBP1;PAPPA2;RERG;BTG1;SMAD3;SDCBP;FLCN;USP47;EXOSC2;TAF9B;RPS6KA3;PTPRJ;DCUN1D5;ITCH;SPHK2;CSNK2A1;IP6K2;SMARCA4;STK11;TGFB2;DDX3X;CDK11B
prerank,histone exchange (GO:0043486),0.36329454952644685,0.9579172326804324,0.5086206896551724,0.8532245302074463,1.0,11/37,19.40%,CENPQ;CENPN;RNF8;CENPT;RSF1;ACTR6;CENPL;RUVBL1;SRCAP;SPTY2D1;RBBP4
prerank,sensory perception of chemical stimulus (GO:0007606),0.4296057957245792,0.9579000482672734,0.5135135135135135,0.8528066411141125,1.0,3/15,9.32%,SYT10;CD36;GNAS
prerank,proton transmembrane transport (GO:1902600),0.362795026154964,0.9578542179457423,0.5278810408921933,0.8524531278726755,1.0,7/36,18.39%,SLC9A1;HVCN1;ATP5PO;SLC36A2;DMAC2L;ATP6V1F;ATP6V1H
prerank,regulation of blood vessel endothelial cell migration (GO:0043535),0.34462211203930176,0.9569660619273421,0.5402567094515752,0.8539557787449756,1.0,23/54,27.44%,PRKCA;CD40;APOE;PRKD2;FGFR1;AKT3;NF1;PPARG;STAT5A;FGF2;TNF;ANGPT1;FGF18;ETS1;ACVRL1;ATP5F1A;TGFB1;AKT1;GADD45A;PDPK1;ANGPT2;JUP;HIF1A
prerank,positive regulation of nitric oxide biosynthetic process (GO:0045429),0.38150753388115416,0.9569137223052444,0.523117569352708,0.8536265945593567,1.0,6/25,17.84%,NOS1AP;PKD2;CD36;SMAD3;TNF;PTGS2
prerank,UV protection (GO:0009650),-0.383158707282631,-0.9568339985766325,0.49691358024691357,0.8218484737638926,1.0,2/10,3.56%,ERCC5;CAT
prerank,regulation of cardiac muscle cell membrane repolarization (GO:0099623),0.39269585848809263,0.9566538107409255,0.5358090185676393,0.8537413018717497,1.0,3/21,7.35%,NOS1AP;CACNA2D1;KCNA5
prerank,heme biosynthetic process (GO:0006783),-0.30472185913226896,-0.9563248761821783,0.5150375939849624,0.821533407859149,1.0,5/22,11.54%,ABCG2;FLVCR1;CPOX;ABCB10;UROS
prerank,regulation of protein sumoylation (GO:0033233),0.4194882415423853,0.9562905768882579,0.5384615384615384,0.8541176193869615,1.0,7/17,25.22%,ZMIZ1;GNL3;SAE1;RASD2;PIAS1;PARK7;RWDD3
prerank,negative regulation of signal transduction by p53 class mediator (GO:1901797),0.4227829844717689,0.95592488519852,0.5509065550906556,0.854422145547114,1.0,2/17,3.53%,SNAI1;SNAI2
prerank,superoxide anion generation (GO:0042554),-0.3589055331251106,-0.9558498461634013,0.5317220543806647,0.821088192554218,1.0,8/13,44.62%,NCF2;NOX1;CYBA;TAFA4;NCF1;NOX3;NCF4;DUOX1
prerank,pathway-restricted SMAD protein phosphorylation (GO:0060389),0.4509373854976769,0.95583401467336,0.5315870570107858,0.8541898225241327,1.0,4/11,23.69%,TGFBR1;ACVR1;TGFB2;TGFB1
prerank,negative regulation of cysteine-type endopeptidase activity (GO:2000117),0.35424473728716555,0.9556028615589697,0.5413173652694611,0.8542560815860137,1.0,16/44,25.24%,CDKN2D;SIAH2;DNAJB6;SH3RF1;FNIP1;LAMTOR5;USP47;TNF;RPS6KA3;CSNK2A1;DDX3X;SRC;YWHAE;CARD16;AKT1;PCID2
prerank,glycerolipid metabolic process (GO:0046486),-0.37456983840174096,-0.9548893255467121,0.5147058823529411,0.8218580237109278,1.0,7/11,18.64%,DGKB;DGKG;DGKQ;DGKA;PGP;DGKZ;GAL3ST1
prerank,regulation of ventricular cardiac muscle cell action potential (GO:0098911),-0.3617081154486736,-0.9548214528350948,0.5028735632183908,0.8203540531132162,1.0,2/12,0.68%,CAV1;CTNNA3
prerank,production of miRNAs involved in gene silencing by miRNA (GO:0035196),0.3704901736476782,0.9547725033560657,0.5418781725888325,0.855684752334619,1.0,11/29,26.33%,SMAD2;PUM1;TARBP2;DICER1;DGCR8;SMAD3;HNRNPA2B1;LIN28B;TUT7;ZC3H7B;SMAD1
prerank,mitotic nuclear membrane organization (GO:0101024),0.34778218643009245,0.9545788436533631,0.5507075471698113,0.8551942077582783,1.0,16/51,18.34%,CHMP4B;CHMP4A;NUP37;CC2D1B;REEP4;VPS4A;PPP2R2A;SIRT2;NUP188;LEMD2;RCC1;KPNB1;NUP35;CCNB2;CHMP3;CHMP7
prerank,mitotic nuclear membrane reassembly (GO:0007084),0.34778218643009245,0.9545788436533631,0.5507075471698113,0.8551942077582783,1.0,16/51,18.34%,CHMP4B;CHMP4A;NUP37;CC2D1B;REEP4;VPS4A;PPP2R2A;SIRT2;NUP188;LEMD2;RCC1;KPNB1;NUP35;CCNB2;CHMP3;CHMP7
prerank,"DNA-templated transcription, elongation (GO:0006354)",-0.23322641613213185,-0.9543087732319477,0.5042016806722689,0.8199755960065107,1.0,19/64,19.58%,MLLT3;ELOC;NELFB;CTR9;ERCC3;EAF2;LEO1;SSRP1;POLR2H;GTF2H2;POLR2G;POLR2F;CCNK;ELOB;SUPT4H1;POLR2E;GTF2H4;NELFE;POLR2A
prerank,negative chemotaxis (GO:0050919),0.3622929119644259,0.9542961047148983,0.534504391468005,0.8553412864633242,1.0,3/33,2.36%,EPHA7;SLIT3;SLIT1
prerank,myeloid dendritic cell activation (GO:0001773),0.4389203369151923,0.9536792201348048,0.5545171339563862,0.8562630350711347,1.0,1/12,4.15%,BATF
prerank,negative regulation of peptide hormone secretion (GO:0090278),0.4045750101120411,0.9534736849603467,0.5344585091420534,0.856271010048525,1.0,3/18,8.99%,SFRP1;IRS1;INHBB
prerank,embryonic hemopoiesis (GO:0035162),0.4378512404812357,0.9533356697668508,0.5331325301204819,0.856117340563778,1.0,1/12,0.40%,KMT2A
prerank,monocyte differentiation (GO:0030224),-0.3814069359532323,-0.9529563872517011,0.48118279569892475,0.8217334671928208,1.0,2/10,1.52%,PIR;BMP4
prerank,regulation of RNA splicing (GO:0043484),-0.23049566149694484,-0.9529098978597883,0.5663716814159292,0.8202098938826141,1.0,29/69,24.71%,MBNL1;QKI;CWC22;SNRNP70;ERN1;KHDRBS2;LARP7;YTHDC1;METTL4;SRRM4;RPS13;TMBIM6;PTBP2;U2AF2;PRX;SRSF10;CLK1;AHNAK2;POLR2A;KHDRBS3;ZPR1;SLC38A2;FASTK;HNRNPH3;PQBP1;RPS26;TIA1;HSPA1A;AHNAK
prerank,DNA damage checkpoint signaling (GO:0000077),0.3737202750394706,0.9528454693020645,0.527599486521181,0.8567255078125761,1.0,4/28,6.96%,BRIP1;E2F1;ATM;ATR
prerank,positive regulation of protein-containing complex assembly (GO:0031334),0.3112134691161323,0.9523688447034666,0.5922023182297155,0.8573249077383915,1.0,18/113,15.60%,MMP3;ABCA1;LCP1;TIRAP;ASAP1;FSCN1;ATM;ATR;CD36;BAX;DDB1;SLF2;FNIP1;GTF2H1;GSK3B;STUB1;TPPP;TNF
prerank,intrinsic apoptotic signaling pathway in response to DNA damage (GO:0008630),0.3454060723215663,0.9522909032371044,0.5548996458087367,0.8570339150499624,1.0,8/48,11.67%,BCL3;BCL2;E2F1;ATM;IKBKE;BAX;BAG6;BCL2L2
prerank,mesonephric tubule development (GO:0072164),0.43046805795201554,0.9521670936088235,0.5260115606936416,0.8568503982202159,1.0,3/15,10.82%,ROBO2;PKD2;SALL1
prerank,positive regulation of calcium ion transmembrane transporter activity (GO:1901021),0.38705213893713253,0.9520133386876859,0.5146666666666667,0.8567363194106336,1.0,5/22,13.46%,VMP1;SLC9A1;PKD2;CALM3;CALM2
prerank,cell projection assembly (GO:0030031),0.3962198896497361,0.9518054700315631,0.5329744279946165,0.8567478015022053,1.0,5/22,12.98%,RHOJ;RAC1;CDC42;PARVA;NEFH
prerank,glycerol metabolic process (GO:0006071),0.4640001622241686,0.9510819267875166,0.5366242038216561,0.8578654925761735,1.0,1/10,1.44%,PDXP
prerank,positive regulation of mitochondrion organization (GO:0010822),0.33274541876219754,0.9503878482244885,0.5364758698092031,0.8589539248230201,1.0,8/57,9.43%,DCN;TREM2;BBC3;FBXO7;SPIRE1;BAX;RALA;ADCK1
prerank,stress granule assembly (GO:0034063),0.3994686732503952,0.9503376969985577,0.547683923705722,0.8586019910071301,1.0,6/20,20.30%,ATXN2;DYNC1H1;YTHDF3;PRRC2C;DDX3X;YTHDF2
prerank,myoblast differentiation (GO:0045445),0.4216743592530312,0.950003179220826,0.5319465081723626,0.8588687634980151,1.0,3/14,3.90%,TCF7L2;DDX17;JAG1
prerank,negative regulation of viral entry into host cell (GO:0046597),-0.36385512583262974,-0.9493180805114113,0.5058479532163743,0.8277709151446795,1.0,2/12,7.03%,LY6E;GSN
prerank,regulation of organelle assembly (GO:1902115),0.3244814803072961,0.9493096378870254,0.5540691192865106,0.8598956401906183,1.0,16/72,15.84%,CEP295NL;ATXN2;ALMS1;ATG3;NPRL2;RABGAP1;TBC1D2B;IFT88;TBC1D16;DYNC2LI1;TBC1D20;SENP6;MSN;TBC1D19;TBC1D13;IFT20
prerank,microtubule bundle formation (GO:0001578),0.35053623772008247,0.9490598225350987,0.5465538089480049,0.8599717296228002,1.0,12/42,25.51%,PSRC1;NAV1;NCKAP5;MAP1S;PLK1;TPPP;TPPP3;NCKAP5L;KIF20A;CFAP74;NUMA1;DCX
prerank,peptide hormone secretion (GO:0030072),0.37524055183054233,0.948976413711911,0.544137022397892,0.8596954198468634,1.0,2/26,4.59%,EDN3;ANXA1
prerank,nucleocytoplasmic transport (GO:0006913),0.35506682385394245,0.9486923701697314,0.5736906211936662,0.8598867591403982,1.0,9/40,15.71%,ATXN1;SMN1;ANP32A;BACH2;HTATIP2;NXT2;NEMF;NCBP2;NXT1
prerank,ventricular cardiac muscle tissue morphogenesis (GO:0055010),0.3661873738528232,0.9485505913343892,0.542566709021601,0.8597372482246555,1.0,6/31,13.51%,ZFPM2;TNNI3;TNNC1;TGFBR1;RBPJ;TPM1
prerank,fibrinolysis (GO:0042730),0.43606483620831044,0.9483287976914978,0.5359375,0.8597497926482205,1.0,1/13,4.65%,PLAT
prerank,regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043281),0.32154496673871685,0.9482941365149244,0.5582417582417583,0.8593811724233635,1.0,22/80,22.58%,EPHA7;CASP1;CTSD;CDKN2D;SIAH2;DNAJB6;NOD1;SH3RF1;FNIP1;LAMTOR5;USP47;TNF;RPS6KA3;ACVR1C;FIS1;CSNK2A1;DAPK1;DDX3X;CYCS;SRC;YWHAE;CARD16
prerank,protein-containing complex disassembly (GO:0032984),0.3397524332790468,0.9480831731307667,0.5541327124563445,0.8593879790967252,1.0,17/54,22.72%,STX17;DVL2;UBQLN1;FZD1;LIX1L;LAMP2;VPS4A;CSNK1A1;LRP6;GSK3B;CHMP3;DVL1;CLN3;RUBCNL;VTI1B;SNX14;VPS16
prerank,GPI anchor metabolic process (GO:0006505),0.3798185070473672,0.9479562494715393,0.5440613026819924,0.8592073552825664,1.0,12/26,27.60%,PIGW;PIGN;PGAP4;PIGL;DPM2;PIGG;PIGC;PIGH;GPLD1;PIGP;PIGM;MPPE1
prerank,carboxylic acid metabolic process (GO:0019752),-0.26989330534603817,-0.9478031777842735,0.5515695067264574,0.8300407968557177,1.0,4/33,4.96%,DDO;SLC2A1;CSGALNACT1;GLUD1
prerank,DNA integrity checkpoint signaling (GO:0031570),0.35825433906147935,0.9477097283596856,0.56125,0.8592877801781388,1.0,8/36,16.33%,BRIP1;DNA2;E2F1;ATM;ATR;SETMAR;CLOCK;TIMELESS
prerank,negative regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043154),0.3416882212755085,0.9475736228384107,0.5521191294387171,0.8591095425821803,1.0,16/50,22.58%,CDKN2D;SIAH2;DNAJB6;SH3RF1;FNIP1;LAMTOR5;USP47;TNF;RPS6KA3;CSNK2A1;CAAP1;DDX3X;SRC;YWHAE;PARK7;CARD16
prerank,positive regulation of signaling receptor activity (GO:2000273),0.3591290271985204,0.9474563476559749,0.5581395348837209,0.8589314905537345,1.0,8/36,17.19%,NRP1;JAK2;EGF;HDAC1;EPHB2;CCL2;FBXW7;BTC
prerank,cyclic purine nucleotide metabolic process (GO:0052652),0.38749258673446896,0.9471166738683174,0.5299727520435967,0.8592493425164823,1.0,3/21,6.25%,ADCY7;ADCY2;NPR2
prerank,mitotic DNA replication (GO:1902969),0.4469084765845116,0.9470083736038237,0.5277337559429477,0.8590301591960254,1.0,2/10,8.04%,LIG1;MCM2
prerank,determination of bilateral symmetry (GO:0009855),0.38263686654776,0.946991810078296,0.5532786885245902,0.8586232940973587,1.0,6/24,17.78%,DNAAF4;PKD2;GALNT11;NPHP3;DNAH11;BBS7
prerank,response to hydroxyurea (GO:0072710),0.4455448593579672,0.9467765020335808,0.5274566473988439,0.8586641760331651,1.0,4/11,16.33%,DDX11;ATRX;FMR1;TIMELESS
prerank,cell-substrate junction assembly (GO:0007044),0.36366607595230604,0.9466342839544274,0.5636588380716935,0.8585060702447362,1.0,4/33,3.60%,DLC1;LAMC1;PEAK1;RHOD
prerank,regulation of protein secretion (GO:0050708),0.3102154603473548,0.9464925431811018,0.5830687830687831,0.8583737855877822,1.0,19/119,10.44%,CACNA1A;PRKCA;ITPR1;APOE;DNAJC1;RAPGEF4;ABCG1;TREM2;CACNA1C;CACNA2D2;KCNG2;PPID;CCL5;KCNA5;FRMD4A;LLGL1;TGFB3;EIPR1;ERP29
prerank,Rac protein signal transduction (GO:0016601),0.4087746492781955,0.9464861194657334,0.5370101596516691,0.8579451325434334,1.0,5/18,13.21%,FARP2;RAC1;AIF1;DBNL;ABI2
prerank,cardiocyte differentiation (GO:0035051),0.4574720004139251,0.9464580815226504,0.5511182108626198,0.8575553695816414,1.0,2/10,9.65%,GATA6;AKAP13
prerank,cellular response to type I interferon (GO:0071357),0.35592592633159165,0.9461830365026204,0.5363748458692972,0.8572747303124243,1.0,14/41,24.36%,JAK1;IRF7;STAT1;IRF1;PSMB8;OASL;IFNAR2;SP100;IP6K2;IFI27;IRF9;IRF3;IFI35;IFNAR1
prerank,type I interferon signaling pathway (GO:0060337),0.35592592633159165,0.9461830365026204,0.5363748458692972,0.8572747303124243,1.0,14/41,24.36%,JAK1;IRF7;STAT1;IRF1;PSMB8;OASL;IFNAR2;SP100;IP6K2;IFI27;IRF9;IRF3;IFI35;IFNAR1
prerank,response to interleukin-4 (GO:0070670),0.4573655409514921,0.9459537353926116,0.565015479876161,0.8573230929369097,1.0,3/10,10.96%,XCL1;TCF7;XBP1
prerank,positive regulation of CREB transcription factor activity (GO:0032793),-0.3183777767258359,-0.9458967052121546,0.5440613026819924,0.8332428442617795,1.0,6/18,14.18%,RPS6KA5;CD200;RELN;PRKD1;EPHA5;ADCY1
prerank,cellular protein metabolic process (GO:0044267),0.2955454683946687,0.9455704036138773,0.6659979939819458,0.8577092403103963,1.0,49/396,13.09%,C3;MMP2;ENAM;KNG1;IGFBP7;SPP1;RRBP1;RPSA;LAMB1;CP;LAMC1;TNIP1;PLOD2;ASMT;FSTL1;IGFBP4;TIMP1;VCAN;APOE;GATA6;FBN1;STOML2;PRKCSH;IGFBP5;RPL3L;MIA3;PLAT;CKAP4;PABPC4;CALU;ATG3;LTBP1;SIAH2;MRPL36;UBE2L3;OMA1;SDC2;CCDC59;PHKA2;TNC;FARSB;GSPT1;PCMT1;FAM20C;PCSK5;ARAF;GALNT11;HM13;PAPPA2
prerank,iron ion homeostasis (GO:0055072),0.33119503897644287,0.9453817260330897,0.537122969837587,0.8576870267795673,1.0,10/58,13.81%,HEPH;CP;SLC11A2;FXN;CUL1;ATP6V1G1;NUBP1;ACO1;SKP1;SLC22A17
prerank,macrophage chemotaxis (GO:0048246),0.45139518790456634,0.9453647201275713,0.5461658841940532,0.8572810394876725,1.0,2/10,13.55%,CCL5;CCL2
prerank,magnesium ion transport (GO:0015693),0.4319379047655174,0.9450483632331588,0.5392749244712991,0.8575256204820103,1.0,5/12,19.11%,NIPAL2;MMGT1;NIPAL4;SLC41A1;TUSC3
prerank,purine nucleotide metabolic process (GO:0006163),-0.30134320679311777,-0.9448899438081777,0.551440329218107,0.8341751796401603,1.0,8/24,18.58%,FHIT;NT5E;ITPA;NT5C2;PRPSAP1;NT5C;PRPS1;PRPS1L1
prerank,negative regulation of locomotion (GO:0040013),0.4414300256190138,0.9447422913341756,0.5477239353891337,0.857738043217206,1.0,1/12,0.77%,FBLN1
prerank,regulation of anoikis (GO:2000209),0.40829040908198916,0.9446316435391476,0.553763440860215,0.8575309029642916,1.0,8/19,21.94%,SNAI2;BCL2;TLE1;PTK2;ITGA5;TLE5;ITGB1;SRC
prerank,beta-catenin destruction complex disassembly (GO:1904886),0.3903132957448527,0.944466319586416,0.56,0.8574440306334954,1.0,6/21,18.76%,DVL2;FZD1;CSNK1A1;LRP6;GSK3B;DVL1
prerank,regulation of cAMP-mediated signaling (GO:0043949),0.37609494385280273,0.9440698206253156,0.5329815303430079,0.8578451814847002,1.0,5/24,16.46%,PDE3A;RNF157;PRKAR1B;GNAI1;RASD2
prerank,negative regulation of phosphate metabolic process (GO:0045936),0.3836703202529693,0.9440389717774325,0.5357142857142857,0.857464778340988,1.0,3/22,5.59%,DYNLL1;CDKN2B;CDKN2D
prerank,regulation of transcription involved in G1/S transition of mitotic cell cycle (GO:0000083),0.36350707858464676,0.9436790875044118,0.5579617834394904,0.8578050405810957,1.0,6/32,11.49%,BACH1;CDK14;E2F1;BRD4;FBXO5;TFDP1
prerank,neuron projection fasciculation (GO:0106030),0.44869989165194857,0.9431608210882347,0.555921052631579,0.858450301679062,1.0,4/10,13.99%,AMIGO1;EPHB3;EPHB2;ARHGAP35
prerank,positive regulation of immunoglobulin production (GO:0002639),0.3632053001806277,0.9430327031129615,0.550761421319797,0.8582635685562069,1.0,8/31,16.39%,XCL1;SASH3;SHLD3;XBP1;EPHB2;RIF1;TNFRSF4;HMCES
prerank,positive regulation of protein localization to cell periphery (GO:1904377),0.3421201197213317,0.9429442158583689,0.5577830188679245,0.8580044756912527,1.0,14/52,15.60%,LRP1;NKD2;TREM2;GPSM2;EGFR;PIK3R1;SQSTM1;KIF5B;CLIP3;EPHB2;GNAI1;SPTBN1;ITGA3;TNF
prerank,blood vessel endothelial cell migration (GO:0043534),0.3830974206156707,0.9428657942365947,0.5443383356070941,0.8577340044488789,1.0,4/22,4.61%,NRP1;EGR3;MYH9;MIA3
prerank,cellular amide metabolic process (GO:0043603),0.31379685598396495,0.9418876743128508,0.6079484425349087,0.8594206962200918,1.0,26/102,22.86%,DNPEP;CPXM1;ABCA2;ST6GAL1;MTHFD1L;MTHFR;ACOT9;THEM4;SGPL1;ACOT13;NLN;PANK2;NSMAF;PCCA;MTHFD2L;ACSF2;ST3GAL1;SMPD3;PLPP3;ORMDL3;MLYCD;THOP1;PLA2G4E;ACOT11;FPGS;GNE
prerank,anion transmembrane transport (GO:0098656),0.3246248376854225,0.9417923000848497,0.5911664779161948,0.8591873175660232,1.0,7/67,10.06%,SLC7A2;SLC1A3;SLC16A12;SLC25A19;SLC35B1;LRRC8A;SLC13A5
prerank,JNK cascade (GO:0007254),-0.26111572378113196,-0.9409040580503998,0.5297619047619048,0.8428362671512181,1.0,20/40,29.45%,MAP3K5;UBE2N;TAB3;IRAK1;CRKL;UBC;IKBKG;MAPK10;MAP3K7;ARHGEF6;UBA52;MINK1;NOD2;UBB;MAPK8;MAP4K3;RIPK2;MAP3K11;SH2D3C;MAP3K13
prerank,protein dephosphorylation (GO:0006470),0.3083230403516975,0.9408007905962545,0.5983350676378772,0.8608239689187586,1.0,45/135,23.57%,PDXP;PTPN7;DUSP2;DUSP5;PTPN3;DUSP26;PTEN;PTPN13;SSH1;PPP4R1;DUSP18;NCK1;PTPN6;PPP2R5A;PTPRZ1;PTPN1;PPP2R2A;PTPN18;DAPP1;CDC14B;PTPN5;PPP3CA;FBXW11;PPP1CB;PPM1H;PTPN2;PPP2R5E;UBASH3B;PPP4R2;PTPRJ;PTPN9;SSH2;ILKAP;RPAP2;STK11;TIMM50;MTM1;CTDSP2;PPP2R5D;PPP2R5C;PPP1CC;PTPRM;PPM1D;DUSP6;PTPN12
prerank,protein K63-linked deubiquitination (GO:0070536),-0.27314066497131717,-0.9404952241746861,0.5641025641025641,0.8422460120570474,1.0,11/31,17.31%,STAMBP;USP8;ATXN3;CYLD;BABAM1;SPATA2;OTUD4;OTUD1;USP13;USP16;USP20
prerank,negative regulation of stem cell differentiation (GO:2000737),0.4382240809352785,0.9399338501961974,0.5532544378698225,0.8621853252621425,1.0,2/12,3.90%,ZFP36L2;JAG1
prerank,nucleobase-containing small molecule interconversion (GO:0015949),0.3693175285681818,0.9398918399669388,0.541501976284585,0.8618278769641692,1.0,12/27,28.60%,TXNRD1;GUK1;DTYMK;AK8;CTPS1;AK2;RRM2B;CMPK1;AK5;AK6;NME2;AK4
prerank,regulation of protein dephosphorylation (GO:0035304),0.35027290952314655,0.9398731112719664,0.5551515151515152,0.8614122228939389,1.0,6/37,13.46%,DLC1;PPP1R2;PPP2R5A;CALM3;PPP1R16A;CALM2
prerank,negative regulation of endocytosis (GO:0045806),-0.2925323356066844,-0.9388587898419616,0.5725806451612904,0.8446340468287566,1.0,5/24,15.65%,CAV1;PRKD1;MCTP1;RUBCN;LRSAM1
prerank,negative regulation of JNK cascade (GO:0046329),-0.2778635258836133,-0.9387078441596632,0.5727699530516432,0.8433205066950462,1.0,6/31,9.01%,MECOM;PRKN;SH3RF2;DUSP10;CYLD;PINK1
prerank,activation of GTPase activity (GO:0090630),0.3141006823858194,0.9387040118537433,0.5864332603938731,0.863444683781628,1.0,31/89,22.95%,ARHGAP24;SYDE1;ARHGAP42;SIPA1L3;RABGAP1L;TAX1BP3;RABGAP1;TBC1D2B;EPHA1;TBC1D16;TBC1D7;SLC27A4;TBC1D8B;ARHGEF19;MTSS2;TBC1D13;NTRK3;RAP1GAP;PIP5K1A;EVI5L;NTF3;SGSM3;ADPRH;CORO1C;SIPA1L2;ARHGEF26;RUNDC1;BCAS3;TBC1D1;TBC1D10B;ARHGAP22
prerank,glycosphingolipid metabolic process (GO:0006687),0.343909504192841,0.9382959400483315,0.5727923627684964,0.8638530679042872,1.0,16/42,22.73%,ABCA2;UGCG;CLN6;B4GALNT1;B3GALNT1;GALC;A4GALT;SMPD4;GBA2;SMPD3;CTSA;NEU3;GLB1;NEU1;ST8SIA3;CPTP
prerank,negative regulation of amyloid-beta formation (GO:1902430),0.4036477170385784,0.9381845703417571,0.5470332850940666,0.8636366979905645,1.0,3/17,9.50%,APOE;RTN2;BIN1
prerank,lipoxygenase pathway (GO:0019372),0.41127000323633656,0.9376730706943335,0.5491923641703378,0.8642641571899251,1.0,3/14,17.84%,ALOX5AP;PON3;PTGS2
prerank,nucleoside salvage (GO:0043174),0.4622072006329714,0.9375420623830808,0.546969696969697,0.8640993784434434,1.0,6/10,29.71%,UCKL1;TK1;TK2;DCK;UPP2;HPRT1
prerank,calcium ion transmembrane transport (GO:0070588),0.3204267534850644,0.9373579553466928,0.5819761129207384,0.8640615481772821,1.0,10/86,7.70%,MCOLN2;CACNA1A;SLC24A5;STOML2;CACNA2D1;PKD2;CACNA1C;ATP2A2;TRPC6;ATP2B1
prerank,mitochondrial outer membrane permeabilization (GO:0097345),0.4205740149752606,0.9370257810354993,0.5601173020527859,0.8643150443315611,1.0,2/13,8.27%,VDAC2;BAX
prerank,clathrin coat assembly (GO:0048268),0.4185874002146299,0.9370107503896896,0.5580029368575624,0.8639013944115822,1.0,2/15,4.38%,CLTC;CALY
prerank,positive regulation of alpha-beta T cell proliferation (GO:0046641),-0.3378427375044313,-0.9369307516899216,0.50920245398773,0.8458798245959305,1.0,3/14,6.08%,CD81;CD55;IL18
prerank,Golgi to endosome transport (GO:0006895),0.4139693643516562,0.9366816464626333,0.5544554455445545,0.8641326530295427,1.0,8/16,23.92%,WIPI1;AP4M1;VPS13C;EPS15;GBF1;KIF16B;AP1AR;CORO7
prerank,regulation of stem cell population maintenance (GO:2000036),0.39963967203549133,0.9366812644902368,0.5481586402266289,0.8636932684185179,1.0,2/18,5.09%,PTN;ZC3H13
prerank,neuropeptide signaling pathway (GO:0007218),-0.23520848838335698,-0.936459641702923,0.5327868852459017,0.8453945149440502,1.0,7/58,7.06%,SORCS1;GLRA3;SORT1;SORCS2;CPE;SORCS3;RAPGEF2
prerank,cellular response to hydroxyurea (GO:0072711),0.4494666443995321,0.9363333907761383,0.5458579881656804,0.8639805423601673,1.0,4/10,16.33%,DDX11;ATRX;FMR1;TIMELESS
prerank,regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307),0.4025856353286058,0.9361618530199464,0.557510148849797,0.863879429518977,1.0,2/17,4.53%,NOS1AP;CACNA2D1
prerank,response to steroid hormone (GO:0048545),0.36693392328204544,0.9361539172459385,0.5746835443037974,0.8634576185041493,1.0,5/31,9.37%,YAP1;ABCA2;UBE2L3;CATSPER3;TGFB3
prerank,cyclic-nucleotide-mediated signaling (GO:0019935),0.35553477744606127,0.9356486811510868,0.5645569620253165,0.8641034578838614,1.0,6/35,10.26%,PDE3A;PDE7B;APOE;ADCY2;CD36;AHR
prerank,extrinsic apoptotic signaling pathway via death domain receptors (GO:0008625),0.3709041364159771,0.9355688938575111,0.5855513307984791,0.8638270134131212,1.0,10/28,20.26%,CASP8AP2;BCL2;BAX;BAG3;ZDHHC3;CASP8;TNF;TNFRSF1A;SPI1;DDX3X
prerank,regulation of postsynapse organization (GO:0099175),-0.2815820596222763,-0.9351381829815447,0.5470085470085471,0.847013268167764,1.0,11/28,16.02%,EPHA4;SHANK3;ARHGAP44;PDLIM5;IL1RAPL1;ZDHHC15;PPFIA2;SRCIN1;ABI3;TANC2;SIPA1L1
prerank,regulation of programmed cell death (GO:0043067),0.3020001291344025,0.9349163086309522,0.6180698151950719,0.8647436459406792,1.0,25/161,12.94%,BCL3;BCL6;BIRC3;JAK2;STAT1;LRRK2;AIFM2;CASP1;USP42;NF2;STEAP3;ANP32A;ATM;CREBBP;BAX;IFT57;CXCL10;PTPN6;OMA1;GAS1;CTSB;RTKN;MAGED1;HTATIP2;TRAF2
prerank,nucleotide-sugar biosynthetic process (GO:0009226),0.3923393128104487,0.9347508194815746,0.5637860082304527,0.8646471103816225,1.0,9/19,27.91%,GFPT2;UAP1L1;GMPPB;UGDH;AMDHD2;UAP1;GNPDA2;PMM2;RENBP
prerank,heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0007157),0.35401750139645366,0.9347260074917197,0.5731414868105515,0.8642552601118618,1.0,6/37,7.50%,JAML;TENM3;AMIGO1;ICAM1;TENM4;DCHS1
prerank,regulation of defense response to virus (GO:0050688),0.41851988629837233,0.9346557079720067,0.5568513119533528,0.8639625767961044,1.0,2/14,8.52%,TNFAIP3;ILRUN
prerank,RNA phosphodiester bond hydrolysis (GO:0090501),0.3744557986931559,0.9346421358567575,0.577922077922078,0.8635589352888883,1.0,9/27,22.27%,RNASE1;NHP2;XRN1;DICER1;POP1;RNASEH1;CPSF3;TOE1;LACTB2
prerank,defense response to fungus (GO:0050832),0.4054358919996279,0.93462055750129,0.5497835497835498,0.8631614455997705,1.0,2/17,15.04%,RNASE7;GAPDH
prerank,"nucleotide-excision repair, DNA gap filling (GO:0006297)",-0.29792503100599943,-0.934329650249579,0.5587044534412956,0.8474540209983478,1.0,15/24,27.83%,PCNA;UBC;POLK;RFC3;UBA52;RFC2;POLD2;RPA2;UBB;LIG4;POLB;POLE;RFC4;RPA3;POLD4
prerank,positive regulation of protein secretion (GO:0050714),0.3174185366341245,0.9342685754359393,0.574468085106383,0.8634719124974158,1.0,11/69,9.37%,TCF7L2;TLR2;ABCG1;TREM2;BLK;PPID;WLS;FRMD4A;ACSL4;LRRC8A;TGFB3
prerank,response to gamma radiation (GO:0010332),0.3754837217002547,0.9335445783554183,0.5380577427821522,0.8645189878536772,1.0,5/24,15.24%,YAP1;ATM;ATR;TRIM13;MDM2
prerank,ncRNA metabolic process (GO:0034660),0.3475589095330229,0.9333030827571203,0.5693251533742332,0.8645798092581546,1.0,6/37,12.73%,DDX17;KHSRP;ZCCHC8;TARBP2;DICER1;DGCR8
prerank,modulation by symbiont of host process (GO:0044003),0.4395696022967026,0.9329536266517473,0.5402476780185759,0.8648666844726288,1.0,4/10,22.21%,TLR2;ENO1;HGS;RPS27A
prerank,long-chain fatty-acyl-CoA metabolic process (GO:0035336),-0.29440930256189457,-0.9328708229009461,0.5775193798449613,0.8495396618914853,1.0,8/23,17.97%,TECR;ACSL1;ELOVL5;ELOVL7;DGAT1;ACOT7;HACD1;ACSL3
prerank,positive regulation of protein binding (GO:0032092),0.3379593560443158,0.9324279981246972,0.5783410138248848,0.8655297644143497,1.0,15/56,18.94%,LRP1;TCF7L2;VTN;LRRK2;APOE;ADD2;TRIM21;NMD3;TERT;GSK3B;ABL1;PSEN1;TRIB3;STK4;SPPL3
prerank,exonucleolytic catabolism of deadenylated mRNA (GO:0043928),0.35718770073930656,0.9323463892679198,0.5500650195058517,0.8652605212090527,1.0,8/29,20.00%,LSM7;EDC4;EXOSC4;DCP2;EXOSC2;EXOSC1;EXOSC3;LSM6
prerank,protein localization to cell surface (GO:0034394),-0.27257499078040137,-0.9323438228964387,0.5954545454545455,0.849225002351327,1.0,9/26,17.47%,ANK2;PTPRK;FBLN5;GGA1;PTPRU;VCL;UNC50;PRRT1;WNT11
prerank,positive regulation of TORC1 signaling (GO:1904263),0.4107678128353178,0.9323379950891177,0.5687679083094556,0.8648438092795933,1.0,7/16,23.45%,KLHL22;LAMTOR5;FLCN;TELO2;SIK3;CLEC16A;GPR137
prerank,negative regulation of mRNA catabolic process (GO:1902373),0.3649372749767553,0.9322721011066403,0.5506329113924051,0.8645408673953361,1.0,10/29,21.67%,TENT5A;E2F1;DHX34;FMR1;PAIP1;AXIN2;THRAP3;GDNF;YBX1;FUS
prerank,protein localization to cell junction (GO:1902414),-0.3020429521529596,-0.9321071623983194,0.57421875,0.8481712896716537,1.0,3/22,2.79%,TJP1;TJP2;PCLO
prerank,muscle tissue development (GO:0060537),0.41836080825734984,0.9320986901679689,0.5511695906432749,0.8644663745647816,1.0,6/13,17.85%,CSRP1;SHH;NF1;STRA6;PTCH1;SMO
prerank,epithelial cell-cell adhesion (GO:0090136),0.43837972863726726,0.9319212776453705,0.5605590062111802,0.8644210447595585,1.0,2/11,2.47%,THBS4;ITGB5
prerank,regulation of secretion by cell (GO:1903530),0.3341148771599071,0.930922015985875,0.6059907834101382,0.8660884855515065,1.0,14/54,17.38%,DNAJC1;ANXA1;RAB21;RAB8B;RALA;RAB10;LLGL1;MCTP2;KCNMB4;FMR1;HCRT;RAB8A;CPLANE2;RAB12
prerank,myelination (GO:0042552),0.337742406776456,0.9308131969868223,0.5736160188457008,0.8658872321401775,1.0,10/46,14.94%,TNFRSF21;B4GALT5;AMIGO1;PMP22;NF1;MYRF;CXCR4;SIRT2;TPPP;EPB41L3
prerank,negative regulation of growth (GO:0045926),0.30437089309029414,0.9307329139998289,0.6182008368200836,0.8656177206511504,1.0,19/121,14.35%,ENPP1;PPP1R9B;BCL6;SLIT3;PSRC1;SFRP1;SFRP2;CDKN2D;FRZB;SERTAD2;CYP27B1;CDKN2AIP;ACVR1B;ENO1;CCAR2;RERG;BTG1;SMAD3;FLCN
prerank,glucose 6-phosphate metabolic process (GO:0051156),0.3865453566893125,0.9305200759235419,0.5655737704918032,0.8656304797152656,1.0,7/21,16.27%,HKDC1;HK2;TALDO1;TKT;G6PC3;H6PD;GCK
prerank,telomere organization (GO:0032200),0.33864638570156885,0.9302966361511447,0.5707317073170731,0.8656432259433005,1.0,12/43,21.90%,PARP3;DNA2;ATM;ATR;TERT;RIF1;SP100;LTO1;PARP1;CTC1;TERF2IP;PRKDC
prerank,regulation of vasoconstriction (GO:0019229),-0.28064584013028215,-0.9302373920928646,0.5641025641025641,0.8512658321348838,1.0,9/27,21.30%,CAV1;ADRA1B;ADRA1A;CHRM3;ACE;PER2;ACE2;ZDHHC21;AGTR1
prerank,Golgi ribbon formation (GO:0090161),0.42354422627665,0.9298567056421325,0.5621301775147929,0.8661220331552837,1.0,2/13,5.62%,STX6;TRIP11
prerank,neural crest cell differentiation (GO:0014033),0.3989891191675176,0.9294716287779038,0.5655853314527504,0.8664518080838631,1.0,7/18,26.28%,SNAI2;KLHL12;LRP6;PEF1;NOLC1;SOX11;TAPT1
prerank,regulation of presynapse organization (GO:0099174),0.39539799647249324,0.9293644052767449,0.5656292286874154,0.8658140454109203,1.0,2/18,2.77%,GPC6;MDGA1
prerank,regulation of presynapse assembly (GO:1905606),0.39539799647249324,0.9293644052767449,0.5656292286874154,0.8658140454109203,1.0,2/18,2.77%,GPC6;MDGA1
prerank,peptide catabolic process (GO:0043171),0.3742918690280621,0.9292197412639421,0.5714285714285714,0.8656664532256715,1.0,8/23,22.11%,ANPEP;CPQ;XPNPEP1;ENPEP;NPEPPS;LVRN;CTSH;GGT7
prerank,positive regulation of proteolysis involved in cellular protein catabolic process (GO:1903052),0.3628858700953682,0.9290600031671283,0.5675324675324676,0.865568598955127,1.0,12/28,24.60%,TREM2;PTEN;FMR1;PTK2;SMURF1;FBXW7;CTSC;PSMC6;CDK5RAP3;DDRGK1;NUPR1;ATP5IF1
prerank,DNA replication-independent nucleosome assembly (GO:0006336),0.3497172389327315,0.9286786119328975,0.5658056580565806,0.8658911128607811,1.0,10/38,19.40%,CENPQ;UBN1;CENPN;ASF1A;ATRX;CENPT;RSF1;CENPL;RUVBL1;RBBP4
prerank,production of siRNA involved in RNA interference (GO:0030422),0.4447371378420709,0.9284224227336879,0.5642201834862385,0.8660017257150336,1.0,3/10,12.10%,TARBP2;DICER1;TERT
prerank,ESCRT complex disassembly (GO:1904896),0.4474536247585782,0.928376676963817,0.5683229813664596,0.8652338383194729,1.0,5/10,26.40%,VPS4A;CHMP7;CHMP2B;VTA1;VPS4B
prerank,ESCRT III complex disassembly (GO:1904903),0.4474536247585782,0.928376676963817,0.5683229813664596,0.8652338383194729,1.0,5/10,26.40%,VPS4A;CHMP7;CHMP2B;VTA1;VPS4B
prerank,histone H4 acetylation (GO:0043967),-0.24413509246807283,-0.9283172445161458,0.6455696202531646,0.8543518517679496,1.0,12/47,13.15%,LEF1;JADE1;EPC1;ACTL6A;JADE2;BRCA2;EP300;WDR5;JADE3;NAA60;TRIM16;APBB1
prerank,regulation of cholesterol biosynthetic process (GO:0045540),0.4002887481740574,0.9280598811196671,0.5706051873198847,0.8654492136175338,1.0,3/17,4.50%,ABCA2;APOE;ABCG1
prerank,positive regulation of superoxide anion generation (GO:0032930),0.4194972692472394,0.9278911720515153,0.5447870778267254,0.8653605167259506,1.0,1/13,2.59%,CRP
prerank,regulation of mitotic spindle assembly (GO:1901673),0.3876056203842252,0.9272980348218667,0.5642076502732241,0.8661315479552625,1.0,8/19,26.40%,CHMP4B;PLK1;EML3;CHMP3;CHMP2B;PDCD6IP;DRG1;VPS4B
prerank,positive regulation of cell division (GO:0051781),0.3493247688409653,0.9264419552563158,0.5822002472187886,0.867452835267033,1.0,8/38,14.40%,SVIL;SHH;CDC42;CSPP1;SIRT2;CDC14B;DRD3;OPN1MW
prerank,metal ion export (GO:0070839),0.36190919513153186,0.9262353865794845,0.5743329097839899,0.8674820603949228,1.0,4/31,7.35%,KCNT2;SLC9A1;SLC4A4;KCNA5
prerank,protein localization to nucleus (GO:0034504),0.3070586224776124,0.9260766145454611,0.610223642172524,0.8673611731499069,1.0,21/102,15.96%,COL1A1;BCL3;MMP12;STAT3;PINX1;PLK1;E2F3;TNPO1;FAM53B;NUP153;NUP188;PRICKLE1;MORC3;KPNB1;SKP1;BANP;NXT2;TOR1AIP2;MDM2;NXT1;NUP214
prerank,GPI anchor biosynthetic process (GO:0006506),0.3651169900010983,0.9254075341458181,0.582687338501292,0.8683053630419023,1.0,14/30,27.60%,PIGW;PIGN;PGAP4;PIGL;DPM2;PIGG;PIGC;PIGK;PIGX;PIGH;PIGP;PIGT;PIGM;MPPE1
prerank,positive regulation of neuroinflammatory response (GO:0150078),0.42830247706486424,0.925339869139065,0.5540334855403348,0.8680065248893208,1.0,3/12,15.60%,TREM2;IL33;TNF
prerank,negative regulation of cell cycle (GO:0045786),0.32038652521318,0.9252616273265,0.6038159371492705,0.8677208149150115,1.0,12/73,13.71%,RUNX3;NR2F2;MAD2L1;PTPN3;PTEN;HEXIM1;PLK1;GAS1;CDK6;BTG1;TRIM35;SMAD3
prerank,positive regulation of protein localization to plasma membrane (GO:1903078),0.33252887009969856,0.9252004031618049,0.5844004656577415,0.8674271821570154,1.0,13/52,15.60%,LRP1;NKD2;TREM2;EGFR;PIK3R1;SQSTM1;KIF5B;CLIP3;EPHB2;ATP2C1;SPTBN1;ITGA3;TNF
prerank,positive regulation of heterochromatin assembly (GO:0031453),0.43439230711552157,0.9249768056856491,0.5763239875389408,0.8674604344064278,1.0,5/11,22.32%,SETDB1;SETDB2;MPHOSPH8;RESF1;ATF7IP
prerank,homophilic cell adhesion via plasma membrane adhesion molecules (GO:0007156),0.32940047999526256,0.9246496015658021,0.5869565217391305,0.8676607120418754,1.0,6/59,3.43%,PALLD;ROBO2;PCDHB6;TENM3;AMIGO1;SDK2
prerank,late endosome to vacuole transport via multivesicular body sorting pathway (GO:0032511),0.40127747902307825,0.9244617884109799,0.5459770114942529,0.8675918883931376,1.0,7/16,27.52%,CHMP4B;CHMP4A;LEPROTL1;CHMP7;LEPROT;VTA1;SNF8
prerank,regulation of oxidative stress-induced intrinsic apoptotic signaling pathway (GO:1902175),-0.32217499189336735,-0.9241964497949269,0.5358361774744027,0.8631305955480725,1.0,8/17,20.56%,SFPQ;HSPB1;NME5;SIRT1;HTRA2;MAPK7;PPIA;SOD1
prerank,regulation of protein catabolic process (GO:0042176),0.3089940186195206,0.9239158041087274,0.6148936170212767,0.8682813161646902,1.0,29/99,23.52%,TNFAIP3;MAD2L1;WNT5A;IRAK3;SMURF2;AZIN2;EGFR;RAB7A;OAZ3;AREL1;DDB1;FZR1;SIRT2;SMURF1;BANP;GSK3B;MDM2;TNF;ITCH;HGS;CTSA;CSNK2A1;NEDD4;WDR91;CENATAC;DACT1;ASB5;ATG7;NKD1
prerank,positive regulation of lipid kinase activity (GO:0090218),0.36100492204508217,0.9239140047544048,0.5524296675191815,0.8678556077384256,1.0,8/29,15.88%,PDGFRA;PDGFRB;IRS1;AMBRA1;FGF2;PTK2;PIK3R4;ATG14
prerank,intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:0042771),-0.3072395933328134,-0.9237991955588123,0.5743944636678201,0.8624793748837168,1.0,8/19,18.01%,HIPK1;MSH2;EP300;DDIT4;DYRK2;TP53;SIRT1;TMEM109
prerank,leukotriene metabolic process (GO:0006691),0.3887319160873425,0.9235242935679171,0.5563282336578581,0.8682220180682904,1.0,3/19,9.99%,PLA2G5;ALOX5AP;DPEP2
prerank,axonal transport (GO:0098930),0.34979809178643195,0.9231918277896457,0.5858708891595615,0.8684812285726212,1.0,9/36,18.40%,AP3B1;DYNC1H1;RAB21;AP3S1;DTNBP1;FBXW11;AP3D1;KIF3A;NEFL
prerank,regulation of biomineral tissue development (GO:0070167),0.36966808122485206,0.923127773760908,0.5782493368700266,0.8681827636689465,1.0,5/26,13.16%,ENPP1;DDR2;CYP27B1;FBXO5;ANKH
prerank,protein kinase A signaling (GO:0010737),-0.3514291668306896,-0.9229750705557502,0.551829268292683,0.8629963869051694,1.0,3/12,10.31%,EZR;RDX;MYOM1
prerank,base conversion or substitution editing (GO:0016553),0.4292260533758173,0.9227877350701554,0.5776119402985075,0.8684580780763882,1.0,1/11,2.06%,APOBEC1
prerank,purine nucleotide catabolic process (GO:0006195),-0.34943698975435794,-0.9226576256875738,0.5768115942028985,0.8621780084523317,1.0,4/13,15.05%,NT5E;ITPA;NT5C2;NT5C
prerank,regulation of protein localization to Cajal body (GO:1904869),-0.36227370942040793,-0.9226094393526922,0.5484764542936288,0.8589702136176883,1.0,4/11,9.62%,CCT5;LARP7;CCT4;DKC1
prerank,positive regulation of protein localization to Cajal body (GO:1904871),-0.36227370942040793,-0.9226094393526922,0.5484764542936288,0.8589702136176883,1.0,4/11,9.62%,CCT5;LARP7;CCT4;DKC1
prerank,adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway (GO:0007193),-0.23665590476327722,-0.9224112643640325,0.6259541984732825,0.8578073891372711,1.0,14/57,15.61%,GRM7;GRM8;ADCY5;CHRM2;ADCY9;HTR1F;CHRM3;ADCY4;PDE2A;ADRA2A;ADCY1;GNAI3;AKAP12;DRD2
prerank,response to interleukin-6 (GO:0070741),0.44494384491250505,0.9223581905444915,0.5650793650793651,0.8688872657976191,1.0,3/10,10.12%,SBNO2;PID1;NFKB1
prerank,positive regulation of metaphase/anaphase transition of cell cycle (GO:1902101),0.4244343034796467,0.9222530050241426,0.5725429017160687,0.8678191798257637,1.0,5/12,23.49%,ANAPC11;CDC27;CDC16;NSMCE2;CDC23
prerank,positive regulation of mitotic metaphase/anaphase transition (GO:0045842),0.4244343034796467,0.9222530050241426,0.5725429017160687,0.8678191798257637,1.0,5/12,23.49%,ANAPC11;CDC27;CDC16;NSMCE2;CDC23
prerank,positive regulation of mitotic sister chromatid separation (GO:1901970),0.4244343034796467,0.9222530050241426,0.5725429017160687,0.8678191798257637,1.0,5/12,23.49%,ANAPC11;CDC27;CDC16;NSMCE2;CDC23
prerank,lipid modification (GO:0030258),-0.2575280931334313,-0.9222117432439223,0.5862068965517241,0.8566662181672162,1.0,7/37,14.70%,DGKB;MBOAT1;DGKI;DGKG;DGKQ;DGKA;DGKZ
prerank,macromolecule catabolic process (GO:0009057),0.36651002127036564,0.9222086850386203,0.5894736842105263,0.8674888164733763,1.0,9/26,23.69%,CLN6;SMURF1;PIK3R4;MVB12A;SH3GLB1;SNX25;NEDD4;KIF16B;TGFB1
prerank,negative regulation of vascular permeability (GO:0043116),0.43256780405128176,0.9221737755048877,0.554364471669219,0.8671226296344057,1.0,1/12,0.41%,PDE3A
prerank,positive regulation of protein localization to membrane (GO:1905477),0.30998514289166673,0.9221215821750454,0.625,0.8667949724921438,1.0,19/98,15.60%,CEMIP;LRP1;NKD2;BCL2;TREM2;BBC3;E2F1;EGFR;PIK3R1;SQSTM1;KIF5B;TFDP1;CLIP3;EPHB2;ITGB1BP1;CASP8;SPTBN1;ITGA3;TNF
prerank,negative regulation of viral genome replication (GO:0045071),0.3492576473129732,0.922088507317067,0.5840597758405978,0.8664386457190744,1.0,8/40,15.60%,TNIP1;SHFL;ILF3;CCL5;EIF2AK2;OASL;SETDB1;TNF
prerank,Arp2/3 complex-mediated actin nucleation (GO:0034314),0.40767883918567716,0.9217747458877192,0.573049645390071,0.8666281863888903,1.0,5/15,20.67%,ACTR2;WHAMM;TRIM27;ARPC2;WASHC1
prerank,glutamine family amino acid metabolic process (GO:0009064),-0.2596992345507065,-0.9217273483936695,0.5771144278606966,0.8562472728971768,1.0,11/33,22.85%,MTHFS;SLC39A8;PRODH;GLUD1;GCLM;GLS;GLUL;GCLC;SIRT4;ALDH4A1;PYCR2
prerank,DNA-dependent DNA replication (GO:0006261),0.3010162046780514,0.9209892427553403,0.6438213914849429,0.8677845523556801,1.0,28/128,23.15%,PSMA7;POLE3;BAZ1A;DNA2;MCM2;PSMD4;PSMD11;PSMB8;MCM7;WDHD1;DBF4;PSMA6;PSMD14;POLA2;POLG;PSMC6;PSMB10;PSMD12;PSMB1;LRWD1;PSMA8;PSMF1;SIRT7;HELB;ORC6;RPS27A;PSME2;PSMA4
prerank,sphingoid biosynthetic process (GO:0046520),-0.3588224806139885,-0.9200340397031266,0.553072625698324,0.8571797713414033,1.0,6/11,19.25%,ACER2;SPTLC2;SPTLC1;ASAH1;ASAH2;SPHK1
prerank,sphingosine biosynthetic process (GO:0046512),-0.3588224806139885,-0.9200340397031266,0.553072625698324,0.8571797713414033,1.0,6/11,19.25%,ACER2;SPTLC2;SPTLC1;ASAH1;ASAH2;SPHK1
prerank,positive regulation of cold-induced thermogenesis (GO:0120162),0.3091112284399119,0.9196909691039552,0.6126609442060086,0.8699555797953606,1.0,14/90,11.57%,ADIPOQ;PLAC8;CMKLR1;JAK2;ALMS1;DYNC1H1;OGT;EHMT1;CD36;OMA1;GNAS;CXCR4;ELOVL6;HDAC3
prerank,fatty-acyl-CoA biosynthetic process (GO:0046949),0.36417714526937267,0.9196370982995947,0.5800256081946222,0.8696420557262557,1.0,8/29,15.07%,FASN;HACD2;ACSL4;HSD17B12;SCD5;ELOVL6;HSD17B8;ELOVL1
prerank,fatty acid derivative biosynthetic process (GO:1901570),0.3530549545916254,0.919406582703239,0.5914634146341463,0.8697038095481125,1.0,5/35,11.83%,PAM;FASN;ALOX5AP;SCD5;HSD17B8
prerank,"RNA splicing, via transesterification reactions with bulged adenosine as nucleophile (GO:0000377)",-0.1973577061773843,-0.9192571866784994,0.8333333333333334,0.8574691895490125,1.0,77/241,25.57%,ELAVL2;SFPQ;WDR33;NOVA2;CWC22;SNRPN;FRG1;CSTF2;SRRM2;RBM5;CDC40;U2SURP;SNRNP70;AQR;PRPF38A;PRPF4;HNRNPU;USP49;DDX5;RALY;HNRNPA3;CWF19L1;SNRPC;YTHDC1;SRSF7;PPIL3;CPSF2;HNRNPR;SNRPG;POLR2H;CWC25;SNRPD3;RBM19;RBM8A;POLR2G;POLR2F;PRPF19;ZCRB1;LSM5;U2AF2;MAGOH;EIF4A3;ISY1;SRSF10;PDCD7;PPWD1;IK;POLR2E;SF3A3;HNRNPA1;PSPC1;CLP1;CPSF4;CACTIN;TXNL4A;PABPN1;NOVA1;POLR2A;ZMAT2;SF3B5;PRPF6;DDX39A;CWC27;SF3B4;HNRNPH3;PQBP1;SF3B6;TFIP11;SNRPF;WBP4;DNAJC8;SNRPA1;DDX39B;GCFC2;WDR83;SNRPA;POLR2J
prerank,positive regulation of axonogenesis (GO:0050772),0.3319809875476003,0.9192446747216253,0.5976047904191617,0.8695920570146443,1.0,8/43,11.38%,ROBO2;AMIGO1;PLXNC1;DBN1;DBNL;PLXND1;L1CAM;PLXNA3
prerank,replication fork processing (GO:0031297),0.34578613998619345,0.9190038768211366,0.585,0.8696821611242169,1.0,9/38,13.92%,DNA2;FBH1;ATR;CDK9;DDX11;MMS22L;ATRX;SETMAR;NUCKS1
prerank,regulation of neuron migration (GO:2001222),0.36352261363247684,0.9188449774458455,0.5808917197452229,0.8695791422583248,1.0,4/26,7.48%,COL3A1;TNN;MDK;NIPBL
prerank,phosphatidylinositol acyl-chain remodeling (GO:0036149),0.3929792711030247,0.918607487873547,0.5605006954102921,0.8696651128977602,1.0,5/17,23.71%,PLA2G5;PLA2G12A;PLA2G4A;PLA2G4E;LCLAT1
prerank,dendrite morphogenesis (GO:0048813),0.35321143196767046,0.9181054700874929,0.5741206030150754,0.8702014759781082,1.0,8/35,12.47%,FARP1;PTN;EPHB3;PTEN;CDC42;SDC2;DLG4;EPHB2
prerank,negative regulation of type I interferon production (GO:0032480),0.3429105003791177,0.9180830156526966,0.5965770171149144,0.869816058709581,1.0,9/40,17.44%,TNFAIP3;REL;IKBKE;ILRUN;SIRPA;RELB;DHX58;YY1;ITCH
prerank,oligodendrocyte development (GO:0014003),0.40689315513240804,0.9180028033251049,0.5806451612903226,0.8695372078060156,1.0,4/15,16.25%,B4GALT5;MYRF;TPPP;EIF2B3
prerank,O-glycan processing (GO:0016266),0.3265670414489561,0.9180010171102108,0.6056009334889149,0.8691140836420757,1.0,5/54,5.45%,B4GALT5;ST3GAL3;ST6GAL1;GXYLT2;GALNT3
prerank,peptidyl-proline hydroxylation (GO:0019511),-0.3554649941442076,-0.9179477814180746,0.5329341317365269,0.8590119366273323,1.0,4/11,24.24%,P4HTM;EGLN3;P3H2;P4HA3
prerank,protein autoubiquitination (GO:0051865),0.3226324635315662,0.9176227770629342,0.6027397260273972,0.8694582087735429,1.0,16/61,19.95%,SH3RF3;RNF157;CNOT4;TRIM21;RNF11;RNF19B;RNF8;TRIM13;SH3RF1;TRAF2;STUB1;MDM2;ITCH;TRIM17;RNF213;RNF181
prerank,negative regulation of cell growth (GO:0030308),0.29927057199093154,0.9165838745124122,0.6431578947368422,0.8711193152855368,1.0,20/121,14.35%,ENPP1;PPP1R9B;BCL6;SLIT3;PSRC1;SFRP1;SFRP2;CDKN2D;FRZB;SERTAD2;CYP27B1;CDKN2AIP;ACVR1B;ENO1;FGF13;CCAR2;RERG;BTG1;SMAD3;FLCN
prerank,ether lipid biosynthetic process (GO:0008611),-0.3833719022492465,-0.9161640764808413,0.5802139037433155,0.8619063767777452,1.0,3/10,7.05%,CHPT1;LPCAT2;AGPS
prerank,icosanoid metabolic process (GO:0006690),0.3393750778482796,0.9159588730366052,0.5723114956736712,0.8719445813289071,1.0,5/40,12.26%,CYP1B1;ALOX5AP;DPEP2;PON3;FADS1
prerank,histone deacetylation (GO:0016575),0.3368630662096056,0.9157245023653818,0.6033254156769596,0.8720018181526923,1.0,10/43,14.72%,MIER2;RCOR1;HDAC1;MTA2;PRDM5;HDAC5;SIRT2;HDAC3;TBL1X;ELK4
prerank,positive regulation of regulated secretory pathway (GO:1903307),0.3951956526709737,0.9156911189946765,0.5898550724637681,0.8716521322574733,1.0,2/17,6.49%,UNC13D;SYT10
prerank,positive regulation of cell morphogenesis involved in differentiation (GO:0010770),0.32914242651636394,0.9156224812024626,0.5971223021582733,0.8713541888905992,1.0,8/48,8.21%,NRP1;CARMIL1;MDK;RAC1;LIMS1;CDC42;OBSL1;DOCK1
prerank,regulation of cellular catabolic process (GO:0031329),0.32413370277509257,0.914615642085951,0.5958429561200924,0.8729488580770121,1.0,22/62,24.29%,ITPR1;LRRK2;PIP4K2A;DRAM1;RMC1;ATM;RPTOR;PIP4K2B;RRAGC;DCAF12;ABL1;RAB8A;SMCR8;TRIB3;DAPK1;TPCN2;WDR91;DAPK2;DDIT3;GPR137;SCARB2;NUPR1
prerank,positive regulation of extrinsic apoptotic signaling pathway (GO:2001238),-0.27215963009384125,-0.9139652875970367,0.5895196506550219,0.8656779225557661,1.0,9/29,17.12%,CAV1;TNFSF10;THBS1;WWOX;CYLD;BID;DEDD2;GPER1;HTRA2
prerank,regulation of immunoglobulin production (GO:0002637),0.3695998436239252,0.9138743549601899,0.5807327001356852,0.8739776205024827,1.0,5/23,15.25%,FCGR2B;SASH3;XBP1;EPHB2;TNFRSF4
prerank,"positive regulation of gene expression, epigenetic (GO:0045815)",0.33213258370290355,0.9138582953936358,0.6150234741784038,0.8735848818362698,1.0,8/48,8.02%,ZMIZ1;TAF1D;SERTAD2;PADI2;ARID1B;PHF2;POLR1E;ASF1A
prerank,positive regulation of protein depolymerization (GO:1901881),0.4298953780369589,0.9136078187366541,0.5781990521327014,0.8736336059315678,1.0,1/11,1.44%,PDXP
prerank,endoplasmic reticulum membrane organization (GO:0090158),0.4236236462736732,0.9134804686922696,0.5734375,0.8734751719179464,1.0,5/11,21.17%,ATL2;ATL1;VCPIP1;BNIP1;LPCAT3
prerank,positive regulation of phospholipase C activity (GO:0010863),0.34182566123831887,0.9132622906870266,0.583732057416268,0.873472149614455,1.0,10/40,17.36%,PDGFRA;PDGFRB;EDNRA;FGFR1;EGFR;ARHGAP6;FGF2;NTRK3;LPAR2;LPAR1
prerank,cAMP biosynthetic process (GO:0006171),0.4462183429214389,0.9127714677668137,0.5971786833855799,0.8740557060651306,1.0,2/10,4.92%,ADCY7;ADCY2
prerank,histone H3 deacetylation (GO:0070932),-0.32291532524220184,-0.9122410212068323,0.5789473684210527,0.8684862013634749,1.0,6/15,16.81%,SFPQ;HDAC9;SMARCAD1;HDAC4;PER2;SIRT1
prerank,macrophage differentiation (GO:0030225),-0.34919558451724364,-0.9121519392224575,0.5481927710843374,0.8670956025987081,1.0,2/13,1.65%,BMP4;IL15
prerank,membrane protein proteolysis (GO:0033619),0.34377332523931686,0.9119370255659504,0.6132190942472461,0.8752952581791668,1.0,14/37,24.92%,ADAM19;PRTN3;MYH9;NFKB1;HM13;PSEN1;SPPL3;CTSH;PSENEN;RBMX;TGFB1;AFG3L2;ADAM9;RHBDD1
prerank,regulation of ERBB signaling pathway (GO:1901184),0.40355012005509283,0.9118483619657809,0.5884146341463414,0.8750254442234229,1.0,5/15,14.53%,EGF;EGFR;PTPN18;RBPJ;MVB12A
prerank,porphyrin-containing compound biosynthetic process (GO:0006779),-0.2860141744038769,-0.9116499715843086,0.532520325203252,0.8666928668142754,1.0,5/24,11.54%,ABCG2;FLVCR1;CPOX;ABCB10;UROS
prerank,protein heterooligomerization (GO:0051291),0.3963338672822875,0.9112817744582317,0.5958333333333333,0.8757297512448442,1.0,4/17,11.83%,PKD2;TMEM120B;FARSB;HSD17B8
prerank,regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903798),0.38766839159915173,0.911218589778456,0.577683615819209,0.8754444503882548,1.0,6/18,19.35%,NCOR2;EGFR;MAP2K1;TERT;TNF;MAP2K2
prerank,vacuolar acidification (GO:0007035),0.3809300919426297,0.9109535060852676,0.5920529801324503,0.8755622181959127,1.0,6/21,19.14%,ATP6AP2;CLN6;TCIRG1;ATP6V0A2;ATP6V1H;CLN3
prerank,maintenance of protein location in nucleus (GO:0051457),0.38390671443208313,0.9107150803822476,0.5771349862258953,0.8756137737601357,1.0,7/20,22.31%,BCL3;MORC3;SKP1;SUN1;SP100;CHCHD10;PARK7
prerank,axoneme assembly (GO:0035082),-0.26795512046308007,-0.9105108637022293,0.6120689655172413,0.8677982364898895,1.0,19/30,46.22%,CCDC39;RP1;TTLL3;SPAG1;LRGUK;GAS8;DRC1;JHY;FOXJ1;CCDC65;DNAAF2;CFAP206;CCDC40;DNAAF3;RSPH1;RSPH6A;SPAG17;DNAAF1;RSPH4A
prerank,phosphatidylglycerol acyl-chain remodeling (GO:0036148),0.3933073669706435,0.910426171707929,0.5882352941176471,0.875770884116808,1.0,4/17,20.46%,PLA2G5;CRLS1;PLA2G12A;PLA2G4A
prerank,negative regulation of transcription elongation from RNA polymerase II promoter (GO:0034244),0.4223877712340302,0.9103556154075337,0.5936599423631124,0.8754861175344072,1.0,5/12,20.02%,EAPP;HEXIM1;RNF8;TCERG1;RNF168
prerank,"nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:0000288)",0.32410607499630817,0.9101059235471284,0.6098130841121495,0.8755531353073935,1.0,22/52,29.54%,TNKS1BP1;LSM7;CNOT4;EDC4;SAMD4A;EXOSC4;RC3H2;DCP2;EXOSC2;EXOSC1;EXOSC3;LSM6;TUT7;CNOT3;CNOT9;SAMD4B;PATL1;PATL2;EXOSC5;PARN;CNOT2;POLR2D
prerank,positive regulation of long-term synaptic potentiation (GO:1900273),-0.33593413022228114,-0.9099222271481977,0.5714285714285714,0.8676059531347278,1.0,8/13,31.37%,SHANK3;RELN;ADCY1;SHISA7;LGMN;AKAP5;ADCY8;EIF2AK4
prerank,dendritic spine organization (GO:0097061),0.3628535358868057,0.9099171479211078,0.5793650793650794,0.8755126377955986,1.0,10/26,19.76%,TREM2;EPHB3;PTEN;CDC42;DLG4;EPHB2;ITGA3;CTNND2;PICK1;ARF1
prerank,translational elongation (GO:0006414),-0.210185032172662,-0.9094899950803496,0.6071428571428571,0.8669946513891669,1.0,42/101,27.33%,MRPS9;MRPS15;PTCD3;MRPL39;MRPS28;MRPS35;ERAL1;TSFM;MRPS31;MRPL4;EEF1D;EEF2;MRPS7;MRPS18C;MRPS25;MRPL28;MRPL30;MRPL42;MRPL22;MRPL40;MRPL46;MRPS24;MRPS16;MRPS22;MRPS18B;MRPL20;MRPL58;MRPL23;MRPS10;EEF1G;MRPS12;MRPL18;MRPS34;MRPL43;MRPL44;MRPS21;MRPL35;MRPL2;MRPL13;MRPL54;MRPL16;MRPL34
prerank,regulation of phosphatidylinositol 3-kinase activity (GO:0043551),0.3455303516994259,0.9094319587572571,0.5728395061728395,0.8760771058359336,1.0,9/34,15.88%,PDGFRA;PDGFRB;IRS1;AMBRA1;PIK3R1;FGF2;PTK2;PIK3R4;ATG14
prerank,positive regulation of DNA biosynthetic process (GO:2000573),0.31581240969442337,0.9083187870663786,0.6255707762557078,0.8778298220894413,1.0,7/60,6.96%,PDGFRB;CCT8;PARM1;PRKD2;ATM;PKIB;ATR
prerank,"regulation of retrograde protein transport, ER to cytosol (GO:1904152)",0.4155744660941527,0.9077542786066993,0.5985294117647059,0.878505404034867,1.0,4/13,15.46%,ERLEC1;UBE2J1;EDEM1;BRSK2
prerank,N-terminal protein amino acid modification (GO:0031365),0.41485053968047647,0.9076425664805854,0.5967741935483871,0.8782929655164371,1.0,6/14,26.71%,NAA50;METAP1;METAP1D;NTMT1;AANAT;NAA15
prerank,establishment of protein localization to organelle (GO:0072594),0.311218685458092,0.9074387376300233,0.6140350877192983,0.8782627067213112,1.0,19/72,18.17%,IL10RA;MMP12;STAT3;HK2;CD68;RALA;E2F3;TNPO1;FAM53B;NUP153;LAMP2;NUP188;PRICKLE1;KPNB1;NXT2;NXT1;NUP214;PEX19;HEATR3
prerank,gluconeogenesis (GO:0006094),0.3399843520071788,0.9074153503699836,0.6078431372549019,0.877878671495107,1.0,1/39,0.16%,SLC39A14
prerank,SNARE complex assembly (GO:0035493),-0.374431022025991,-0.906878271032196,0.5545977011494253,0.8715153020207174,1.0,2/10,6.76%,STXBP6;VAMP4
prerank,ganglion development (GO:0061548),0.41807475048272996,0.9067068769501432,0.5782414307004471,0.8788059461665226,1.0,2/11,10.46%,NRP1;FZD3
prerank,cellular response to exogenous dsRNA (GO:0071360),-0.3451589375831562,-0.9066022834929011,0.5487804878048781,0.8705995926600018,1.0,4/12,11.17%,CAV1;MAVS;IFIH1;IFIT1
prerank,negative regulation of JUN kinase activity (GO:0043508),0.4385362602734256,0.9065227849514788,0.5734157650695518,0.8787456131373544,1.0,3/10,14.08%,AIDA;MAPK8IP1;HIPK3
prerank,regulation of superoxide anion generation (GO:0032928),0.40421295239264043,0.9063350965811261,0.565406976744186,0.8786808600396661,1.0,1/14,2.59%,CRP
prerank,negative regulation of biosynthetic process (GO:0009890),0.4034003496211363,0.9063152007670583,0.5830985915492958,0.8782913963781132,1.0,7/16,25.98%,EMILIN1;COA8;TRAP1;PARK7;ABCD2;ABCB7;SLC18A2
prerank,mitochondrial calcium ion homeostasis (GO:0051560),-0.2963549559412556,-0.905668181989448,0.5719844357976653,0.8713168094326401,1.0,6/21,10.19%,LETM1;SLC8A3;MCUB;SLC8B1;BCAP31;MICU1
prerank,hematopoietic stem cell differentiation (GO:0060218),0.43266976938730306,0.9054367047704837,0.5808936825885979,0.8796089057994898,1.0,2/10,4.15%,SFRP1;BATF
prerank,phagosome maturation (GO:0090382),0.3436148023447025,0.9049657642530021,0.6089743589743589,0.8801018212533425,1.0,11/35,19.14%,RAB34;RAB7A;ATP6V1G1;RAB32;ATP6V1D;ATP6V1F;TCIRG1;ATP6V0A2;ATP6V1H;ATP6V1G2;RAB31
prerank,long-chain fatty acid biosynthetic process (GO:0042759),0.3588624657741156,0.9048971712088619,0.594885598923284,0.8798115630159296,1.0,5/23,17.84%,EPHX2;CYP1A1;ELOVL6;FADS1;PTGS2
prerank,DNA-dependent DNA replication maintenance of fidelity (GO:0045005),0.3380893963471815,0.9045777387173513,0.6119402985074627,0.8799742983125883,1.0,11/40,18.63%,FBH1;ATR;CDK9;DDX11;MMS22L;ATRX;MCM9;SETMAR;NUCKS1;TIMELESS;EME2
prerank,regulation of DNA damage checkpoint (GO:2000001),-0.3669657961839732,-0.9042549793320944,0.5669515669515669,0.8729846117617317,1.0,4/10,25.11%,FEM1B;RFWD3;RPA2;DDX39B
prerank,negative regulation of axonogenesis (GO:0050771),-0.26998120344151216,-0.9041959249977065,0.5583333333333333,0.871507362799252,1.0,9/27,18.84%,MAP2;DCC;ULK2;LINGO1;MAG;SEMA3G;RNF6;CDKL3;TRIM46
prerank,negative regulation of ubiquitin-dependent protein catabolic process (GO:2000059),-0.2500939059499896,-0.9041409714108269,0.6397849462365591,0.8700305838678376,1.0,11/37,16.00%,FHIT;UCHL5;RPL5;CAMLG;MAP1A;HSP90AB1;NOP53;WAC;SGTA;TRIM39;HFE
prerank,amyloid fibril formation (GO:1990000),0.3269472993726519,0.904080756889844,0.6414435389988359,0.880522391257465,1.0,6/51,7.23%,HSPG2;IAPP;USP9X;SERF1A;SIAH2;CD36
prerank,positive regulation of T cell cytokine production (GO:0002726),-0.29694899852042517,-0.9040233331719351,0.5811320754716981,0.8687150304341644,1.0,7/20,17.87%,CD81;CD55;PRKCZ;IL18;MALT1;MAP3K7;RSAD2
prerank,fatty-acyl-CoA metabolic process (GO:0035337),0.3830027920529108,0.9039503845206519,0.601360544217687,0.880328062082598,1.0,4/20,11.83%,FASN;ACSL4;SCD5;HSD17B8
prerank,regulation of centrosome cycle (GO:0046605),0.3704797658710989,0.9037358526880347,0.5967523680649527,0.8803088949926513,1.0,8/21,26.40%,CHMP4B;XRCC3;FBXW5;CHMP3;NAT10;CHMP2B;PDCD6IP;VPS4B
prerank,positive regulation of posttranscriptional gene silencing (GO:0060148),0.4277033514067151,0.9036742111650602,0.598145285935085,0.8800142808083663,1.0,4/11,17.64%,STAT3;PUM1;FMR1;WTIP
prerank,peptidyl-threonine dephosphorylation (GO:0035970),0.3742303782379226,0.9035697954998575,0.5957161981258366,0.8798021536735439,1.0,3/22,7.28%,DUSP2;DUSP5;DUSP18
prerank,receptor recycling (GO:0001881),-0.3548217833875369,-0.9033909750768355,0.5837696335078534,0.8686251523946266,1.0,7/10,23.72%,PHETA1;PLEKHJ1;LMTK2;SORL1;RAB11B;NSG1;EHD3
prerank,erythrocyte development (GO:0048821),-0.35928474133417976,-0.9033329558293856,0.6233062330623306,0.8671766519411233,1.0,5/10,33.25%,ABCB10;NCKAP1L;ALAS2;ALAS1;SH2B3
prerank,regulation of cellular pH (GO:0030641),0.35787226792488597,0.9031624664825566,0.6187419768934531,0.8801970580496435,1.0,9/29,19.14%,LACC1;SLC9A1;SLC4A4;SLC4A5;TM9SF4;SLC9A8;SLC4A7;SLC9A9;CLN3
prerank,mitotic DNA damage checkpoint signaling (GO:0044773),0.3181341926254041,0.9029671109761696,0.6255760368663594,0.8801809590725646,1.0,18/57,23.91%,TAOK1;BABAM2;ATM;PLK1;MDC1;FBXO31;FZR1;TAOK3;CDC14B;RINT1;ATF2;EME2;BRSK1;CDK5RAP3;PRKDC;RAD9A;SDE2;UIMC1
prerank,inositol phosphate dephosphorylation (GO:0046855),0.41181823392105477,0.9028007795924065,0.5840978593272171,0.8796471407479131,1.0,2/11,5.32%,INPP1;PTEN
prerank,phosphorylated carbohydrate dephosphorylation (GO:0046838),0.41181823392105477,0.9028007795924065,0.5840978593272171,0.8796471407479131,1.0,2/11,5.32%,INPP1;PTEN
prerank,mitochondrial translational termination (GO:0070126),-0.209508015426344,-0.9027805153036088,0.6785714285714286,0.8670108073762576,1.0,39/88,27.33%,MRPS9;MRPS15;PTCD3;MRPL39;MRPS28;MRPS35;ERAL1;MTRF1;MRPS31;MRPL4;MRPS7;MRPS18C;MRPS25;MRPL28;MRPL30;MRPL42;MRPL22;MRPL40;MRPL46;MRPS24;MRPS16;MRPS22;MRPS18B;MRPL20;MRPL58;MRPL23;MRPS10;MRPS12;MRPL18;MRPS34;MRPL43;MRPL44;MRPS21;MRPL35;MRPL2;MRPL13;MRPL54;MRPL16;MRPL34
prerank,modulation by symbiont of entry into host (GO:0052372),0.394872580216897,0.9027615023449459,0.600828729281768,0.8793166405717286,1.0,5/16,18.81%,TRIML2;TRIM21;TRIM62;EXOC7;TRIM27
prerank,positive regulation of endothelial cell chemotaxis (GO:2001028),-0.31939198860953233,-0.9025185599035737,0.5947712418300654,0.8660394307787774,1.0,5/15,10.63%,KDR;TMSB4X;HSPB1;PRKD1;SEMA5A
prerank,regulation of hippo signaling (GO:0035330),-0.3120071448964483,-0.9024424127450759,0.5964285714285714,0.8646462751775892,1.0,4/17,8.62%,MOB3B;SCHIP1;MARK3;WWC2
prerank,protein tetramerization (GO:0051262),-0.22286551669898005,-0.9022975831593365,0.6868686868686869,0.8634581756457944,1.0,24/67,25.94%,KCNJ2;SAMHD1;UPB1;ALDH9A1;GBP5;KCNJ12;GLS;OSBPL2;HCN1;GRIN2B;GOLGA2;CBR4;APIP;KCNC3;USP16;CRYZ;MCOLN1;CBY1;PKD2L1;CTH;ALDOA;TRPA1;HSD17B10;SSBP1
prerank,negative regulation of hydrolase activity (GO:0051346),0.3257450177828428,0.9016035960745388,0.6179906542056075,0.8811388401515251,1.0,3/49,5.58%,SLC39A14;LRRK2;PPP1R36
prerank,nuclear pore organization (GO:0006999),-0.3252557872102064,-0.9012170408318352,0.5817610062893082,0.8643245634957673,1.0,8/14,30.40%,NUP133;TMEM170A;NUP93;NUP205;SEH1L;AHCTF1;NUP98;RTN4
prerank,positive regulation of double-strand break repair via homologous recombination (GO:1905168),0.401002694566968,0.9010063888203271,0.600297176820208,0.8818433940067987,1.0,6/14,22.18%,ACTR2;MMS19;TIMELESS;PARP1;FUS;WRAP53
prerank,body fluid secretion (GO:0007589),0.3992412509630193,0.9006085881236057,0.5670995670995671,0.8821945591533381,1.0,2/15,9.86%,APLN;GUCA1B
prerank,cAMP-mediated signaling (GO:0019933),0.36343612726027286,0.9003307621307205,0.6046195652173914,0.8822865263786143,1.0,3/24,4.92%,PDE3A;PDE7B;ADCY2
prerank,positive regulation of autophagy (GO:0010508),0.30848662454029013,0.9000188286796854,0.6543878656554712,0.8824932359233775,1.0,18/81,19.64%,DCN;TRIML2;LRRK2;NPRL2;FBXO7;TRIM21;TRIM8;TRIM13;FLCN;GSK3B;TPCN1;SH3GLB1;PLEKHF1;ORMDL3;TRIM27;FOXO3;DAPK1;STK11
prerank,retinoic acid metabolic process (GO:0042573),0.4034660397785401,0.8997939253713789,0.5990922844175491,0.8825115751940661,1.0,1/14,3.34%,ALDH1A2
prerank,plasma membrane tubulation (GO:0097320),0.4027770375624865,0.8997637800307304,0.584319526627219,0.8821483157168402,1.0,5/13,15.66%,CHMP4A;SNX33;WHAMM;EHD2;SNX9
prerank,regulation of phospholipid metabolic process (GO:1903725),-0.36326411618528287,-0.8995227264271223,0.6076696165191741,0.8667001842071982,1.0,4/10,22.19%,DNAJC19;ABCA3;MFSD2A;PHB2
prerank,regulation of neurotransmitter transport (GO:0051588),-0.3153522992422704,-0.89895103945163,0.5956678700361011,0.8664342979254559,1.0,4/16,14.12%,SNCAIP;MEF2C;MCTP1;RIMS1
prerank,blood vessel diameter maintenance (GO:0097746),0.34259867013183265,0.8989345765075657,0.6285714285714286,0.883326254922567,1.0,3/34,4.75%,EDN3;CRP;EDNRA
prerank,positive regulation of protein import into nucleus (GO:0042307),0.35537163024127766,0.8988307255341453,0.6023166023166023,0.8830928129895093,1.0,7/28,16.37%,UBR5;PIK3R1;BAG3;HDAC3;ZIC1;SMAD3;PSEN1
prerank,regulation of cilium movement (GO:0003352),-0.36644564896902426,-0.8986103806241781,0.5733695652173914,0.8656258449134193,1.0,8/10,38.61%,CCDC39;CFAP298;ODAD2;DRC1;CFAP43;CCDC65;CFAP206;CCDC40
prerank,negative regulation of G0 to G1 transition (GO:0070317),0.33681249921329415,0.8982333363442515,0.6055825242718447,0.8837824356109081,1.0,10/36,19.40%,EHMT1;YAF2;E2F1;RNF2;TFDP1;EZH2;RBBP8;PHC3;CBX5;RBBP4
prerank,fatty acid oxidation (GO:0019395),0.317852848053747,0.8981204756840866,0.6293706293706294,0.8835706214066457,1.0,5/57,9.41%,ADIPOQ;EHHADH;ADH5;ACOX1;SLC27A2
prerank,response to progesterone (GO:0032570),0.39004768670526635,0.897416168244171,0.6115007012622721,0.8845113383515409,1.0,7/18,23.69%,YAP1;CATSPER3;TGFB3;TGFB2;SRC;WBP2;TGFB1
prerank,excitatory postsynaptic potential (GO:0060079),0.3852317085140997,0.8973707055297858,0.5904628330995793,0.8841712394459936,1.0,7/19,19.92%,LRRK2;NPAS4;MPP2;GRIN2A;GSK3B;GRIN1;RAB3GAP1
prerank,regulation of long-term neuronal synaptic plasticity (GO:0048169),-0.36148185532780297,-0.8972491647119828,0.6074498567335244,0.867203294966087,1.0,4/10,15.61%,SHANK3;SYP;SYNGR1;DRD2
prerank,regulation of cardiac muscle contraction (GO:0055117),-0.2529083455431509,-0.8966968044894149,0.6559139784946236,0.866949289664448,1.0,7/34,9.98%,PDE4B;ATP1B1;ANK2;ADRA1A;CALM1;PDE4D;KCNQ1
prerank,regulation of chromosome organization (GO:0033044),-0.2844417229993351,-0.896654055795276,0.6007905138339921,0.8654887598906761,1.0,3/22,6.82%,RB1;CENPV;UPF1
prerank,positive regulation of reactive oxygen species metabolic process (GO:2000379),0.3236406452844015,0.8966460340110263,0.6351981351981352,0.885182909865731,1.0,5/47,7.23%,CRP;PDGFRB;DHRS4;PID1;CD36
prerank,mRNA processing (GO:0006397),-0.1904515809531457,-0.896207711318408,0.75,0.8649721635403159,1.0,98/287,27.34%,ELAVL2;SFPQ;WDR33;NOVA2;CWC22;SNRPN;FRG1;CSTF2;RNGTT;SRRM2;RBM5;CDC40;U2SURP;PPARGC1A;SNRNP70;ERN1;AQR;PRPF38A;PRPF4;ERCC3;HNRNPU;USP49;DDX5;RALY;HNRNPA3;CWF19L1;RPRD1A;SNRPC;YTHDC1;SRSF7;PPIL3;CPSF2;HNRNPR;SNRPG;SRRM4;POLR2H;CWC25;SNRPD3;RBM19;GTF2H2;RBM8A;POLR2G;POLR2F;PRPF19;ZC3H11A;ZCRB1;LSM5;CMTR1;SUPT4H1;U2AF2;MAGOH;EIF4A3;ISY1;SRSF10;PDCD7;PPWD1;IK;POLR2E;SF3A3;HNRNPA1;PSPC1;CLP1;CPSF4;CACTIN;TXNL4A;PABPN1;GTF2H4;NOVA1;POLR2A;ZMAT2;SF3B5;PRPF6;DDX39A;CWC27;SF3B4;HNRNPH3;PQBP1;SF3B6;TFIP11;SNRPF;WBP4;DNAJC8;POLDIP3;SNRPA1;DDX39B;GCFC2;WDR83;CHTOP;SNRPA;POLR2J;PPIE;PRKACA;PRMT9;PABPC1;DHX9;RBMX2;USP39;CMTR2
prerank,stress-activated MAPK cascade (GO:0051403),0.3200470751414034,0.8960172112331272,0.6397727272727273,0.8860126270166369,1.0,13/61,14.75%,ZFP36L1;MAP2K4;CCM2;CUL1;LGALS9;NOD1;NFKB1;MAPK11;PTGER4;FBXW11;SKP1;IRAK2;MAPK9
prerank,DNA strand elongation involved in DNA replication (GO:0006271),0.38289751187471344,0.8957914607921726,0.6146408839779005,0.8860110645079438,1.0,4/18,15.17%,POLE3;LIG1;MCM7;LIG3
prerank,regulation of myoblast differentiation (GO:0045661),-0.2648745169025706,-0.8956601904914718,0.6132075471698113,0.864691267330816,1.0,5/32,5.71%,RANBP3L;BMP4;PLCB1;AKIRIN1;MEF2C
prerank,cellular response to starvation (GO:0009267),0.2900660287433773,0.8951324980566188,0.6907216494845361,0.8868631192039641,1.0,40/147,20.04%,DAP;WIPI1;SFRP1;NUAK1;LRRK2;MIOS;NPRL2;EIF2AK3;INHBB;RPTOR;ASNS;LAMP2;XBP1;TBL2;ATP6V1G1;EIF2AK2;FNIP1;FADS1;LAMTOR5;ATP6V1D;PIK3C3;PIK3R4;FLCN;BRSK2;RRAGC;ATP6V1F;ATG14;TCIRG1;KPTN;KLF10;ATF2;SH3GLB1;PICK1;VPS41;RIPOR1;ATP6V1H;ATP6V1G2;FOXO3;BRSK1;CPEB4
prerank,mitotic cytokinesis (GO:0000281),0.32392482792108485,0.8948548786030216,0.6336866902237926,0.8869600908364619,1.0,13/47,19.06%,JTB;CHMP4B;SNX33;PLK1;SNX18;INCENP;RTKN;SPTBN1;SNX9;SON;CUL7;ROCK2;MYH10
prerank,DNA methylation (GO:0006306),0.36205918343199267,0.8947948924767966,0.6056527590847914,0.8866594518700811,1.0,14/23,30.72%,EHMT1;ATRX;DNMT3B;PICK1;BAZ2A;KMT2E;GATAD2A;ATF7IP;PPM1D;DNMT3A;MTRR;EHMT2;N6AMT1;FOS
prerank,release of sequestered calcium ion into cytosol (GO:0051209),0.35571430031380125,0.8947121826138651,0.6041397153945667,0.8864046055052127,1.0,5/26,12.01%,ITPR1;XCL1;PKD2;IBTK;FGF2
prerank,regulation of mRNA processing (GO:0050684),0.339720294687715,0.894152352630209,0.6347607052896725,0.8870225373465166,1.0,10/32,20.57%,ZFP36L1;KHDRBS1;RBM39;SAFB2;METTL16;HNRNPK;SON;SAFB;SLTM;CDK11B
prerank,acylglycerol catabolic process (GO:0046464),0.35263489405237847,0.8940359554638041,0.6360153256704981,0.8868249569094566,1.0,3/30,10.36%,LIPC;LPL;ABHD16A
prerank,regulation of neuron differentiation (GO:0045664),0.30729815745940026,0.8939783253928667,0.6391639163916392,0.8865259297722936,1.0,18/76,23.27%,ZEB1;TCF4;LRRK2;FGFR1;NREP;BIN1;HEYL;TCF3;NEPRO;RHOA;MMD;NTF3;CALR;ZFHX3;CDK5RAP3;BMP7;YWHAG;SOX11
prerank,synaptic vesicle transport along microtubule (GO:0099517),0.39953989837953524,0.8933104592882538,0.6078147612156295,0.886971929301952,1.0,4/15,16.67%,AP3B1;AP3S1;DTNBP1;AP3D1
prerank,anterograde synaptic vesicle transport (GO:0048490),0.39953989837953524,0.8933104592882538,0.6078147612156295,0.886971929301952,1.0,4/15,16.67%,AP3B1;AP3S1;DTNBP1;AP3D1
prerank,positive regulation of nitric-oxide synthase activity (GO:0051000),0.3938017293332417,0.8932653635254445,0.5994194484760522,0.8866434936853723,1.0,4/16,15.60%,NOS1AP;APOE;TERT;TNF
prerank,regulation of vascular endothelial cell proliferation (GO:1905562),0.37982417806637475,0.8931157752077873,0.6163434903047091,0.8864963059102409,1.0,7/18,13.55%,APLN;FGFR1;MDK;AKT3;PPARG;FGF2;CCL2
prerank,phagosome acidification (GO:0090383),0.35286250209438896,0.8927283573686635,0.5989445910290238,0.8868323397475719,1.0,8/26,18.85%,RAB7A;ATP6V1G1;ATP6V1D;ATP6V1F;TCIRG1;ATP6V0A2;ATP6V1H;ATP6V1G2
prerank,homotypic cell-cell adhesion (GO:0034109),0.3279106756457031,0.8926925122839832,0.5995145631067961,0.8864873828859222,1.0,9/39,18.52%,PDGFRA;CSRP1;MYH9;STXBP1;GNAS;METAP1;UBASH3B;STXBP3;PLPP3
prerank,receptor internalization (GO:0031623),0.32502815475639313,0.8925879224868211,0.6399026763990268,0.8862820366721089,1.0,7/44,12.37%,CLTC;LRP1;ADM;CD36;DNM1;GRB2;DRD3
prerank,positive regulation of locomotion (GO:0040017),0.35646723325200763,0.8925807289524144,0.636968085106383,0.8858738979535438,1.0,3/27,6.53%,PDGFRB;TREM2;AIF1
prerank,hexose biosynthetic process (GO:0019319),0.33369099577612354,0.892034154460993,0.620563035495716,0.8864713539449258,1.0,12/42,25.94%,SLC39A14;ENO1;G6PC3;GAPDH;ENO2;SLC25A10;PGAM1;SORD;CHST15;PGM1;MDH2;ATF4
prerank,positive regulation of blood vessel endothelial cell migration (GO:0043536),0.32684617398199445,0.8918450894351112,0.6477683956574186,0.886388858481184,1.0,8/48,9.16%,PRKCA;RHOJ;CD40;ANXA1;PRKD2;FGFR1;AKT3;STAT5A
prerank,positive regulation of endothelial cell migration (GO:0010595),0.30082437633755993,0.8912829397957844,0.6482084690553745,0.8869971736900634,1.0,23/84,20.99%,SPARC;PRKCA;NRP1;WNT5A;CD40;EGF;PRKD2;FGFR1;RAC1;AKT3;STAT5A;SASH1;FGF2;ITGB1BP1;ABL1;ANGPT1;ROCK2;RIN2;PLPP3;FGF18;CALR;ETS1;BCAS3
prerank,regulation of Arp2/3 complex-mediated actin nucleation (GO:0034315),-0.31068298233027913,-0.8905800715594815,0.6666666666666666,0.8745663950674408,1.0,6/17,22.56%,FCHSD2;CTNNA2;NCKAP1;WASF2;ARFIP1;CORO1B
prerank,axonal fasciculation (GO:0007413),0.4069801378171993,0.8903171329828397,0.5978428351309707,0.8883643141225591,1.0,4/12,13.99%,AMIGO1;EPHB3;EPHB2;ARHGAP35
prerank,positive regulation of gene silencing by miRNA (GO:2000637),0.3556217908812885,0.8900182790403993,0.6261319534282018,0.8885146313118402,1.0,10/27,24.62%,STAT3;EGFR;MAP2K1;PUM1;TNRC6B;FMR1;WTIP;MAP2K2;TGFB1;EIF4G1
prerank,morphogenesis of an epithelial sheet (GO:0002011),0.43219462260465064,0.8895550936588528,0.6027397260273972,0.8889676976904218,1.0,5/10,27.00%,BMP5;LRP6;BMP7;SOX11;ARHGAP12
prerank,cell migration involved in sprouting angiogenesis (GO:0002042),0.3848692576713446,0.8893944751389442,0.6109510086455331,0.8888609323372771,1.0,3/17,4.61%,NRP1;EGR3;MIA3
prerank,epithelial cilium movement involved in extracellular fluid movement (GO:0003351),0.3788203370839197,0.889293551621621,0.6208393632416788,0.8886160582022846,1.0,3/18,12.71%,DNAAF4;SPEF2;NPHP3
prerank,DNA metabolic process (GO:0006259),0.280586059674222,0.8891631910040514,0.7686116700201208,0.8884484845007448,1.0,70/270,23.89%,RAD51B;PARP3;TCF7L2;MPG;BACH1;POLE3;LIG1;DNA2;SMC1A;RAD52;INO80;PWWP3A;ATM;MGMT;ATR;XRCC3;ASF1A;MCM2;USP3;DDB1;ALKBH1;TOP2B;MMS19;ZNF445;TERT;MCM7;WDHD1;SETMAR;PDS5B;DBF4;RNASEH2A;AXIN2;HMGB2;RIF1;PDS5A;GTF2H1;LIG3;RNASEH1;ENDOV;HMGB3;RBBP8;SP100;DFFB;TIMELESS;DNASE1L2;LTO1;TOP3B;XRCC2;POLI;POLA2;NTHL1;POLG;SMARCB1;PARP1;LRWD1;CTC1;SIRT7;TERF2IP;HELB;PRKDC;ORC6;RPS27A;PARK7;XRCC1;KMT5B;TDP1;RAD9A;FANCC;RFC1;PARP4
prerank,lysosome localization (GO:0032418),0.33297976974493,0.8889820833213689,0.6290909090909091,0.8883677919291246,1.0,9/37,20.54%,BORCS6;MILR1;MYH9;RAB34;KIF5B;FLCN;KXD1;NDEL1;FAM98A
prerank,regulation of response to stress (GO:0080134),-0.3625900982959595,-0.8886986266404321,0.6060606060606061,0.877337111012017,1.0,5/10,28.52%,CORO2B;OPRM1;SLC38A2;STOX1;ADCY8
prerank,telomere maintenance via telomere trimming (GO:0090737),0.4241031233036253,0.8884074851505829,0.5785256410256411,0.8882219626335018,1.0,2/10,7.89%,DNA2;XRCC3
prerank,formation of extrachromosomal circular DNA (GO:0001325),0.4241031233036253,0.8884074851505829,0.5785256410256411,0.8882219626335018,1.0,2/10,7.89%,DNA2;XRCC3
prerank,t-circle formation (GO:0090656),0.4241031233036253,0.8884074851505829,0.5785256410256411,0.8882219626335018,1.0,2/10,7.89%,DNA2;XRCC3
prerank,determination of left/right symmetry (GO:0007368),0.33792424728351894,0.8881931680323663,0.628140703517588,0.8882140647835133,1.0,8/36,17.85%,DNAAF4;PKD2;SHH;GALNT11;NPHP3;DNAH11;BBS7;SMO
prerank,negative regulation of peptidyl-threonine phosphorylation (GO:0010801),0.38385450762928436,0.8877616958922843,0.5979827089337176,0.8886078398529834,1.0,6/17,13.46%,SPRED1;SPRED2;CALM3;SPRY2;SIRT2;CALM2
prerank,organonitrogen compound catabolic process (GO:1901565),0.3079400859561927,0.8872509231069237,0.6430232558139535,0.8891389362325905,1.0,13/57,20.55%,LIPC;ANPEP;PLA2G5;CLN6;CPQ;PLA2G7;SGPL1;ENPEP;NPEPPS;LVRN;ADO;PLA2G4A;AMDHD2
prerank,negative regulation of mononuclear cell migration (GO:0071676),-0.3416296945872236,-0.8872374400509272,0.5955056179775281,0.8791531200069514,1.0,4/12,11.21%,PLCB1;CCN3;SLIT2;WASL
prerank,negative regulation of defense response to virus (GO:0050687),0.4222647721831187,0.8871082272826295,0.6009036144578314,0.8889992711237615,1.0,3/10,17.44%,ILRUN;TARBP2;ITCH
prerank,protein O-linked glycosylation (GO:0006493),0.2990040967260657,0.887028050880249,0.6834061135371179,0.8887467915467693,1.0,21/96,18.97%,B4GALT5;PLOD2;ST3GAL3;TRAK1;ST6GAL1;OGT;TMTC4;GXYLT2;GALNT3;GALNTL6;B3GLCT;SLC35C1;GALNT11;DPM2;POMT2;TET2;ST3GAL2;ST3GAL1;GALNT16;PLOD1;POFUT2
prerank,negative regulation of heart contraction (GO:0045822),-0.34943972494148534,-0.8868866450785996,0.6041666666666666,0.878339786205083,1.0,7/11,31.40%,ATP1A2;PDE4D;SRI;PLN;SPX;PIK3CG;GRK2
prerank,fat-soluble vitamin metabolic process (GO:0006775),0.36382582291256416,0.886553029578034,0.6150740242261103,0.8892278670378614,1.0,4/22,17.66%,ALDH1A2;CYP27B1;CYP1A1;CYP2R1
prerank,neuromuscular junction development (GO:0007528),0.35517411395440157,0.8863253584675228,0.6143437077131259,0.8892566514263354,1.0,5/24,8.50%,PDZRN3;CACNB1;LRRK2;PPFIBP2;PPFIBP1
prerank,autophagy of nucleus (GO:0044804),0.3913771692936542,0.8860675959185369,0.6319444444444444,0.8893254144523757,1.0,2/16,5.78%,WIPI1;ATG3
prerank,positive regulation of DNA metabolic process (GO:0051054),0.3114817463386465,0.8859315490659823,0.6575028636884307,0.8891594914281366,1.0,10/61,12.01%,PARP3;PDGFRB;USP9X;GNL3;PRKD2;BABAM2;EGFR;RNF8;ATRX;FGF2
prerank,positive regulation of metabolic process (GO:0009893),0.2962211134582105,0.885749508340408,0.6839872746553552,0.8890751045188389,1.0,15/103,11.57%,ADIPOQ;PLAC8;CMKLR1;JAK2;FASN;ALMS1;DYNC1H1;OGT;EHMT1;CD36;OMA1;GNAS;CXCR4;ELOVL6;HDAC3
prerank,positive regulation of axon extension (GO:0045773),0.3618863882334654,0.8856994512492945,0.6153846153846154,0.888752543469157,1.0,5/22,11.08%,NRP1;DBN1;DBNL;DSCAM;L1CAM
prerank,neuromuscular process controlling balance (GO:0050885),-0.339509680606087,-0.8856142112781257,0.5964912280701754,0.8795433581303608,1.0,2/12,5.68%,NRXN1;PCDH15
prerank,oligosaccharide-lipid intermediate biosynthetic process (GO:0006490),0.4050012822638965,0.8854645903143308,0.6073529411764705,0.8887800393626881,1.0,8/13,31.58%,SRD5A3;ALG6;ALG8;DPAGT1;ALG1;ALG11;ALG14;ALG9
prerank,protein localization to vacuole (GO:0072665),-0.332878442426135,-0.885159337233327,0.625,0.879006658344747,1.0,9/13,32.78%,CD81;RNF128;LMBRD1;ATP13A2;SH3BP4;LAMTOR4;RTN4;GLMP;MFSD1
prerank,long-chain fatty acid import into cell (GO:0044539),0.42503088231780506,0.8849621767115897,0.6063348416289592,0.8892941498149891,1.0,4/10,11.30%,CD36;SLC27A2;SLC27A4;RPS6KB1
prerank,response to cAMP (GO:0051591),0.3327904912911603,0.8845065362152464,0.6524908869987849,0.8896977126654769,1.0,4/37,4.71%,ZFP36L1;STAT1;IGFBP5;PKD2
prerank,skeletal muscle organ development (GO:0060538),0.34681760640613246,0.8842305002509814,0.6357615894039735,0.8897905469488175,1.0,2/26,4.49%,SVIL;CFLAR
prerank,positive regulation of neural precursor cell proliferation (GO:2000179),0.36706985133937886,0.8841221406281026,0.6091794158553546,0.8895706862641739,1.0,6/21,15.90%,MDK;DISC1;SMARCD3;FZD3;FZD9;CX3CL1
prerank,positive regulation of response to DNA damage stimulus (GO:2001022),0.31565924713559235,0.8831444224155836,0.6538011695906433,0.8909459823740007,1.0,12/53,12.57%,EEF1E1;PLA2R1;FBH1;SPRED1;SPRED2;BABAM2;ATM;ATR;EGFR;RNF8;FMR1;CCAR2
prerank,mesenchymal cell development (GO:0014031),0.3813412593687203,0.8831071881277466,0.6319444444444444,0.890607290101268,1.0,7/18,26.28%,SNAI2;HEYL;KLHL12;PEF1;NOLC1;SOX11;TAPT1
prerank,"regulation of synaptic transmission, GABAergic (GO:0032228)",-0.31309368017099726,-0.8830954770585072,0.589171974522293,0.882269016347618,1.0,6/15,15.61%,SYN3;CNTNAP4;ADRA1A;USP46;NLGN1;DRD2
prerank,activation of NF-kappaB-inducing kinase activity (GO:0007250),-0.32317162714311976,-0.8830724926382252,0.5972696245733788,0.8807642955866845,1.0,6/14,18.78%,CARD10;CARD14;IRAK1;MALT1;MAP3K7;ZFP91
prerank,response to ethanol (GO:0045471),0.392449375006011,0.8829086760530882,0.6096181046676096,0.8905508748150522,1.0,4/14,19.11%,ADCY7;DRD3;GRIN2A;GRIN1
prerank,mitochondrial genome maintenance (GO:0000002),-0.3432776420144756,-0.8821596365544593,0.6285714285714286,0.881339286716415,1.0,4/11,12.57%,SLC25A4;MPV17;MGME1;MEF2A
prerank,production of small RNA involved in gene silencing by RNA (GO:0070918),0.36691918835853476,0.8819716548776169,0.6312247644683715,0.8919477600724331,1.0,4/20,12.10%,PUM1;TARBP2;DICER1;TERT
prerank,regulation of Ras protein signal transduction (GO:0046578),0.29913238643586004,0.8818983344373391,0.6754098360655738,0.8916818946881844,1.0,14/86,12.47%,DLC1;JAK2;OGT;DENND4C;OPHN1;MAPKAP1;FOXM1;SQSTM1;AKAP13;ERBIN;SPRY2;GRB2;ARFGAP1;EPHB2
prerank,positive regulation of dendrite development (GO:1900006),-0.3507278503555825,-0.881646982686079,0.6056338028169014,0.8809109408073412,1.0,4/10,9.41%,COBL;ALK;PACSIN1;ZDHHC15
prerank,positive regulation of muscle cell differentiation (GO:0051149),-0.278443253100532,-0.8814977136182326,0.6323529411764706,0.8797059677514425,1.0,7/24,15.46%,CTNNA2;MEF2C;MAPK12;MEF2A;BOC;MYOCD;CAMK1
prerank,regulation of store-operated calcium entry (GO:2001256),-0.35869648022431405,-0.8814734297894514,0.6126373626373627,0.8782068302351839,1.0,4/10,22.05%,SLC8B1;HOMER2;HOMER3;STIM1
prerank,"DNA damage response, signal transduction resulting in transcription (GO:0042772)",-0.35204863424944705,-0.8812925185416589,0.6027777777777777,0.8770959191692329,1.0,5/11,22.36%,TP53;KAT5;TFAP4;RPS6KA6;HIPK2
prerank,regulation of histone methylation (GO:0031060),0.40094742808094647,0.8807051089651298,0.5922038980509745,0.8934806324246317,1.0,4/13,20.24%,MTHFR;NSD1;AASS;JARID2
prerank,pteridine-containing compound metabolic process (GO:0042558),-0.3314499996691863,-0.8801672488992832,0.6193548387096774,0.8780199913261543,1.0,3/13,7.91%,NOS3;CALM1;PTS
prerank,central nervous system neuron differentiation (GO:0021953),0.34256888100107097,0.880160663062059,0.632183908045977,0.8940988198035108,1.0,11/33,21.20%,WNT2;MDGA1;OPHN1;AGTPBP1;LRP6;DRAXIN;GBA2;NPY;KNDC1;FAIM2;ATP7A
prerank,response to X-ray (GO:0010165),0.39166560051424176,0.8800681861459076,0.6061493411420205,0.8938595953171216,1.0,5/14,17.53%,ANXA1;ATM;NIPBL;NUCKS1;IKBIP
prerank,regulation of early endosome to late endosome transport (GO:2000641),0.3771675365113266,0.8798749191933812,0.5955678670360111,0.8937941762318854,1.0,9/18,23.28%,DNAJC13;RAB21;MAP2K1;MSN;CHMP3;PTPN23;MAP2K2;SRC;MAPK1
prerank,branching involved in ureteric bud morphogenesis (GO:0001658),0.3782902240580731,0.8798455946839366,0.6134094151212554,0.893432955076855,1.0,5/16,16.77%,PKD2;SHH;SALL1;FGF2;GDNF
prerank,I-kappaB phosphorylation (GO:0007252),0.42815938497090855,0.8796714018589372,0.625,0.8933362632429386,1.0,3/10,18.60%,TLR2;TLR7;TLR3
prerank,ribosomal small subunit assembly (GO:0000028),0.38470658170149824,0.8796602031543019,0.6131284916201117,0.892936432195067,1.0,1/16,1.01%,RPSA
prerank,positive regulation of chondrocyte differentiation (GO:0032332),0.424882318335111,0.8795248644109677,0.6144,0.8927971026538274,1.0,1/10,1.74%,SOX5
prerank,"nuclear-transcribed mRNA catabolic process, exonucleolytic (GO:0000291)",0.3323545678146939,0.8794809879777343,0.633248730964467,0.8924508479777609,1.0,9/31,21.50%,LSM7;EDC4;EXOSC4;DCP2;EXOSC2;EXOSC1;EXOSC3;LSM6;DIS3L2
prerank,negative regulation of peptidyl-lysine acetylation (GO:2000757),0.42612171097111695,0.8793401508984103,0.6411764705882353,0.8922961357888439,1.0,2/10,10.98%,TAF7;NOC2L
prerank,extracellular transport (GO:0006858),0.41023012165245776,0.8793147173986972,0.6021021021021021,0.8919270779403308,1.0,2/12,10.21%,DNAAF4;SPEF2
prerank,positive regulation of NIK/NF-kappaB signaling (GO:1901224),0.31771057425974303,0.8791948544434409,0.6402877697841727,0.8917389252122612,1.0,20/50,25.91%,TLR2;LIMS1;EGFR;LGALS9;NOD1;TLR7;CD14;SASH1;EIF2AK2;TNF;RHOA;TCIM;TRIM44;TLR3;DDX3X;TERF2IP;RPS3;IFI35;RTKN2;NLRP12
prerank,regulation of delayed rectifier potassium channel activity (GO:1902259),0.37917644303903764,0.8791572491200559,0.61212976022567,0.8914014192952042,1.0,1/17,1.62%,NOS1AP
prerank,calcium ion transport (GO:0006816),0.29435041852263144,0.8791347989397919,0.6930379746835443,0.8910337625156091,1.0,12/113,7.68%,MCOLN2;CACNA1A;SLC24A5;ITPR1;CACNA2D1;PKD2;CACNA1C;ATP2A2;CCR1;CYP27B1;CCL5;TRPC6
prerank,protein maturation by iron-sulfur cluster transfer (GO:0097428),-0.3226852499920019,-0.8790963072131215,0.6476190476190476,0.8789267033302371,1.0,7/13,27.72%,GLRX3;YAE1;GLRX5;BOLA2;CIAO1;NFU1;CIAO2B
prerank,unsaturated fatty acid metabolic process (GO:0033559),0.32360119876473337,0.879074680624032,0.6320191158900836,0.8907487520684708,1.0,5/41,15.07%,CYP1B1;ACOX1;SCD5;FADS1;ELOVL1
prerank,negative regulation of proteasomal protein catabolic process (GO:1901799),-0.24687563076798685,-0.8790267194594474,0.6594594594594595,0.8775506837353934,1.0,12/36,19.13%,FHIT;UCHL5;CAMLG;MAP1A;AQP11;HSP90AB1;NOP53;WAC;TRIM39;HFE;PRKCG;N4BP1
prerank,negative regulation of calcium ion transport (GO:0051926),-0.30458442334052005,-0.8789723598446263,0.6196721311475409,0.8761544092189076,1.0,4/15,12.28%,ATP1A2;INPP5K;TMBIM6;ADRA2A
prerank,nucleosome assembly (GO:0006334),0.3401903615492086,0.8789722412830324,0.6326530612244898,0.8905334338620611,1.0,10/31,20.85%,UBN1;ASF1A;ATRX;GRWD1;HMGB2;RSF1;NAP1L3;SPTY2D1;RBBP4;NAP1L1
prerank,cellular response to hexose stimulus (GO:0071331),0.35514792794432076,0.8789320996575535,0.6211920529801325,0.8902023357756975,1.0,1/23,0.16%,SLC39A14
prerank,carbohydrate homeostasis (GO:0033500),0.3032681856399563,0.8785773578276792,0.6769911504424779,0.8904473678520367,1.0,7/67,8.94%,ADIPOQ;TCF7L2;USF1;IRS1;STAT3;PYGL;PPARG
prerank,cell-cell adhesion via plasma-membrane adhesion molecules (GO:0098742),0.2846195843399502,0.8784272018702036,0.7192982456140351,0.8903027692203427,1.0,26/159,15.37%,PALLD;CDH11;ROBO2;GPC6;PCDHB6;JAML;TENM3;AMIGO1;PCDHB16;SDK2;MILR1;ADGRL3;ICAM1;TENM4;DCHS1;OBSL1;ACVR1;DSCAM;L1CAM;CDH6;SDK1;ATP2C1;LRRC4;FGFRL1;CDH18;CDH24
prerank,positive regulation of epidermal growth factor receptor signaling pathway (GO:0045742),-0.25304653621351886,-0.8779914263344522,0.6683168316831684,0.8768705932523244,1.0,8/33,15.12%,TGFA;AFAP1L2;HIP1R;HIP1;BCAR3;ADRA2A;CCDC88A;GPER1
prerank,activation of cysteine-type endopeptidase activity (GO:0097202),-0.32896625879943486,-0.8776312732950865,0.6276923076923077,0.8761696991397984,1.0,9/13,36.76%,CYFIP2;PERP;LGMN;TBC1D10A;RIPK2;BAD;NLRC4;FADD;BAK1
prerank,monocarboxylic acid transport (GO:0015718),0.31762278805890115,0.877626496541726,0.6647058823529411,0.8913150625198425,1.0,5/51,7.23%,NR1H4;SLC10A6;SLC16A12;ATP8B1;CD36
prerank,transport along microtubule (GO:0010970),0.3928207264496528,0.8774613525068556,0.626453488372093,0.8912019853300003,1.0,4/13,11.82%,CDC42;BAG3;COPG1;CLIP3
prerank,negative regulation of ubiquitin-protein transferase activity (GO:0051444),0.4017883470822385,0.8773333479084674,0.6297376093294461,0.8910183522987942,1.0,6/15,25.79%,MAD2L1;FBXO5;ABL1;DTX3L;PARK7;RPL11
prerank,regulation of cyclin-dependent protein kinase activity (GO:1904029),0.31355941850885116,0.877221995526715,0.6525821596244131,0.8908069217080821,1.0,11/50,16.38%,CDKN2B;CDKN2D;CCNE2;CCND3;CDK7;CCNT1;GTF2H1;CDC25A;CDC37;CCNB2;CCNH
prerank,regulation of hydrogen peroxide-induced cell death (GO:1903205),0.4183567388290211,0.8772218322208966,0.6167400881057269,0.8903971669142882,1.0,4/10,27.42%,LRRK2;NFE2L2;PARK7;RIPK1
prerank,microtubule polymerization or depolymerization (GO:0031109),0.3510038235984382,0.8767759813854857,0.6472184531886025,0.8908032830569944,1.0,8/24,21.98%,NCKAP5;KIF2A;FGF13;STMN4;TPPP;TPPP3;CKAP5;NCKAP5L
prerank,cellular senescence (GO:0090398),0.3467182361124216,0.8767418960341373,0.6207349081364829,0.8904516560051008,1.0,7/27,20.49%,CDKN2B;TBX2;MAP2K1;TBX3;SPI1;NSMCE2;CALR
prerank,positive regulation of sprouting angiogenesis (GO:1903672),-0.30912815088620366,-0.8766230815310534,0.6485623003194888,0.8768724799658472,1.0,3/15,10.14%,TJP1;FGF1;KLF4
prerank,glutathione metabolic process (GO:0006749),-0.243924494190283,-0.8766159429846231,0.708994708994709,0.875368899509725,1.0,11/38,21.68%,GSR;CHAC2;GCLM;CTNS;GSTA3;GSTZ1;GCLC;GSTM5;GSTM1;SOD1;HAGH
prerank,positive regulation of phosphoprotein phosphatase activity (GO:0032516),0.3775129017215887,0.8766045924251169,0.639367816091954,0.8903009628293129,1.0,4/17,16.16%,PDGFRB;CALM3;CALM2;ITGA1
prerank,positive regulation of dendritic spine development (GO:0060999),0.3645506566579595,0.8764236420909132,0.6251655629139072,0.8902355339070868,1.0,8/20,18.99%,APOE;DBN1;DBNL;FMR1;CAPRIN1;DLG5;PSEN1;CAMK2B
prerank,RNA processing (GO:0006396),0.2818532493347202,0.8760265775725168,0.7410440122824974,0.89053320209282,1.0,48/176,23.37%,RBMS1;ATXN1;PPP1R9B;APOBEC1;TSEN2;SYNCRIP;DDX17;CELF1;SNRNP40;PABPC4;KHSRP;ZCCHC8;SRSF2;DHX15;NONO;DHX8;RBM39;SETX;DICER1;CCAR2;ALKBH5;USB1;RBMS2;NCBP2;RRAGC;AKAP8L;SNRNP35;SRSF1;HNRNPK;HNRNPUL1;SON;TCERG1;RNPC3;RBM6;AURKAIP1;PRPF18;HNRNPA2B1;LSM6;LIN28B;TENT4A;FUS;SF3B2;SF3B1;U2AF1;RSRC1;RBM3;CDK12;TUT7
prerank,glycoprotein catabolic process (GO:0006516),0.37278100571037354,0.8750207034176641,0.6366237482117311,0.8919598426966175,1.0,7/17,18.64%,MMP12;ADAMTS12;ADAMTS9;EDEM1;CTSL;FBXO2;NGLY1
prerank,regulation of histone H3-K9 methylation (GO:0051570),0.42403341929244787,0.874566171180474,0.6230529595015576,0.892392461367215,1.0,5/10,24.26%,ATRX;RIF1;DNMT3B;JARID2;KDM1A
prerank,pyruvate metabolic process (GO:0006090),-0.221989194798357,-0.8744409177894475,0.74,0.8785531581829268,1.0,16/52,25.17%,BSG;ME3;SLC16A1;PFKM;ME1;ALDOC;PDHA1;PDHB;HOGA1;LDHB;ME2;HK1;HAGH;NR4A3;TPI1;ALDOA
prerank,protein alkylation (GO:0008213),0.3616539563731591,0.8737306689901524,0.6493860845839018,0.8934978333386894,1.0,6/22,20.54%,ETFBKMT;GSPT1;PCMT1;VCPKMT;LCMT1;FAM98A
prerank,peptidyl-serine phosphorylation (GO:0018105),0.28345797491748614,0.8736529614385876,0.7322348094747683,0.8932296148656731,1.0,35/153,19.80%,NEK6;PRKCA;MAST4;LRRK2;CAMK2D;PRKD2;CSNK2A2;MARK1;ATM;EIF2AK3;AKT3;IKBKE;ATR;PLK1;TGFBR1;RICTOR;CSNK1A1;HIPK4;MORC3;RPS6KB1;MAST2;CSNK1D;CAMK1G;HIPK3;GSK3B;MAPK9;RPS6KA3;ROCK2;CSNK2A1;STK4;CDK5;MAP2K2;CSNK1G2;BRSK1;CAMK1D
prerank,mesenchymal to epithelial transition (GO:0060231),-0.35637597789567854,-0.873566828059051,0.6038781163434903,0.878981796225484,1.0,1/10,1.52%,BMP4
prerank,positive regulation of apoptotic signaling pathway (GO:2001235),-0.22294537010961799,-0.872626193192036,0.7622377622377622,0.8795171983275339,1.0,16/55,20.08%,CAV1;TPD52L1;TNFSF10;BCL2L1;CRADD;WWOX;CYLD;BCAP31;TP53;BID;DEDD2;GPER1;TRIM39;STYXL1;GSDME;FAS
prerank,pre-mRNA cleavage required for polyadenylation (GO:0098789),-0.33270219075513974,-0.8726162010742736,0.6437125748502994,0.8780348335496644,1.0,3/13,9.32%,CSTF2;CPSF2;TUT1
prerank,positive regulation of microtubule polymerization (GO:0031116),0.34299004604778927,0.8724655975329207,0.6264591439688716,0.8949749976053931,1.0,10/28,25.32%,PSRC1;NAV3;RAC1;FES;PAK1;CKAP5;RPS3;AKAP9;NUMA1;DRG1
prerank,electron transport chain (GO:0022900),0.38325012913092493,0.8722425062672575,0.6211699164345403,0.8949717504265119,1.0,2/15,3.55%,ETFA;POR
prerank,positive regulation of organelle organization (GO:0010638),0.33406872855621783,0.8719234329088282,0.6517412935323383,0.8951230568025191,1.0,11/32,21.68%,PLA2G5;ANXA1;TREM2;RAB3GAP2;LMAN1;GSK3B;SMCR8;DOC2B;P2RX7;RAB3GAP1;ANXA2
prerank,ribosomal large subunit biogenesis (GO:0042273),0.3129381327728419,0.8717376485485815,0.6837209302325581,0.8950556922453261,1.0,16/54,21.29%,MAK16;RPL3L;PES1;NHP2;WDR74;NOC2L;RPL14;NIP7;NOP2;GTF3A;LTO1;HEATR3;RSL1D1;MRPL1;NOP16;EBNA1BP2
prerank,organelle fission (GO:0048285),0.35131742818930456,0.8711835044393704,0.6484687083888149,0.8956356844024363,1.0,7/24,20.33%,SEC16B;DNM1;PEX19;FIS1;TMCC1;PEX11A;CORO1C
prerank,regulation of mitochondrial membrane potential (GO:0051881),0.32577438285858457,0.8709705273692648,0.6638036809815951,0.8955714410253303,1.0,14/40,25.27%,LRRK2;STOML2;BCL2;PID1;BAX;PPA2;ABL1;SLC25A36;PRELID1;PARK7;CCN6;ATP5IF1;AKT1;SLC25A33
prerank,translational termination (GO:0006415),-0.20003088062749458,-0.8706310203084475,0.7536231884057971,0.8808413811074758,1.0,42/95,27.33%,MRPS9;MRPS15;PTCD3;MRPL39;MRPS28;MRPS35;ERAL1;MTRF1;MRPS31;MRPL4;MRPS7;MRPS18C;APEH;MRPS25;MRPL28;MRPL30;MRPL42;GSPT2;MRPL22;MRPL40;MRPL46;MRPS24;MRPS16;MRPS22;MRPS18B;MRPL20;MRPL58;MRPL23;MRPS10;MRPS12;MRPL18;MRPS34;MRPL43;MRPL44;TRMT112;MRPS21;MRPL35;MRPL2;MRPL13;MRPL54;MRPL16;MRPL34
prerank,inositol phosphate catabolic process (GO:0071545),0.395789408159942,0.8703656815176082,0.627906976744186,0.8962296834781566,1.0,2/12,5.32%,INPP1;PTEN
prerank,phosphatidylinositol phosphate biosynthetic process (GO:0046854),0.3230961940733846,0.8694123335422148,0.6355721393034826,0.8975577097990567,1.0,10/39,16.05%,PIP4K2A;TMEM150A;PIK3R1;PI4K2B;ITPKC;PIP4K2B;PI4KA;PIK3C3;TTC7A;SOCS5
prerank,cellular response to fluid shear stress (GO:0071498),-0.333727427998902,-0.869358712913983,0.6219512195121951,0.8821415540991603,1.0,6/12,19.60%,SREBF2;KLF2;MEF2C;KLF4;MAPK7;MAP2K5
prerank,striated muscle contraction (GO:0006941),-0.22118037569407792,-0.8693241888826087,0.7196969696969697,0.8807191202859813,1.0,17/53,27.47%,DMD;ATP1B1;ATP1A2;RCSD1;DTNA;KCNQ1;ARHGEF11;SCN4B;TNNT3;PIK3CA;RYR2;SCN3B;CASQ2;ALDOA;KCNH2;STAC;STAC2
prerank,C-terminal protein amino acid modification (GO:0018410),-0.34187883037561373,-0.8689840031085294,0.6410256410256411,0.8799622872744046,1.0,4/11,20.02%,FOLH1;ATG12;ATG5;ICMT
prerank,regulation of T cell differentiation in thymus (GO:0033081),0.39751017790483983,0.8689343046976017,0.6280487804878049,0.8979950017312921,1.0,2/13,5.73%,GLI2;SHH
prerank,regulation of ruffle assembly (GO:1900027),0.3523757379715917,0.8689338234481948,0.6494708994708994,0.897585988973138,1.0,2/23,2.45%,CARMIL2;ARHGAP24
prerank,protein K48-linked ubiquitination (GO:0070936),-0.21989706440704468,-0.8689060321857863,0.7553956834532374,0.8786172688536826,1.0,23/54,26.68%,KLHL3;PRKN;UBE2E3;RNF152;HACE1;SKP2;RBX1;UBE2Q2;UBE3A;NEDD4L;TRIM32;UBE2B;RNF6;RNF34;KBTBD7;RNF5;RNF126;RNF187;UBE2A;BFAR;RNF216;RNF146;UBE2G2
prerank,leukotriene biosynthetic process (GO:0019370),0.38979975900062674,0.8688166746233391,0.6383601756954612,0.8973965928115987,1.0,4/14,22.11%,PLA2G5;ALOX5AP;PLA2G4A;GGT7
prerank,negative regulation of apoptotic signaling pathway (GO:2001234),0.29350191139115994,0.8685765061999369,0.6975982532751092,0.8973861568292045,1.0,24/77,23.13%,TCF7L2;BCL2;CFLAR;CSNK2A2;FXN;SIAH2;TGFBR1;ACVR1;FZD9;NOC2L;BCL2L2;SH3RF1;PELI3;TNF;CX3CL1;PPIF;CSNK2A1;CAAP1;DDX3X;IGF1;PRELID1;SRC;PARK7;HTT
prerank,nucleoside catabolic process (GO:0009164),-0.3411310987210518,-0.8683740450294264,0.6307692307692307,0.8783295179597633,1.0,4/11,15.05%,NT5E;UPB1;DERA;NT5C
prerank,ribonucleoside monophosphate biosynthetic process (GO:0009156),0.3973023844732713,0.8682957203397107,0.658753709198813,0.8974943987685468,1.0,4/14,14.95%,ADSL;GMPS;GART;PPAT
prerank,B cell activation (GO:0042113),-0.2150048217788852,-0.8682422749244143,0.8294573643410853,0.8771077474153822,1.0,12/68,10.23%,KIT;HDAC9;MSH2;MEF2C;TPD52;PRKCB;ITGA4;VCAM1;DNAJB9;HDAC4;NHEJ1;PIK3CD
prerank,regulation of hydrolase activity (GO:0051336),0.29805637350929914,0.867861688671102,0.6862967157417894,0.8978641502234236,1.0,18/71,15.23%,VAV2;ARHGAP15;VAV3;EPHB3;PLXNC1;FGD4;RABGAP1;NF1;PLXND1;EPHA1;RAB3GAP2;EFNA5;PLXNA3;PTK2;FBXW11;ITGB1BP1;FGD6;RAP1GAP
prerank,rRNA metabolic process (GO:0016072),-0.18882860009756916,-0.8672727717320478,0.90625,0.8777036431194855,1.0,50/160,22.20%,SENP3;RPL34;WDR43;RPL8;RPL18A;RPL36;RPL19;RPL38;RPL5;RPLP0;NVL;KRR1;RPL32;RPL10;RPL15;RPL29;RPS16;RPS27;DKC1;RPS19;RPL13;RPL27;RPL7A;RPL35;RPL28;RRP7A;EMG1;RPL30;NOP53;RPS17;RPL37A;UTP15;DEDD2;RPS6;RPL41;WDR12;LAS1L;POP5;NOB1;RPL7;DDX49;RPL13A;DIS3L;NOL9;RRP12;UBA52;UTP14A;PDCD11;RPLP1;RPL21
prerank,positive regulation of secretion by cell (GO:1903532),0.29806579336869604,0.8672052705429754,0.6825749167591565,0.8986590706825844,1.0,9/70,10.12%,EDN3;UNC13D;RAB2B;ABCG1;TREM2;PPID;FRMD4A;TGFB3;DTNBP1
prerank,regulation of synapse organization (GO:0050807),0.3448219199242188,0.8670610537985274,0.6593264248704663,0.898512242052264,1.0,10/26,22.95%,MDGA1;WNT5A;ABHD17C;TNF;ABL1;CAMK2B;CLN3;NEDD4;YWHAZ;ARHGAP22
prerank,negative regulation of leukocyte activation (GO:0002695),-0.3092418128498308,-0.8668826328053163,0.6727941176470589,0.8769978192266871,1.0,5/15,15.67%,LRFN5;CD200;GRN;GPER1;HAVCR2
prerank,positive regulation of interleukin-10 production (GO:0032733),0.3395934798792818,0.8664401957667903,0.6628205128205128,0.8992237434213087,1.0,4/30,8.51%,XCL1;TSLP;STAT3;LGALS9
prerank,negative regulation of leukocyte cell-cell adhesion (GO:1903038),0.37271989937090044,0.8663805908103862,0.6315028901734104,0.898926570206522,1.0,4/18,24.65%,MIA3;GPNMB;ASS1;AKT1
prerank,acyl-CoA metabolic process (GO:0006637),0.3281950863266998,0.866326229534154,0.6477132262051916,0.8986170371927996,1.0,9/35,21.84%,ACOT9;DLST;THEM4;ACOT13;MCEE;SUCLG2;ACSF2;MLYCD;ACOT11
prerank,mitochondrial protein processing (GO:0034982),0.4081584957150059,0.865982367999143,0.6403785488958991,0.8987949772320429,1.0,6/11,23.80%,STOML2;OMA1;PMPCB;SPG7;PMPCA;AFG3L2
prerank,positive regulation of immune response (GO:0050778),0.30081367163249684,0.8658628841269844,0.680045871559633,0.8986063591995669,1.0,7/64,10.96%,IL23R;POLR3D;CCL5;FCGR2B;LGALS9;SASH3;XBP1
prerank,calcium ion import (GO:0070509),0.3458834423958914,0.8657431183498399,0.6549865229110512,0.8984188465105214,1.0,5/28,12.33%,CACNA1A;CACNA1C;ATP2A2;MICU2;MS4A1
prerank,negative regulation of protein secretion (GO:0050709),0.3253656609069371,0.8652210507270569,0.6528822055137845,0.8989538273664759,1.0,6/38,12.37%,SFRP1;APOE;IRS1;INHBB;ERP29;DRD3
prerank,negative regulation of microtubule polymerization or depolymerization (GO:0031111),0.3250508807963266,0.8650558542204559,0.6344221105527639,0.8988241988738719,1.0,6/32,12.61%,TAOK1;NAV3;CAMSAP2;CLIP3;FGF13;TPX2
prerank,"maturation of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000466)",0.3620985442144944,0.8648881577488724,0.660300136425648,0.8987114816532633,1.0,8/22,23.16%,PES1;ERI1;NOP9;NOP14;EXOSC2;EXOSC3;KRI1;ERI3
prerank,positive regulation of lyase activity (GO:0051349),0.3951801745589424,0.8641635301438019,0.6576319543509273,0.8995808622515509,1.0,3/14,7.57%,CACNA1C;FXN;NF1
prerank,positive regulation of interleukin-13 production (GO:0032736),0.41281860969273804,0.863759709752529,0.6446153846153846,0.8998962264786727,1.0,3/10,17.95%,TSLP;LGALS9;SPHK2
prerank,regulation of cell cycle G2/M phase transition (GO:1902749),0.2933527364000776,0.8636389187475403,0.6991247264770241,0.8997212175583023,1.0,23/82,24.38%,DYNLL1;ALMS1;DYNC1H1;HAUS3;CCP110;TUBG1;CNTRL;PLK1;CEP41;PCM1;DCTN3;TPX2;CSNK1D;CEP72;TUBA1A;PCNT;ACTR1A;CKAP5;NINL;YWHAE;YWHAG;AKAP9;PAFAH1B1
prerank,pyrimidine-containing compound metabolic process (GO:0072527),-0.3434405425528105,-0.8634384566943524,0.625,0.8828988014926654,1.0,4/11,21.31%,TPK1;SLC19A3;ENPP3;ERH
prerank,negative regulation of neuron death (GO:1901215),0.2928578895522602,0.8634309665898021,0.712742980561555,0.8996809404162276,1.0,22/93,20.04%,FGF20;LRRK2;APOE;BCL2;CHMP4B;CHMP4A;MDK;FBXO7;TGFB3;PTPRZ1;FZD9;GPNMB;SNX6;TRAF2;CCL2;GSK3B;GDNF;UNC5B;CLN3;CDK5;NTF3;CPEB4
prerank,"DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator (GO:0006978)",-0.3558207000307848,-0.8631994129614946,0.6189189189189189,0.8819139069334665,1.0,5/10,22.36%,TP53;KAT5;TFAP4;RPS6KA6;HIPK2
prerank,carbohydrate catabolic process (GO:0016052),0.3237983935451761,0.862743459111764,0.6549636803874092,0.9004812878886767,1.0,11/38,23.41%,HKDC1;HK2;MAN2C1;ENO1;GAPDH;GCK;ENO2;NEU3;NEU1;PGAM4;PGAM1
prerank,cellular response to leucine (GO:0071233),0.4061019553818684,0.8626623948856698,0.6357827476038339,0.8998095788351614,1.0,2/10,9.40%,KLHL22;RPTOR
prerank,response to leucine (GO:0043201),0.4061019553818684,0.8626623948856698,0.6357827476038339,0.8998095788351614,1.0,2/10,9.40%,KLHL22;RPTOR
prerank,very long-chain fatty acid metabolic process (GO:0000038),0.3402689883925583,0.8622710374160132,0.646606914212548,0.9001030694425076,1.0,7/30,15.07%,SLC27A6;HACD2;ACOX1;SLC27A2;SLC27A4;ELOVL6;ELOVL1
prerank,canonical glycolysis (GO:0061621),0.3464674698139859,0.8620470941669712,0.6529255319148937,0.8996815244761757,1.0,6/24,19.16%,HK2;FOXK2;ENO1;GAPDH;GCK;ENO2
prerank,glucose catabolic process to pyruvate (GO:0061718),0.3464674698139859,0.8620470941669712,0.6529255319148937,0.8996815244761757,1.0,6/24,19.16%,HK2;FOXK2;ENO1;GAPDH;GCK;ENO2
prerank,chromosome condensation (GO:0030261),0.3263367384070779,0.862019417522583,0.6713197969543148,0.8993262117092842,1.0,13/36,24.02%,ERN2;CSNK2A2;KMT5A;PLK1;INCENP;AKAP8L;DFFB;CSNK2A1;TENT4A;ACIN1;AIFM1;NCAPD2;NCAPG2
prerank,regulation of protein-containing complex disassembly (GO:0043244),-0.30044237087565717,-0.8615319000137519,0.6738461538461539,0.8840026167300791,1.0,5/16,11.19%,IGF1R;INSR;UPF1;BNIP3;MTRF1
prerank,axon development (GO:0061564),0.2923284917066603,0.8612200444548849,0.6929824561403509,0.9003014335602918,1.0,21/78,19.65%,SLITRK6;AMIGO1;BAIAP2;EPHB3;NREP;MAP1S;CAMSAP2;RAB10;LLGL1;ATL1;L1CAM;S100A6;EPHB2;NEFH;ARHGAP35;BRSK2;MAPK8IP3;RAB8A;CDK5;SPTBN4;BRSK1
prerank,regulation of activin receptor signaling pathway (GO:0032925),0.37830438519131365,0.8610969166288795,0.6418338108882522,0.9001186823915341,1.0,3/15,11.28%,ACVR1B;ACVR1;ACVR2A
prerank,autonomic nervous system development (GO:0048483),0.37542743317554433,0.8604193681721601,0.6666666666666666,0.9009007573129432,1.0,5/17,23.27%,NRP1;NF1;GDNF;SEMA3A;SOX11
prerank,positive regulation of cellular protein catabolic process (GO:1903364),-0.2967023085587496,-0.8602941121161148,0.6509090909090909,0.8850500206521025,1.0,5/18,9.18%,EZR;CD81;RDX;VPS11;RNF128
prerank,positive regulation of telomere maintenance via telomerase (GO:0032212),0.32808080883431234,0.860244165690705,0.6534017971758665,0.9007938900699162,1.0,4/32,6.96%,CCT8;ATM;PKIB;ATR
prerank,cellular response to glucagon stimulus (GO:0071377),0.37210692329426903,0.8593824498673396,0.6446991404011462,0.901902861123029,1.0,3/17,9.25%,ADCY7;ADCY2;PRKAR1B
prerank,regulation of sprouting angiogenesis (GO:1903670),0.32841306167651796,0.8593134445687326,0.6696542893725992,0.9016271324069529,1.0,7/33,13.47%,CREB3L1;JAK1;RHOJ;CEMIP2;ADAMTS9;FGF2;ITGA5
prerank,positive regulation of cytokinesis (GO:0032467),0.3308571040168207,0.8585825508353725,0.6527249683143219,0.9025061472176643,1.0,7/32,17.36%,SVIL;CDC42;CSPP1;CDC14B;DRD3;OPN1MW;RHOA
prerank,protein localization to chromatin (GO:0071168),0.36603799842414375,0.8585056647070259,0.6566951566951567,0.9022364079365368,1.0,6/18,19.85%,NIPBL;PLK1;LEMD2;MCM9;CHMP7;LRWD1
prerank,selective autophagy (GO:0061912),0.3047783007561357,0.8584536853386946,0.6689497716894978,0.9019216045687011,1.0,19/56,22.31%,DYNLL1;DYNC1H1;AMBRA1;ATM;UBQLN1;RAB7A;SQSTM1;IFT88;ARL13B;ATG14;PCNT;PEX5;UBA5;NBR1;WDFY3;AUP1;DDRGK1;RPS27A;PARK7
prerank,negative regulation of sprouting angiogenesis (GO:1903671),0.4038757575535966,0.8582967061550807,0.6615146831530139,0.9018085596926139,1.0,1/11,0.58%,CREB3L1
prerank,ureteric bud development (GO:0001657),0.37329383019027274,0.8578167173221287,0.648068669527897,0.9022503506157308,1.0,3/17,10.82%,ROBO2;PKD2;SALL1
prerank,positive regulation of dendrite morphogenesis (GO:0050775),0.36038091549285406,0.8572252842237383,0.6611570247933884,0.9029128934361151,1.0,6/19,18.99%,DBN1;DBNL;OBSL1;CAPRIN1;CUL7;CAMK2B
prerank,cellular response to catecholamine stimulus (GO:0071870),0.34737868751334755,0.8564979361008828,0.6403162055335968,0.9037714330104137,1.0,7/23,17.80%,SLC9A1;LRRK2;SIRT2;APLP1;GNG2;ABL1;GABPA
prerank,cilium assembly (GO:0060271),0.2680574734501156,0.8544625347617119,0.8375125376128385,0.9069023580549666,1.0,76/296,22.14%,TEKT4;DYNLL1;STK36;CEP19;ALMS1;ACTR2;DYNC1H1;ASAP1;TRIP11;HAUS3;RAB8B;CCP110;TUBG1;SNX10;CNTRL;DISC1;PLK1;IFT57;PARVA;EXOC4;IFT88;WDR35;TNPO1;PDE6D;FAM161A;CPLANE1;B9D2;TMEM138;CEP41;PCM1;DCTN3;DYNC2LI1;CDC14B;GALNT11;NPHP3;CLUAP1;CSNK1D;DYNC2H1;ATP6V1D;IFT52;EHD2;BBS10;EXOC5;ARL13B;CC2D2A;IFT20;CEP72;IQCB1;RAB8A;IFT81;CFAP410;PTPN23;CPLANE2;BBOF1;KIF3C;WDPCP;BBS7;TUBA1A;KIF3A;KIFAP3;PCNT;CEP126;EXOC7;EXOC1;KIF27;IFT172;ACTR1A;GBF1;CEP162;EHD1;CKAP5;ARF4;NINL;WDR90;YWHAE;RAB1A
prerank,regulation of actin cytoskeleton reorganization (GO:2000249),0.32562134618508365,0.8543607388605952,0.672069825436409,0.9066586990455492,1.0,6/35,8.86%,PDGFRA;NRP1;BAIAP2;MDK;CDC42;SEMA3E
prerank,negative regulation of proteolysis involved in cellular protein catabolic process (GO:1903051),-0.2600377467532369,-0.8539198078186243,0.702928870292887,0.8969456387929354,1.0,7/25,17.76%,EPHA4;RPL5;HSP90AB1;SGTA;TRIM39;HFE;PRKCG
prerank,protein depolymerization (GO:0051261),-0.2519050041368285,-0.8537343774846073,0.7272727272727273,0.895844520884255,1.0,16/27,34.51%,TWF2;GSN;MICAL3;MICAL1;STMN2;TWF1;KIF18A;DSTN;STMN3;KIF24;MICAL2;KIF18B;CFL2;STMN1;CFL1;WDR1
prerank,actin filament capping (GO:0051693),0.3692006339772513,0.8530657590891636,0.6463245492371706,0.908104940454024,1.0,4/18,12.38%,SVIL;ADD2;VILL;CAPZA1
prerank,barbed-end actin filament capping (GO:0051016),0.3692006339772513,0.8530657590891636,0.6463245492371706,0.908104940454024,1.0,4/18,12.38%,SVIL;ADD2;VILL;CAPZA1
prerank,positive regulation of myeloid leukocyte mediated immunity (GO:0002888),-0.3442702505276468,-0.8525286961435954,0.6520376175548589,0.8967677538215593,1.0,4/11,28.95%,MAVS;CAMK4;ITGB2;TYROBP
prerank,synaptic vesicle transport (GO:0048489),-0.33369257950405423,-0.8523104538697927,0.6590909090909091,0.895714098609493,1.0,5/11,18.98%,RAB27A;SNAPIN;TOR1A;SYNJ1;DNM2
prerank,cellular response to calcium ion (GO:0071277),0.29528353080086145,0.8522716028386101,0.7177508269018743,0.9090748126403385,1.0,10/67,12.78%,WNT5A;CAMK2D;CPNE7;PKD2;CPNE2;SYT10;ALOX5AP;SYT2;ADGRV1;SYT3
prerank,negative regulation of peptidyl-serine phosphorylation (GO:0033137),0.3496971953153962,0.8522094574155088,0.6587078651685393,0.9087763097773525,1.0,5/21,8.44%,PTEN;CNKSR3;RASSF2;NCK2;NCK1
prerank,regulation of protein targeting to mitochondrion (GO:1903214),0.32073808711708773,0.8521261536289234,0.6633785450061652,0.9085171767085523,1.0,12/38,17.44%,LRRK2;CSNK2A2;UBE2L3;SAE1;LMAN1;TOMM7;FBXW7;BAG4;NPEPPS;ARIH2;SH3GLB1;MICALL2
prerank,positive regulation of protein import (GO:1904591),0.33300818385653547,0.8517607407213407,0.6607369758576874,0.9087516744664829,1.0,7/30,16.37%,UBR5;PIK3R1;BAG3;HDAC3;ZIC1;SMAD3;PSEN1
prerank,positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway (GO:1901030),0.3274054702376907,0.8509341770083898,0.6851612903225807,0.9097687069601987,1.0,11/31,22.82%,BCL2;BBC3;E2F1;BAX;TFDP1;CASP8;GSK3B;CHCHD10;YWHAE;YWHAZ;YWHAG
prerank,glycolytic process (GO:0006096),0.33606204267988066,0.8507270210518457,0.6585365853658537,0.9097189742194025,1.0,9/28,25.57%,HKDC1;HK2;ENO1;GAPDH;GCK;ENO2;PGAM4;PGAM1;PGM1
prerank,"DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:0006977)",0.3058564162157631,0.850134049765636,0.6945080091533181,0.9103346908484793,1.0,8/54,11.49%,TNKS1BP1;CNOT4;E2F1;ATM;CARM1;BAX;E2F8;TFDP1
prerank,response to glucagon (GO:0033762),0.3602697623224814,0.8500507007412916,0.6460674157303371,0.9100685555237881,1.0,3/19,9.25%,ADCY7;ADCY2;PRKAR1B
prerank,cellular polysaccharide biosynthetic process (GO:0033692),0.3376589231125332,0.8499699624269305,0.6649076517150396,0.9098141274811173,1.0,4/25,9.05%,EXT1;HS2ST1;EXT2;B3GALNT1
prerank,ribosome assembly (GO:0042255),-0.22254638741870927,-0.8498713661157014,0.7639751552795031,0.899278814979881,1.0,16/47,21.03%,RPL5;RPLP0;RPL10;RPS27;RPS19;ERAL1;RPF2;RRP7A;EFL1;NOP53;MRPS7;MRPL22;MRPL20;NLE1;MPV17L2;RPS5
prerank,cellular response to oxidative stress (GO:0034599),0.28054714519172175,0.8495660823261656,0.7457805907172996,0.9101189634697686,1.0,38/118,26.54%,PDGFRA;LRRK2;ARNT;PKD2;PLA2R1;RAD52;AIF1;EGFR;TXNRD1;ETV5;SIRT2;SETX;MGAT3;SELENOS;TPM1;PRDX5;PRDX6;MAPK9;ABL1;TMEM161A;NFE2L2;GPX8;FOXO3;DAPK1;PARP1;CYCS;PARK7;TXNRD2;MAPK1;FANCC;RPS3;AKT1;SLC25A24;CYBB;ATF4;ADNP2;FOXO1;VRK2
prerank,nuclear-transcribed mRNA poly(A) tail shortening (GO:0000289),0.3565579132337003,0.8488995270663227,0.657103825136612,0.9108255442676162,1.0,3/21,7.93%,TNKS1BP1;CNOT4;SAMD4A
prerank,regulation of glycogen biosynthetic process (GO:0005979),0.3384432385006161,0.8486067868110746,0.6840659340659341,0.9109358425072269,1.0,2/24,4.33%,ENPP1;IRS1
prerank,regulation of telomere capping (GO:1904353),0.3443900905070287,0.8485525846908097,0.671251719394773,0.9106219424424375,1.0,8/23,27.22%,ATM;PKIB;SMG6;TNKS2;MAP2K7;MAPK1;PNKP;TERF2
prerank,negative regulation of cellular component movement (GO:0051271),0.37664005730810407,0.8483085871329868,0.6712707182320442,0.9106196172699925,1.0,1/15,0.77%,FBLN1
prerank,"endonucleolytic cleavage of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000479)",0.3896390807743868,0.8480060636781154,0.6494082840236687,0.9107234538076424,1.0,5/13,21.70%,NOP9;NOP14;BMS1;RCL1;KRI1
prerank,negative regulation of cell cycle process (GO:0010948),0.29876532144593815,0.8477327989940402,0.7309007981755986,0.9107919797539357,1.0,16/61,19.56%,EHMT1;YAF2;E2F1;CCP110;RNF2;E2F8;FBXO5;VPS4A;TOM1L1;TFDP1;EZH2;RBBP8;PHC3;CBX5;RBBP4;AURKAIP1
prerank,regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:1902165),0.3945959701773334,0.8474267801341099,0.6564885496183206,0.9109084486090405,1.0,2/12,15.93%,BCL2;TAF9B
prerank,"negative regulation of DNA-templated transcription, elongation (GO:0032785)",0.38608722210745666,0.847042970976253,0.6737588652482269,0.9111779009604252,1.0,5/13,20.02%,EAPP;HEXIM1;RNF8;TCERG1;RNF168
prerank,tetrahydrofolate metabolic process (GO:0046653),0.41199151367064374,0.8467961299674247,0.6433021806853583,0.9111904079075486,1.0,3/10,14.45%,MTHFD1L;MTHFR;MTHFD2L
prerank,cellular response to purine-containing compound (GO:0071415),-0.34735252167812114,-0.8466469246296985,0.6620879120879121,0.9045552772947577,1.0,8/10,48.21%,P2RY6;RYR2;CASQ2;P2RY1;RYR3;SLC8A1;RYR1;CACNA1S
prerank,renal absorption (GO:0070293),0.4145331760256813,0.8466357319784414,0.6419019316493314,0.9110577143406967,1.0,1/10,1.15%,MAGED2
prerank,DNA packaging (GO:0006323),-0.28783237789955074,-0.8463224486207787,0.693069306930693,0.9037103466731762,1.0,9/16,34.50%,CDAN1;TP53;KAT6A;H1-0;BANF1;CHAF1A;NAA10;BANF2;HAT1
prerank,regulation of telomere maintenance via telomerase (GO:0032210),0.3024235439418137,0.8462812572231015,0.6911242603550296,0.9112665017953527,1.0,17/51,25.50%,CCT8;ATM;PKIB;ATR;PINX1;XRN1;DCP2;SMG6;NAT10;TNKS2;CTC1;SRC;MAP2K7;MAPK1;PNKP;CCT6A;CCT3
prerank,anterior/posterior pattern specification (GO:0009952),0.30445531811074295,0.846262336692904,0.7084785133565621,0.9108962295121227,1.0,8/53,12.50%,ATP6AP2;SMAD2;HOXB3;WLS;TGFBR1;BHLHE40;HEYL;PCSK5
prerank,DNA conformation change (GO:0071103),0.36171134747513967,0.8461931992011807,0.6533149171270718,0.9106037989604011,1.0,5/17,17.59%,TOP2B;HMGB2;ABL1;HMGB3;TOP3B
prerank,pulmonary valve development (GO:0003177),0.3595652739108978,0.846169892772593,0.6589358799454298,0.910233236058234,1.0,7/18,20.07%,ROBO2;JAG1;HEYL;STRA6;ROBO1;TNFRSF1A;TGFB2
prerank,positive regulation of response to cytokine stimulus (GO:0060760),0.3858275921692054,0.8460145043008226,0.6616541353383458,0.9100839479588317,1.0,5/13,22.55%,WNT5A;TSLP;IL7;TRIM44;AGPAT1
prerank,regulation of reactive oxygen species biosynthetic process (GO:1903426),0.33880911663508045,0.8459331563464105,0.6760925449871465,0.9098163983962706,1.0,11/26,25.98%,CD36;COA8;SPHK2;GRIN1;TRAP1;PARK7;CCN6;ABCD2;ABCB7;SLC25A33;SLC18A2
prerank,regulation of protein modification by small protein conjugation or removal (GO:1903320),0.35625934939541704,0.8456083267619127,0.672108843537415,0.9099719272952824,1.0,7/20,20.67%,ZMIZ1;UBQLN1;TGFBR1;DCUN1D1;DCUN1D5;ITCH;WASHC1
prerank,mitochondrial gene expression (GO:0140053),-0.2273948784450338,-0.845561152578262,0.7231638418079096,0.903745778680904,1.0,19/42,27.06%,MRPS15;PTCD3;MRPS28;TFAM;MRPS7;QRSL1;FASTKD2;MRPS24;MRPS16;TFB2M;MRPS18B;GATC;MRPL23;MRPS12;MRPS34;MRPS21;FASTKD5;MRPL2;MRPL16
prerank,negative regulation of leukocyte migration (GO:0002686),-0.34165052483131486,-0.8450215268100478,0.6656891495601173,0.9033422926650068,1.0,3/10,8.54%,CD200;SLIT2;HOXA7
prerank,negative regulation of insulin secretion (GO:0046676),0.36368540023669815,0.8447636876767778,0.6700434153400868,0.9109985618381558,1.0,3/17,8.99%,SFRP1;IRS1;INHBB
prerank,regulation of voltage-gated calcium channel activity (GO:1901385),0.34678324137801025,0.8447203491723124,0.6756393001345895,0.9106750278135957,1.0,5/22,12.37%,NOS1AP;CBARP;CACNB1;FMR1;DRD3
prerank,proteasome assembly (GO:0043248),0.4043053192715832,0.844391393761634,0.6598425196850394,0.9108399721106986,1.0,2/11,9.76%,PSMD4;PSMD11
prerank,positive regulation of microtubule polymerization or depolymerization (GO:0031112),0.3297267285313615,0.8443583315857973,0.6587926509186351,0.9104963474898878,1.0,3/26,6.18%,PSRC1;NAV3;RAC1
prerank,"transcription, DNA-templated (GO:0006351)",0.2698827612990517,0.8443116915448267,0.8026315789473685,0.9101761877841194,1.0,48/207,19.66%,PAX1;BCL3;DEAF1;SOX5;NFIX;SMN1;TRIP11;E2F1;CEBPD;TAF4;TAF7;CBFB;SNAPC3;GTF2F2;CDK9;TTF2;NFKB1;CDK7;MBD1;NFE2L3;XBP1;MMS19;TFDP1;SETX;GLIS3;CCNT1;POLR2K;HIPK3;GTF2H1;GTF3A;RSF1;PRMT5;CRCP;TCEA1;NCBP2;RRAGC;POLR2B;TAF9B;NKX2-8;CCNH;TAF2;POLR3K;CDC73;POLR3A;FOXO3;BAZ2A;GTF2F1;PARP1
prerank,histone H2A ubiquitination (GO:0033522),0.3606302713488651,0.844012546148492,0.6359712230215827,0.910251250826679,1.0,9/17,26.85%,RNF2;DDB1;RNF8;SKP1;RNF168;DTX3L;PCGF1;RYBP;CUL4B
prerank,positive regulation of establishment of protein localization (GO:1904951),0.3618237333424152,0.8437956991139172,0.6708683473389355,0.9102132628217255,1.0,7/18,25.50%,CCT8;TREM2;CEP120;TNF;WRAP53;CCT6A;CCT3
prerank,plasma membrane repair (GO:0001778),-0.3131585824292351,-0.84365488762843,0.6839237057220708,0.9046909604765798,1.0,4/13,16.19%,MYOF;DYSF;SYT7;AHNAK2
prerank,embryonic skeletal system morphogenesis (GO:0048704),0.33068344833102103,0.8436265566859518,0.6981132075471698,0.9100982039445125,1.0,3/31,8.31%,PDGFRA;HOXB3;TGFBR1
prerank,establishment of protein localization to membrane (GO:0090150),0.2918474061681189,0.8435676808228794,0.7293318233295584,0.9098019042565438,1.0,12/66,16.79%,RFTN1;GORASP2;ATG3;EGFR;SEC63;RAB3GAP2;RAB10;ZDHHC3;SDCBP;RTP4;ZDHHC9;VPS37C
prerank,negative regulation of nuclear division (GO:0051784),-0.3355146232968761,-0.8434165624140662,0.6475409836065574,0.9036882926766792,1.0,2/11,3.41%,BMP4;TOM1L2
prerank,negative regulation of hippo signaling (GO:0035331),-0.32540506617365006,-0.8433200569373762,0.6803519061583577,0.9023514554901739,1.0,8/12,36.00%,MARK3;WWC2;CIT;LIMD1;MAPK14;WWC1;VGLL4;MAP2K3
prerank,regulation of amyloid precursor protein biosynthetic process (GO:0042984),0.40079927980682645,0.8430233521272732,0.6762481089258698,0.9103591576243134,1.0,2/11,7.67%,ABCA2;SOAT1
prerank,negative regulation of ATPase activity (GO:0032780),0.3697823978795043,0.8429251248459427,0.6703146374829001,0.9101300413419819,1.0,7/16,25.33%,TNNI3;PXK;VCPKMT;PPIF;TNNT2;ATP5IF1;THADA
prerank,positive regulation of mRNA 3'-end processing (GO:0031442),0.40363994468078546,0.8428832626062029,0.6713395638629284,0.9097942757326561,1.0,3/10,17.88%,CPEB1;NCBP2;CDC73
prerank,spermatid development (GO:0007286),0.32413943992110683,0.8428035658836585,0.67578125,0.9095248787102119,1.0,5/32,14.06%,IQCG;ACRBP;RNF8;ZMYND15;SYCP3
prerank,positive regulation by host of viral transcription (GO:0043923),-0.30131958066379694,-0.8427131631986404,0.68,0.9020031506449064,1.0,3/15,6.62%,LEF1;JUN;EP300
prerank,nucleus organization (GO:0006997),0.30319815904617503,0.8424458593288796,0.6841491841491841,0.9097076256800484,1.0,17/47,26.40%,CHMP4B;CHMP4A;REEP4;BIN1;VPS4A;LEMD2;NUP35;SUN1;CHMP3;CHMP7;PITPNB;NDC1;CHMP2B;PDCD6IP;NUMA1;NUP155;VPS4B
prerank,cellular response to radiation (GO:0071478),0.31224894312444246,0.8423914704048668,0.6893764434180139,0.9093969043902405,1.0,8/40,14.41%,TNKS1BP1;INO80;KDM4D;GRB2;TANK;CLOCK;OPN1MW;OPN1MW3
prerank,membrane organization (GO:0061024),0.2684826177461483,0.8423255965518532,0.8150406504065041,0.9090918793355242,1.0,58/227,21.26%,CLTC;STON2;SH3KBP1;WNT5A;DNAJC6;CHMP4B;CHMP4A;EGF;ACTR2;AZIN2;DVL2;ITSN1;EGFR;CBL;UBXN2A;RABIF;REEP4;TLCD2;DNM1;SYT2;BIN1;GAPVD1;VPS4A;TLCD1;GRB2;LEMD2;STX11;AGFG1;ATP2C1;A4GALT;TOR1AIP2;SUN1;SPTBN1;RTP4;VAPA;SNX9;EPS15L1;TMEM43;FNBP1;CHMP3;AP3D1;SH3GLB1;BTC;USO1;PICK1;SYNJ2;HGS;CHMP7;CLN3;TMCC1;ARRB1;ARPC2;EPS15;TIMM50;CORO1C;LPCAT3;RABEP1;VTI1B
prerank,histone H2A monoubiquitination (GO:0035518),-0.2911457126728881,-0.8422610313035588,0.6928104575163399,0.90143912333472,1.0,3/17,7.36%,PCGF5;TRIM37;BCOR
prerank,striated muscle cell differentiation (GO:0051146),-0.29941742998823595,-0.84207976099659,0.6729559748427673,0.9003658619855125,1.0,6/16,22.11%,SORT1;MEF2C;MYOCD;SKI;MTLN;CBY1
prerank,rhodopsin mediated signaling pathway (GO:0016056),-0.34174955562066517,-0.8416760151725805,0.6596858638743456,0.8997328308493244,1.0,5/10,39.64%,SAG;PDE6A;CNGB1;PDE6G;PDE6B
prerank,dicarboxylic acid transport (GO:0006835),-0.26273699677861845,-0.8416477295164425,0.6930232558139535,0.8983282035378602,1.0,7/28,9.91%,SLC26A7;SLC13A3;SLC22A6;SLC1A1;GJA1;ARL6IP5;SLC1A2
prerank,positive regulation of cilium assembly (GO:0045724),0.35640777216173625,0.8410683914882643,0.6652421652421653,0.9108381327552542,1.0,4/18,13.99%,CCP110;ENTR1;CEP120;ARHGAP35
prerank,inner ear receptor cell stereocilium organization (GO:0060122),0.4078405343066851,0.8409910438191714,0.6835236541598695,0.9105679654925165,1.0,2/10,11.18%,IFT88;ADGRV1
prerank,cytoplasmic pattern recognition receptor signaling pathway (GO:0002753),0.34045295197983966,0.8407539053655453,0.6743589743589744,0.9105589260501222,1.0,7/26,17.44%,TNFAIP3;ALPK1;NOD1;TIFA;IRAK2;CASP8;ITCH
prerank,tail-anchored membrane protein insertion into ER membrane (GO:0071816),0.362965561859032,0.8407537899208424,0.6699857752489331,0.9101605340645985,1.0,5/17,16.42%,EMC1;EMC7;BAG6;EMC8;MMGT1
prerank,cAMP metabolic process (GO:0046058),0.38816378736461155,0.8405687801945173,0.6583941605839416,0.9100637411221669,1.0,2/13,4.92%,ADCY7;ADCY2
prerank,activation of protein kinase A activity (GO:0034199),0.3686455364117027,0.8401326248540785,0.6685878962536023,0.9104169073216011,1.0,3/16,9.25%,ADCY7;ADCY2;PRKAR1B
prerank,negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:1902166),0.39628691204729644,0.8401068078447756,0.6697247706422018,0.9100578500610293,1.0,2/11,15.93%,BCL2;TAF9B
prerank,response to zinc ion (GO:0010043),0.3388252786316134,0.8399156391912896,0.6848958333333334,0.9099733892945997,1.0,2/25,2.48%,PAM;HVCN1
prerank,positive regulation of keratinocyte differentiation (GO:0045618),-0.3382522655613055,-0.8398586552728841,0.6533742331288344,0.9004677143861961,1.0,3/10,19.50%,PRKCH;TRIM16;ETV4
prerank,response to metal ion (GO:0010038),0.2945757524192822,0.8398239843441543,0.7272727272727273,0.9097269357859153,1.0,11/67,15.54%,SEC31A;PAM;HVCN1;SLC11A2;BCL2;FXN;CALM3;PPP3CA;CALM2;KCNMA1;KHK
prerank,maintenance of protein localization in organelle (GO:0072595),0.35840331712319645,0.8396264252398362,0.6620498614958449,0.9096777924670904,1.0,4/19,13.74%,BCL3;HK2;MORC3;SKP1
prerank,positive regulation of isotype switching (GO:0045830),0.3665282293089542,0.8393607755853241,0.6783216783216783,0.9097024579146201,1.0,7/15,26.04%,CD40;SHLD3;RIF1;HMCES;KMT5B;TGFB1;PAXIP1
prerank,immune response-regulating cell surface receptor signaling pathway (GO:0002768),0.3942658013124791,0.8392952941220484,0.6826625386996904,0.9094024939388771,1.0,4/10,23.99%,CD40;BAG6;BTLA;CD24
prerank,glucosamine-containing compound metabolic process (GO:1901071),-0.3165717451189711,-0.8390875143603653,0.6891495601173021,0.9005765591157243,1.0,5/13,25.05%,OGA;CHST3;NAGK;CHST7;CHST2
prerank,"positive regulation of protein localization to chromosome, telomeric region (GO:1904816)",0.39078527184066164,0.8389164193500349,0.6806201550387597,0.9096231960526394,1.0,2/12,4.47%,CCT8;GNL3
prerank,regulation of cytoplasmic translation (GO:2000765),0.36949658963637344,0.8387321093127784,0.684971098265896,0.9095409426612666,1.0,2/14,12.19%,CPEB1;FMR1
prerank,protein import (GO:0017038),0.2859963281340031,0.838729850419143,0.7196885428253615,0.9091489458383955,1.0,21/84,18.62%,APOE;RAB8B;MMP12;STAT3;SNX33;E2F3;TNPO1;FAM53B;NUP153;LAMP2;NUP188;PRICKLE1;ALDH3A2;KPNB1;NXT2;NXT1;NUP214;PEX19;HEATR3;FIS1;PEX5
prerank,regulation of double-strand break repair via homologous recombination (GO:0010569),0.3075991898705978,0.8386959442301393,0.6858513189448441,0.9088169825954268,1.0,15/42,22.37%,ACTR2;FBH1;SHLD3;MMS19;PPP4C;RIF1;TIMELESS;PPP4R2;PARP1;TERF2IP;HELB;CGAS;FUS;WRAP53;SETD2
prerank,"synaptic transmission, cholinergic (GO:0007271)",0.356412343270114,0.8371658721812615,0.6514131897711979,0.9109347536946334,1.0,1/19,3.63%,APOE
prerank,extrinsic apoptotic signaling pathway (GO:0097191),0.29156596641843524,0.8370803418765794,0.7290969899665551,0.9106713588782861,1.0,19/70,20.72%,JAK2;CASP8AP2;BCL2;SIVA1;BAX;ACVR1B;BAG3;BCL2L2;TRAF2;SMAD3;CASP8;GSK3B;TNF;TNFRSF1A;TLR3;P2RX7;TGFB2;DDX3X;IFI27
prerank,aromatic amino acid family catabolic process (GO:0009074),0.3739570519786791,0.8369804074016518,0.6685714285714286,0.9104740825063495,1.0,3/15,16.96%,HGD;KYAT1;QDPR
prerank,negative regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030948),0.38230149450969486,0.8369217460936313,0.6666666666666666,0.9101775148880712,1.0,4/13,20.05%,PTPN1;EMILIN1;HGS;NEDD4
prerank,regulation of protein localization to membrane (GO:1905475),0.32585337548392246,0.83677695893766,0.6985769728331177,0.9100034644182247,1.0,8/28,21.43%,MMP14;GPC6;VPS4A;SPTBN1;CLN3;CDK5;VTI1B;GPC4
prerank,protein lipidation (GO:0006497),0.2963016003667466,0.8366954068991337,0.7187141216991964,0.9097436180621723,1.0,19/59,24.01%,WIPI1;UGCG;PIGW;PIGN;PGAP4;PIGL;ZDHHC3;DPM2;PIK3C3;PIGG;PIGC;ZDHHC9;ZDHHC6;WDR45;HHAT;PIGH;ATG7;GPLD1;PIGP
prerank,long-chain fatty acid transport (GO:0015909),0.32429484112431606,0.8362205445553909,0.6871794871794872,0.9101502461143887,1.0,7/30,11.30%,SLC27A6;APOE;CD36;PPARG;SLC27A2;SLC27A4;RPS6KB1
prerank,negative regulation of cyclase activity (GO:0031280),-0.3073376771935419,-0.8361846475424682,0.6972477064220184,0.9049406488234538,1.0,4/14,15.61%,PALM;GRM3;GNAI3;DRD2
prerank,regulation of protein export from nucleus (GO:0046825),0.3451147253774086,0.8359183810247032,0.6862483311081442,0.9102671485037884,1.0,8/23,22.31%,TCF7L2;BAG3;GSK3B;SP100;IFI27;SIRT7;YWHAE;PARK7
prerank,tRNA wobble uridine modification (GO:0002098),-0.3036854625192381,-0.835543999035316,0.7044198895027625,0.9048814528229325,1.0,2/14,4.31%,TRMT9B;ALKBH8
prerank,acylglycerol biosynthetic process (GO:0046463),-0.2660221768143648,-0.8354943067948234,0.731404958677686,0.9034987889299634,1.0,3/23,9.28%,PLCE1;LPGAT1;DGAT1
prerank,regulation of non-canonical Wnt signaling pathway (GO:2000050),0.3705787730570869,0.8353964673859854,0.6928571428571428,0.9107491963217883,1.0,4/15,13.10%,SFRP4;SFRP1;NPHP3;CSNK1D
prerank,apoptotic nuclear changes (GO:0030262),0.3390499203149111,0.8351782723004261,0.6868421052631579,0.9107151440302724,1.0,8/24,22.52%,ERN2;DICER1;KPNB1;HMGB2;DFFB;ACVR1C;CDK5RAP3;ACIN1
prerank,regulation of activated T cell proliferation (GO:0046006),0.3229871937991526,0.8350833114244839,0.7122762148337596,0.910476545999391,1.0,1/30,0.46%,IL23R
prerank,regulation of high voltage-gated calcium channel activity (GO:1901841),0.40290410412476885,0.8349592888909958,0.6835637480798771,0.9102917320898786,1.0,3/10,9.97%,NOS1AP;CACNA2D1;CALM3
prerank,regulation of neuronal synaptic plasticity (GO:0048168),-0.2555291957392341,-0.8348342370161433,0.6892430278884463,0.9033214465887933,1.0,9/29,16.22%,SLC4A10;SHISA6;MCTP1;SYP;SHISA7;NCDN;SYNGR1;DRD2;SLC8A2
prerank,negative regulation of lipid biosynthetic process (GO:0051055),0.34954030865401853,0.8348272068696134,0.6657571623465212,0.9101048469118749,1.0,4/20,18.59%,ABCA2;BMP5;FBXW7;TRIB3
prerank,"mitochondrial electron transport, NADH to ubiquinone (GO:0006120)",-0.22846669102872835,-0.8347984140902991,0.8072916666666666,0.9019573708306419,1.0,17/38,30.14%,NDUFS1;NDUFV2;NDUFA13;NDUFA8;NDUFA11;NDUFC2;NDUFB7;NDUFA1;NDUFB11;NDUFV1;NDUFA10;NDUFA3;NDUFC1;NDUFA12;NDUFS3;NDUFB10;NDUFA6
prerank,negative regulation of mitochondrion organization (GO:0010823),0.3240790947059481,0.8347966652296438,0.6980891719745222,0.9097677910910958,1.0,10/33,21.94%,IAPP;FXN;OMA1;ADCK1;FZD9;FLCN;PPIF;VAT1;IGF1;PRELID1
prerank,negative regulation of adenylate cyclase activity (GO:0007194),-0.31257231261753743,-0.8345251297107884,0.7181008902077152,0.9010585136019569,1.0,4/13,15.61%,PALM;GRM3;GNAI3;DRD2
prerank,peptidyl-serine modification (GO:0018209),0.2690309176242869,0.8344523160250715,0.8014329580348004,0.9099571860794187,1.0,48/166,24.65%,NEK6;PRKCA;MAST4;LRRK2;CAMK2D;PRKD2;CSNK2A2;GALNT3;MARK1;ATM;EIF2AK3;AKT3;IKBKE;ATR;PLK1;TGFBR1;RICTOR;CSNK1A1;HIPK4;MORC3;RPS6KB1;MAST2;CSNK1D;CAMK1G;HIPK3;GSK3B;MAPK9;RPS6KA3;ROCK2;GALNT16;CSNK2A1;STK4;CDK5;CSNK1G2;BRSK1;PARP1;CAMK1D;NTMT1;PKN1;PRKDC;LATS2;POGLUT3;MAPK1;DCLK3;MKNK1;VRK3;PRKCI;AKT1
prerank,stress-activated protein kinase signaling cascade (GO:0031098),0.33293111723689395,0.8342238368699478,0.680306905370844,0.909930250477857,1.0,11/27,23.28%,CCM2;CUL1;NFKB1;MAPK11;FBXW11;SKP1;MAP3K20;MAP2K7;RPS27A;TNIP2;MAPK1
prerank,negative regulation of protein kinase activity (GO:0006469),0.2851168583023767,0.8341226899586711,0.7620087336244541,0.9096841464101446,1.0,38/88,26.15%,GSKIP;DUSP26;SPRED1;MVP;NF1;TAF7;EPHA1;SH3BP5L;PTPN1;DTNBP1;SH3BP5;TARBP2;WWTR1;PYDC1;THY1;LRP6;ITGB1BP1;RTRAF;UBASH3B;ABL1;PRKRIP1;SMCR8;TRIB3;DVL1;TRIM27;CORO1C;CDK5RAP3;TRIB1;PARK7;YWHAG;TSC2;LRP5;AKT1;GADD45A;PDPK1;CDKN1B;GNAQ;WARS1
prerank,negative regulation of receptor internalization (GO:0002091),0.38454230822632585,0.8340917734598757,0.6830015313935681,0.9093456287684784,1.0,4/12,19.63%,ATXN2;DLG4;SDCBP;ANKRD13B
prerank,protein acylation (GO:0043543),-0.235585988925234,-0.8337775252772548,0.7540106951871658,0.900998800795559,1.0,20/38,29.61%,ZDHHC13;EP300;ZDHHC5;SELENOK;ZDHHC15;GLUL;KAT6A;KAT2B;KAT2A;SPHK1;ZDHHC21;NAA80;ZDHHC20;ZDHHC7;ZDHHC14;ZDHHC17;ZDHHC23;NAA10;ZDHHC16;ZDHHC12
prerank,regulation of microtubule cytoskeleton organization (GO:0070507),0.31548361714345846,0.8328359716543424,0.6965601965601965,0.911006467555091,1.0,8/37,15.32%,TAOK1;EFNA5;MAPRE2;STMN4;GSK3B;TPPP;PHLDB1;PHLDB2
prerank,protein monoubiquitination (GO:0006513),-0.2389933445006448,-0.8323239406159514,0.7947368421052632,0.9023909863678915,1.0,9/36,16.32%,PRKN;HUWE1;CTR9;LEO1;UBE2O;RBX1;WAC;OBI1;UBE2B
prerank,protein localization to plasma membrane (GO:0072659),0.27482042012143326,0.8322357635430611,0.7611464968152867,0.9115984739040276,1.0,36/129,18.27%,ADIPOQ;NKD2;GORASP2;FLOT2;PIGW;RAP2A;MYO5A;PACS1;TMEM150A;DENND4C;SEC16A;RAB8B;RAB34;STXBP1;RAB10;ZDHHC3;FGF13;ANK1;SMURF1;LRP6;ITGB1BP1;EHD2;EPB41L3;SPTBN1;TTC7A;TNF;ASB3;RAB8A;PIP5K1A;TNFRSF1A;PTCH1;ROCK2;RAB12;PLEKHF1;TSPAN14;KCNIP3
prerank,ubiquinone metabolic process (GO:0006743),0.37253520344532,0.8320969078478804,0.6926406926406926,0.9114210096347884,1.0,3/15,6.89%,AIFM2;COQ8B;COQ6
prerank,negative regulation of lipid metabolic process (GO:0045833),0.3390043129138646,0.8308607339877636,0.6952380952380952,0.9130245671458889,1.0,3/22,15.60%,APOD;PPP2R5A;TNF
prerank,myotube differentiation (GO:0014902),0.35496062277214346,0.8306305778896916,0.6838440111420613,0.9129981670320502,1.0,3/17,8.37%,ADAM12;ADAMTS5;ADAMTS15
prerank,negative regulation of metabolic process (GO:0009892),0.2947419628449927,0.8305384783251374,0.7219626168224299,0.9127683612350149,1.0,16/54,23.03%,ADIPOQ;ADAMTS5;LAMA4;PLCL1;ARRDC3;ACOT13;RBPJ;FLCN;LGR4;FIS1;STK11;ACOT11;NR1D1;NRDC;CCDC3;DDIT3
prerank,protein localization to membrane (GO:0072657),0.26775525661542426,0.8303891026544337,0.8128834355828221,0.9126115655241471,1.0,47/187,17.72%,ADIPOQ;RFTN1;SH3PXD2B;NKD2;PTN;AP4M1;FLOT2;PIGW;RAP2A;MYO5A;PACS1;TMEM150A;DENND4C;SEC16A;RAB8B;TM9SF4;RAB34;STXBP1;RAB10;ZDHHC3;DLG4;FGF13;ANK1;SMURF1;RAB32;THY1;LRP6;ITGB1BP1;EHD2;LRRC4;EPB41L3;SPTBN1;TTC7A;TNF;RAB8A;PIP5K1A;AP3D1;TNFRSF1A;SH3GLB1;PTCH1;TM9SF2;ROCK2;PICK1;RAB12;PLEKHF1;HGS;TSPAN14
prerank,adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains (GO:0002460),0.3533250744427814,0.8298523226277529,0.6882758620689655,0.9130757590022457,1.0,4/17,12.00%,JAG1;STAT3;GNL1;BACH2
prerank,cellular response to light stimulus (GO:0071482),0.2911764219682087,0.8294198601945705,0.7486095661846496,0.9133803027474984,1.0,22/66,28.30%,INO80;ATR;CREBBP;NOC2L;FMR1;OPN1MW;OPN1MW3;USP47;CDC25A;YY1;TMEM161A;PARP1;NEDD4;GPR88;SDE2;KDM1A;RHBDD1;GNB1;ATF4;CASP9;RRH;USP28
prerank,protein maturation (GO:0051604),0.27324519862070706,0.8293927200883705,0.7555791710945803,0.9130336699979061,1.0,20/95,21.04%,MMP14;ADAM19;CPXM1;XPNPEP3;NAA50;OGT;CTSS;MMP16;MMS19;PCSK5;NDUFAB1;HSPD1;STUB1;PSEN1;PTCH1;TSPAN14;CLN3;LMF2;PCSK2;PSENEN
prerank,myotube cell development (GO:0014904),0.4018585489913046,0.8292311310720364,0.680952380952381,0.9129120436927782,1.0,1/10,2.33%,MYORG
prerank,endosome transport via multivesicular body sorting pathway (GO:0032509),0.3341678380854419,0.8292022018465838,0.6879895561357703,0.9125667965650153,1.0,11/25,26.65%,CHMP4B;CHMP4A;MVB12A;CHMP3;LEPROTL1;CHMP7;LEPROT;CHMP2B;VTA1;VPS4B;VCP
prerank,cardiac left ventricle morphogenesis (GO:0003214),0.37226667136574837,0.8289936451263802,0.6726726726726727,0.9125105716019624,1.0,2/13,12.71%,SFRP2;RBPJ
prerank,microtubule anchoring at microtubule organizing center (GO:0072393),0.38793658073223203,0.828758652625703,0.7206106870229008,0.9125181351117287,1.0,7/12,24.45%,CEP19;NIN;PCM1;KIF3A;HOOK3;NINL;CCDC120
prerank,negative regulation of blood vessel endothelial cell migration (GO:0043537),0.3149799035272896,0.8284145457719899,0.6913425345043914,0.9126823193475241,1.0,14/33,27.02%,APOE;PPARG;HDAC5;FGF2;ITGB1BP1;TNF;PDCD10;RHOA;STARD13;ACVRL1;TGFB1;GADD45A;ANGPT2;JUP
prerank,regulation of cell motility (GO:2000145),0.27126229002350916,0.8276788433508819,0.7821052631578947,0.9134416442975426,1.0,16/121,12.01%,FBLN1;FGF20;SERPINE2;FGF7;EGF;AMOTL1;FGF9;PLXNC1;RAC1;EGFR;KIF2A;PLXND1;CDK6;PLXNA3;MGAT3;FGF2
prerank,histone modification (GO:0016570),0.2767129578373534,0.8275120404413027,0.7571277719112989,0.9133183878169352,1.0,28/109,22.35%,MIER2;RCOR1;NAA50;EHMT1;PADI2;HDAC1;MTA2;CREBBP;CARM1;USP3;PRDM5;NSD3;INCENP;HDAC5;SIRT2;USP22;NSD1;TBL1X;EZH2;RUVBL1;MTA3;PHF20;BAZ2A;NTMT1;SIRT7;PRMT6;PARK7;RCOR2
prerank,melanosome organization (GO:0032438),-0.25135244201750023,-0.8274784900124396,0.7447698744769874,0.9103723082323919,1.0,7/26,17.90%,KIF13A;AP1M1;SNAPIN;HPS1;AP1G1;BLOC1S5;BLOC1S6
prerank,post-transcriptional gene silencing by RNA (GO:0035194),0.3482373690337591,0.8272460349192945,0.684931506849315,0.9133414994868593,1.0,4/20,17.64%,CELF1;TNRC6B;MOV10;WTIP
prerank,regulation of purine nucleotide metabolic process (GO:1900542),0.30760220037119945,0.827173389707284,0.7200956937799043,0.9130660083100478,1.0,9/41,16.27%,LACC1;RAE1;OGT;NUP37;NUP153;NUP188;NUP35;NUP214;GCK
prerank,tRNA export from nucleus (GO:0006409),0.31683381870258687,0.827111677995258,0.7078651685393258,0.9123965798168371,1.0,7/32,15.96%,RAE1;NUP37;NUP153;XPOT;NUP188;NUP35;NUP214
prerank,tRNA-containing ribonucleoprotein complex export from nucleus (GO:0071431),0.31683381870258687,0.827111677995258,0.7078651685393258,0.9123965798168371,1.0,7/32,15.96%,RAE1;NUP37;NUP153;XPOT;NUP188;NUP35;NUP214
prerank,purine-containing compound catabolic process (GO:0072523),-0.31461924765589183,-0.8266653504860131,0.7307692307692307,0.9103886912765985,1.0,4/13,15.05%,NT5E;ITPA;NT5C2;NT5C
prerank,regulation of synaptic vesicle exocytosis (GO:2000300),-0.28012581679340925,-0.826645954188417,0.7330827067669173,0.9089602723552707,1.0,7/18,14.12%,PREPL;SLC4A8;SNAPIN;RIMS2;RAP1A;NLGN1;RIMS1
prerank,glutathione derivative metabolic process (GO:1901685),0.3463459667743435,0.826618998394807,0.7002724795640327,0.9123914631624909,1.0,4/20,14.57%,MGST1;AKR1A1;GSTT1;GSTK1
prerank,glutathione derivative biosynthetic process (GO:1901687),0.3463459667743435,0.826618998394807,0.7002724795640327,0.9123914631624909,1.0,4/20,14.57%,MGST1;AKR1A1;GSTT1;GSTK1
prerank,DNA repair (GO:0006281),0.2601649721519672,0.8260395493581755,0.8592964824120602,0.9129336700154359,1.0,49/284,16.33%,RAD51B;PARP3;MPG;BRIP1;BACH1;LIG1;TNKS1BP1;DNA2;SMC1A;RAD52;INO80;CDKN2D;FBH1;ASCC3;BABAM2;PWWP3A;ATM;MGMT;ATR;XRCC3;ASF1A;USP3;FTO;TDP2;DCLRE1C;MDC1;DDB1;ALKBH1;SLC30A9;RNF8;MMS19;SETX;FANCE;RAD23A;ALKBH5;WDHD1;VCPIP1;PDS5B;RNASEH2A;NUCKS1;PDS5A;GTF2H1;USP47;LIG3;ABL1;ENDOV;MC1R;RBBP8;TIMELESS
prerank,negative regulation by host of viral transcription (GO:0043922),-0.316861950662542,-0.8257370341924496,0.7374631268436578,0.9093046612666993,1.0,3/12,5.82%,INPP5K;JUN;PSMC3
prerank,positive regulation of wound healing (GO:0090303),0.3144569903849187,0.8256951935187654,0.7038895859473023,0.9131238482768116,1.0,7/36,13.07%,VTN;ANXA1;APOH;HPSE;XBP1;MYLK;PTK2
prerank,metal ion transport (GO:0030001),0.280040686762651,0.8246608758847894,0.7718340611353712,0.9144033368381381,1.0,17/86,17.78%,CACNA1A;ITPR1;CACNA2D1;PKD2;CACNA1C;CCR1;NIPAL2;CYP27B1;CCL5;SLC30A9;ATP2C1;CACNG3;PSEN1;MMGT1;NIPAL4;SLC41A1;CALCRL
prerank,cyclooxygenase pathway (GO:0019371),0.3993240456078112,0.824595643233674,0.6913767019667171,0.9141177693953763,1.0,4/10,20.28%,PTGES;PTGS2;PTGES2;TBXAS1
prerank,phospholipid transport (GO:0015914),0.2950269408428434,0.8241862555596826,0.7368421052631579,0.9144092764585096,1.0,5/52,5.72%,ABCA1;APOE;ATP8B1;ABCG1;PLTP
prerank,neuron apoptotic process (GO:0051402),0.347349335263584,0.8235811488671128,0.6967213114754098,0.9149938844581182,1.0,2/19,3.96%,TNFRSF21;BCL2
prerank,regulation of establishment of endothelial barrier (GO:1903140),0.36167650202770363,0.8231542392377639,0.6666666666666666,0.9153023534481787,1.0,5/17,17.28%,S1PR2;S1PR3;TNF;TNFRSF1A;ROCK2
prerank,cation transmembrane transport (GO:0098655),0.2980721131491568,0.8229345815546307,0.7146282973621103,0.915283184150231,1.0,3/44,6.81%,SLC7A2;PKD2;SLC25A19
prerank,glycerophospholipid catabolic process (GO:0046475),0.3243504510980923,0.8227680128327577,0.710594315245478,0.915155977605428,1.0,9/27,21.63%,LIPC;PLA2G5;PLA2G7;ABHD16A;GDPD3;PRDX6;SMPD4;PLA2G4A;PLA2G4E
prerank,tRNA methylation (GO:0030488),-0.23834879982150228,-0.8225547730326448,0.7452830188679245,0.9138208016184342,1.0,13/34,25.75%,TRMT1L;ALKBH8;NSUN6;TRMT10A;LCMT2;TRMT5;TRMT44;TYW3;TARBP1;TRMO;TRMT12;TRMT112;HSD17B10
prerank,negative regulation of RNA metabolic process (GO:0051253),0.35012733210628005,0.8224059043748441,0.6855072463768116,0.9153335836966553,1.0,4/18,15.60%,NCOR2;PTBP3;TERT;TNF
prerank,protein oxidation (GO:0018158),0.38314313442455694,0.82132407501134,0.6904024767801857,0.9166885211742126,1.0,2/11,11.74%,LOXL1;LOXL3
prerank,"mRNA splicing, via spliceosome (GO:0000398)",-0.17653568491429172,-0.8212508541627049,1.0,0.914740095904781,1.0,82/264,25.57%,ELAVL2;SFPQ;WDR33;NOVA2;CWC22;SNRPN;FRG1;CSTF2;SRRM2;RBM5;CDC40;U2SURP;SNRNP70;AQR;PRPF38A;PRPF4;DCPS;HNRNPU;USP49;DDX5;RALY;HNRNPA3;CWF19L1;SNRPC;YTHDC1;SRSF7;PPIL3;CPSF2;HNRNPR;SNRPG;POLR2H;CWC25;SNRPD3;RBM19;RBM8A;POLR2G;POLR2F;SCNM1;PRPF19;ZCRB1;LSM5;SNUPN;U2AF2;MAGOH;EIF4A3;ISY1;SRSF10;PDCD7;PPWD1;IK;POLR2E;SF3A3;HNRNPA1;PSPC1;CLP1;CPSF4;CACTIN;TXNL4A;PABPN1;NOVA1;POLR2A;ZMAT2;SF3B5;PRPF6;CLNS1A;DDX39A;GEMIN8;CWC27;SF3B4;HNRNPH3;PQBP1;SF3B6;TFIP11;SNRPF;WBP4;DNAJC8;SNRPA1;DDX39B;GCFC2;WDR83;SNRPA;POLR2J
prerank,purine nucleoside bisphosphate metabolic process (GO:0034032),0.319974223645353,0.8208283204216075,0.7189119170984456,0.9167047727405824,1.0,8/29,21.84%,ACOT9;THEM4;ACOT13;ACSF2;ACAT1;MLYCD;CROT;ACOT11
prerank,ribonucleoside bisphosphate metabolic process (GO:0033875),0.319974223645353,0.8208283204216075,0.7189119170984456,0.9167047727405824,1.0,8/29,21.84%,ACOT9;THEM4;ACOT13;ACSF2;ACAT1;MLYCD;CROT;ACOT11
prerank,positive regulation of immunoglobulin mediated immune response (GO:0002891),0.37385835204491424,0.8208186569978807,0.7011834319526628,0.9163300263728126,1.0,4/14,16.39%,XCL1;SHLD3;RIF1;HMCES
prerank,negative regulation of receptor signaling pathway via STAT (GO:1904893),0.3902070792566357,0.8207421321078978,0.6790123456790124,0.9160629385129577,1.0,2/11,5.65%,BCL3;NF2
prerank,macrophage migration (GO:1905517),0.37203806056079386,0.8205963224876481,0.685459940652819,0.9159147581512651,1.0,2/13,13.55%,CCL5;CCL2
prerank,positive regulation of nervous system process (GO:0031646),0.35869056632392926,0.8201827773978232,0.6937321937321937,0.9161847539139776,1.0,6/18,17.65%,TENM4;MYRF;DICER1;HCRT;TPPP;EGR2
prerank,response to histamine (GO:0034776),-0.3305088643128462,-0.8201695348373405,0.6904761904761905,0.9153650711712429,1.0,3/10,15.61%,GABRB1;GABRB2;DRD2
prerank,positive regulation of DNA repair (GO:0045739),0.2996149533309987,0.8197558551624693,0.7393364928909952,0.9164479568398091,1.0,18/46,23.91%,SPIRE2;BABAM2;MGMT;EGFR;SPIRE1;FOXM1;SLF2;RNF8;DDX11;NPAS2;TIMELESS;TMEM161A;PARP1;RNF168;WRAP53;XRCC1;RPS3;UIMC1
prerank,response to estrogen (GO:0043627),0.31666433468177496,0.8193879239984774,0.6972010178117048,0.9166134011426956,1.0,4/31,6.76%,SFRP1;ARID5A;RBBP5;CYP27B1
prerank,regulation of protein ubiquitination (GO:0031396),0.27277830480623566,0.8189562837047357,0.786540483701367,0.9169164203130398,1.0,17/108,11.57%,TNFAIP3;MYCBP2;BIRC3;LRRK2;OGT;UBQLN1;PINX1;TGFBR1;UBE2L3;SQSTM1;TBC1D7;PHF23;SPRY2;PRICKLE1;SASH1;DCUN1D1;HDAC3
prerank,regulation of neuron projection arborization (GO:0150011),0.3539820361036925,0.8189476065379445,0.7005649717514124,0.9165396380586792,1.0,6/15,21.80%,WNT5A;DVL2;DLG4;MOV10;DVL1;MYO9A
prerank,negative regulation of cell cycle G1/S phase transition (GO:1902807),0.31771488953769367,0.8189353425252559,0.729936305732484,0.916169290871283,1.0,9/31,17.88%,CDKN2B;PKD2;PTEN;CDKN2D;CDK6;GPNMB;CCL2;WEE1;CDC73
prerank,positive regulation of chromosome organization (GO:2001252),0.3611873968475738,0.8188941959867659,0.7102941176470589,0.9158560202829992,1.0,3/15,11.03%,GNL3;DDX11;ATRX
prerank,tricarboxylic acid metabolic process (GO:0072350),0.3786185612060033,0.8181698101581065,0.6920731707317073,0.9166136281710697,1.0,6/12,21.58%,IDH3B;ACO1;IDH2;ACO2;IREB2;ASS1
prerank,positive regulation of protein metabolic process (GO:0051247),0.27048526560533737,0.8177289808677652,0.7936507936507936,0.9168963735750619,1.0,36/110,26.65%,IL23R;TNFAIP3;ABCA2;WNT5A;APOE;SMURF2;PAEP;RAB7A;OAZ3;AREL1;SLC25A37;DDB1;FZR1;RANBP9;SMURF1;GSK3B;TNF;PSEN1;ROCK2;ITCH;CSNK2A1;NEDD4;RAB1A;DACT1;ASB5;ATG7;NKD1;TGFB1;AGT;EIF4G1;AKT1;CDKN1B;INHBA;CSF1;FOXO1;VCP
prerank,cardiac muscle cell contraction (GO:0086003),0.3492639414420318,0.8168746680032745,0.723433242506812,0.9178343091686,1.0,4/19,11.40%,CAMK2D;CACNA2D1;CACNA1C;SCN2B
prerank,ncRNA export from nucleus (GO:0097064),0.30813494593567875,0.8164206757866951,0.7130541871921182,0.9181956318185929,1.0,8/36,15.96%,RAE1;NUP37;NUP153;XPOT;NUP188;NUP35;NCBP2;NUP214
prerank,intracellular protein transmembrane transport (GO:0065002),0.30048684740380127,0.8159435049003757,0.7209876543209877,0.9185854057711514,1.0,16/42,25.62%,PEX10;RTN2;SEC61A2;SEC63;DNLZ;HSPD1;PEX5;TIMM23;TIMM17A;TIMM50;SEC61A1;HSPA5;AIFM1;PEX12;TOMM40L;PEX6
prerank,negative regulation of DNA biosynthetic process (GO:2000279),0.3196807129636751,0.8156300760056774,0.7428940568475452,0.9187039518523443,1.0,8/30,22.29%,ADIPOQ;PINX1;XRN1;DCP2;NAT10;CTC1;SRC;ACVRL1
prerank,positive regulation of chromatin organization (GO:1905269),-0.3147103890400478,-0.8151278240476657,0.7228571428571429,0.9232786500235799,1.0,3/12,13.62%,UBE2N;SIN3A;TAL1
prerank,L-serine metabolic process (GO:0006563),-0.33578268184260873,-0.815094775068243,0.6925207756232687,0.9218846900452282,1.0,4/10,33.34%,CBS;SERINC3;SHMT1;PHGDH
prerank,positive regulation of telomere maintenance (GO:0032206),0.3156455384333154,0.8149854189921395,0.7417654808959157,0.9193304437767019,1.0,9/31,25.16%,GNL3;ATM;PKIB;ATRX;TNKS2;HNRNPA2B1;MAP2K7;MAPK1;PNKP
prerank,positive regulation of ruffle assembly (GO:1900029),0.36894866702795215,0.8146750984209704,0.6917404129793511,0.9194185489098459,1.0,1/13,1.92%,CARMIL2
prerank,ribosomal large subunit assembly (GO:0000027),-0.25774908573026406,-0.8142364141371614,0.7576923076923077,0.9219494972561627,1.0,8/24,20.34%,RPL5;RPLP0;RPL10;RPF2;NOP53;FASTKD2;MRPL20;NLE1
prerank,response to calcium ion (GO:0051592),0.27177176017381705,0.81421912304122,0.8025210084033614,0.9197301572789969,1.0,24/102,20.93%,SEC31A;WNT5A;CAMK2D;CPNE7;PKD2;CPNE2;SYT10;ALOX5AP;SYT2;CALM3;ADGRV1;KCNMB4;PPP3CA;SYT3;CALM2;KCNMA1;PPIF;PEF1;CPNE8;CARF;NEDD4;TNNT2;HPCA;KCNIP2
prerank,regulation of DNA recombination (GO:0000018),-0.23322435879092426,-0.814190278806096,0.8,0.9205762253057017,1.0,16/32,38.35%,SMARCAD1;MSH2;RTEL1;SHLD2;H1-0;MRE11;RPA2;CHEK1;SPIDR;RAD51AP1;SIRT6;ZCWPW1;FIGNL1;IL7R;MSH3;BLM
prerank,desensitization of G protein-coupled receptor signaling pathway (GO:0002029),0.38256818572287477,0.8139458576554807,0.7083993660855784,0.9197575831657938,1.0,3/11,19.57%,ADM;DRD3;ARRB1
prerank,regulation of cell communication by electrical coupling involved in cardiac conduction (GO:1901844),0.3776792155387349,0.8139214707505541,0.6902017291066282,0.9194068761630045,1.0,4/12,14.43%,CAMK2D;CALM3;CALM2;GJD3
prerank,termination of RNA polymerase II transcription (GO:0006369),-0.23665363779997325,-0.8135293198336626,0.7638888888888888,0.9202970953647127,1.0,12/33,24.07%,WDR33;CSTF2;CPSF2;SNRPG;SNRPD3;LSM11;CLP1;CPSF4;PABPN1;SCAF8;LSM10;SNRPF
prerank,neurotransmitter transport (GO:0006836),0.281328981285963,0.813465984780893,0.7745535714285714,0.9197541525055407,1.0,6/73,4.39%,SLC1A3;SLC6A2;CASK;SLC28A2;SLC29A1;PPFIA4
prerank,divalent inorganic cation homeostasis (GO:0072507),-0.24417607569181737,-0.8131763241727947,0.7903225806451613,0.9194585195688854,1.0,2/25,2.11%,CAV1;PRKN
prerank,microtubule anchoring (GO:0034453),-0.3109653096508531,-0.8130505016057593,0.6997167138810199,0.9182397248405844,1.0,1/12,0.47%,BICD1
prerank,negative regulation of cellular protein catabolic process (GO:1903363),0.39291937339549554,0.8118701335370259,0.6998420221169036,0.9218224731202712,1.0,1/10,2.13%,NELL1
prerank,phosphatidic acid biosynthetic process (GO:0006654),0.2957353386768066,0.8116441777509633,0.7407847800237812,0.9218129441243689,1.0,13/46,23.71%,PLA2G5;PLD1;DDHD2;DGKH;PLA2G12A;GPD1;GPAM;AGPAT5;GPAT3;ABHD8;PLA2G4A;AGPAT1;LCLAT1
prerank,positive regulation of purine nucleotide biosynthetic process (GO:1900373),0.36922342529293417,0.8112773892830509,0.6877697841726619,0.9220025725255399,1.0,3/13,9.59%,TREM2;PID1;ENO1
prerank,programmed necrotic cell death (GO:0097300),0.3478034838486303,0.8112707157427472,0.7150837988826816,0.921625203264471,1.0,5/18,18.60%,LY96;MLKL;CD14;PPIF;TLR3
prerank,microvillus organization (GO:0032528),0.37381959058370207,0.8112591327695536,0.704647676161919,0.9212546543253779,1.0,2/13,4.12%,MAP4K4;RAP2A
prerank,cardiac muscle contraction (GO:0060048),-0.22807351437010864,-0.8108519816965211,0.8,0.9208938154683837,1.0,3/34,2.13%,DMD;ATP1B1;ATP1A2
prerank,RNA export from nucleus (GO:0006405),-0.18715526995864976,-0.8107838428425274,0.9459459459459459,0.9195681489700923,1.0,24/100,16.99%,WDR33;CDC40;NUP133;UPF1;YTHDC1;SRSF7;CPSF2;XPO5;NUP50;MCM3AP;RBM8A;NUP93;ZC3H11A;NUP160;NUP43;U2AF2;MAGOH;EIF4A3;NUP85;NUP205;HHEX;SEH1L;HNRNPA1;POM121
prerank,regulation of postsynaptic neurotransmitter receptor activity (GO:0098962),-0.33444247767163365,-0.8103753003522495,0.6802168021680217,0.9188273507364659,1.0,2/10,4.52%,DLGAP1;DLGAP2
prerank,negative regulation of G1/S transition of mitotic cell cycle (GO:2000134),0.3115189561107957,0.8098496652211703,0.7330827067669173,0.9230363291178307,1.0,9/33,17.88%,CDKN2B;PKD2;PTEN;CDKN2D;CDK6;GPNMB;CCL2;WEE1;CDC73
prerank,nucleotide-binding oligomerization domain containing signaling pathway (GO:0070423),0.32629443773455113,0.8092802767564957,0.7470967741935484,0.9235447864293534,1.0,6/28,17.44%,TNFAIP3;LACC1;NOD1;IRAK2;CASP8;ITCH
prerank,peroxisomal membrane transport (GO:0015919),0.3235873598325539,0.8091379693458263,0.7322834645669292,0.9233687320083004,1.0,10/27,26.94%,PEX10;RAB8B;ALDH3A2;PEX19;FIS1;PEX5;ABCD2;PEX12;PEX6;PXMP4
prerank,microvillus assembly (GO:0030033),0.3631889140807434,0.8089100328545659,0.6947674418604651,0.9233460306486159,1.0,2/14,4.12%,MAP4K4;RAP2A
prerank,folic acid-containing compound metabolic process (GO:0006760),0.34349256022036556,0.8087309458384984,0.7233748271092669,0.9232325021372426,1.0,7/19,26.21%,MTHFD1L;MTHFR;GGH;MTHFD2L;FPGS;SLC19A1;MTRR
prerank,positive regulation of glucose import (GO:0046326),0.3396802183231629,0.8087107790666737,0.7307692307692307,0.92287215744922,1.0,3/21,7.45%,ADIPOQ;IRS1;PIK3R1
prerank,cardiac ventricle morphogenesis (GO:0003208),0.30199854063026577,0.8086701186935689,0.7344497607655502,0.9225471264667925,1.0,7/41,13.51%,SFRP2;JAG1;TNNI3;TNNC1;HEYL;RBPJ;TPM1
prerank,regulation of organelle organization (GO:0033043),0.27329230113010955,0.8086006085418774,0.7607497243660419,0.9222673020549651,1.0,22/80,23.96%,ZEB2;TAOK1;SYDE1;MYO5A;CAPN2;CAMSAP2;SQSTM1;LMAN1;MSN;PTK2;PDCD10;PDE4DIP;CPLANE2;FIS1;CLN3;MTM1;SIRT7;CLEC16A;PRMT6;MAPK1;AKAP9;SCARB2
prerank,negative regulation of secretion (GO:0051048),0.38734870953697503,0.8083316151575503,0.6698872785829307,0.9222844107744439,1.0,1/10,4.28%,EGF
prerank,regulation of axon regeneration (GO:0048679),-0.31338017146307195,-0.8082600262209976,0.7121212121212122,0.9211606441767894,1.0,2/12,1.17%,INPP5F;EPHA4
prerank,positive regulation of protein sumoylation (GO:0033235),0.3916952541474541,0.8078615594892574,0.7001569858712716,0.9226287295911418,1.0,5/10,25.22%,GNL3;SAE1;RASD2;PIAS1;RWDD3
prerank,cell projection organization (GO:0030030),0.3155921992834449,0.8074313523515169,0.7224334600760456,0.9228903408043069,1.0,5/30,12.98%,RHOJ;RAC1;CDC42;PARVA;NEFH
prerank,cellular response to glucose starvation (GO:0042149),0.2971732933754498,0.8073609498790509,0.7165841584158416,0.9226186053787024,1.0,15/41,20.04%,NUAK1;EIF2AK3;ASNS;XBP1;TBL2;PIK3C3;PIK3R4;BRSK2;ATG14;KPTN;SH3GLB1;PICK1;FOXO3;BRSK1;CPEB4
prerank,hydrogen peroxide metabolic process (GO:0042743),-0.2618459232493017,-0.8072987643832685,0.7443609022556391,0.9214092979221902,1.0,4/19,12.83%,MAOB;CAT;PRDX2;NOX1
prerank,positive regulation of cardiac muscle tissue growth (GO:0055023),0.3545543030396778,0.806706135135965,0.6987087517934003,0.9232421698381409,1.0,4/16,12.71%,ZFPM2;TBX2;FGF2;RBPJ
prerank,regulation of postsynaptic membrane potential (GO:0060078),-0.23626272858814573,-0.806652455993892,0.8164251207729468,0.9211491398805195,1.0,15/34,25.52%,GRID2;GABRA2;GABRA5;MEF2C;GABRG3;GRIN2D;GRIN2B;GABRG1;DRD2;GABRE;GABRA4;INSYN2A;GLRA1;GABRG2;CHRNA4
prerank,cell communication by electrical coupling involved in cardiac conduction (GO:0086064),-0.2790755305629371,-0.8064668440809365,0.7043189368770764,0.9200359896772261,1.0,3/17,6.02%,ATP1B1;ATP1A2;GJA1
prerank,telomere maintenance via telomere lengthening (GO:0010833),0.30975589947191234,0.8061316339598903,0.7372353673723536,0.9237268704717,1.0,10/33,23.85%,ZBTB48;TNKS1BP1;PINX1;NHP2;TERT;TELO2;CTC1;TERF2IP;WRAP53;RFC1
prerank,respiratory electron transport chain (GO:0022904),-0.29688802264442943,-0.8061051815705219,0.7549668874172185,0.9192276575494546,1.0,8/14,26.04%,GPD2;PPARGC1A;ETFRF1;ETFB;SLC25A12;UQCRFS1;ETFDH;SLC25A13
prerank,mitotic G1 DNA damage checkpoint signaling (GO:0031571),0.28438816370512293,0.805880159792168,0.7727272727272727,0.9237497876921232,1.0,9/63,11.49%,TNKS1BP1;CNOT4;E2F1;ATM;CARM1;BAX;E2F8;FBXO31;TFDP1
prerank,protein import into peroxisome matrix (GO:0016558),0.3718869989938777,0.8057319646158836,0.6666666666666666,0.9236133594354364,1.0,1/12,2.66%,PEX10
prerank,central nervous system neuron development (GO:0021954),0.361156346201311,0.8053620263745387,0.7032163742690059,0.9237942733771735,1.0,6/15,21.20%,B4GALT5;PTEN;ARHGAP35;GBA2;NPY;ATP7A
prerank,ciliary basal body-plasma membrane docking (GO:0097711),0.267583515075692,0.8052155150716123,0.7955508474576272,0.9236295438866782,1.0,25/94,22.82%,DYNLL1;ALMS1;DYNC1H1;HAUS3;CCP110;TUBG1;CNTRL;PLK1;B9D2;CEP41;PCM1;DCTN3;CSNK1D;CC2D2A;CEP72;IQCB1;TUBA1A;PCNT;ACTR1A;CEP162;CKAP5;NINL;YWHAE;C2CD3;YWHAG
prerank,negative regulation of antigen receptor-mediated signaling pathway (GO:0050858),0.334430917485659,0.8047611155530658,0.7235772357723578,0.9239470629780182,1.0,5/22,17.11%,FCGR2B;UBASH3A;THY1;PTPN2;PTPRJ
prerank,stem cell differentiation (GO:0048863),0.30151322754842264,0.8045890684518568,0.7460701330108828,0.9238451715684511,1.0,8/39,15.01%,SFRP1;BATF;SOX21;SHH;PSMD11;PUM1;LRP6;SP7
prerank,cellular macromolecule catabolic process (GO:0044265),0.2853940154339357,0.804536449886972,0.7455621301775148,0.9235379621535728,1.0,13/49,18.64%,PABPC4;SIAH2;SND1;ADAMTS9;MTREX;RNASEH2A;RNASEH1;DFFB;DNASE1L2;SIDT2;RAB12;FBXO2;NGLY1
prerank,positive regulation of neuron migration (GO:2001224),-0.3123687854345558,-0.804494762625316,0.7110481586402266,0.920617283082559,1.0,3/11,9.11%,SEMA6A;RAPGEF2;SHTN1
prerank,cellular response to glucose stimulus (GO:0071333),0.3106473854503702,0.8040116784744701,0.7369077306733167,0.9239625057650667,1.0,1/30,0.16%,SLC39A14
prerank,protein O-linked glycosylation via serine (GO:0018242),-0.3225697246162069,-0.8037253999454602,0.7315068493150685,0.9205560747752349,1.0,4/10,15.29%,GALNT13;POGLUT1;POGLUT2;GALNT1
prerank,cell cycle checkpoint signaling (GO:0000075),-0.2948436844361104,-0.8037250348185453,0.7435897435897436,0.9191354635487299,1.0,3/12,12.61%,NABP1;ZWILCH;ZWINT
prerank,Golgi inheritance (GO:0048313),0.37893420977466613,0.8034362544177637,0.7010309278350515,0.9244704197046867,1.0,6/11,27.57%,VCPIP1;PDCD10;GBF1;STK25;YWHAZ;STX5
prerank,antibacterial humoral response (GO:0019731),0.3544463535919667,0.8033044894407909,0.7088068181818182,0.924266336091468,1.0,1/16,3.51%,RNASE7
prerank,negative regulation of cold-induced thermogenesis (GO:0120163),0.29267970219297834,0.8031074288304404,0.7630619684082625,0.9242065656513648,1.0,17/46,26.18%,ADIPOQ;ADAMTS5;LAMA4;PLCL1;ARRDC3;ACOT13;RBPJ;FLCN;LGR4;STK11;ACOT11;NR1D1;NRDC;DDIT3;DOCK7;ATF4;ZNF423
prerank,acyl-CoA biosynthetic process (GO:0071616),0.3525764406139223,0.8030006251312749,0.71900826446281,0.9239748885826148,1.0,5/16,19.88%,FASN;SCD5;HSD17B8;ACAT1;MLYCD
prerank,positive regulation of cellular protein metabolic process (GO:0032270),0.26857975167957837,0.8029632494099155,0.8173076923076923,0.923643102462204,1.0,15/101,15.59%,PRR16;BCL3;PLD1;CLN6;OGT;SAMD4A;PLK1;YTHDF3;RPS6KB1;FMR1;MSN;FBXW11;CASP8;STUB1;NIBAN1
prerank,positive regulation of transcription initiation from RNA polymerase II promoter (GO:0060261),0.32763340438740945,0.8029206736590832,0.7173333333333334,0.9233201616139358,1.0,4/22,9.69%,MED13;SUB1;MED12;MED14
prerank,endoplasmic reticulum mannose trimming (GO:1904380),-0.2665078275795658,-0.8026027841902116,0.7694915254237288,0.9196161206710464,1.0,8/18,23.95%,EDEM2;RNF185;UBC;RNF139;RNF5;UBA52;UBB;RNF103
prerank,protein prenylation (GO:0018342),0.3901475163309597,0.8024093004869091,0.6993670886075949,0.9237058711142052,1.0,4/10,21.86%,CHML;PTAR1;FNTB;RABGGTB
prerank,negative regulation of protein kinase B signaling (GO:0051898),0.30019260162737277,0.8019354630519735,0.7426470588235294,0.9240420277984143,1.0,14/38,24.65%,PTEN;THEM4;SFRP5;DRD3;FLCN;OTUD3;PHLPP2;PTPRJ;TRIB3;PPP2R5C;TSC2;DDIT3;XDH;AKT1
prerank,amide biosynthetic process (GO:0043604),0.29011318914161216,0.8014835008790353,0.766546329723225,0.9243244141457714,1.0,7/47,12.50%,ASMT;PAM;CERS6;ASL;SPTSSA;CERS2;PCSK5
prerank,protein complex oligomerization (GO:0051259),0.2725223813482836,0.8014320076974378,0.796976241900648,0.9240179813246998,1.0,13/85,13.02%,SLC9A1;STOML2;TRMT61B;PKD2;TMEM120B;ATL2;MPP2;LRRC8A;TIFA;ATL1;ALS2;MS4A1;HGSNAT
prerank,rRNA 3'-end processing (GO:0031125),0.38826849755771875,0.8014289876466366,0.7165605095541401,0.9236395430913538,1.0,4/10,23.16%,ERI1;EXOSC2;EXOSC3;ERI3
prerank,regulation of JUN kinase activity (GO:0043506),0.30710184291030135,0.8013004184782574,0.74726609963548,0.9234400702240027,1.0,8/33,15.60%,DVL2;AIDA;MAPK8IP1;SASH1;TAOK3;TRAF2;HIPK3;TNF
prerank,cytoskeleton-dependent intracellular transport (GO:0030705),0.3235263045808575,0.8011112823393177,0.7457180500658761,0.9233479945958484,1.0,8/23,20.17%,MYO10;HOOK2;KIF1C;KIF5B;KIF5C;TUBA1A;KIF5A;HOOK3
prerank,negative regulation of catabolic process (GO:0009895),0.2903423491876157,0.8009262703371274,0.781582054309327,0.923239767754376,1.0,7/47,15.60%,MAD2L1;IRAK3;AZIN2;EGFR;SIRT2;BANP;TNF
prerank,phosphatidylinositol biosynthetic process (GO:0006661),0.259310801065286,0.800447889124314,0.8174186778593914,0.9236007542738687,1.0,33/119,20.94%,PIGW;PIP4K2A;PTEN;PTPN13;TMEM150A;PIP5K1B;PIK3R1;PIGN;FIG4;PI4K2B;ITPKC;PIP4K2B;PGAP4;PIGL;PIK3R5;SACM1L;FGF2;DPM2;PI4KA;PIK3C3;PIK3R4;PIGG;RUFY1;PIGC;TTC7A;SOCS5;PIP5K1A;SYNJ2;IP6K2;ARF1;MTMR1;MTM1;EFR3A
prerank,endocardial cushion morphogenesis (GO:0003203),-0.2597208532301777,-0.800199109452008,0.7735849056603774,0.9223866175662834,1.0,2/18,1.71%,BMP4;NOS3
prerank,regulation of nucleocytoplasmic transport (GO:0046822),0.3730978389097355,0.7988247583706339,0.7265861027190332,0.9256617905358552,1.0,6/12,23.69%,KHDRBS1;NUP214;NEDD4;IFI27;SIRT7;TGFB1
prerank,cardiac conduction system development (GO:0003161),0.3220367277539272,0.7984481967883919,0.7367021276595744,0.9258666518458526,1.0,2/24,3.64%,TBX18;GATA6
prerank,protein insertion into membrane (GO:0051205),0.3033203234365823,0.798004041437002,0.7394094993581515,0.9261668423990883,1.0,6/32,15.63%,TRAM2;EGFR;WDR83OS;ALDH3A2;RTP4;VAPA
prerank,prostaglandin biosynthetic process (GO:0001516),0.34155078471684885,0.7979718842675723,0.7283950617283951,0.9258275480411433,1.0,6/18,20.46%,PTGES;PRXL2B;PTGS2;PTGES2;TBXAS1;PLA2G4A
prerank,response to muscle stretch (GO:0035994),-0.2883838331151623,-0.7978803601896262,0.7258064516129032,0.9250739557313107,1.0,2/15,7.03%,DMD;GSN
prerank,sensory perception of pain (GO:0019233),0.3308330347344603,0.7968789930554036,0.715076071922545,0.9270535901001534,1.0,1/21,1.41%,PTGES
prerank,phosphatidylethanolamine metabolic process (GO:0046337),-0.24595484357409322,-0.7968120968700156,0.788,0.9254563382732766,1.0,9/27,28.33%,PNPLA8;CHKA;NAAA;PLA2G6;PLAAT3;ETNPPL;SELENOI;PLA2G15;SLC27A1
prerank,positive regulation of cellular component movement (GO:0051272),-0.24811079168186168,-0.7965146881849529,0.7833935018050542,0.9245117962509267,1.0,7/24,22.24%,SPOCK2;RPS19;CCDC25;NTN1;TRIM32;CSF1R;CAVIN1
prerank,nuclear pore complex assembly (GO:0051292),-0.3220161996064854,-0.7959971870262553,0.7244318181818182,0.9239361626798654,1.0,6/10,30.40%,TMEM170A;NUP93;NUP205;AHCTF1;NUP98;RTN4
prerank,negative regulation of histone acetylation (GO:0035067),0.3820329270304326,0.7950364704128451,0.7308823529411764,0.9294546928109367,1.0,3/11,17.54%,TAF7;NOC2L;SPI1
prerank,transepithelial transport (GO:0070633),0.34888420755833915,0.7949522899650048,0.7217514124293786,0.9292102270604482,1.0,1/15,0.58%,SLC1A3
prerank,purine nucleotide biosynthetic process (GO:0006164),0.36711712607280544,0.7949485065964889,0.7224806201550388,0.9288349235639298,1.0,3/12,14.95%,ADSL;GART;PPAT
prerank,regulation of blood circulation (GO:1903522),0.300390937369341,0.7947018645221748,0.7383292383292384,0.9288350250966156,1.0,8/34,20.93%,CAMK2D;TBX2;KCNG2;KCNMB4;TPM1;DES;TNNT2;KCNIP2
prerank,"maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000463)",-0.288843382184675,-0.7945278231250391,0.7333333333333333,0.9249354183437631,1.0,6/14,21.88%,RPL35;RPF2;WDR12;RPL7;NOL9;URB1
prerank,phospholipid catabolic process (GO:0009395),-0.2408248223229443,-0.7944821947852388,0.8026315789473685,0.9236091368149575,1.0,9/24,30.61%,GPCPD1;GDPD1;SMPDL3A;GDE1;PLA2G4C;ENPP6;PNPLA6;PLA2G4F;ENPP2
prerank,positive regulation of ATPase activity (GO:0032781),0.2886268431349098,0.7944633094226717,0.7505966587112172,0.9288125961186379,1.0,3/41,4.23%,VMP1;DYNLL1;DNAJB1
prerank,phospholipid dephosphorylation (GO:0046839),-0.21732423397296702,-0.794270147915402,0.8617021276595744,0.9225389232969514,1.0,9/37,18.45%,INPP5F;MTMR10;INPP5K;MTMR11;OCRL;SYNJ1;MTMR7;PLPPR4;MTMR12
prerank,negative regulation of tyrosine phosphorylation of STAT protein (GO:0042532),-0.31950660812928955,-0.7941989250459909,0.7340720221606648,0.9212463004586102,1.0,2/10,5.71%,INPP5F;PPP2R1A
prerank,modulation of chemical synaptic transmission (GO:0050804),0.26660149363088254,0.793486462635141,0.8304904051172708,0.9298724747695075,1.0,19/107,15.95%,CEL;ADIPOQ;CACNA1A;LRRK2;NPAS4;PTEN;OPHN1;PXK;DLG4;MCTP2;KCNMB4;FMR1;DLGAP3;HCRT;LRRC4;UNC13A;TNF;GRIK5;NPTXR
prerank,cellular response to thyroid hormone stimulus (GO:0097067),0.37283515448778115,0.7928552961892761,0.7214397496087637,0.9304052118213855,1.0,5/12,23.47%,CTSS;CTSB;CTSL;CTSH;BRD8
prerank,cellular biogenic amine biosynthetic process (GO:0042401),0.3550377493799386,0.7922493790792852,0.7280453257790368,0.9309052418536162,1.0,1/15,2.04%,ASMT
prerank,protein peptidyl-prolyl isomerization (GO:0000413),-0.2707575171324526,-0.7922065552459018,0.7902097902097902,0.9232008404022672,1.0,9/20,26.25%,FKBP5;PPIG;PPIL3;PPIL2;PPWD1;PPIA;CWC27;PPIE;FKBP1A
prerank,glycoprotein biosynthetic process (GO:0009101),0.2681166165772944,0.7915862904254137,0.778149386845039,0.9315054430496343,1.0,9/79,11.01%,TNIP1;B4GALT5;ALG5;CHST13;ST3GAL3;TMEM106A;DDOST;B3GALNT1;GCNT2
prerank,positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G protein-coupled signaling pathway (GO:0051482),0.3159556229573673,0.7912723304292455,0.7708066581306018,0.9316134707799658,1.0,1/27,0.71%,P2RY10
prerank,cristae formation (GO:0042407),-0.2430228807294621,-0.7910003769798439,0.7808764940239044,0.923880033784212,1.0,8/27,14.83%,LETM1;ATP5MG;ATP5PD;ATP5F1C;ATP5F1D;SAMM50;MICOS13;ATP5ME
prerank,negative regulation of neuron apoptotic process (GO:0043524),0.2766191225705614,0.7907337997660884,0.7945516458569807,0.9320275753412411,1.0,16/69,20.04%,FGF20;APOE;BCL2;MDK;NONO;TGFB3;PTPRZ1;FZD9;SNX6;CCL2;CX3CL1;GDNF;UNC5B;CLN3;NTF3;CPEB4
prerank,"chemical synaptic transmission, postsynaptic (GO:0099565)",0.31834266975511694,0.7905145068464947,0.7416331994645248,0.9319750734751305,1.0,7/25,19.92%,LRRK2;NPAS4;MPP2;GRIN2A;GSK3B;GRIN1;RAB3GAP1
prerank,regulation of microtubule polymerization (GO:0031113),0.2921702997851223,0.7903613616676015,0.7512135922330098,0.9318116044974067,1.0,16/40,27.44%,PSRC1;NAV3;RAC1;CAMSAP2;CLIP3;ABL1;GBA2;CAMSAP1;FES;PAK1;RPS3;AKAP9;NUMA1;DRG1;TBCD;DYRK1A
prerank,regulation of dendrite extension (GO:1903859),0.3368189952651532,0.7900904198367534,0.7224546722454672,0.9318253051716311,1.0,6/18,19.73%,RNF157;SYT2;SYT3;SMURF1;UNC13A;RASAL1
prerank,"base-excision repair, AP site formation (GO:0006285)",0.33903407997664503,0.7897124064751263,0.7467994310099573,0.9320197672359615,1.0,1/17,1.23%,MPG
prerank,inorganic cation transmembrane transport (GO:0098662),0.25158459170325514,0.7896842501718835,0.9069069069069069,0.9316774757200675,1.0,17/268,5.95%,MCOLN2;SLC39A14;SLC1A3;CACNA1A;SLC6A2;SLC9A1;HVCN1;SLC24A5;SLC11A2;SCN7A;ATP5PO;PKD2;CACNA1C;ATP2A2;KCNF1;SLC4A4;KCNG2
prerank,regulation of protein modification process (GO:0031399),0.28418909190751174,0.789465978781481,0.7680473372781065,0.9316133812306163,1.0,12/50,17.19%,ABCA2;SPRED1;SPRED2;KDM4D;CDK9;PPP1R16A;FNIP1;CCAR2;PTK2;FLCN;ATG14;PUM3
prerank,positive regulation of dendrite extension (GO:1903861),0.34102374573747674,0.7893563494345995,0.7263751763046544,0.9313933136973525,1.0,6/17,19.73%,RNF157;SYT2;SYT3;SMURF1;UNC13A;RASAL1
prerank,cellular response to amino acid stimulus (GO:0071230),0.3007853648790554,0.7893348919079051,0.7563451776649747,0.9310411341020982,1.0,7/33,15.64%,CPEB1;KLHL22;CAPN2;RPTOR;XBP1;LAMTOR5;RRAGC
prerank,negative regulation of lyase activity (GO:0051350),-0.27640880066644075,-0.7892905573415224,0.7692307692307693,0.9253440860609242,1.0,4/16,15.61%,PALM;GRM3;GNAI3;DRD2
prerank,heparan sulfate proteoglycan biosynthetic process (GO:0015012),0.33341975558241466,0.7891523424895769,0.721835883171071,0.9309102040721505,1.0,5/19,15.48%,EXT1;HS2ST1;EXT2;EXTL3;UGDH
prerank,cytosolic calcium ion transport (GO:0060401),0.31493097415962684,0.7890980167915226,0.7425227568270482,0.9306028542818415,1.0,5/28,10.68%,CACNA2D1;CACNA1C;ATP2A2;ATP2B1;MICU2
prerank,negative regulation of DNA-dependent DNA replication (GO:2000104),0.3693251658812049,0.7886397560809036,0.7032967032967034,0.9308850647154877,1.0,4/11,16.33%,FBH1;FBXO5;LIG3;TIMELESS
prerank,homeostasis of number of cells (GO:0048872),-0.30933108576259377,-0.7886328761746914,0.7350427350427351,0.924998450282272,1.0,2/12,4.17%,NOS3;CCN3
prerank,regulation of NIK/NF-kappaB signaling (GO:1901222),0.27040807607091166,0.7883865802604704,0.7921348314606742,0.9308885452570725,1.0,32/76,28.99%,BCL3;TLR2;LIMS1;RASSF2;EGFR;LGALS9;NOD1;TLR7;CD14;SASH1;EIF2AK2;TNF;RHOA;SPI1;TCIM;TRIM44;TLR3;DDX3X;TERF2IP;BMP7;RPS3;ADGRG3;IFI35;RTKN2;NLRP12;TRIM6;NFAT5;PPM1B;RELA;ILK;DLG1;ZC3H12A
prerank,glycoprotein metabolic process (GO:0009100),0.2824054249079332,0.7881583406383239,0.7592592592592593,0.9308743075630874,1.0,14/53,22.44%,TNIP1;B4GALT5;PRKCSH;MAN1C1;MAN2A1;HPSE;ADAMTS9;ST3GAL2;FBXO2;NGLY1;MGAT4A;B4GALT7;PARK7;ST8SIA3
prerank,cellular response to metal ion (GO:0071248),0.25784503844967543,0.7881142178264631,0.8595213319458896,0.9305603081219306,1.0,15/123,11.18%,ADCY7;HVCN1;WNT5A;LRRK2;CAMK2D;CPNE7;PKD2;CPNE2;SYT10;EGFR;ALOX5AP;SYT2;SLC13A5;DLG4;ADGRV1
prerank,regulation of monooxygenase activity (GO:0032768),0.3253076516065408,0.78799357303981,0.7421981004070556,0.9303717362009977,1.0,3/23,7.06%,NOS1AP;POR;EGFR
prerank,mitochondrial ATP synthesis coupled proton transport (GO:0042776),0.34683870504528164,0.7877369114458225,0.72,0.9303564635183992,1.0,6/16,24.26%,STOML2;ATP5PO;DMAC2L;ATP5MC1;ATP5F1A;ATP5MC3
prerank,positive regulation of transcription by RNA polymerase I (GO:0045943),-0.2558091823706463,-0.787688679688991,0.7819548872180451,0.9252388689145877,1.0,4/22,6.52%,NCL;WDR43;PHF8;PWP1
prerank,positive regulation of cellular carbohydrate metabolic process (GO:0010676),0.38389324427180316,0.7875751535458835,0.7336448598130841,0.9302148717906334,1.0,4/10,24.65%,IRS1;PTH1R;GPLD1;AKT1
prerank,positive regulation of DNA recombination (GO:0045911),0.3123431879418817,0.7874872423724676,0.7384615384615385,0.929948799615794,1.0,10/27,22.83%,ACTR2;SHLD3;MMS19;RIF1;TIMELESS;HMCES;PARP1;FUS;WRAP53;KMT5B
prerank,amide transport (GO:0042886),0.3166732740781409,0.7873607967318333,0.7243172951885566,0.9297675177952621,1.0,2/26,5.72%,SLC14A2;PLTP
prerank,cellular response to osmotic stress (GO:0071470),0.32623735453776936,0.7872927328409305,0.7386058981233244,0.9294909102581353,1.0,2/21,4.71%,ZFP36L1;PKD2
prerank,negative regulation of cation transmembrane transport (GO:1904063),0.347386672975217,0.7871548965447543,0.7544581618655692,0.9293242575144937,1.0,3/18,9.50%,CBARP;CAMK2D;BIN1
prerank,positive regulation of endothelial cell apoptotic process (GO:2000353),-0.28669048452744555,-0.7869791159798334,0.7639344262295082,0.9250177642127828,1.0,5/14,15.47%,THBS1;ITGA4;ECSCR;GPER1;PDCD4
prerank,positive regulation of phospholipid transport (GO:2001140),0.37630330224701436,0.7868210876025533,0.6923076923076923,0.9294279589766663,1.0,1/10,3.63%,APOE
prerank,axonal transport of mitochondrion (GO:0019896),0.35960745245553954,0.7867289491842359,0.7100591715976331,0.9291824937999361,1.0,1/11,4.05%,TRAK1
prerank,prostanoid biosynthetic process (GO:0046457),0.3441592784341512,0.7867246878732297,0.7240896358543417,0.9288099980203569,1.0,5/15,20.46%,PTGES;PRXL2B;PTGS2;TBXAS1;PLA2G4A
prerank,necroptotic process (GO:0070266),0.3430635812084415,0.7866686519846452,0.7517831669044223,0.9285087405844497,1.0,3/16,10.63%,LY96;MLKL;CD14
prerank,regulation of extrinsic apoptotic signaling pathway (GO:2001236),0.2748378055741323,0.7864959930062357,0.7952488687782805,0.9283902377567479,1.0,13/63,16.24%,TCF7L2;CFLAR;FGFR1;SIAH2;TNFRSF12A;TGFBR1;ACVR1;SH3RF1;TRAF2;PELI3;CASP8;TNF;SP100
prerank,negative regulation of fibroblast proliferation (GO:0048147),0.3334842653575823,0.7864314371862796,0.73828125,0.9281065915676704,1.0,3/18,11.00%,SFRP1;NF1;MORC3
prerank,oligodendrocyte differentiation (GO:0048709),0.332057123426177,0.7864041028080048,0.7379972565157751,0.9277695161297712,1.0,6/19,19.19%,SHH;PTPRZ1;MYRF;TPPP;EIF2B3;CDK5
prerank,maturation of LSU-rRNA (GO:0000470),0.32069656012670333,0.7863745991263589,0.7698309492847855,0.9274310387628556,1.0,7/26,19.55%,MAK16;PES1;NHP2;DDX18;NOP2;RSL1D1;MRPL1
prerank,regulation of peptidyl-serine phosphorylation (GO:0033135),0.26674336432010454,0.7862722510259584,0.810752688172043,0.9271967186482397,1.0,29/93,24.65%,SFRP2;TNKS1BP1;PRKD2;PTEN;CNKSR3;RASSF2;EGFR;NCK2;NCK1;RPTOR;SPRY2;FNIP1;ARAF;NSD1;NTRK3;TNF;PDCD10;NLRP2B;STK4;SPTBN4;NTF3;PAK1;TERF2IP;PARK7;TGFB1;PFN2;AKAP9;EIF4G1;AKT1
prerank,regulation of cell migration involved in sprouting angiogenesis (GO:0090049),0.30271503688171714,0.7862328455667829,0.7410714285714286,0.9268700544422596,1.0,11/32,20.98%,RHOJ;ANXA1;AKT3;HDAC5;FGF2;ITGB1BP1;PDCD10;RHOA;PTGS2;STARD13;MAP3K3
prerank,positive regulation of protein localization to cell surface (GO:2000010),0.35427330433862647,0.7856012151163086,0.7398496240601504,0.9273618983581369,1.0,3/13,15.60%,TM9SF4;SNX33;TNF
prerank,protein export from nucleus (GO:0006611),-0.2412018286069491,-0.7854474091726915,0.7929515418502202,0.9261099805551655,1.0,5/27,14.33%,RANBP3L;XPO5;DESI1;STRADA;NUTF2
prerank,positive regulation of histone deacetylation (GO:0031065),0.3639661290215508,0.7849363854739154,0.7237237237237237,0.9279478939932061,1.0,3/12,15.99%,PRKD2;NIPBL;AKAP8L
prerank,peptidyl-lysine modification (GO:0018205),0.26179328741011887,0.7846408885002819,0.8336933045356372,0.9280177749417441,1.0,28/99,22.83%,PLOD2;RAE1;USPL1;NUP37;LOXL1;PIAS2;ETFBKMT;NUP153;SIRT2;NUP188;SAE1;LOXL3;SENP6;NDUFAB1;NUP35;VCPKMT;NUP214;EGR2;TRPM4;PLOD1;NSMCE2;SENP5;SIRT7;ATP7A;PIAS1;PARK7;SIRT3;NDC1
prerank,"Wnt signaling pathway, calcium modulating pathway (GO:0007223)",0.29500999243292203,0.7845104654292843,0.7493638676844784,0.9278330195958506,1.0,7/36,14.86%,TCF7L2;WNT5A;TNRC6B;FZD3;PPP3CA;GNG2;MOV10
prerank,negative regulation of DNA binding (GO:0043392),0.3138181251706248,0.7842151034318052,0.7577720207253886,0.9278966225589962,1.0,7/28,17.85%,JAK2;E2F1;ILRUN;MDFI;RSF1;SP100;SMO
prerank,organelle fusion (GO:0048284),0.3207244893373034,0.7840437245755955,0.7307692307692307,0.9277713781389748,1.0,8/22,26.41%,BAX;EEA1;MIGA2;FIS1;SPG7;AFG3L2;MFN2;MIEF2
prerank,positive regulation of telomere maintenance via telomere lengthening (GO:1904358),0.2955132766307797,0.7838952099160188,0.760759493670886,0.9275865298217563,1.0,4/35,6.96%,CCT8;ATM;PKIB;ATR
prerank,positive regulation of pathway-restricted SMAD protein phosphorylation (GO:0010862),0.28860715996751585,0.7836651133352701,0.7874396135265701,0.9275491563225078,1.0,13/45,25.37%,BMP5;TGFBR1;ACVR1;INHBB;TGFB3;ACVR2A;SDCBP;TGFB2;ACVRL1;BMP7;TGFB1;GDF9;INHBA
prerank,positive regulation of protein export from nucleus (GO:0046827),0.34636643233248254,0.7827824164388724,0.7294117647058823,0.9284596512837744,1.0,3/15,14.70%,TCF7L2;BAG3;GSK3B
prerank,positive regulation of establishment of protein localization to mitochondrion (GO:1903749),0.2812941164754041,0.7818919345242782,0.7627314814814815,0.929356481586739,1.0,18/52,22.82%,BCL2;CSNK2A2;BBC3;E2F1;UBE2L3;SAE1;TFDP1;TOMM7;FBXW7;CASP8;NPEPPS;ARIH2;SH3GLB1;MICALL2;LEPROT;YWHAE;YWHAZ;YWHAG
prerank,positive regulation of striated muscle cell differentiation (GO:0051155),0.3169796401699706,0.7816943855736038,0.7535014005602241,0.9292521588749918,1.0,1/23,0.98%,MMP14
prerank,regulation of long-term synaptic potentiation (GO:1900271),0.3143504577978211,0.7815438422615182,0.7529411764705882,0.929092919333266,1.0,6/28,15.79%,PTN;APOE;SQSTM1;EPHB2;GSK3B;ABL1
prerank,mRNA metabolic process (GO:0016071),0.2637645946499819,0.7815280788017873,0.8367567567567568,0.9287422151143557,1.0,27/90,22.32%,ZFP36L2;CELF1;SRSF2;DHX15;NONO;SLBP;METTL16;DCP2;ALKBH5;HIPK3;NCBP2;RNH1;AKAP8L;SRSF1;SON;TCERG1;CPSF3;DXO;AURKAIP1;PRPF18;HNRNPA2B1;TBRG4;LSM6;YTHDF2;DIS3L2;SF3B2;U2AF1
prerank,polyol biosynthetic process (GO:0046173),0.34202993272286863,0.7815005509408177,0.7359050445103857,0.9284034519040244,1.0,7/16,24.74%,CYP27B1;ITPKC;FGF2;CYP2R1;IP6K2;IPMK;CYP27A1
prerank,cellular protein-containing complex assembly (GO:0034622),0.25363432530194274,0.7810569505411027,0.8633540372670807,0.9286342843003619,1.0,28/159,16.88%,CLTC;TCF4;SMAD2;CHMP4B;CHMP4A;CALY;NCK2;STXBP1;PSMD4;NCK1;OMA1;COG4;BIN1;NUP153;PSMD11;TRAF2;SMAD3;HSPD1;TBCA;COX7A2L;TTC12;BBS10;CENPT;SNX9;SRP19;CHMP3;ANGPT1;PDE4DIP
prerank,chaperone-mediated protein complex assembly (GO:0051131),-0.2516811230319922,-0.7803385103303005,0.7881040892193308,0.9329659314639628,1.0,7/20,25.62%,HSP90AB1;MKKS;HOPX;TMEM35A;HSPA1A;PTGES3;PTGES3L
prerank,mononuclear cell differentiation (GO:1903131),0.31548361886596443,0.7802930729080841,0.7496671105193076,0.929343749541088,1.0,5/24,14.12%,MYH9;TREM2;BLK;PPARG;RELB
prerank,microtubule depolymerization (GO:0007019),0.329333750950209,0.7791053454783643,0.7450704225352113,0.9306605925940692,1.0,5/17,21.98%,NCKAP5;KIF2A;STMN4;CKAP5;NCKAP5L
prerank,positive regulation of macroautophagy (GO:0016239),0.2823564585261941,0.7790965535634097,0.7690504103165299,0.9302937523569808,1.0,6/48,11.01%,DCN;PIP4K2A;BAG3;RAB3GAP2;PIP4K2B;TRIM13
prerank,protein neddylation (GO:0045116),-0.2911033439134195,-0.7789947128529954,0.7603833865814696,0.9337474825899608,1.0,4/13,18.29%,DCUN1D4;RBX1;DCUN1D3;RNF7
prerank,histone mRNA metabolic process (GO:0008334),0.30916422051431874,0.7778791940288478,0.7638709677419355,0.9316519462330051,1.0,8/27,17.46%,ATM;XRN1;ERI1;SLBP;EXOSC4;DCP2;NCBP2;CPSF3
prerank,protein targeting to mitochondrion (GO:0006626),-0.2080210452086995,-0.7771637464576169,0.9172413793103448,0.9351895044286976,1.0,15/52,21.09%,IMMP2L;GRPEL2;TOMM70;DNAJC19;NDUFA13;DNAJC15;BCAP31;TIMM17B;TOMM40;SAMM50;TIMM21;TIMM8B;ROMO1;TOMM5;CHCHD4
prerank,synaptic vesicle fusion to presynaptic active zone membrane (GO:0031629),-0.30116362370490884,-0.7770676161023541,0.7388724035608308,0.9339315096901931,1.0,1/12,2.02%,SNAP25
prerank,negative regulation of hydrogen peroxide-induced cell death (GO:1903206),0.35692625675360595,0.777062479576554,0.7439198855507868,0.9324533307159434,1.0,3/13,22.31%,LRRK2;NFE2L2;PARK7
prerank,inositol phosphate-mediated signaling (GO:0048016),0.3239741876073171,0.7762962734836738,0.7473118279569892,0.9331286895056096,1.0,3/19,12.38%,EDN3;HRH1;PPP3CA
prerank,regulation of neural precursor cell proliferation (GO:2000177),0.3116766756885482,0.7761828641859818,0.7355263157894737,0.9329133350535516,1.0,4/22,10.47%,LRRK2;MDK;PTPRZ1;FZD9
prerank,negative regulation of GTPase activity (GO:0034260),-0.2455196128672385,-0.7760909507230098,0.79296875,0.9340660921919763,1.0,12/22,33.78%,RDX;RCC2;GMIP;RASA4;F11R;ARL2;SH3BP4;DAB2IP;HRAS;FZD10;FICD;CPEB2
prerank,embryonic appendage morphogenesis (GO:0035113),0.3584582038997933,0.7758613366242432,0.7414561664190193,0.9330121804384688,1.0,5/12,22.93%,SHH;LRP6;PTCH1;TGFB2;MEGF8
prerank,peptide metabolic process (GO:0006518),0.26427267039858965,0.7758318387628903,0.8278508771929824,0.9326772086523617,1.0,14/75,16.92%,DNPEP;CPXM1;ANPEP;CPQ;MGAT3;GSTT1;NLN;PCSK5;HM13;ENPEP;GSTK1;NPEPPS;PSEN1;LVRN
prerank,tRNA transport (GO:0051031),0.2949538786440761,0.7756478136984039,0.7959949937421777,0.9325713083730892,1.0,11/35,25.38%,RAE1;NUP37;NUP153;XPOT;NUP188;NUP35;NUP214;YBX1;NDC1;SEC13;NUP155
prerank,protein localization to Golgi apparatus (GO:0034067),0.307992859618629,0.7756118198635242,0.7496723460026212,0.9322562569012677,1.0,15/27,28.12%,OBSL1;VPS13C;CSNK1D;IFT20;RIPOR1;COG7;GBF1;TMED10;RAB6A;ARL5B;GAK;RAB33B;SYS1;ARL5C;ARL5A
prerank,cellular response to amino acid starvation (GO:0034198),0.2675819608893101,0.7755865238794638,0.8098434004474273,0.9319161948519933,1.0,18/71,18.85%,DAP;MIOS;NPRL2;EIF2AK3;RPTOR;ATP6V1G1;EIF2AK2;LAMTOR5;ATP6V1D;FLCN;RRAGC;ATP6V1F;TCIRG1;KPTN;ATF2;SH3GLB1;ATP6V1H;ATP6V1G2
prerank,CENP-A containing chromatin organization (GO:0061641),0.30434579054442856,0.7754455998992056,0.7666232073011734,0.9313730406096214,1.0,7/29,19.40%,CENPQ;CENPN;CENPT;RSF1;CENPL;RUVBL1;RBBP4
prerank,CENP-A containing nucleosome assembly (GO:0034080),0.30434579054442856,0.7754455998992056,0.7666232073011734,0.9313730406096214,1.0,7/29,19.40%,CENPQ;CENPN;CENPT;RSF1;CENPL;RUVBL1;RBBP4
prerank,negative regulation of translational initiation (GO:0045947),0.3462364787352986,0.7753349862882665,0.7366863905325444,0.9311524645169695,1.0,3/13,16.03%,PAIP2;FMR1;EIF4EBP1
prerank,protein targeting to peroxisome (GO:0006625),0.3031956704724226,0.7752768620532026,0.7696335078534031,0.9308592899043164,1.0,11/29,26.94%,PEX10;RAB8B;ALDH3A2;PEX19;FIS1;PEX5;ABCD2;PEX12;PEX6;HACL1;PXMP4
prerank,positive regulation of SMAD protein signal transduction (GO:0060391),0.3572180839767957,0.774929679567844,0.7406832298136646,0.930993322438929,1.0,3/13,9.37%,JAK2;TGFBR1;TGFB3
prerank,regulation of cell development (GO:0060284),0.2922304373342393,0.7744961075634775,0.7695121951219512,0.9312222756505614,1.0,8/36,20.30%,YAP1;BHLHE40;HEYL;CLOCK;HMGB2;CX3CL1;FBXO22;YTHDF2
prerank,nucleotide metabolic process (GO:0009117),-0.24158235371297207,-0.7741657440961884,0.8174273858921162,0.935629942703864,1.0,5/23,19.37%,FHIT;NMNAT3;ME1;AK1;ENPP3
prerank,nuclear transport (GO:0051169),0.3387211026796365,0.7737590767177811,0.755072463768116,0.9318867607240725,1.0,6/16,26.72%,ANP32A;NXT2;NXT1;RSRC1;XPO1;PSIP1
prerank,ER-associated misfolded protein catabolic process (GO:0071712),0.36124085132252254,0.7728115470717306,0.7518910741301059,0.9328070836230864,1.0,6/11,26.65%,UGGT2;BAG6;POMT2;AUP1;UGGT1;VCP
prerank,regulation of transcription regulatory region DNA binding (GO:2000677),-0.2325386466182737,-0.7725900037216628,0.847457627118644,0.9366615109282641,1.0,6/25,22.12%,RB1;SIN3A;HEY2;PER2;H1-0;HEY1
prerank,tRNA processing (GO:0008033),-0.1955854134461388,-0.7723074254682839,0.937007874015748,0.9356735650519202,1.0,17/61,19.64%,DTWD2;CSTF2;TRMT9B;TYW5;ELP5;RTCB;NSUN6;ADAT1;QTRT1;TRMT10A;LCMT2;TRMT10B;POP5;FAM98B;CLP1;CPSF4;THUMPD1
prerank,cardiac ventricle development (GO:0003231),-0.2572345894652801,-0.7721672230171281,0.796078431372549,0.9345149769074623,1.0,7/20,22.12%,MATR3;PDE2A;HEY2;HECTD1;TMEM65;ENG;HEY1
prerank,proteoglycan biosynthetic process (GO:0030166),0.3013518932777375,0.7721267040829705,0.7679269882659713,0.9333515524983726,1.0,6/31,15.48%,CHST13;EXT1;EXT2;CHST11;EXTL3;UGDH
prerank,histone H3-K9 demethylation (GO:0033169),0.3596551426747207,0.7720848341184067,0.7315233785822021,0.9330351014204109,1.0,4/11,24.26%,KDM4D;KDM7A;KDM3B;KDM1A
prerank,protein localization to organelle (GO:0033365),0.2501599358150854,0.7715317720688948,0.8686131386861314,0.9334248282641711,1.0,46/133,27.58%,COL1A1;LRRK2;TRAM2;SNX10;OBSL1;CD68;WDR83OS;WDR35;LAMP2;ALDH3A2;CSNK1D;ATP6V1D;BANP;TUB;TULP3;MDM2;VAPA;IFT20;FAM83H;RIPOR1;DVL1;COG7;GBF1;YBX1;DDX3X;CALR;EHD1;AUP1;YWHAE;DDRGK1;BMP7;DDX1;ZBTB7A;RAB6A;TOR1AIP1;GAK;COG3;RAB33B;RPL11;ZNF423;SYS1;CNTLN;PRNP;LAMP5;STX5;ISG15
prerank,leukocyte tethering or rolling (GO:0050901),0.33475605534827924,0.7711751046272991,0.743065693430657,0.9335294308920743,1.0,2/17,5.90%,SPN;ADD2
prerank,oligosaccharide biosynthetic process (GO:0009312),0.3191999357724603,0.7705861255194244,0.7472067039106145,0.9339825096547383,1.0,2/20,3.39%,B4GALNT2;ST3GAL3
prerank,detection of mechanical stimulus involved in sensory perception (GO:0050974),0.3446994000122476,0.7704733244463071,0.7466467958271237,0.9337643314055775,1.0,6/15,23.61%,COL11A1;PIEZO2;ADGRV1;LHFPL5;SCN1A;TMEM120A
prerank,ATP synthesis coupled proton transport (GO:0015986),0.33443338593365246,0.7694960023002742,0.7361516034985423,0.9347311422998198,1.0,6/17,24.26%,STOML2;ATP5PO;DMAC2L;ATP5MC1;ATP5F1A;ATP5MC3
prerank,negative regulation of small GTPase mediated signal transduction (GO:0051058),0.3179161867118596,0.7694572784677017,0.7602739726027398,0.9344157216504896,1.0,10/21,28.32%,CGNL1;MAPKAP1;SPRY2;EPHB2;TGFB2;MFN2;SYNGAP1;SPRY4;ARHGAP12;LZTR1
prerank,inner mitochondrial membrane organization (GO:0007007),-0.20248837724898786,-0.7694168265374833,0.8647058823529412,0.9372714464814237,1.0,22/47,30.52%,LETM1;TOMM70;ATP5MG;TMEM11;ATP5PD;NDUFA13;ATP5F1C;ATP5F1D;SAMM50;MICOS13;ATP5ME;TIMM8B;ROMO1;HSPA9;DNAJC11;UQCC3;IMMT;CHCHD3;GHITM;TIMM9;TIMM10;ATP5F1B
prerank,positive regulation of cell migration involved in sprouting angiogenesis (GO:0090050),0.3258818781144175,0.7689125849068409,0.7556818181818182,0.9348183605658109,1.0,4/18,12.01%,RHOJ;ANXA1;AKT3;FGF2
prerank,regulation of gastrulation (GO:0010470),0.3472137325613253,0.7688679742208264,0.7383040935672515,0.9345027457447974,1.0,3/14,15.32%,TENM4;PHLDB1;PHLDB2
prerank,positive regulation of cellular senescence (GO:2000774),0.3578337965589089,0.7680741998732327,0.7274119448698315,0.9352186389789442,1.0,3/10,21.65%,EEF1E1;YPEL3;CGAS
prerank,megakaryocyte differentiation (GO:0030219),-0.2995416023477944,-0.7677188140984648,0.7869822485207101,0.938350394289479,1.0,3/11,15.66%,KIT;TAL1;ZFPM1
prerank,aspartate family amino acid metabolic process (GO:0009066),0.32383477419246015,0.7676833238410655,0.765034965034965,0.935392038294192,1.0,3/18,9.85%,ASPG;MTHFR;ASNS
prerank,protein K63-linked ubiquitination (GO:0070534),0.2881129945629104,0.767546841190453,0.7829268292682927,0.9352112802289055,1.0,15/41,20.05%,TRIM21;TRIM56;RNF8;UBE2E2;TRAF2;PELI3;STUB1;TRAF3IP2;ARIH2;ITCH;UBE2S;TRIM27;TRAF5;RNF168;NEDD4
prerank,UV-damage excision repair (GO:0070914),0.3583147476251,0.7672159416784199,0.7560975609756098,0.9352954589572793,1.0,3/12,16.08%,INO80;DDB1;MC1R
prerank,positive regulation of cell junction assembly (GO:1901890),0.2699484037825993,0.7671500226164191,0.8114086146682189,0.9350225506521861,1.0,6/56,6.18%,MAP4K4;NRP1;SFRP1;EPHB3;RAC1;LIMS1
prerank,positive regulation of epidermal growth factor-activated receptor activity (GO:0045741),0.36205827082537667,0.7668665208662271,0.7380952380952381,0.9350607946075524,1.0,3/10,17.19%,EGF;FBXW7;BTC
prerank,negative regulation of homotypic cell-cell adhesion (GO:0034111),0.3699726797449529,0.766807508801424,0.7123287671232876,0.9347697451565528,1.0,2/10,11.19%,SERPINE2;ADAMTS18
prerank,negative regulation of cell projection organization (GO:0031345),0.28096776510378807,0.7665216981701053,0.7961859356376639,0.9347908444033665,1.0,6/48,10.32%,MYLIP;DPYSL3;APOE;PTEN;DENND5A;SPRY2
prerank,cellular response to topologically incorrect protein (GO:0035967),-0.22393473183151832,-0.7660228358849348,0.8577777777777778,0.9394992643392714,1.0,14/31,31.14%,PRKN;HSPA14;ERN1;ATXN3;DNAJC18;TMBIM6;HSF1;HSPA9;DAB2IP;HSPA1A;HSPB8;HSPA1B;HDAC6;HSPA2
prerank,covalent chromatin modification (GO:0016569),0.3450403351602883,0.7659562467856291,0.7582089552238805,0.9352101696860585,1.0,4/14,22.31%,HDAC1;MBD2;SIRT7;PARK7
prerank,spliceosomal tri-snRNP complex assembly (GO:0000244),0.3395689717868667,0.7655757698627788,0.7416545718432511,0.9353396082960287,1.0,6/13,26.82%,SRSF12;PRPF31;USP4;DDX20;SART3;PRPF8
prerank,nitric oxide mediated signal transduction (GO:0007263),0.33477027743213805,0.7650304329480386,0.7421203438395415,0.9357231746752975,1.0,2/16,7.23%,APOE;CD36
prerank,response to amino acid starvation (GO:1990928),0.26473882014904315,0.7650186126099912,0.8337078651685393,0.9353640994037079,1.0,18/72,18.85%,DAP;MIOS;NPRL2;EIF2AK3;RPTOR;ATP6V1G1;EIF2AK2;LAMTOR5;ATP6V1D;FLCN;RRAGC;ATP6V1F;TCIRG1;KPTN;ATF2;SH3GLB1;ATP6V1H;ATP6V1G2
prerank,positive regulation of brown fat cell differentiation (GO:0090336),-0.2823656712574456,-0.7649676552348517,0.78419452887538,0.9396227195130914,1.0,4/13,15.56%,SOX13;HNRNPU;TFE3;METRNL
prerank,negative regulation of ion transport (GO:0043271),0.31277670204187585,0.7647759007055711,0.772020725388601,0.9353366511619512,1.0,2/24,8.32%,GPM6B;PXK
prerank,regulation of response to oxidative stress (GO:1902882),-0.29549100731047595,-0.7647593459279609,0.7570621468926554,0.9385370904439526,1.0,3/11,9.01%,PRKN;MCTP1;PINK1
prerank,pulmonary valve morphogenesis (GO:0003184),0.33048655919698283,0.7646793080855765,0.7558945908460472,0.9350896445605537,1.0,6/17,20.07%,ROBO2;JAG1;HEYL;STRA6;ROBO1;TGFB2
prerank,icosanoid secretion (GO:0032309),0.3568116647223057,0.7645054299419922,0.7511664074650077,0.9349572810071943,1.0,3/12,12.37%,PLA2G5;ANXA1;DRD3
prerank,pyrimidine nucleoside biosynthetic process (GO:0046134),0.3586215845422197,0.7640749267431017,0.7359307359307359,0.9351837532366386,1.0,6/12,29.24%,UCKL1;TK1;TK2;DCK;UMPS;UPP2
prerank,response to thyroid hormone (GO:0097066),0.3531379732407334,0.7637389096214867,0.7668711656441718,0.9352630164017409,1.0,5/13,23.47%,CTSS;CTSB;CTSL;CTSH;BRD8
prerank,ion transport (GO:0006811),0.2545804089426301,0.7635344716922703,0.8688352570828961,0.935176874144085,1.0,16/111,12.85%,SLC1A3;SLC15A3;SLC9A1;SLC24A5;VDAC2;SLC12A4;PIEZO2;GLRB;TRPC6;SLC20A1;LASP1;LRRC8A;SLC36A2;SLC9A8;SLC17A5;SLC15A1
prerank,renal water homeostasis (GO:0003091),0.3099992585996399,0.7633641639701425,0.766042780748663,0.9350312187770756,1.0,3/23,9.25%,ADCY7;ADCY2;PRKAR1B
prerank,mRNA transport (GO:0051028),0.2557510945748457,0.7629539171481665,0.8560687432867884,0.935214470312606,1.0,21/101,19.73%,ZFP36L1;RAE1;SMG7;NUP37;SRSF2;NUP153;NUP188;SLBP;FMR1;AGFG1;ALKBH5;SMG6;NUP35;NCBP2;NXT1;NUP214;SRSF1;CPSF3;KIF5C;THOC3;HNRNPA2B1
prerank,atrial septum development (GO:0003283),-0.2827863943197352,-0.7629478325674607,0.7667638483965015,0.9398963320027461,1.0,10/13,43.04%,ANK2;HEY2;ZFPM1;NOTCH2;GJA5;TBX20;DAND5;GATA4;MDM4;ISL1
prerank,endocardial cushion development (GO:0003197),-0.24260374942930948,-0.7628498944569607,0.8106995884773662,0.938673414818905,1.0,2/21,1.71%,BMP4;NOS3
prerank,peptidyl-serine dephosphorylation (GO:0070262),0.3385577115068469,0.7628147612162023,0.7530487804878049,0.9350207987099778,1.0,3/14,12.38%,NCK1;PPP2R2A;PPP3CA
prerank,peptidyl-proline modification (GO:0018208),-0.2391441570020448,-0.7625514962539355,0.8492063492063492,0.9377272248629379,1.0,10/25,26.25%,FKBP5;PPIG;PPIL3;PPIL2;PPWD1;P3H2;PPIA;CWC27;PPIE;FKBP1A
prerank,sensory perception (GO:0007600),0.27783595073283285,0.7624327767354421,0.7935943060498221,0.9351627410187369,1.0,6/45,13.55%,PTGES;GNAS;MYO7A;ADGRV1;TMEM150C;CCL2
prerank,organonitrogen compound biosynthetic process (GO:1901566),0.24812465202353753,0.7622390936536421,0.8791322314049587,0.9350715120072749,1.0,21/151,13.01%,TNIP1;B4GALT5;PAM;CERS6;APOE;TYW1;PRKD2;CSNK2A2;MGST1;CEPT1;AKR1A1;HACD2;ASL;MOCS1;SGPL1;SPTSSA;CERS2;ELOVL6;GSTT1;PCSK5;ALDH3A2
prerank,positive regulation of leukocyte degranulation (GO:0043302),0.3500515745121163,0.7619715935833029,0.7488789237668162,0.9350532591100199,1.0,1/13,2.70%,GAB2
prerank,pentose-phosphate shunt (GO:0006098),-0.30067051218245167,-0.7614765119735287,0.7873563218390804,0.9379472372105631,1.0,5/11,18.61%,DERA;RBKS;SHPK;PGM2;PGLS
prerank,vesicle organization (GO:0016050),0.27779676947433674,0.761241943256688,0.8046511627906977,0.9356921183820737,1.0,10/46,11.31%,DNAJC13;ARFGEF2;SNX10;HOOK2;WASHC4;SNX33;DNM1;SQSTM1;PI4K2B;ALS2
prerank,anterograde trans-synaptic signaling (GO:0098916),0.24210894634464009,0.7606770226920357,0.9120323559150657,0.9360801906431744,1.0,18/224,9.25%,CEL;SLC1A3;CACNA1A;GPR176;PCDHB6;SLC6A2;PDE7B;PCDHB16;CACNB1;HTR1D;SLC12A4;SYT10;GLRB;HRH4;PMP22;EXOC4;HRH1;PRKAR1B
prerank,protein targeting (GO:0006605),0.2486451257609538,0.7603815437757518,0.8571428571428571,0.9361238017326001,1.0,26/118,20.82%,LTBP2;AP4M1;TRAK1;ATG3;FBXO7;SEC63;ZDHHC3;LAMP2;EDEM1;TOMM7;SDCBP;KIF13B;CDC37;RTP4;CACNG3;ZDHHC9;TIMM13;VPS37C;PEX19;FIS1;TIMM23;AIP;ZDHHC6;TIMM17A;SEC61A1;GIPC1
prerank,alanine transport (GO:0032328),0.3636531846573148,0.7602239012686068,0.753125,0.935977883415577,1.0,2/10,11.80%,SLC38A3;SLC36A2
prerank,intestinal absorption (GO:0050892),0.3446834500092685,0.7600896459284547,0.7557471264367817,0.9357845219785833,1.0,2/13,7.23%,UGCG;CD36
prerank,outer dynein arm assembly (GO:0036158),0.3396093311032647,0.7599209300623259,0.7626865671641792,0.9356360083774149,1.0,4/14,22.36%,DNAAF4;ODAD1;DNAAF5;DNAL1
prerank,"DNA-templated transcription, termination (GO:0006353)",0.26119653125494285,0.7597524167655054,0.841324200913242,0.9354928919874038,1.0,20/68,23.08%,TAF1D;SMN1;POLR1E;CSTF1;TTF2;CDK7;SETX;SLBP;POLR2K;GTF2H1;PRMT5;NCBP2;CCNH;POLR3K;CPSF3;CSTF2T;POLR1B;FIP1L1;TBP;POLR2L
prerank,TOR signaling (GO:0031929),0.3029111683828628,0.7596352400021855,0.7809278350515464,0.9352841163505128,1.0,7/26,16.03%,MAPKAP1;RPTOR;RICTOR;RPS6KB1;FNIP1;FLCN;EIF4EBP1
prerank,aminoglycan metabolic process (GO:0006022),0.3681064251931653,0.7595649330052472,0.7708006279434851,0.935009759078144,1.0,1/10,4.72%,CLN6
prerank,regulation of release of cytochrome c from mitochondria (GO:0090199),-0.20813578304530383,-0.7594302094260384,0.8757062146892656,0.9395098984745254,1.0,8/40,15.12%,PRKN;TNFSF10;BCL2L1;PINK1;BNIP3;TP53;BID;GPER1
prerank,calcium import into the mitochondrion (GO:0036444),-0.31286648393683963,-0.7593218664711716,0.775623268698061,0.9382920590642199,1.0,4/10,19.20%,MCUB;MICU1;MCU;SMDT1
prerank,regulation of microtubule polymerization or depolymerization (GO:0031110),0.2965199993776912,0.7586301267102274,0.7681347150259067,0.9359295359910087,1.0,7/28,18.91%,MAP1S;CAMSAP2;MAPRE2;STMN4;ABL1;GBA2;CAMSAP1
prerank,phosphatidic acid metabolic process (GO:0046473),0.2745123226714308,0.7579410545143057,0.8011904761904762,0.9365180891322594,1.0,13/48,23.71%,PLA2G5;PLD1;DDHD2;DGKH;PLA2G12A;GPD1;GPAM;AGPAT5;GPAT3;ABHD8;PLA2G4A;AGPAT1;LCLAT1
prerank,regulation of glycolytic process (GO:0006110),0.2650951122155511,0.7577196091682521,0.8306997742663657,0.9364576009254395,1.0,21/68,24.29%,RAE1;ARNT;OGT;SLC4A4;NUP37;PFKFB4;ZBTB20;NUP153;NUP188;NUP35;NUP214;GCK;PSEN1;P2RX7;PRXL2C;IGF1;ZBTB7A;NDC1;PGAM1;SEC13;NUPR1
prerank,negative regulation of receptor signaling pathway via JAK-STAT (GO:0046426),0.3293895357629534,0.756711152876565,0.7727930535455861,0.937464461979217,1.0,5/16,17.61%,BCL3;NF2;PTPN2;PARP14;HGS
prerank,nucleic acid phosphodiester bond hydrolysis (GO:0090305),0.2596176778412041,0.7567030601843256,0.8452115812917594,0.9371095883352543,1.0,9/72,14.38%,ENPP1;DNA2;FBH1;EDC4;RNASE1;DDB1;DICER1;SETMAR;GTF2H1
prerank,"retrograde protein transport, ER to cytosol (GO:0030970)",0.32621127724108084,0.7563370646080368,0.7831149927219796,0.9372108922688467,1.0,8/17,31.47%,HM13;SELENOS;SYVN1;AUP1;RHBDD1;VCP;DERL2;HSP90B1
prerank,intracellular estrogen receptor signaling pathway (GO:0030520),0.3272342033103431,0.7559600687696677,0.773109243697479,0.937353803185299,1.0,5/16,18.75%,DDX17;PADI2;RBFOX2;TADA3;SAFB
prerank,histone monoubiquitination (GO:0010390),0.3045175209594454,0.7552474500655816,0.7726675427069645,0.9379464783848571,1.0,11/24,26.85%,RNF2;DDB1;SKP1;UBE2E1;RNF40;CDC73;RNF168;DTX3L;PCGF1;RYBP;CUL4B
prerank,cell morphogenesis involved in neuron differentiation (GO:0048667),0.26007701285319385,0.7544741420461207,0.8453837597330367,0.9385957094959293,1.0,18/75,19.65%,SLITRK6;FARP1;CDHR1;BAIAP2;OPHN1;MAP1S;RAB10;LLGL1;SDC2;ATL1;S100A6;NEFH;BRSK2;RAB8A;DVL1;CDK5;SPTBN4;BRSK1
prerank,tRNA wobble base modification (GO:0002097),-0.27445783181985395,-0.7540671051822082,0.8213256484149856,0.9443794023214941,1.0,2/14,4.31%,TRMT9B;ALKBH8
prerank,vitamin D metabolic process (GO:0042359),0.34347642453714444,0.753957749663731,0.7563909774436091,0.9389145648960926,1.0,3/13,17.66%,CYP27B1;CYP1A1;CYP2R1
prerank,acetyl-CoA metabolic process (GO:0006084),-0.2670557605108263,-0.7534323938701438,0.8299319727891157,0.9438706156412027,1.0,8/15,29.09%,HMGCS2;ACLY;ACSS1;PPCS;HMGCS1;DIP2A;ACACB;MVD
prerank,cardiac cell development (GO:0055006),0.3528829649473658,0.753032593187361,0.7585669781931464,0.939767375897162,1.0,1/11,3.90%,JAG1
prerank,regulation of alcohol biosynthetic process (GO:1902930),0.3419110591663988,0.7528926280888916,0.7595129375951294,0.9395866674129894,1.0,7/12,29.17%,ABCA2;KPNB1;H6PD;LPCAT3;SREBF1;SEC14L2;MBTPS1
prerank,telomere maintenance via telomerase (GO:0007004),0.298256476847629,0.7527765020483345,0.7902813299232737,0.9393887383971394,1.0,8/28,23.85%,TNKS1BP1;PINX1;NHP2;TERT;TELO2;TERF2IP;WRAP53;RFC1
prerank,"energy coupled proton transport, down electrochemical gradient (GO:0015985)",-0.31070304395752807,-0.751654266431902,0.7864864864864864,0.9449473130583579,1.0,4/10,12.78%,ATP5MG;ATP5PD;ATP5F1C;ATP5F1D
prerank,sphingolipid catabolic process (GO:0030149),-0.266647067287915,-0.7507786143989197,0.8317757009345794,0.944783993545454,1.0,5/15,19.25%,ACER2;ASAH1;ASAH2;SMPDL3A;SPHK1
prerank,positive regulation of epidermal cell differentiation (GO:0045606),0.33601001536217145,0.750496962119595,0.7708333333333334,0.9419884135977911,1.0,2/15,6.76%,SFRP4;CYP27B1
prerank,regulation of chromosome segregation (GO:0051983),0.33291679312477884,0.7504356446718881,0.7752808988764045,0.9416993247454992,1.0,5/16,27.98%,CSNK2A2;PUM1;CSNK2A1;NUMA1;CDC6
prerank,"RNA phosphodiester bond hydrolysis, endonucleolytic (GO:0090502)",0.3349337841967996,0.7504098360836423,0.7514367816091954,0.9413636797061146,1.0,6/15,28.99%,DICER1;POP1;RNASEH1;LACTB2;NYNRIN;ZC3H12A
prerank,response to UV (GO:0009411),0.25343520003078807,0.7499570390193842,0.8655282817502669,0.9415874527994323,1.0,19/95,20.05%,BCL3;USF1;MFAP4;INO80;CDKN2D;ATR;EGFR;CREBBP;NOC2L;FMR1;CCAR2;USP47;CDC25A;YY1;MC1R;TMEM161A;BRSK1;PARP1;NEDD4
prerank,negative regulation of response to wounding (GO:1903035),0.31565787169295545,0.7491217792230809,0.7750677506775068,0.9423175997150727,1.0,4/19,12.01%,CASK;MDK;CERS2;FGF2
prerank,positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway (GO:1900740),0.3080851596402118,0.7490287266057998,0.7761194029850746,0.9417052627089385,1.0,8/23,22.82%,BCL2;BBC3;E2F1;TFDP1;CASP8;YWHAE;YWHAZ;YWHAG
prerank,regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway (GO:1900739),0.3080851596402118,0.7490287266057998,0.7761194029850746,0.9417052627089385,1.0,8/23,22.82%,BCL2;BBC3;E2F1;TFDP1;CASP8;YWHAE;YWHAZ;YWHAG
prerank,protein destabilization (GO:0031648),0.29159748570588645,0.747925112859566,0.7971758664955071,0.9428221247453841,1.0,11/32,23.13%,SERF1A;CREBBP;TRIM21;PLK1;RAD23A;FBXW11;MDM2;CDC73;CTSH;NR1D1;HTT
prerank,phosphatidylinositol metabolic process (GO:0046488),0.2453320132362737,0.747783990680986,0.8891257995735607,0.9426389171285929,1.0,26/109,20.59%,PDGFRB;PLA2G5;PIGW;PIP4K2A;PTEN;PTPN13;PIP5K1B;PIK3R1;FIG4;PI4K2B;PIP4K2B;PIK3R5;SACM1L;FGF2;PI4KA;PIK3C3;PIK3R4;RUFY1;PLA2G12A;PIP5K1A;SYNJ2;PLCB3;ARF1;MTMR1;PLA2G4A;MTM1
prerank,positive regulation of hemostasis (GO:1900048),0.3586103196645495,0.7477740784122253,0.7858267716535433,0.9419151165270031,1.0,2/10,9.14%,APOH;HPSE
prerank,positive regulation of coagulation (GO:0050820),0.3586103196645495,0.7477740784122253,0.7858267716535433,0.9419151165270031,1.0,2/10,9.14%,APOH;HPSE
prerank,positive regulation of phosphatase activity (GO:0010922),0.30899491018734493,0.7475423963597387,0.8016085790884718,0.9418775565770008,1.0,8/21,27.55%,PDGFRB;CALM3;CALM2;ITGA1;GPLD1;MTMR9;PTPA;PLEK
prerank,gastrulation (GO:0007369),0.33027790185174744,0.7474524663618776,0.7768115942028986,0.9416247012832312,1.0,5/15,24.09%,SMAD2;NPHP3;UGDH;MEGF8;LRP5
prerank,positive regulation of cellular protein localization (GO:1903829),0.25773689486848883,0.7472251526550626,0.8530751708428246,0.941562386597547,1.0,12/69,15.60%,YAP1;CENPQ;GNL3;EIF2AK3;TM9SF4;ENTR1;SNX33;PLK1;WWTR1;LAMTOR5;GSK3B;TNF
prerank,lipid biosynthetic process (GO:0008610),0.25798063273265914,0.7465019142864463,0.8509249183895539,0.9421524149227838,1.0,11/77,16.55%,LIPC;PAM;LPL;MVK;XBP1;SCD5;HSD17B8;FADS1;NDUFAB1;GPAM;PIP5K1A
prerank,ventricular cardiac muscle tissue development (GO:0003229),0.305912866930313,0.7461475928192037,0.7783857729138167,0.9422592730706453,1.0,4/23,13.51%,TNNI3;TNNC1;ADAMTS9;TPM1
prerank,intracellular pH reduction (GO:0051452),-0.21718434107279544,-0.7459829648281326,0.8405797101449275,0.9500245422658264,1.0,8/33,16.58%,GPR89B;GPR89A;CLCN3;DMXL2;ATP6V1A;ATP6V0D1;ATP6V0B;ATP6V1E1
prerank,aggrephagy (GO:0035973),0.29993263170965057,0.745350163520546,0.7889908256880734,0.9429255815718851,1.0,5/27,8.94%,DYNLL1;DYNC1H1;UBQLN1;SQSTM1;IFT88
prerank,B cell homeostasis (GO:0001782),0.3601604219228484,0.745304867205543,0.7647951441578149,0.9426114661446993,1.0,1/10,1.91%,TNFAIP3
prerank,neuronal action potential (GO:0019228),-0.24222844269062818,-0.7447213807263534,0.8391608391608392,0.9503609562370132,1.0,5/22,15.40%,SCN2A;SCN8A;SCN3A;GPER1;SCN9A
prerank,fatty acid beta-oxidation using acyl-CoA dehydrogenase (GO:0033539),0.36340583985946195,0.7442857153984305,0.7749603803486529,0.9436177881963203,1.0,1/10,3.19%,ETFA
prerank,"base-excision repair, gap-filling (GO:0006287)",0.28184998768784014,0.7442017533298644,0.8107098381070984,0.9433661463699698,1.0,2/35,3.11%,MPG;LIG1
prerank,sprouting angiogenesis (GO:0002040),0.26553429835211156,0.7440232881137872,0.839766081871345,0.9432264328983657,1.0,13/51,19.18%,CCBE1;NRP1;EGR3;MIA3;PARVA;SEMA3E;E2F8;FGF2;ITGB1BP1;ANGPT1;ROBO1;RNF213;VEGFC
prerank,motor neuron axon guidance (GO:0008045),0.3224352437539597,0.7427077064649339,0.7833572453371592,0.9445576033344273,1.0,2/15,6.18%,SLIT1;RAC1
prerank,positive regulation of reactive oxygen species biosynthetic process (GO:1903428),-0.28327943348869145,-0.7420097200116721,0.7976190476190477,0.9526561810632778,1.0,2/12,6.67%,RAB27A;TLR4
prerank,cognition (GO:0050890),0.27782003539737954,0.7415905734979876,0.8317307692307693,0.9456116260317511,1.0,11/42,19.11%,CHD7;METTL23;NIPBL;NF1;HOXA1;MGAT3;SOBP;STRA6;TNF;HRH3;TUSC3
prerank,alpha-amino acid metabolic process (GO:1901605),0.2714893610985789,0.7404628433125038,0.8237367802585194,0.9466768303397892,1.0,5/45,11.46%,ALDH18A1;ASPG;MTHFR;ASNS;KYAT1
prerank,smooth muscle contraction (GO:0006939),0.33027906826638526,0.7403727700039565,0.788235294117647,0.94641769191961,1.0,4/14,20.09%,EDNRA;MYLK;ROCK2;TPCN2
prerank,import into nucleus (GO:0051170),0.25505082516981675,0.7402931761995469,0.8513966480446927,0.9461571558216826,1.0,15/73,15.96%,SMN1;MMP12;STAT3;E2F3;TNPO1;FAM53B;NUP153;NUP188;PRICKLE1;BACH2;HTATIP2;KPNB1;NXT2;NXT1;NUP214
prerank,positive regulation of insulin secretion (GO:0032024),0.2749524502462023,0.7401478452796268,0.8260309278350515,0.9459695387603343,1.0,4/36,9.15%,TCF7L2;BLK;ACSL4;LRRC8A
prerank,response to light stimulus (GO:0009416),-0.1905401604100242,-0.7399278226112455,0.9477611940298507,0.9539539677948939,1.0,20/55,26.53%,ERCC5;ERCC3;ERCC6;GTF2H2;UVSSA;TRIM32;DRD2;MAPK10;UBE2B;CIRBP;PRIMPOL;CRY2;MEN1;DDB2;UBE2A;OPN3;SPRTN;PCLAF;MAPK8;MAP4K3
prerank,glycerophospholipid biosynthetic process (GO:0046474),0.23405365898715663,0.7398468329348674,0.9174311926605505,0.9459997339608462,1.0,39/172,20.59%,PLA2G5;CPNE7;PLD1;PIP4K2A;CSNK2A2;PTEN;PTPN13;PIP5K1B;CEPT1;PIK3R1;FIG4;PI4K2B;PIP4K2B;PIK3R5;SACM1L;FGF2;DDHD2;CRLS1;PI4KA;PIK3C3;PIK3R4;RUFY1;DGKH;PGS1;PTDSS2;PLA2G12A;GPD1;GPAM;PIP5K1A;SYNJ2;AGPAT5;CSNK2A1;GPAT3;CLN3;ARF1;ABHD8;MTMR1;PLA2G4A;MTM1
prerank,response to muramyl dipeptide (GO:0032495),0.3390945807502451,0.7398140140467158,0.7860326894502229,0.9456761846433203,1.0,2/12,9.88%,NOD1;ERBIN
prerank,negative regulation of release of cytochrome c from mitochondria (GO:0090201),-0.2669781141801344,-0.7395010335508814,0.863905325443787,0.9531356810625132,1.0,2/15,4.39%,PRKN;BCL2L1
prerank,long-chain fatty-acyl-CoA biosynthetic process (GO:0035338),0.31754854161800483,0.7394689613074658,0.7883211678832117,0.9457587494640366,1.0,5/18,15.07%,HACD2;ACSL4;HSD17B12;ELOVL6;ELOVL1
prerank,calcium ion transmembrane import into cytosol (GO:0097553),0.2751207974483239,0.7394038549771724,0.8221153846153846,0.9454802236439054,1.0,7/41,13.46%,ITPR1;XCL1;CACNA2D1;PKD2;IBTK;FGF2;GRIN2A
prerank,signal transduction by p53 class mediator (GO:0072331),0.2820627100241549,0.7392823113357164,0.8089330024813896,0.9452756859480651,1.0,2/30,4.15%,BCL3;BATF
prerank,photoreceptor cell development (GO:0042461),0.334832192270476,0.7391754892706175,0.7976710334788938,0.9450374242243363,1.0,2/14,10.27%,CDHR1;MYO7A
prerank,regulation of SMAD protein signal transduction (GO:0060390),0.30397018640897133,0.7390539925090579,0.8,0.9448284345353113,1.0,4/21,11.29%,JAK2;TGFBR1;TGFB3;WWTR1
prerank,cellular response to cAMP (GO:0071320),0.29163226101905937,0.7389330315280762,0.8280657395701644,0.9446172166331314,1.0,3/30,4.71%,ZFP36L1;IGFBP5;PKD2
prerank,"negative regulation of mRNA splicing, via spliceosome (GO:0048025)",0.3365811380928199,0.7384913905279138,0.7807017543859649,0.9448102878232492,1.0,5/14,24.64%,SRSF12;SAP18;SFSWAP;RBMX;PCBP4
prerank,protein glycosylation (GO:0006486),0.24327138126007344,0.7383817018772547,0.879746835443038,0.944583320175527,1.0,26/125,19.95%,MGAT5;B4GALT5;ALG5;PLOD2;ST3GAL3;TRAK1;OGT;GFPT2;DDOST;MAN1C1;B3GALNT1;TMEM258;GCNT2;MGAT3;STT3A;ALG6;POMT2;TET2;ST3GAL2;ST3GAL1;PLOD1;ALG8;TUSC3;MGAT4A;COG7;C1GALT1C1
prerank,regulation of epithelial cell migration (GO:0010632),0.26746619924068166,0.7382907379820346,0.8311840562719812,0.9443243023401798,1.0,16/51,24.33%,PTN;RHOJ;DOCK1;SASH1;PTK2;PTPN23;ARSB;CTSH;TGFB2;CORO1C;EMP2;SRC;INSL3;PFN2;CLASP2;BMPER
prerank,transcription initiation from RNA polymerase I promoter (GO:0006361),0.2833917752537696,0.7375295461748109,0.7908163265306123,0.944889502998187,1.0,10/32,24.23%,TAF1D;POLR1E;CDK7;POLR2K;GTF2H1;CCNH;POLR1B;TBP;POLR2L;TAF1A
prerank,ketone body metabolic process (GO:1902224),-0.2971820849310149,-0.7370950748594913,0.7869318181818182,0.9548252642221433,1.0,2/10,9.80%,HMGCS2;HMGCL
prerank,protein exit from endoplasmic reticulum (GO:0032527),0.29613500530942327,0.7369677456249226,0.8086838534599728,0.9452177317744863,1.0,11/23,32.62%,SEC16A;LMAN1;SELENOS;SYVN1;AUP1;SEC13;VCP;RANGRF;DERL2;HSP90B1;SURF4
prerank,positive regulation of DNA binding (GO:0043388),0.28606835350701026,0.7359624612368928,0.8094059405940595,0.9461266848231173,1.0,9/31,23.69%,EGF;PINX1;PPARG;SIRT2;HMGB2;IGF1;PARK7;TWIST1;TGFB1
prerank,cell junction maintenance (GO:0034331),0.32933380102947524,0.7355701903048317,0.7847730600292826,0.9462694703365419,1.0,1/14,3.46%,PRTN3
prerank,positive regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903800),-0.2894394825167295,-0.7353932806783658,0.7840909090909091,0.9556708485959541,1.0,3/11,12.58%,BMP4;DDX5;TP53
prerank,protein hydroxylation (GO:0018126),0.32241209055397063,0.7352273561735618,0.7880986937590712,0.946345039398602,1.0,1/15,1.96%,PLOD2
prerank,long-term memory (GO:0007616),0.31621760581278013,0.7351936352437669,0.7898448519040903,0.9460188610561169,1.0,2/19,3.70%,APOE;NPAS4
prerank,regulation of proteolysis involved in cellular protein catabolic process (GO:1903050),0.30178398809761214,0.7343644932014883,0.8184210526315789,0.946685660429956,1.0,8/24,24.60%,DNAAF4;APOE;USP14;PSMD14;CTSC;RHBDF1;PSME2;ATP5IF1
prerank,Rap protein signal transduction (GO:0032486),-0.2938472784324113,-0.7337564250522519,0.8143712574850299,0.9564868930036808,1.0,3/10,13.56%,RAPGEF3;RAPGEF2;RAP1A
prerank,regulation of posttranscriptional gene silencing (GO:0060147),0.2661438804186614,0.7330649492696046,0.8486612339930152,0.9475590060897443,1.0,10/50,15.96%,RAE1;NUP37;NUP153;PUM1;NUP188;FMR1;POLR2K;NUP35;POLR2B;NUP214
prerank,regulation of gene silencing by RNA (GO:0060966),0.2661438804186614,0.7330649492696046,0.8486612339930152,0.9475590060897443,1.0,10/50,15.96%,RAE1;NUP37;NUP153;PUM1;NUP188;FMR1;POLR2K;NUP35;POLR2B;NUP214
prerank,positive regulation of ERBB signaling pathway (GO:1901186),-0.22793308162657758,-0.7329029412874871,0.8937007874015748,0.9562833614875587,1.0,6/25,15.12%,AFAP1L2;HIP1R;HIP1;BCAR3;CCDC88A;GPER1
prerank,regulation of protein binding (GO:0043393),0.2451463726031236,0.732865503327018,0.8928950159066809,0.9474532138919256,1.0,29/114,22.58%,LRP1;TCF7L2;VTN;LRRK2;ADD2;TRIM21;DISC1;PLK1;BAX;NMD3;DDX11;HDAC5;EFHB;TERT;ITGB1BP1;GSK3B;CTNNBIP1;PSEN1;TLE5;TRIB3;DVL1;STK4;SPPL3;GTF2F1;DTX3L;DACT1;PARK7;CTSZ;CARD16
prerank,mRNA catabolic process (GO:0006402),0.26754552171695545,0.7322096045653838,0.8423529411764706,0.947871230202532,1.0,14/44,24.46%,ZFP36L2;DHX34;XRN1;METTL16;EXOSC4;DCP2;THRAP3;RNH1;DXO;LSM6;YTHDF2;DIS3L2;TUT7;NBDY
prerank,organic hydroxy compound biosynthetic process (GO:1901617),0.26744708908176257,0.7320762927011237,0.8335315101070154,0.9476620405926868,1.0,2/44,4.75%,CYP7B1;INSIG2
prerank,negative regulation of neuron projection development (GO:0010977),0.26246061840413304,0.731955909781801,0.8522860492379836,0.947455386923586,1.0,19/56,26.84%,MYLIP;DPYSL3;APOE;PTEN;DENND5A;THY1;LPAR1;RHOA;PTPN9;SEMA3A;RTN4RL1;EFNB2;LRP4;PTPRS;GAK;RUFY3;STX1B;ARHGDIA;CBFA2T2
prerank,meiosis I (GO:0007127),0.30444038426261066,0.7319316486226981,0.8090787716955942,0.947119496125714,1.0,3/23,14.06%,MYBL1;FOXJ3;SYCP3
prerank,regulation of TORC1 signaling (GO:1903432),0.27989296650386425,0.7317721616205536,0.8487179487179487,0.9469444583078664,1.0,12/33,23.45%,KLHL22;ATM;LAMTOR5;FLCN;RRAGC;KPTN;SMCR8;TELO2;STK11;SIK3;CLEC16A;GPR137
prerank,pyrimidine nucleoside metabolic process (GO:0006213),-0.2657232894132837,-0.7316215796094678,0.8215488215488216,0.9565181385832012,1.0,5/14,21.31%,NT5E;UPB1;NT5C;DHODH;ERH
prerank,regulation of TOR signaling (GO:0032006),0.2565992334703716,0.7313774184679575,0.8537414965986394,0.947075596288342,1.0,16/67,19.21%,MIOS;TREM2;NPRL2;RPTOR;TBC1D7;RICTOR;HDAC3;FNIP1;LAMTOR5;ARAF;FLCN;RRAGC;TTI1;SMCR8;GPAT3;TELO2
prerank,cellular response to unfolded protein (GO:0034620),-0.22083672126676177,-0.7313370181904549,0.864406779661017,0.9554872233489662,1.0,11/26,28.83%,PRKN;HSPA14;ERN1;ABCB10;TMBIM6;HSF1;HSPA9;DAB2IP;HSPA1A;HSPB8;HSPA1B
prerank,eye photoreceptor cell development (GO:0042462),-0.26180411123347724,-0.7305164613458968,0.8253012048192772,0.9550716015004546,1.0,5/15,21.93%,RP1;BBS4;RORB;TULP1;RPGRIP1L
prerank,positive regulation of protein acetylation (GO:1901985),0.336694560089915,0.7302412650373361,0.7901049475262368,0.9481271723051654,1.0,2/12,9.58%,TAOK1;FAM161A
prerank,regulation of biosynthetic process (GO:0009889),0.33783190006904795,0.7301673584212255,0.7928902627511591,0.9478634472080666,1.0,11/11,66.24%,SPHK2;CCN6;SLC25A33;PIKFYVE;PCK1;UCP1;SNCA;GSTP1;THRSP;ALOX5;MID1IP1
prerank,positive regulation of release of cytochrome c from mitochondria (GO:0090200),-0.2194281300066448,-0.7296094230559657,0.8888888888888888,0.9549263687115256,1.0,6/25,15.12%,TNFSF10;PINK1;BNIP3;TP53;BID;GPER1
prerank,posttranscriptional regulation of gene expression (GO:0010608),0.2631613668324624,0.729331802836615,0.8779620853080569,0.9485213368890638,1.0,14/45,25.85%,ATXN2;RBM4B;PUM1;GCNT2;METTL16;METAP1;ATG14;PUM3;FOXO3;NOLC1;RBM3;CYFIP1;ZC3H7B;GEMIN5
prerank,negative regulation of oxidative stress-induced cell death (GO:1903202),-0.2241882767323203,-0.7293106917373051,0.908256880733945,0.9539033971889125,1.0,8/26,19.45%,PRKN;HSPB1;PINK1;NME5;SIRT1;HTRA2;MAPK7;PPIA
prerank,regulation of dendrite development (GO:0050773),0.2784584753140967,0.7290320232468127,0.8412121212121212,0.9485336253727028,1.0,7/37,10.01%,PTN;RAP2A;MARK1;DBN1;BMP5;CAMSAP2;SDC2
prerank,"positive regulation of CD4-positive, alpha-beta T cell activation (GO:2000516)",0.35338402651269296,0.7289732001997437,0.7943485086342229,0.9482420278932898,1.0,2/10,8.51%,XCL1;LGALS9
prerank,hydrogen peroxide catabolic process (GO:0042744),0.34574042255421844,0.7288493853781839,0.8116385911179173,0.9480252130874733,1.0,2/11,14.09%,PXDN;PRDX5
prerank,negative regulation of protein modification process (GO:0031400),0.2480123256366445,0.7288160550323346,0.879424778761062,0.9476981483435855,1.0,30/79,26.15%,FBLN1;LRRK2;PID1;PTEN;PTPN13;ZBED3;IBTK;WWTR1;SIRPA;EPHB2;LRP6;GSK3B;TPPP;NTRK3;NIBAN1;ATG14;PLPP3;CORO1C;CDK5RAP3;TERF2IP;PRKDC;PARK7;XRCC1;XDH;TGFB1;FKBP8;PNKP;CDYL;PTPA;WARS1
prerank,cytoplasmic microtubule organization (GO:0031122),0.2613446884840618,0.728421468768069,0.8433179723502304,0.9478270196243758,1.0,18/54,26.40%,FSD1;DYNC1H1;CAMSAP2;HOOK2;PCM1;CLIP3;KPNB1;TPPP;RHOA;TUBGCP4;CEP126;CAMSAP1;HOOK3;FIGN;FIGNL2;NUMA1;CCDC88B;VPS4B
prerank,positive regulation of protein catabolic process (GO:0045732),0.24757976444026236,0.7279013711770249,0.88,0.9480948887672755,1.0,31/84,27.61%,TNFAIP3;WNT5A;APOE;SMURF2;RAB7A;OAZ3;SNX33;AREL1;DDB1;FZR1;MSN;SMURF1;GSK3B;TNF;SNX9;ITCH;CSNK2A1;NEDD4;NRDC;DACT1;ASB5;ATG7;GPLD1;NKD1;ADAM9;CDKN1B;FOXO1;VCP;SNF8;STX5;FURIN
prerank,photoperiodism (GO:0009648),0.28727918970441063,0.7271469847724799,0.8197747183979975,0.948695390331121,1.0,8/28,24.94%,RBM4B;BHLHE40;CRTC1;CLOCK;PPP1CB;FBXL12;PPP1CC;FBXL22
prerank,regulation of transcription elongation from RNA polymerase II promoter (GO:0034243),0.29029818707363647,0.7266077262372465,0.7937743190661478,0.9489950093918972,1.0,8/25,20.02%,EAPP;HEXIM1;BRD4;RNF8;CDK13;TCERG1;CDC73;RNF168
prerank,serine family amino acid metabolic process (GO:0009069),-0.25658489405180684,-0.7264560203750705,0.8523076923076923,0.9560522040683934,1.0,7/16,39.78%,CBS;GCLC;SEPHS2;CTH;SHMT1;GLYAT;DAO
prerank,protein insertion into mitochondrial inner membrane (GO:0045039),-0.2857675264440414,-0.7264433281831169,0.8267045454545454,0.9547101428578771,1.0,8/11,37.97%,TOMM70;NDUFA13;TIMM8B;ROMO1;TIMM9;TIMM10;AGK;TIMM22
prerank,immunoglobulin mediated immune response (GO:0016064),-0.2954339503218868,-0.7263038217825311,0.8217270194986073,0.9534993500496367,1.0,1/10,1.96%,CD81
prerank,positive regulation of intrinsic apoptotic signaling pathway (GO:2001244),0.27120640266781193,0.7261383298442743,0.8247162673392182,0.9491979701043763,1.0,5/37,8.44%,BCL2;FBH1;BBC3;BAX;NCK1
prerank,regulation of retinoic acid receptor signaling pathway (GO:0048385),0.3389917285195757,0.7257731684326422,0.7871362940275651,0.9492819572120169,1.0,4/12,20.49%,ASXL1;EZH2;DHRS3;CALR
prerank,regulation of stress-activated protein kinase signaling cascade (GO:0070302),0.34949244571542126,0.7251357479343232,0.7749627421758569,0.9496875903376633,1.0,4/10,23.28%,MAP2K1;MAP2K2;NBR1;MAPK1
prerank,negative regulation of inclusion body assembly (GO:0090084),0.3496002416496841,0.7249120518599894,0.7894736842105263,0.949582226794427,1.0,2/10,8.29%,DNAJB1;DNAJB6
prerank,positive regulation of calcium ion-dependent exocytosis (GO:0045956),0.3258602141694048,0.7247020917298149,0.791476407914764,0.9494741927305458,1.0,2/13,19.54%,SYT10;DOC2B
prerank,histone H2B ubiquitination (GO:0033523),0.3543245329086684,0.7245963381195917,0.8200899550224887,0.9492424968786373,1.0,5/10,22.19%,RNF8;UBE2E1;RNF40;CDC73;DTX3L
prerank,phosphate ion transmembrane transport (GO:0035435),-0.2792175569695131,-0.7235942438525832,0.7982456140350878,0.9553341234630572,1.0,8/12,33.01%,SLC20A2;XPR1;SLC37A3;SLC25A14;SLC37A2;SLC25A30;SLC37A4;SLC25A11
prerank,positive regulation of protein targeting to mitochondrion (GO:1903955),0.2852135972261597,0.7228526280291948,0.8303571428571429,0.9510078009705141,1.0,9/30,17.44%,CSNK2A2;UBE2L3;SAE1;TOMM7;FBXW7;NPEPPS;ARIH2;SH3GLB1;MICALL2
prerank,mitotic recombination (GO:0006312),0.3187742183459382,0.7222261697744776,0.8161244695898161,0.9513892361734637,1.0,2/15,7.89%,RAD52;XRCC3
prerank,histone H2A acetylation (GO:0043968),-0.2546560727033954,-0.7221292162609737,0.821656050955414,0.9557083449999481,1.0,5/16,22.93%,EPC1;ACTL6A;DMAP1;NAA40;YEATS4
prerank,melanosome transport (GO:0032402),0.30622456382800733,0.7220014967030293,0.8070422535211268,0.9509415658900989,1.0,4/18,17.78%,MLPH;MYO5A;RAB27B;BBS7
prerank,pigment granule transport (GO:0051904),0.30622456382800733,0.7220014967030293,0.8070422535211268,0.9509415658900989,1.0,4/18,17.78%,MLPH;MYO5A;RAB27B;BBS7
prerank,negative regulation of telomere maintenance via telomere lengthening (GO:1904357),0.29481367991653423,0.7217071401945521,0.8186813186813187,0.9509406940624359,1.0,8/24,21.94%,PINX1;XRN1;DCP2;NAT10;TNKS2;PARP1;CTC1;SRC
prerank,cell differentiation in hindbrain (GO:0021533),0.3441608144364059,0.7214031136015666,0.7981651376146789,0.9509460939673628,1.0,5/11,21.20%,OPHN1;AGTPBP1;KNDC1;FAIM2;ATP7A
prerank,regulation of ATP metabolic process (GO:1903578),0.2606312750113443,0.7211221264892654,0.8623853211009175,0.9509428703241735,1.0,19/54,25.38%,RAE1;OGT;NUP37;NUP153;NUP188;COX7A2L;NUP35;NUP214;GCK;SPHK2;FIS1;ATP7A;ZBTB7A;NDC1;PGAM1;SEC13;ATP5IF1;SLC25A33;NUP155
prerank,protein localization to lysosome (GO:0061462),0.28535950367140317,0.7207739103491302,0.8428571428571429,0.9510074035036059,1.0,11/28,26.04%,AP4M1;RAB7A;VPS4A;LAMTOR5;ZFYVE16;KPTN;HGS;NEDD4;SCARB2;GGA3;NCOA4
prerank,negative regulation of DNA replication (GO:0008156),0.3302461126791545,0.7207442296735697,0.8199121522693997,0.9506823501948821,1.0,2/13,14.27%,ATR;PDS5A
prerank,mitotic DNA integrity checkpoint signaling (GO:0044774),-0.27845785412024976,-0.7207342854926897,0.8289855072463768,0.9559850462491678,1.0,6/12,37.13%,HUS1;TOPBP1;ORC1;NAE1;HUS1B;TICRR
prerank,negative regulation of mRNA processing (GO:0050686),0.3231323554844078,0.7206756180290234,0.7991266375545851,0.9504064621574548,1.0,5/15,24.64%,SRSF12;SAP18;SFSWAP;RBMX;PCBP4
prerank,regulation of autophagy of mitochondrion (GO:1903146),-0.24329786296580433,-0.7197408141744429,0.8308823529411765,0.9557881964969045,1.0,4/19,9.99%,SREBF2;PRKN;PINK1;CAMKK2
prerank,positive regulation of cation transmembrane transport (GO:1904064),0.2661460649701764,0.7186359853917322,0.8464373464373465,0.9524298515722515,1.0,7/41,15.27%,NOS1AP;AMIGO1;CTSS;KCNJ9;KCNMB4;GNG2;KCNMA1
prerank,gas transport (GO:0015669),-0.28453809057356055,-0.718088373703724,0.8181818181818182,0.9562981618526476,1.0,2/10,12.76%,IPCEF1;CA2
prerank,embryonic heart tube development (GO:0035050),0.323655936053205,0.7177377307077621,0.7964860907759883,0.9531377799418412,1.0,2/14,8.79%,TBX2;ACVR1
prerank,embryonic axis specification (GO:0000578),0.31701153551831235,0.7175611609494346,0.811377245508982,0.9529949621641431,1.0,3/15,17.24%,SMAD2;PTCH1;TBX3
prerank,termination of RNA polymerase I transcription (GO:0006363),0.2798239449930024,0.7174435990235604,0.812743823146944,0.9527674594937929,1.0,10/30,24.23%,TAF1D;POLR1E;CDK7;POLR2K;GTF2H1;CCNH;POLR1B;TBP;POLR2L;TAF1A
prerank,regulation of microtubule-based process (GO:0032886),0.26709134641956106,0.7168672819989893,0.8292079207920792,0.9530893187814277,1.0,7/36,15.32%,TAOK1;EFNA5;MEMO1;GSK3B;TPPP;PHLDB1;PHLDB2
prerank,cardiac muscle tissue development (GO:0048738),0.255649345571779,0.7164823059151102,0.8561236623067776,0.9531750985881452,1.0,7/50,12.98%,TBX18;GATA6;TBX2;BMP5;AKAP13;ADAMTS9;SMAD5
prerank,glial cell differentiation (GO:0010001),0.28271607143181277,0.7156344232638209,0.8416347381864623,0.953806854429935,1.0,8/28,19.19%,SHH;STAT3;PTPRZ1;MYRF;TPPP;PICK1;EGR2;CDK5
prerank,apoptotic DNA fragmentation (GO:0006309),0.3122069518963334,0.7155854991746684,0.8330975954738331,0.9535029175137202,1.0,4/16,16.32%,DICER1;KPNB1;HMGB2;DFFB
prerank,positive regulation of nitrogen compound metabolic process (GO:0051173),0.2981217631984895,0.7148409407334153,0.8196948682385575,0.9540552882753497,1.0,4/19,15.60%,EGF;TMEM106A;NFKB1;TNF
prerank,regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001239),0.28474821150689433,0.7142617794618583,0.832258064516129,0.9543627955907656,1.0,7/26,17.81%,SNAI2;BCL2;FGFR1;TERT;TNF;GDNF;UNC5B
prerank,cellular macromolecule biosynthetic process (GO:0034645),0.2247987791917535,0.7142596497947049,0.973973973973974,0.9540040431666287,1.0,46/306,18.32%,RBMS1;RRBP1;RPSA;BCL3;TNIP1;B4GALT5;ASMT;EIF4G2;BRIP1;POLE3;APOE;EXT1;DNA2;RPL3L;EXT2;PABPC4;E2F1;ATM;ATR;MRPL36;MCM2;NT5M;RMI1;FARSB;MMS19;GSPT1;TERT;MCM7;GRWD1;MCM9;POLR2K;RPL14;DBF4;RNASEH2A;RRAGC;POLR2B;NKX2-8;RBBP8;TIMELESS;ST3GAL2;RPLP2;EEFSEC;RPS25;RPL12;MRPS18A;POLA2
prerank,protein catabolic process (GO:0030163),0.24857120068438376,0.7139745813111539,0.8801369863013698,0.9539541015592976,1.0,8/59,10.90%,APOE;CLN6;CTSD;SIAH2;DDB1;LAMP2;ADAMTS9;BAG6
prerank,regulation of intrinsic apoptotic signaling pathway (GO:2001242),0.2563565013611433,0.7136681315065178,0.8537170263788969,0.9539680630413916,1.0,16/49,24.29%,BCL2;BBC3;UBQLN1;EIF2AK3;BAX;NOC2L;BCL2L2;PTPMT1;PPIF;FIS1;DDX3X;BCLAF1;SRC;DAPK2;DDIT3;NUPR1
prerank,"tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388)",0.3184647004236295,0.7128153454470118,0.8125960061443932,0.9545939551317298,1.0,5/14,22.40%,TSEN2;TRPT1;RTRAF;ZBTB8OS;DDX1
prerank,RNA-dependent DNA biosynthetic process (GO:0006278),0.2803093602818458,0.7124669800389014,0.8403575989782887,0.954625953375871,1.0,8/29,23.85%,TNKS1BP1;PINX1;NHP2;TERT;TELO2;TERF2IP;WRAP53;RFC1
prerank,negative regulation of transposition (GO:0010529),0.30536183504761794,0.712241216354604,0.8162083936324168,0.9545213949340584,1.0,4/16,23.37%,MYBL1;MOV10;SIRT7;TUT7
prerank,response to amino acid (GO:0043200),0.27441024873539627,0.7118039244267641,0.8596938775510204,0.9546751016696475,1.0,9/31,20.04%,CPEB1;CAPN2;GLRB;RPTOR;XBP1;LAMTOR5;RRAGC;GRIN1;CPEB4
prerank,mitochondrion organization (GO:0007005),0.2261470376071606,0.7117042939132971,0.9334016393442623,0.9544458347575171,1.0,45/165,22.71%,LRRK2;STOML2;AIFM2;TRAK1;PID1;FBXO7;PPRC1;AKT3;HK2;MTX2;BAX;DNM1;VPS13C;OMA1;ADCK1;AGTPBP1;ATPAF1;TERT;MSTO1;TOMM7;MIGA2;RAB32;HSPD1;COX7A2L;GABPB1;SLC25A36;TIMM13;GABPA;FIS1;TIMM23;AIP;SPG7;PARP1;TIMM17A;TIMM50;MTX1;MTM1;CYCS;CHCHD10;ATP7A;BCS1L;PARK7;AIFM1;SIRT3;POLRMT
prerank,phosphatidylglycerol metabolic process (GO:0046471),0.2918610842700737,0.7116836595966657,0.8373655913978495,0.9541091148598223,1.0,6/24,20.46%,PLA2G5;CRLS1;PGS1;PLA2G12A;GPAM;PLA2G4A
prerank,negative regulation of leukocyte chemotaxis (GO:0002689),-0.28095321890426095,-0.7101555246242812,0.827485380116959,0.963830318889802,1.0,4/11,19.46%,CCN3;SLIT2;RIN3;MIF
prerank,positive regulation of ion transport (GO:0043270),0.2544855885324939,0.7100108941786017,0.8795749704840614,0.9556769487692675,1.0,13/48,21.25%,CCR1;CNKSR3;CCL5;TRPC6;ATP2B1;KIF5B;MYLK;SNX4;GDNF;ORAI1;P2RX7;STIM2;CRACR2A
prerank,brain morphogenesis (GO:0048854),-0.27123310259185773,-0.7097890661449593,0.8554913294797688,0.962897557358434,1.0,4/12,14.90%,SHANK3;CTNNA2;BBS4;MKKS
prerank,N-glycan processing (GO:0006491),0.30619228707379326,0.7096213491028052,0.8305322128851541,0.9557717509267565,1.0,3/18,8.63%,PRKCSH;MAN1C1;MAN2A1
prerank,entry into host (GO:0044409),0.31563873127769704,0.7094846545751091,0.8309037900874635,0.9555668667854093,1.0,3/13,11.35%,CBL;CXCR4;GRB2
prerank,regulation of lymphocyte proliferation (GO:0050670),0.31016705516755266,0.7082858486442143,0.8212765957446808,0.9566074756450436,1.0,3/16,23.27%,AHR;LST1;SOX11
prerank,positive regulation of cellular respiration (GO:1901857),0.3354217247795944,0.7077002204573968,0.8220588235294117,0.9569178304881732,1.0,6/11,26.65%,IL10RB;PRELID1;PARK7;NUPR1;IFNAR1;VCP
prerank,positive regulation of glucose metabolic process (GO:0010907),0.31272342667407227,0.7074954750252722,0.8235294117647058,0.9567767108873891,1.0,5/14,24.65%,IRS1;DDB1;PTPN2;GPLD1;AKT1
prerank,AMP metabolic process (GO:0046033),0.32047734177444553,0.707324365540106,0.827178729689808,0.9565996582884675,1.0,7/13,28.60%,ADSL;AMPD3;NT5C1A;XDH;AMPD2;AK3;AK4
prerank,chaperone cofactor-dependent protein refolding (GO:0051085),0.28696247111271644,0.7070972935546516,0.859375,0.9564994385887162,1.0,11/25,30.25%,DNAJB1;DNAJC7;HSPE1;SDF2;HSPA5;GAK;HSPA13;DNAJB5;ST13;BAG1;DNAJB14
prerank,regulation of cell projection organization (GO:0031344),0.3170152600957551,0.7069753745404368,0.8432835820895522,0.9562796411828225,1.0,3/13,14.86%,TREM2;SPRY2;MOV10
prerank,hemidesmosome assembly (GO:0031581),0.33744893808084037,0.706807647188126,0.8140556368960469,0.956114200345414,1.0,1/11,1.55%,LAMC1
prerank,positive regulation of cytokine production involved in inflammatory response (GO:1900017),-0.25472566363965976,-0.7059444367153065,0.8660130718954249,0.9657409962870915,1.0,3/15,9.65%,TLR4;IL17D;GBP5
prerank,N-acetylglucosamine metabolic process (GO:0006044),-0.2521626507137214,-0.7058012312230045,0.8599348534201955,0.9645438612865425,1.0,5/15,25.05%,OGA;CHST3;NAGK;CHST7;CHST2
prerank,positive regulation of transcription regulatory region DNA binding (GO:2000679),-0.22703909430772876,-0.7056170192485312,0.888,0.9634053721974721,1.0,2/20,6.62%,RB1;EP300
prerank,regulation of intracellular pH (GO:0051453),0.2703147151772614,0.7056081082427981,0.8627450980392157,0.9571182037936162,1.0,5/34,7.07%,SLC9A1;LRRK2;SLC4A4;SLC4A5;TM9SF4
prerank,protein sumoylation (GO:0016925),0.2531543456980358,0.7056052145928318,0.870023419203747,0.9567614978070984,1.0,11/49,19.01%,RAE1;NUP37;PIAS2;NUP153;NUP188;SAE1;NUP35;NUP214;EGR2;TRPM4;NSMCE2
prerank,leukocyte adhesion to vascular endothelial cell (GO:0061756),0.3027524741944059,0.7053184459969448,0.8314285714285714,0.9567186289623407,1.0,2/18,5.90%,SPN;ADD2
prerank,nucleoside diphosphate metabolic process (GO:0009132),0.312005135792162,0.7041195649121679,0.8207681365576103,0.9577518089155702,1.0,7/15,28.60%,ENTPD7;AK8;ENTPD6;CMPK1;AK5;NME2;AK4
prerank,establishment of melanosome localization (GO:0032401),0.29474309510454255,0.7039427047416921,0.8284518828451883,0.9575783990513291,1.0,2/19,4.87%,MLPH;MYO5A
prerank,negative regulation of binding (GO:0051100),0.24268668205167895,0.7037757055658173,0.9055555555555556,0.9574240435371454,1.0,23/81,22.58%,JAK2;LRRK2;E2F1;DISC1;BAX;ILRUN;MDFI;DDX11;EFHB;ITGB1BP1;GSK3B;RSF1;CTNNBIP1;SP100;TLE5;SMO;PEX19;DVL1;GTF2F1;DACT1;PARK7;CTSZ;CARD16
prerank,ubiquitin-dependent ERAD pathway (GO:0030433),-0.1713643542583741,-0.7037294729359562,0.9814814814814815,0.9640661208726269,1.0,24/69,27.99%,ERLIN1;STT3B;EDEM2;RNF185;UBE4A;DNAJB9;DNAJC18;ANKZF1;SGTA;WFS1;FBXO44;ECPAS;DNAJB2;UBQLN2;RNF5;HERPUD1;RNF103;NPLOC4;UBE2J2;UFD1;UBE2G2;TMEM129;UBXN4;TRIM25
prerank,prostaglandin metabolic process (GO:0006693),0.28347717588812815,0.7027147492171663,0.8496042216358839,0.9582612202682717,1.0,3/26,9.00%,PTGES;PRXL2B;ACOX1
prerank,pyrimidine nucleoside catabolic process (GO:0046135),-0.27988652081037413,-0.7023573615525474,0.8435754189944135,0.9642011238343853,1.0,3/10,15.05%,NT5E;UPB1;NT5C
prerank,organelle transport along microtubule (GO:0072384),0.2709456625694068,0.7022148033474523,0.8608247422680413,0.9584764368856393,1.0,13/31,25.74%,TRAK1;MAP1S;CDC42;COPG1;KIF5B;FBXW11;CLN3;NDEL1;RAB1A;HTT;RAB6A;PAFAH1B1;ARHGAP21
prerank,negative regulation of ATP metabolic process (GO:1903579),0.30229535036644606,0.7015844526877253,0.8151260504201681,0.9588203416236031,1.0,5/17,19.66%,PID1;FLCN;PPIF;FIS1;PARP1
prerank,vitamin transport (GO:0051180),0.27531173212359966,0.7009650772375939,0.8468354430379746,0.9591485635710556,1.0,1/29,0.70%,TCN1
prerank,regulation of microtubule nucleation (GO:0010968),-0.28292544865388053,-0.700808293680105,0.8304093567251462,0.9645360102250916,1.0,4/10,29.19%,EML2;HSPA1A;HSPA1B;DCTN1
prerank,histone lysine demethylation (GO:0070076),0.2822668686621457,0.7006183969560701,0.8362183754993342,0.9591754739599052,1.0,5/25,18.69%,PHF2;KDM4D;KDM7A;KDM2A;KDM3B
prerank,carbohydrate transport (GO:0008643),-0.2786045455878878,-0.7000933192715543,0.8643067846607669,0.9639913006422303,1.0,6/11,36.09%,AQP11;SLC26A6;SLC2A2;SLC23A1;SLC23A2;AQP1
prerank,protein polyglutamylation (GO:0018095),0.33000410257448926,0.6999878427801687,0.8310708898944194,0.9595221992951779,1.0,3/11,15.30%,CEP41;TTLL4;TPGS1
prerank,regulation of transcription of nucleolar large rRNA by RNA polymerase I (GO:1901836),0.32747954221766495,0.6998400007858138,0.809748427672956,0.9593324677848473,1.0,5/11,21.10%,NOL11;DDX11;SMARCB1;SMARCA4;SIRT7
prerank,microtubule-based transport (GO:0099111),0.3223784837604484,0.6992150348816634,0.8106870229007633,0.959668478702108,1.0,2/12,10.21%,DNAAF4;SPEF2
prerank,embryonic heart tube morphogenesis (GO:0003143),0.2581128170136289,0.6985051958321169,0.8748495788206979,0.9600881491910626,1.0,9/43,19.90%,PKD2;TBX2;SHH;ACVR1;NPHP3;TBX3;BBS7;SMO;SETDB2
prerank,positive regulation of telomerase activity (GO:0051973),-0.20222896349568767,-0.6983001314086383,0.9552238805970149,0.9645364858748376,1.0,15/33,32.53%,NVL;CCT4;DKC1;HSP90AB1;KLF4;NAF1;HMBOX1;TCP1;PRKCQ;PTGES3;MAP3K4;MAPK3;NEK7;ACD;XRCC5
prerank,negative regulation of calcineurin-NFAT signaling cascade (GO:0070885),0.3259148429827099,0.6981441970236181,0.8199697428139183,0.9597803703559101,1.0,2/12,14.70%,FHL2;GSK3B
prerank,negative regulation of calcineurin-mediated signaling (GO:0106057),0.3259148429827099,0.6981441970236181,0.8199697428139183,0.9597803703559101,1.0,2/12,14.70%,FHL2;GSK3B
prerank,sulfur amino acid catabolic process (GO:0000098),-0.2954307785768125,-0.6979388175493745,0.8732782369146006,0.9635819666297648,1.0,4/10,30.18%,TXN2;CBS;CTH;MPST
prerank,regulation of actin polymerization or depolymerization (GO:0008064),0.2813771011947249,0.6978031071764703,0.8626943005181347,0.9597839057669788,1.0,8/28,21.60%,CXCL12;DBN1;DBNL;ARHGAP35;PLEKHG2;GBA2;BRK1;ABITRAM
prerank,regulation of telomerase RNA localization to Cajal body (GO:1904872),0.29892956173172014,0.6972252176616177,0.8232044198895028,0.9600699262180824,1.0,4/18,17.02%,CCT8;NHP2;DCP2;RUVBL1
prerank,nucleic acid-templated transcription (GO:0097659),0.2560596625147601,0.6971895701276309,0.8707729468599034,0.9597510125403236,1.0,10/42,19.19%,BCL3;E2F1;MMS19;TERT;POLR2K;RRAGC;POLR2B;NKX2-8;POLR3A;BAZ2A
prerank,mitotic G1/S transition checkpoint signaling (GO:0044819),-0.2744373160503352,-0.6971314209106938,0.8677685950413223,0.9630868904896289,1.0,6/12,30.71%,RFWD3;TP53;WAC;RPA2;PLK3;CCND1
prerank,regulation of mitochondrial fusion (GO:0010635),0.33135252244666646,0.696469939656876,0.8328267477203647,0.9601877637633955,1.0,3/11,9.43%,PID1;OMA1;ADCK1
prerank,regulation of sequestering of calcium ion (GO:0051282),-0.2617353533293999,-0.6961093830031424,0.8436578171091446,0.9628243752606943,1.0,4/12,22.00%,ANK2;RYR2;MTLN;CASQ2
prerank,negative regulation of phosphatase activity (GO:0010923),-0.21615037444683122,-0.6953731375347664,0.9083333333333333,0.9622795768701082,1.0,11/25,29.40%,URI1;SH3RF2;SEMA4D;MASTL;STYXL1;CRY2;TIPRL;SH2D4A;FKBP1A;PPP1R26;PPP1R15A
prerank,"protein alpha-1,2-demannosylation (GO:0036508)",0.28468501243255834,0.6953532781996996,0.8477970627503337,0.9610722091551761,1.0,5/22,16.30%,UGGT2;MAN1C1;EDEM1;TRIM13;SYVN1
prerank,energy reserve metabolic process (GO:0006112),0.29415126912811895,0.694852364099432,0.8477653631284916,0.9612467992643116,1.0,3/19,7.04%,PID1;GFPT2;PYGL
prerank,regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314),0.2833685943208525,0.694435391801528,0.8463508322663252,0.9613391643740035,1.0,6/24,16.68%,CAMK2D;PKD2;CALM3;FKBP1B;CALM2;SELENON
prerank,phosphate ion transport (GO:0006817),-0.2450436233850759,-0.6943289340063185,0.890625,0.961974273006224,1.0,8/16,33.01%,SLC20A2;XPR1;SLC37A3;SLC25A14;SLC37A2;SLC25A30;SLC37A4;SLC25A11
prerank,regulation of DNA-dependent DNA replication (GO:0090329),-0.27352970183104164,-0.6940625919865974,0.8377581120943953,0.9609283395741273,1.0,2/12,9.33%,TIPIN;METTL4
prerank,intraciliary retrograde transport (GO:0035721),0.3223537662901521,0.6932480822745553,0.8402555910543131,0.962243668052003,1.0,3/12,13.18%,WDR35;DYNC2LI1;DYNC2H1
prerank,negative regulation of histone methylation (GO:0031061),0.3336019729465057,0.6929758313825075,0.8184615384615385,0.9621949092031851,1.0,5/10,24.26%,PHF1;DNMT3B;AASS;JARID2;KDM1A
prerank,superoxide metabolic process (GO:0006801),0.2736086525092561,0.692969710795245,0.8666666666666667,0.9618407817187327,1.0,1/29,1.04%,SH3PXD2B
prerank,response to nutrient levels (GO:0031667),0.29563086077367,0.6921655769808766,0.8453900709219858,0.9623625713262752,1.0,3/17,11.30%,CD68;RPTOR;RPS6KB1
prerank,RNA stabilization (GO:0043489),0.2659273532509358,0.6905473656139361,0.8707317073170732,0.9637558549926639,1.0,9/33,21.67%,TENT5A;E2F1;PAIP1;AXIN2;ZCCHC17;THRAP3;GDNF;YBX1;FUS
prerank,detection of calcium ion (GO:0005513),0.3144655704937182,0.6899580668222983,0.8323529411764706,0.9640281300539226,1.0,4/13,20.93%,CALM3;KCNMB4;CALM2;KCNIP2
prerank,cGMP biosynthetic process (GO:0006182),0.3249502722145949,0.6898049339520531,0.8322683706070287,0.9638379933565293,1.0,1/10,6.25%,NPR2
prerank,mesoderm development (GO:0007498),-0.23475106574746393,-0.689652371360463,0.8964285714285715,0.9639262382005748,1.0,4/18,11.91%,TIE1;TBX1;BMX;IKZF1
prerank,positive regulation of cell adhesion mediated by integrin (GO:0033630),0.2939019840214532,0.6890884124914565,0.8523676880222841,0.9642722079297419,1.0,2/17,7.35%,SFRP2;CCL5
prerank,pharyngeal system development (GO:0060037),0.3026984466988077,0.68766432619557,0.8532763532763533,0.9654076934600428,1.0,5/15,22.39%,BMP5;TGFBR1;PTCH1;TGFB2;BMP7
prerank,protein insertion into mitochondrial membrane (GO:0051204),-0.21123426285471364,-0.6873914047646258,0.9138576779026217,0.9648074723691672,1.0,10/23,29.81%,TOMM70;NDUFA13;COX18;SAMM50;TIMM8B;ROMO1;BMF;BAD;TIMM9;TIMM10
prerank,small nucleolar ribonucleoprotein complex assembly (GO:0000491),0.33373053506538336,0.6867025531163689,0.8184713375796179,0.9660519765385104,1.0,6/10,34.49%,PIH1D2;RUVBL1;ZNHIT6;SHQ1;PIH1D1;RUVBL2
prerank,"regulation of alternative mRNA splicing, via spliceosome (GO:0000381)",0.24542964493283304,0.6865011809871261,0.9034883720930232,0.9659102744320064,1.0,10/52,16.00%,RBFOX1;DDX17;KHDRBS1;CELF1;SRSF12;RBFOX2;FMR1;SAP18;THRAP3;CELF5
prerank,positive regulation of syncytium formation by plasma membrane fusion (GO:0060143),0.30533700753333987,0.6863757574306103,0.8477951635846372,0.9656796913548071,1.0,5/15,24.55%,TREM2;CD53;EHD2;EHD1;ADAM9
prerank,negative regulation of transferase activity (GO:0051348),0.27100153674365607,0.6857862795636297,0.8550913838120104,0.9659520740256311,1.0,8/28,22.31%,NPRL2;PINX1;FBXO5;GSK3B;ABL1;SRC;DTX3L;PARK7
prerank,regulation of DNA repair (GO:0006282),0.2531202539173647,0.6856851394483285,0.8957845433255269,0.9657075259658013,1.0,15/44,23.91%,UBR5;RAD52;BABAM2;EGFR;CDK9;RNF8;AXIN2;NPAS2;TMEM161A;RNF168;SIRT7;WRAP53;TRIP12;RPS3;UIMC1
prerank,protein mannosylation (GO:0035268),0.27932264553735986,0.6850832690414828,0.8520475561426685,0.9659587146105423,1.0,6/22,21.96%,TMTC4;DPY19L3;DPM2;POMT2;DPY19L4;CRPPA
prerank,positive regulation of protein transport (GO:0051222),0.23953704498099493,0.6850117273219369,0.9207248018120046,0.9656655325258333,1.0,21/67,24.78%,ABCG1;TREM2;PPID;FRMD4A;TGFB3;PCM1;ATP2C1;TNF;PDCD10;RIPOR1;PCNT;EXOC1;MYH10;CLN3;TGFB2;TMED10;BCAS3;IGF1;TGFB1;ADAM9;RUFY3
prerank,carboxylic acid transmembrane transport (GO:1905039),0.2557867116994753,0.6847749573532043,0.8795620437956204,0.9655402988230414,1.0,6/40,13.05%,SLC38A3;SLC7A7;SLC38A4;SLC36A2;SLC7A11;SLC7A8
prerank,steroid biosynthetic process (GO:0006694),0.2435372936998197,0.6844810838039921,0.9018264840182648,0.9654883225758563,1.0,2/56,4.75%,CYP7B1;INSIG2
prerank,negative regulation of oxidative stress-induced neuron death (GO:1903204),0.32187407444914595,0.6843811542059383,0.8404726735598228,0.9652363987788444,1.0,2/11,8.43%,FBXO7;NONO
prerank,positive regulation of fatty acid oxidation (GO:0046321),0.31358428457040344,0.6835396716363291,0.849478390461997,0.9657549890586672,1.0,4/12,23.59%,IRS1;MLYCD;TWIST1;ABCD2
prerank,ganglioside metabolic process (GO:0001573),0.28462334636230824,0.6832770455931803,0.8565737051792829,0.9656755847166348,1.0,3/20,7.76%,ABCA2;CLN6;B4GALNT1
prerank,protein acetylation (GO:0006473),0.26627826449813935,0.6829091090157138,0.8634020618556701,0.9657084875866565,1.0,5/30,16.99%,NAT9;NAA50;CREBBP;CLOCK;NAT10
prerank,metallo-sulfur cluster assembly (GO:0031163),0.277324170630158,0.6829013433822251,0.8690476190476191,0.9653602423948552,1.0,8/22,24.73%,FXN;MMS19;NUBP2;NUBP1;LYRM4;HSCB;ISCA2;ABCB7
prerank,positive regulation of peptidyl-serine phosphorylation (GO:0033138),0.23853984355886076,0.6827290173404968,0.9173098125689085,0.9651841149333408,1.0,23/73,26.24%,SFRP2;TNKS1BP1;PRKD2;EGFR;RPTOR;SPRY2;FNIP1;ARAF;NTRK3;TNF;PDCD10;STK4;NTF3;PAK1;TERF2IP;PARK7;TGFB1;PFN2;AKAP9;EIF4G1;AKT1;DOCK7;TRIM6
prerank,regulation of macroautophagy (GO:0016241),0.22710778398528683,0.6819667113264755,0.9222577209797657,0.9656424748548345,1.0,25/105,20.05%,DCN;LRRK2;SNX5;UBQLN1;EXOC4;RPTOR;TRIM13;ATP6V1G1;SNX6;LAMTOR5;ATP6V1D;GAPDH;RRAGC;SH3GLB1;ATP6V0A2;ATP6V1H;SMCR8;EXOC7;EXOC1;ATP6V1G2;CLN3;CDK5;UCHL1;CAPNS1;NEDD4
prerank,positive regulation of catabolic process (GO:0009896),0.23760786984539878,0.6817546328648763,0.9143179255918827,0.9655169055248927,1.0,18/65,23.52%,TNFAIP3;WNT5A;SMURF2;RAB7A;OAZ3;AREL1;DDB1;FZR1;SMURF1;GSK3B;TNF;ITCH;CSNK2A1;NEDD4;DACT1;ASB5;ATG7;NKD1
prerank,negative regulation of secretion by cell (GO:1903531),0.2547580426581916,0.6816777580322042,0.8970223325062034,0.9652338109561519,1.0,8/38,20.17%,APOE;ANXA1;ERP29;DRD3;TNFRSF1A;DPH3;HRH3;RHBDF1
prerank,regulation of adenylate cyclase activity (GO:0045761),0.27905822935862734,0.6815973695937123,0.8726790450928382,0.9649642132534704,1.0,5/22,12.75%,CACNA1C;NF1;ADGRV1;DRD3;LTB4R2
prerank,in utero embryonic development (GO:0001701),0.2775424066639882,0.6807096059490385,0.8656126482213439,0.965500160212726,1.0,4/25,14.35%,CHD7;TGFBR1;TGFB3;FLCN
prerank,sarcomere organization (GO:0045214),0.26996966881440754,0.6806391536492031,0.8682795698924731,0.9652234547410792,1.0,3/27,13.51%,CSRP1;FHOD3;TPM1
prerank,cellular response to arsenic-containing substance (GO:0071243),-0.2463879545214614,-0.6805650932398972,0.8601398601398601,0.9698813693304494,1.0,5/15,25.78%,MKNK2;HSF1;HNRNPA1;GSTO2;ATF3
prerank,pre-miRNA processing (GO:0031054),-0.2497009730146446,-0.6805001552793025,0.8924050632911392,0.9686210601242193,1.0,2/14,5.98%,ADAR;DROSHA
prerank,regulation of carbohydrate catabolic process (GO:0043470),0.25345322515046115,0.680446437441256,0.8823529411764706,0.9650698276549896,1.0,14/41,25.38%,RAE1;OGT;NUP37;NUP153;NUP188;NUP35;NUP214;GCK;ZBTB7A;NDC1;PGAM1;SCARB2;SEC13;NUP155
prerank,cellular response to oxygen levels (GO:0071453),0.32340337131465563,0.6801538126415471,0.8188622754491018,0.9650281490666986,1.0,4/10,20.04%,ATP6V1G1;PICK1;ATP6V0A2;CPEB4
prerank,establishment of protein localization to endoplasmic reticulum (GO:0072599),0.2955692357747499,0.6801019683629488,0.8456090651558074,0.9647246372905626,1.0,6/15,23.52%,RAB3GAP2;RAB10;EDEM1;RAB3GAP1;SEC61A1;SRP14
prerank,negative regulation of DNA recombination (GO:0045910),0.25059362707609933,0.6794288432139092,0.889294403892944,0.9650714111570364,1.0,11/43,23.08%,PARP3;FBH1;SHLD3;ATRX;POLR2K;RIF1;POLR2B;TERF2IP;HELB;CGAS;POLR2L
prerank,insulin secretion (GO:0030073),-0.22834191942099968,-0.678960189702003,0.9338235294117647,0.9687534054189874,1.0,7/19,25.05%,CYB5R4;RIMS2;PTPRN2;ADCYAP1;RAB11B;RAB11FIP2;SELENOT
prerank,regulation of microglial cell activation (GO:1903978),-0.24271130526188656,-0.6784417486178098,0.9037267080745341,0.967893397430206,1.0,3/15,9.45%,LDLR;GRN;TTBK1
prerank,establishment of protein localization to mitochondrion (GO:0072655),0.24743503246479676,0.678167745008122,0.8852657004830918,0.9660207965038909,1.0,17/46,25.56%,FBXO7;HK2;RALA;DNLZ;TOMM7;HSPD1;TIMM13;FIS1;TIMM23;AIP;TIMM17A;TIMM50;AIFM1;TOMM22;AKT1;TOMM40L;MFN2
prerank,transcription by RNA polymerase I (GO:0006360),0.2591491773107586,0.6778487787957254,0.8795944233206591,0.9659864006085415,1.0,10/34,24.23%,TAF1D;POLR1E;CDK7;POLR2K;GTF2H1;CCNH;POLR1B;TBP;POLR2L;TAF1A
prerank,regulation of sister chromatid cohesion (GO:0007063),0.319671338007953,0.6777141802761372,0.8283582089552238,0.9657582857436319,1.0,3/12,13.89%,DDX11;CTCF;AXIN2
prerank,nuclear envelope organization (GO:0006998),0.2865607751915386,0.676558302255942,0.8803301237964236,0.9665743574318949,1.0,5/20,16.09%,REEP4;VPS4A;LEMD2;SUN1;TMEM43
prerank,negative regulation of protein binding (GO:0032091),0.2337801551946735,0.6763909221049861,0.9216335540838853,0.9663934603204147,1.0,17/71,22.58%,ADIPOQ;LRRK2;ATP2A2;DISC1;BAX;DDX11;EFHB;ITGB1BP1;GSK3B;CTNNBIP1;TLE5;DVL1;GTF2F1;DACT1;PARK7;CTSZ;CARD16
prerank,negative regulation of G protein-coupled receptor signaling pathway (GO:0045744),0.27905018876286347,0.6761031740792146,0.8926630434782609,0.9663268489961877,1.0,3/20,13.15%,RNF157;CCL5;APLP1
prerank,positive regulation of histone modification (GO:0031058),0.2611237394550567,0.6756724421615491,0.8753117206982544,0.966414449941673,1.0,12/33,26.04%,NIPBL;CDK9;TADA2B;FMR1;GLYR1;AKAP8L;ARRB1;ZBTB7B;KDM1A;SART3;TADA2A;PAXIP1
prerank,nucleobase-containing small molecule catabolic process (GO:0034656),-0.23774189194223394,-0.6749330842766067,0.903114186851211,0.9696827541353379,1.0,1/14,1.37%,ENTPD1
prerank,negative regulation of transforming growth factor beta production (GO:0071635),0.3231010890586735,0.6746131606873772,0.852760736196319,0.9671369220379947,1.0,1/10,3.64%,GATA6
prerank,extrinsic apoptotic signaling pathway in absence of ligand (GO:0097192),0.27783670954916845,0.6742592893064059,0.8497191011235955,0.9671376972632773,1.0,4/20,14.70%,BCL2;BAX;BCL2L2;GSK3B
prerank,nuclear migration (GO:0007097),0.3053397867148901,0.6732230036653756,0.8520710059171598,0.9678137050918998,1.0,4/13,13.33%,DYNC1H1;CEP120;PCM1;FBXW11
prerank,chromatin remodeling at centromere (GO:0031055),0.2613593044271153,0.6729317908688065,0.8735483870967742,0.9677421679561916,1.0,7/31,19.40%,CENPQ;CENPN;CENPT;RSF1;CENPL;RUVBL1;RBBP4
prerank,7-methylguanosine RNA capping (GO:0009452),0.2586283444241201,0.6728856731116963,0.867515923566879,0.9670702894440161,1.0,9/31,19.27%,GTF2F2;CDK7;POLR2K;GTF2H1;RAMAC;NCBP2;POLR2B;CCNH;GTF2F1
prerank,7-methylguanosine mRNA capping (GO:0006370),0.2586283444241201,0.6728856731116963,0.867515923566879,0.9670702894440161,1.0,9/31,19.27%,GTF2F2;CDK7;POLR2K;GTF2H1;RAMAC;NCBP2;POLR2B;CCNH;GTF2F1
prerank,purine-containing compound biosynthetic process (GO:0072522),0.2737854137499125,0.6727733403613717,0.8786279683377308,0.966828374541382,1.0,7/25,23.67%,ADSL;GMPS;GART;PPAT;AMPD3;AMPD2;DCK
prerank,cellular response to acid chemical (GO:0071229),0.26512561065045004,0.672605573043555,0.8899082568807339,0.9666469159393044,1.0,6/27,15.64%,CPEB1;CAPN2;RPTOR;XBP1;LAMTOR5;RRAGC
prerank,negative regulation of T cell receptor signaling pathway (GO:0050860),0.29261786301543946,0.672185878805623,0.8423988842398884,0.9667250729981939,1.0,4/17,17.11%,UBASH3A;THY1;PTPN2;PTPRJ
prerank,melanosome localization (GO:0032400),0.28013864267865196,0.6721458569450793,0.875,0.9664071260312174,1.0,2/21,4.87%,MLPH;MYO5A
prerank,regulation of neurotransmitter secretion (GO:0046928),0.26200877574771736,0.6720381487125091,0.8841309823677582,0.9661579039813178,1.0,7/32,14.70%,LRRK2;DTNBP1;MCTP2;KCNMB4;FMR1;HCRT;GSK3B
prerank,ribonucleoprotein complex assembly (GO:0022618),-0.14847936463385575,-0.6719646702915705,1.0,0.9709248448803681,1.0,46/132,28.45%,RBM5;RPL38;RPL5;RPLP0;SNRPC;YTHDC1;RPL10;RPS27;RPS19;HSP90AB1;SNRPG;ERAL1;SNRPD3;RPF2;RRP7A;NOP53;PRPF19;SNUPN;MRPS7;ISY1;SRSF10;NAF1;EIF2S2;CLP1;TXNL4A;CELF2;MRPL20;NLE1;CELF6;PRPF6;CLNS1A;RPS5;GEMIN8;PWP2;EIF4H;SNRPF;DDX39B;GCFC2;PTGES3;LUC7L;DENR;DHX9;USP39;CELF4;LSM4;RPL24
prerank,protein stabilization (GO:0050821),0.2175118682683192,0.6712438688590739,0.9600818833162743,0.9665660774021586,1.0,53/168,27.13%,CCT8;USP9X;FLOT2;PTEN;RAB21;SEC16A;RASSF2;PIK3R1;PARVA;BAG3;ZBED3;LAMP2;DNLZ;CDK7;BAG6;MORC3;COA8;HSPD1;TBL1X;OTUD3;FBXW7;BAG4;GAPDH;CDC37;TAF9B;SYVN1;CCNH;PDCD10;TRIM44;PEX19;PLPP3;DVL1;STK4;TELO2;COG7;CALR;IGF1;PARK7;ATF7IP;TNIP2;PFN2;MTMR9;COG3;CCT6A;CCT3;PEX6;RPL11;GNAQ;ATP1B2;NAA15;USP19;NAPG;NCLN
prerank,sno(s)RNA 3'-end processing (GO:0031126),0.31641144259427867,0.6711972456733702,0.8318181818181818,0.9662571860641656,1.0,6/11,29.02%,EXOSC4;EXOSC2;EXOSC3;FBL;EXOSC5;PARN
prerank,chromatin assembly or disassembly (GO:0006333),0.31220023628549776,0.6711947080319978,0.8346333853354134,0.965909800347862,1.0,3/11,19.40%,MTA2;NOC2L;RBBP4
prerank,membrane protein intracellular domain proteolysis (GO:0031293),0.28183320987801347,0.6703095235841494,0.8736842105263158,0.9664213338412408,1.0,12/20,31.37%,NFKB1;HM13;PSEN1;PSENEN;TGFB1;ADAM9;RHBDD1;RELA;MBTPS1;PSEN2;TRAF6;NCSTN
prerank,negative regulation by host of viral process (GO:0044793),0.32563374092982617,0.6702065053241464,0.8525345622119815,0.9661695558896796,1.0,1/10,2.59%,CRP
prerank,N-terminal protein amino acid acetylation (GO:0006474),0.2889668578503692,0.6696357629282548,0.8679245283018868,0.9663742057987702,1.0,2/16,7.53%,NAA50;CREBBP
prerank,phosphatidylcholine biosynthetic process (GO:0006656),-0.19418568867817318,-0.6693521870192547,0.937799043062201,0.9719080142341969,1.0,12/32,29.96%,CHPT1;CHKA;MFSD2A;ABHD3;PCTP;PCYT1A;SLC44A5;CSNK2B;LCAT;SLC27A1;CHAT;STARD10
prerank,positive regulation of RNA splicing (GO:0033120),-0.19891089596765416,-0.66929176638211,0.9347826086956522,0.9706381207926774,1.0,13/29,30.69%,NCL;ERN1;DAZAP1;U2AF2;CIRBP;POLR2A;ZPR1;SLC38A2;SF3B4;HSPA1A;CELF4;NUP98;RBM20
prerank,regulation of histone modification (GO:0031056),0.3029365935155543,0.6678604594236327,0.8502906976744186,0.9678178123228603,1.0,4/13,15.99%,MTHFR;CDK9;FLCN;AKAP8L
prerank,RNA methylation (GO:0001510),0.2354804069121242,0.6674424345725684,0.905373831775701,0.9678415993379615,1.0,26/60,30.91%,TRMT61B;ZC3H13;METTL1;METTL16;MTERF4;NOP2;MRM2;WDR6;TGS1;THUMPD3;RBM15;FBL;BUD23;BCDIN3D;THADA;METTL5;TRDMT1;TRMT61A;METTL14;DIMT1;NSUN4;FTSJ3;THUMPD2;METTL2A;METTL2B;MTO1
prerank,folic acid metabolic process (GO:0046655),0.28750157138909427,0.6667755644934797,0.8776077885952712,0.9681286888446156,1.0,6/18,26.21%,MTHFD1L;MTHFR;MTHFD2L;FPGS;SLC19A1;MTRR
prerank,homologous chromosome pairing at meiosis (GO:0007129),-0.20052101521792476,-0.6664526923864494,0.9514563106796117,0.9716848615895365,1.0,13/29,40.32%,RAD21;P3H4;PRDM9;SYCP2;MEI4;REC8;TRIP13;SYCE2;ZCWPW1;MEIOB;TEX12;FANCD2;IHO1
prerank,alpha-linolenic acid metabolic process (GO:0036109),0.30745736773827936,0.6655941202753733,0.8563049853372434,0.9689180196233069,1.0,3/12,15.07%,ACOX1;FADS1;ELOVL1
prerank,sulfation (GO:0051923),-0.26128071802048936,-0.6655312592230506,0.8429003021148036,0.9711237813678123,1.0,4/11,34.21%,UST;SULT1A1;CHST5;SULT2B1
prerank,regulation of interleukin-1 production (GO:0032652),0.29178908113111285,0.6654559964977271,0.852017937219731,0.9687059892894936,1.0,3/15,20.29%,ANXA1;SIRPA;TMED10
prerank,regulation of protein metabolic process (GO:0051246),0.2418479951217362,0.6648528840815567,0.9050410316529894,0.9689418678914908,1.0,8/44,17.61%,APOE;SHH;GSAP;SSH1;SPOP;MDM2;ROCK2;HGS
prerank,mRNA splice site selection (GO:0006376),0.263101645893968,0.6644854770306435,0.8912466843501327,0.968952093525092,1.0,6/30,18.54%,CELF1;SRSF12;SETX;CELF5;SRSF1;SFSWAP
prerank,neutrophil activation (GO:0042119),0.30090295270261336,0.6643451257609388,0.8502994011976048,0.9687380355207962,1.0,2/12,9.89%,CCL5;PREX1
prerank,glycolipid biosynthetic process (GO:0009247),0.25069404484227426,0.6642052407434648,0.9019370460048426,0.9685158988856208,1.0,9/38,16.52%,PIGW;PIGN;PGAP4;PIGL;DPM2;A4GALT;PIGG;PIGC;ST3GAL2
prerank,positive regulation of morphogenesis of an epithelium (GO:1905332),0.2703181252689827,0.663133131748334,0.8896551724137931,0.9691653089529355,1.0,5/23,17.85%,EGF;MDK;FGF2;GDNF;SMO
prerank,protein targeting to membrane (GO:0006612),0.22333613484037904,0.6623127336477391,0.9437086092715232,0.9695797432382939,1.0,23/83,24.66%,CHMP4B;CHMP4A;ATG3;RAB8B;SEC63;ZDHHC3;SSR2;ALDH3A2;SDCBP;RTP4;ZDHHC9;SRP19;VPS37C;PEX19;FIS1;PEX5;ZDHHC6;SEC61A1;SRP14;ABCD2;VPS37A;PRKCI;PEX12
prerank,reticulophagy (GO:0061709),-0.2457494604772801,-0.6616576277467685,0.8828828828828829,0.9729125058854704,1.0,3/12,21.21%,ULK2;TEX264;UFL1
prerank,cardiac muscle cell differentiation (GO:0055007),-0.22192838486405517,-0.6614833115108731,0.9243986254295533,0.9717282661363145,1.0,12/21,39.86%,MEF2C;CXADR;MYOCD;CBY1;MYH11;TTN;ALPK3;TCAP;SIK1;IRX3;MYH6;ALPK2
prerank,negative regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway (GO:0039532),0.3095386548620308,0.658776237374155,0.8528072837632777,0.9725190222224914,1.0,2/10,14.35%,SEC14L1;DHX58
prerank,modulation by host of viral genome replication (GO:0044827),0.30565173390385286,0.6579278979145682,0.872992700729927,0.9729517470167149,1.0,5/13,20.72%,TBC1D20;FMR1;NUCKS1;VAPA;IFI27
prerank,protein modification process (GO:0036211),0.22385548757394766,0.6577642291989123,0.9432071269487751,0.9727363305327074,1.0,21/76,22.84%,PLOD2;PLAT;ATG3;UBE2L3;PHKA2;ARAF;ABL1;YES1;ST3GAL1;PPP4R2;MMP15;FBXO2;FBXO22;UBE2S;LCMT1;PARP1;ADPRH;RABGGTB;PRKDC;B4GALT7;PIGH
prerank,mitotic cell cycle checkpoint signaling (GO:0007093),0.2699480438542575,0.657567014620134,0.8969616908850726,0.972566633284053,1.0,6/23,20.97%,PABIR1;VPS4A;SETMAR;CHFR;WEE1;CDK5RAP3
prerank,heart looping (GO:0001947),0.24595561158012058,0.6573365055114783,0.9089790897908979,0.972430658932626,1.0,8/39,19.90%,PKD2;TBX2;SHH;NPHP3;TBX3;BBS7;SMO;SETDB2
prerank,cellular response to misfolded protein (GO:0071218),0.27821893344953164,0.6572948813762733,0.8717241379310345,0.9721115434967279,1.0,8/20,26.65%,UGGT2;BAG6;POMT2;STUB1;UBE2W;AUP1;UGGT1;VCP
prerank,phospholipid biosynthetic process (GO:0008654),0.24958124845364404,0.656868979366834,0.9064475347661188,0.9721466946860655,1.0,10/36,20.86%,CPNE7;FADS1;SRD5A3;CRLS1;GPAM;PIP5K1A;SPHK2;AGPAT5;CLN3;SAMD8
prerank,glutathione biosynthetic process (GO:0006750),-0.2613269978594904,-0.656520765425077,0.922360248447205,0.9744391632193724,1.0,5/11,27.78%,CHAC2;GCLM;GCLC;HAGH;GGT1
prerank,negative regulation of signal transduction in absence of ligand (GO:1901099),0.26998956759361464,0.6560005251129123,0.8809201623815968,0.9722288500622243,1.0,6/21,17.81%,SNAI2;BCL2;TERT;TNF;GDNF;UNC5B
prerank,negative regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001240),0.26998956759361464,0.6560005251129123,0.8809201623815968,0.9722288500622243,1.0,6/21,17.81%,SNAI2;BCL2;TERT;TNF;GDNF;UNC5B
prerank,snRNA metabolic process (GO:0016073),0.276377068215034,0.6558273853843415,0.8683473389355743,0.9720280289714959,1.0,6/17,27.85%,ZCCHC8;MTREX;INTS1;INTS8;INTS6;INTS4
prerank,positive regulation of histone acetylation (GO:0035066),0.2680425930385835,0.6555176846219752,0.896,0.9719465601534668,1.0,9/23,28.61%,TADA2B;GLYR1;SPHK2;ARRB1;SMARCB1;WBP2;TADA2A;PAXIP1;RPS6KA4
prerank,base-excision repair (GO:0006284),0.23728389650969245,0.6554247742198457,0.9150943396226415,0.9716797013983793,1.0,3/48,3.96%,MPG;LIG1;DNA2
prerank,double-strand break repair via nonhomologous end joining (GO:0006303),0.2309857151495169,0.6548534009829788,0.9228998849252014,0.9718608554753055,1.0,17/58,22.56%,BABAM2;ATM;DCLRE1C;MDC1;RNF8;PAXX;SETMAR;HMGB2;RIF1;LIG3;IFFO1;KDM2A;PSMD14;NSMCE2;RNF168;PRKDC;ZBTB7A
prerank,positive regulation of T-helper cell differentiation (GO:0045624),0.2913027286272102,0.6545739456809685,0.8575803981623277,0.9717620457953816,1.0,3/14,16.05%,ANXA1;NFKBIZ;SOCS5
prerank,negative regulation of protein ubiquitination (GO:0031397),0.23392229829170352,0.6543604045765228,0.919774011299435,0.9716089978514043,1.0,15/50,24.65%,TNFAIP3;OGT;PINX1;SQSTM1;FBXO5;SPRY2;ABL1;NXN;ARRB1;SIRT7;DTX3L;PARK7;RPS3;USP4;AKT1
prerank,cellular amino acid catabolic process (GO:0009063),0.22224581891759299,0.654278837262765,0.9516129032258065,0.971340043369106,1.0,16/87,19.01%,SDSL;ACADSB;CRYM;DLST;AMT;GLDC;HGD;HIBCH;ALDH7A1;KYAT1;GLS2;QDPR;CARNS1;ACAT1;AASS;HIBADH
prerank,negative regulation of myoblast differentiation (GO:0045662),-0.23996940493004748,-0.6540930239793357,0.913312693498452,0.974906907574681,1.0,1/13,1.52%,BMP4
prerank,mitochondrial calcium ion transmembrane transport (GO:0006851),0.27112260031170027,0.6539083719962461,0.8878378378378379,0.971312154522833,1.0,9/20,25.49%,STOML2;MICU2;PMPCB;SPG7;PMPCA;MCUR1;AFG3L2;MICU3;MAIP1
prerank,methylguanosine-cap decapping (GO:0110156),0.31279668368294566,0.6538822774413248,0.8746130030959752,0.9709807039541283,1.0,2/10,12.16%,EDC4;DCP2
prerank,telomere maintenance via recombination (GO:0000722),-0.25948228923792793,-0.6534769642182594,0.9096209912536443,0.9740755351499292,1.0,3/11,15.73%,SMC6;ERCC1;RAD51D
prerank,monocarboxylic acid metabolic process (GO:0032787),0.21469428969772156,0.6531466515683485,0.9493670886075949,0.9713024966274069,1.0,26/117,24.16%,LPL;FASN;ALDH1A2;ACADSB;MTHFD1L;CD36;PPARG;THEM4;ACSL4;SGPL1;SLC27A4;CYP1A1;PANK2;PCCA;ACSF2;GPAM;GBA2;DLAT;CROT;IGF1;ACOT11;PDHX;SLC6A8;CPT1A;SCPEP1;AGXT
prerank,cytoplasmic translational initiation (GO:0002183),0.28103387590014767,0.6529080238935658,0.8629943502824858,0.9711829370917716,1.0,4/17,16.25%,EIF4A1;EIF5;DHX29;EIF2B3
prerank,homocysteine metabolic process (GO:0050667),0.3051796426511274,0.6523342853797016,0.8719512195121951,0.9713815645526497,1.0,1/11,6.42%,MTHFR
prerank,calcium ion transport into cytosol (GO:0060402),0.27027551913448467,0.6519517925686287,0.8952254641909815,0.97137040804158,1.0,4/21,13.46%,CACNA2D1;CACNA1C;MS4A1;GRIN2A
prerank,regulation of T cell cytokine production (GO:0002724),0.2873224129117812,0.6517742713961553,0.8796033994334278,0.9711853017571459,1.0,3/15,17.88%,XCL1;TRAF2;TRPM4
prerank,regulation of leukocyte adhesion to vascular endothelial cell (GO:1904994),0.3008414058888991,0.6516650365323549,0.87701317715959,0.9709387794820911,1.0,7/13,30.57%,MDK;TNF;RHOA;ETS1;NFAT5;RELA;TRAF6
prerank,establishment of skin barrier (GO:0061436),0.29203027252218244,0.6514574891102226,0.8802395209580839,0.9704395977801323,1.0,1/15,3.81%,UGCG
prerank,regulation of water loss via skin (GO:0033561),0.29203027252218244,0.6514574891102226,0.8802395209580839,0.9704395977801323,1.0,1/15,3.81%,UGCG
prerank,negative regulation of intrinsic apoptotic signaling pathway by p53 class mediator (GO:1902254),0.29118077458151176,0.6504939377563036,0.8553008595988538,0.9709502932192218,1.0,3/15,15.93%,BCL2;MDM2;TAF9B
prerank,negative regulation of cell migration involved in sprouting angiogenesis (GO:0090051),0.2909083218548313,0.6499625798636323,0.8751793400286944,0.9710751959058186,1.0,5/14,19.39%,HDAC5;ITGB1BP1;PDCD10;RHOA;STARD13
prerank,inorganic ion transmembrane transport (GO:0098660),0.2914350360745074,0.6497959240985929,0.8709677419354839,0.9708702385898973,1.0,1/12,4.71%,PKD2
prerank,regulation of response to DNA damage stimulus (GO:2001020),0.2427031002080752,0.6497754350511585,0.908433734939759,0.9705392654829236,1.0,9/40,21.10%,KMT5A;CDK9;FBXO5;FMR1;NEK4;NPAS2;ABL1;BCLAF1;SIRT7
prerank,membrane depolarization (GO:0051899),0.2513753652424204,0.6497253826731834,0.8950695322376738,0.9702329399417593,1.0,2/32,3.66%,CACNA1A;SCN7A
prerank,ribonucleoprotein complex biogenesis (GO:0022613),0.22968976246038003,0.6496511078354459,0.9362912400455062,0.9699490171418194,1.0,16/57,22.05%,PES1;MRPL36;WDR74;NOC2L;RPL14;NIP7;DDX31;GTF3A;NOP14;TGS1;LTO1;RPS25;HEATR3;NOP16;EBNA1BP2;BYSL
prerank,cell differentiation in spinal cord (GO:0021515),0.31187328730607305,0.6491734626594058,0.8548644338118022,0.9700319227452816,1.0,1/10,2.77%,MDGA1
prerank,T-helper cell differentiation (GO:0042093),0.29575107282949664,0.648473141060576,0.898021308980213,0.9703272019036193,1.0,2/14,11.72%,BATF;PTGER4
prerank,phosphatidylcholine acyl-chain remodeling (GO:0036151),-0.197359029346461,-0.6482266655857104,0.9563106796116505,0.9765960062466008,1.0,7/29,20.45%,LPCAT2;PNPLA8;PLA2G6;DBI;PLA2G4C;TMEM86B;NR1H2
prerank,cellular response to chemical stress (GO:0062197),0.21972495904882483,0.6481595000929494,0.9552715654952076,0.9702765892801615,1.0,31/96,26.54%,LRRK2;PKD2;RAD52;ATM;AIF1;TXNRD1;ETV5;SIRT2;SETX;MGAT3;SELENOS;PRDX5;PRDX6;ABL1;TMEM161A;NFE2L2;GPX8;FOXO3;PARP1;DDX3X;CYCS;PARK7;TXNRD2;ATG7;FANCC;SLC25A24;CYBB;ATF4;ADNP2;FOXO1;VRK2
prerank,positive regulation of telomerase RNA localization to Cajal body (GO:1904874),0.29009552641364506,0.6481373552173127,0.8709677419354839,0.9699483866403736,1.0,2/15,8.17%,CCT8;NHP2
prerank,response to ionizing radiation (GO:0010212),0.22444052712052032,0.6458639964445028,0.9528619528619529,0.9715520354186964,1.0,11/70,13.75%,TNKS1BP1;ANXA1;INO80;BABAM2;ATM;KDM4D;RNF8;TRIM13;GRB2;TANK;CLOCK
prerank,nuclear export (GO:0051168),0.22130528160873247,0.6453563406640892,0.9368879216539717,0.9716371697608769,1.0,14/80,18.80%,ATXN1;RAE1;WASHC4;SRSF2;XPO7;NUP153;NUP188;SMURF1;NEMF;NCBP2;NUP214;SRSF1;EGR2;THOC3
prerank,mismatch repair (GO:0006298),-0.19412327594609122,-0.6449058231377635,0.9592592592592593,0.9776862640680655,1.0,12/27,27.93%,MLH3;MSH2;PCNA;ERCC1;XPC;MSH5;POLD2;RPA2;MUTYH;RPA3;POLD4;PMS2
prerank,mitotic chromosome condensation (GO:0007076),0.2565519543209771,0.6443434261741716,0.9116094986807388,0.972172163720916,1.0,8/26,24.02%,CSNK2A2;KMT5A;PLK1;AKAP8L;CSNK2A1;TENT4A;NCAPD2;NCAPG2
prerank,regulation of cell communication by electrical coupling (GO:0010649),0.29627355415536205,0.6438861860735594,0.876967095851216,0.9721961870364678,1.0,3/13,13.46%,CAMK2D;CALM3;CALM2
prerank,RNA splicing (GO:0008380),0.21722549906962582,0.6435225709389885,0.9548387096774194,0.9721627035004458,1.0,23/95,23.01%,PPP1R9B;SYNCRIP;SNRNP40;KHSRP;SRSF2;DHX15;NONO;DHX8;CCAR2;USB1;NCBP2;RRAGC;SNRNP35;TCERG1;RNPC3;PRPF18;LSM6;FUS;SF3B2;SF3B1;U2AF1;RSRC1;CDK12
prerank,nonribosomal peptide biosynthetic process (GO:0019184),-0.24829833189126116,-0.6434836664419026,0.9147540983606557,0.9774171064448477,1.0,5/12,27.78%,CHAC2;GCLM;GCLC;HAGH;GGT1
prerank,regulation of glycogen metabolic process (GO:0070873),-0.24568297619883855,-0.6432547915128481,0.9142857142857143,0.9762391300531523,1.0,2/12,12.55%,INPP5K;PPP1R3C
prerank,negative regulation of response to cytokine stimulus (GO:0060761),0.3017096662871289,0.6429145745381798,0.8788819875776398,0.9723462266070073,1.0,2/10,16.40%,IRAK3;TLE5
prerank,regulation of response to endoplasmic reticulum stress (GO:1905897),0.2875117373527383,0.6422249314241205,0.8951255539143279,0.9725808066190443,1.0,2/13,8.05%,EIF2AK3;FCGR2B
prerank,rRNA processing (GO:0006364),0.2045040898780814,0.6414907168782417,0.9815573770491803,0.972832152857869,1.0,45/172,22.05%,C1D;MAK16;NOL11;HELQ;PES1;NHP2;ERI1;WDR74;RRP1B;RRP1;MTREX;EXOSC4;NOP56;MPHOSPH6;RPL14;PIH1D2;NOP2;NOP14;EXOSC2;UTP3;PELP1;WDR36;BMS1;MRM2;RPLP2;EXOSC1;NAT10;POP4;RCL1;RPS25;RPL12;ESF1;SRFBP1;EXOSC3;RSL1D1;MRPL1;LSM6;WDR18;NOLC1;EBNA1BP2;FBL;RPL22;DDX10;PRKDC;BYSL
prerank,protein kinase C-activating G protein-coupled receptor signaling pathway (GO:0007205),-0.26007338357105536,-0.6403966285688124,0.9078212290502793,0.976921797889198,1.0,1/10,2.43%,PARD3
prerank,positive regulation of small GTPase mediated signal transduction (GO:0051057),0.24802139353872094,0.6399789439727963,0.9181585677749361,0.9737729455404034,1.0,11/30,30.64%,JAK2;ERBIN;GRB2;VAV1;IGF1;SRC;RAPGEF1;ITGAV;MMD2;RASGEF1A;FGF10
prerank,purine ribonucleotide catabolic process (GO:0009154),-0.2122539022227415,-0.6399432845544529,0.9446640316205533,0.9759324054581705,1.0,7/21,23.07%,NT5E;PDE2A;PDE4D;NT5C2;NUDT11;FITM2;NUDT16
prerank,dicarboxylic acid metabolic process (GO:0043648),0.2293566864520188,0.6395801243793431,0.9298850574712644,0.9737588233995769,1.0,15/52,26.21%,ALDH18A1;MTHFD1L;MTHFR;DLST;SDHAF3;MTHFD2L;IDH2;ASS1;FPGS;SDHA;SLC19A1;ADHFE1;L2HGDH;MDH2;MTRR
prerank,regulation of branching involved in ureteric bud morphogenesis (GO:0090189),-0.23227134867146199,-0.6394961390704641,0.916923076923077,0.9749061044158231,1.0,1/15,1.52%,BMP4
prerank,very-low-density lipoprotein particle assembly (GO:0034379),-0.24842117614064135,-0.6391306706303105,0.896551724137931,0.973858599022635,1.0,3/12,17.97%,DGAT1;MFSD2A;ACSL3
prerank,motile cilium assembly (GO:0044458),-0.23953434951713576,-0.6385475731902979,0.9125364431486881,0.9729238254631853,1.0,7/12,45.53%,CCDC39;E2F4;BBS5;CCDC40;DNAAF3;RSPH6A;DNAAF1
prerank,purine-containing compound salvage (GO:0043101),-0.24431055038874058,-0.6382717474957634,0.9390243902439024,0.9718065358881668,1.0,4/12,23.68%,GMPR;APRT;DGUOK;ADK
prerank,activation of phospholipase C activity (GO:0007202),0.25502901777606746,0.6380994807342238,0.9114249037227214,0.9746338922972434,1.0,5/29,17.36%,EDNRA;EGFR;ARHGAP6;LPAR2;LPAR1
prerank,positive regulation of cyclase activity (GO:0031281),0.28835513134595037,0.6369016865021663,0.8847262247838616,0.9753116690835554,1.0,2/14,7.57%,CACNA1C;NF1
prerank,myelination in peripheral nervous system (GO:0022011),0.28664699736683147,0.6368475213551316,0.8844444444444445,0.9750056080647387,1.0,3/13,11.76%,NF1;SIRT2;DICER1
prerank,protein K48-linked deubiquitination (GO:0071108),-0.2007588426522574,-0.6366482745544371,0.9534883720930233,0.9715015323775679,1.0,7/23,17.31%,MINDY1;USP8;ATXN3;OTUD4;OTUB1;USP5;USP20
prerank,3'-UTR-mediated mRNA stabilization (GO:0070935),0.28469364440338113,0.6361625468322293,0.8781869688385269,0.9752070627457853,1.0,1/14,4.50%,TIRAP
prerank,response to organophosphorus (GO:0046683),0.27749293719038526,0.6353984074827747,0.8969957081545065,0.9754821829290181,1.0,1/16,3.24%,STAT1
prerank,regulation of transferase activity (GO:0051338),0.2711313787424138,0.6350048713411622,0.8938547486033519,0.9754564694847249,1.0,6/17,24.35%,ATM;PINX1;SMG6;EMP2;PARP4;SPTSSB
prerank,cardiac muscle tissue morphogenesis (GO:0055008),-0.18910415023360094,-0.6339327584386234,0.978448275862069,0.9720532060552525,1.0,3/29,6.58%,S1PR1;TGFBR3;PROX1
prerank,entrainment of circadian clock by photoperiod (GO:0043153),0.25230382171272764,0.6328868020741574,0.9095477386934674,0.9768288463275349,1.0,7/27,24.94%,RBM4B;BHLHE40;CRTC1;PPP1CB;FBXL12;PPP1CC;FBXL22
prerank,sulfur amino acid metabolic process (GO:0000096),0.2535468731870374,0.632617416244919,0.906721536351166,0.9767080327421535,1.0,2/24,6.42%,AHCY;MTHFR
prerank,regulation of generation of precursor metabolites and energy (GO:0043467),0.23066735389974852,0.6315739879477951,0.9371362048894063,0.9772066391077115,1.0,15/48,25.38%,RAE1;OGT;NUP37;NUP153;NUP188;NUP35;KHK;NUP214;GCK;RUBCNL;ZBTB7A;NDC1;PGAM1;SEC13;NUP155
prerank,triglyceride biosynthetic process (GO:0019432),0.27041408215109863,0.6301601313125057,0.8929577464788733,0.9779867723596635,1.0,4/18,18.90%,MOGAT3;GK;GPAM;GPAT3
prerank,positive regulation of leukocyte adhesion to vascular endothelial cell (GO:1904996),0.28413483156946123,0.6301540801417834,0.9132947976878613,0.9776428888597472,1.0,7/16,27.97%,MDK;TNF;RHOA;ETS1;FUT4;NFAT5;RELA
prerank,response to unfolded protein (GO:0006986),0.22865691330257082,0.6299277104825344,0.9490521327014217,0.9774732403311149,1.0,7/48,10.85%,DNAJB1;SERPINH1;BAX;BAG3;PTPN1;HSPH1;HSPE1
prerank,peptidyl-methionine modification (GO:0018206),0.29145462397735844,0.6297487182037792,0.889060092449923,0.9772751515235273,1.0,4/12,26.71%,METAP1;METAP1D;NAA30;NAA15
prerank,protein localization to microtubule organizing center (GO:1905508),0.2780990053550503,0.629571184730208,0.9129213483146067,0.9770746412574884,1.0,5/15,22.80%,SNX10;PCM1;CSNK1D;HOOK3;C2CD3
prerank,phosphatidylcholine metabolic process (GO:0046470),0.21607235066427238,0.6291060748253385,0.9607623318385651,0.9770989392342957,1.0,5/70,8.20%,LIPC;PLA2G5;CSNK2A2;CEPT1;PLA2G7
prerank,Golgi to lysosome transport (GO:0090160),0.2926489623527996,0.6289022980539604,0.8979591836734694,0.9769125334109423,1.0,2/11,11.70%,AP4M1;ANKFY1
prerank,regulation of transposition (GO:0010528),0.2799626577068084,0.6280173138934383,0.9049707602339181,0.9772685120633331,1.0,1/13,6.79%,MYBL1
prerank,regulation of attachment of spindle microtubules to kinetochore (GO:0051988),0.29891660238077056,0.6276468080875688,0.8798151001540832,0.9772280191056678,1.0,2/10,10.71%,CDC42;SIRT2
prerank,branched-chain amino acid catabolic process (GO:0009083),0.2631228067957816,0.6273570060030563,0.9153005464480874,0.9767427804905584,1.0,8/20,27.49%,ACADSB;HIBCH;ACAT1;HIBADH;ECHS1;BCAT1;AUH;DBT
prerank,branched-chain amino acid metabolic process (GO:0009081),0.2631228067957816,0.6273570060030563,0.9153005464480874,0.9767427804905584,1.0,8/20,27.49%,ACADSB;HIBCH;ACAT1;HIBADH;ECHS1;BCAT1;AUH;DBT
prerank,cGMP metabolic process (GO:0046068),-0.24306728249836657,-0.6265757308723126,0.94,0.9754053991963176,1.0,2/12,9.13%,NPR1;PDE2A
prerank,positive regulation of establishment of protein localization to telomere (GO:1904851),0.3016520206985211,0.6258874748567674,0.8920634920634921,0.9775434043030253,1.0,1/10,3.29%,CCT8
prerank,mitochondrial transport (GO:0006839),0.2263937222252713,0.6253006553749064,0.9511627906976744,0.9776386504214043,1.0,17/53,25.56%,BCL2;FBXO7;MTX2;SLC25A16;TOMM7;TIMM13;PPIF;FIS1;TIMM23;AIP;SPG7;TIMM17A;BCS1L;TOMM22;SLC25A24;MAIP1;MFN2
prerank,regulation of secretion (GO:0051046),0.289231414017989,0.6239424372240011,0.9016393442622951,0.9783373211640478,1.0,4/13,26.06%,EGF;POFUT2;GPLD1;OPRK1
prerank,regulation of brown fat cell differentiation (GO:0090335),0.27727952969728914,0.6236236289528263,0.9081779053084649,0.9782283295622758,1.0,6/16,22.88%,FTO;VSTM2A;FLCN;PTGS2;BMP7;ZBTB7B
prerank,negative regulation of cell division (GO:0051782),0.296604427590756,0.6221789303804343,0.91350531107739,0.9789857283561013,1.0,2/11,10.27%,E2F8;VPS4A
prerank,'de novo' posttranslational protein folding (GO:0051084),0.24539906348381443,0.6219645217296796,0.9285714285714286,0.9788073330696551,1.0,12/30,30.25%,DNAJB1;DNAJC7;HSPE1;SDF2;HSPA5;GAK;UGGT1;HSPA13;DNAJB5;ST13;BAG1;DNAJB14
prerank,protein homooligomerization (GO:0051260),0.20573939490285,0.6214791332875909,0.9779643231899265,0.9788156122145869,1.0,12/114,11.31%,STEAP4;ALDH1A2;TRMT61B;PKD2;ATL2;MLKL;ALOX5AP;MPP2;TIFA;ACOT13;ATL1;ALS2
prerank,regulation of ion transport (GO:0043269),0.21491940128068782,0.6213883272934954,0.9590254706533776,0.9785368776534797,1.0,10/76,12.78%,FGF20;SYT10;KCNA5;PXK;SYT2;DTNBP1;KCNJ9;SNX6;DRD3;SYT3
prerank,positive regulation of protein deacetylation (GO:0090312),-0.23007059048295536,-0.6212049849451668,0.9504950495049505,0.9774036258417524,1.0,5/14,24.69%,AKAP8;SAP30BP;APLNR;BRMS1;FNTA
prerank,regulation of DNA metabolic process (GO:0051052),0.22789338425716388,0.6207747000137527,0.9353658536585366,0.9786792332910712,1.0,10/44,21.50%,SUB1;CDK9;TOM1L1;SMG6;NUCKS1;MPHOSPH8;WDR18;SIRT7;TERF2IP;HELB
prerank,activation of protein kinase B activity (GO:0032148),0.24208871932978807,0.6200781038652423,0.9305912596401028,0.9788440542010628,1.0,10/29,25.10%,WNT5A;MAPKAP1;RICTOR;ITGB1BP1;NTRK3;NTF3;IGF1;PARK7;AKT1;PDPK1
prerank,positive regulation of JUN kinase activity (GO:0043507),0.25597382069003954,0.6198813879348665,0.9236842105263158,0.9786361893831543,1.0,5/23,15.60%,DVL2;SASH1;TAOK3;TRAF2;TNF
prerank,ncRNA processing (GO:0034470),0.19559697302189083,0.6194904046550618,0.9918533604887984,0.9785841386952642,1.0,65/200,27.93%,C1D;SMAD2;ZCCHC8;NOL11;HELQ;PES1;TRPT1;TARBP2;WDR74;RRP1B;RRP1;DICER1;MTREX;EXOSC4;NOP56;POP1;MPHOSPH6;DGCR8;RPL14;SMAD3;PIH1D2;NOP14;EXOSC2;UTP3;PELP1;WDR36;BMS1;INTS1;MRM2;RPLP2;EXOSC1;POP4;RCL1;RPS25;RPL12;ESF1;FARS2;EXOSC3;HNRNPA2B1;WDR18;LIN28B;NOLC1;EBNA1BP2;FBL;RPL22;DDX10;BYSL;UTP11;RPS9;TUT7;INTS8;RPF1;RPL36A;TEX10;RPL11;INTS6;SMAD1;MPHOSPH10;MDN1;LYAR;UTP4;UTP6;RPL27A;INTS4;DHX37
prerank,histone H3-K36 demethylation (GO:0070544),-0.24611040766281722,-0.6191205805729817,0.9209809264305178,0.9773335438125076,1.0,6/10,34.12%,PHF8;RIOX2;KDM4C;KDM4A;KDM8;RIOX1
prerank,regulation of establishment of protein localization to telomere (GO:0070203),0.2912933943883811,0.6189464414567357,0.8969230769230769,0.9786448346583497,1.0,1/11,3.29%,CCT8
prerank,positive regulation of lipid catabolic process (GO:0050996),0.2578442519789455,0.6188273111102136,0.9203413940256046,0.9783961900958242,1.0,1/19,4.33%,IRS1
prerank,negative regulation of telomere maintenance via telomerase (GO:0032211),0.26111797168728795,0.6180975888330202,0.9181446111869032,0.9786047823404479,1.0,6/19,21.94%,PINX1;XRN1;DCP2;NAT10;CTC1;SRC
prerank,response to purine-containing compound (GO:0014074),0.2636060883182607,0.6177120435783945,0.9176136363636364,0.9785361091374728,1.0,1/17,3.24%,STAT1
prerank,"RNA splicing, via transesterification reactions (GO:0000375)",0.251141492823881,0.6176679509325131,0.9242021276595744,0.9782220505736089,1.0,2/25,5.96%,SNRNP40;KHSRP
prerank,spliceosomal complex assembly (GO:0000245),-0.16103887429737487,-0.6171573039573928,0.9939759036144579,0.977224571009704,1.0,21/46,34.15%,RBM5;YTHDC1;SNRPG;PRPF19;SRSF10;SF3A3;TXNL4A;CELF2;CELF6;PRPF6;DDX39B;GCFC2;LUC7L;USP39;CELF4;SRPK3;SRSF5;SNRPD1;SNRPD2;SNRPE;DDX23
prerank,determination of heart left/right asymmetry (GO:0061371),0.2284046090418248,0.6170601611217141,0.9376498800959233,0.9783205129252257,1.0,8/42,19.90%,PKD2;TBX2;SHH;NPHP3;TBX3;BBS7;SMO;SETDB2
prerank,"alternative mRNA splicing, via spliceosome (GO:0000380)",0.26405848581217645,0.6151577770600122,0.9087018544935807,0.9793389969941981,1.0,3/16,16.06%,DDX17;CDK13;SRSF1
prerank,establishment of protein localization to plasma membrane (GO:0061951),0.23152515287868636,0.6151421188792503,0.9446494464944649,0.9790025010555693,1.0,4/36,9.03%,GORASP2;RAB34;RAB7A;RAB10
prerank,regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway (GO:1901028),0.2612827833258171,0.6137470931064202,0.9035812672176309,0.9796426067356558,1.0,4/18,20.81%,BAX;FZD9;GSK3B;CHCHD10
prerank,maturation of SSU-rRNA (GO:0030490),-0.17091182842104619,-0.6132745698508988,0.9891891891891892,0.9780630999361866,1.0,10/34,22.91%,RIOK1;NGDN;RPS16;RPS19;RIOK3;RPS8;NOB1;NOL10;TSR3;PWP2
prerank,negative regulation of double-strand break repair (GO:2000780),0.23810926840764562,0.6132284726378086,0.9305555555555556,0.9796617835777178,1.0,9/30,23.06%,UBR5;FBH1;SHLD3;RNF169;RIF1;HELB;CGAS;TRIP12;TWIST1
prerank,mitochondrial RNA metabolic process (GO:0000959),0.2791348849343322,0.6119202215837833,0.9074889867841409,0.980239978108422,1.0,7/14,30.70%,EARS2;FOXO3;POLRMT;SLC25A33;TWNK;PNPT1;TEFM
prerank,negative regulation of osteoblast differentiation (GO:0045668),0.23616907320120825,0.6118590184390048,0.9360613810741688,0.979935509960016,1.0,4/31,9.47%,TNN;SUFU;PPARG;CDK6
prerank,"RNA splicing, via endonucleolytic cleavage and ligation (GO:0000394)",0.270898373139111,0.6110610237354831,0.9133738601823708,0.9801319665507576,1.0,5/15,22.40%,TSEN2;TRPT1;RTRAF;ZBTB8OS;DDX1
prerank,resolution of meiotic recombination intermediates (GO:0000712),0.2704517346472975,0.6098461886894624,0.9284692417739628,0.9806731944347601,1.0,3/16,18.63%,RMI1;TOP2B;EME2
prerank,negative regulation of sodium ion transmembrane transport (GO:1902306),0.30134802098762103,0.607197365950062,0.900163666121113,0.982155787851665,1.0,1/10,3.71%,CAMK2D
prerank,regulation of transcription by RNA polymerase III (GO:0006359),0.25574572553416214,0.6061209319863091,0.9210526315789473,0.9825458339016253,1.0,4/19,17.74%,RPTOR;CHD8;PRDX5;NAB2
prerank,peptidyl-arginine modification (GO:0018195),0.27332945167150535,0.6051790960315735,0.9217134416543574,0.9828379907522321,1.0,3/15,22.31%,PADI2;PRMT5;PARK7
prerank,peripheral nervous system development (GO:0007422),0.24840962905851677,0.6050161669289599,0.9166666666666666,0.9826033658591052,1.0,6/23,19.65%,PMP22;NF1;ALDH3A2;GDNF;EGR2;NTF3
prerank,ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway (GO:0043162),0.2474026656970119,0.6047720076437271,0.9363395225464191,0.9824184015813465,1.0,9/22,27.52%,VPS4A;TOM1L1;MVB12A;VPS37C;PTPN23;NEDD4;VPS37A;VPS4B;SNF8
prerank,protein transmembrane import into intracellular organelle (GO:0044743),0.23381784700099414,0.6042803721124267,0.9473684210526315,0.9823971716628511,1.0,11/31,25.62%,PEX10;DNLZ;HSPD1;PEX5;TIMM23;TIMM17A;TIMM50;AIFM1;PEX12;TOMM40L;PEX6
prerank,negative regulation of neuroinflammatory response (GO:0150079),0.2695590205957379,0.6032848643019654,0.9212827988338192,0.9827120770284254,1.0,6/14,27.66%,TREM2;CX3CL1;IGF1;NR1D1;PTPRC;CD200R1
prerank,regulation of telomere maintenance (GO:0032204),0.23816883548822498,0.603239101369208,0.9383202099737533,0.9823969823521919,1.0,3/26,13.14%,GNL3;ATRX;SMG6
prerank,regulation of telomerase activity (GO:0051972),0.22042343815791732,0.6029272291356227,0.9602888086642599,0.982264301635534,1.0,4/45,7.32%,PARM1;ATM;PKIB;PINX1
prerank,synaptonemal complex assembly (GO:0007130),-0.21749512881979616,-0.6018129385928319,0.9523809523809523,0.9813812433193655,1.0,6/15,32.34%,RAD21;P3H4;SYCP2;REC8;TRIP13;SYCE2
prerank,synaptonemal complex organization (GO:0070193),-0.21749512881979616,-0.6018129385928319,0.9523809523809523,0.9813812433193655,1.0,6/15,32.34%,RAD21;P3H4;SYCP2;REC8;TRIP13;SYCE2
prerank,aerobic respiration (GO:0009060),-0.20061311443936333,-0.6016171240503099,0.9809160305343512,0.9801850552092477,1.0,6/20,19.48%,ME3;UQCRB;ATP5F1D;UQCRC2;SLC25A14;UQCR10
prerank,regulation of T cell mediated immunity (GO:0002709),-0.2393976702299418,-0.598889624375466,0.9454545454545454,0.9803883310641001,1.0,3/10,29.33%,ZBTB1;AGER;CCR2
prerank,DNA duplex unwinding (GO:0032508),0.21350199013364984,0.5977667800863927,0.964243146603099,0.9852654220648129,1.0,8/50,14.38%,ANXA1;ASCC3;MCM2;DDB1;DDX11;MCM7;MCM9;GTF2H1
prerank,carnitine metabolic process (GO:0009437),0.2779519690054326,0.59764851640578,0.9046898638426626,0.9850027618774192,1.0,4/12,23.67%,TMLHE;CPT2;CROT;CPT1A
prerank,regulation of cellular protein catabolic process (GO:1903362),0.2588721979491009,0.5964341312488872,0.9449152542372882,0.9854023402324033,1.0,5/18,22.24%,NELL1;MSN;WDR91;CDK5RAP3;DACT1
prerank,ERAD pathway (GO:0036503),0.2000563015299174,0.5963470641906597,0.986870897155361,0.9851070309719611,1.0,20/83,22.49%,ERLEC1;UBQLN1;RCN3;UGGT2;UBE2J1;EDEM1;BAG6;TRIM13;SELENOS;POMT2;STUB1;BRSK2;SYVN1;RNF103-CHMP3;RNF121;FBXO2;PSMC6;AUP1;RHBDD2;HSPA5
prerank,positive regulation of sodium ion transport (GO:0010765),0.2754381620841839,0.5960391704114002,0.9215976331360947,0.9849700331657818,1.0,1/12,5.79%,CNKSR3
prerank,mRNA-containing ribonucleoprotein complex export from nucleus (GO:0071427),0.20032958566482983,0.5938504757474841,0.982646420824295,0.986020843888365,1.0,23/96,24.25%,RAE1;SMG7;NUP37;SRSF2;NUP153;NUP188;SLBP;AGFG1;ALKBH5;SMG6;NUP35;NCBP2;NXT1;NUP214;SRSF1;CPSF3;THOC3;HNRNPA2B1;FIP1L1;U2AF1;NDC1;FYTTD1;SEC13
prerank,"mRNA cis splicing, via spliceosome (GO:0045292)",0.2633327274705015,0.5935781742633662,0.9334298118668596,0.9858418745598784,1.0,7/16,27.42%,SRSF12;NCBP2;SRSF1;SFSWAP;SNRNP200;PSIP1;RBM22
prerank,steroid hormone biosynthetic process (GO:0120178),-0.17556123595200845,-0.5932747702301275,0.9803921568627451,0.9817435766107616,1.0,13/29,39.55%,HSD17B11;STARD3NL;HSD17B7;STAR;HSD17B2;TSPOAP1;TSPO;DHCR7;FDX1;FDX2;HSD17B14;AKR1B1;HSD17B1
prerank,negative regulation of protein modification by small protein conjugation or removal (GO:1903321),0.2107835315662066,0.5924406071670204,0.9717194570135747,0.9861933320519602,1.0,6/54,10.32%,TNFAIP3;OGT;PINX1;TRIM21;SQSTM1;SPRY2
prerank,ribosome biogenesis (GO:0042254),0.1871649473427929,0.5911626548485188,0.9948927477017364,0.9866391307312551,1.0,45/187,22.05%,C1D;NOL11;HELQ;ABCE1;PES1;MRPL36;WDR74;NOC2L;RRP1B;RRP1;MTREX;EXOSC4;NOP56;MPHOSPH6;RPL14;PIH1D2;NIP7;DDX31;GTF3A;DHX29;NOP14;EXOSC2;UTP3;PELP1;WDR36;BMS1;MRM2;RPLP2;EXOSC1;POP4;LTO1;RCL1;RPS25;RPL12;HEATR3;ESF1;EXOSC3;NOP16;WDR18;NOLC1;EBNA1BP2;FBL;RPL22;DDX10;BYSL
prerank,"nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway (GO:0035872)",0.24600490450111068,0.5911197238144282,0.9396782841823056,0.9863224370656106,1.0,5/24,17.44%,TNFAIP3;NOD1;IRAK2;CASP8;ITCH
prerank,protein modification by small protein conjugation or removal (GO:0070647),0.26981232769661095,0.5890401454793627,0.9184247538677919,0.9872530614538807,1.0,5/13,23.33%,SAE1;SENP6;UBA5;UBA1;ATG7
prerank,"maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000462)",-0.17161753645977962,-0.5887512052936378,0.978448275862069,0.9825590945823255,1.0,15/29,37.62%,NGDN;RPS16;RPS19;RPS21;RPS8;NOL10;PWP2;WDR46;ABT1;TSR2;UTP20;DCAF13;RPS14;RPP40;MRPS11
prerank,regulation of lamellipodium morphogenesis (GO:2000392),0.2800523844075832,0.5871896851597719,0.9211356466876972,0.9880396884701703,1.0,3/11,21.94%,PDPN;CORO1C;SRC
prerank,mitochondrion morphogenesis (GO:0070584),0.27409210218107033,0.5871447904885287,0.9231974921630094,0.9877231968778721,1.0,4/11,25.67%,PID1;FIS1;MTM1;MYH14
prerank,peptidyl-glutamic acid modification (GO:0018200),0.23519450206964312,0.5870428023802526,0.9488559892328399,0.9874471359479394,1.0,5/24,19.66%,CEP41;AGTPBP1;TTLL4;TPGS1;PARP1
prerank,rRNA modification (GO:0000154),0.2424782361524359,0.5867641584248172,0.9371657754010695,0.9872699629881169,1.0,10/21,29.34%,NHP2;MTERF4;MRM2;NAT10;FBL;BUD23;METTL5;DIMT1;NSUN4;FTSJ3
prerank,negative regulation of double-strand break repair via homologous recombination (GO:2000042),0.258084531614095,0.586424025935424,0.9337260677466863,0.9871295077928594,1.0,5/16,21.65%,FBH1;SHLD3;RIF1;HELB;CGAS
prerank,internal peptidyl-lysine acetylation (GO:0018393),0.23218470007133493,0.5855377259048563,0.9496688741721855,0.9873000940104284,1.0,7/27,24.21%,NAA50;CREBBP;BAG6;RUVBL1;PHF20;BRD8;MORF4L2
prerank,regulation of oxidative phosphorylation (GO:0002082),0.2594297380835448,0.5844416399770789,0.9457579972183588,0.9875680784565469,1.0,7/16,28.60%,COX7A2L;PPIF;ATP7A;NUPR1;SLC25A33;VCP;AK4
prerank,mature B cell differentiation involved in immune response (GO:0002313),-0.2281571318298418,-0.5831242469068615,0.9604863221884499,0.9837181587834919,1.0,5/12,28.59%,LFNG;MFNG;DOCK11;DLL1;NOTCH2
prerank,positive regulation of telomere capping (GO:1904355),0.24946691272538785,0.5830442009148294,0.9287790697674418,0.9880265417892452,1.0,5/17,25.16%,PKIB;TNKS2;MAP2K7;MAPK1;PNKP
prerank,protein localization to cilium (GO:0061512),0.22495550634990658,0.5823500757342173,0.9551282051282052,0.9880737517578507,1.0,9/32,21.48%,SNX10;WDR35;CSNK1D;ATP6V1D;TUB;TULP3;IFT20;RABEP1;EHD1
prerank,mRNA export from nucleus (GO:0006406),0.1946212591488111,0.5812967902054719,0.9860365198711063,0.9883447691037986,1.0,26/102,25.38%,RAE1;SMG7;NUP37;SRSF2;NUP153;NUP188;SLBP;AGFG1;ALKBH5;SMG6;NUP35;NCBP2;NXT1;NUP214;SRSF1;CPSF3;THOC3;HNRNPA2B1;FIP1L1;U2AF1;NDC1;FYTTD1;SEC13;IWS1;PCID2;NUP155
prerank,quinone biosynthetic process (GO:1901663),0.2598573594379819,0.5796704848744789,0.936231884057971,0.9889156186786898,1.0,2/14,6.89%,COQ8B;COQ6
prerank,mitochondrial membrane organization (GO:0007006),0.22192872663641486,0.5793874898134657,0.9615384615384616,0.988730196368506,1.0,11/32,25.56%,BCL2;MTX2;APOOL;PPIF;SPG7;TIMM50;MTX1;CHCHD6;MICOS10;MAIP1;MFN2
prerank,regulation of fatty acid beta-oxidation (GO:0031998),0.25809843871293026,0.5781755500260726,0.9433681073025335,0.9890271783593697,1.0,1/14,4.33%,IRS1
prerank,regulation of cardiac muscle cell differentiation (GO:2000725),0.26901943599453804,0.5757612885693549,0.9245852187028658,0.9900163585296109,1.0,3/11,23.69%,FRS2;EFNB2;TGFB1
prerank,"mitochondrial electron transport, ubiquinol to cytochrome c (GO:0006122)",0.27022677504299303,0.5754790681210329,0.9158878504672897,0.9898107259568476,1.0,1/11,3.95%,UQCRC1
prerank,mitochondrial translation (GO:0032543),0.18893117346756386,0.5751743703412806,0.9925531914893617,0.9896334705839468,1.0,12/104,12.89%,MRPL48;MRPS26;MTRF1L;MRPL57;NDUFA7;IARS2;MRPL36;MRPL17;EARS2;MRPL19;MRPL15;DAP3
prerank,protein localization to centrosome (GO:0071539),0.24768052290110584,0.5748761284103523,0.953360768175583,0.9894463344840121,1.0,7/17,28.87%,SNX10;PCM1;CSNK1D;HOOK3;C2CD3;NUDCD3;CEP192
prerank,negative regulation of RNA splicing (GO:0033119),0.24612084015862903,0.5738234356297425,0.9541547277936963,0.9896586228283961,1.0,6/19,24.64%,SRSF12;PTBP3;SAP18;SFSWAP;RBMX;PCBP4
prerank,gene silencing by miRNA (GO:0035195),0.21906683319379533,0.5734373368250697,0.9595448798988622,0.9895112377454449,1.0,6/32,17.64%,PUM1;TARBP2;TNRC6B;DICER1;MOV10;WTIP
prerank,regulation of T-helper 17 cell differentiation (GO:2000319),0.2725689932572794,0.5733027738387371,0.9312602291325696,0.9892393955275137,1.0,2/10,14.77%,RC3H2;NFKBIZ
prerank,myeloid cell development (GO:0061515),0.24315510244328786,0.5731496045391496,0.9512893982808023,0.9889912890937882,1.0,1/18,2.88%,TLR2
prerank,ubiquinone biosynthetic process (GO:0006744),0.2536720865650426,0.5725567834533429,0.9541547277936963,0.9889612714158271,1.0,2/15,6.89%,COQ8B;COQ6
prerank,regulation of mitochondrial membrane permeability (GO:0046902),0.24756788018031498,0.5723483650509248,0.9465541490857946,0.9887383903036462,1.0,4/18,19.60%,BCL2;THEM4;PPIF;SPG7
prerank,protein deneddylation (GO:0000338),0.26864833147799705,0.5719243753386514,0.9316493313521546,0.9886172401068893,1.0,3/10,23.58%,COPS7A;COPS6;COPS3
prerank,tryptophan metabolic process (GO:0006568),0.2679518115378394,0.5704776849302787,0.938622754491018,0.9890063754095602,1.0,2/11,21.20%,KYAT1;ATP7A
prerank,detection of chemical stimulus involved in sensory perception of taste (GO:0050912),0.26794201045130506,0.5703757451899181,0.942684766214178,0.9887082033714641,1.0,2/11,21.28%,RTP4;PKD1L3
prerank,2-oxoglutarate metabolic process (GO:0006103),0.2574782882789648,0.5703022461105735,0.9366715758468336,0.9884109495463909,1.0,4/13,25.13%,DLST;IDH2;ADHFE1;L2HGDH
prerank,snRNA transcription (GO:0009301),0.19889632460378956,0.5699031291345611,0.9887133182844243,0.9882712163562933,1.0,17/70,23.68%,POU2F1;USPL1;SNAPC3;GTF2F2;CDK9;CDK7;CCNT1;POLR2K;NCBP2;POLR2B;INTS1;RPAP2;GTF2F1;ELL2;TBP;POLR2L;INTS8
prerank,mitotic intra-S DNA damage checkpoint signaling (GO:0031573),-0.19864101123856664,-0.5693066415665038,0.967948717948718,0.9880350237182173,1.0,4/15,21.71%,TIPIN;HUS1;MUS81;MRE11
prerank,rRNA transcription (GO:0009303),0.2491989451803006,0.5685758332122902,0.9425770308123249,0.9886183056416588,1.0,5/17,27.09%,POLR1E;GTF3A;SIRT7;GTF3C4;BRF1
prerank,snRNA processing (GO:0016180),-0.20520439635052556,-0.567071247097295,0.9753521126760564,0.9875337344179704,1.0,6/16,28.67%,TUT1;INTS2;INTS11;INTS5;INTS3;INTS12
prerank,positive regulation of secretion (GO:0051047),-0.22380682942908395,-0.5665178370956961,0.9513677811550152,0.9864688191122838,1.0,1/11,4.30%,NPR1
prerank,ncRNA 3'-end processing (GO:0043628),0.2517886753481753,0.5664773578571186,0.9393063583815029,0.9893485685191054,1.0,5/14,27.31%,ERI1;TOE1;INTS8;INTS6;INTS14
prerank,sensory perception of smell (GO:0007608),0.2681329255820644,0.566072819866018,0.9423368740515933,0.9891912345173829,1.0,1/11,6.49%,SYT10
prerank,nucleobase-containing compound biosynthetic process (GO:0034654),-0.18912176910623474,-0.5653670378967743,0.9806949806949807,0.9855861791171843,1.0,6/19,23.68%,GMPR;APRT;DGUOK;CDA;POLD2;ADK
prerank,positive regulation of RNA metabolic process (GO:0051254),0.208688222856853,0.5643836591028569,0.9724220623501199,0.9896719978695481,1.0,18/45,28.50%,EGFR;PIK3R1;MAP2K1;NFKB1;NMD3;SETX;MAP2K2;DXO;LIN28B;SIRT7;BUD23;TGFB1;GRSF1;RIPK1;RBM22;DYRK1A;RELA;DIMT1
prerank,positive regulation of integrin activation (GO:0033625),-0.22331901140144017,-0.5635967834071478,0.9649595687331537,0.9849526296570289,1.0,1/11,4.05%,RASIP1
prerank,neuron projection organization (GO:0106027),0.2498242479256114,0.561769367498473,0.95900439238653,0.9905670680276416,1.0,7/15,30.20%,GSK3B;PSEN1;PICK1;ARF1;ABCD2;PRNP;ATP1A3
prerank,DNA biosynthetic process (GO:0071897),0.24634758263524048,0.5610178349256018,0.950937950937951,0.9905909737867226,1.0,2/16,12.10%,CDKN2D;TERT
prerank,fluid transport (GO:0042044),-0.2204807372691227,-0.5595902386848725,0.9695290858725761,0.9851427314654667,1.0,2/12,17.03%,AQP11;SLC26A6
prerank,cellular modified amino acid biosynthetic process (GO:0042398),0.23297461124636465,0.5586742872676747,0.9431664411366711,0.9913331452882116,1.0,5/20,22.23%,PLOD2;CNDP2;PTDSS2;GGCT;FPGS
prerank,positive regulation of branching involved in ureteric bud morphogenesis (GO:0090190),0.25511722041261065,0.5586611148609225,0.9431643625192012,0.9909972208307006,1.0,4/12,24.86%,GDNF;SMO;AGT;PAX8
prerank,positive regulation of cell aging (GO:0090343),0.258309009859759,0.5582336898513894,0.9424242424242424,0.9908467403645238,1.0,3/11,21.65%,EEF1E1;YPEL3;CGAS
prerank,phosphatidylethanolamine acyl-chain remodeling (GO:0036152),0.2261879844332725,0.557288008447703,0.9578947368421052,0.9909432285754022,1.0,5/23,21.63%,PLA2G5;PLA2G12A;PLA2G4A;LPCAT3;PLA2G4E
prerank,protein import into peroxisome membrane (GO:0045046),0.231539523362311,0.5571920021377602,0.9512855209742895,0.9906404056033431,1.0,8/22,26.94%,RAB8B;ALDH3A2;PEX19;FIS1;PEX5;ABCD2;PEX12;PXMP4
prerank,centromere complex assembly (GO:0034508),0.21203284309906478,0.5570603204103108,0.9659090909090909,0.9903537411603343,1.0,7/36,19.40%,CENPQ;CENPN;CENPT;RSF1;CENPL;RUVBL1;RBBP4
prerank,negative regulation of neuron differentiation (GO:0045665),-0.17337955581024161,-0.5567742477991363,0.9893617021276596,0.9848516145981605,1.0,2/22,8.57%,CNTN4;DTX1
prerank,tyrosine metabolic process (GO:0006570),0.2666115140727109,0.5559435546782258,0.9480916030534351,0.9905158495321948,1.0,1/11,8.39%,HGD
prerank,gliogenesis (GO:0042063),0.2426912695671064,0.5541555204002074,0.955617198335645,0.9909442072692767,1.0,2/15,9.47%,ANXA1;CDK6
prerank,regulation of phosphatase activity (GO:0010921),0.22886131336059404,0.5541410341498033,0.9696969696969697,0.9906106411828967,1.0,7/24,25.78%,PPP1R36;PPP1R2;CDK5RAP3;HTT;MTMR9;GPATCH2;PTPA
prerank,"positive regulation of mRNA splicing, via spliceosome (GO:0048026)",-0.19167329017283632,-0.5534998146011016,0.9834983498349835,0.9846528629572813,1.0,6/16,29.12%,NCL;DAZAP1;CIRBP;SF3B4;CELF4;NUP98
prerank,protein O-linked mannosylation (GO:0035269),0.23524146039056895,0.5518719101030991,0.9569444444444445,0.9912273325299087,1.0,3/18,14.36%,TMTC4;DPM2;POMT2
prerank,DNA replication initiation (GO:0006270),0.206764643690843,0.5507298069964252,0.9749687108886108,0.9913761798724191,1.0,7/37,22.02%,POLE3;MCM2;MCM7;DBF4;POLA2;LRWD1;ORC6
prerank,alpha-amino acid catabolic process (GO:1901606),0.21466114924582524,0.5499350166560131,0.9631043256997456,0.99135938555791,1.0,5/29,17.91%,ACADSB;HGD;KYAT1;THNSL2;ACAT1
prerank,iron-sulfur cluster assembly (GO:0016226),0.2210841397063818,0.5486772375728726,0.9733688415446072,0.9915293010906903,1.0,8/24,24.73%,FXN;MMS19;NUBP2;NUBP1;LYRM4;HSCB;ISCA2;ABCB7
prerank,regulation of chromatin binding (GO:0035561),0.26739598072411364,0.5468962715085812,0.958664546899841,0.9918977523650081,1.0,2/10,10.61%,KDM4D;DDX11
prerank,double-strand break repair via break-induced replication (GO:0000727),0.24918066961943847,0.5462695924158523,0.9492307692307692,0.9918051789311724,1.0,2/12,12.28%,MCM2;MCM7
prerank,indolalkylamine catabolic process (GO:0046218),0.26399723528781666,0.5459729632256864,0.9447077409162717,0.9915816200984894,1.0,1/10,11.46%,KYAT1
prerank,energy derivation by oxidation of organic compounds (GO:0015980),0.22125140815762145,0.5456225911545923,0.9565789473684211,0.9913808136127491,1.0,2/24,5.87%,PID1;GFPT2
prerank,tRNA metabolic process (GO:0006399),0.23844808105169749,0.5451071093084654,0.9628099173553719,0.9912419179067827,1.0,5/17,23.46%,TRPT1;POP1;DTD1;FARS2;YARS2
prerank,"nucleotide-excision repair, DNA damage recognition (GO:0000715)",0.22308734651000597,0.5444688655779156,0.9732262382864793,0.9911542832973687,1.0,9/23,28.47%,COPS7A;DDB1;PARP1;COPS6;RPS27A;RAD23B;COPS3;CUL4B;XPA
prerank,positive regulation of p38MAPK cascade (GO:1900745),0.22660503356328396,0.5439088991836705,0.9637096774193549,0.9910561262825555,1.0,7/22,28.99%,SASH1;PJA2;SPI1;XDH;GADD45A;RELL1;ZC3H12A
prerank,negative regulation of endoplasmic reticulum unfolded protein response (GO:1900102),0.24176302023342564,0.5438096640937344,0.9422222222222222,0.9907626811872626,1.0,4/13,22.49%,NCK1;PTPN1;DDRGK1;HSPA5
prerank,signal peptide processing (GO:0006465),0.2517669688777148,0.5436849898799416,0.9671150971599403,0.9904757820556869,1.0,3/11,18.94%,PCSK5;HM13;SPPL3
prerank,regulation of IRE1-mediated unfolded protein response (GO:1903894),0.23730978053849133,0.5422801812152122,0.9478260869565217,0.9906743141954911,1.0,4/14,22.49%,BAX;PTPN1;DDRGK1;HSPA5
prerank,B cell mediated immunity (GO:0019724),0.25965343676271335,0.5403194590774534,0.9473684210526315,0.9910865354451118,1.0,1/10,8.05%,FCGR2B
prerank,modulation by host of symbiont process (GO:0051851),0.20610577405494657,0.5399134758688742,0.981675392670157,0.9909079282570151,1.0,7/31,19.61%,HDAC1;CCL5;RRP1B;CCNT1;NUCKS1;SMARCB1;SMARCA4
prerank,nucleotide biosynthetic process (GO:0009165),0.22886767051207585,0.5393974929556496,0.962589928057554,0.9907646455816745,1.0,5/18,22.26%,ADSL;GART;PPAT;NMNAT2;RRM2B
prerank,phosphatidylethanolamine biosynthetic process (GO:0006646),0.243413912463807,0.5384340894329966,0.9712121212121212,0.9907960052099524,1.0,1/14,6.77%,CEPT1
prerank,modification-dependent macromolecule catabolic process (GO:0043632),0.2552892525814851,0.5349951218772234,0.9540412044374009,0.9917349457389804,1.0,5/10,27.58%,CHFR;DIS3L2;RPS27A;TUT7;ISG15
prerank,positive regulation of mRNA processing (GO:0050685),0.22488241310475127,0.5346010951904442,0.970310391363023,0.9915275246636529,1.0,7/21,22.89%,PRDX6;THRAP3;NCBP2;CDC73;TRA2A;RBMX;RBM3
prerank,spliceosomal snRNP assembly (GO:0000387),0.197599354623496,0.5342088620436772,0.9878787878787879,0.9913174328229178,1.0,11/38,26.82%,SMN1;SRSF12;COIL;PRMT5;TGS1;PRPF31;USP4;DDX20;SART3;GEMIN5;PRPF8
prerank,endoplasmic reticulum to cytosol transport (GO:1903513),0.23465441162227266,0.5341222539924194,0.9587628865979382,0.9910080314108858,1.0,6/15,31.47%,SELENOS;SYVN1;AUP1;VCP;DERL2;HSP90B1
prerank,telomere maintenance in response to DNA damage (GO:0043247),0.25868689691284175,0.5313907571192125,0.9491525423728814,0.9916498207673089,1.0,3/10,21.23%,DCLRE1C;RIF1;TERF2IP
prerank,mitochondrion transport along microtubule (GO:0047497),-0.19904515231511657,-0.5302655681649879,0.9841772151898734,0.9899664495169996,1.0,1/13,2.42%,LRPPRC
prerank,inositol phosphate biosynthetic process (GO:0032958),0.24816219004224063,0.5282692310458035,0.9552715654952076,0.9923779149743485,1.0,4/11,24.41%,ITPKC;FGF2;IP6K2;IPMK
prerank,transcription by RNA polymerase III (GO:0006383),0.20963901325956538,0.5281003371810405,0.9603580562659847,0.9921004153428677,1.0,11/27,28.11%,SNAPC3;POLR2K;GTF3A;CRCP;POLR3K;GTF3C4;TBP;POLR2L;BRF1;SNAPC5;ICE1
prerank,regulation of DNA recombination at telomere (GO:0072695),0.22052251994902589,0.5257242585211237,0.9739368998628258,0.9921985182470783,1.0,8/19,29.98%,ATRX;POLR2K;POLR2B;TERF2IP;POLR2L;TERF2;POLR2D;TERF1
prerank,negative regulation of DNA recombination at telomere (GO:0048239),0.22052251994902589,0.5257242585211237,0.9739368998628258,0.9921985182470783,1.0,8/19,29.98%,ATRX;POLR2K;POLR2B;TERF2IP;POLR2L;TERF2;POLR2D;TERF1
prerank,regulation of neutrophil migration (GO:1902622),0.24971291953648053,0.5244856262843548,0.9487951807228916,0.9922475195955552,1.0,1/10,6.18%,RAC1
prerank,intermediate filament organization (GO:0045109),0.22239548812051224,0.5216165538502471,0.9747191011235955,0.9928237696638816,1.0,4/17,20.59%,DNAJB6;NEFL;DES;MTM1
prerank,regulation of actin nucleation (GO:0051125),0.24264253678944978,0.5213457312297819,0.9747023809523809,0.9925641137882504,1.0,3/12,19.76%,WHAMM;PICK1;ARF1
prerank,carboxylic acid catabolic process (GO:0046395),0.24189741019476826,0.5176983752619829,0.9655172413793104,0.9933322052127957,1.0,5/12,27.91%,PON3;AMDHD2;GNPDA2;NPL;RENBP
prerank,T cell proliferation (GO:0042098),0.2331785300326051,0.5165251176322201,0.959479015918958,0.9933467822385904,1.0,3/13,15.25%,MSN;CTPS1;TNFRSF4
prerank,axonemal dynein complex assembly (GO:0070286),0.20275489848294007,0.5133259046758094,0.9805699481865285,0.9939313281467432,1.0,5/27,22.36%,DNAAF4;TTC12;ODAD1;DNAAF5;DNAL1
prerank,tRNA modification (GO:0006400),0.17507411347566176,0.5078302307211019,0.9942660550458715,0.9951195610334496,1.0,9/62,16.84%,TYW1;TRMT61B;ANKRD16;DTWD1;ALKBH1;METTL1;PUS3;WDR6;THUMPD3
prerank,ether lipid metabolic process (GO:0046485),0.2219846584226269,0.5064000733418985,0.9745889387144993,0.9951671037965579,1.0,2/14,8.96%,PLA2G7;DHRS7B
prerank,RNA modification (GO:0009451),0.18071325601504354,0.5060228174298844,0.9916765755053508,0.9949309644478825,1.0,20/54,29.46%,ANKRD16;DTWD1;PUS7L;ALKBH1;METTL1;PUS3;NOP2;MRM2;NAT10;RBM15;URM1;BCDIN3D;QTRT2;TRDMT1;TRMT61A;WDR4;NSUN4;PARN;FTSJ3;AARS1
prerank,positive regulation of cell cycle phase transition (GO:1901989),0.22406424008868897,0.5033972810635913,0.984081041968162,0.9953029997253748,1.0,5/15,28.89%,EZH2;CDC73;DDRGK1;GLI1;KLHL18
prerank,positive regulation of T cell receptor signaling pathway (GO:0050862),0.22130482408618102,0.4923054478541914,0.9784791965566715,0.9976111001201224,1.0,1/14,4.70%,PRKD2
prerank,interstrand cross-link repair (GO:0036297),0.1757151857448176,0.4912212715385228,0.994061757719715,0.9975074923937755,1.0,7/53,13.92%,ATR;XRCC3;DCLRE1C;RNF8;FANCE;MCM9;NUCKS1
prerank,tRNA 5'-end processing (GO:0099116),-0.17457069585651303,-0.48726801704741757,0.9867986798679867,0.9971610533783813,1.0,7/15,32.71%,POP5;RPP38;HSD17B10;RPP21;SSB;RPP25L;POP7
prerank,snRNA transcription by RNA polymerase II (GO:0042795),0.16949796038859968,0.4860985728765172,0.9966254218222722,0.998240477593404,1.0,21/69,28.11%,POU2F1;SNAPC3;GTF2F2;CDK9;CDK7;CCNT1;POLR2K;NCBP2;POLR2B;INTS1;RPAP2;GTF2F1;ELL2;TBP;POLR2L;INTS8;INTS6;INTS14;INTS4;SNAPC5;ICE1
prerank,peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine (GO:0018231),0.19713532088574282,0.48349128343892045,0.9820193637621023,0.9980658561978981,1.0,4/22,19.83%,ZDHHC3;CLIP3;ZDHHC9;ZDHHC6
prerank,peptidyl-L-cysteine S-palmitoylation (GO:0018230),0.19713532088574282,0.48349128343892045,0.9820193637621023,0.9980658561978981,1.0,4/22,19.83%,ZDHHC3;CLIP3;ZDHHC9;ZDHHC6
prerank,calcium-ion regulated exocytosis (GO:0017156),0.1905192922242579,0.4833866761561134,0.9882506527415144,0.9977507869798655,1.0,3/27,12.78%,SYT10;SYT2;SYT3
prerank,nucleoside phosphate biosynthetic process (GO:1901293),0.21449431219348447,0.4801949486832059,0.9730134932533733,0.9980121580932833,1.0,7/14,28.60%,AK8;NMNAT2;CMPK1;AK5;AK3;NME2;AK4
prerank,cell part morphogenesis (GO:0032990),0.21647706865320343,0.4800265127240148,0.9601837672281777,0.9977070836224835,1.0,4/13,25.67%,PID1;FIS1;MTM1;MYH14
prerank,piRNA metabolic process (GO:0034587),0.19599223604501823,0.473202650784062,0.9850136239782016,0.9986148891895941,1.0,1/19,6.79%,MYBL1
prerank,water transport (GO:0006833),-0.18341926901920894,-0.4729649491182362,0.9971671388101983,0.9977270367321692,1.0,2/12,21.03%,AQP11;CFTR
prerank,calcium-mediated signaling using intracellular calcium source (GO:0035584),0.19884132768689042,0.47178483947131145,0.9862258953168044,0.9985126160928611,1.0,4/19,18.44%,STIMATE;FKBP1B;PTPRJ;FIS1
prerank,regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway (GO:2001267),0.22824349509770614,0.4712720356786408,0.9821958456973294,0.9982599319603552,1.0,3/11,22.31%,LGALS9;CAAP1;PARK7
prerank,response to UV-B (GO:0010224),0.21516193373854198,0.46973321184693156,0.9836309523809523,0.9981968482113449,1.0,1/12,5.44%,MFAP4
prerank,cellular response to alkaloid (GO:0071312),-0.1599262993243874,-0.46895344855135623,0.9933554817275747,0.9968955488825031,1.0,11/17,45.14%,CASP3;RYR2;CASQ2;CASP6;TGM2;SPIDR;RYR3;BLM;CRHBP;SLC8A1;RYR1
prerank,DNA unwinding involved in DNA replication (GO:0006268),0.2054086578166399,0.467695920074394,0.9828080229226361,0.9981842813656544,1.0,2/16,12.28%,MCM2;MCM7
prerank,negative regulation of activated T cell proliferation (GO:0046007),0.22391928595278948,0.4655309595761264,0.9779874213836478,0.9981929498384636,1.0,1/10,8.51%,LGALS9
prerank,DNA replication checkpoint signaling (GO:0000076),0.19984085332321833,0.4649150306314708,0.9787234042553191,0.9979528902285061,1.0,1/16,3.96%,DNA2
prerank,regulation of transcription by RNA polymerase I (GO:0006356),0.19627656194029167,0.4644366061534552,0.9876373626373627,0.9976969964040462,1.0,6/18,27.02%,EIF2AK3;POLR2K;SIRT7;POLR2L;ATF4;LYAR
prerank,regulation of p38MAPK cascade (GO:1900744),0.1795816856349087,0.4643325834601456,0.9937965260545906,0.9973745306432208,1.0,4/35,12.11%,TREM2;LGALS9;SASH1;PJA2
prerank,regulation of T cell receptor signaling pathway (GO:0050856),0.17756907611105047,0.45856842381724444,0.9925465838509316,0.9978793590484815,1.0,5/33,17.11%,PRKD2;UBASH3A;THY1;PTPN2;PTPRJ
prerank,regulation of rhodopsin mediated signaling pathway (GO:0022400),0.17958881898855372,0.44862501569427377,0.9958448753462604,0.9988667245368663,1.0,6/23,27.33%,GUCA1B;METAP1;FNTB;GRK4;NMT1;CAMKMT
prerank,pyrimidine deoxyribonucleotide catabolic process (GO:0009223),-0.16490927928946858,-0.4341111077010009,0.9938461538461538,0.9983753158627937,1.0,3/13,16.90%,SMUG1;NT5C;OGG1
prerank,tryptophan catabolic process (GO:0006569),0.20417980834135432,0.43223948733555956,0.9938556067588326,1.0,1.0,1/11,11.46%,KYAT1
prerank,Golgi to plasma membrane protein transport (GO:0043001),0.1680444732581096,0.43096894354950877,0.9923371647509579,1.0,1.0,3/30,9.03%,SEC16A;RAB34;RAB10
prerank,dolichol-linked oligosaccharide biosynthetic process (GO:0006488),0.18417582417582418,0.4303712094834752,0.9959016393442623,0.9998629958782986,1.0,17/17,81.60%,SRD5A3;ALG6;ALG8;DPAGT1;ALG1;ALG14;ALG9;ALG2;MPDU1;ALG3;MVD;ALG13;NUS1;DOLPP1;DOLK;ALG12;DHDDS
prerank,atrial septum morphogenesis (GO:0060413),0.2037508215364999,0.4246097529503403,0.9904458598726115,1.0,1.0,2/10,20.07%,ACVR1;TGFB2
prerank,epithelial cell development (GO:0002064),0.17678407110384353,0.42420779007430603,0.9931693989071039,0.9997612289005824,1.0,3/20,18.44%,SIPA1L3;SLC4A7;DACT2
prerank,histone deubiquitination (GO:0016578),0.17976278579199967,0.4187775372482213,1.0,0.9998736889089712,1.0,2/18,12.95%,USP3;USP22
prerank,poly-N-acetyllactosamine biosynthetic process (GO:0030311),0.19122309720113617,0.414325593045902,0.9909365558912386,0.9998723963949355,1.0,3/12,25.99%,B3GALNT1;B3GNT9;B3GALT1
prerank,poly-N-acetyllactosamine metabolic process (GO:0030309),0.18918559825808526,0.41325137428752357,0.9985007496251874,0.9996133391311578,1.0,3/13,25.99%,B3GALNT1;B3GNT9;B3GALT1
prerank,telomere capping (GO:0016233),0.17437573852231314,0.4051649981371963,0.998546511627907,0.9998053942379407,1.0,4/16,21.90%,DCLRE1C;CTC1;TERF2IP;PRKDC
prerank,organelle disassembly (GO:1903008),0.154289098020768,0.4006198532215608,0.9987593052109182,0.9997217241355142,1.0,13/33,32.12%,KIF5B;MTIF2;UBA5;GBF1;DDRGK1;KIF9;ATG2A;MRRF;VCP;STX5;RB1CC1;ULK1;MCTS1
prerank,mitochondrial transcription (GO:0006390),0.19401464279482306,0.39976412673156875,0.9968992248062015,0.9994325209749947,1.0,5/10,30.70%,FOXO3;POLRMT;SLC25A33;TWNK;TEFM
prerank,negative regulation of type I interferon-mediated signaling pathway (GO:0060339),0.1737764046453108,0.3871080125756129,0.9985714285714286,0.9996725363987623,1.0,3/15,20.30%,YTHDF3;PTPN2;YTHDF2
prerank,copper ion homeostasis (GO:0055070),0.16928211532301926,0.38694216850502183,0.9986168741355463,0.9993451515827746,1.0,5/17,27.29%,SLC31A1;ARF1;ATP7A;COMMD1;PRNP
prerank,tRNA 5'-leader removal (GO:0001682),0.17053966632711773,0.3694462914676855,1.0,0.999592641946701,1.0,2/13,17.14%,POP1;POP4
prerank,cellular copper ion homeostasis (GO:0006878),0.1587630625975816,0.34973858042696804,0.9971264367816092,0.9996370723978351,1.0,3/14,21.20%,SLC31A1;ARF1;ATP7A
